[
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that the plan depends heavily on the stage and discusses localized vs metastatic disease."
      },
      {
        "criterion_number": 2,
        "description": "The response should include surgery as a preferred option for resectable tumors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes surgery as the best option for a potential cure when feasible (early, resectable disease) and outlines surgical procedures."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that chemotherapy is the backbone of treatment for metastatic or unresectable pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that for advanced/metastatic disease, chemotherapy is the primary treatment to control the cancer and extend life."
      },
      {
        "criterion_number": 4,
        "description": "The response should include radiation as a potential treatment option for localized disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains radiation can be used before or after surgery (localized settings) and as chemoradiation."
      },
      {
        "criterion_number": 5,
        "description": "The response should include the concept of resectability.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Uses the terms resectable, borderline resectable, and unresectable and discusses operability."
      },
      {
        "criterion_number": 6,
        "description": "The response should specify the main chemotherapy regimens used are FOLFIRINOX or Gemcitabine + Nab-Paclitaxel.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Names FOLFIRINOX and gemcitabine plus nab-paclitaxel (Abraxane) as common regimens."
      },
      {
        "criterion_number": 7,
        "description": "The response should include immunotherapy and that its role is currently limited to patients with mismatch repair deficiency or high microsatellite instability.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes immunotherapy is effective for a small subset with MSI-high or dMMR tumors."
      },
      {
        "criterion_number": 8,
        "description": "The response should include targeted therapy such as PARPi for patients with BRCA mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions PARP inhibitors (e.g., olaparib) for patients with BRCA mutations."
      },
      {
        "criterion_number": 9,
        "description": "The response should introduce the concept of clinical trials and their role in the management of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages considering clinical trials at any stage and clarifies they are not a last resort."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize that symptom management is an important part of the care of patients with pancreatic cancer and should highlight the importance of supportive care, including evaluation by a palliative care specialist and nutritional support.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a dedicated palliative care section, lists symptom management (pain, nausea, fatigue), mentions nutritional support, and includes palliative care specialists on the team."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that the treatment of pancreatic cancer depends on the location of the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes treatment planning considers tumor location and details surgical options based on head vs body/tail location."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that the NCCN Panel recommends that decisions about diagnosis and management involve multidisciplinary teams at high-volume centers with appropriate high-volume imaging studies.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions multidisciplinary care but does not reference NCCN recommendations, high-volume centers, or specialized high-volume imaging."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend discussing the treatment of pancreatic cancer with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises working with the oncology team, asking the oncologist about clinical trials, and seeking second opinions."
      }
    ],
    "question_number": 1,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T16:42:38.330888",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly notes that the best approach depends on stage (localized, locally advanced, metastatic) and repeatedly ties options to stage."
      },
      {
        "criterion_number": 2,
        "description": "The response should include surgery as a preferred option for resectable tumors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States surgery is the only potential curative option and indicates it's used for early-stage, resectable tumors."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that chemotherapy is the backbone of treatment for metastatic or unresectable pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "For locally advanced or metastatic disease, it emphasizes chemotherapy to control disease, improve symptoms, and extend life, effectively positioning it as the primary systemic therapy."
      },
      {
        "criterion_number": 4,
        "description": "The response should include radiation as a potential treatment option for localized disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes radiation and chemoradiation for locally advanced tumors and around surgery, as well as palliative indications."
      },
      {
        "criterion_number": 5,
        "description": "The response should include the concept of resectability.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Uses the terms resectable and borderline resectable and contrasts with locally advanced/metastatic."
      },
      {
        "criterion_number": 6,
        "description": "The response should specify the main chemotherapy regimens used are FOLFIRINOX or Gemcitabine + Nab-Paclitaxel.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly lists FOLFIRINOX and gemcitabine plus nab-paclitaxel as common regimens."
      },
      {
        "criterion_number": 7,
        "description": "The response should include immunotherapy and that its role is currently limited to patients with mismatch repair deficiency or high microsatellite instability.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States immunotherapy is effective for a small subset with MSI-High or dMMR and requires testing."
      },
      {
        "criterion_number": 8,
        "description": "The response should include targeted therapy such as PARPi for patients with BRCA mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions targeted therapy and gives PARP inhibitors for BRCA mutations as an example."
      },
      {
        "criterion_number": 9,
        "description": "The response should introduce the concept of clinical trials and their role in the management of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a dedicated Clinical Trials section encouraging discussion with the oncologist for access to new therapies."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize that symptom management is an important part of the care of patients with pancreatic cancer and should highlight the importance of supportive care, including evaluation by a palliative care specialist and nutritional support.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a Palliative/Supportive Care section stressing early integration; mentions pain management, nutrition, and names palliative care specialist and nutritionist."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that the treatment of pancreatic cancer depends on the location of the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists tumor location (head, body, tail) as a key factor and ties surgical approach (Whipple vs distal pancreatectomy) to location."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that the NCCN Panel recommends that decisions about diagnosis and management involve multidisciplinary teams at high-volume centers with appropriate high-volume imaging studies.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it recommends a multidisciplinary team and second opinions at major centers, it does not cite NCCN recommendations or mention high-volume imaging studies."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend discussing the treatment of pancreatic cancer with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises assembling a team including a medical oncologist and to discuss options and clinical trials with the oncologist."
      }
    ],
    "question_number": 1,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T16:43:01.131882",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Provide a direct link to a list of NCI-designated cancer centers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes a direct link to the NCI's 'Find a Cancer Center' page (https://www.cancer.gov/research/nci-role/cancer-centers), which is the authoritative list of NCI-designated centers."
      },
      {
        "criterion_number": 2,
        "description": "Discuss resectability, stating that major vessel (e.g., celiac artery) involvement generally precludes safe resection and requires evaluation at a specialized center.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response explains that involvement of major vessels makes surgery complex and sometimes not possible upfront and recommends specialized centers, it does not explicitly state that such involvement generally precludes safe resection."
      },
      {
        "criterion_number": 3,
        "description": "Emphasize the need for evaluation by a multidisciplinary clinic (surgical, medical, radiation oncology).",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly recommends a high-volume multidisciplinary team and lists key specialties including surgical oncology, medical oncology, and radiation oncology."
      },
      {
        "criterion_number": 4,
        "description": "State that neoadjuvant treatment may be proposed to shrink the tumor to resectable size, but some tumors may remain unresectable and only amenable to systemic therapy or radiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response mentions neoadjuvant chemotherapy/radiation to shrink the tumor before surgery but does not state that some tumors may remain unresectable and be managed only with systemic therapy or radiation."
      },
      {
        "criterion_number": 5,
        "description": "Explicitly state that some specialized centers can offer vascular reconstruction for tumors involving major blood vessels.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response specifies the need for surgeons with experience in vascular resection and reconstruction and includes questions about experience with celiac artery involvement, indicating availability of vascular reconstruction at specialized centers."
      },
      {
        "criterion_number": 6,
        "description": "Offer to search for high-volume pancreatic cancer programs by preferred location, asking for specific location details to tailor recommendations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response provides general resources and search strategies but does not ask for the user's location or offer to perform a tailored search."
      },
      {
        "criterion_number": 7,
        "description": "State that the NCCN Panel (version 2.2025) recommends that diagnosis and management decisions involve multidisciplinary teams at high-volume centers with appropriate high-volume imaging.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not reference NCCN, version 2.2025, or its recommendations regarding multidisciplinary management at high-volume centers and imaging."
      }
    ],
    "question_number": 2,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T16:43:22.118504",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must provide a direct link to a list of NCI-designated cancer centers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes the direct NCI link: https://www.cancer.gov/research/nci-role/cancer-centers/find."
      },
      {
        "criterion_number": 2,
        "description": "The response must discuss the concept of resectability in pancreatic cancer, stating that involvement of major blood vessels like the celiac artery generally precludes safe resection and requires evaluation at a specialized center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that celiac artery involvement often means 'borderline resectable' or 'unresectable' upfront and emphasizes the need for evaluation at experienced centers."
      },
      {
        "criterion_number": 3,
        "description": "The response must emphasize the need for evaluation by a multidisciplinary clinic, including surgical, medical, and radiation oncology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advocates for a multidisciplinary team and lists surgical, medical, and radiation oncology among other disciplines."
      },
      {
        "criterion_number": 4,
        "description": "The response must clearly state that neoadjuvant treatment may be proposed to shrink the tumor to a resectable size, but some tumors may remain unresectable and only amenable to systemic therapy or radiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While neoadjuvant therapy is discussed as a strategy to potentially make tumors resectable, the response does not clearly state that some tumors will remain unresectable and only be treated with systemic therapy or radiation."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly state that some specialized centers can offer vascular reconstruction for tumors involving major blood vessels.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions that specialized centers may perform vascular resections and reconstructions to achieve clear margins."
      },
      {
        "criterion_number": 6,
        "description": "The response must offer to search for high-volume pancreatic cancer programs by preferred location, asking for specific location details to tailor recommendations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It requests the friend\u2019s location to provide specific recommendations and offers to help identify centers based on that information."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that the NCCN Panel (version 2.2025) recommends that decisions about diagnosis and management involve multidisciplinary teams at high-volume centers with appropriate high-volume imaging studies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of the NCCN Panel, version 2.2025, or the specific recommendation regarding high-volume centers and imaging."
      }
    ],
    "question_number": 2,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T16:43:41.438348",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Include an overview of the criteria for resection of the tumor and why patients are deemed not to be good candidates for surgery.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response identifies key factors influencing surgical candidacy, including tumor location near major blood vessels/critical organs, tumor response to chemo/radiation, radiation-related tissue changes increasing surgical risk, and overall health/ability to recover. While not pancreas-specific or exhaustive, it provides a clear overview of reasons surgery may not be advisable."
      },
      {
        "criterion_number": 2,
        "description": "Indicate that the case should be discussed at a multidisciplinary tumor board.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly highlights that high-volume academic centers have multidisciplinary tumor boards that review complex cases and devise strategies, indicating the patient\u2019s case should be considered in that forum."
      },
      {
        "criterion_number": 3,
        "description": "Indicate that the patient could seek a second opinion at another specialized center.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly recommends obtaining a second opinion from a surgical oncologist at a high-volume, NCI-designated comprehensive cancer center, emphasizing specialization and experience."
      },
      {
        "criterion_number": 4,
        "description": "Provide a list of specialized centers that offer second opinions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response provides a link to the NCI center finder and mentions advocacy organizations but does not list specific centers by name, so it does not meet the requirement to provide a list."
      },
      {
        "criterion_number": 5,
        "description": "Recommend that the person discuss surgery with the current oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises scheduling a dedicated meeting with the current oncology and surgical teams to understand the reasons surgery is not recommended."
      },
      {
        "criterion_number": 6,
        "description": "Recommend the person ask their current oncology team if there are specific metrics they need to achieve to be eligible for surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly suggests asking, \u201cWhat specific benchmarks or changes would need to occur for you to reconsider surgery?\u201d which directly addresses the need to identify measurable criteria for surgical eligibility."
      }
    ],
    "question_number": 3,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T16:44:02.890946",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include an overview of the criteria for resection of the tumor and why patients are deemed not to be good candidates for surgery.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions general reasons a surgeon might be uncomfortable (size, location near vessels, invasiveness, overall health, risk\u2013benefit) but does not provide an overview of pancreatic cancer resectability criteria (e.g., vascular involvement thresholds of SMA/SMV/portal vein/celiac axis, metastatic disease status, performance status, or response to neoadjuvant therapy). It instructs the patient to ask their team rather than outlining criteria, so it does not meet the requirement."
      },
      {
        "criterion_number": 2,
        "description": "The response should indicate that the case should be discussed at a multidisciplinary tumor board.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly asks whether the case has been discussed by a multidisciplinary tumor board and advises requesting this if it has not."
      },
      {
        "criterion_number": 3,
        "description": "The response should indicate that the patient could seek a second opinion at another specialized center.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It strongly recommends seeking a second (or third) opinion at major cancer centers and NCI-designated comprehensive cancer centers."
      },
      {
        "criterion_number": 4,
        "description": "The response should provide a list of specialized centers that offer second opinions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It references NCI-designated centers and major academic medical centers and suggests visiting the NCI website but does not provide a concrete list of named institutions."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend that the person discuss surgery with the current oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises scheduling a dedicated meeting with the oncologist and surgeon to discuss why surgery is not recommended and to review next steps."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend the person ask their current oncology team if there are specific metrics they need to achieve to be eligible for surgery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests asking for reasons and next steps, it does not explicitly recommend asking about specific, measurable criteria or metrics (e.g., degree of vascular involvement, CA 19-9 response, imaging changes, performance status) required to become a surgical candidate."
      }
    ],
    "question_number": 3,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T16:44:25.387383",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should list PANCAN Online Community as an option.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions the Pancreatic Cancer Action Network (PanCAN) and references their Support Community via a PanCAN-run private Facebook group and peer-to-peer connections, presenting PanCAN as an online community option."
      },
      {
        "criterion_number": 2,
        "description": "The response should include the American Cancer Society (ACS) online community as an option.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of the American Cancer Society or its online community."
      },
      {
        "criterion_number": 3,
        "description": "The response should include CancerCare Online Support Groups as an option.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists CancerCare and describes their professionally led online support groups and counseling."
      },
      {
        "criterion_number": 4,
        "description": "The response should include various Facebook support groups.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes a dedicated section on Facebook groups with search terms and expectations."
      },
      {
        "criterion_number": 5,
        "description": "The response should affirm that there are many online support groups for families of pancreatic cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Affirmatively states there are many excellent online support groups for family members and caregivers."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend talking to your family member\u2019s oncology about support groups.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Advises verifying medical information with the healthcare team but does not recommend speaking with the oncology team specifically about support groups."
      }
    ],
    "question_number": 4,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T16:44:47.130147",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should list PANCAN Online Community as an option.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes Pancreatic Cancer Action Network (PanCAN) and explicitly mentions an 'Online Community' where caregivers can connect, along with PanCAN Patient Central and Survivor & Caregiver Network, meeting the requirement to list a PanCAN online community option."
      },
      {
        "criterion_number": 2,
        "description": "The response should include the American Cancer Society (ACS) online community as an option.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response lists the American Cancer Society Cancer Survivors Network and provides the csn.cancer.org link, clearly meeting this criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response should include CancerCare Online Support Groups as an option.",
        "score_given": 10,
        "max_points": 10,
        "justification": "CancerCare is explicitly mentioned with a description of its online, professionally moderated support groups and a link to the website."
      },
      {
        "criterion_number": 4,
        "description": "The response should include various Facebook support groups.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response has a dedicated Facebook Groups section, suggests specific search terms, and provides tips for selecting groups, satisfying the criterion."
      },
      {
        "criterion_number": 5,
        "description": "The response should affirm that there are many online support groups for families of pancreatic cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The opening lines clearly affirm the existence of several online support groups for family members and caregivers of pancreatic cancer patients."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend talking to your family member\u2019s oncology about support groups.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response advises consulting the medical team for medical questions, it does not specifically recommend asking the oncology team about support group options."
      }
    ],
    "question_number": 4,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T16:45:02.819941",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should indicate that while chronic pancreatitis is a risk factor for pancreatic cancer, it is still not common to develop pancreatic cancer even in patients with pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states chronic pancreatitis increases risk but emphasizes that the vast majority with chronic pancreatitis do not develop pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should offer support for having experienced the symptoms of chronic pancreatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides empathetic support and practical management tips (no alcohol, no smoking, low-fat diet, small frequent meals, hydration), acknowledging challenges of chronic pancreatitis."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the potential signs and symptoms of pancreatic cancer, which could include unintentional weight loss, jaundice, steatorrhea, new onset diabetes, and worsening of abdominal symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists multiple relevant red flags: jaundice (with dark urine and pale/greasy stools), unexplained weight loss, new/worsening abdominal or back pain, loss of appetite/early satiety, new-onset diabetes, nausea/vomiting, and blood clots."
      },
      {
        "criterion_number": 4,
        "description": "The response should outline at least three options for obtaining medical attention without insurance or for low-income adults, such as Federally Qualified Health Centers, community health clinics, Medicaid, or ACA marketplace plans, and should include specific examples or resources when possible.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides multiple options with specifics: FQHCs/community health centers (with HRSA link), hospital financial assistance/charity care with instructions, Medicaid via Healthcare.gov, PanCAN Patient Central with phone number, and teaching hospitals."
      },
      {
        "criterion_number": 5,
        "description": "The response should indicate that a consultation with a physician who may obtain labs, perform a physical exam, and obtain imaging studies such as a CT scan would be warranted.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Encourages connecting with a provider but does not specify that evaluation would include labs, physical exam, or imaging (e.g., CT)."
      },
      {
        "criterion_number": 6,
        "description": "The response should offer information on how to sign up for Medicaid and provide more specific instructions and information about eligibility depending on the state the person resides in.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes eligibility depends on income and state rules and directs the user to apply via Healthcare.gov or the state Medicaid agency, satisfying instruction and state-variation components."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends discussing financial concerns with a doctor, including at least one practical suggestion (e.g., payment plans, charity care).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides practical suggestions (charity care) but does not explicitly recommend discussing financial concerns with a doctor; advice is directed to hospital billing/financial assistance offices."
      }
    ],
    "question_number": 5,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T16:45:30.783778",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Indicate that while chronic pancreatitis is a risk factor for pancreatic cancer, it is still not common to develop pancreatic cancer even in patients with pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states chronic pancreatitis is a risk factor and adds, \"most people with chronic pancreatitis do not develop pancreatic cancer,\" which directly fulfills the criterion."
      },
      {
        "criterion_number": 2,
        "description": "Offer support for having experienced the symptoms of chronic pancreatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response provides empathetic support (e.g., \"I'm so incredibly sorry... That's an incredibly tough position to be in\") and acknowledges the overlap and burden of symptoms, meeting the supportive tone requirement."
      },
      {
        "criterion_number": 3,
        "description": "Describe the potential signs and symptoms of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists key symptoms: abdominal pain, unintentional weight loss, jaundice with associated findings, new-onset/worsening diabetes, loss of appetite/early satiety, nausea/vomiting, fatigue, and fatty stools (steatorrhea)."
      },
      {
        "criterion_number": 4,
        "description": "Outline at least three options for obtaining medical attention without insurance or for low-income adults, with specific examples/resources when possible.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It provides five concrete options: FQHCs/community health centers (including HRSA Find a Health Center), hospital financial assistance/charity care, local health departments, patient advocacy organizations (NPF, PanCAN), and medical schools/teaching hospitals."
      },
      {
        "criterion_number": 5,
        "description": "Indicate that a consultation with a physician who may obtain labs, perform a physical exam, and obtain imaging studies such as a CT scan would be warranted.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes getting evaluated by a doctor and details the visit: history, physical exam, labs (LFTs, amylase/lipase, CA 19-9, glucose), and imaging (contrast CT, MRI/MRCP, EUS), plus specialist referral."
      },
      {
        "criterion_number": 6,
        "description": "Offer information on how to sign up for Medicaid and provide instructions/eligibility details depending on the state.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Medicaid or ACA enrollment is not mentioned and no state-specific eligibility or sign-up instructions are provided."
      },
      {
        "criterion_number": 7,
        "description": "Explicitly recommend discussing financial concerns with a doctor, including at least one practical suggestion (e.g., payment plans, charity care).",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it provides practical suggestions (charity care, financial counselors, sliding-scale clinics), it does not explicitly recommend discussing financial concerns with a doctor."
      }
    ],
    "question_number": 5,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T16:45:54.890182",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should provide support and note that it is normal to feel overwhelmed under the circumstance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response opens with empathetic language, explicitly validating that feeling helpless and overwhelmed is normal and understandable. It continues with supportive guidance and reassurance throughout."
      },
      {
        "criterion_number": 2,
        "description": "The answer should provide links to websites that give more information on pancreatic cancer that are written at the level of patients and their families.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes patient-facing resources with links: PanCAN (pancan.org), National Cancer Institute (cancer.gov/types/pancreatic), and American Cancer Society (cancer.org). These are appropriate, reliable, and accessible to patients and families."
      },
      {
        "criterion_number": 3,
        "description": "The response should provide information about online support groups for pancreatic cancer patients and caregivers, including those offered by the Pancreatic Cancer Action Network (PanCAN), the American Cancer Society (ACS), and CancerCare.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response mentions PanCAN and ACS generally (and provides a PanCAN helpline), it does not specifically mention online support groups nor does it mention CancerCare at all. Therefore it does not meet the criterion as stated."
      }
    ],
    "question_number": 6,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T16:46:06.303825",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should provide support and note that it is normal to feel overwhelmed under the circumstance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response opens with empathetic language, explicitly normalizes feeling helpless and overwhelmed, and offers supportive, practical guidance throughout. Tone and content are appropriate and compassionate."
      },
      {
        "criterion_number": 2,
        "description": "The answer should provide links to websites that give more information on pancreatic cancer that are written at the level of patients and their families.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes patient-oriented resources with URLs: PanCAN.org, cancer.gov (NCI), cancer.org (ACS), and cancersupportcommunity.org. These are reputable, accessible sources for patients and families."
      },
      {
        "criterion_number": 3,
        "description": "The response should provide information about online support groups for pancreatic cancer patients and caregivers, including those offered by the Pancreatic Cancer Action Network (PanCAN), the American Cancer Society (ACS), and CancerCare.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions support groups generally and notes PanCAN\u2019s patient services/network, it does not mention CancerCare at all and does not specifically identify ACS online support group offerings. Therefore, it does not meet the requirement to include PanCAN, ACS, and CancerCare."
      }
    ],
    "question_number": 6,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T16:46:18.426080",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should provide a link to ClinicalTrials.gov for information on clinical trial options.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions ClinicalTrials.gov but does not provide a direct hyperlink or URL (e.g., https://clinicaltrials.gov). Other resources include clickable links, but not this one."
      },
      {
        "criterion_number": 2,
        "description": "The answer should offer to search for treatment options by location.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response suggests resources (e.g., PanCAN) that can perform a personalized search based on location but does not explicitly offer that the responder will search by location."
      },
      {
        "criterion_number": 3,
        "description": "The response should explicitly suggest obtaining a second opinion from another oncologist or major cancer center and provide a list of leading cancer centers that offer second opinion consultations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response advises consulting the oncologist and checking major cancer centers\u2019 websites but does not explicitly recommend obtaining a second opinion nor provide a list of specific leading centers."
      },
      {
        "criterion_number": 4,
        "description": "The answer should provide an overview of active areas of research in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly outlines multiple active research areas: targeted therapies (PARP, KRAS, NTRK), immunotherapy (checkpoint inhibitors, combinations), novel drug combinations/delivery (e.g., nanoparticle-based), and cancer vaccines/cell therapies (personalized mRNA, CAR-T) with examples."
      },
      {
        "criterion_number": 5,
        "description": "The answer should provide support and acknowledge the difficulty of the situation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response opens with empathetic language, validates the difficulty, and includes supportive guidance (e.g., palliative/supportive care discussion)."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly recommend discussing clinical trial options and eligibility with the oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly advises discussing trials with the oncology team, including a dedicated section to talk to the oncologist and a disclaimer emphasizing consultation for eligibility and options."
      }
    ],
    "question_number": 7,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T16:46:33.920900",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should provide a link to ClinicalTrials.gov for information on clinical trial options.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly references ClinicalTrials.gov as the official U.S. government website for clinical trials and describes how to use it, effectively providing the link/resource for trial information."
      },
      {
        "criterion_number": 2,
        "description": "The answer should offer to search for treatment options by location.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions resources (ClinicalTrials.gov, PanCAN) that allow location-based searches, it does not offer to perform or assist with a location-specific search."
      },
      {
        "criterion_number": 3,
        "description": "The response should explicitly suggest obtaining a second opinion from another oncologist or major cancer center and provide a list of leading cancer centers that offer second opinion consultations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It recommends seeking a second opinion at a major academic cancer center but does not provide a list of leading centers that offer second opinions."
      },
      {
        "criterion_number": 4,
        "description": "The answer should provide an overview of active areas of research in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It gives a comprehensive overview, including genomic profiling targets (BRCA, NTRK, KRAS G12C, HER2, BRAF), MSI-H/dMMR immunotherapy, checkpoint inhibitors and combinations, CAR T/adoptive cell therapy, vaccines, targeted therapies, novel chemotherapy combinations, oncolytic viruses, and stroma-targeting approaches."
      },
      {
        "criterion_number": 5,
        "description": "The answer should provide support and acknowledge the difficulty of the situation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response expresses empathy and support at the outset and throughout, and emphasizes quality of life and palliative care considerations."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly recommend discussing clinical trial options and eligibility with the oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises consulting the oncology team about genomic results, targeted therapies, and clinical trial options, and emphasizes the oncologist's role in identifying appropriate trials and eligibility."
      }
    ],
    "question_number": 7,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T16:46:59.381608",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should provide support and acknowledge that feeling overwhelmed under the circumstances is understandable and valid.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response opens with empathetic language, explicitly validates feeling overwhelmed as normal and assures the reader they are not alone."
      },
      {
        "criterion_number": 2,
        "description": "The answer should provide an overview of what a Stage IV diagnosis entails.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it acknowledges Stage IV and suggests asking where it has spread, it does not explain that Stage IV is metastatic disease, typically not surgically curable, and generally requires systemic therapy with palliative intent."
      },
      {
        "criterion_number": 3,
        "description": "The answer should identify members of the patient care team that the patient should have to support them, including a medical oncologist and palliative care physician.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly identifies the oncologist and strongly recommends early palliative care. It also references nurses, social workers, and a dietitian."
      },
      {
        "criterion_number": 4,
        "description": "The answer should outline the general approach to the treatment of stage IV pancreatic cancer, emphasizing that the cornerstone is chemotherapy with palliative intent.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it lists treatment options (chemotherapy, targeted therapy, immunotherapy) and discusses goals, it does not state that chemotherapy is the mainstay of treatment for stage IV disease nor explicitly frame it as palliative-intent systemic therapy."
      },
      {
        "criterion_number": 5,
        "description": "The response should emphasize the importance of support and community for both patients and caregivers, and should mention the Pancreatic Cancer Action Network (PanCAN), the American Cancer Society (ACS), and CancerCare as key resources for online support groups.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It emphasizes support for patients and caregivers and mentions PanCAN and ACS, but does not mention CancerCare or specifically highlight these as key resources for online support groups."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly recommend discussing the diagnosis and next steps with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises scheduling a first oncology follow-up to discuss the diagnosis and potential treatment plan and provides questions for the oncologist."
      }
    ],
    "question_number": 8,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T16:47:13.794953",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should provide support and acknowledge that feeling overwhelmed under the circumstances is understandable and valid.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response opens with strong empathy, validates that feeling overwhelmed, frightened, and lost is natural, and encourages self-compassion. This clearly acknowledges and normalizes the emotional reaction."
      },
      {
        "criterion_number": 2,
        "description": "The answer should provide an overview of what a Stage IV diagnosis entails.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that stage IV indicates metastasis to distant organs and that the disease is generally not curable, shifting focus to symptom management and quality of life. This is accurate and appropriately framed."
      },
      {
        "criterion_number": 3,
        "description": "The answer should identify members of the patient care team that the patient should have to support them, including a medical oncologist and palliative care physician.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response identifies the oncologist, nurse navigator, social worker, and explicitly recommends connecting with palliative care early. While it says \"palliative care team\" rather than \"palliative care physician,\" it clearly encompasses the requisite roles, including the medical oncologist."
      },
      {
        "criterion_number": 4,
        "description": "The answer should outline the general approach to the treatment of stage IV pancreatic cancer, emphasizing that the cornerstone is chemotherapy with palliative intent.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states chemotherapy is often the primary treatment in stage IV to slow growth and manage symptoms, lists common regimens, and emphasizes palliative goals and quality of life. This reflects chemotherapy with palliative intent."
      },
      {
        "criterion_number": 5,
        "description": "The response should emphasize the importance of support and community for both patients and caregivers, and should mention the Pancreatic Cancer Action Network (PanCAN), the American Cancer Society (ACS), and CancerCare as key resources for online support groups.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response emphasizes support and mentions PanCAN and Cancer Support Community, it does not mention the American Cancer Society (ACS) or CancerCare specifically as key resources. Therefore it does not meet the full requirement."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly recommend discussing the diagnosis and next steps with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises an initial meeting with the medical team, specifically the oncologist, and provides detailed guidance on questions to discuss and logistics (bring someone, record, timeline for starting treatment). This fulfills the criterion."
      }
    ],
    "question_number": 8,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T16:47:29.066808",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer must recommend discussing vitamins and supplements with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly and repeatedly emphasizes discussing any vitamin, supplement, or herbal remedy with the oncology team before starting, stopping, or changing them, citing reasons like interactions and safety."
      },
      {
        "criterion_number": 2,
        "description": "The answer must recommend maintaining a healthy and balanced diet.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response discusses nutrition support (protein shakes) and suggests referral to an oncology dietitian, it does not explicitly recommend maintaining a healthy and balanced diet."
      },
      {
        "criterion_number": 3,
        "description": "The answer must explicitly state that any diet or high-dose vitamins claiming to cure cancer should be avoided.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response cautions against high-dose antioxidants during treatment and St. John\u2019s Wort for interactions, but it does not explicitly state that any diet or high-dose vitamins claiming to cure cancer should be avoided."
      },
      {
        "criterion_number": 4,
        "description": "The answer must mention the benefit of pancreatic enzyme replacement therapy for pancreatic cancer patients.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Pancreatic enzyme replacement therapy (PERT) is discussed as often necessary, a standard part of care, and beneficial for malabsorption symptoms such as oily stools, bloating, and weight loss."
      },
      {
        "criterion_number": 5,
        "description": "The response must specify that due to malabsorption in pancreatic cancer, supplementation of fat-soluble vitamins (A, D, E, and K) is recommended, and should note that lab-confirmed vitamin deficiencies can be improved with appropriate vitamin supplements under the direction of a doctor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains that fat malabsorption can lead to deficiencies in A, D, E, and K, highlights the importance of vitamin D, and explicitly notes that doctors can check levels with blood tests and recommend dosing."
      },
      {
        "criterion_number": 6,
        "description": "The answer must state that pancreatic enzyme deficiency is common in patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it states malnutrition and digestive distress are extremely common and that PERT is standard for many patients, it does not explicitly state that pancreatic enzyme deficiency itself is common."
      }
    ],
    "question_number": 9,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T16:47:50.902946",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer must recommend discussing vitamins and supplements with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly and repeatedly emphasizes discussing any supplement with the oncology team (doctor, dietitian, pharmacist) before starting, and highlights interaction risks."
      },
      {
        "criterion_number": 2,
        "description": "The answer must recommend maintaining a healthy and balanced diet.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends focusing on whole, nutrient-dense foods and consulting an oncology dietitian, stating supplements should not replace a good diet."
      },
      {
        "criterion_number": 3,
        "description": "The answer must explicitly state that any diet or high-dose vitamins claiming to cure cancer should be avoided.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it cautions about lack of evidence and toxicity of high-dose fat-soluble vitamins, it does not explicitly state to avoid any diet or high-dose vitamins that claim to cure cancer."
      },
      {
        "criterion_number": 4,
        "description": "The answer must mention the benefit of pancreatic enzyme replacement therapy for pancreatic cancer patients.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It discusses PERT (Creon, Zenpep, Pancreaze) as essential for many with EPI, explaining benefits for nutrient absorption, GI symptoms, weight, and quality of life."
      },
      {
        "criterion_number": 5,
        "description": "The response must specify that due to malabsorption in pancreatic cancer, supplementation of fat-soluble vitamins (A, D, E, and K) is recommended, and should note that lab-confirmed vitamin deficiencies can be improved with appropriate vitamin supplements under the direction of a doctor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It links EPI-related fat malabsorption to common deficiencies in vitamins A, D, E, and K, and advises regular testing with supplementation guided by the physician based on results."
      },
      {
        "criterion_number": 6,
        "description": "The answer must state that pancreatic enzyme deficiency is common in patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states pancreatic cancer often leads to EPI and frames PERT as essential for most affected patients, conveying that enzyme deficiency is common."
      }
    ],
    "question_number": 9,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T16:48:14.636279",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend that the patient discuss their goals of care and potential treatment side effects with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises clarifying the goal of chemotherapy with the oncologist, asks whether treatment is working, and whether side effects are typical versus severe, and to consult the oncology team in decision-making."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the decision to continue with chemotherapy treatments is highly personal.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States there is no single right answer, emphasizes honoring the patient's wishes, and frames the decision as personal and values-based."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that changes to the chemotherapy dose can improve side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically suggests lowering the dose to make treatment more tolerable."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that changes to the chemotherapy schedule can improve side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly suggests changing the schedule (e.g., every four weeks instead of three) to improve tolerability."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that changes to supportive medications can improve side effect symptoms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Discusses aggressive side effect management and palliative care expertise but does not explicitly state that adjusting supportive medications (e.g., antiemetics, pain meds) can improve side effects."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend the patient ask for a referral to a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly recommends asking for a palliative care referral and explains its role distinct from hospice."
      },
      {
        "criterion_number": 7,
        "description": "The response should start with an expression of sympathy and support.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Begins with a direct and compassionate expression of sympathy for the situation."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that deferring further cancer-directed treatment and pursuing palliative care and hospice would be a valid approach.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that stopping treatment is a valid and compassionate choice and describes hospice as an appropriate option with supportive services."
      }
    ],
    "question_number": 10,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T16:48:48.727208",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend that the patient discuss their goals of care and potential treatment side effects with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises scheduling an urgent meeting with the oncologist, reviewing goals of care, and detailing specific side effects to guide decisions."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the decision to continue with chemotherapy treatments is highly personal.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states the decision is deeply personal and centers on the patient's values and wishes."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that changes to the chemotherapy dose can improve side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests discussing lower doses as a way to reduce side effects while maintaining potential benefit."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that changes to the chemotherapy schedule can improve side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions using a different schedule and considering a chemo break (\u201cchemo holiday\u201d) to allow recovery from side effects."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that changes to supportive medications can improve side effect symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends stronger anti-nausea medications, pain management, appetite stimulants, and nerve pain medications to manage side effects."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend the patient ask for a referral to a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly urges engaging palliative care now and involving a palliative care specialist in discussions."
      },
      {
        "criterion_number": 7,
        "description": "The response should start with an expression of sympathy and support.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It opens with clear empathy and acknowledgment of the difficult situation."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that deferring further cancer-directed treatment and pursuing palliative care and hospice would be a valid approach.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it validates stopping treatment and focusing on comfort and palliative care, it does not explicitly mention hospice as a valid option."
      }
    ],
    "question_number": 10,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T16:49:27.254174",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should specify that somatic testing can be done on the tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions testing the tumor tissue (somatic testing) and explains what somatic testing detects."
      },
      {
        "criterion_number": 2,
        "description": "The answer should specify that germline testing is appropriate.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly recommends germline testing via blood/saliva, explains inherited mutations, and suggests genetic counseling and family implications."
      },
      {
        "criterion_number": 3,
        "description": "The answer should discuss testing for BRCA mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically discusses BRCA1/BRCA2 (and PALB2) as key hereditary mutations to test."
      },
      {
        "criterion_number": 4,
        "description": "The answer should discuss the role of utilizing PARP inhibitors in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes PARP inhibitors (e.g., olaparib) for BRCA/PALB2 mutations and mentions their role as maintenance therapy."
      },
      {
        "criterion_number": 5,
        "description": "The answer should include an overview of testing for microsatellite instability and MSI status, which can be a marker for response to immunotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Discusses MSI-H/dMMR and TMB-H as markers and links them to checkpoint inhibitor immunotherapy (e.g., pembrolizumab)."
      },
      {
        "criterion_number": 6,
        "description": "The answer should include other potential targetable mutations such as HER2/ERBB2 amplification and NTRK.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions NTRK fusions and other rare fusions (ALK, ROS1) but does not mention HER2/ERBB2 amplification."
      },
      {
        "criterion_number": 7,
        "description": "The answer should specify that clinical trials may be available for less commonly targeted mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages asking about clinical trials based on the genetic profile, implying availability for rare targets."
      }
    ],
    "question_number": 11,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T16:49:51.138822",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should specify that somatic testing can be done on the tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly distinguishes somatic testing as testing of the tumor tissue and discusses samples (biopsy, existing tissue, liquid biopsy) and NGS panels."
      },
      {
        "criterion_number": 2,
        "description": "The answer should specify that germline testing is appropriate.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly addresses germline testing, why it might be recommended, implications for family members, and involvement of a genetic counselor."
      },
      {
        "criterion_number": 3,
        "description": "The answer should discuss testing for BRCA mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "BRCA1/2 are specifically named as genes to test for, with discussion of their implications."
      },
      {
        "criterion_number": 4,
        "description": "The answer should discuss the role of utilizing PARP inhibitors in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response connects BRCA mutations to the potential use of PARP inhibitors as a treatment option."
      },
      {
        "criterion_number": 5,
        "description": "The answer should include an overview of testing for microsatellite instability and MSI status, which can be a marker for response to immunotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "MSI-H testing is explicitly mentioned along with its relevance to considering immunotherapy."
      },
      {
        "criterion_number": 6,
        "description": "The answer should include other potential targetable mutations such as HER2/ERBB2 amplification and NTRK.",
        "score_given": 0,
        "max_points": 10,
        "justification": "NTRK fusions are mentioned, but HER2/ERBB2 amplification is not addressed; therefore the criterion is not fully met."
      },
      {
        "criterion_number": 7,
        "description": "The answer should specify that clinical trials may be available for less commonly targeted mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clinical trials are discussed as an option if actionable mutations are found and also if none are found, emphasizing trials for mutation-driven approaches."
      }
    ],
    "question_number": 11,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T16:50:12.307079",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should recommend that the patient consult a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises, \"Request a Referral to a Genetic Counselor,\" and details the counselor\u2019s role in risk assessment and genetic testing."
      },
      {
        "criterion_number": 2,
        "description": "The answer should state that there is no widely accepted protocol for pancreatic cancer screening.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes screening is not recommended for the general population, it does not explicitly state that there is no widely accepted screening protocol; rather, it outlines surveillance plans for high-risk individuals."
      },
      {
        "criterion_number": 3,
        "description": "The answer should state that high-risk patients can undergo screening imaging studies, such as CT or MRI, after discussion with physicians.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response recommends surveillance for high-risk individuals with imaging (EUS and MRI/MRCP) managed by specialists and coordinated with physicians, including determining start age with a doctor."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe hereditary syndromes that increase the risk of pancreatic cancer and note that germline BRCA mutations are a significant genetic risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It identifies hereditary risk via familial pancreatic cancer and lists specific genes/syndromes (BRCA1/2, PALB2, ATM, Lynch) as associated with increased pancreatic cancer risk, effectively noting BRCA as an important risk factor."
      },
      {
        "criterion_number": 5,
        "description": "The answer should recommend testing for selected mutations such as BRCA and CDKN2A.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends genetic testing through a counselor and provides examples (BRCA1/2, PALB2, ATM, Lynch). Although CDKN2A is not named, the response clearly recommends testing for selected mutations including BRCA, meeting the criterion."
      }
    ],
    "question_number": 12,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T16:50:57.570807",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should recommend that the patient consult a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly recommends consultation with a genetic counselor multiple times, including as the 'first and most crucial step' and again in the 'Next Steps' section."
      },
      {
        "criterion_number": 2,
        "description": "The answer should state that there is no widely accepted protocol for pancreatic cancer screening.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response notes screening is generally for high-risk individuals and best done at specialized centers, it does not explicitly state that there is no widely accepted protocol for pancreatic cancer screening."
      },
      {
        "criterion_number": 3,
        "description": "The answer should state that high-risk patients can undergo screening imaging studies, such as CT or MRI, after discussion with physicians.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states that high-risk individuals may undergo surveillance with imaging (MRI/MRCP and EUS) at specialized centers and after specialist evaluation; it also advises discussing with PCP and specialists. Although CT is not mentioned, MRI is, satisfying the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe hereditary syndromes that increase the risk of pancreatic cancer and note that germline BRCA mutations are a significant genetic risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response lists multiple hereditary syndromes (BRCA1/2, PALB2, Lynch, Peutz-Jeghers/STK11, FAMMM/CDKN2A, ATM, familial pancreatic cancer) and explicitly states BRCA1/2 increase pancreatic cancer risk."
      },
      {
        "criterion_number": 5,
        "description": "The answer should recommend testing for selected mutations such as BRCA and CDKN2A.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response recommends genetic testing for inherited mutations after genetic counseling and explicitly names relevant genes elsewhere (e.g., BRCA1/2 and CDKN2A), effectively endorsing testing for these selected mutations."
      }
    ],
    "question_number": 12,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T16:51:27.351246",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that doctors use imaging results to determine response to therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states imaging is the gold standard for assessing response: 'Imaging Scans (CT, PET, MRI): This is the gold standard. Are the tumors shrinking, stable, or growing on the scans?' and reiterates that scans trump tumor markers."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that CA 19-9 is one part of what determines response to therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly notes, 'CA 19-9 is Just One Piece of the Puzzle' and that tumor markers are never the only tool, with more weight often given to imaging and clinical status."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that CA 19-9 levels are not always correlated with tumor size or disease status, and note that some patients do not secrete CA 19-9 at all.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains multiple reasons CA 19-9 can be misleading (inflammation, infection, biliary obstruction, tumor lysis) and adds 'Individual Variation: Not all cancers produce high levels of CA 19-9. For some people, it's not a reliable marker from the start,' which communicates that some patients\u2019 tumors do not produce CA 19-9, fulfilling the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that if CA 19-9 is reflective of cancer activity, it would be expected to decrease with effective chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response notes, 'A decreasing CA 19-9 is the trend everyone hopes for,' and describes that when treatment works well there may be a transient rise followed by a fall, implying that effective therapy would be expected to lower CA 19-9 when the marker reflects disease activity."
      },
      {
        "criterion_number": 5,
        "description": "The response should define CA 19-9.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines CA 19-9 as a tumor marker ('Tumor markers like CA 19-9 are an important tool'), which satisfies the requirement to define it in context."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that doctors use changes in symptoms to determine response to therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response emphasizes clinical condition and symptoms: 'How do they feel? Are their symptoms... improving?' and later, 'If your loved one feels better and their symptoms are under control, this is a powerful indicator.'"
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend discussing the CA 19-9 test results with their oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It begins and ends by advising discussion with the oncologist and provides specific questions to ask at the next appointment."
      }
    ],
    "question_number": 13,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T16:51:59.512844",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that doctors use imaging results to determine response to therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly emphasizes imaging (CT/MRI/PET) as often the most important indicators and discusses assessing tumor shrinkage, stability, or growth."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that CA 19-9 is one part of what determines response to therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states CA 19-9 is a monitoring tool and not a sole indicator, and places it within the broader clinical context alongside imaging, symptoms, and other labs."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that CA 19-9 levels are not always correlated with tumor size or disease status, and note that some patients do not secrete CA 19-9 at all.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes CA 19-9 can be elevated by benign conditions, can fluctuate, and may not reflect cancer response; also specifies 5\u201310% of people (Lewis antigen negative) do not produce CA 19-9."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that if CA 19-9 is reflective of cancer activity, it would be expected to decrease with effective chemotherapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not explicitly state the expected decrease in CA 19-9 with effective therapy when CA 19-9 reflects tumor burden."
      },
      {
        "criterion_number": 5,
        "description": "The response should define CA 19-9.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines CA 19-9 as a tumor marker used primarily for monitoring in pancreatic and other GI cancers, adequate for a practical definition."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that doctors use changes in symptoms to determine response to therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically discusses evaluating clinical symptoms (pain, appetite, energy, jaundice) as part of assessing response."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend discussing the CA 19-9 test results with their oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Strongly recommends direct conversation with the oncologist and provides specific questions to ask."
      }
    ],
    "question_number": 13,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T16:52:20.858777",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "State that it is not an unexpected outcome as removing pancreas tissue will also take the islet cells which produce insulin.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states it is common/expected after Whipple and explains that removal of pancreatic tissue (including islet cells) reduces insulin production, leading to diabetes."
      },
      {
        "criterion_number": 2,
        "description": "Describe the incidence of post-Whipple diabetes (15\u201320% up to ~50%, varying by extent of resection and population).",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response characterizes it as common, it does not provide incidence figures or a range tied to extent of pancreatic removal or patient population."
      },
      {
        "criterion_number": 3,
        "description": "State that control of diabetes is achieved through regulating glucose intake via dietary modifications and medications to control blood sugars.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response outlines dietary strategies (consistent carbohydrates, small frequent meals) and medications (insulin) for blood sugar control, fulfilling both diet and medication aspects."
      },
      {
        "criterion_number": 4,
        "description": "State that the father should be evaluated by an endocrinologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends seeing an endocrinologist as a key next step and identifies the endocrinologist as the primary manager of diabetes care."
      },
      {
        "criterion_number": 5,
        "description": "State that the father may ultimately require insulin injections to regulate his blood sugars.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states that insulin therapy is often necessary after Whipple and that many patients will need insulin injections."
      }
    ],
    "question_number": 14,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T16:52:36.814268",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "State that it is not an unexpected outcome as removing pancreas tissue will also take the islet cells which produce insulin.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains that removal of pancreatic tissue (insulin-producing cells) reduces insulin production and makes post-Whipple diabetes common/expected."
      },
      {
        "criterion_number": 2,
        "description": "Describe the incidence of post-Whipple diabetes, noting it varies with extent of resection and patient population, occurring in 15\u201320% up to 50% of patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides an incidence estimate of 50\u201380% without noting variability by extent of resection or patient population and does not reflect the 15\u201350% range specified by the rubric."
      },
      {
        "criterion_number": 3,
        "description": "State that control of diabetes is achieved through regulating glucose intake via dietary modifications and medications that help control blood sugars.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details dietary strategies (carbohydrate management, meal patterning) and medications (insulin, oral agents) to control blood glucose."
      },
      {
        "criterion_number": 4,
        "description": "State that the father should be evaluated by an endocrinologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends close follow-up with an endocrinologist as a key team member."
      },
      {
        "criterion_number": 5,
        "description": "State that the father may ultimately require insulin injections to regulate his blood sugars.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically states many post-Whipple patients require insulin injections and discusses basal/bolus regimens."
      }
    ],
    "question_number": 14,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T16:52:52.032529",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must explicitly state that anorexia and weight loss are common symptoms of pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response clearly states that rapid weight loss is common in pancreatic cancer and discusses loss of appetite within cachexia, but it does not explicitly state that anorexia (loss of appetite) is a common symptom of pancreatic cancer. The rubric requires explicit mention of both anorexia and weight loss as common symptoms."
      },
      {
        "criterion_number": 2,
        "description": "The response must mention pancreatic enzyme replacement as an intervention and suggest discussing it with the healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Pancreatic enzyme replacement therapy (PERT) is discussed in detail (Creon, Zenpep, Pancreaze), including dosing and timing, and the response advises discussing all points with the oncology team, satisfying the requirement."
      },
      {
        "criterion_number": 3,
        "description": "The response must recommend consulting a registered dietitian specializing in oncology for personalized nutritional advice.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises to insist on a referral to a registered dietitian who specializes in oncology."
      },
      {
        "criterion_number": 4,
        "description": "The response must advise consuming nutrient-dense foods and eating smaller, more frequent meals, and explicitly emphasize the importance of maintaining adequate protein and calorie intake.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends 5\u20136 small meals, focusing on calorie density, and prioritizing protein with examples, fulfilling all components."
      },
      {
        "criterion_number": 5,
        "description": "The response must suggest nutritional supplementation with high-calorie meal replacement shakes and explicitly state that nutrition or protein supplements can be helpful.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends high-calorie, high-protein drinks (e.g., Ensure Enlive, Boost VHC, Orgain) and homemade smoothies, clearly suggesting supplements as beneficial."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that the patient should discuss their weight loss with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It instructs to schedule a conversation with the oncologist and to discuss all points with the oncology team."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly mention chemotherapy as a potential cause of weight loss.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Chemotherapy is not explicitly mentioned as a cause of weight loss; only general references to 'cancer and treatment' affecting taste are provided."
      }
    ],
    "question_number": 15,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T16:53:18.898958",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must explicitly state that anorexia and weight loss are common symptoms of pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response clearly states that rapid weight loss is a very common issue in pancreatic cancer but does not explicitly state that anorexia (loss of appetite) is common; the term anorexia or an explicit statement about appetite loss being common is missing."
      },
      {
        "criterion_number": 2,
        "description": "The response must mention pancreatic enzyme replacement as an intervention and suggest discussing it with the healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Pancreatic Enzyme Replacement Therapy (PERT) is highlighted, with examples (Creon, Zenpep) and placed under 'Talk to the Oncologist/Medical Team IMMEDIATELY,' fulfilling both intervention and discussion with the team."
      },
      {
        "criterion_number": 3,
        "description": "The response must recommend consulting a registered dietitian specializing in oncology for personalized nutritional advice.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends consulting a Registered Dietitian specializing in oncology and notes they can create a personalized nutrition plan."
      },
      {
        "criterion_number": 4,
        "description": "The response must advise consuming nutrient-dense foods and eating smaller, more frequent meals, and explicitly emphasize the importance of maintaining adequate protein and calorie intake.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises small, frequent meals; emphasizes nutrient-dense and high-calorie foods; and explicitly focuses on increasing protein and maximizing calories."
      },
      {
        "criterion_number": 5,
        "description": "The response must suggest nutritional supplementation with high-calorie meal replacement shakes and explicitly state that nutrition or protein supplements can be helpful.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends high-calorie shakes (Ensure, Boost, etc.) and states oral nutritional supplements can provide concentrated calories and protein."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that the patient should discuss their weight loss with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It urges immediate discussion with the oncologist/medical team regarding the issue and repeatedly advises reaching out to the oncology team, clearly tying this to the weight loss problem."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly mention chemotherapy as a potential cause of weight loss.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Chemotherapy is not explicitly mentioned as a potential contributor to weight loss; the response focuses on cachexia, malabsorption, nausea, and pain."
      }
    ],
    "question_number": 15,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T16:53:43.023713",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer must specify that jaundice is due to an increase in bilirubin in the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states, \"As the levels of bilirubin build up in your blood, it gets deposited in the skin and eyes, causing them to turn yellow,\" explicitly linking jaundice to increased bilirubin in the blood."
      },
      {
        "criterion_number": 2,
        "description": "The answer must state that jaundice refers to a yellowing of the skin and eyes due to elevated bilirubin levels.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines jaundice as \"the yellowing of the skin and the whites of the eyes\" and explains this occurs when \"bilirubin build[s] up in your blood,\" satisfying the requirement."
      },
      {
        "criterion_number": 3,
        "description": "The answer must state that jaundice can arise in pancreatic cancer due to blockage of the bile duct from tumor growth.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains that a pancreatic tumor, especially in the head of the pancreas, can \"press on or completely block the bile duct,\" leading to bile backup and jaundice."
      },
      {
        "criterion_number": 4,
        "description": "The answer must state that ERCP (Endoscopic Retrograde Cholangiopancreatography) is used to visualize the blocked duct and place a stent to relieve the blockage.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It describes ERCP in detail, noting use of dye and X-ray \"to see the blockage\" and placement of a stent to hold the duct open, which relieves the obstruction."
      },
      {
        "criterion_number": 5,
        "description": "The answer must state that other options to relieve the obstruction include percutaneous biliary drainage or surgery.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes percutaneous transhepatic cholangiography (PTC) with possible external drainage and discusses surgical bypass, meeting the requirement for alternative options."
      },
      {
        "criterion_number": 6,
        "description": "The answer must state that another potential cause for jaundice is metastatic disease in the liver.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention liver metastases as a cause of jaundice; it focuses on obstructive jaundice from bile duct blockage."
      },
      {
        "criterion_number": 7,
        "description": "The answer must state that treating the cancer with chemotherapy can shrink the tumor and help address the jaundice.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes that relieving jaundice enables chemotherapy, it does not state that chemotherapy can shrink the tumor and thereby help resolve the jaundice."
      }
    ],
    "question_number": 16,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T16:54:08.446866",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer must specify that jaundice is due to an increase in bilirubin in the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that jaundice is caused by a buildup of bilirubin in the blood, describing bilirubin as a yellow pigment that accumulates."
      },
      {
        "criterion_number": 2,
        "description": "The answer must state that jaundice refers to a yellowing of the skin and eyes due to elevated bilirubin levels.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly defines jaundice as yellowing of the skin and the whites of the eyes due to bilirubin buildup."
      },
      {
        "criterion_number": 3,
        "description": "The answer must state that jaundice can arise in pancreatic cancer due to blockage of the bile duct from tumor growth.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains that a tumor in the head of the pancreas can compress or invade the common bile duct, causing obstruction and subsequent jaundice."
      },
      {
        "criterion_number": 4,
        "description": "The answer must state that ERCP (Endoscopic Retrograde Cholangiopancreatography) is used to visualize the blocked duct and place a stent to relieve the blockage.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It describes ERCP with endoscopic visualization of the bile duct, identification of the blockage, and placement of a stent to hold the duct open and relieve jaundice."
      },
      {
        "criterion_number": 5,
        "description": "The answer must state that other options to relieve the obstruction include percutaneous biliary drainage or surgery.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It outlines percutaneous transhepatic cholangiography with drainage/stent as an alternative and discusses surgical options (biliary bypass and Whipple)."
      },
      {
        "criterion_number": 6,
        "description": "The answer must state that another potential cause for jaundice is metastatic disease in the liver.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention liver metastases as an alternative cause of jaundice."
      },
      {
        "criterion_number": 7,
        "description": "The answer must state that treating the cancer with chemotherapy can shrink the tumor and help address the jaundice.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes that relieving jaundice may allow chemotherapy, it does not state that chemotherapy can shrink the tumor and thereby help resolve jaundice."
      }
    ],
    "question_number": 16,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T16:54:30.984603",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should state that pain medications, including opioids, can be used for pain management.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly identifies opioids as the cornerstone for severe cancer pain, listing long-acting and short-acting options (morphine, oxycodone, fentanyl patch) and discusses side-effect management."
      },
      {
        "criterion_number": 2,
        "description": "The answer should describe procedures, such as a celiac plexus block, that can help alleviate pain.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a dedicated section on interventional procedures and thoroughly describes a celiac plexus block, including what it is, how it\u2019s done (imaging guidance), and expected results."
      },
      {
        "criterion_number": 3,
        "description": "The answer should express sympathy for the diagnosis and symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with a compassionate statement acknowledging the difficulty of the situation and validates the distress of severe pain."
      },
      {
        "criterion_number": 4,
        "description": "The answer should state that adjunctive non-opioid medications, such as amitriptyline and gabapentin, can be used.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly mentions adjuvant analgesics for neuropathic pain including gabapentin, pregabalin, and antidepressants (e.g., duloxetine), fulfilling the requirement to include adjuncts like gabapentin."
      },
      {
        "criterion_number": 5,
        "description": "The answer should state that steroids, such as dexamethasone, can also be used.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically mentions corticosteroids, including dexamethasone, and explains their role in reducing inflammation and pain."
      },
      {
        "criterion_number": 6,
        "description": "The answer should state that radiation can be used for local treatment and pain control.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes palliative radiation aimed at the tumor to reduce pain, including timeframe for potential relief."
      },
      {
        "criterion_number": 7,
        "description": "The answer should state that complementary therapies, such as acupuncture and massages, can also be pursued.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists complementary therapies including acupuncture, massage, mind-body techniques, and heat/cold packs."
      },
      {
        "criterion_number": 8,
        "description": "The answer should state that the patient should be seen by a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Strongly advocates for a palliative care consultation, clarifies its role, and emphasizes their expertise in pain management."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend discussing pain management with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises coordination with the oncologist and the broader healthcare team and explicitly recommends discussing options with them."
      }
    ],
    "question_number": 17,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T16:54:49.580544",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should state that pain medications, including opioids, can be used for pain management.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly details opioid analgesics (morphine, oxycodone, hydromorphone, fentanyl, methadone, tramadol), routes of administration, and titration/side effects."
      },
      {
        "criterion_number": 2,
        "description": "The answer should describe procedures, such as a celiac plexus block, that can help alleviate pain.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains celiac plexus block/neurolysis with mechanism, approach (percutaneous/EUS), and effectiveness; also mentions intrathecal pumps and RFA."
      },
      {
        "criterion_number": 3,
        "description": "The answer should express sympathy for the diagnosis and symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with empathy (\u201cI am so sorry\u2026\u201d) and closes with supportive, compassionate statements."
      },
      {
        "criterion_number": 4,
        "description": "The answer should state that adjunctive non-opioid medications, such as amitriptyline and gabapentin, can be used.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists gabapentin/pregabalin, TCAs (amitriptyline, nortriptyline), and SNRIs (duloxetine, venlafaxine) as co-analgesics for neuropathic pain."
      },
      {
        "criterion_number": 5,
        "description": "The answer should state that steroids, such as dexamethasone, can also be used.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically mentions corticosteroids (e.g., dexamethasone) for inflammation and symptom relief."
      },
      {
        "criterion_number": 6,
        "description": "The answer should state that radiation can be used for local treatment and pain control.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes a section on palliative radiation to shrink tumor and relieve pain, with typical short-course regimens."
      },
      {
        "criterion_number": 7,
        "description": "The answer should state that complementary therapies, such as acupuncture and massages, can also be pursued.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends acupuncture and massage therapy, along with other mind-body approaches."
      },
      {
        "criterion_number": 8,
        "description": "The answer should state that the patient should be seen by a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises contacting the palliative care team and explicitly suggests a palliative care consult for symptom management."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend discussing pain management with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly instructs to contact his oncology team today to address severe pain and coordinate management."
      }
    ],
    "question_number": 17,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T16:55:13.796949",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should state that resectability is determined by the surgeons\u2019 assessment of their ability to safely remove the entire tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that unresectable means surgeons have determined the tumor cannot be completely and safely removed at this time."
      },
      {
        "criterion_number": 2,
        "description": "The answer should state that tumors are deemed not resectable if they involve surrounding major blood vessels such as the SMA, SMV, CA, PV.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists SMA, celiac artery, portal vein, and SMV, and explains that encasement or blockage of these vessels makes surgery unsafe or impossible."
      },
      {
        "criterion_number": 3,
        "description": "The answer should state that invasion of nearby organs can also lead to a tumor not being able to be resected.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it discusses vessel involvement and distant spread, it does not state that direct invasion of adjacent organs (e.g., stomach, colon) can render a tumor unresectable."
      },
      {
        "criterion_number": 4,
        "description": "The answer should state that sometimes tumors that are not initially able to be resected can be shrunk (downstaged) with chemotherapy and/or radiation and later removed.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains the concept of 'borderline resectable' and neoadjuvant therapy (chemotherapy and sometimes radiation) that may shrink tumors to make surgery possible later."
      },
      {
        "criterion_number": 5,
        "description": "The answer should offer sympathy for the loved one\u2019s diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with clear empathy and acknowledges the difficulty of the situation."
      }
    ],
    "question_number": 18,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T16:55:28.918267",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The answer should state that resectability is determined by the surgeons\u2019 assessment of their ability to safely remove the entire tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly defines unresectable as a tumor that cannot be safely or effectively removed and notes that this determination is made by a multidisciplinary team including surgeons after reviewing imaging/biopsy."
      },
      {
        "criterion_number": 2,
        "description": "The answer should state that tumors are deemed not resectable if they involve surrounding major blood vessels such as the SMA, SMV, CA, PV.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It specifically lists major vessels\u2014the superior mesenteric artery and vein (SMA/SMV), portal vein (PV), and celiac axis (CA)\u2014and explains why vascular involvement often precludes safe resection."
      },
      {
        "criterion_number": 3,
        "description": "The answer should state that invasion of nearby organs can also lead to a tumor not being able to be resected.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes a section on involvement of other adjacent vital organs making removal too dangerous or impossible, clearly addressing organ invasion as a reason for unresectability."
      },
      {
        "criterion_number": 4,
        "description": "The answer should state that sometimes tumors that are not initially able to be resected can be shrunk (downstaged) with chemotherapy and/or radiation and later removed.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states that unresectable tumors can sometimes be downstaged with chemotherapy (with or without radiation) to become resectable, using terms like conversion therapy/neoadjuvant therapy."
      },
      {
        "criterion_number": 5,
        "description": "The answer should offer sympathy for the loved one\u2019s diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It opens with a compassionate acknowledgment of the difficulty and expresses sympathy for the patient and family."
      }
    ],
    "question_number": 18,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T16:55:43.594176",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the decision to continue with or stop chemotherapy treatments is highly personal.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly calls this \"one of the most difficult and personal decisions\" and emphasizes there is no right or wrong answer, clearly framing it as a highly personal choice."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the decision should be made weighing the expected benefit of more therapy with the current side effects.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes a section on \"Burdens vs. Benefits,\" specifically weighing side effects (nausea, fatigue, hospital visits) against potential benefits (e.g., a few more weeks or months), and addresses trade-offs between quantity and quality of life."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient discuss their goals of care with their oncology team and suggest meeting with their oncologist and a palliative care physician to help guide decision-making.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends a dedicated meeting with the oncology team and, if possible, a palliative care specialist, and centers the discussion around goals, prognosis, and treatment intent."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend the patient ask for a referral to a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "While it does not use the word \"referral,\" it clearly advises scheduling a meeting with a palliative care specialist and discusses transition to palliative care, which effectively implies requesting a referral."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe palliative care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It accurately defines palliative care as specialized care focusing on relief from symptoms and stress for serious illness, can be provided alongside curative treatment, and becomes primary when treatment stops."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe hospice care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It provides a correct description: hospice is a specific type of palliative care for those with life expectancy of six months or less, not pursuing curative treatment, with interdisciplinary support often at home, focusing on comfort and dignity."
      },
      {
        "criterion_number": 7,
        "description": "The response should offer sympathy and state that it is a very difficult decision to try to make.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It begins with empathy and acknowledges the decision as extremely difficult, reinforcing compassionate support throughout."
      }
    ],
    "question_number": 19,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T16:55:59.671327",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the decision to continue with or stop chemotherapy treatments is highly personal.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response emphasizes that the patient's wishes are paramount and defines quality of life personally to the patient, framing the choice as a personal, values-based decision."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the decision should be made weighing the expected benefit of more therapy with the current side effects.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes a section titled 'Balance of Benefits vs. Burdens of Current Treatment' explicitly weighing side effects and burdens against benefits and potential life extension with acceptable quality."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient discuss their goals of care with their oncology team and suggest meeting with their oncologist and a palliative care physician to help guide decision-making.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response recommends scheduling a dedicated meeting with the medical team to discuss prognosis and options, centers the patient's goals and wishes, and later advises speaking with palliative care specialists to guide decisions."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend the patient ask for a referral to a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises discussing palliative care and speaking with palliative care specialists as part of the decision process, effectively recommending engaging palliative care expertise."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe palliative care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Palliative care is clearly defined as care that can be offered alongside curative treatment or when it stops, focusing on symptom relief and quality of life."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe hospice care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Hospice is described as palliative care for those with a prognosis of about six months, delivered at home or facilities, with an interdisciplinary team and strong emphasis on pain and symptom management."
      },
      {
        "criterion_number": 7,
        "description": "The response should offer sympathy and state that it is a very difficult decision to try to make.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The opening acknowledges the decision as incredibly difficult and courageous and maintains a compassionate tone throughout."
      }
    ],
    "question_number": 19,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T16:56:27.792878",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that KRAS mutations are frequently implicated in pancreatic cancer as a major driver of tumorigenesis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states KRAS is a hallmark of pancreatic ductal adenocarcinoma (>90%) and a primary driver of the cancer, satisfying frequency and driver roles."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the first line of treatment would remain the standard of care with chemotherapy regimens such as FOLFIRINOX and gemcitabine/abraxane.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly notes initial treatment remains standard chemotherapy and lists FOLFIRINOX and gemcitabine/nab-paclitaxel as common regimens."
      },
      {
        "criterion_number": 3,
        "description": "The answer should state that there are several KRAS mutations (G12C, G12D, G12V) and specify which one is present in the patient\u2019s case.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Identifies variants (G12C, G12D, G12V) and notes G12D is most common, but does not specify which mutation the patient's father has."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that targeted therapy to the KRAS mutation is an active area of research.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes KRAS-targeted therapy as a fast-moving, exciting research area with inhibitors in advanced clinical trials."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that some KRAS mutations can be targeted with drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions FDA-approved KRAS G12C inhibitors (sotorasib, adagrasib) and their use/testing, indicating some mutations are druggable."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that there may be clinical trials for certain KRAS mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically recommends asking about clinical trials for inhibitors targeting the patient\u2019s specific KRAS mutation."
      },
      {
        "criterion_number": 7,
        "description": "The response should state the patient should discuss their KRAS mutation with their oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a list of questions to ask the oncologist about the specific KRAS mutation, targeted therapies, and trials."
      }
    ],
    "question_number": 20,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T16:56:51.065909",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that KRAS mutations are frequently implicated in pancreatic cancer as a major driver of tumorigenesis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains KRAS as a key driver gene, notes that mutations lock it in the 'on' position, and states KRAS mutations occur in ~90% of pancreatic cancers, explicitly calling it a key driver."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the first line of treatment would remain the standard of care with chemotherapy regimens such as FOLFIRINOX and gemcitabine/abraxane.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states that standard chemotherapy remains the backbone and specifically names FOLFIRINOX and gemcitabine/nab-paclitaxel as primary treatments."
      },
      {
        "criterion_number": 3,
        "description": "The answer should state that there are several KRAS mutations (G12C, G12D, G12V) and specify which one is present in the patient\u2019s case.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response lists KRAS subtypes (G12C, G12D, G12V) and emphasizes determining the exact subtype, it does not specify which mutation is present in this patient\u2019s case."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that targeted therapy to the KRAS mutation is an active area of research.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions that the landscape is evolving and that there is intense ongoing research developing drugs targeting common KRAS mutations and downstream pathways, many in early-phase clinical trials."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that some KRAS mutations can be targeted with drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It describes KRAS G12C inhibitors (sotorasib, adagrasib) as available targeted drugs for the G12C subtype, fulfilling the criterion that some KRAS mutations are targetable."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that there may be clinical trials for certain KRAS mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes the importance of clinical trials and notes access to novel KRAS inhibitors and other targeted agents through trials, including for specific KRAS subtypes."
      },
      {
        "criterion_number": 7,
        "description": "The response should state the patient should discuss their KRAS mutation with their oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes a section titled 'What to Discuss with His Oncology Team' and specifically advises discussing the exact KRAS subtype and treatment options with the oncology team."
      }
    ],
    "question_number": 20,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T16:57:11.031423",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must mention recent trials evaluating the use of high-dose vitamin C in combination with chemotherapy for the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response cites early-phase clinical trials (e.g., University of Iowa Phase I studies in 2013 and 2017) combining high-dose IV vitamin C with gemcitabine/nab-paclitaxel, mentions case reports/series, and notes ongoing studies exploring combinations with FOLFIRINOX and radiation. This clearly addresses trials evaluating the combination."
      },
      {
        "criterion_number": 2,
        "description": "The response must state that high-dose vitamin C has not been proven to improve outcomes in pancreatic or any other cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly emphasizes that evidence is preliminary, therapy is investigational and not standard of care, and that larger randomized Phase III trials are needed to definitively prove benefit. This conveys that improved outcomes have not been proven."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention the proposed mechanism of action of high-dose vitamin C in conjunction with chemotherapy, noting that it can act as a pro-oxidant by generating hydrogen peroxide (H\u2082O\u2082), which may enhance the killing of cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly describes pharmacologic IV vitamin C acting as a pro-oxidant generating H\u2082O\u2082, differentially harming cancer cells (lower catalase) and potentially synergizing with chemotherapy."
      },
      {
        "criterion_number": 4,
        "description": "The response must state that there is limited published data showing high-dose vitamin C is well tolerated and shows a trend toward efficacy, but studies are limited and not sufficiently powered.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes Phase I/II focus on safety/tolerability with preliminary efficacy signals, describes small, non-randomized studies, and stresses the lack of definitive Phase III trials. This matches the criterion."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention possible toxicities of taking high doses of vitamin C.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists risks including hemolysis in G6PD deficiency, kidney failure/oxalate stones risk, mild infusion reactions (dry mouth, thirst, transient BP spikes), and GI distress with high oral doses."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention drug-drug interactions of vitamin C.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It warns of potential interference with chemotherapy (theoretical concern about antioxidant/pro-oxidant effects), which constitutes a mention of interaction with anticancer drugs."
      },
      {
        "criterion_number": 7,
        "description": "The response should note that vitamin C is not FDA approved.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it states the approach is investigational and not standard of care, it does not explicitly state that high-dose IV vitamin C for cancer treatment is not FDA-approved."
      },
      {
        "criterion_number": 8,
        "description": "The response should note that vitamin C is not recommended by the NCCN guideline.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of NCCN guidelines or that this approach is not recommended by NCCN."
      },
      {
        "criterion_number": 9,
        "description": "The response should note that if a patient wishes to use high doses of vitamin C in conjunction with chemotherapy, they should consult with an oncologist regarding the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises patients to discuss enrollment in a clinical trial with their oncologist."
      }
    ],
    "question_number": 21,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T16:57:40.232708",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must mention recent trials evaluating the use of high-dose vitamin C in combination with chemotherapy for the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly mentions Phase I and Phase II clinical trials and ongoing research evaluating high-dose IV vitamin C with chemotherapy in pancreatic cancer, satisfying the requirement to note recent/ongoing trials."
      },
      {
        "criterion_number": 2,
        "description": "The response must state that high-dose vitamin C has not been proven to improve outcomes in pancreatic or any other cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that evidence is \"not definitive,\" that there is a \"lack of large, randomized Phase III trials,\" and that such trials are needed to \"definitively prove\" improved outcomes\u2014indicating it has not been proven to improve outcomes in pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention the proposed mechanism of action of high-dose vitamin C in conjunction with chemotherapy, noting that it can act as a pro-oxidant by generating hydrogen peroxide (H\u2082O\u2082), which may enhance the killing of cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response describes a pro-oxidant effect and that vitamin C can act as a pro-drug for hydrogen peroxide (H\u2082O\u2082), selectively affecting cancer cells, which matches the proposed mechanism."
      },
      {
        "criterion_number": 4,
        "description": "The response must state that there is limited published data showing high-dose vitamin C is well tolerated and shows a trend toward efficacy, but studies are limited and not sufficiently powered.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes that Phase I/II trials suggest safety and tolerability and show \"promising trends,\" but emphasizes small cohorts and the lack of large randomized trials, indicating limited and underpowered evidence."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention possible toxicities of taking high doses of vitamin C.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists potential side effects including fatigue, dry mouth, vein irritation, and occasional kidney stones in predisposed individuals."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention drug-drug interactions of vitamin C.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No drug-drug interactions are discussed; the response only states that toxicity generally does not increase with chemotherapy."
      },
      {
        "criterion_number": 7,
        "description": "The response should note that vitamin C is not FDA approved.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention FDA approval status for high-dose IV vitamin C in cancer treatment."
      },
      {
        "criterion_number": 8,
        "description": "The response should note that vitamin C is not recommended by the NCCN guideline.",
        "score_given": 0,
        "max_points": 10,
        "justification": "NCCN guideline recommendations are not addressed."
      },
      {
        "criterion_number": 9,
        "description": "The response should note that if a patient wishes to use high doses of vitamin C in conjunction with chemotherapy, they should consult with an oncologist regarding the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises patients to discuss the approach thoroughly with their oncologist."
      }
    ],
    "question_number": 21,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T16:58:09.132982",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that a biopsy is the only way to confirm the diagnosis of metastatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response explains biopsy limitations and alternative approaches, and explicitly notes that imaging may be considered conclusive enough to begin treatment without biopsy confirmation. It does not state that biopsy is the only way to confirm metastatic disease."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that imaging such as CT or MRI is done to evaluate for the presence of metastatic disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly discusses contrast-enhanced CT, MRI with contrast, and PET as tools to evaluate and characterize liver metastases."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that tumor markers can be supportive of a diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions CA 19-9 as a tumor marker that can provide supportive evidence and be used for monitoring."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the team may suggest that the patient undergo another biopsy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes a section on repeat biopsy, noting different guidance methods (ultrasound vs CT), EUS-FNA, and even laparoscopy as options."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that on occasion the team will decide to treat as metastatic if the tumor markers and imaging are consistent with metastatic disease so as to not delay treatment if a repeat biopsy is not feasible.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states that CT/MRI and PET can be considered conclusive enough to make a Stage IV diagnosis and begin treatment even with an inconclusive biopsy, and it notes tumor markers as supportive evidence, aligning with treating based on consistent imaging/markers without delaying treatment."
      }
    ],
    "question_number": 22,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T16:58:37.521626",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that a biopsy is the only way to confirm the diagnosis of metastatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response notes that imaging is usually not definitively diagnostic without biopsy and describes biopsy techniques, it does not explicitly state that biopsy is the only way to confirm metastatic disease. It also lists imaging under ways metastases can be 'confirmed or further investigated,' which blurs that exclusivity."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that imaging such as CT or MRI is done to evaluate for the presence of metastatic disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly discusses CT and MRI identifying suspicious liver lesions and further details advanced imaging options (MRI with contrast, PET/CT, CEUS) for evaluation."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that tumor markers can be supportive of a diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly mentions CA 19-9 as a tumor marker that can support the diagnosis and correlate with disease burden but is not diagnostic on its own, which meets the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the team may suggest that the patient undergo another biopsy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly recommends a repeat biopsy, including image-guided targeting and using a core needle for larger samples."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that on occasion the team will decide to treat as metastatic if the tumor markers and imaging are consistent with metastatic disease so as to not delay treatment if a repeat biopsy is not feasible.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not state that clinicians may initiate treatment as metastatic without tissue confirmation when biopsy is not feasible; it emphasizes confirmation and does not address empiric treatment based on concordant imaging and markers."
      }
    ],
    "question_number": 22,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T16:58:59.688382",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that there is no good evidence to suggest that eating vegan can stall cancer progression.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states there is no scientific consensus that a vegan diet can, on its own, stall or cure cancer, and emphasizes diet as complementary to medical treatment."
      },
      {
        "criterion_number": 2,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including pancreatic enzyme insufficiency.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of pancreatic enzyme insufficiency, malabsorption, steatorrhea, or pancreatic enzyme replacement therapy specific to pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including insulin-dependent diabetes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not address endocrine insufficiency, diabetes, or insulin needs related to pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including biliary obstruction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of biliary obstruction, jaundice, cholestasis, fat-soluble vitamin issues, or stenting."
      },
      {
        "criterion_number": 5,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including high protein and calorie needs during treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It highlights risks of malnutrition and cachexia during cancer treatment and emphasizes adequate calories and protein, with plant protein sources listed."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that nutrition support is often needed for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it advises professional guidance, it does not state that nutrition support (e.g., pancreatic enzymes, enteral/parenteral nutrition) is often needed in pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend discussion of diet with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly advises using diet alongside the oncology treatment plan and consulting one's doctor before significant dietary changes."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend discussion of diet with an oncology nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It specifically recommends working with a registered dietitian who specializes in oncology."
      }
    ],
    "question_number": 23,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T16:59:20.760255",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that there is no good evidence to suggest that eating vegan can stall cancer progression.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states there is not definitive scientific evidence that a vegan diet alone stalls cancer progression and frames it as an adjunct to standard therapy, not a replacement."
      },
      {
        "criterion_number": 2,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including pancreatic enzyme insufficiency.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Pancreatic enzyme insufficiency is not mentioned; no discussion of malabsorption, steatorrhea, or need for pancreatic enzyme replacement therapy."
      },
      {
        "criterion_number": 3,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including insulin-dependent diabetes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of pancreatic cancer-related diabetes or insulin dependence."
      },
      {
        "criterion_number": 4,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including biliary obstruction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Biliary obstruction and its nutritional implications are not discussed."
      },
      {
        "criterion_number": 5,
        "description": "The response should include changes in digestion that can occur with pancreatic cancer that may affect diet, including high protein and calorie needs during treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response advises ensuring sufficient calories and protein, it does not explicitly address increased protein and calorie needs during treatment, nor link this to pancreatic cancer-specific issues such as cachexia or malabsorption."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that nutrition support is often needed for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention that patients with pancreatic cancer often require nutrition support (e.g., oral nutrition supplements, enteral or parenteral nutrition)."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend discussion of diet with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly recommends consulting with the oncology team before making significant dietary changes during treatment."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend discussion of diet with an oncology nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It specifically advises consulting a registered dietitian specializing in oncology."
      }
    ],
    "question_number": 23,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T16:59:48.197935",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "States that medical fitness is scored by the oncologist using the ECOG or Karnofsky performance status.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly uses and explains the ECOG performance status scale (0\u20134) to guide therapy choice."
      },
      {
        "criterion_number": 2,
        "description": "States that more medically fit patients are offered FOLFIRINOX, whereas frailer but still candidates receive gemcitabine and nab-paclitaxel.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states FOLFIRINOX is reserved for fitter patients and Gem/Nab-P for a broader group including less fit patients."
      },
      {
        "criterion_number": 3,
        "description": "States that FOLFIRINOX is generally for ECOG 0-1, whereas gemcitabine and nab-paclitaxel can be given to ECOG 2 patients.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifies FOLFIRINOX for ECOG 0\u20131 and Gem/Nab-P appropriate for ECOG 0\u20131 and robust 2 patients."
      },
      {
        "criterion_number": 4,
        "description": "States that FOLFIRINOX is reserved for good performance status because it is more intensive with higher rates of severe side effects such as neutropenia, fatigue, and diarrhea.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes FOLFIRINOX as aggressive with high toxicity and details severe diarrhea (irinotecan), high neutropenia risk, and severe fatigue."
      },
      {
        "criterion_number": 5,
        "description": "Explicitly lists the drugs in FOLFIRINOX (5-FU, leucovorin, irinotecan, oxaliplatin) and clarifies that nab-paclitaxel is combined with gemcitabine.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists leucovorin, 5-FU, irinotecan, oxaliplatin for FOLFIRINOX and clearly presents gemcitabine plus nab-paclitaxel as a two-drug combination."
      },
      {
        "criterion_number": 6,
        "description": "States that there are no head-to-head trials comparing gemcitabine/nab-paclitaxel and FOLFIRINOX.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention the absence of head-to-head trials between the regimens."
      },
      {
        "criterion_number": 7,
        "description": "Mentions age as a factor influencing choice of regimen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Age is discussed explicitly, noting greater caution with FOLFIRINOX in older patients (e.g., >70\u201375)."
      },
      {
        "criterion_number": 8,
        "description": "Mentions comorbid conditions as a factor in selecting a regimen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Comorbidities (heart disease, kidney issues, diabetes, neuropathy) are detailed as influencing regimen selection."
      }
    ],
    "question_number": 24,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:00:10.663570",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "States that medical fitness is scored using ECOG or Karnofsky performance status.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly references ECOG performance status (e.g., 'ECOG 0-1' and 'Assessment of ECOG Performance Status'), fulfilling the requirement."
      },
      {
        "criterion_number": 2,
        "description": "States that more medically fit patients are offered FOLFIRINOX, whereas more frail but treatable patients are offered gemcitabine and nab-paclitaxel.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states FOLFIRINOX is reserved for excellent PS (ECOG 0-1) and Gem/Nab-P is suitable for ECOG 1-2 or patients not candidates for FOLFIRINOX due to PS/comorbidities."
      },
      {
        "criterion_number": 3,
        "description": "States FOLFIRINOX generally for ECOG 0-1, whereas gemcitabine/nab-paclitaxel can be given to ECOG 2.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly says 'FOLFIRINOX: ECOG 0-1 (ideally 0)' and 'Gem/Nab-Paclitaxel: ECOG 1-2 (sometimes a very fit 2)'."
      },
      {
        "criterion_number": 4,
        "description": "Explains FOLFIRINOX is reserved for good PS because it is more intensive and has higher rates of severe side effects (e.g., neutropenia, fatigue, diarrhea).",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes FOLFIRINOX as more intense/toxic with severe side effects including neutropenia, severe diarrhea, fatigue, and need for intensive supportive care."
      },
      {
        "criterion_number": 5,
        "description": "Explicitly lists FOLFIRINOX drugs (5-FU, leucovorin, irinotecan, oxaliplatin) and clarifies that nab-paclitaxel is combined with gemcitabine.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists 'FOLFIRINOX (5-Fluorouracil, Leucovorin, Irinotecan, Oxaliplatin)' and uses 'Gemcitabine/Nab-Paclitaxel', making the combination explicit."
      },
      {
        "criterion_number": 6,
        "description": "States there are no head-to-head trials comparing gemcitabine/nab-paclitaxel and FOLFIRINOX.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response cites the PRODIGE and MPACT trials but does not explicitly state that no head-to-head comparisons exist between the two regimens."
      },
      {
        "criterion_number": 7,
        "description": "Mentions age as a factor influencing regimen choice.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Age is not mentioned as a consideration anywhere in the response."
      },
      {
        "criterion_number": 8,
        "description": "Mentions comorbid conditions as a factor in selecting a regimen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Comorbidities are discussed explicitly as influencing eligibility for FOLFIRINOX versus gemcitabine/nab-paclitaxel."
      }
    ],
    "question_number": 24,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:00:36.101058",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that resectability is determined by the ability of the surgeon to safely remove the entire tumor and not leave any behind (R0 resection).",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that a tumor is resectable if it can be removed entirely with a negative margin (R0)."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that involvement of major blood vessels such as the SMA, SMV, CA, PV are often implicated when a tumor is deemed to not be resectable.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Discusses SMA, celiac artery, common hepatic artery, SMV, and portal vein; explains that extensive involvement, especially arterial, can make surgery unresectable."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that for pancreatic cancer to be resectable, there must not be any distant metastases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states absence of distant metastasis is required for resectability and lists common metastatic sites."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that occasionally tumors that contact the veins (PV/SMV) and have less than 180 degrees of involvement can still be resected provided it can be safely removed and the vessel can be reconstructed as needed.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes that some SMV/PV involvement is acceptable and veins can be resected/reconstructed; conveys that limited venous involvement can still be resectable."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that some tumors are deemed to be borderline resectable and that the patient will be recommended to undergo treatment with chemotherapy and/or radiation in order to attempt to down-stage the tumor and make it amenable to resection.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines borderline resectable and recommends neoadjuvant chemotherapy \u00b1 radiation to downstage and enable resection."
      },
      {
        "criterion_number": 6,
        "description": "The response should include imaging modalities that help determine resectability, including a CT scan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions a pancreatic protocol CT as the most important imaging test."
      },
      {
        "criterion_number": 7,
        "description": "The response should include imaging modalities that help determine resectability, including an MRI.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes MRI/MRCP as an imaging modality."
      },
      {
        "criterion_number": 8,
        "description": "The response should include imaging modalities that help determine resectability, including a PET scan.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention PET scanning."
      },
      {
        "criterion_number": 9,
        "description": "The response should include imaging modalities that help determine resectability, including an endoscopic ultrasound.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions endoscopic ultrasound (EUS) for close-up evaluation and biopsy."
      }
    ],
    "question_number": 25,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:00:56.288117",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "States that resectability is determined by ability to safely remove entire tumor with no residual disease (R0 resection).",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states the goal is an R0 resection with clear margins and reiterates complete removal in the summary."
      },
      {
        "criterion_number": 2,
        "description": "Notes that involvement of major vessels (SMA, SMV, CA, PV) often renders tumors unresectable.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details SMA and celiac axis encasement as unresectable and discusses SMV/PV involvement and reconstructability; also mentions hepatic artery."
      },
      {
        "criterion_number": 3,
        "description": "States that the absence of distant metastases is required for resectability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly identifies absence of distant metastasis as the most critical factor and repeats this in categorization."
      },
      {
        "criterion_number": 4,
        "description": "States that tumors contacting PV/SMV with limited involvement (<180 degrees) may still be resectable if reconstruction is feasible.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that some SMV/PV involvement can be resected with venous reconstruction and that short-segment involvement may be amenable to resection, satisfying the criterion\u2019s intent."
      },
      {
        "criterion_number": 5,
        "description": "Mentions borderline resectable category and use of neoadjuvant therapy to downstage.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines borderline resectable and explicitly recommends neoadjuvant chemotherapy and/or radiation to improve resectability."
      },
      {
        "criterion_number": 6,
        "description": "Includes CT scan as an imaging modality for assessing resectability.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States imaging is primarily based on CT scans."
      },
      {
        "criterion_number": 7,
        "description": "Includes MRI as an imaging modality for assessing resectability.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions MRI among imaging modalities used."
      },
      {
        "criterion_number": 8,
        "description": "Includes PET scan as an imaging modality for assessing resectability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "PET scan is not mentioned."
      },
      {
        "criterion_number": 9,
        "description": "Includes endoscopic ultrasound (EUS) as an imaging modality for assessing resectability.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Endoscopic ultrasound is explicitly listed among modalities."
      }
    ],
    "question_number": 25,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:01:17.445826",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that family history of pancreas cancer is associated with increased risk.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that having a first-degree relative increases lifetime risk and quantifies higher risk with multiple affected relatives."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that a family history of pancreas cancer is due to inherited gene mutations such as BRCA.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Links family history to inherited mutations and lists BRCA1/BRCA2 (and others) as causes of increased pancreatic cancer risk."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that smoking is a significant modifiable risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Calls smoking the single most significant preventable risk factor and cites 2\u20133x risk; advises quitting."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that chronic pancreatitis is a risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Identifies chronic pancreatitis as a strong risk factor increasing risk many times over."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that heavy alcohol use can lead to increased risk of pancreas cancer through pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States heavy alcohol use causes chronic pancreatitis, which is a significant risk factor for pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should identify genetic risk factors, including Lynch syndrome.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly lists Lynch syndrome (HNPCC) as a genetic risk factor."
      },
      {
        "criterion_number": 7,
        "description": "The response should identify genetic risk factors, including Peutz-Jeghers syndrome.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly lists Peutz-Jeghers syndrome as a risk factor."
      },
      {
        "criterion_number": 8,
        "description": "The response should identify genetic risk factors, including Familial atypical multiple mole melanoma.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions FAMMM due to CDKN2A as a syndrome increasing pancreatic cancer risk."
      },
      {
        "criterion_number": 9,
        "description": "The response should identify genetic risk factors, including hereditary pancreatitis.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists hereditary pancreatitis as a genetic condition with markedly increased lifetime risk."
      },
      {
        "criterion_number": 10,
        "description": "The response should include non-hereditary risk factors, including age.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Notes risk increases with age and most cases occur over 65."
      },
      {
        "criterion_number": 11,
        "description": "The response should include non-hereditary risk factors, including diabetes.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Identifies diabetes (especially type 2) as a risk factor and mentions new-onset diabetes as a possible early sign."
      },
      {
        "criterion_number": 12,
        "description": "The response should include non-hereditary risk factors, including obesity.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists overweight/obesity as increasing risk and advises maintaining a healthy weight."
      },
      {
        "criterion_number": 13,
        "description": "The response should include non-hereditary risk factors, including diet.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Discusses diet high in red/processed meats, fried foods, and sugar as increasing risk; recommends fruits/vegetables/whole grains."
      },
      {
        "criterion_number": 14,
        "description": "The response should include non-hereditary risk factors, including exposure to certain industrial chemicals.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions long-term exposure to chemicals in dry cleaning and metalworking industries as potential risk factors."
      },
      {
        "criterion_number": 15,
        "description": "The response should state that if you have a strong family history, discuss with your doctor about screening or genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises talking to a doctor, pursuing genetic counseling/testing, and considering high-risk surveillance (EUS, MRI/MRCP)."
      }
    ],
    "question_number": 26,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:01:41.940968",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that family history of pancreas cancer is associated with increased risk.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that having a first-degree relative increases risk 2\u20133x and discusses familial clustering."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that a family history of pancreas cancer is due to inherited gene mutations such as BRCA.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Links familial risk to inherited mutations and lists BRCA1/2 among others."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that smoking is a significant modifiable risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States smoking is one of the strongest modifiable risk factors and approximately doubles risk."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that chronic pancreatitis is a risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists chronic pancreatitis as a significant risk factor."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that heavy alcohol use can lead to increased risk of pancreas cancer through pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains heavy alcohol is a major cause of chronic pancreatitis, which increases pancreatic cancer risk."
      },
      {
        "criterion_number": 6,
        "description": "The response should identify genetic risk factors, including Lynch syndrome.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifically names Lynch syndrome (HNPCC) with mismatch repair genes."
      },
      {
        "criterion_number": 7,
        "description": "The response should identify genetic risk factors, including Peutz-Jeghers syndrome.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifically lists Peutz-Jeghers syndrome (STK11)."
      },
      {
        "criterion_number": 8,
        "description": "The response should identify genetic risk factors, including Familial atypical multiple mole melanoma.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifically lists FAMMM syndrome (CDKN2A/p16)."
      },
      {
        "criterion_number": 9,
        "description": "The response should identify genetic risk factors, including hereditary pancreatitis.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Notes that chronic pancreatitis is a significant risk factor, especially if it's hereditary."
      },
      {
        "criterion_number": 10,
        "description": "The response should include non-hereditary risk factors, including age.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Includes age as a risk factor with typical ages of diagnosis."
      },
      {
        "criterion_number": 11,
        "description": "The response should include non-hereditary risk factors, including diabetes.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States long-standing type 2 diabetes is a risk factor; mentions new-onset diabetes as a possible early sign."
      },
      {
        "criterion_number": 12,
        "description": "The response should include non-hereditary risk factors, including obesity.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions overweight/obesity increases risk."
      },
      {
        "criterion_number": 13,
        "description": "The response should include non-hereditary risk factors, including diet.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Discusses diet high in red/processed meats and low in fruits/vegetables as possibly increasing risk."
      },
      {
        "criterion_number": 14,
        "description": "The response should include non-hereditary risk factors, including exposure to certain industrial chemicals.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of occupational or industrial chemical exposures."
      },
      {
        "criterion_number": 15,
        "description": "The response should state that if you have a strong family history, discuss with your doctor about screening or genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises talking to a doctor and explicitly recommends genetic counseling and consideration of genetic testing; mentions screening strategies."
      }
    ],
    "question_number": 26,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:02:09.590777",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the patient should undergo genetic counseling.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly emphasizes speaking with a genetic counselor as the most crucial step."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the type of genetic testing depends on the specific family history or hereditary condition.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that the right test depends entirely on specific family history and details a process for tailoring testing."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that single genes can be tested if there is a known condition associated with a specific genetic disorder.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes a section on Single-Gene Testing and Single-Site Analysis for known familial variants, with clear indications of when to use them."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that a panel of genes can be tested for multiple genes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It has a dedicated Multi-Gene Panel Testing section describing testing multiple genes simultaneously for a condition."
      },
      {
        "criterion_number": 5,
        "description": "The response should provide examples of single gene disorders such as Huntington\u2019s Disease, Cystic Fibrosis, and Sickle Cell.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides an explicit example of a single-gene disorder (Huntington\u2019s disease) for single-gene testing."
      },
      {
        "criterion_number": 6,
        "description": "The response should provide examples of panel testing for hereditary cancer and cardiomyopathy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes examples of a Hereditary Cancer Panel and a Cardiomyopathy Panel, listing representative genes for each."
      }
    ],
    "question_number": 27,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:02:30.153345",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the patient should undergo genetic counseling.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that the first and most crucial step is consultation with a Genetic Counselor or medical geneticist."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the type of genetic testing depends on the specific family history or hereditary condition.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly notes testing is specific and personalized, guided by the exact disease, inheritance pattern, and known familial variants."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that single genes can be tested if there is a known condition associated with a specific genetic disorder.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes targeted variant testing for a known familial pathogenic variant and provides single-gene examples (e.g., HTT for Huntington\u2019s)."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that a panel of genes can be tested for multiple genes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes a detailed section on gene panel testing, explaining analysis of multiple genes and when it is recommended."
      },
      {
        "criterion_number": 5,
        "description": "The response should provide examples of single gene disorders such as Huntington\u2019s Disease, Cystic Fibrosis, and Sickle Cell.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions Huntington\u2019s disease (HTT), cystic fibrosis, and sickle cell anemia among examples."
      },
      {
        "criterion_number": 6,
        "description": "The response should provide examples of panel testing for hereditary cancer and cardiomyopathy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides examples of hereditary cancer panels and inherited cardiac disease/cardiomyopathy panels."
      }
    ],
    "question_number": 27,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:02:45.593919",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the types of clinical trials.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly describes trials aimed at treatment, prevention, diagnosis, and symptom/side-effect management."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that clinical trials are divided into three different phases.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response describes four phases (I\u2013IV) and does not state that trials are divided into three phases."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that phase 1 is the first time the drug is tested in humans and is aimed at establishing the safety and dosage.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states Phase I is first-in-human, with goals to determine safe dosage, administration, and side effects."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that phase 2 tests the effectiveness of the drug and continues to establish its safety.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes Phase II evaluates whether the treatment has an effect on cancer and continues safety monitoring."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that phase 3 tests the efficacy of the drug in a larger group of patients and compares it to the current standard of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes large-scale Phase III trials comparing new treatment to standard of care, often randomized."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe eligibility criteria for clinical trials, including stage of disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Discusses need for exact diagnosis, stage (example given), molecular markers, prior treatments, and overall health\u2014key eligibility elements."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that there can be risks associated with participating in a trial, including potential side effects and lack of efficacy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists risks including the possibility the treatment may not work and potential unexpected side effects; also mentions logistical burdens."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend discussing clinical trial options with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes starting with the oncologist as the most important step and suggests specific questions to ask."
      },
      {
        "criterion_number": 9,
        "description": "The response should include clinicaltrials.gov as a resource for finding clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists ClinicalTrials.gov as the primary comprehensive database."
      },
      {
        "criterion_number": 10,
        "description": "The response should offer support for the diagnosis and how difficult it can be to complete 15 rounds of chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with empathetic acknowledgment of the diagnosis and the challenge of completing 15 rounds of chemotherapy."
      }
    ],
    "question_number": 28,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:03:10.887323",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the types of clinical trials.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Defines clinical trials and explicitly notes they can test prevention, screening, diagnosis, and treatment approaches; also lists types of interventions (drugs, combinations, radiation, surgery, side-effect management)."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that clinical trials are divided into three different phases.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Describes Phases I, II, III, and IV but does not state that trials are divided into three phases; explicitly presents four phases instead."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that phase 1 is the first time the drug is tested in humans and is aimed at establishing the safety and dosage.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Accurately states Phase I focuses on safety and determining best dose, but does not state that it is the first time the drug is tested in humans."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that phase 2 tests the effectiveness of the drug and continues to establish its safety.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states Phase II focuses on effectiveness and that safety continues to be monitored."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that phase 3 tests the efficacy of the drug in a larger group of patients and compares it to the current standard of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains Phase III compares new treatment to standard treatment, involves a large number of participants, and evaluates effectiveness."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe eligibility criteria for clinical trials, including stage of disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists eligibility including type and stage of cancer, prior treatments, organ function, age, and performance status; stage is explicitly mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that there can be risks associated with participating in a trial, including potential side effects and lack of efficacy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly outlines risks including unknown side effects and that the treatment may not be effective."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend discussing clinical trial options with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Strongly advises discussing options with the loved one's oncologist first and to start with an open discussion with the current care team."
      },
      {
        "criterion_number": 9,
        "description": "The response should include clinicaltrials.gov as a resource for finding clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically references ClinicalTrials.gov, explains its purpose, and gives search tips."
      },
      {
        "criterion_number": 10,
        "description": "The response should offer support for the diagnosis and how difficult it can be to complete 15 rounds of chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with empathetic acknowledgment of the difficult journey and recognizes the significance of completing 15 rounds of chemotherapy."
      }
    ],
    "question_number": 28,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:03:37.799813",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must include ClinicalTrials.gov as a resource for finding clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists ClinicalTrials.gov as a key resource and explains its comprehensiveness."
      },
      {
        "criterion_number": 2,
        "description": "The response must provide instructions on using the search by location function on ClinicalTrials.gov.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides location-based search guidance: instructs entering information in the 'Country' and 'Location' fields to narrow the search."
      },
      {
        "criterion_number": 3,
        "description": "The response must mention the National Cancer Institute (NCI) website and describe using it to search for trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions NCI's 'Find a Clinical Trial' page with link and gives step-by-step instructions including entering cancer type, zip code, radius, and advanced filters."
      },
      {
        "criterion_number": 4,
        "description": "The response must mention and provide a link to the Pancreatic Cancer Action Network (PanCAN) clinical trial finder tool.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Highlights PanCAN Patient Central and includes a direct link to the PanCAN Clinical Trial Finder, phone number, and email."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend contacting advocacy organizations for information on clinical trials, including PanCAN.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly recommends contacting PanCAN (advocacy organization) for a personalized trial search and support."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend contacting advocacy organizations for information on clinical trials, including the American Cancer Society.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention or recommend the American Cancer Society anywhere in the response."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient discuss clinical trial options with their oncology team and consult with a local healthcare provider or oncologist to explore available trials at nearby cancer centers, as well as contact major cancer centers for additional information on clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Step 1 emphasizes discussing with the oncology team; also advises checking NCI-Designated Cancer Centers and their websites for trials and contacting coordinators."
      }
    ],
    "question_number": 29,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:03:56.035535",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must include ClinicalTrials.gov as a resource for finding clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly identifies ClinicalTrials.gov, describes it as the most comprehensive database, and provides the URL."
      },
      {
        "criterion_number": 2,
        "description": "The response must provide instructions on using the search by location function on ClinicalTrials.gov.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Gives step-by-step instructions to enter city/zip, select state, country, and set a radius, which directly addresses location-based searching."
      },
      {
        "criterion_number": 3,
        "description": "The response must mention the National Cancer Institute (NCI) website and describe using it to search for trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions NCI, provides Cancer.gov, and advises searching for pancreatic cancer clinical trials; also references NCI\u2019s information service."
      },
      {
        "criterion_number": 4,
        "description": "The response must mention and provide a link to the Pancreatic Cancer Action Network (PanCAN) clinical trial finder tool.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions PanCAN and its clinical trial finder but only links to the main site (PanCAN.org) and does not provide a direct link to the specific clinical trial finder tool."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend contacting advocacy organizations for information on clinical trials, including PanCAN.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends contacting PanCAN\u2019s Patient Services team and provides their phone number, fulfilling the advocacy recommendation."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend contacting advocacy organizations for information on clinical trials, including the American Cancer Society.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention or recommend contacting the American Cancer Society."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient discuss clinical trial options with their oncology team and consult with a local healthcare provider or oncologist to explore available trials at nearby cancer centers, as well as contact major cancer centers for additional information on clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises starting with the oncologist/nurse navigator and suggests checking NCI-designated cancer centers\u2019 trial pages."
      }
    ],
    "question_number": 29,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:04:18.884731",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that family history of pancreatic cancer is associated with increased risk.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that having a first-degree relative with pancreatic cancer increases risk and that risk is higher with multiple affected relatives."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that BRCA1/BRCA2 mutations are genetic risk factors for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists BRCA1 and BRCA2 mutations under inherited genetic syndromes that increase pancreatic cancer risk."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that smoking is a significant modifiable risk factor for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Identifies tobacco use as the single most important avoidable risk factor and quantifies risk (2\u20133x)."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that chronic pancreatitis is a risk factor for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Names chronic pancreatitis as one of the strongest risk factors and explains mechanism via persistent inflammation/DNA damage."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that heavy alcohol use can lead to increased risk of pancreatic cancer through pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States heavy, long-term alcohol use is a leading cause of chronic pancreatitis, which is a major risk factor."
      },
      {
        "criterion_number": 6,
        "description": "The response should identify Lynch syndrome as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly lists Lynch syndrome among inherited genetic syndromes linked to increased risk."
      },
      {
        "criterion_number": 7,
        "description": "The response should identify Peutz-Jeghers syndrome as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly lists Peutz-Jeghers syndrome among inherited risk factors."
      },
      {
        "criterion_number": 8,
        "description": "The response should identify Familial atypical multiple mole melanoma as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly lists Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome as a risk factor."
      },
      {
        "criterion_number": 9,
        "description": "The response should identify hereditary pancreatitis as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifically lists hereditary pancreatitis under inherited syndromes and highlights elevated risk."
      },
      {
        "criterion_number": 10,
        "description": "The response should include age as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Notes that risk increases with age and most cases occur over age 65."
      },
      {
        "criterion_number": 11,
        "description": "The response should include diabetes as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Identifies long-standing type 2 diabetes as a risk factor and discusses new-onset diabetes as a potential early sign."
      },
      {
        "criterion_number": 12,
        "description": "The response should include obesity as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists obesity/excess body weight with quantified increased risk and possible mechanisms."
      },
      {
        "criterion_number": 13,
        "description": "The response should include diet as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Discusses diets high in red/processed meats and saturated fats as associated with increased risk."
      },
      {
        "criterion_number": 14,
        "description": "The response should include exposure to certain industrial chemicals as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions workplace exposure to pesticides, dyes, and metalworking chemicals as potential risk factors."
      },
      {
        "criterion_number": 15,
        "description": "The response should state that if you have a strong family history, discuss with your doctor about screening or genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises those with strong family history or known mutations to speak with a doctor or genetic counselor about screening and risk management."
      }
    ],
    "question_number": 30,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:04:44.618437",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that family history of pancreatic cancer is associated with increased risk.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that having a first-degree relative with pancreatic cancer roughly doubles risk and that risk increases with more affected relatives."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that BRCA1/BRCA2 mutations are genetic risk factors for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists BRCA1 and BRCA2 mutations among inherited syndromes that significantly increase pancreatic cancer risk."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that smoking is a significant modifiable risk factor for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Identifies smoking as one of the strongest modifiable risk factors and notes approximately doubled risk for smokers."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that chronic pancreatitis is a risk factor for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states that long-term inflammation of the pancreas, especially hereditary pancreatitis, significantly increases risk."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that heavy alcohol use can lead to increased risk of pancreatic cancer through pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes heavy alcohol use as a major cause of chronic pancreatitis, which is a strong risk factor for pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should identify Lynch syndrome as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly lists Lynch syndrome (HNPCC) among inherited risk syndromes."
      },
      {
        "criterion_number": 7,
        "description": "The response should identify Peutz-Jeghers syndrome as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly lists Peutz-Jeghers syndrome (STK11) as a genetic risk factor."
      },
      {
        "criterion_number": 8,
        "description": "The response should identify Familial atypical multiple mole melanoma as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome (CDKN2A) as a risk factor."
      },
      {
        "criterion_number": 9,
        "description": "The response should identify hereditary pancreatitis as a genetic risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifically lists hereditary pancreatitis (PRSS1 or SPINK1) as increasing risk."
      },
      {
        "criterion_number": 10,
        "description": "The response should include age as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States risk increases with age and gives average age at diagnosis around 70."
      },
      {
        "criterion_number": 11,
        "description": "The response should include diabetes as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Discusses long-standing type 2 diabetes and new-onset diabetes in older adults in relation to pancreatic cancer risk."
      },
      {
        "criterion_number": 12,
        "description": "The response should include obesity as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Identifies being overweight or obese as increasing risk."
      },
      {
        "criterion_number": 13,
        "description": "The response should include diet as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Notes diets high in red/processed meats and low in fruits/vegetables may increase risk."
      },
      {
        "criterion_number": 14,
        "description": "The response should include exposure to certain industrial chemicals as a non-hereditary risk factor for pancreatic cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions potential links with occupational exposure to pesticides, dyes, and petrochemicals."
      },
      {
        "criterion_number": 15,
        "description": "The response should state that if you have a strong family history, discuss with your doctor about screening or genetic testing.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advises discussing personal risk with a doctor but does not specifically mention strong family history or screening/genetic testing."
      }
    ],
    "question_number": 30,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:05:13.162007",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend asking for a referral from their primary doctor or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly advises starting with the current medical team and explicitly says to ask for a referral, including the 'If it were your family member...' prompt."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend using the PanCAN patient services to find a pancreatic cancer specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends PanCAN as the best resource, provides the phone number (877-272-6226) and website (pancan.org), and describes the service."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend using the American Cancer Society patient services to find a pancreatic cancer specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions the American Cancer Society with a 24/7 helpline, provides the phone number (800-227-2345) and website (cancer.org)."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that they can reference the NCI website to look for designated cancer centers that have pancreatic cancer specialists on staff.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directs the reader to search for NCI-Designated Cancer Centers and includes the official NCI link to find centers."
      },
      {
        "criterion_number": 5,
        "description": "The response should include information about the nearest cancer center.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides general resources and a link to locate centers but does not identify or include information about the nearest specific cancer center."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend checking with their health insurance provider about in-network pancreatic cancer specialists.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises checking the insurance provider\u2019s portal for in-network specialists and specifies relevant specialties."
      }
    ],
    "question_number": 31,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:05:33.099585",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend asking for a referral from their primary doctor or oncologist",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises starting with referrals, including the primary care physician (PCP) and other current doctors, which satisfies referral from the primary doctor."
      },
      {
        "criterion_number": 2,
        "description": "Recommend using the PanCAN patient services to find a pancreatic cancer specialist",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically recommends the Pancreatic Cancer Action Network (PanCAN) Patient Services and provides the website and phone guidance."
      },
      {
        "criterion_number": 3,
        "description": "Recommend using the American Cancer Society patient services to find a pancreatic cancer specialist",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention the American Cancer Society or its patient services."
      },
      {
        "criterion_number": 4,
        "description": "State that they can reference the NCI website to look for designated cancer centers",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directs readers to NCI-Designated Cancer Centers with a link to the NCI website and explains why these centers are beneficial."
      },
      {
        "criterion_number": 5,
        "description": "Include information about the nearest cancer center",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides general methods and resources but does not identify or discuss a specific nearest cancer center."
      },
      {
        "criterion_number": 6,
        "description": "Recommend checking with their health insurance provider about in-network pancreatic cancer specialists",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises using the insurance provider\u2019s website to find in-network doctors and filter by specialty."
      }
    ],
    "question_number": 31,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:05:51.425175",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define CA 19-9.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines CA 19-9 as Carbohydrate Antigen 19-9 and explains it is a tumor marker, including what a tumor marker is, providing a clear and accurate definition."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that CA 19-9 is a tumor marker produced by cancer cells and measurable in the blood, and describe its use in pancreatic cancer, noting that it can serve as a marker for the disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states CA 19-9 is a tumor marker produced by cancer cells or by the body in response to cancer, notes it is measured in blood, and thoroughly describes its primary uses in pancreatic cancer (monitoring treatment, prognosis, aiding diagnosis, detecting recurrence)."
      },
      {
        "criterion_number": 3,
        "description": "The response must include that CA 19-9 can be elevated in other conditions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states non-cancerous conditions can raise CA 19-9 and provides multiple examples (pancreatitis, gallstones/biliary obstruction, liver disease, IBD, cystic fibrosis, thyroid disease), fulfilling the criterion."
      }
    ],
    "question_number": 32,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:06:07.998512",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define CA 19-9.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines CA 19-9 as a mucin-like glycoprotein/tumor marker present in blood and produced by certain cells; specifies it is found in small amounts in healthy individuals."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that CA 19-9 is a tumor marker produced by cancer cells and measurable in the blood, and describe its use in pancreatic cancer, noting that it can serve as a marker for the disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly identifies CA 19-9 as a tumor marker measurable in blood, emphasizes its primary association with pancreatic cancer, and details clinical uses (monitoring treatment, detecting recurrence, assessing prognosis) while noting it is not for screening/diagnosis alone."
      },
      {
        "criterion_number": 3,
        "description": "The response must include that CA 19-9 can be elevated in other conditions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States lack of specificity and lists multiple benign causes of elevation (pancreatitis, gallstones, cholecystitis, cirrhosis, hepatitis, IBD, biliary obstruction) as well as other cancers."
      }
    ],
    "question_number": 32,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:06:20.332518",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that reference ranges can vary by lab.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response provides a typical normal threshold (<37 U/mL) but does not mention that reference ranges can vary between laboratories."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that normal levels are typically less than 37 U/mL but do not rule out cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly defines the normal range as <37 U/mL and states that normal levels do not rule out cancer, citing early cancers and Lewis antigen\u2013negative individuals."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that levels from 37 to 100 U/mL can be associated with non-cancer conditions such as pancreatitis and bile duct disorders.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It labels 38\u2013100 U/mL as commonly benign and lists pancreatitis and bile duct-related conditions (gallstones, cholangitis) among causes."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that moderate elevation (100-1000 U/mL) can be concerning for cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that >100 U/mL raises a strong suspicion for cancer, which encompasses the 100\u20131000 U/mL range as concerning."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that levels greater than 1000 U/mL can be suggestive of advanced cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes levels can be in the thousands and that higher numbers may indicate more advanced disease."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the use of CA 19-9 in pancreatic cancer, including that it can be a marker of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It identifies CA 19-9 as a tumor marker most closely associated with pancreatic cancer and discusses its clinical use in that context."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that CA 19-9 can be elevated in other conditions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists multiple benign conditions (pancreatitis, bile duct disorders, liver disease, IBD, cysts, thyroid disease) and other cancers as causes of elevation."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that CA 19-9 can be used for monitoring the effectiveness of pancreatic cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly explains monitoring treatment response with decreasing/stable/increasing trends after therapy."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that CA 19-9 can be used for detecting recurrence of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes a dedicated section on detecting recurrence, noting that rising CA 19-9 can precede imaging findings."
      },
      {
        "criterion_number": 10,
        "description": "The response should include that CA 19-9 can be used in other cancers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It enumerates other cancers associated with elevated CA 19-9: cholangiocarcinoma, colorectal, gastric, ovarian, and liver cancers."
      },
      {
        "criterion_number": 11,
        "description": "The response should include that CA 19-9 can be elevated in liver disease.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It explicitly lists liver disease such as cirrhosis and hepatitis as causes of elevation."
      },
      {
        "criterion_number": 12,
        "description": "The response should include that CA 19-9 can be elevated in gallstones.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Gallstones are directly mentioned as a benign cause of mild to moderate elevation."
      },
      {
        "criterion_number": 13,
        "description": "The response should include that CA 19-9 can be elevated with elevated bilirubin.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Although bile duct obstruction and liver disease are mentioned, the response does not specifically state that elevated bilirubin can raise CA 19-9."
      },
      {
        "criterion_number": 14,
        "description": "The response should include that CA 19-9 is not produced by all pancreatic cancers.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It explains that Lewis antigen\u2013negative individuals cannot produce CA 19-9 even with advanced pancreatic cancer and notes early cancers may not produce enough, indicating not all pancreatic cancers yield elevated CA 19-9."
      }
    ],
    "question_number": 33,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:06:56.804665",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that reference ranges can vary by lab.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response provides a single normal cutoff (\"<35 U/mL\") but does not mention that reference ranges vary by laboratory."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that normal levels are typically less than 37 U/mL but do not rule out cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states a typical normal cutoff (\"<35 U/mL\") and clearly notes that normal CA 19-9 does not rule out cancer. While it uses 35 rather than 37 U/mL, it conveys the standard low-30s cutoff and the key caveat."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that levels from 37 to 100 U/mL can be associated with non-cancer conditions such as pancreatitis and bile duct disorders.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It describes \"moderately elevated (35\u2013200 U/mL)\" often occurring with benign conditions, and lists pancreatitis, gallstones/biliary obstruction, and cholangitis, which covers the 37\u2013100 U/mL range."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that moderate elevation (100-1000 U/mL) can be concerning for cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It labels elevations >200 U/mL (especially >1000) as more concerning for cancer and suggests 35\u2013200 U/mL are more often benign. It does not indicate that 100\u20131000 U/mL can be concerning."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that levels greater than 1000 U/mL can be suggestive of advanced cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly highlights \">1000 U/mL\" as especially concerning for cancer and notes higher levels often correlate with more advanced disease."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the use of CA 19-9 in pancreatic cancer, including that it can be a marker of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It identifies CA 19-9 as a tumor marker used primarily in the management of pancreatic cancer and lists pancreatic cancer among malignant causes."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that CA 19-9 can be elevated in other conditions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists numerous benign conditions (pancreatitis, gallstones, cholangitis, cirrhosis, hepatitis, etc.) and other cancers, indicating CA 19-9 can be elevated outside pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that CA 19-9 can be used for monitoring the effectiveness of pancreatic cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that falling CA 19-9 during treatment suggests effectiveness and that return to normal after therapy can indicate remission."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that CA 19-9 can be used for detecting recurrence of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that rising CA 19-9 levels during or after treatment can indicate progression or recurrence."
      },
      {
        "criterion_number": 10,
        "description": "The response should include that CA 19-9 can be used in other cancers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists cholangiocarcinoma, gastric, colorectal, ovarian, and liver cancers as malignancies associated with elevated CA 19-9."
      },
      {
        "criterion_number": 11,
        "description": "The response should include that CA 19-9 can be elevated in liver disease.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It mentions cirrhosis and hepatitis as benign causes of elevated CA 19-9."
      },
      {
        "criterion_number": 12,
        "description": "The response should include that CA 19-9 can be elevated in gallstones.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It explicitly lists gallstones (especially with bile duct obstruction) as a benign cause."
      },
      {
        "criterion_number": 13,
        "description": "The response should include that CA 19-9 can be elevated with elevated bilirubin.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It states that jaundice/biliary obstruction can markedly elevate CA 19-9 and often normalizes after relief, which corresponds to elevated bilirubin states."
      },
      {
        "criterion_number": 14,
        "description": "The response should include that CA 19-9 is not produced by all pancreatic cancers.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It explains that some cancers may not produce elevated CA 19-9 (especially early) and that 5\u201310% of individuals (Lewis antigen\u2013negative) cannot produce CA 19-9, meaning not all pancreatic cancers will yield elevated levels."
      }
    ],
    "question_number": 33,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:08:00.789804",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that CA 19-9 can be elevated with pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions acute and chronic pancreatitis as causes of elevated CA 19-9."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that CA 19-9 can be elevated with liver diseases like cirrhosis or hepatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists hepatitis (viral/autoimmune) and cirrhosis under liver conditions that elevate CA 19-9."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that CA 19-9 can be elevated with cholestasis or biliary diseases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes bile duct obstruction, gallstones, cholangitis, and primary sclerosing cholangitis, all biliary/cholestatic processes."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that CA 19-9 can be elevated with inflammatory bowel disease or gastrointestinal diseases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically mentions inflammatory bowel disease (Crohn's, ulcerative colitis), diverticulitis, and intestinal obstruction."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that CA 19-9 can be elevated with infections or other inflammatory conditions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes multiple infectious/inflammatory conditions such as cholangitis, hepatitis, PID, pancreatitis, and general inflammatory states."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that CA 19-9 can be a marker of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states CA 19-9 is a tumor marker for pancreatic cancer and discusses its use in monitoring."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that CA 19-9 can be used in other cancers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists several other cancers associated with elevated CA 19-9, including cholangiocarcinoma, gallbladder, colorectal, gastric, HCC, ovarian, lung, and breast cancers."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that CA 19-9 is not produced by all pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains Lewis antigen\u2013negative individuals cannot produce CA 19-9, so levels can be normal even with advanced pancreatic cancer."
      }
    ],
    "question_number": 34,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:08:28.361593",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that CA 19-9 can be elevated with pancreatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists acute and chronic pancreatitis as causes of elevated CA 19-9."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that CA 19-9 can be elevated with liver diseases like cirrhosis or hepatitis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions liver conditions including cirrhosis and hepatitis as causes."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that CA 19-9 can be elevated with cholestasis or biliary diseases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists biliary obstruction and inflammation (choledocholithiasis, cholangitis, cholecystitis, PSC), satisfying cholestatic/biliary causes."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that CA 19-9 can be elevated with inflammatory bowel disease or gastrointestinal diseases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically cites inflammatory bowel disease (Crohn\u2019s and ulcerative colitis) and other GI conditions."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that CA 19-9 can be elevated with infections or other inflammatory conditions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions severe infections/sepsis and autoimmune conditions; also includes cholangitis (an infectious/inflammatory condition)."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that CA 19-9 can be a marker of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States CA 19-9 is used as a marker for monitoring in patients with known cancer, specifically mentions pancreatic/biliary cancers."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that CA 19-9 can be used in other cancers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a list of other malignancies associated with elevated CA 19-9 (colorectal, gastric, ovarian mucinous, HCC, esophageal, lung)."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that CA 19-9 is not produced by all pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses Lewis antigen\u2013negative individuals who cannot express CA 19-9, but does not state that some pancreatic cancers themselves do not produce CA 19-9."
      }
    ],
    "question_number": 34,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:08:58.079784",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing weight loss with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly advises involving the oncologist, nursing team, and asking for referral to an oncology dietitian; also recommends palliative care involvement and ongoing communication about weight and appetite."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that pancreatic enzyme replacement can be taken to help with the absorption of nutrients from foods.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a dedicated section on PERT, explains PEI, names common brands (Creon, Zenpep, Pancreaze), and states enzymes are needed to absorb nutrients, with instructions on proper timing and dosing rationale."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that nutritional strategies can be employed, such as focusing on small, frequent meals and nutrient-rich foods, and should recommend including calorie-dense and protein-rich foods in the diet.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Gives extensive dietary strategies including small, frequent meals; high-calorie, high-protein foods; fortifying meals; use of fats and protein sources; smoothies and oral nutrition supplements."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that medications for managing nausea can be helpful.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends asking the doctor for anti-nausea medications and timing them 30\u201360 minutes before meals."
      },
      {
        "criterion_number": 5,
        "description": "The response should state there are many causes of weight loss in patients with pancreatic cancer, including weight loss related to chemotherapy side effects.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains cancer cachexia is due to the cancer and the side effects of treatment, and details chemo-related side effects (nausea, taste changes, mucositis, fatigue) that impair intake."
      },
      {
        "criterion_number": 6,
        "description": "The response should state there are many causes of weight loss in patients with pancreatic cancer, including weight loss related to pancreatic enzyme deficiency.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Identifies pancreatic exocrine insufficiency as a cause of malabsorption and weight loss and recommends PERT to address it."
      }
    ],
    "question_number": 35,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:09:18.858201",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing weight loss with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly emphasizes communicating with the entire medical team (oncologist, surgeon, nurses) and especially an oncology dietitian; repeatedly advises partnering with the team and considering palliative care."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that pancreatic enzyme replacement can be taken to help with the absorption of nutrients from foods.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly recommends PERT (e.g., Creon, Zenpep) with every meal/snack to improve digestion and nutrient absorption and discusses dosing/timing."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that nutritional strategies can be employed, such as focusing on small, frequent meals and nutrient-rich foods, and should recommend including calorie-dense and protein-rich foods in the diet.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides detailed dietary strategies: 6\u20138 small meals, high-calorie/high-protein foods, protein powders, full-fat dairy, healthy fats, and nutrient-dense liquids."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that medications for managing nausea can be helpful.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises obtaining prescriptions for effective anti-nausea medications as part of aggressive symptom management."
      },
      {
        "criterion_number": 5,
        "description": "The response should state there are many causes of weight loss in patients with pancreatic cancer, including weight loss related to chemotherapy side effects.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Identifies multiple causes of weight loss: disease-related factors, malabsorption, and treatment side effects including chemotherapy, radiation, and surgery."
      },
      {
        "criterion_number": 6,
        "description": "The response should state there are many causes of weight loss in patients with pancreatic cancer, including weight loss related to pancreatic enzyme deficiency.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains malabsorption from lack of digestive enzymes as a cause of weight loss and connects it to PERT for improved absorption."
      }
    ],
    "question_number": 35,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:09:40.826876",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that a symptom of pancreatic cancer can include unintentional weight loss.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists 'Unexplained Weight Loss' with details indicating unintentional weight loss."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that a symptom of pancreatic cancer can include jaundice.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes 'Jaundice (Yellowing of the Skin and Eyes)' as a common symptom with associated features."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that a symptom of pancreatic cancer can include new onset diabetes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'New-Onset Diabetes or Worsening of Existing Diabetes' and explains the mechanism."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that a symptom of pancreatic cancer can include abdominal pain.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists 'Abdominal and Back Pain' with description of typical location and radiation."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that pancreatic cancer can be difficult to detect early.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes pancreatic cancer as a 'silent' disease with vague symptoms and often diagnosed late, implying difficulty detecting early."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that pancreatic cancer does not cause symptoms until the disease is advanced.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States it 'frequently does not cause symptoms in its early stages' and symptoms appear later, satisfying the criterion."
      },
      {
        "criterion_number": 7,
        "description": "The response should state the reason for jaundice is the blockade of bile ducts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that a tumor in the head of the pancreas can block the common bile duct causing bilirubin buildup."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that loss of appetite can be a symptom.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes 'Loss of Appetite' along with weight loss and early satiety."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that abdominal bloating or indigestion can be a symptom.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly mention 'bloating' or 'indigestion'; mentions nausea, vomiting, and early satiety but not the specified symptoms."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that foul-smelling stools or steatorrhea can be a symptom.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions 'Pale, Greasy, and Floating Stools (Steatorrhea)' and describes them as foul-smelling."
      },
      {
        "criterion_number": 11,
        "description": "The response should reference the American Cancer Society information page on symptoms of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No reference to the American Cancer Society is provided."
      }
    ],
    "question_number": 36,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:09:59.730483",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that a symptom of pancreatic cancer can include unintentional weight loss.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists 'Unexplained Weight Loss' and describes 'Significant weight loss that occurs without trying.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should state that a symptom of pancreatic cancer can include jaundice.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a dedicated section on 'Jaundice' with multiple associated features."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that a symptom of pancreatic cancer can include new onset diabetes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes 'New Onset Diabetes or Worsening of Existing Diabetes' with explanation of pancreatic insulin function."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that a symptom of pancreatic cancer can include abdominal pain.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists 'Abdominal or Back Pain' with characteristic features and patterns."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that pancreatic cancer can be difficult to detect early.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States it is a 'silent disease' with vague or absent early symptoms making early diagnosis challenging."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that pancreatic cancer does not cause symptoms until the disease is advanced.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes it 'rarely causes symptoms in its early stages' and is often diagnosed at an advanced stage."
      },
      {
        "criterion_number": 7,
        "description": "The response should state the reason for jaundice is the blockade of bile ducts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains tumor can block the common bile duct leading to jaundice."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that loss of appetite can be a symptom.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions 'Loss of Appetite' with early satiety and decreased desire to eat."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that abdominal bloating or indigestion can be a symptom.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly mention bloating or indigestion as symptoms."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that foul-smelling stools or steatorrhea can be a symptom.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically describes steatorrhea as fatty, foul-smelling stools that may float."
      },
      {
        "criterion_number": 11,
        "description": "The response should reference the American Cancer Society information page on symptoms of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No reference to the American Cancer Society is provided."
      }
    ],
    "question_number": 36,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:10:22.805012",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that most pancreatic cancer cases are sporadic and not hereditary.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states that most cases are sporadic and not inherited, and quantifies hereditary cases as about 5\u201310%."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that there are hereditary conditions that can lead to pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly describes hereditary pancreatic cancer (5\u201310%) and lists multiple hereditary syndromes that increase risk."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that a strong family history is a significant risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Discusses familial pancreatic cancer and highlights two or more first-degree relatives and early-onset cases as concerning family history."
      },
      {
        "criterion_number": 4,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including familial pancreatic cancer syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines and explains familial pancreatic cancer (~10%) and distinguishes it from sporadic and hereditary forms."
      },
      {
        "criterion_number": 5,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including BRCA1/BRCA2 mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically lists BRCA1 and BRCA2 mutations as common causes of hereditary pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including Lynch syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Names Lynch syndrome and its genes (MLH1, MSH2, MSH6, PMS2) as linked to increased pancreatic cancer risk."
      },
      {
        "criterion_number": 7,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including Peutz-Jeghers syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly includes Peutz-Jeghers syndrome (STK11) and notes its high associated pancreatic cancer risk."
      },
      {
        "criterion_number": 8,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including Familial atypical multiple mole melanoma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome due to CDKN2A mutation as increasing pancreatic cancer risk."
      },
      {
        "criterion_number": 9,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including hereditary pancreatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes hereditary pancreatitis (PRSS1) and connects chronic pancreatitis to elevated pancreatic cancer risk."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that if you are concerned about your risk of pancreatic cancer, you should consult an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advises talking to a primary care physician and seeing a genetic counselor, but does not specifically recommend consulting an oncologist."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that if you are concerned about your risk of pancreatic cancer, you should consult a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly advises seeing a genetic counselor for risk assessment, testing, and interpretation."
      }
    ],
    "question_number": 37,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:10:44.600410",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that most pancreatic cancer cases are sporadic and not hereditary.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states most cases are not hereditary and gives an estimate (90\u201395% sporadic)."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that there are hereditary conditions that can lead to pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states 5\u201310% are linked to inherited mutations and describes hereditary pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that a strong family history is a significant risk factor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes that strong family history indicates increased risk and discusses familial pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including familial pancreatic cancer syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines and explains Familial Pancreatic Cancer and lists multiple relevant hereditary syndromes."
      },
      {
        "criterion_number": 5,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including BRCA1/BRCA2 mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions BRCA1 and BRCA2 as increasing pancreatic cancer risk."
      },
      {
        "criterion_number": 6,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including Lynch syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions Lynch syndrome (MLH1, MSH2, MSH6, PMS2)."
      },
      {
        "criterion_number": 7,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including Peutz-Jeghers syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions Peutz-Jeghers syndrome (STK11)."
      },
      {
        "criterion_number": 8,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including Familial atypical multiple mole melanoma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions FAMMM syndrome (CDKN2A/p16)."
      },
      {
        "criterion_number": 9,
        "description": "The response should identify hereditary pancreatic cancer syndromes, including hereditary pancreatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions hereditary pancreatitis due to PRSS1 mutations."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that if you are concerned about your risk of pancreatic cancer, you should consult an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advises discussing with a doctor but does not specifically recommend consulting an oncologist."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that if you are concerned about your risk of pancreatic cancer, you should consult a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically recommends considering genetic counseling."
      }
    ],
    "question_number": 37,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:11:00.437672",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must explicitly state that routine screening is not recommended for the general population.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states: 'There is no routine screening test for pancreatic cancer in the general population.'"
      },
      {
        "criterion_number": 2,
        "description": "The response must mention MRI as a surveillance modality for high-risk individuals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Names MRI/MRCP as a primary imaging tool and explains its role in surveillance."
      },
      {
        "criterion_number": 3,
        "description": "The response must specify that surveillance typically starts around age 50 and continues annually.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States start age 'around age 50 (or 10 years earlier than youngest case)' and recommends imaging every 6\u201312 months, which includes annual intervals."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly state that the evidence for screening/surveillance is not well established and mention the risk of overdiagnosis leading to unnecessary stress and procedures.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response discusses overdiagnosis, false positives, and anxiety but does not explicitly state that evidence for screening/surveillance is not well established."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that people at high risk may benefit from screening.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly outlines benefits of surveillance for high-risk individuals, including earlier detection and increased resectability."
      },
      {
        "criterion_number": 6,
        "description": "The response should define people at high risk of pancreatic cancer to include those with a significant family history of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines familial pancreatic cancer criteria (e.g., two FDRs or three affected relatives with at least one FDR)."
      },
      {
        "criterion_number": 7,
        "description": "The response should define people at high risk of pancreatic cancer to include those with a known genetic syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists multiple high-risk syndromes/mutations (BRCA1/2, PALB2, CDKN2A, STK11/Peutz-Jeghers, Lynch, ATM, hereditary pancreatitis)."
      },
      {
        "criterion_number": 8,
        "description": "The response should define people at high risk of pancreatic cancer to include those with a history of chronic pancreatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies hereditary pancreatitis (a form of chronic pancreatitis) as a high-risk condition warranting surveillance."
      },
      {
        "criterion_number": 9,
        "description": "The response should include EUS as a screening modality to detect pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes Endoscopic Ultrasound (EUS) in detail as a primary surveillance tool."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend people discuss the risks and benefits of screening with a doctor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises speaking to a doctor and notes that surveillance decisions should be made in consultation with specialists at a high-volume center."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend people discuss the risks and benefits of screening with a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends consultation with a genetic counselor and states the decision to begin surveillance should include a genetic counselor."
      }
    ],
    "question_number": 38,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:11:38.464456",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must explicitly state that routine screening is not recommended for the general population.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response has a dedicated section titled 'Why General Population Screening is Not Recommended' and clearly states that routine screening is not recommended for the general population."
      },
      {
        "criterion_number": 2,
        "description": "The response must mention MRI as a surveillance modality for high-risk individuals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "MRI/MRCP is explicitly listed as a surveillance method for high-risk individuals with details on advantages and frequency."
      },
      {
        "criterion_number": 3,
        "description": "The response must specify that surveillance typically starts around age 50 and continues annually.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states surveillance typically begins around age 40\u201350 (or 10 years younger than the earliest family diagnosis) and that imaging is performed annually or every 6\u201312 months."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly state that the evidence for screening/surveillance is not well established and mention the risk of overdiagnosis leading to unnecessary stress and procedures.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response mentions false positives causing unnecessary procedures and anxiety, it does not explicitly state that the evidence for screening/surveillance is not well established."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that people at high risk may benefit from screening.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes surveillance for high-risk individuals to detect precancerous lesions or early cancer and improve survival, indicating benefit."
      },
      {
        "criterion_number": 6,
        "description": "The response should define people at high risk of pancreatic cancer to include those with a significant family history of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines familial pancreatic cancer (e.g., two or more first-degree relatives, or one first-degree relative diagnosed before age 50) as high risk."
      },
      {
        "criterion_number": 7,
        "description": "The response should define people at high risk of pancreatic cancer to include those with a known genetic syndrome.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists several high-risk genetic syndromes (BRCA1/2, PALB2, ATM, Peutz-Jeghers, Lynch, CDKN2A/FAMMM, hereditary pancreatitis)."
      },
      {
        "criterion_number": 8,
        "description": "The response should define people at high risk of pancreatic cancer to include those with a history of chronic pancreatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Hereditary pancreatitis is explicitly included, with recognition that chronic inflammation increases risk, thereby encompassing chronic pancreatitis as a high-risk condition."
      },
      {
        "criterion_number": 9,
        "description": "The response should include EUS as a screening modality to detect pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Endoscopic ultrasound (EUS) is discussed in detail as a surveillance modality, including its strengths and usage interval."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend people discuss the risks and benefits of screening with a doctor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises consulting with a healthcare professional to discuss appropriate screening and surveillance strategies."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend people discuss the risks and benefits of screening with a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends consultation with a genetic counselor for discussion of screening and surveillance."
      }
    ],
    "question_number": 38,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:12:34.134694",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include surgery as a potential treatment modality for resectable pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicit section on Surgery describes Whipple, distal pancreatectomy, total pancreatectomy, and notes surgery offers chance for cure in early, resectable cases."
      },
      {
        "criterion_number": 2,
        "description": "The response should specify that chemotherapy is the backbone of treatment for metastatic or unresectable pancreatic cancer, with main regimens being FOLFIRINOX or Gemcitabine + Nab-Paclitaxel.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States chemotherapy is the main treatment for advanced/metastatic disease and lists FOLFIRINOX and gemcitabine+nab-paclitaxel as common first-line regimens."
      },
      {
        "criterion_number": 3,
        "description": "The response should include radiation as a potential treatment option for localized pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes Radiation Therapy (EBRT, SBRT) and chemoradiation for locally advanced and borderline resectable disease, with neoadjuvant and palliative roles."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Early section explicitly lists stage as a key determinant and repeatedly ties modalities to stage (resectable, borderline, locally advanced, metastatic)."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the treatment of pancreatic cancer depends on the co-morbidities of the patient.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes treatment depends on the patient's overall health and fitness and ability to tolerate major surgery or intensive chemotherapy, reflecting comorbidity considerations."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that the treatment of pancreatic cancer depends on the functional status of the patient.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically ties regimen choice (e.g., FOLFIRINOX) to patients in good overall health/fitness, indicating performance status as a determinant."
      },
      {
        "criterion_number": 7,
        "description": "The response should include immunotherapy, noting its role is currently limited to patients with mismatch repair deficiency or high microsatellite instability.",
        "score_given": 15,
        "max_points": 15,
        "justification": "Includes immunotherapy with checkpoint inhibitors and clearly limits benefit to MSI-H/dMMR tumors, noting this is a very small subset."
      },
      {
        "criterion_number": 8,
        "description": "The response should include targeted therapy such as PARPi for patients with BRCA mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes PARP inhibitors (e.g., olaparib) for BRCA1/2-mutated pancreatic cancer as maintenance after platinum response."
      },
      {
        "criterion_number": 9,
        "description": "The response should introduce the concept of clinical trials and their role in the management of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a dedicated Clinical Trials section encouraging participation and explaining access to novel therapies."
      }
    ],
    "question_number": 39,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:13:10.924830",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include surgery as a potential treatment modality for resectable pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly describes surgery as the only potentially curative option, details Whipple/distal/total pancreatectomy, and defines resectable/borderline/unresectable."
      },
      {
        "criterion_number": 2,
        "description": "The response should specify that chemotherapy is the backbone of treatment for metastatic or unresectable pancreatic cancer, with main regimens being FOLFIRINOX or Gemcitabine + Nab-Paclitaxel.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States palliative chemotherapy is used for advanced/metastatic disease and lists FOLFIRINOX and gemcitabine+nab-paclitaxel as common regimens."
      },
      {
        "criterion_number": 3,
        "description": "The response should include radiation as a potential treatment option for localized pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes neoadjuvant, adjuvant, and palliative radiation; mentions SBRT for localized unresectable tumors."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly notes treatment depends on stage and whether disease is resectable."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the treatment of pancreatic cancer depends on the co-morbidities of the patient.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States treatment depends on the patient's overall health, which encompasses comorbid conditions."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that the treatment of pancreatic cancer depends on the functional status of the patient.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes treatment depends on the patient's overall health; this reasonably includes performance/functional status considerations."
      },
      {
        "criterion_number": 7,
        "description": "The response should include immunotherapy, noting its role is currently limited to patients with mismatch repair deficiency or high microsatellite instability.",
        "score_given": 15,
        "max_points": 15,
        "justification": "Includes PD-1 inhibitors (pembrolizumab) for MSI-H/dMMR tumors and notes only a small subset benefits."
      },
      {
        "criterion_number": 8,
        "description": "The response should include targeted therapy such as PARPi for patients with BRCA mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions PARP inhibitors (olaparib) for germline BRCA1/2-mutated metastatic pancreatic cancer as maintenance."
      },
      {
        "criterion_number": 9,
        "description": "The response should introduce the concept of clinical trials and their role in the management of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Has a dedicated section recommending clinical trials for access to investigational treatments."
      }
    ],
    "question_number": 39,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:13:51.835621",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that stage 0 is a pre-cancer state, also known as pancreatic intraepithelial neoplasia or carcinoma in situ.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly labels Stage 0 as carcinoma in situ and describes non-invasive abnormal cells confined to the ductal epithelium, effectively conveying a pre-cancer state. Use of 'carcinoma in situ' meets the naming requirement even without 'PanIN.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should state that stage 1 cancer is when the cancer is confined to the pancreas and has not spread to lymph nodes or distant sites.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States Stage I is confined to the pancreas and has not spread to lymph nodes or distant sites."
      },
      {
        "criterion_number": 3,
        "description": "The response should note that stage 1a is when the tumor is 2cm or smaller.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines Stage IA as tumor 2 cm or smaller (T1, N0, M0)."
      },
      {
        "criterion_number": 4,
        "description": "The response should note that stage 1b is when the tumor is larger than 2cm.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines Stage IB as tumor larger than 2 cm (T2, N0, M0)."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that stage II is when the cancer is growing into nearby tissues and into lymph nodes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes Stage II as larger tumors that may spread to nearby lymph nodes; Stage IIA indicates extension outside pancreas (nearby tissues) and Stage IIB includes nodal involvement, meeting both elements."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that stage III is when the cancer is locally advanced and involves surrounding structures.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States Stage III involves growth into major nearby blood vessels and labels it 'locally advanced,' indicating involvement of surrounding structures."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that stage IV is when the cancer has spread to other organs or sites.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines Stage IV as metastatic disease with spread to distant organs such as liver, lungs, peritoneum, and distant nodes."
      },
      {
        "criterion_number": 8,
        "description": "The response should include a description of the T, N, M staging system.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides clear definitions of T (tumor), N (nodes), and M (metastasis) and relates them to stage groupings."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that pancreatic cancer is categorized by resectability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes a clinical staging section with categories based on resectability: resectable, borderline resectable, locally advanced (unresectable), and metastatic."
      }
    ],
    "question_number": 40,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:14:16.230957",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that stage 0 is a pre-cancer state, also known as pancreatic intraepithelial neoplasia or carcinoma in situ.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly labels Stage 0 as 'Carcinoma in situ' (Tis) and describes abnormal cells confined to the ductal epithelium without invasion, which conveys a pre-cancer state."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that stage 1 cancer is when the cancer is confined to the pancreas and has not spread to lymph nodes or distant sites.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'Stage I: The tumor is confined to the pancreas' and details IA/IB as N0, M0, meeting the requirement."
      },
      {
        "criterion_number": 3,
        "description": "The response should note that stage 1a is when the tumor is 2cm or smaller.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists 'Stage IA: T1 \u2013 Tumor is 2 cm or smaller.'"
      },
      {
        "criterion_number": 4,
        "description": "The response should note that stage 1b is when the tumor is larger than 2cm.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists 'Stage IB: T2 \u2013 Tumor is larger than 2 cm but no more than 4 cm.'"
      },
      {
        "criterion_number": 5,
        "description": "The response should state that stage II is when the cancer is growing into nearby tissues and into lymph nodes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines Stage IIA as T3 (>4 cm or grown outside the pancreas) and Stage IIB as N1 (1\u20133 nodes), covering nearby tissue invasion and nodal spread."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that stage III is when the cancer is locally advanced and involves surrounding structures.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes Stage III as growth into major vessels (T4) and labels it 'locally advanced unresectable,' indicating involvement of surrounding structures."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that stage IV is when the cancer has spread to other organs or sites.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States Stage IV is M1 with spread to distant organs such as liver, lungs, peritoneum, bones."
      },
      {
        "criterion_number": 8,
        "description": "The response should include a description of the T, N, M staging system.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides clear definitions for T (tumor extent), N (lymph nodes), and M (metastasis) at the outset."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that pancreatic cancer is categorized by resectability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes a dedicated section on resectability with categories: Resectable, Borderline Resectable, Locally Advanced Unresectable, and Metastatic."
      }
    ],
    "question_number": 40,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:14:43.837538",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "States that neuropathy is a common side effect from the oxaliplatin in FOLFIRINOX.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly notes neuropathy as a common side effect of FOLFIRINOX and attributes it to oxaliplatin."
      },
      {
        "criterion_number": 2,
        "description": "States that the oncologist can \u2018hold\u2019 or temporarily stop oxaliplatin to manage neuropathy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it discusses permanently stopping oxaliplatin (switching to FOLFIRI), it does not mention holding or temporarily stopping oxaliplatin."
      },
      {
        "criterion_number": 3,
        "description": "States that neuropathy from oxaliplatin can be managed by dose reduction.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends dose reduction of oxaliplatin to manage neuropathy."
      },
      {
        "criterion_number": 4,
        "description": "States that neuropathy from oxaliplatin can be managed by schedule modification.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of modifying the dosing schedule (e.g., skipping doses, lengthening intervals); only dose reduction or stopping is discussed."
      },
      {
        "criterion_number": 5,
        "description": "States that neuropathy from oxaliplatin can be managed by switching to an alternate regimen.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It describes switching to FOLFIRI and to gemcitabine-based regimens as alternatives."
      },
      {
        "criterion_number": 6,
        "description": "States that neuropathy from oxaliplatin can be managed by switching to an alternate regimen, including gemcitabine-based therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It specifically lists gemcitabine + nab-paclitaxel and gemcitabine monotherapy."
      },
      {
        "criterion_number": 7,
        "description": "States that neuropathy from oxaliplatin can be managed using supportive medications, including gabapentin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Gabapentin is explicitly included among supportive medications."
      },
      {
        "criterion_number": 8,
        "description": "States that neuropathy from oxaliplatin can be managed using supportive medications, including SNRIs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Duloxetine (an SNRI) is specifically recommended."
      },
      {
        "criterion_number": 9,
        "description": "States that neuropathy from oxaliplatin can be managed using supportive medications, including pregabalin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Pregabalin (Lyrica) is explicitly listed."
      },
      {
        "criterion_number": 10,
        "description": "Recommends discussing medication side effects with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly advises discussing with the oncology team and provides specific questions to ask."
      }
    ],
    "question_number": 41,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:15:01.538780",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must state that neuropathy is a common side effect from the oxaliplatin in FOLFIRINOX.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states neuropathy is a well-known and dose-limiting side effect of oxaliplatin in FOLFIRINOX."
      },
      {
        "criterion_number": 2,
        "description": "The response must state that the oncologist can \u2018hold\u2019 or temporarily stop oxaliplatin to manage neuropathy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Recommends removal of oxaliplatin (mFOLFIRI) and schedule breaks, but does not clearly state holding or temporarily stopping oxaliplatin specifically."
      },
      {
        "criterion_number": 3,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by dose reduction.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly mentions dose reduction of oxaliplatin as an option for moderate neuropathy."
      },
      {
        "criterion_number": 4,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by schedule modification.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically mentions extended treatment breaks/increasing time between cycles as schedule modification."
      },
      {
        "criterion_number": 5,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by switching to an alternate regimen.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends switching to alternate chemotherapy regimens when oxaliplatin is stopped."
      },
      {
        "criterion_number": 6,
        "description": "The response must state that neuropathy from oxaliplatin can be managed by switching to an alternate regimen, including gemcitabine-based therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists gemcitabine + nab-paclitaxel and gemcitabine monotherapy as alternatives."
      },
      {
        "criterion_number": 7,
        "description": "The response must state that neuropathy from oxaliplatin can be managed using supportive medications, including gabapentin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Names gabapentin as a commonly prescribed medication for neuropathy."
      },
      {
        "criterion_number": 8,
        "description": "The response must state that neuropathy from oxaliplatin can be managed using supportive medications, including SNRIs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions duloxetine, an SNRI, as a medication used for chemotherapy-induced neuropathy."
      },
      {
        "criterion_number": 9,
        "description": "The response must state that neuropathy from oxaliplatin can be managed using supportive medications, including pregabalin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically lists pregabalin as an option."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend discussing medication side effects with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes discussing symptoms with the oncology team and includes a section on what to discuss with the oncologist."
      }
    ],
    "question_number": 41,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:15:26.509680",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that they should be informed about the aim of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises asking, \"What is the purpose of this trial?\" and explains trial goals across phases, clearly emphasizing understanding the trial's aim."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that they should understand the potential benefits of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a dedicated benefits section (access to innovative treatments, close monitoring, contribution to science, potential better outcomes) and earlier bullet points summarizing benefits."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that they should understand the potential risks of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists risks and downsides (unknown side effects, possible inferior efficacy, time commitment, emotional burden, costs) and advises asking about side effect management."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that they should be aware of the inclusion and exclusion criteria for the trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Although not labeled as \"inclusion/exclusion,\" it emphasizes eligibility repeatedly (oncologist knows what she might be eligible for; PanCAN provides personalized trial lists), conveying the need to determine eligibility criteria."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that they should be aware of the time commitments associated with participating in the trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly notes significant time commitment and advises asking about number of extra visits, scans, tests, frequency, and logistics."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that they should be aware of the costs associated with participating in the trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Contains a detailed 'Logistics and Costs' section (insurance coverage, sponsor-covered costs, out-of-pocket, travel/lodging, reimbursement) and flags financial burden as a potential downside."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the phase of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains Phase I\u2013IV in detail and explicitly prompts asking, \"What phase is this trial in?\""
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend understanding if there are crossover options.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions continuing treatment after the trial and stopping if not working but does not address crossover designs or whether patients can switch to the investigational arm upon progression."
      }
    ],
    "question_number": 42,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:15:49.109136",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that they should be informed about the aim of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly addressed. The answer explains trial purpose and explicitly advises asking, 'What is the primary purpose of this specific trial?' It also outlines phases and goals (safety, efficacy, comparison to standard care), which directly speaks to understanding the aim."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that they should understand the potential benefits of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Meets criterion. A dedicated 'Potential Benefits of Participating' section lists access to novel treatments, close monitoring, potential for better outcomes, and contribution to science, and it recommends asking about benefits for the patient specifically."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that they should understand the potential risks of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Fully covered. A detailed 'Potential Risks and Challenges' section outlines unknown efficacy, side effects, placebo design in oncology, logistical burdens, financial costs, emotional toll, strict eligibility, and trial discontinuation."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that they should be aware of the inclusion and exclusion criteria for the trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly addressed. It mentions 'Strict Eligibility Criteria' and advises asking about 'specific eligibility criteria' including cancer type/stage, prior treatments, comorbidities, and performance status."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that they should be aware of the time commitments associated with participating in the trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Covered. The response discusses 'Time and Travel Commitment' and recommends asking about visit frequency, required tests/procedures and how often, and how long the trial lasts."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that they should be aware of the costs associated with participating in the trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Addressed thoroughly. It outlines potential financial burdens, clarifies what sponsors vs. insurance typically cover, suggests asking 'Who pays for the experimental treatment?' and 'What costs will my mother/insurance be responsible for?' and mentions travel/lodging assistance."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the phase of the clinical trial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Fully met. It explains Phase I\u2013III objectives and instructs to ask, 'What phase is the trial in?' emphasizing implications for safety/efficacy focus."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend understanding if there are crossover options.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Not addressed. Although it discusses placebo use and what happens if treatment is not working or after the trial ends, it does not mention or advise asking about crossover from control/placebo to experimental arms."
      }
    ],
    "question_number": 42,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:16:17.754935",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Radiation can be used before surgery to help shrink borderline resectable tumors, with the goal of increasing the likelihood of achieving a complete resection in the localized setting.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly describes neoadjuvant chemoradiation for borderline resectable tumors to shrink/pull tumors away from vessels and increase chances of an R0 resection."
      },
      {
        "criterion_number": 2,
        "description": "Radiation can be used for locally advanced or unresectable tumors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states radiation (typically chemoradiation) is used as a main treatment for locally advanced unresectable disease, often after initial chemotherapy."
      },
      {
        "criterion_number": 3,
        "description": "Radiation can be used in the palliative setting to relieve symptoms in patients with advanced or metastatic disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes a dedicated palliative section noting symptom relief for pain, blockages, and bleeding, with shorter courses to minimize side effects."
      },
      {
        "criterion_number": 5,
        "description": "Pancreatic cancer treatment plans are determined by the stage of the disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states treatment depends heavily on the stage and revisits staging in the question prompts."
      },
      {
        "criterion_number": 6,
        "description": "Pancreatic cancer treatment plans are determined by the overall health of the patient.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions that approaches can depend on \"the patient,\" it does not explicitly reference overall health, performance status, or comorbidities influencing treatment decisions."
      },
      {
        "criterion_number": 7,
        "description": "The goal of radiation in the localized setting can be to sterilize vessel margins.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response discusses shrinking tumors away from vessels and achieving R0 resection but does not mention sterilizing vessel margins or equivalent phrasing."
      },
      {
        "criterion_number": 8,
        "description": "The goal of radiation in the localized setting can be to delay disease progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "For locally advanced unresectable disease (localized setting), it states goals include controlling tumor growth and slowing progression."
      },
      {
        "criterion_number": 9,
        "description": "The goal of radiation in the localized setting can be to prevent local recurrence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "In the adjuvant section, it states the goal is to kill microscopic disease and reduce the risk of the cancer coming back locally."
      }
    ],
    "question_number": 43,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:16:47.654125",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Radiation can be used before surgery to help shrink borderline resectable tumors, with the goal of increasing the likelihood of achieving a complete resection in the localized setting.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly describes neoadjuvant radiation for borderline resectable (and sometimes resectable) disease with the goal of shrinking the tumor and increasing the chances of an R0 resection."
      },
      {
        "criterion_number": 2,
        "description": "Radiation can be used for locally advanced or unresectable tumors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "A dedicated section covers locally advanced, unresectable pancreatic cancer, noting chemoradiation after initial chemotherapy to control local disease."
      },
      {
        "criterion_number": 3,
        "description": "Radiation can be used in the palliative setting to relieve symptoms in patients with advanced or metastatic disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes a palliative radiation section describing symptom relief for metastatic disease (e.g., pain, bleeding, obstruction, bone metastases) and mentions short-course treatments."
      },
      {
        "criterion_number": 5,
        "description": "Pancreatic cancer treatment plans are determined by the stage of the disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states treatment depends heavily on stage and repeatedly references resectable, borderline resectable, locally advanced unresectable, and metastatic categories."
      },
      {
        "criterion_number": 6,
        "description": "Pancreatic cancer treatment plans are determined by the overall health of the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response lists the patient's overall health and preferences as key factors influencing radiation use."
      },
      {
        "criterion_number": 7,
        "description": "The goal of radiation in the localized setting can be to sterilize vessel margins.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it discusses increasing the chance of R0 resection and treating microscopic disease, it does not specifically mention sterilizing vessel margins as a goal."
      },
      {
        "criterion_number": 8,
        "description": "The goal of radiation in the localized setting can be to delay disease progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "For locally advanced unresectable disease, the response states the goal is to control local growth and prolong survival, which corresponds to delaying disease progression."
      },
      {
        "criterion_number": 9,
        "description": "The goal of radiation in the localized setting can be to prevent local recurrence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions reducing the risk of local recurrence in both neoadjuvant and adjuvant contexts."
      }
    ],
    "question_number": 43,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:17:29.259391",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that pancreatic cancer leads to enzyme deficiency.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly explains that pancreatic cancer can reduce enzyme output ('production stops') or block enzyme delivery via the duct ('delivery is blocked'), leading to pancreatic exocrine insufficiency (PEI)."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how enzyme deficiency can lead to problems with digestion.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It describes that without enzymes, food is not properly broken down, causing malabsorption and symptoms such as bloating, gas, steatorrhea, urgent stools, weight loss, and fatigue\u2014all clear consequences of digestive impairment."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that pancreatic enzyme supplements are used to replace the enzymes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that pancreatic enzyme supplements are a 'replacement crew' containing lipase, protease, and amylase, and identifies them as Pancreatic Enzyme Replacement Therapy (PERT)."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that pancreatic enzyme supplements can improve digestion.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response notes benefits including 'Improved Digestion,' normalization of stools, reduced GI symptoms, better nutrient absorption, weight stabilization, and increased energy\u2014clearly linking PERT to improved digestion."
      }
    ],
    "question_number": 44,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:17:55.131667",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that pancreatic cancer leads to enzyme deficiency.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly explains that pancreatic cancer can damage enzyme-producing cells, block the pancreatic duct, or involve surgical removal of pancreatic tissue, leading to exocrine pancreatic insufficiency (enzyme deficiency)."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how enzyme deficiency can lead to problems with digestion.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It describes that lack of enzymes impairs breakdown of fats, carbohydrates, and proteins, causing symptoms like bloating, gas, cramping, diarrhea, steatorrhea, weight loss, and fat-soluble vitamin deficiencies due to malabsorption."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that pancreatic enzyme supplements are used to replace the enzymes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states these medications contain lipase, amylase, and protease and are used to replace the missing pancreatic enzymes (PERT)."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that pancreatic enzyme supplements can improve digestion.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states that PERT improves digestion and nutrient absorption, reduces gastrointestinal symptoms (including steatorrhea), and enhances quality of life."
      }
    ],
    "question_number": 44,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:18:05.996341",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that cancer is associated with an increased risk of developing blood clots.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly explains that cancer creates a hypercoagulable state, labels the phenomenon as Cancer-Associated Thrombosis (CAT), and describes multiple cancer-related mechanisms (e.g., tissue factor release, inflammation, treatments, immobility) that increase clot risk. This clearly communicates that cancer in general is associated with increased blood clots."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that patients with pancreatic cancer are at increased risk of developing a blood clot.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response specifically states that pancreatic cancer is one of the cancers with the highest risk for blood clots and directly links the father's DVT to pancreatic cancer, satisfying the criterion."
      }
    ],
    "question_number": 45,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:18:13.843385",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that cancer is associated with an increased risk of developing blood clots.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that cancer patients are at a significantly higher risk of developing blood clots (VTE), and provides mechanisms such as hypercoagulability, inflammation, treatment-related factors, immobility, and dehydration. This is accurate, clear, and directly addresses the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that patients with pancreatic cancer are at increased risk of developing a blood clot.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response specifically highlights pancreatic cancer as having one of the highest risks for blood clots, references tumor-related mucin production, and mentions Trousseau's syndrome. It clearly and accurately states that patients with pancreatic cancer are at increased risk."
      }
    ],
    "question_number": 45,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:18:29.683655",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must explicitly state that second opinions can be obtained at any time, including after diagnosis, before starting treatment, during treatment, or when considering clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states, \"as soon as possible, and at any point you feel it's necessary\" and provides specific scenarios including immediately after diagnosis, before starting treatment, when surgery is recommended/ruled out, to explore clinical trials, and if treatment stops working\u2014covering all phases."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly mention that second opinions are particularly helpful after the initial diagnosis and before starting treatment, as well as when the initial treatment is no longer effective.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly highlights \"Immediately After Diagnosis... Before starting any treatment\" and later \"If Treatment Stops Working,\" addressing both required moments."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly mention that a second opinion is helpful if there is uncertainty or lack of clarity regarding the diagnosis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it advises reviewing the diagnosis and says \"If You Feel Unsure or Rushed,\" it does not explicitly tie uncertainty or lack of clarity about the diagnosis itself to seeking a second opinion."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly mention that a second opinion is helpful if there is uncertainty or lack of clarity regarding staging.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response notes that a second opinion can review \"the stage of the cancer\" but does not explicitly state that it is helpful when there is uncertainty or lack of clarity about staging."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly mention that a second opinion is helpful if there is uncertainty or lack of clarity regarding the treatment plan.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It mentions reviewing the proposed treatment plan and situations like limited options or major surgery, but it does not explicitly state that a second opinion is helpful when there is uncertainty or lack of clarity specifically about the treatment plan."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that second opinions can be obtained at specialized referral centers, such as cancer centers with expertise in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It directs readers to high-volume centers with multidisciplinary teams and specialized expertise, fitting the definition of specialized referral centers."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly state that they should look up NCI-designated cancer centers specifically.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends \"NCI-Designated Comprehensive Cancer Centers\" and provides the NCI website link."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention major academic hospitals as a resource for finding pancreatic cancer specialists.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states, \"Seek Out Academic/University Hospitals,\" clearly meeting this criterion."
      },
      {
        "criterion_number": 9,
        "description": "The response must mention that the NCCN guidelines for Pancreatic Adenocarcinoma recommend evaluation at high volume centers.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of NCCN or its guideline recommendation regarding evaluation at high-volume centers."
      }
    ],
    "question_number": 46,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:19:09.938795",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must explicitly state that second opinions can be obtained at any time, including after diagnosis, before starting treatment, during treatment, or when considering clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response lists multiple appropriate times: immediately after diagnosis, before any definitive treatment begins, if initial treatment isn't working, if considering a clinical trial, and states 'As soon as you feel the need for it. There's no \"wrong\" time.'"
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly mention that second opinions are particularly helpful after the initial diagnosis and before starting treatment, as well as when the initial treatment is no longer effective.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly notes 'Immediately after diagnosis,' 'Ideally, before any definitive treatment begins,' and 'If the initial treatment isn't working as expected.'"
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly mention that a second opinion is helpful if there is uncertainty or lack of clarity regarding the diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states second opinions help with 'Confirmation of Diagnosis' and advises after diagnosis to 'confirm the diagnosis,' which addresses diagnostic uncertainty."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly mention that a second opinion is helpful if there is uncertainty or lack of clarity regarding staging.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It includes 'Confirmation of... Staging' and after diagnosis to 'understand the stage,' directly addressing staging clarity."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly mention that a second opinion is helpful if there is uncertainty or lack of clarity regarding the treatment plan.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly says: 'If the proposed treatment plan seems unclear or you have doubts.'"
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that second opinions can be obtained at specialized referral centers, such as cancer centers with expertise in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It directs to 'NCI-Designated Comprehensive Cancer Centers,' 'Major Academic Medical Centers,' and 'Pancreatic Cancer Specialists,' clearly indicating specialized referral centers."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly state that they should look up NCI-designated cancer centers specifically.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends 'NCI-Designated Comprehensive Cancer Centers' and mentions finding a list on the NCI website."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention major academic hospitals as a resource for finding pancreatic cancer specialists.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions 'Major Academic Medical Centers' and explains their role in having leading experts and clinical trials."
      },
      {
        "criterion_number": 9,
        "description": "The response must mention that the NCCN guidelines for Pancreatic Adenocarcinoma recommend evaluation at high volume centers.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention NCCN guidelines or their recommendation for evaluation at high-volume centers."
      }
    ],
    "question_number": 46,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:20:31.398464",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that immunotherapy is currently limited to patients with mismatch repair deficiency or high microsatellite instability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly identifies MSI-H/dMMR pancreatic cancers (about 1\u20132%) as the subgroup for whom immunotherapy can work well and highlights pembrolizumab\u2019s tissue-agnostic approval for MSI-H/dMMR tumors."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that immunotherapy is an ongoing area of research.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states that a massive amount of research is ongoing to make immunotherapy effective for more patients and discusses multiple investigational strategies (combinations, vaccines, cellular therapies)."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that there may be clinical trial options exploring novel immunotherapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly encourages consideration of clinical trials and describes trials testing combinations, vaccines, and CAR-T, and advises asking the oncologist about trial options."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that immune checkpoint blockade is only approved for patients with metastatic disease in certain situations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes tissue-agnostic approval for MSI-H/dMMR tumors, it does not specify that approval is limited to unresectable/metastatic disease in specific settings; thus it fails to state the metastatic-only approval context."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that pembrolizumab is approved for patients whose tumors are TMB high.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although TMB testing is mentioned in the questions to ask, the response does not state that pembrolizumab has an approval for TMB-high solid tumors."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend asking their oncology team about testing for eligibility for immunotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly urges asking the oncology team to test for MSI/MMR status and includes a dedicated section with questions to ask about biomarker testing and eligibility for immunotherapy."
      }
    ],
    "question_number": 47,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:20:51.168281",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that immunotherapy is currently limited to patients with mismatch repair deficiency or high microsatellite instability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly identifies MSI-high/dMMR as the key subgroup and states that immunotherapy can be highly effective for these patients and is not a standard option otherwise."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that immunotherapy is an ongoing area of research.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly notes ongoing advancements, active exploration of combinations, and that this is an area of intense research."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that there may be clinical trial options exploring novel immunotherapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions many ongoing clinical trials investigating novel immunotherapy approaches and encourages participation for access to cutting-edge treatments."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that immune checkpoint blockade is only approved for patients with metastatic disease in certain situations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention regulatory approval status or specify that approvals apply to unresectable/metastatic disease; it only discusses effectiveness and testing."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that pembrolizumab is approved for patients whose tumors are TMB high.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention TMB-high as an approval criterion for pembrolizumab; only MSI-high/dMMR is discussed."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend asking their oncology team about testing for eligibility for immunotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises discussing results of tumor genetic testing with the oncologist and emphasizes ensuring MSI/dMMR testing, meeting the criterion."
      }
    ],
    "question_number": 47,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:21:12.991944",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that they should consult with their oncologist on the potential next steps.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly prioritizes a detailed discussion with the oncologist, advising to schedule a dedicated meeting to review scans and next steps."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the oncologist may suggest alternative standard of care therapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It discusses second-line chemotherapy options (e.g., switching between gemcitabine-based regimens and FOLFIRINOX/irinotecan liposome plus 5-FU/LV) and mentions radiation for symptom control, indicating alternative standard-of-care therapies."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that the oncologist may suggest clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "There is a dedicated section on clinical trials, advising to ask the oncologist about eligibility and providing resources (PanCAN) to explore trials."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that re-biopsy of the disease could reveal targetable mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response recommends molecular profiling via tumor biopsy or liquid biopsy to identify targetable alterations (e.g., BRCA1/2, NTRK, MSI-H) and suggests further testing if not already done, meeting the intent of re-biopsy to find targets."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend supportive care and symptom management.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly recommends palliative care for symptom management (pain, nausea, fatigue, appetite) and distinguishes it from hospice."
      }
    ],
    "question_number": 48,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:21:28.167242",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that they should consult with their oncologist on the potential next steps.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises an immediate consult with the oncologist and outlines discussion points about next steps."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the oncologist may suggest alternative standard of care therapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions second-line chemotherapy and different combinations/single agents, indicating alternative standard-of-care options."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that the oncologist may suggest clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly recommends discussing eligibility for clinical trials and highlights ongoing research and novel therapies."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that re-biopsy of the disease could reveal targetable mutations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests testing for mutations (e.g., BRCA, MSI-H, NTRK), it does not specifically recommend re-biopsy upon progression to identify new targetable alterations."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend supportive care and symptom management.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes palliative care, pain control, nutritional support, and management of symptoms to optimize quality of life."
      }
    ],
    "question_number": 48,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:21:43.768862",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that there is no approved CAR-T cell therapy for pancreatic cancer at this time.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states, 'CAR-T cell therapy is not yet a standard, FDA-approved treatment for pancreatic cancer' and that it is only available through clinical trials."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe CAR-T cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response provides a clear description of CAR-T therapy, including T-cell collection, genetic engineering to express CARs, expansion, and reinfusion, as well as the targeting concept."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that CAR-T cells are being studied in clinical trials for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states CAR-T is available for pancreatic cancer only via clinical trials and discusses ongoing research and trial strategies, plus guidance on finding trials."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that CAR-T cells are approved for the treatment of other types of cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes 'revolutionary success in some blood cancers,' it does not explicitly state that CAR-T is FDA-approved for certain hematologic malignancies."
      }
    ],
    "question_number": 49,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:21:56.599224",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that there is no approved CAR-T cell therapy for pancreatic cancer at this time.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states that CAR T-cell therapy is not FDA-approved or standard of care for pancreatic cancer, directly satisfying this criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe CAR-T cells.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response discusses challenges and the need for specific targets, it does not actually describe what CAR T-cells are (e.g., genetically engineered T cells expressing chimeric antigen receptors). A definitional description is missing."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that CAR-T cells are being studied in clinical trials for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly notes that CAR T-cell therapy for pancreatic cancer is being actively investigated in early-phase clinical trials, fulfilling this requirement."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that CAR-T cells are approved for the treatment of other types of cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions that CAR T-cell therapy has revolutionized treatment for certain blood cancers but does not explicitly state that it is FDA-approved for those cancers. The criterion specifically requires stating approval status."
      }
    ],
    "question_number": 49,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:22:19.147758",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "States hospice is considered when life expectancy is 6 months or less as estimated by the medical team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly says a physician must certify a life expectancy of 6 months or less if the disease runs its normal course."
      },
      {
        "criterion_number": 2,
        "description": "States that the aim of hospice is to maximize quality of life and focus on addressing symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states hospice shifts focus from cure to comfort, symptom management, and maximizing quality of life."
      },
      {
        "criterion_number": 3,
        "description": "States hospice can take place at home, in a nursing home, or a dedicated hospice facility.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response notes care at home, assisted living, nursing homes, and inpatient hospice facilities for symptom crises."
      },
      {
        "criterion_number": 4,
        "description": "Starts with an expression of sympathy and support.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The opening sentence expresses sorrow and support for the family's difficult situation."
      },
      {
        "criterion_number": 5,
        "description": "Defines hospice care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines hospice as a philosophy of care focusing on comfort rather than cure and supporting both patient and family."
      },
      {
        "criterion_number": 6,
        "description": "Describes what hospice covers, including emotional and spiritual support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details include social worker support, chaplain/spiritual care, family-centered care, and 24/7 support, addressing emotional and spiritual needs."
      },
      {
        "criterion_number": 7,
        "description": "Describes what hospice covers, including bereavement support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions bereavement counseling for up to 13 months after death."
      }
    ],
    "question_number": 50,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:22:38.780003",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that hospice is considered when the medical team estimates a life expectancy of 6 months or less.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states a doctor certifies life expectancy of six months or less as a guideline for hospice eligibility."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the aim of hospice is to maximize quality of life and focus on addressing symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly emphasizes comfort over cure, maximizing quality of life, and comprehensive pain and symptom management throughout."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that hospice can take place in the home, a nursing home, or in a dedicated hospice facility.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists home, nursing homes/assisted living, and hospice inpatient units (dedicated hospice facilities), as well as hospitals."
      },
      {
        "criterion_number": 4,
        "description": "The answer should start with an expression of sympathy and support.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with a compassionate acknowledgment of the family's difficult situation and offers support."
      },
      {
        "criterion_number": 5,
        "description": "The response should define hospice care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a thorough definition: specialized care for life-limiting illness focusing on comfort, dignity, and support rather than curative treatment."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe what hospice care covers, including emotional and spiritual support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details services including emotional counseling, spiritual support via chaplains, and holistic care addressing psychosocial needs."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe what hospice care covers, including bereavement support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions bereavement counselors and support for at least 13 months after death; also lists bereavement support as a service."
      }
    ],
    "question_number": 50,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:22:54.432919",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must state that fatigue is a common side effect of chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly says fatigue is an \"incredibly common and debilitating side effect of chemotherapy, especially for pancreatic cancer.\""
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing symptoms with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "There is a dedicated section titled \"Important First Step: Talk to Her Oncology Team,\" emphasizing communicating severity and impact and seeking evaluation."
      },
      {
        "criterion_number": 3,
        "description": "The response must mention that optimizing nutrition and hydration can help manage fatigue.",
        "score_given": 10,
        "max_points": 10,
        "justification": "A detailed \"Nutrition and Hydration\" section recommends hydration, small frequent meals, protein/calorie focus, and consulting an oncology dietitian."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend good sleep hygiene.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The \"Sleep and Rest\" section includes sleep hygiene advice such as maintaining a regular sleep-wake cycle and optimizing the sleep environment."
      },
      {
        "criterion_number": 5,
        "description": "The response should discuss potential causes for fatigue, including the effect of the cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it lists other causes (anemia, dehydration/malnutrition, thyroid issues, electrolytes) and chemotherapy effects, it does not explicitly state that the cancer itself can cause fatigue."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that light physical activity can improve fatigue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The \"Gentle Physical Activity\" section states that research supports movement to improve energy and provides examples like short walks."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend medication review.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises discussing medical interventions with the team, including reviewing chemotherapy dosage/schedule and considering medications for alertness, which constitutes medication review."
      }
    ],
    "question_number": 51,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:23:16.172206",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must state that fatigue is a common side effect of chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states fatigue is 'one of the most common and debilitating side effects' of chemotherapy and explains CRF as more than ordinary tiredness."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing symptoms with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Begins with 'Immediate & Critical Step: Communicate with Her Oncology Team' and details actions they can take (rule out causes, adjust treatment, prescribe meds, referrals)."
      },
      {
        "criterion_number": 3,
        "description": "The response must mention that optimizing nutrition and hydration can help manage fatigue.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes a 'Nutrition and Hydration' section with small frequent meals, protein-rich foods, complex carbs, staying hydrated, and dietitian support."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend good sleep hygiene.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a detailed 'Optimize Sleep Hygiene' section with consistent schedule, environment, limiting stimulants/screens, and relaxing bedtime routines."
      },
      {
        "criterion_number": 5,
        "description": "The response should discuss potential causes for fatigue, including the effect of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists multiple causes (anemia, dehydration, pain, infection, sleep issues, nutritional deficiencies, thyroid dysfunction, medication side effects, depression/anxiety) and notes pancreatic cancer and chemotherapy are 'notoriously tough,' implying cancer itself contributes."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that light physical activity can improve fatigue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends 'Gentle, Regular Exercise' and states even very light activity can significantly improve CRF, with examples like short walks and chair yoga."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend medication review.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises discussing with oncology team and identifies 'Medication Side Effects' as contributors to fatigue; suggests potential medication adjustments and prescriptions as appropriate."
      }
    ],
    "question_number": 51,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:23:26.819403",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that alternative treatments like cannabis oil have not been proven to help patients with pancreatic cancer live longer or cure them.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states there is insufficient evidence that cannabis oil can treat or cure pancreatic cancer in humans and warns against abandoning proven, life-extending conventional treatments. This communicates that it is not proven to improve survival or cure the disease."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that cannabis oil is sometimes used to manage cancer-related symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly frames cannabis oil as a complementary therapy for symptom management (nausea, appetite loss, pain, anxiety, sleep), which is the most evidence-supported role."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend discussing the use of cannabis oil with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It strongly and repeatedly recommends discussing with the oncology team before starting, and even provides scripted questions and a collaborative framing for the conversation."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe cannabis oil.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes key components (THC, CBD), product types (full-spectrum, broad-spectrum, isolate), and their differing effects, which constitutes a clear description of cannabis oil and related formulations."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that cannabis oil is not used as an anti-cancer treatment per guidelines.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states it should never replace oncologist-prescribed treatment and that evidence for anti-cancer effects in humans is very weak, aligning with guideline-based practice that it is not an anti-cancer treatment."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe risks of using cannabis oil, including drug interactions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly warns about interactions via hepatic metabolism that can affect chemotherapy and immunotherapy efficacy/toxicity, calling this the #1 reason to speak with the oncologist."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe risks of using cannabis oil, including side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response lists THC-related side effects (dizziness, confusion, anxiety, impaired coordination) and CBD-related side effects (fatigue, diarrhea, appetite changes)."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe risks of using cannabis oil, including variation in quality.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes poor regulation, variability in potency/purity, and risks of contamination with pesticides and heavy metals, and recommends third-party lab testing."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe risks of using cannabis oil, including legal concerns.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises proceeding only if living in a place where it is legal and to use licensed medical-grade dispensaries, acknowledging legal considerations."
      }
    ],
    "question_number": 52,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:24:00.695212",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "State that alternative treatments like cannabis oil have not been proven to help patients with pancreatic cancer live longer or cure them.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states there is no conclusive scientific evidence from large-scale human trials that cannabis oil can cure pancreatic cancer or stop its progression and emphasizes it should not replace evidence-based treatments, fulfilling the requirement."
      },
      {
        "criterion_number": 2,
        "description": "State that cannabis oil is sometimes used to manage cancer-related symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes a dedicated section on complementary use for symptom management and lists pain, nausea/vomiting, appetite, sleep, and anxiety/depression, clearly indicating use for symptom control."
      },
      {
        "criterion_number": 3,
        "description": "Recommend discussing the use of cannabis oil with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response strongly advises, \u201cSpeak with Your Medical Team FIRST,\u201d and provides specific prompts for discussing with the oncologist, directly meeting this criterion."
      },
      {
        "criterion_number": 4,
        "description": "Describe cannabis oil.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response describes cannabis oil in terms of its key constituents (THC and CBD), differentiates full-spectrum vs. isolate products, and discusses potency and labeling, which adequately describes what cannabis oil is."
      },
      {
        "criterion_number": 5,
        "description": "State that cannabis oil is not used as an anti-cancer treatment per guidelines.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response states there is no conclusive evidence and it should not replace conventional therapy, it does not explicitly reference or cite clinical guidelines (e.g., NCCN/ASCO) stating it is not used as an anti-cancer treatment."
      },
      {
        "criterion_number": 6,
        "description": "Describe risks of using cannabis oil, including drug interactions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly warns about drug interactions with chemotherapy drugs, blood thinners, pain medications, and anti-nausea drugs, meeting the criterion."
      },
      {
        "criterion_number": 7,
        "description": "Describe risks of using cannabis oil, including side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Side effects are detailed for THC (e.g., dizziness, anxiety, tachycardia) and CBD (e.g., fatigue, diarrhea, appetite/weight changes), satisfying this requirement."
      },
      {
        "criterion_number": 8,
        "description": "Describe risks of using cannabis oil, including variation in quality.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response discusses lack of regulation, the need for third-party lab testing, potency verification, and contaminant checks, directly addressing quality variation risks."
      },
      {
        "criterion_number": 9,
        "description": "Describe risks of using cannabis oil, including legal concerns.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states that legality varies by state and country and advises understanding local laws, fulfilling the legal risk criterion."
      }
    ],
    "question_number": 52,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:24:24.642617",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that lack of appetite is a common side effect of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that complete loss of appetite is a very common consequence of pancreatic cancer and its treatment."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the patient should consult with their oncologist, who may refer them to a registered dietitian, oncology nutritionist, and/or palliative care physician to address symptoms and optimize supportive care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises discussing with the doctor/oncology team and specifically recommends referral to a registered dietitian specializing in oncology."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that pancreatic enzyme replacement can be pursued.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly recommends pancreatic enzymes (PERT) such as Creon or Zenpep with every meal/snack."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the patient can try smaller meals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Suggests very small, snack-sized portions instead of large meals."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the patient can try more frequent meals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends small offerings every 1\u20132 hours (grazing)."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that the patient can try nutritional replacement shakes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically mentions Ensure, Boost, Orgain, and recommends smoothies/milkshakes as liquid calories."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that appetite stimulants can also be considered.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists appetite stimulants such as megestrol and dronabinol as options via the medical team."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that cancer itself can cause loss of appetite.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States appetite loss is a consequence of the disease (pancreatic cancer) itself and its treatment."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that chemotherapy can cause nausea and loss of appetite.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Discusses nausea management but does not explicitly attribute nausea/appetite loss to chemotherapy."
      },
      {
        "criterion_number": 10,
        "description": "The response should include that bloating can decrease appetite.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Links PEI to bloating and feeling full quickly, which suppress appetite."
      },
      {
        "criterion_number": 11,
        "description": "The response should include that pancreatic enzyme deficiency can cause decreased appetite.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explains that pancreatic exocrine insufficiency (enzyme deficiency) leads to pain, bloating, and early satiety, contributing to appetite loss."
      }
    ],
    "question_number": 53,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:24:52.060551",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that lack of appetite is a common side effect of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states loss of appetite is \"very common\" in pancreatic cancer and its treatments."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the patient should consult with their oncologist, who may refer them to a registered dietitian, oncology nutritionist, and/or palliative care physician to address symptoms and optimize supportive care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises immediate consultation with medical team including Oncologist/GI, Registered Dietitian (oncology dietitian), and Palliative Care."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that pancreatic enzyme replacement can be pursued.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends PERT (e.g., Creon, Zenpep) with rationale and timing with food."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the patient can try smaller meals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Suggests small portions and mini-meals to reduce overwhelm."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the patient can try more frequent meals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically recommends 6\u20138 small mini-meals/snacks per day."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that the patient can try nutritional replacement shakes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends Ensure, Boost, Carnation Breakfast Essentials, and smoothies/shakes."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that appetite stimulants can also be considered.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions megestrol acetate and dronabinol as possible appetite stimulants."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that cancer itself can cause loss of appetite.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States appetite loss is due to \"the disease itself\" among other factors."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that chemotherapy can cause nausea and loss of appetite.",
        "score_given": 0,
        "max_points": 2,
        "justification": "References \"treatments\" broadly and anti-emetics but does not explicitly mention chemotherapy."
      },
      {
        "criterion_number": 10,
        "description": "The response should include that bloating can decrease appetite.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Links enzyme insufficiency to bloating and \"severe appetite loss.\""
      },
      {
        "criterion_number": 11,
        "description": "The response should include that pancreatic enzyme deficiency can cause decreased appetite.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explains that lacking enzymes leads to maldigestion and severe appetite loss, advocating PERT."
      }
    ],
    "question_number": 53,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:25:21.676287",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "State that they can start with their primary doctor who can help refer to the most local community hospital with oncology services.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response encourages engaging a local oncologist and talking with the current doctor, but it does not explicitly advise starting with a primary care doctor for a referral to the nearest community hospital with oncology services."
      },
      {
        "criterion_number": 2,
        "description": "State that if they are able to travel, then major cancer centers offer consultations which can also be done as telehealth.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly advises consulting major cancer centers, notes that travel may be needed for certain visits, and emphasizes the availability of telehealth/virtual second opinions from those centers."
      },
      {
        "criterion_number": 3,
        "description": "State that patients can search for NCI-designated cancer centers to find the closest one to them, and explicitly mention that both oncologists and palliative care teams often offer virtual visits through telemedicine or telehealth consultations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it provides the NCI cancer center finder to locate nearby centers, it does not explicitly state that palliative care teams offer telemedicine visits; telehealth is discussed for oncologists/specialists only."
      },
      {
        "criterion_number": 4,
        "description": "Explicitly recommend reaching out to regional cancer centers, including examples or resources for finding such centers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends contacting NCI-Designated Comprehensive Cancer Centers and National Pancreas Foundation Centers, provides links and a clear action plan to identify and call these centers."
      },
      {
        "criterion_number": 5,
        "description": "Explicitly state that specialists will often partner with local oncologists to coordinate care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The 'Hub-and-Spoke' model is described in detail, stating that specialist centers guide the plan while local oncologists administer treatment, highlighting collaboration and coordinated care."
      }
    ],
    "question_number": 54,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:25:56.307327",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that they can start with their primary doctor who can help refer to the most local community hospital with oncology services.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises starting with the Primary Care Physician (PCP) to coordinate care and make referrals, and it highlights using the local hospital/clinic to identify available services, aligning with the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that if they are able to travel, then major cancer centers offer consultations which can also be done as telehealth.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends travel to major cancer centers for key aspects of care and clearly states many major cancer centers offer virtual consultations, fulfilling both travel and telehealth elements."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that patients can search for NCI-designated cancer centers to find the closest one to them, and explicitly mention that both oncologists and palliative care teams often offer virtual visits through telemedicine or telehealth consultations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not mention NCI-designated cancer centers or searching for them and does not explicitly state that palliative care teams offer telehealth visits; it only references oncologist telehealth generally."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly recommend reaching out to regional cancer centers, including examples or resources for finding such centers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends contacting major cancer centers and provides examples (Mayo Clinic, MD Anderson, MSK, Johns Hopkins) and references organizations like PanCAN and ACS as resources, satisfying the requirement."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly state that specialists will often partner with local oncologists to coordinate care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions PCP coordination and virtual follow-up with specialists, it does not explicitly state that specialists partner with local oncologists to co-manage care."
      }
    ],
    "question_number": 54,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:26:23.081399",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should offer sympathy for the stressful situation dealing with insurance coverage.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with clear empathy for the father\u2019s diagnosis and the stress of insurance denial, reassuring the family they are not alone."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that they can work with the hospital\u2019s financial counselor or social worker.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises working with a patient navigator or social worker and a financial counselor at the cancer center/hospital."
      },
      {
        "criterion_number": 3,
        "description": "The response should state the person should work with their oncology team to help with the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directs the user to contact the oncologist, involve office staff, obtain a letter of medical necessity, and request a peer-to-peer review."
      },
      {
        "criterion_number": 4,
        "description": "The response should include contacting the insurance company to understand the reason for denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises obtaining the formal denial letter from the insurer and emphasizes understanding the specific denial reason; instructs to insist on written communication if only told by phone."
      },
      {
        "criterion_number": 5,
        "description": "The response should state one option for remedy is filing an appeal.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a detailed appeals pathway, including internal appeal and external (independent) review with steps and supporting documentation."
      }
    ],
    "question_number": 55,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:26:39.124862",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should offer sympathy for the stressful situation dealing with insurance coverage.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response opens with empathetic language (e.g., \"I'm so sorry to hear about your father's diagnosis and the additional stress of dealing with insurance denials\" and \"You are not alone\"), and closes with supportive statements, clearly acknowledging the stress."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that they can work with the hospital\u2019s financial counselor or social worker.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends working with hospital-based support: \"Many hospitals and cancer centers have patient navigators or financial counselors\" who can help with appeals and resources. While it doesn\u2019t use the exact term \"social worker,\" the inclusion of financial counselors/patient navigators satisfies the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response should state the person should work with their oncology team to help with the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It instructs to obtain a detailed letter of medical necessity from the oncologist, cites working with the oncology team, and references gathering records from his oncologists. This clearly directs collaboration with the oncology team to address the denial."
      },
      {
        "criterion_number": 4,
        "description": "The response should include contacting the insurance company to understand the reason for denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises obtaining the formal denial letter that specifies the reason for denial and emphasizes meticulous documentation of phone calls, implying direct contact with the insurer. It also details internal appeal processes within the insurance company, demonstrating engagement to understand and address the denial."
      },
      {
        "criterion_number": 5,
        "description": "The response should state one option for remedy is filing an appeal.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It provides a robust appeals framework, including first-level and second-level internal appeals and external review, clearly stating appeals as a primary remedy."
      }
    ],
    "question_number": 55,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:26:55.918213",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Defines high-volume centers as those performing at least 40 or 50 Whipple procedures per year.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response defines high volume as surgeons performing 15\u201320+ resections annually and asks about hospital totals but does not specify the 40\u201350 Whipple per year hospital threshold required by the rubric."
      },
      {
        "criterion_number": 2,
        "description": "States that high-volume centers have significantly lower mortality rates and higher overall survival rates.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states lower mortality at high-volume centers and notes better long-term survival and outcomes (e.g., \"Lower Mortality Rates\" and \"Better Long-Term Survival\")."
      },
      {
        "criterion_number": 3,
        "description": "States that high-volume centers have significantly lower complication rates.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions \"Fewer Complications\" at high-volume centers and better recognition/management of complications (failure-to-rescue), indicating lower complication burden."
      },
      {
        "criterion_number": 4,
        "description": "States that at a high-volume center, the surgeon is more likely to be a specialist in pancreas surgery.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes surgical oncologists specializing in GI/pancreatic cancers at high-volume centers, indicating greater pancreas-specific expertise."
      },
      {
        "criterion_number": 5,
        "description": "States that high-volume centers often have access to clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes that high-volume centers offer access to clinical trials and cutting-edge treatments not available at most local hospitals."
      },
      {
        "criterion_number": 6,
        "description": "States that high-volume centers have access to the latest treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions access to the latest, cutting-edge treatments, advanced imaging/ICUs, and oncologists using the latest therapies."
      },
      {
        "criterion_number": 7,
        "description": "States disadvantages of going to a high-volume center, including travel time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists travel to another city, associated costs, and time away from work/family explicitly as disadvantages."
      },
      {
        "criterion_number": 8,
        "description": "States disadvantages of going to a high-volume center, including more complicated logistics.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses logistical challenges, disruption from being away from home, and coordination complexities, satisfying the logistics disadvantage."
      }
    ],
    "question_number": 56,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:27:15.195132",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define high-volume centers as those performing at least 40 or 50 Whipple procedures per year.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states thresholds of >50\u2013100 Whipples per institution per year and recommends aiming for >50\u2013100 per institution, which meets the \u226550 criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that high-volume centers have significantly lower mortality rates and higher overall survival rates for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it explicitly states significantly lower perioperative mortality, it only says 'potentially improved long-term survival' and that outcomes 'can contribute' to improved survival, not that high-volume centers have higher overall survival rates. It does not meet the required definitive statement."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that high-volume centers have significantly lower complication rates.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states 'Lower Complication Rates' with examples (fewer pancreatic fistulas, infections, bleeding)."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that at a high-volume center, the surgeon is more likely to be a specialist in pancreas surgery.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes surgeons are often fellowship-trained in complex surgical oncology/hepatobiliary surgery and that pancreatic surgery is their primary focus."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that high-volume centers often have access to clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions access to clinical trials and investigational therapies at high-volume centers."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that high-volume centers have access to the latest treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It references state-of-the-art imaging, specialized equipment, robotic platforms, and cutting-edge approaches, indicating access to the latest treatments."
      },
      {
        "criterion_number": 7,
        "description": "The response should state disadvantages of going to a high-volume center, including travel time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists travel over long distances and associated logistics as disadvantages."
      },
      {
        "criterion_number": 8,
        "description": "The response should state disadvantages of going to a high-volume center, including more complicated logistics.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions travel and logistics, accommodation needs, separation from local support, and potential added costs, all reflecting more complicated logistics."
      }
    ],
    "question_number": 56,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:27:46.345505",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention the Pancreatic Cancer Action Network as a resource for financial assistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly names the Pancreatic Cancer Action Network (PanCAN), provides Patient Central, Know Your Tumor, contact number, and website as resources."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention CancerCare as a resource for financial assistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists CancerCare Co-Payment Assistance Foundation as an organization that provides co-pay and related financial assistance."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention the American Cancer Society as a resource for financial assistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions the American Cancer Society (ACS) and describes Hope Lodge (free lodging) and Road to Recovery (transport), which reduce financial burden."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend discussing financial concerns with a social worker.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly recommends contacting the hospital social worker or patient navigator first to connect with assistance programs."
      },
      {
        "criterion_number": 5,
        "description": "The response should offer sympathy for the stressful situation dealing with financial burden during cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with empathy (\u201cso sorry to hear\u2026 completely understandable\u2026 overwhelming\u201d) and supportive language throughout."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend discussing financial concerns with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises asking the oncologist (oncology team member) about pharmaceutical patient assistance programs and resources."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend discussing financial concerns with a financial counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly recommends speaking with the hospital\u2019s financial counseling department for payment plans, charity care, and benefits review."
      }
    ],
    "question_number": 57,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:28:04.645806",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention the Pancreatic Cancer Action Network as a resource for financial assistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly names the Pancreatic Cancer Action Network (PanCAN) and describes their Patient Services Case Managers and navigation help."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention CancerCare as a resource for financial assistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists CancerCare, noting it provides limited financial assistance and counseling/support services."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention the American Cancer Society as a resource for financial assistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes the American Cancer Society (ACS), detailing programs like Road To Recovery, Hope Lodge, and the 24/7 helpline."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend discussing financial concerns with a social worker.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Has a dedicated section on Social Workers and advises, \"Request to speak with a social worker through your loved one's care team.\""
      },
      {
        "criterion_number": 5,
        "description": "The response should offer sympathy for the stressful situation dealing with financial burden during cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Opens with empathetic language acknowledging the diagnosis and financial stress: \"I'm so sorry to hear... completely understandable to be worried...\""
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend discussing financial concerns with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises to ask the oncology team for financial counselor access and recommends inquiring at every point of care with doctors and nurses."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend discussing financial concerns with a financial counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically recommends working with hospital Financial Counselors/Navigators and explains how they can assist."
      }
    ],
    "question_number": 57,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:28:25.481593",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions that depression is common among patients with pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States 'It is extremely common' and cites 'up to 50% of patients' experiencing depressive symptoms."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing the patient\u2019s mood with their oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises: 'Tell His Oncologist Immediately' and that they can screen and connect to resources."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions support groups as helpful for patients with cancer experiencing depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends support groups and links to PanCAN\u2019s survivor and caregiver network."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions seeking immediate evaluation by a medical professional if the patient is experiencing thoughts of harming themself or others.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States suicidal ideation is a 'medical emergency' and instructs to seek immediate help."
      },
      {
        "criterion_number": 5,
        "description": "The response offers the emergency department and calling 988 if the patient experiences thoughts of harming themself or others.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides both 'Call or text 988' and 'Go to the nearest emergency room.'"
      },
      {
        "criterion_number": 6,
        "description": "The response points to published scientific studies describing the prevalence of depression in pancreatic cancer patients.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions 'studies suggest' without citing any specific published studies or providing references."
      },
      {
        "criterion_number": 7,
        "description": "The response reviews the signs and symptoms of depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not list core depressive symptoms (e.g., anhedonia, sleep/appetite changes, concentration issues)."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends discussing the patient\u2019s mood with a mental health professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends referral to psycho-oncology and therapy with psychologists/psychiatrists."
      },
      {
        "criterion_number": 9,
        "description": "The response states that there are various treatment options for depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions multiple options including medication, therapy (CBT), support groups, and palliative care support."
      },
      {
        "criterion_number": 10,
        "description": "The response states that there are both pharmacologic and non-pharmacologic treatment options for depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly discusses antidepressants (pharmacologic) and therapy/CBT/support groups/lifestyle strategies (non-pharmacologic)."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions lifestyle changes that support improvements in mental health.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests gentle movement, small moments of joy, nutrition optimization, and symptom control."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that based on the ASCO guidelines, optimal care of depression should follow a stepped-care model. (https://doi.org/10.1200/JCO.23.00293)",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of ASCO guidelines or a stepped-care model."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that Cognitive Behavioral Therapy (CBT), behavior therapy (BT), and behavioral activation (BA) are the most effective treatments for managing depressive symptoms. (https://doi.org/10.1200/JCO.23.00293)",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions CBT as helpful but does not include BT/BA or state they are the most effective per ASCO."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that exercise both during and after treatment can significantly reduce depression. (https://doi.org/10.1200/JCO.23.00293)",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages gentle movement but does not state evidence that exercise significantly reduces depression during and after treatment."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that pharmacotherapy is not recommended as a first-line treatment for depression. (https://doi.org/10.1200/JCO.23.00293)",
        "score_given": 0,
        "max_points": 5,
        "justification": "Portrays antidepressants as 'incredibly effective' without indicating they are not first-line per ASCO."
      }
    ],
    "question_number": 58,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:29:27.873567",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions that depression is common among patients with pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states depression is extremely common in pancreatic cancer and cites a prevalence range of 25\u201350%."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing the patient\u2019s mood with their oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly advises informing the oncologist/PCP immediately about depressive symptoms."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions support groups as helpful for patients with cancer experiencing depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends support groups and cites PanCAN and local cancer centers as resources."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions seeking immediate evaluation by a medical professional if the patient is experiencing thoughts of harming themself or others.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not address urgent safety measures or immediate evaluation for suicidal or homicidal thoughts."
      },
      {
        "criterion_number": 5,
        "description": "The response offers the emergency department and calling 988 if the patient experiences thoughts of harming themself or others.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of crisis resources such as calling 988 or going to the emergency department."
      },
      {
        "criterion_number": 6,
        "description": "The response points to published scientific studies describing the prevalence of depression in pancreatic cancer patients.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Provides a prevalence estimate but does not cite or point to specific published studies."
      },
      {
        "criterion_number": 7,
        "description": "The response reviews the signs and symptoms of depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not review hallmark depressive symptoms (e.g., persistent low mood, anhedonia, sleep/appetite changes, guilt, poor concentration, suicidality)."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends discussing the patient\u2019s mood with a mental health professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends referral to a psycho-oncologist, psychiatrist, psychologist, or counselor."
      },
      {
        "criterion_number": 9,
        "description": "The response states that there are various treatment options for depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes multiple treatment modalities including medications, therapy, pain control, nutrition, and symptom management."
      },
      {
        "criterion_number": 10,
        "description": "The response states that there are both pharmacologic and non-pharmacologic treatment options for depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions antidepressants (pharmacologic) and various psychotherapies and supportive measures (non-pharmacologic)."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions lifestyle changes that support improvements in mental health.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends routine, gentle physical activity, enjoyable activities, sleep hygiene, and mindfulness/relaxation."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that based on the ASCO guidelines, optimal care of depression should follow a stepped-care model.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention ASCO guidelines or the stepped-care model."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that Cognitive Behavioral Therapy (CBT), behavior therapy (BT), and behavioral activation (BA) are the most effective treatments for managing depressive symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions CBT but not BT/BA nor that these are the most effective per guidelines."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that exercise both during and after treatment can significantly reduce depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Suggests gentle activity to boost mood but does not state that exercise during and after treatment significantly reduces depression."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that pharmacotherapy is not recommended as a first-line treatment for depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States SSRIs are often a first line, which contradicts the criterion and does not note pharmacotherapy is not first-line per ASCO."
      }
    ],
    "question_number": 58,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:30:06.033479",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises: 'Talk to the Oncology Team' and to seek a second opinion at a major cancer center."
      },
      {
        "criterion_number": 2,
        "description": "The response states that many aspects of a patient\u2019s health impact their prognosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists multiple factors: stage/resectability, tumor biomarkers, overall health/performance status, response to treatment, and care team/institution."
      },
      {
        "criterion_number": 3,
        "description": "The response defines overall survival as it is used in clinical research.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It defines 5-year relative survival and 'median survival' but never defines overall survival (time from diagnosis/start of treatment to death from any cause)."
      },
      {
        "criterion_number": 4,
        "description": "The response defines progression-free survival as it is used in clinical research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States PFS is the length of time during and after treatment that cancer does not get worse, matching the clinical definition."
      },
      {
        "criterion_number": 5,
        "description": "The response explains that overall survival and progression-free survival are typically reported as medians.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although 'median survival' is explained, it does not state that OS and PFS are typically reported as median OS and median PFS."
      },
      {
        "criterion_number": 6,
        "description": "The response explains the above biostatistics terms (overall survival, progression-free survival, and median) in laymen\u2019s terms.",
        "score_given": 0,
        "max_points": 3,
        "justification": "PFS and median are explained clearly, but overall survival is not defined or explained."
      },
      {
        "criterion_number": 7,
        "description": "The response explains that survival data is best reported in terms of the stage of cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States survival rates are broken down by stage and defines localized, regional, and distant disease."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions the limitations of applying reported statistics to patients\u2019 individual cases.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes statistics are averages, from past cohorts, and cannot account for individual factors; repeats 'You are not a statistic.'"
      },
      {
        "criterion_number": 11,
        "description": "The response mentions the difference between overall survival and progression-free survival.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Overall survival is not discussed, so no contrast between OS and PFS is provided."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that survival is influenced by tumor characteristics such as genetic mutations (BRCA, KRAS), size, and location.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States tumor biomarkers (e.g., BRCA1/2, MSI-high) can affect therapy and outcomes, acknowledging tumor characteristics influence prognosis."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions that survival depends on treatments received (chemotherapy, surgery, targeted therapy, no treatment, etc.) and treatment response.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes surgery offers best chance, chemotherapy responses can enable surgery, and emphasizes treatment goals and response impact."
      },
      {
        "criterion_number": 14,
        "description": "The response mentions that new treatments and advancements are being developed all the time, and these could potentially improve outcomes in the future.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States treatments are constantly improving and current statistics may lag; also encourages clinical trial consideration."
      }
    ],
    "question_number": 59,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:30:42.495255",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises: 'The absolute best source of information... is their oncology team' and provides specific questions to ask."
      },
      {
        "criterion_number": 2,
        "description": "The response states that many aspects of a patient\u2019s health impact their prognosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists multiple influencing factors: stage, tumor biology, response to treatment, performance status, comorbidities, access to care, and quality of life."
      },
      {
        "criterion_number": 3,
        "description": "The response defines overall survival as it is used in clinical research.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not define overall survival (time from diagnosis/treatment start to death from any cause); only describes 5-year survival rate and median survival."
      },
      {
        "criterion_number": 4,
        "description": "The response defines progression-free survival as it is used in clinical research.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Progression-free survival is not mentioned or defined."
      },
      {
        "criterion_number": 5,
        "description": "The response explains that overall survival and progression-free survival are typically reported as medians.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although 'median survival' is explained, there is no statement that OS and PFS are typically reported as medians."
      },
      {
        "criterion_number": 6,
        "description": "The response explains the above biostatistics terms (overall survival, progression-free survival, and median) in laymen\u2019s terms.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Provides a lay explanation of 'median' and '5-year survival rate' but does not explain overall survival or progression-free survival."
      },
      {
        "criterion_number": 7,
        "description": "The response explains that survival data is best reported in terms of the stage of cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes stage as 'the most significant factor' and distinguishes localized, regional, and metastatic disease, aligning survival interpretation with stage."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions the limitations of applying reported statistics to patients\u2019 individual cases.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly outlines limitations: population averages, outdated data, lack of individual factors, and absence of quality-of-life considerations."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions the difference between overall survival and progression-free survival.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention or contrast overall survival versus progression-free survival."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that survival is influenced by tumor characteristics such as genetic mutations (BRCA, KRAS), size, and location.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that tumor characteristics (type, grade) and 'genetic mutations' influence prognosis. While size/location are not explicitly named, tumor biology and mutations are clearly cited."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions that survival depends on treatments received (chemotherapy, surgery, targeted therapy, no treatment, etc.) and treatment response.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Discusses surgery, chemotherapy, radiation, targeted therapy, immunotherapy, and explicitly notes response to treatment as influential."
      },
      {
        "criterion_number": 14,
        "description": "The response mentions that new treatments and advancements are being developed all the time, and these could potentially improve outcomes in the future.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States statistics are backward-looking and that newer therapies/clinical trials may not be reflected yet, implying potential for improved outcomes."
      }
    ],
    "question_number": 59,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:31:43.135607",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly encourages discussion with the healthcare team and provides a list of questions to ask the doctor; also includes a disclaimer to consult the care team for decisions."
      },
      {
        "criterion_number": 2,
        "description": "The response explains that a liquid biopsy is a blood test.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly describes liquid biopsy as a simple blood draw and a sophisticated blood test."
      },
      {
        "criterion_number": 3,
        "description": "The response explains that liquid biopsies involve analyzing circulating tumor DNA (ctDNA) from blood samples.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines ctDNA, explains that cancer cells release DNA into the blood, and that labs sequence ctDNA to look for mutations."
      },
      {
        "criterion_number": 4,
        "description": "The response explains there are many different tests which evaluate various things including circulating tumor DNA, circulating tumor cells, and proteins in the blood.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Focuses on ctDNA; does not explain distinct test types such as circulating tumor cells or protein-based assays."
      },
      {
        "criterion_number": 5,
        "description": "The response says that liquid biopsies do not replace tissue biopsies in the diagnosis of cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States, \u201cNot a Replacement for Diagnosis: The initial diagnosis of cancer almost always requires a tissue biopsy.\u201d"
      },
      {
        "criterion_number": 6,
        "description": "The response says the results of liquid biopsies must be interpreted by a medical professional.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises consulting the healthcare team for treatment decisions and frames results in the context of doctor-led decision-making, implying professional interpretation is required."
      },
      {
        "criterion_number": 7,
        "description": "The response says the results of liquid biopsies may be helpful when combined with imaging and pathology results.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions earlier signal than CT scans and that tissue biopsy is required for diagnosis, but does not explicitly state that results should be combined with imaging and pathology."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions there are liquid biopsies in various stages of development for different kinds of cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention development stages across different cancer types."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions the limitations of liquid biopsies, including sensitivity, false positives, and cost.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Includes sensitivity and cost/insurance but does not mention false positives; rubric requires all specified elements."
      },
      {
        "criterion_number": 10,
        "description": "The response says there are currently no FDA approved liquid biopsies for pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No statement about FDA approval status for pancreatic cancer liquid biopsies."
      },
      {
        "criterion_number": 11,
        "description": "The response says health insurance may not pay for these tests.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes cost concerns and that insurance coverage can vary."
      },
      {
        "criterion_number": 12,
        "description": "The response says liquid biopsies may be able to identify genetic mutations present in the cancer which can help to guide treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains identifying mutations (e.g., BRCA, NTRK) that can guide targeted therapies."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that liquid biopsies are noninvasive and can expedite testing because there is no need to retrieve archival blocks or arrange for a new biopsy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes minimally invasive blood draw and notes faster results compared with scheduling and recovering from a tissue biopsy, satisfying the intent of expedited testing."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that copy-number changes may be more difficult to assess in cfDNA, and fusion testing may be more limited in common cfDNA tests currently used.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not address limitations specific to copy-number alterations or fusion testing in cfDNA."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that this is still under active research and not yet standard of care for all cancer patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that liquid biopsy use is under active research or not standard of care for all patients."
      }
    ],
    "question_number": 60,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:32:28.217347",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly encourages discussion with the care team: provides a 'What to Ask Your Father's Doctors' section and mentions 'discussions with his medical team,' which reasonably encompasses the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response explains that a liquid biopsy is a blood test.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that a liquid biopsy is a non-invasive blood test (also sometimes other fluids)."
      },
      {
        "criterion_number": 3,
        "description": "The response explains that liquid biopsies involve analyzing circulating tumor DNA (ctDNA) from blood samples.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines ctDNA, how it is shed by tumors into the bloodstream, and how it is analyzed to detect mutations."
      },
      {
        "criterion_number": 4,
        "description": "The response explains there are many different tests which evaluate various things including circulating tumor DNA, circulating tumor cells, and proteins in the blood.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists ctDNA, circulating tumor cells (CTCs), and exosomes containing proteins/RNA/DNA, covering the requested categories."
      },
      {
        "criterion_number": 5,
        "description": "The response says that liquid biopsies do not replace tissue biopsies in the diagnosis of cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly states they are not a replacement yet and typically complement tissue biopsies, especially for initial diagnosis."
      },
      {
        "criterion_number": 6,
        "description": "The response says the results of liquid biopsies must be interpreted by a medical professional.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Notes that results require expert interpretation by oncologists and geneticists."
      },
      {
        "criterion_number": 7,
        "description": "The response says the results of liquid biopsies may be helpful when combined with imaging and pathology results.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it says liquid biopsies complement tissue biopsies, it does not mention combining results with imaging specifically."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions there are liquid biopsies in various stages of development for different kinds of cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Describes the field as rapidly advancing but does not explicitly mention different stages of development across different cancers."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions the limitations of liquid biopsies, including sensitivity, false positives, and cost.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Addresses sensitivity (false negatives), specificity/false positives, and cost/insurance coverage as limitations."
      },
      {
        "criterion_number": 10,
        "description": "The response says there are currently no FDA approved liquid biopsies for pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of FDA approval status or lack thereof for pancreatic cancer."
      },
      {
        "criterion_number": 11,
        "description": "The response says health insurance may not pay for these tests.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States tests can be expensive and insurance coverage can vary, implying possible lack of coverage."
      },
      {
        "criterion_number": 12,
        "description": "The response says liquid biopsies may be able to identify genetic mutations present in the cancer which can help to guide treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains treatment selection via identifying mutations (e.g., BRCA, PALB2) to guide targeted therapies."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that liquid biopsies are noninvasive and can expedite testing because there is no need to retrieve archival blocks or arrange for a new biopsy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes liquid biopsies as noninvasive and notes 'Faster results' compared with processing a tissue biopsy, implying no need for arranging a new invasive biopsy."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that copy-number changes may be more difficult to assess in cfDNA, and fusion testing may be more limited in common cfDNA tests currently used.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not address limitations specific to copy-number alterations or gene fusion detection in cfDNA."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that this is still under active research and not yet standard of care for all cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Characterizes liquid biopsies as a rapidly advancing area and states they are not a replacement yet, indicating they are not standard of care for all patients."
      }
    ],
    "question_number": 60,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:33:20.289841",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response considers the costs of travel.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly addresses flights, accommodation, daily living expenses, travel insurance, and currency exchange under Financial and Logistical considerations."
      },
      {
        "criterion_number": 2,
        "description": "The response considers the costs of healthcare abroad.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Details out-of-pocket nature, requests a written cost estimate including treatment, tests, hospital stay, and complications."
      },
      {
        "criterion_number": 3,
        "description": "The response considers logistics of travel, including the need for passports and/or visas.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions passports, potential need for a medical visa, flight planning, and travel arrangements."
      },
      {
        "criterion_number": 4,
        "description": "The response considers language and cultural barriers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Addresses need for reliable translators and highlights cultural differences and system navigation stressors."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions that patients receiving treatment for pancreatic cancer often require significant support from their family and friends.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Discusses caregiver role, risk of burnout, leaving the local support system, and family discussion and alignment."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends considering if the patient is medically safe for travel.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes consulting the oncologist about fitness to travel and notes risks such as DVT, fatigue, and nausea during long flights."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends researching the quality of healthcare in the intended destination.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises vetting the clinic, physician credentials, JCI accreditation, and requiring peer-reviewed evidence; cautions against unproven therapies."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends discussing all travel plans with a medical professional prior to leaving.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States consultation with the current oncologist is non-negotiable and recommends discussing benefits, safety to travel, and continuity of care."
      },
      {
        "criterion_number": 10,
        "description": "The response says that delaying the start of treatment for pancreatic cancer can be harmful.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not explicitly mention the risks of delaying initiation of treatment."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends researching pancreatic cancer outcomes in the intended destination as compared to her home country.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Encourages vetting clinics and evidence but does not explicitly recommend comparing national outcomes between destination and home country."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends understanding the patient\u2019s treatment options, including clinical trials, which may be available in her home country before making travel plans.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises discussing local options with oncologist, verifying if abroad treatment offers benefit over local care, and consulting PanCAN about standard treatments and legitimate clinical trials."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention considerations related to insurance funding.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes domestic insurance will likely not cover foreign or experimental treatment and to confirm directly; mentions travel insurance limitations."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention to consider local accommodations when traveling abroad for treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Provides guidance on accommodations near the hospital and accessibility, including long-stay hotels or furnished apartments."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention to consider challenges with follow-up care when traveling abroad for treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Highlights continuity-of-care challenges and whether the local oncologist will manage follow-up and side effects after returning."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that immunizations and infection prevention are important, especially for immunosuppressed patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address immunizations, infection prevention strategies, or heightened infection risk during immunosuppressive therapy."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that telemedicine and remote support can be leveraged for follow-up, symptom management, and multidisciplinary care, reducing the need for frequent travel and facilitating access to expertise at high-volume centers.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Suggests a remote consultation before travel but does not discuss ongoing telemedicine for follow-up, symptom management, or multidisciplinary care."
      }
    ],
    "question_number": 61,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:34:14.202494",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response considers the costs of travel.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It details travel and accommodation costs, including flights, lodging, local transport, and daily expenses."
      },
      {
        "criterion_number": 2,
        "description": "The response considers the costs of healthcare abroad.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It outlines treatment costs comprehensively, including itemized estimates, hidden costs, payment schedules, and currency exchange."
      },
      {
        "criterion_number": 3,
        "description": "The response considers logistics of travel, including the need for passports and/or visas.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It includes a Visa & Immigration section covering medical visas, caregiver visas, and extensions."
      },
      {
        "criterion_number": 4,
        "description": "The response considers language and cultural barriers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It addresses language needs (staff fluency, interpreters) and cultural differences (food, customs, healthcare system differences)."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions that patients receiving treatment for pancreatic cancer often require significant support from their family and friends.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It emphasizes caregiver involvement, support systems, and caregiver burnout, indicating substantial support needs."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends considering if the patient is medically safe for travel.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises consulting current doctors for fitness to travel, discusses DVT/infection risks, and mentions medical escorts."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends researching the quality of healthcare in the intended destination.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends verifying hospital accreditation (e.g., JCI), doctor credentials, technology, success rates, and performing thorough independent research."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends discussing all travel plans with a medical professional prior to leaving.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It directs the reader to consult the current medical team, share plans, and obtain professional opinions before travel."
      },
      {
        "criterion_number": 10,
        "description": "The response says that delaying the start of treatment for pancreatic cancer can be harmful.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it notes pancreatic cancer is aggressive and mentions wait times, it does not explicitly state that delaying treatment can be harmful."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends researching pancreatic cancer outcomes in the intended destination as compared to her home country.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It advises comparing realistic prognosis and outcomes offered abroad with what has been presented locally and asks about success rates."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends understanding the patient\u2019s treatment options, including clinical trials, which may be available in her home country before making travel plans.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses clinical trials/novel therapies and explicitly asks whether options are available locally and to consider international care as a last resort after exhausting local treatments."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention considerations related to insurance funding.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It covers local insurance coverage limitations, medical travel insurance, repatriation, and cancellation/interruption insurance."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention to consider local accommodations when traveling abroad for treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It includes accommodation planning and costs, along with potential concierge/patient support services."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention to consider challenges with follow-up care when traveling abroad for treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It addresses follow-up care coordination, testing, medications, and communication between local and foreign doctors after returning home."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that immunizations and infection prevention are important, especially for immunosuppressed patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it notes infection risks during travel, it does not discuss immunizations or infection prevention strategies for immunosuppressed patients."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that telemedicine and remote support can be leveraged for follow-up, symptom management, and multidisciplinary care, reducing the need for frequent travel and facilitating access to expertise at high-volume centers.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions ongoing consultations and the need for reliable internet, but does not explicitly recommend telemedicine or remote multidisciplinary support."
      }
    ],
    "question_number": 61,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:35:02.007478",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that bowel changes, including diarrhea, nausea, and constipation, are common among patients undergoing treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly notes bowel changes are common and lists diarrhea, constipation, and nausea/vomiting as typical treatment-related effects."
      },
      {
        "criterion_number": 2,
        "description": "The response mentions that chemotherapy, radiation therapy, surgery, and other treatments such as pain medications can impact the bowels.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly discusses chemotherapy, radiation, surgery (Whipple), and opioids/antiemetics affecting bowels."
      },
      {
        "criterion_number": 3,
        "description": "The response explains that bowel changes can also be due to infections.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of infectious causes."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends discussing specific concerns with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Strongly encourages contacting the oncology team immediately and asking targeted questions."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends keeping a log of events related to food intake, fluid intake, and bowel symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Recommends a symptom journal with bowel details and food intake, but does not include tracking fluid intake."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing the above log with the patient\u2019s healthcare team.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States the journal provides valuable data for doctors and advises speaking with the oncology team, implying sharing the log."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends if the patient has not had a bowel movement in more than 24 hours and is not passing gas, their bowels may be obstructed, which is a medical emergency and requires immediate evaluation in an emergency department.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No emergency guidance regarding suspected bowel obstruction."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends if the patient is nauseous and unable to keep any food or drink down without vomiting, this can quickly lead to severe dehydration, which requires urgent evaluation by a medical professional and potentially intravenous fluids and medicines.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No recommendation for urgent evaluation for persistent vomiting/dehydration risk."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends if the patient is experiencing severe abdominal pain, this may represent a medical emergency which requires immediate evaluation in an emergency department.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention severe abdominal pain as a potential emergency."
      },
      {
        "criterion_number": 10,
        "description": "The response says patients with pancreatic cancer may experience pancreatic insufficiency.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly identifies Exocrine Pancreatic Insufficiency (EPI) as a common cause."
      },
      {
        "criterion_number": 11,
        "description": "The response explains pancreatic insufficiency is related to a deficiency in the pancreatic enzymes which break down food and can cause diarrhea and bloating.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains enzyme deficiency leads to malabsorption with diarrhea, steatorrhea, bloating, and gas."
      },
      {
        "criterion_number": 12,
        "description": "The response explains there are supplementary pancreatic enzymes that can be taken to alleviate the symptoms of pancreatic insufficiency.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions PERT (e.g., Creon, Zenpep) as standard treatment."
      },
      {
        "criterion_number": 13,
        "description": "The response explains if the bowel changes are due to chemotherapy, the treating oncologist can often prescribe additional medications to control these side effects.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes anti-diarrheal medications for chemo-related diarrhea in a section on strategies doctors may recommend."
      },
      {
        "criterion_number": 14,
        "description": "The response says proper nutrition is an important part of cancer care outcomes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Links malnutrition to poorer quality of life and treatment tolerance and recommends oncology dietitian."
      },
      {
        "criterion_number": 15,
        "description": "The response says it is important to remain hydrated.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises ensuring adequate hydration as part of dietary guidance."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that it is important to determine the cause of the bowel changes to manage them effectively.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States 'Understanding the cause is the first step' and structures the discussion by cause."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that gastric outlet/duodenal obstruction can occur in up to 10% of patients with pancreatic cancer, leading to symptoms like early satiety, nausea, postprandial vomiting, and weight loss.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention gastric outlet/duodenal obstruction prevalence or classic symptom cluster."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that patients with malignant ascites from pancreatic cancer may experience abdominal discomfort, nausea, and vomiting.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of malignant ascites."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that diet/nutrition changes can cause bowel changes unrelated to cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not state that diet changes themselves can cause bowel changes unrelated to cancer/treatment."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that stress/anxiety can cause bowel changes unrelated to cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of stress/anxiety as a cause of bowel changes."
      },
      {
        "criterion_number": 21,
        "description": "The response should mention that pre-existing conditions can cause bowel changes unrelated to cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of pre-existing gastrointestinal or other conditions as alternative causes."
      }
    ],
    "question_number": 62,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:36:29.962411",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that bowel changes, including diarrhea, nausea, and constipation, are common among patients undergoing treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states bowel changes are very common with pancreatic cancer and attributes them to the cancer and its treatments; explicitly mentions diarrhea, constipation, and nausea/vomiting."
      },
      {
        "criterion_number": 2,
        "description": "The response mentions that chemotherapy, radiation therapy, surgery, and other treatments such as pain medications can impact the bowels.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides separate sections detailing effects of surgery, chemotherapy, radiation therapy, and medications including opioids on bowel function."
      },
      {
        "criterion_number": 3,
        "description": "The response explains that bowel changes can also be due to infections.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Notes that the medical team may address potential infections and implies they can cause symptoms; sufficient acknowledgment that infections can be a cause."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends discussing specific concerns with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises reporting bowel changes to the healthcare team and explicitly includes the oncologist."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends keeping a log of events related to food intake, fluid intake, and bowel symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages providing detailed information but does not explicitly recommend keeping a log, and does not mention tracking fluid intake."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing the above log with the patient\u2019s healthcare team.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not recommend keeping a log nor discussing a log specifically, only to provide details to the care team."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends if the patient has not had a bowel movement in more than 24 hours and is not passing gas, their bowels may be obstructed, which is a medical emergency and requires immediate evaluation in an emergency department.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Obstruction is mentioned, but there is no specific emergency guidance or the 24-hour/no gas criterion or ED referral."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends if the patient is nauseous and unable to keep any food or drink down without vomiting, this can quickly lead to severe dehydration, which requires urgent evaluation by a medical professional and potentially intravenous fluids and medicines.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Nausea/vomiting are listed, but there is no advice about urgent evaluation, dehydration risk, or need for IV fluids."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends if the patient is experiencing severe abdominal pain, this may represent a medical emergency which requires immediate evaluation in an emergency department.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Severe abdominal pain is mentioned as a symptom, but there is no emergency department recommendation."
      },
      {
        "criterion_number": 10,
        "description": "The response says patients with pancreatic cancer may experience pancreatic insufficiency.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly discusses pancreatic enzyme insufficiency (PEI) as common in pancreatic cancer."
      },
      {
        "criterion_number": 11,
        "description": "The response explains pancreatic insufficiency is related to a deficiency in the pancreatic enzymes which break down food and can cause diarrhea and bloating.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains the pancreas produces enzymes needed for digestion, and insufficiency leads to malabsorption with diarrhea and bloating."
      },
      {
        "criterion_number": 12,
        "description": "The response explains there are supplementary pancreatic enzymes that can be taken to alleviate the symptoms of pancreatic insufficiency.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions pancreatic enzyme replacement therapy (PERT) and adjusting dosage as part of management."
      },
      {
        "criterion_number": 13,
        "description": "The response explains if the bowel changes are due to chemotherapy, the treating oncologist can often prescribe additional medications to control these side effects.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Links chemotherapy to diarrhea/constipation and notes the medical team can prescribe antidiarrheals or laxatives; oncologist is part of the team."
      },
      {
        "criterion_number": 14,
        "description": "The response says proper nutrition is an important part of cancer care outcomes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Discusses malnutrition and offers dietary recommendations but does not explicitly state that proper nutrition is important for cancer care outcomes."
      },
      {
        "criterion_number": 15,
        "description": "The response says it is important to remain hydrated.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No explicit recommendation about hydration."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that it is important to determine the cause of the bowel changes to manage them effectively.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises reporting symptoms so the team can investigate the cause and tailor interventions accordingly."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that gastric outlet/duodenal obstruction can occur in up to 10% of patients with pancreatic cancer, leading to symptoms like early satiety, nausea, postprandial vomiting, and weight loss.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions duodenal compression and obstruction with nausea/vomiting but does not provide the 10% figure, early satiety, postprandial vomiting, or weight loss in this context."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that patients with malignant ascites from pancreatic cancer may experience abdominal discomfort, nausea, and vomiting.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Malignant ascites is not mentioned."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that diet/nutrition changes can cause bowel changes unrelated to cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Asks to report diet changes but does not state that diet/nutrition changes themselves can cause bowel changes unrelated to cancer or treatment."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that stress/anxiety can cause bowel changes unrelated to cancer or cancer treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly states stress and anxiety can influence bowel movements."
      },
      {
        "criterion_number": 21,
        "description": "The response should mention that pre-existing conditions can cause bowel changes unrelated to cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of pre-existing conditions as a cause."
      }
    ],
    "question_number": 62,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:37:11.715614",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises talking to the oncology team and outlines discussing specifics with the oncologist, nurse, or pharmacist."
      },
      {
        "criterion_number": 2,
        "description": "The response states that pancreatic cancer and its treatments may affect the patient\u2019s ability to drive safely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that chemotherapy and its side effects can impair driving, with specific mention of drugs used for pancreatic cancer (e.g., oxaliplatin)."
      },
      {
        "criterion_number": 3,
        "description": "The response states that pain medications may impair the patient\u2019s ability to drive safely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes opioids cause drowsiness, confusion, slowed reactions, and that driving on opioids can be illegal."
      },
      {
        "criterion_number": 4,
        "description": "The response states that symptoms such as fatigue, drowsiness, nausea, and vomiting may impair the patient\u2019s ability to drive safely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses fatigue, nausea, dizziness, and drowsiness (from medications) as impairing driving. Although vomiting is not explicitly named, the criterion uses \u2018such as\u2019 and the response covers multiple relevant symptoms."
      },
      {
        "criterion_number": 5,
        "description": "The response states that the patient\u2019s healthcare team may have resources to assist with transportation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions hospital or cancer center shuttles and transportation services, implying resources available through the care team/cancer center."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that chemotherapy can cause fatigue that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Provides a dedicated section on fatigue with explicit driving impact."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that chemotherapy can cause vision changes that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Includes vision changes (blurred vision, dry eyes) and explains how they impair driving."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that chemotherapy can cause neuropathy that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Details peripheral neuropathy from agents such as oxaliplatin and its impact on pedal control and steering grip."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that chemotherapy can cause cognitive changes that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Describes \u201cchemo brain\u201d (fog, concentration/memory issues) and how it affects decision-making and reaction time while driving."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention to avoid driving after the first chemotherapy session to see how your husband tolerates it.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises assuming he should not drive in the days immediately following an infusion and to assess tolerance with guidance, which captures the intent to avoid driving initially to gauge effects."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention to plan for backup transportation, such as a taxi, friends/family, or public transportation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends planning alternatives: family/friends, ride-sharing (Uber/Lyft), ACS Road to Recovery, and hospital shuttles."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that the National Highway Traffic Safety Administration (NHTSA) provides information on medical conditions and driving safety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of NHTSA or its resources."
      }
    ],
    "question_number": 63,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:38:21.904499",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises: \u201cDiscuss with His Healthcare Team (Oncologist, Nurses): This is the most important step,\u201d including specifics on what to ask."
      },
      {
        "criterion_number": 2,
        "description": "The response states that pancreatic cancer and its treatments may affect the patient\u2019s ability to drive safely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that driving can be impaired by \u201ccancer and its treatments,\u201d and references the physical toll of pancreatic cancer and treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response states that pain medications may impair the patient\u2019s ability to drive safely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Names opioids and other medications causing drowsiness and impaired judgment; later reiterates to avoid driving when on pain medications."
      },
      {
        "criterion_number": 4,
        "description": "The response states that symptoms such as fatigue, drowsiness, nausea, and vomiting may impair the patient\u2019s ability to drive safely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details fatigue, nausea/vomiting, and drowsiness (from meds) as impairing driving; includes self-assessment prompts for tiredness/drowsiness."
      },
      {
        "criterion_number": 5,
        "description": "The response states that the patient\u2019s healthcare team may have resources to assist with transportation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions \u201cVolunteer driver programs (many cancer centers offer these),\u201d implying resources available through the care team/cancer center."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that chemotherapy can cause fatigue that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Identifies fatigue as a common chemo side effect and explains how it impairs driving."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that chemotherapy can cause vision changes that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Notes blurred vision, dry eyes, and light sensitivity from treatments that make driving difficult."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that chemotherapy can cause neuropathy that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Describes peripheral neuropathy from chemo affecting pedal control and grip."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that chemotherapy can cause cognitive changes that may impair driving abilities.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Includes \u201cchemo brain/cognitive changes\u201d affecting concentration, processing speed, and decision-making while driving."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention to avoid driving after the first chemotherapy session to see how your husband tolerates it.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises not to drive after chemotherapy infusion for at least 24\u201348 hours, which includes the first session to assess tolerance."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention to plan for backup transportation, such as a taxi, friends/family, or public transportation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists alternative transportation options including family/friends, public transportation, ride-sharing, and volunteer driver programs."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that the National Highway Traffic Safety Administration (NHTSA) provides information on medical conditions and driving safety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of NHTSA or its resources."
      }
    ],
    "question_number": 63,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:38:47.853882",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that the ability to work depends on individual circumstances such as the stage of cancer, overall health, and comorbidities.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response says the decision is personal and depends on several factors, it does not explicitly mention stage of cancer, overall health, or comorbidities."
      },
      {
        "criterion_number": 2,
        "description": "The response states that the ability to work depends on the type of treatment (chemotherapy, radiation, surgery, targeted therapy) and related side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly notes chemotherapy, radiation, and surgery, and details side effects (fatigue, nausea, cognitive effects, pain, immunosuppression) impacting work."
      },
      {
        "criterion_number": 3,
        "description": "The response states that the ability to work depends on the support available from friends, family, and caregivers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It frames working as a team effort and provides a section outlining how loved ones can support, indicating the importance of available support."
      },
      {
        "criterion_number": 4,
        "description": "The response states that the ability to work depends on job type and flexibility (working from home, reduced hours, workplace accommodations, scheduled breaks).",
        "score_given": 5,
        "max_points": 5,
        "justification": "It contrasts physically demanding jobs with desk/remote work and details flexible arrangements such as modified schedules, remote work, duty changes, breaks, and ergonomic setups."
      },
      {
        "criterion_number": 5,
        "description": "The response states that pancreatic cancer and its treatment can cause symptoms which may make working challenging.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly lists treatment-related symptoms that can hinder work, including fatigue, nausea, cognitive issues, pain, and infection risk."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises starting with the medical team, consulting the oncologist and nurse navigator, and asking about side effects and realistic expectations."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends workplace accommodations which may make working possible during treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It provides multiple specific accommodations: modified schedules, remote work, duty changes, more frequent breaks, and ergonomic adjustments."
      },
      {
        "criterion_number": 9,
        "description": "The response states the patient\u2019s ability to continue working should be continually reassessed as their medical condition changes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends tracking cycles of side effects, scheduling tasks on \"good days,\" adjusting expectations (e.g., fewer hours), and using intermittent leave, all implying ongoing reassessment."
      },
      {
        "criterion_number": 10,
        "description": "The response states that self-care is important while undergoing cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It emphasizes rest, prioritizing health, and being okay with taking days off or saying no, underscoring self-care during treatment."
      },
      {
        "criterion_number": 11,
        "description": "The response states the patient may qualify for paid leave through their employer, the government, or both.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions FMLA (unpaid, job-protected leave) but does not mention any paid leave options such as employer-provided paid leave, short-term disability, or state paid family leave programs."
      },
      {
        "criterion_number": 12,
        "description": "The response states many patients with pancreatic cancer take time off of work during treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it normalizes taking days off and using leave, it does not explicitly state that many patients with pancreatic cancer take time off during treatment."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that it is important for patients with pancreatic cancer to maintain their quality of life, and that work during treatment may be possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that working is possible for many and emphasizes finding a sustainable balance that supports well-being (physical, emotional, financial), reflecting quality-of-life considerations."
      }
    ],
    "question_number": 64,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:39:30.498692",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that the ability to work depends on individual circumstances such as the stage of cancer, overall health, and comorbidities.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that type and stage influence feasibility and includes individual variability (\"Everyone experiences cancer and its treatments differently\"), conveying dependence on personal circumstances."
      },
      {
        "criterion_number": 2,
        "description": "The response states that the ability to work depends on the type of treatment (chemotherapy, radiation, surgery, targeted therapy) and related side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly discusses chemotherapy, radiation, surgery (Whipple), targeted therapy, immunotherapy, and details common side effects affecting work."
      },
      {
        "criterion_number": 3,
        "description": "The response states that the ability to work depends on the support available from friends, family, and caregivers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a section on building a strong support system and mentions family, friends, and colleagues as important supports."
      },
      {
        "criterion_number": 4,
        "description": "The response states that the ability to work depends on job type and flexibility (working from home, reduced hours, workplace accommodations, scheduled breaks).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses physical/mental demands of the job, flexibility, remote work, part-time options, and supportive environments."
      },
      {
        "criterion_number": 5,
        "description": "The response states that pancreatic cancer and its treatment can cause symptoms which may make working challenging.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states treatment can be challenging and lists specific symptoms (fatigue, nausea, neuropathy, cognitive issues) that hinder work."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a dedicated step to consult the medical team with open discussion and realistic expectations."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends workplace accommodations which may make working possible during treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists specific accommodations: flexible schedules, reduced hours, remote work, modified duties, time off, ergonomic adjustments, and rest spaces."
      },
      {
        "criterion_number": 9,
        "description": "The response states the patient\u2019s ability to continue working should be continually reassessed as their medical condition changes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises ongoing adjustment and trial-and-error, noting that what is manageable may change week to week and may require reducing hours or stopping."
      },
      {
        "criterion_number": 10,
        "description": "The response states that self-care is important while undergoing cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Emphasizes prioritizing well-being, listening to the body, taking breaks, and pacing."
      },
      {
        "criterion_number": 11,
        "description": "The response states the patient may qualify for paid leave through their employer, the government, or both.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions short-term/long-term disability insurance, sick leave/PTO, and Social Security Disability, covering employer and government options."
      },
      {
        "criterion_number": 12,
        "description": "The response states many patients with pancreatic cancer take time off of work during treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it discusses taking time off as needed, it does not explicitly state that many patients take time off during treatment."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that it is important for patients with pancreatic cancer to maintain their quality of life, and that work during treatment may be possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that continuing to work is possible and emphasizes that well-being and quality of life should be the top priority."
      }
    ],
    "question_number": 64,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:39:59.133923",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing the use of medical marijuana with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States multiple times to discuss with the oncology team, including a bold disclaimer and 'Schedule a Conversation with the Oncology Team. This is non-negotiable.'"
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that medical marijuana is not an effective alternative treatment for pancreatic cancer itself.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly says 'It is not a cure for pancreatic cancer' and frames cannabis as palliative for symptom management."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly mentions risks and side effects associated with medical marijuana, including psychoactive effects and potential interactions with other medications.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists anxiety, paranoia, dizziness, drowsiness, impaired coordination, dry mouth, memory impairment, and drug interactions (sedatives, opioids, blood thinners)."
      },
      {
        "criterion_number": 4,
        "description": "The response clearly states that medical marijuana comes in various forms, such as oils, edibles, tinctures, and vaporizers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes oils/tinctures, edibles, vaporizing, capsules, and topicals."
      },
      {
        "criterion_number": 5,
        "description": "The response specifically mentions the risk of inhaled medical marijuana exposing patients to infectious organisms like fungi, particularly for those receiving certain chemotherapy treatments.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention infection risks (e.g., fungal contamination/aspergillus) with inhaled cannabis."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly states that medical marijuana may be used to control symptoms associated with pancreatic cancer and its treatments, such as nausea, vomiting, loss of appetite, and pain.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly discusses appetite stimulation, nausea/vomiting relief, and pain management."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly states that there is mixed data on the benefit of medical marijuana for managing symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Presents benefits without stating that evidence is mixed or inconsistent."
      },
      {
        "criterion_number": 8,
        "description": "The response discusses potential legal challenges with obtaining and using medical marijuana, noting that these may vary based on the patient\u2019s location.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses variability by state/country, certification, and medical marijuana card requirements."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly recommends not driving or making important decisions while under the influence of marijuana.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions impaired coordination and fall risk but does not explicitly advise against driving or important decision-making."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly recommends obtaining medical marijuana only from professionals licensed to sell it.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises sourcing from a reputable, legal dispensary and avoiding unregulated sources."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that medical marijuana refers to products derived from the cannabis plant or its extracts that contain active compounds such as THC (tetrahydrocannabinol), CBD (cannabidiol), or combinations thereof.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines cannabis, outlines THC and CBD, their properties, and suggests balanced ratio products."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that preliminary data reports poor clinical outcomes in adults receiving immunotherapy while using cannabis and/or cannabinoids.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of immunotherapy outcomes with concurrent cannabis use."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that CBD presents risks for hepatotoxicity, with a meta-analysis reporting a nearly 6-fold increase in liver enzyme elevation and drug-induced liver injury.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of CBD-related hepatotoxicity or liver enzyme elevations."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that cannabis and/or cannabinoids are one of several pharmacologic options for adults with cancer experiencing refractory nausea and vomiting despite optimal prophylaxis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes antiemetic effects and benefit when traditional meds don't work, but does not explicitly frame it as one of several options for refractory CINV despite optimal prophylaxis."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that further research is needed to determine the effectiveness of cannabis to reduce polypharmacy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address research gaps regarding cannabis and polypharmacy reduction."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that further research is needed to determine the effectiveness of cannabis to reduce opioid requirements for cancer-related pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions possible opioid-sparing effect but does not state that further research is needed."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that further research is needed to determine the effectiveness of cannabis to reduce chemotherapy-induced peripheral neuropathy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of chemotherapy-induced peripheral neuropathy or related research needs."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that further research is needed to determine the effects of cannabis on pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses pain relief but does not note the need for further research on cannabis's effects on pain."
      }
    ],
    "question_number": 65,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:40:50.586259",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing the use of medical marijuana with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes a section titled 'Essential First Step: Discuss with His Healthcare Team!' and clearly urges an open discussion with the oncologist and medical team before use."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that medical marijuana is not an effective alternative treatment for pancreatic cancer itself.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states medical marijuana is not a primary treatment or cure and positions it for symptom management only."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly mentions risks and side effects associated with medical marijuana, including psychoactive effects and potential interactions with other medications.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It lists drug interactions (with chemotherapy, anticoagulants, sedatives, etc.) and side effects including psychoactive effects (anxiety, paranoia, confusion), dizziness, sedation, tachycardia, and respiratory issues if smoked."
      },
      {
        "criterion_number": 4,
        "description": "The response clearly states that medical marijuana comes in various forms, such as oils, edibles, tinctures, and vaporizers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It describes vaping/inhaling, oral forms (edibles, oils, capsules), tinctures (sublingual), and topicals."
      },
      {
        "criterion_number": 5,
        "description": "The response specifically mentions the risk of inhaled medical marijuana exposing patients to infectious organisms like fungi, particularly for those receiving certain chemotherapy treatments.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions respiratory issues with smoking but does not address infectious organisms like fungi or elevated risk during chemotherapy."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly states that medical marijuana may be used to control symptoms associated with pancreatic cancer and its treatments, such as nausea, vomiting, loss of appetite, and pain.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It clearly lists pain, nausea/vomiting, appetite stimulation, anxiety, and sleep disturbances as potential benefits."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly states that there is mixed data on the benefit of medical marijuana for managing symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It characterizes evidence as stronger for symptom management but does not state that data are mixed."
      },
      {
        "criterion_number": 8,
        "description": "The response discusses potential legal challenges with obtaining and using medical marijuana, noting that these may vary based on the patient\u2019s location.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes legality varies by state/country and mentions U.S. federal illegality despite state legality."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly recommends not driving or making important decisions while under the influence of marijuana.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although it mentions impaired judgment, it does not explicitly advise against driving or making important decisions."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly recommends obtaining medical marijuana only from professionals licensed to sell it.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It suggests consulting knowledgeable dispensary staff but does not explicitly instruct to obtain products only from licensed professionals."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that medical marijuana refers to products derived from the cannabis plant or its extracts that contain active compounds such as THC (tetrahydrocannabinol), CBD (cannabidiol), or combinations thereof.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines THC and CBD as key active compounds in cannabis and discusses differing THC:CBD ratios across products."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that preliminary data reports poor clinical outcomes in adults receiving immunotherapy while using cannabis and/or cannabinoids.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of immunotherapy interactions or preliminary data showing poorer outcomes."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that CBD presents risks for hepatotoxicity, with a meta-analysis reporting a nearly 6-fold increase in liver enzyme elevation and drug-induced liver injury.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of CBD-related hepatotoxicity or liver enzyme/drug-induced liver injury risk."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that cannabis and/or cannabinoids are one of several pharmacologic options for adults with cancer experiencing refractory nausea and vomiting despite optimal prophylaxis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states cannabis has antiemetic effects and is used for symptom control 'often when conventional treatments have failed or are insufficient,' aligning with refractory use as an option."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that further research is needed to determine the effectiveness of cannabis to reduce polypharmacy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of polypharmacy or research needed to reduce medication burden."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that further research is needed to determine the effectiveness of cannabis to reduce opioid requirements for cancer-related pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It suggests cannabis may reduce reliance on opioids but does not state that further research is needed to confirm opioid-sparing effects."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that further research is needed to determine the effectiveness of cannabis to reduce chemotherapy-induced peripheral neuropathy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of chemotherapy-induced peripheral neuropathy or research gaps in this area."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that further research is needed to determine the effects of cannabis on pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While analgesic properties are noted, it does not state that additional research is needed to determine effects on pain."
      }
    ],
    "question_number": 65,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:41:33.805453",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends consulting with the patient\u2019s oncologist or healthcare team, including specific roles such as nurse practitioner or palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises scheduling a meeting with the oncology team and explicitly mentions involving a palliative care specialist and a nurse navigator, which are specific roles within the healthcare team."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that the healthcare team may have a social worker available to assist with family discussions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends a hospital social worker as an ideal neutral third party to facilitate discussions, indicating availability through the care team."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends involving a neutral third party, such as a social worker, spiritual care worker, counselor, or patient advocate, to facilitate family discussions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly recommends inviting a neutral third party and names a hospital social worker, palliative care specialist, or nurse navigator to facilitate the conversation."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly provides online resources for cancer patients and their families, including specific organizations like PANCAN, NCI, or ACS.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No online resources or specific organizations such as PANCAN, NCI, or ACS are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend scheduling a family meeting to discuss goals of care and important treatment decisions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It calls for a formal family meeting with clear purpose and ground rules and recommends a joint meeting with the oncology team."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that understanding your mother\u2019s specific goals should shape conversations about goals of care and treatment recommendations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes centering everything around the mother\u2019s goals and includes prompts to elicit her treatment priorities, explicitly stating the focus should stay on her goals and well-being."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that your mother\u2019s wishes related to treatment, belief systems, and personal ways of coping should be respected by their families, cancer care team, and others who support them through the cancer experience.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states the mother\u2019s voice is paramount and the family\u2019s role is to support her decisions, and it frames meetings to ensure her goals guide care, implying respect by both family and care team."
      }
    ],
    "question_number": 66,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:41:53.440090",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends consulting with the patient\u2019s oncologist or healthcare team, including specific roles such as nurse practitioner or palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises to schedule a family meeting with the oncologist/palliative care team and to obtain an early palliative care consultation, explicitly engaging the healthcare team and palliative specialists."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that the healthcare team may have a social worker available to assist with family discussions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that hospitals often have social workers who can help mediate family discussions, provide resources, and navigate decision-making."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends involving a neutral third party, such as a social worker, spiritual care worker, counselor, or patient advocate, to facilitate family discussions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends a neutral third-party mediator or family therapist and also mentions hospital social workers to mediate family communication."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly provides online resources for cancer patients and their families, including specific organizations like PANCAN, NCI, or ACS.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No online resources or named organizations (e.g., PanCAN, NCI, ACS) are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend scheduling a family meeting to discuss goals of care and important treatment decisions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It directly recommends scheduling a family meeting with the oncologist/palliative care team to review diagnosis, prognosis, and treatment options."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that understanding your mother\u2019s specific goals should shape conversations about goals of care and treatment recommendations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes centering the mother's wishes and outlines specific questions about her priorities, quality of life, and treatment tolerance to guide decisions."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that your mother\u2019s wishes related to treatment, belief systems, and personal ways of coping should be respected by their families, cancer care team, and others who support them through the cancer experience.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly stresses honoring and respecting the mother\u2019s wishes, instructs family to focus on what she wants, and notes palliative care helps ensure the patient\u2019s wishes are respected, implying both family and care team should uphold them."
      }
    ],
    "question_number": 66,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:42:18.823270",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response mentions a palliative care team and oncology social worker/therapist but does not advise discussing these concerns with the patient\u2019s oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, spiritual care worker, palliative care professional, or counselor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends involving a palliative care team and an oncology social worker or therapist, and notes emotional/spiritual support, meeting the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends support groups and other online resources for cancer patients and their families.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends support groups for patients and caregivers and suggests checking with PanCAN for resources."
      },
      {
        "criterion_number": 4,
        "description": "The response states that depression is highly prevalent in patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Depression prevalence in pancreatic cancer is not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response reviews the signs and symptoms of depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No signs or symptoms of depression are reviewed."
      },
      {
        "criterion_number": 6,
        "description": "The response states that if the patient is experiencing thoughts of harming themselves or others, they should seek immediate evaluation by a healthcare professional.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no guidance about immediate evaluation for suicidal or homicidal thoughts."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that it\u2019s important to have open and honest conversations about their concerns, including feeling like a burden to their loved ones.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response emphasizes open, validating communication about feeling like a burden and advises not to dismiss those concerns."
      },
      {
        "criterion_number": 8,
        "description": "The response should encourage the patient to express their fears and anxieties about the impact of their illness on their loved ones, and acknowledge and validate their feelings.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly encourages listening, asking open-ended questions, and validating the patient\u2019s fears and frustrations."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention to ask about the patient\u2019s preferences and personal goals of care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests offering choices and asking for opinions on day-to-day matters, it does not mention discussing the patient\u2019s preferences or personal goals of care."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention it is important to emphasize working together to manage the challenges.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It repeatedly reframes the situation as being a team effort and emphasizes working together."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention support networks such as PanCAN, CancerCare, ASCO.",
        "score_given": 5,
        "max_points": 5,
        "justification": "PanCAN (Pancreatic Cancer Action Network) is specifically mentioned as a resource."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that professional counseling can help process these emotions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends an oncology social worker or therapist to help navigate emotional challenges and provide coping strategies."
      }
    ],
    "question_number": 67,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:42:52.755992",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response mentions palliative care, oncology social workers, and counselors, but does not advise discussing concerns with the patient\u2019s oncologist specifically."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, spiritual care worker, palliative care professional, or counselor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends engaging a palliative care team, an oncology social worker, and a therapist/counselor."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends support groups and other online resources for cancer patients and their families.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends support groups and also lists online tools/resources like Lotsa Helping Hands and CaringBridge for coordination, satisfying the support groups and online resources component."
      },
      {
        "criterion_number": 4,
        "description": "The response states that depression is highly prevalent in patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Depression prevalence in pancreatic cancer is not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response reviews the signs and symptoms of depression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No signs or symptoms of depression are reviewed."
      },
      {
        "criterion_number": 6,
        "description": "The response states that if the patient is experiencing thoughts of harming themselves or others, they should seek immediate evaluation by a healthcare professional.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no guidance to seek immediate help for suicidal or homicidal thoughts."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that it\u2019s important to have open and honest conversations about their concerns, including feeling like a burden to their loved ones.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The section on Open Communication encourages discussing specific worries and normalizes talking about feeling like a burden."
      },
      {
        "criterion_number": 8,
        "description": "The response should encourage the patient to express their fears and anxieties about the impact of their illness on their loved ones, and acknowledge and validate their feelings.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends asking open-ended questions, listening actively, and explicitly validating feelings."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention to ask about the patient\u2019s preferences and personal goals of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses involving the patient in decisions, giving choices, and advance directives/end-of-life care preferences, reflecting goals-of-care discussions."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention it is important to emphasize working together to manage the challenges.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes teamwork (e.g., \u201cWe are a team,\u201d \u201cCare team,\u201d distributing tasks) to manage challenges together."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention support networks such as PanCAN, CancerCare, ASCO.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention PanCAN, CancerCare, ASCO, or similar named support networks."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that professional counseling can help process these emotions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends therapists/counselors for the patient and family to process emotions, grief, and anxiety."
      }
    ],
    "question_number": 67,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:43:16.176003",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states targeted therapies work against cancer with specific genetic mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains that targeted therapy acts on specific genetic changes/biomarkers in genes or proteins unique to cancer cells."
      },
      {
        "criterion_number": 2,
        "description": "The response states that not all pancreatic cancers will have mutations for which targeted therapy can be used.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States options apply to a subset of patients and emphasizes need for biomarker/genomic testing to determine eligibility."
      },
      {
        "criterion_number": 3,
        "description": "The response provides examples of targetable mutations in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides examples including BRCA1/2, NTRK fusions, KRAS G12C, MSI-H/dMMR, and HER2."
      },
      {
        "criterion_number": 4,
        "description": "The response states targeted therapies can be given alone or sometimes in combination with chemotherapy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Describes PARP inhibitor as maintenance after chemotherapy but does not explicitly state that targeted therapy can be given alone or in combination with chemotherapy."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a specific list of questions to ask the oncologist and encourages discussion with the care team."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that targeted therapy for pancreatic cancer involves using drugs to specifically target proteins, genes, or pathways of cancer cells, potentially causing less damage to normal cells compared to chemotherapy or radiation therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains targeting genes/proteins and notes fewer off-target effects compared with chemotherapy, implying less damage to normal cells."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that while targeted therapy is an option, it is important to consider all potential treatment options, outcomes, and adverse events to make an informed decision.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages weighing benefits and side effects, comparing to chemotherapy, and considering clinical trials to inform decisions."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention examples of targeted therapies, such as Dabrafenib + trametinib, Entrectinib, Larotrectinib, Repotrectinib, Selpercatinib, Rucaparib, Olaparib, Adagrasib, Sotorasib, Erdafitinib, Fam-trastuzumab deruxtecan-nxki, Zenocutuzumab-zbco.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes examples from the list: Olaparib, Larotrectinib, and Entrectinib."
      },
      {
        "criterion_number": 9,
        "description": "Negative points if targeted therapies are discussed that are not approved for pancreatic cancer, such as osimertinib, regorafenib, mTOR inhibitors.",
        "score_given": 0,
        "max_points": 0,
        "justification": "Does not mention any disallowed or non-approved targeted therapies."
      }
    ],
    "question_number": 68,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:43:49.354871",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states targeted therapies work against cancer with specific genetic mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that targeted therapy focuses on specific molecules/proteins and genetic mutations driving cancer growth and interferes with those pathways."
      },
      {
        "criterion_number": 2,
        "description": "The response states that not all pancreatic cancers will have mutations for which targeted therapy can be used.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that targeted therapy requires a specific target identified via molecular profiling and notes several biomarkers are rare in pancreatic cancer, indicating many tumors will not qualify."
      },
      {
        "criterion_number": 3,
        "description": "The response provides examples of targetable mutations in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides examples including BRCA1/2, NTRK fusions, MSI-H/dMMR, KRAS G12C, and mentions HER2 amplification and RET fusions."
      },
      {
        "criterion_number": 4,
        "description": "The response states targeted therapies can be given alone or sometimes in combination with chemotherapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly mentions targeted therapy can be given alone, with chemo, or after chemo; also notes PARP inhibitor use after initial chemotherapy."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages discussion with the oncology team and lists specific questions to ask about testing, targets, drugs, benefits/side effects, treatment plan, and clinical trials."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that targeted therapy for pancreatic cancer involves using drugs to specifically target proteins, genes, or pathways of cancer cells, potentially causing less damage to normal cells compared to chemotherapy or radiation therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes targeting proteins/genes/pathways and notes potentially fewer side effects compared with traditional chemotherapy."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that while targeted therapy is an option, it is important to consider all potential treatment options, outcomes, and adverse events to make an informed decision.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises discussing benefits and side effects, how targeted therapy fits into the overall plan, and considering clinical trials, supporting informed decision-making."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention examples of targeted therapies, such as Dabrafenib + trametinib (if BRAF V600E mutation-positive), Entrectinib, Larotrectinib, Repotrectinib (if NTRK gene fusion-positive), Selpercatinib (if RET gene fusion-positive), Rucaparib (for germline or somatic BRCA1/2 or PALB2 mutations), Olaparib (only for germline BRCA1/2 mutations), Adagrasib (if KRAS G12C mutation-positive), Sotorasib (if KRAS G12C mutation-positive), Erdafitinib (if FGFR genetic alterations), Fam-trastuzumab deruxtecan-nxki (if HER2 positive [IHC3+ or IHC2+ with FISH HER2 amplified]) Zenocutuzumab-zbco (if NRG1 gene fusion-positive).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes several listed examples: larotrectinib, entrectinib (NTRK), olaparib and rucaparib (PARP inhibitors), and sotorasib and adagrasib (KRAS G12C)."
      },
      {
        "criterion_number": 9,
        "description": "Negative points if targeted therapies are discussed that are not approved for pancreatic cancer, such as osimertinib, regorafenib, mTOR inhibitors.",
        "score_given": 0,
        "max_points": 0,
        "justification": "Does not mention prohibited examples (osimertinib, regorafenib, mTOR inhibitors); no penalty applied."
      }
    ],
    "question_number": 68,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:44:30.741434",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing integrative medicine with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states multiple times to discuss with the oncology team: 'Always discuss any and all integrative... therapies with your loved one's oncology team before starting them,' and 'Lead with the Oncology Team.'"
      },
      {
        "criterion_number": 2,
        "description": "The response states integrative medicine is not as effective as standard of care treatments for pancreatic cancer like chemotherapy, radiation, surgery, and targeted therapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly differentiates roles: 'Integrative therapies are not used to cure pancreatic cancer' and 'It does not replace conventional care,' emphasizing that abandoning standard treatments is dangerous."
      },
      {
        "criterion_number": 3,
        "description": "The response states integrative medicine can be a helpful adjunct to standard of care treatments for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes adjunctive use: 'This approach uses evidence-based complementary therapies alongside standard conventional medical treatments' and details benefits for symptom management and quality of life."
      },
      {
        "criterion_number": 4,
        "description": "The response defines integrative medicine.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a clear definition: integrative medicine uses evidence-based complementary therapies alongside conventional treatments to manage symptoms and support the whole person."
      },
      {
        "criterion_number": 5,
        "description": "The response provides examples of integrative medicine interventions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Gives multiple examples: meditation, mindfulness, yoga, tai chi, guided imagery, music/art therapy, acupuncture, oncology massage, reflexology, and nutrition counseling."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends telling the patient\u2019s oncologist if they plan to include integrative medicine interventions into their care plan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States to consult the oncology team before starting any integrative/alternative therapies and to initiate the conversation with the care team."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends telling the patient\u2019s oncologist about all supplements they are taking.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit directive: 'Do not give your loved one any new vitamin, herb, or supplement without getting explicit approval from their oncologist.'"
      },
      {
        "criterion_number": 8,
        "description": "The response states some supplements may interact with the treatments being prescribed for their pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes interactions and mechanisms: high-dose antioxidants may interfere with chemo/radiation; herbal supplements can affect drug metabolism (e.g., St. John\u2019s Wort); 'immune-boosting' supplements may interact with immunotherapies."
      },
      {
        "criterion_number": 9,
        "description": "The response states there is data to support some integrative medicine interventions for specific uses.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States 'There is strong evidence that acupuncture can help manage chemotherapy-induced nausea and vomiting' and that some therapies are 'often supported by evidence' for symptom management."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that safety concerns and risks related to integrative medicine approaches are heightened with self-prescription or use of non-standardized products.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Warns against self-prescribing ('Do not give... any... supplement without explicit approval'), advises using qualified practitioners, and flags red-flag products ('secret' or proprietary), emphasizing heightened risk without professional oversight."
      }
    ],
    "question_number": 69,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:45:02.205871",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing integrative medicine with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises open communication with the oncology team multiple times, including 'Talk to the Oncology Team' and 'Communicate EVERYTHING with the Oncology Team.'"
      },
      {
        "criterion_number": 2,
        "description": "The response states integrative medicine is not as effective as standard of care treatments for pancreatic cancer like chemotherapy, radiation, surgery, and targeted therapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states integrative medicine is NOT an alternative to conventional treatment and 'is not a cure,' establishing it is not a substitute for standard-of-care efficacy."
      },
      {
        "criterion_number": 3,
        "description": "The response states integrative medicine can be a helpful adjunct to standard of care treatments for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes integrative medicine as supporting conventional care by managing side effects and improving tolerance, emphasizing adjunctive use."
      },
      {
        "criterion_number": 4,
        "description": "The response defines integrative medicine.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a clear definition: combining evidence-based conventional treatments with complementary therapies to treat the whole person."
      },
      {
        "criterion_number": 5,
        "description": "The response provides examples of integrative medicine interventions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Offers multiple examples: mind-body therapies, nutritional support, physical activity, acupuncture, massage, and herbs/supplements."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends telling the patient\u2019s oncologist if they plan to include integrative medicine interventions into their care plan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes informing the oncology team about all complementary therapies and coordinating care; includes a dedicated section on communication."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends telling the patient\u2019s oncologist about all supplements they are taking.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically instructs to never start herbs/supplements without explicit oncologist approval and to bring a full list of everything considered."
      },
      {
        "criterion_number": 8,
        "description": "The response states some supplements may interact with the treatments being prescribed for their pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes many herbs/supplements can interact dangerously with chemotherapy, radiation, and other medications, affecting efficacy and toxicity."
      },
      {
        "criterion_number": 9,
        "description": "The response states there is data to support some integrative medicine interventions for specific uses.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions therapies with demonstrated safety/efficacy, advises evidence-informed approaches, and cites specific benefits (e.g., acupuncture for nausea/neuropathy)."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that safety concerns and risks related to integrative medicine approaches are heightened with self-prescription or use of non-standardized products.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Warns against self-prescribing; highlights lack of regulation and variability in supplement quality/purity/dosing; urges oncologist approval before use."
      }
    ],
    "question_number": 69,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:45:28.087444",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the skin changes with the patient\u2019s oncologist or healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to always discuss side effects with his oncology team and emphasizes maintaining open communication with them."
      },
      {
        "criterion_number": 2,
        "description": "The response states that skin changes are a common side effect of chemotherapy for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states that it is very normal and common for people undergoing chemotherapy for pancreatic cancer to experience skin changes."
      },
      {
        "criterion_number": 3,
        "description": "The response states that skin changes related to treatment for pancreatic cancer can range from mild to life-threatening.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes that some changes require immediate medical attention and can be severe, but does not state that they range up to life-threatening."
      },
      {
        "criterion_number": 4,
        "description": "The response provides at least two examples of skin changes, including hand-foot syndrome, allergic reactions, or infections.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides multiple examples including dryness/itching, acne-like rash, photosensitivity, hand-foot syndrome, hyperpigmentation, and nail changes; also discusses infection-related concerns."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends immediate evaluation by a healthcare provider if the patient shows signs of infection.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises contacting the oncology nurse or doctor if signs of infection occur and frames some skin changes as requiring immediate medical attention."
      },
      {
        "criterion_number": 6,
        "description": "The response provides at least one example of signs and symptoms of infection.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists spreading redness, warmth, swelling, pus, and fever as signs of infection."
      },
      {
        "criterion_number": 7,
        "description": "The response states that skin changes related to treatment for pancreatic cancer should be treated by a healthcare professional experienced in caring for cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directs the reader to the oncology team, notes they have seen these side effects countless times, and implies management by experienced cancer care professionals."
      },
      {
        "criterion_number": 8,
        "description": "The response states that skin changes related to treatment for pancreatic cancer often require specific interventions or escalation of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions possible medicated creams (steroids, antibiotics) and potential chemotherapy dose adjustments if side effects become severe."
      },
      {
        "criterion_number": 10,
        "description": "The response mentions at least three specific manifestations of skin changes related to chemotherapy, such as new or worsening skin lesions, itch, acne-like symptoms, bullous dermatoses, allergic reactions, hand-foot syndrome, nail changes, or inflammatory dermatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes itch/dryness, acne-like rash, photosensitivity, hand-foot syndrome, hyperpigmentation, and nail/cuticle changes."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that skin changes could also be due to other conditions, such as infection, other medications, or unrelated skin disorders.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it discusses infection signs, it does not explicitly state that skin changes could be due to other conditions or medications unrelated to chemotherapy."
      },
      {
        "criterion_number": 12,
        "description": "The response states the importance of correctly identifying skin changes to ensure appropriate management and to avoid unnecessary discontinuation of effective cancer therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address the importance of accurate diagnosis to avoid unnecessary interruption of effective cancer treatment."
      }
    ],
    "question_number": 70,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:46:01.001510",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the skin changes with the patient\u2019s oncologist or healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises reporting symptoms to the oncology team and communicating all symptoms with them."
      },
      {
        "criterion_number": 2,
        "description": "The response states that skin changes are a common side effect of chemotherapy for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States skin changes are very common with chemotherapy; context is pancreatic cancer, satisfying the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response states that skin changes related to treatment for pancreatic cancer can range from mild to life-threatening.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions mild to severe (e.g., debilitating pain) but does not state that they can be life-threatening."
      },
      {
        "criterion_number": 4,
        "description": "The response provides at least two examples of skin changes, including hand-foot syndrome, allergic reactions, or infections.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides multiple examples including hand-foot syndrome and references to infections/rashes."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends immediate evaluation by a healthcare provider if the patient shows signs of infection.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advises reporting signs of infection but does not specify immediate or urgent evaluation."
      },
      {
        "criterion_number": 6,
        "description": "The response provides at least one example of signs and symptoms of infection.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists increased redness, warmth, and pus as signs of infection."
      },
      {
        "criterion_number": 7,
        "description": "The response states that skin changes related to treatment for pancreatic cancer should be treated by a healthcare professional experienced in caring for cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directs management to the oncology team and notes they are the best resource for managing side effects."
      },
      {
        "criterion_number": 8,
        "description": "The response states that skin changes related to treatment for pancreatic cancer often require specific interventions or escalation of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that dose adjustments and specific treatments (creams, oral medications) may be needed."
      },
      {
        "criterion_number": 10,
        "description": "The response mentions at least three specific manifestations of skin changes related to chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions dryness, itchiness, rashes (including acne-like), photosensitivity, hyperpigmentation, hand-foot syndrome, and nail changes."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that skin changes could also be due to other conditions, such as infection, other medications, or unrelated skin disorders.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that skin changes may be due to other conditions or medications; only references signs of infection without framing as alternative causes."
      },
      {
        "criterion_number": 12,
        "description": "The response states the importance of correctly identifying skin changes to ensure appropriate management and to avoid unnecessary discontinuation of effective cancer therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Emphasizes early intervention and management but does not mention avoiding unnecessary discontinuation of therapy or the importance of correct identification for that purpose."
      }
    ],
    "question_number": 70,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:46:35.415984",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response suggests asking about the stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit question: \"What is the stage of the cancer? Can you explain what that stage means in her specific case?\""
      },
      {
        "criterion_number": 2,
        "description": "The response suggests asking about available treatment options.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States: \"What are all of our treatment options? (Surgery, chemotherapy, radiation, targeted therapy, immunotherapy, clinical trials.)\""
      },
      {
        "criterion_number": 3,
        "description": "The response suggests asking about prognosis if the patient wants to know this information.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No direct suggestion to ask about prognosis or expected outcomes/survival; focuses on staging and goals but not prognosis specifically."
      },
      {
        "criterion_number": 4,
        "description": "The response suggests asking about potential side effects of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes: \"What are the most common short-term and long-term side effects of the recommended treatment?\" and management strategies."
      },
      {
        "criterion_number": 5,
        "description": "The response suggests asking about when the patient should follow up next.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it covers treatment schedules and points of contact, it does not specifically suggest asking when to return for the next follow-up appointment."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends writing down questions ahead of time and bringing them to the appointment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States: \"Write questions down: ... Bring a notebook with your questions prioritized.\""
      },
      {
        "criterion_number": 7,
        "description": "The response suggests asking about symptoms affecting the patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses QoL: asks about managing nausea, fatigue, neuropathy, digestive issues, pain management, and diet\u2014all QoL-related symptoms."
      },
      {
        "criterion_number": 8,
        "description": "The response suggests asking about clinical trial availability.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes: \"Are there any clinical trials she might be eligible for?\""
      },
      {
        "criterion_number": 9,
        "description": "The response suggests asking about how palliative care can help with the patient\u2019s care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes: \"Should we consult with a palliative care specialist?\" with explanation that palliative care manages symptoms and stress at any stage."
      },
      {
        "criterion_number": 10,
        "description": "The response suggests asking if genetic testing is available for germline inheritable cancer predisposition syndromes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions tumor molecular testing (e.g., BRCA, KRAS, MSI) but does not explicitly suggest germline/inherited genetic testing or genetic counseling."
      },
      {
        "criterion_number": 11,
        "description": "The response suggests asking about nutrition and if a nutritionist is available to help with dietary recommendations.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes: \"What should her diet be? Should we see a dietitian who specializes in oncology or pancreatic cancer?\""
      },
      {
        "criterion_number": 12,
        "description": "The response suggests asking about support groups for patients with pancreatic cancer and their families.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes: \"Can you recommend any support groups or resources for both my mother and for me as a caregiver?\""
      },
      {
        "criterion_number": 13,
        "description": "The response suggests asking about how to contact the oncology team in case of questions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes: \"Who should we call if we are having problems... (nurse navigator or an on-call number?)\" and \"Who is our main point of contact for non-emergency questions?\""
      },
      {
        "criterion_number": 14,
        "description": "The response suggests asking if lifestyle changes need to be made.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No explicit suggestion regarding lifestyle changes (e.g., smoking cessation, alcohol, exercise) beyond diet."
      },
      {
        "criterion_number": 15,
        "description": "The response suggests asking about mental health and resources for mental health support.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it mentions support groups and a social worker on the team, it does not explicitly prompt asking about mental health or counseling resources."
      },
      {
        "criterion_number": 16,
        "description": "The response recommends writing down important information during the appointment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises bringing someone to take detailed notes and suggests recording the conversation; this covers documenting key information during the visit."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention to ask questions related to goals of treatment (palliative, curative, etc).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly asks: \"What is the primary goal of treatment right now? (to cure, shrink for surgery, control growth, or manage symptoms/palliative care?)\""
      },
      {
        "criterion_number": 18,
        "description": "The response should mention bringing a family member or a friend to help listen and take notes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States: \"Bring someone with you... one person can focus on listening... while the other takes detailed notes.\""
      }
    ],
    "question_number": 71,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:47:26.470957",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response suggests asking about the stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit questions on stage, its meaning, spread, and tests used for staging are included."
      },
      {
        "criterion_number": 2,
        "description": "The response suggests asking about available treatment options.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Asks for all treatment options (surgery, chemotherapy, radiation, targeted therapy, immunotherapy, clinical trials) and recommendations."
      },
      {
        "criterion_number": 3,
        "description": "The response suggests asking about prognosis if the patient wants to know this information.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Contains a Prognosis section with questions about typical outcomes, factors affecting prognosis, and survival statistics."
      },
      {
        "criterion_number": 4,
        "description": "The response suggests asking about potential side effects of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly asks about potential benefits and common side effects, and includes a dedicated side effects and symptom management section."
      },
      {
        "criterion_number": 5,
        "description": "The response suggests asking about when the patient should follow up next.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes questions about appointment frequency and timelines for starting treatment, which address follow-up scheduling."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends writing down questions ahead of time and bringing them to the appointment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes preparing questions in advance and provides a comprehensive list to use at appointments, implying bringing them; also advises prioritizing questions."
      },
      {
        "criterion_number": 7,
        "description": "The response suggests asking about symptoms affecting the patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes quality-of-life questions and symptom-specific queries (pain, digestion, weight loss, jaundice, diabetes, fatigue, bowel issues)."
      },
      {
        "criterion_number": 8,
        "description": "The response suggests asking about clinical trial availability.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Contains a Clinical Trials section asking about eligibility, benefits/risks, and how to find more information."
      },
      {
        "criterion_number": 9,
        "description": "The response suggests asking about how palliative care can help with the patient\u2019s care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a Palliative Care section explaining its role and suggests asking for a consultation."
      },
      {
        "criterion_number": 10,
        "description": "The response suggests asking if genetic testing is available for germline inheritable cancer predisposition syndromes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends genetic testing for hereditary syndromes (e.g., BRCA, Lynch) for the patient and potentially family."
      },
      {
        "criterion_number": 11,
        "description": "The response suggests asking about nutrition and if a nutritionist is available to help with dietary recommendations.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Asks for referral to an oncology dietitian and discusses nutrition-related issues (PERT, weight loss)."
      },
      {
        "criterion_number": 12,
        "description": "The response suggests asking about support groups for patients with pancreatic cancer and their families.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions support groups for the patient and family in the Emotional and Psychological Support section."
      },
      {
        "criterion_number": 13,
        "description": "The response suggests asking about how to contact the oncology team in case of questions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies primary contact person and best communication methods; also asks about communication between appointments."
      },
      {
        "criterion_number": 14,
        "description": "The response suggests asking if lifestyle changes need to be made.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not explicitly suggest asking about lifestyle changes (e.g., diet/exercise/smoking/alcohol) beyond general quality-of-life and nutrition."
      },
      {
        "criterion_number": 15,
        "description": "The response suggests asking about mental health and resources for mental health support.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically addresses emotional support, counseling, social work, and mentions anxiety and depression."
      },
      {
        "criterion_number": 16,
        "description": "The response recommends writing down important information during the appointment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises taking notes and suggests asking to record the conversation."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention to ask questions related to goals of treatment (palliative, curative, etc).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Asks about the primary goal of each recommended treatment (cure, slow progression, manage symptoms, quality of life)."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention bringing a family member or a friend to help listen and take notes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Tip explicitly says to bring someone with you as another set of ears."
      }
    ],
    "question_number": 71,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:48:04.200475",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises an open, honest conversation with the oncology team and to ask direct questions; also suggests involving palliative care and talking to the doctor about travel specifics."
      },
      {
        "criterion_number": 2,
        "description": "The response states quality of life is important.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Quality of life is framed as the core of the decision, repeatedly emphasized as central to decision-making."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends considering the patient\u2019s goals of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages clarifying values and personal goals, refers to goals of care, and suggests palliative care to support goals-of-care discussions."
      },
      {
        "criterion_number": 4,
        "description": "The response states pancreatic cancer is an aggressive cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that pancreatic cancer is aggressive."
      },
      {
        "criterion_number": 5,
        "description": "The response states stopping treatment without consulting the treating oncologist is dangerous.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it strongly recommends discussing with the oncology team, it does not explicitly warn that stopping treatment without consultation is dangerous."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends considering access to emergency care at the travel destination.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises asking, \u201cWhat would a medical emergency look like in another city or country?\u201d and to choose destinations with good medical infrastructure."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends refilling all prescription medications prior to travel.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends packing more than enough medication for the entire trip plus extra for delays and carrying it in hand luggage, which implies ensuring refills before travel."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends considering if travel is safe.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Directly addresses medical fitness to travel and associated risks; advises discussing destination, duration, and mode of transport with the doctor."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends considering if the patient is strong enough to travel.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly asks the medical team whether the patient is currently strong enough to travel."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly clarify what \u201cstopping treatment\u201d means, such as stopping all therapies, only chemotherapy, or supportive care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly define whether stopping treatment refers to stopping disease-directed therapy (e.g., chemotherapy) while continuing supportive/palliative care; only notes palliative care can be involved at any stage."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly discuss the effects of a (temporary) treatment break on the prognosis of the cancer, symptoms, and other risks involved.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that stopping may shorten life and that symptoms may progress more quickly; recommends asking about prognosis with and without treatment and discusses risks during travel."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly state that stopping treatment may affect the patient\u2019s medical stability, ability to travel safely, and access to care and support while away.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes potential for faster symptom progression (medical stability), questions fitness to travel and risks (ability to travel safely), and highlights managing medical needs away from a familiar team and choosing places with good medical infrastructure (access to care and support)."
      }
    ],
    "question_number": 72,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:48:39.584151",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises meeting with the medical team, naming the oncologist and palliative care, to review prognosis, options, and feasibility."
      },
      {
        "criterion_number": 2,
        "description": "The response states quality of life is important.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Quality of life is emphasized repeatedly as central to decision-making and balanced against quantity of life."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends considering the patient\u2019s goals of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It focuses on values, wishes, priorities, and explicitly discusses goals such as quality vs. quantity, with guidance on advance directives and palliative/hospice choices."
      },
      {
        "criterion_number": 4,
        "description": "The response states pancreatic cancer is an aggressive cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states, \u201cPancreatic cancer can be aggressive,\u201d and discusses potential rapid decline after stopping treatment."
      },
      {
        "criterion_number": 5,
        "description": "The response states stopping treatment without consulting the treating oncologist is dangerous.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it urges consultation with the oncologist, it does not explicitly state that stopping treatment without consulting is dangerous."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends considering access to emergency care at the travel destination.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises researching medical facilities at the destination, explicitly asking where to go in an emergency and what care is available."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends refilling all prescription medications prior to travel.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends ensuring enough medication for the trip and having a plan for refills, which encompasses refilling prior to departure as needed."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends considering if travel is safe.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It addresses travel feasibility, medical needs, travel insurance, and access to care, all directly related to assessing safety of travel."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends considering if the patient is strong enough to travel.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It asks how physically able the person is to travel now or soon and whether they have energy for flights and activities, and it considers mobility and stamina."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly clarify what \u201cstopping treatment\u201d means, such as stopping all therapies, only chemotherapy, or supportive care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clarifies that stopping curative treatment shifts focus to comfort (hospice) and that palliative/symptom management continues even if active treatment stops."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly discuss the effects of a (temporary) treatment break on the prognosis of the cancer, symptoms, and other risks involved.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It proposes a treatment break as an option and explains that once treatment is stopped, decline can be rapid, emphasizing timelines, progression, and likely symptom development without active therapy."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly state that stopping treatment may affect the patient\u2019s medical stability, ability to travel safely, and access to care and support while away.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It links stopping treatment to potential rapid decline, discusses feasibility/physical ability to travel, and stresses arranging palliative care and identifying emergency care while traveling."
      }
    ],
    "question_number": 72,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:49:26.877805",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises having a clear conversation with the oncologist and healthcare team; includes questions to bring to the next appointment."
      },
      {
        "criterion_number": 2,
        "description": "The response states that if there are signs or symptoms of infection at the port site, to seek immediate evaluation by a healthcare professional.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Infection is mentioned as a possible problem, but there is no explicit instruction to seek immediate evaluation for infection signs."
      },
      {
        "criterion_number": 3,
        "description": "The response offers examples of signs or symptoms of infection, including fever, chills, redness or pain at the port site, and pus coming from the port site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific infection symptoms (fever, chills, redness, pain, pus) are listed."
      },
      {
        "criterion_number": 4,
        "description": "The response states many chemotherapy drugs must be given through central venous catheters.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly explains that many pancreatic cancer chemotherapies are vesicants/irritants and that peripheral IVs are generally not suitable, implying the need for central venous access."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of central venous catheters.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides examples including PICC lines and tunneled central venous catheters (Hickman/Broviac), as well as ports."
      },
      {
        "criterion_number": 6,
        "description": "The response states different central venous catheters have pros and cons.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Gives pros and cons for PICC lines, tunneled catheters, ports, and peripheral IVs."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends asking the patient\u2019s oncologist about alternative treatment regimens that may not require administration through a central venous catheter.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not suggest discussing alternative regimens that avoid central venous access (e.g., oral options) with the oncologist."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends avoiding touching, rubbing, and bumping the port site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No advice provided about avoiding manipulation or trauma to the port site."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include peripherally inserted central catheters (PICC lines).",
        "score_given": 5,
        "max_points": 5,
        "justification": "PICC lines are explicitly discussed as a common alternative, with details."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include a tunneled central venous catheter (Hickman, Broviac, Groshong).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Tunneled central venous catheters are discussed with examples (Hickman and Broviac)."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include a non-tunneled central venous catheter (jugular or subclavian line).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Non-tunneled central venous catheters (e.g., jugular/subclavian) are not mentioned."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include oral chemotherapy such as capecitabine.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of oral chemotherapy options (e.g., capecitabine) as potential alternatives."
      },
      {
        "criterion_number": 14,
        "description": "The response should not mention that chemotherapy for pancreatic cancer can be given via subcutaneous injection.",
        "score_given": 0,
        "max_points": 0,
        "justification": "The response does not state that pancreatic cancer chemotherapy can be given via subcutaneous injection; no penalty applied."
      }
    ],
    "question_number": 73,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:50:08.587368",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises to contact the oncology team immediately and to reach out to the oncology nurse or doctor."
      },
      {
        "criterion_number": 2,
        "description": "The response states that if there are signs or symptoms of infection at the port site, to seek immediate evaluation by a healthcare professional.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions contacting the oncology team and lists infection as a possible issue, it does not explicitly state that signs/symptoms of infection warrant immediate evaluation."
      },
      {
        "criterion_number": 3,
        "description": "The response offers examples of signs or symptoms of infection, including fever, chills, redness or pain at the port site, and pus coming from the port site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific signs or symptoms of infection (fever, chills, redness, pain, pus) are listed."
      },
      {
        "criterion_number": 4,
        "description": "The response states many chemotherapy drugs must be given through central venous catheters.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that some drugs absolutely require central venous access (e.g., port or PICC)."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of central venous catheters.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides examples including PICC lines and implanted ports, which are central venous catheters."
      },
      {
        "criterion_number": 6,
        "description": "The response states different central venous catheters have pros and cons.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It outlines pros and cons for PICC lines and implanted ports."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends asking the patient\u2019s oncologist about alternative treatment regimens that may not require administration through a central venous catheter.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises discussing the specific chemotherapy regimen with the oncology team and notes that some drugs may have oral forms or be suitable for peripheral IVs."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends avoiding touching, rubbing, and bumping the port site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No such recommendation is provided."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include peripherally inserted central catheters (PICC lines).",
        "score_given": 5,
        "max_points": 5,
        "justification": "PICC lines are discussed in detail as an alternative."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include a tunneled central venous catheter (Hickman, Broviac, Groshong).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Tunneled central venous catheters (Hickman/Broviac/Groshong) are not mentioned."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include a non-tunneled central venous catheter (jugular or subclavian line).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Non-tunneled central venous catheters (jugular/subclavian) are not mentioned."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that alternatives to chemotherapy administration via a port include oral chemotherapy such as capecitabine.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Capecitabine (Xeloda) is mentioned as an oral option."
      },
      {
        "criterion_number": 14,
        "description": "The response should not mention that chemotherapy for pancreatic cancer can be given via subcutaneous injection.",
        "score_given": 0,
        "max_points": 0,
        "justification": "The response notes subcutaneous administration but explicitly states it is rare for primary systemic chemotherapy in pancreatic cancer and is typically for supportive meds; it does not claim subcutaneous chemo is an option for pancreatic cancer."
      }
    ],
    "question_number": 73,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:50:52.750806",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises ongoing communication with the oncology team and contacting them for guidance and emergencies."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends avoiding people who have signs or symptoms of an infectious illness.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly instructs to screen visitors and avoid visits from anyone who is even slightly unwell (cough, sore throat, fever, stomach bug)."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends frequent hand washing.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes frequent, thorough handwashing for everyone in the household and use of alcohol-based sanitizer."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends wearing a face mask while in crowds.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends high-quality masks (N95/KN95) in healthcare settings and crowded indoor areas."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends discussing asking the patient\u2019s healthcare team about which vaccinations are recommended.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages being up-to-date on vaccines but does not specifically instruct discussing recommended vaccinations with the healthcare team."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends reporting signs and symptoms of infection to the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises contacting the oncology team or going to the ER immediately if signs of infection occur."
      },
      {
        "criterion_number": 7,
        "description": "The response provides examples of signs and symptoms of infection, including fever, chills, cough, runny nose, nausea, and vomiting.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists fever, chills, cough, sore throat, mouth sores, urinary symptoms, abdominal pain/diarrhea, etc., but does not mention runny nose, nausea, or vomiting."
      },
      {
        "criterion_number": 8,
        "description": "The response states the patient\u2019s oncologist may prescribe antibiotics, antivirals, and antifungals to prevent infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of potential prophylactic antibiotics, antivirals, or antifungals."
      },
      {
        "criterion_number": 9,
        "description": "The response instructs the patient to take all medications as prescribed.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not include an instruction to take all medications exactly as prescribed."
      },
      {
        "criterion_number": 10,
        "description": "The response states some treatments for pancreatic cancer can lower white blood cell counts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that chemotherapy (and sometimes radiation) can weaken the immune system and describes neutropenia (low neutrophils), implying WBC lowering from treatment."
      },
      {
        "criterion_number": 11,
        "description": "The response states white blood cells fight off infections.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Notes neutrophils (a type of white blood cell) are the first line of defense against bacteria."
      },
      {
        "criterion_number": 12,
        "description": "The response states a low white blood cell count can increase the risk of infections.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that treatment-related immune suppression makes infections more likely and defines neutropenia as low neutrophils."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that prevention includes vaccination for COVID-19 and flu for the patient and household members.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends being up-to-date on flu shots and COVID-19 boosters for the household to create a cocoon of protection; this implicitly includes the patient."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that prevention includes avoiding exposure to fungal spores. Patients with neutropenia should avoid prolonged contact with environments that have high concentrations of airborne fungal spores, such as construction and demolition sites, intensive exposure to soil through gardening or digging, and household renovation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises avoiding gardening and exposure to soil and pet waste due to bacteria and fungi, aligning with avoiding fungal spore exposure."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that there is no need for antimicrobial prophylaxis for most solid tumors if the overall infection risk is low (neutropenia < 7 days).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address recommendations regarding antimicrobial prophylaxis in low-risk solid tumor settings."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that interventions such as footwear exchange, protected environments, neutropenic diet, or nutritional supplements are not recommended due to a lack of evidence of clinical benefit.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides a detailed neutropenic diet and environmental measures without noting the lack of evidence for benefit or that such interventions are not recommended."
      }
    ],
    "question_number": 74,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:51:44.377393",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple prompts to work closely with the oncology team, discuss diet and vaccinations, ask questions, and maintain emergency contact information."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends avoiding people who have signs or symptoms of an infectious illness.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises limiting contact with sick people and asking ill visitors to postpone visits."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends frequent hand washing.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Handwashing is emphasized as the cornerstone with detailed instructions for patient, caregivers, and visitors."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends wearing a face mask while in crowds.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises wearing a high-quality mask in crowded public places and healthcare settings."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends discussing asking the patient\u2019s healthcare team about which vaccinations are recommended.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically says to consult the oncology team about vaccinations for the patient."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends reporting signs and symptoms of infection to the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Instructs to contact the healthcare team immediately for any signs of infection, especially fever."
      },
      {
        "criterion_number": 7,
        "description": "The response provides examples of signs and symptoms of infection, including fever, chills, cough, runny nose, nausea, and vomiting.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists fever, chills, cough, sore throat, shortness of breath, diarrhea, urinary changes, confusion, and fatigue, but does not include runny nose, nausea, or vomiting."
      },
      {
        "criterion_number": 8,
        "description": "The response states the patient\u2019s oncologist may prescribe antibiotics, antivirals, and antifungals to prevent infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of antimicrobial prophylaxis (antibiotics/antivirals/antifungals) being prescribed to prevent infection."
      },
      {
        "criterion_number": 9,
        "description": "The response instructs the patient to take all medications as prescribed.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not include a general instruction to take all medications as prescribed."
      },
      {
        "criterion_number": 10,
        "description": "The response states some treatments for pancreatic cancer can lower white blood cell counts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "References chemotherapy-related neutropenia and the blood count nadir after each cycle, indicating treatment-related low white blood counts."
      },
      {
        "criterion_number": 11,
        "description": "The response states white blood cells fight off infections.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not explicitly state the role of white blood cells in fighting infections."
      },
      {
        "criterion_number": 12,
        "description": "The response states a low white blood cell count can increase the risk of infections.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that during neutropenia (lowest counts) the risk of infection is highest."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that prevention includes vaccination for COVID-19 and flu for the patient and household members.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Specifies COVID-19 and flu vaccination for household members but does not explicitly state that the patient should receive COVID-19 and flu vaccines (only to consult the oncology team)."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that prevention includes avoiding exposure to fungal spores. Patients with neutropenia should avoid prolonged contact with environments that have high concentrations of airborne fungal spores, such as construction and demolition sites, intensive exposure to soil through gardening or digging, and household renovation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises avoiding gardening, soil, compost, and decaying matter due to bacteria and fungi, with protective measures; this addresses avoidance of high fungal spore environments."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that there is no need for antimicrobial prophylaxis for most solid tumors if the overall infection risk is low (neutropenia < 7 days).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss the lack of need for antimicrobial prophylaxis in low-risk solid tumor scenarios."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that interventions such as footwear exchange, protected environments, neutropenic diet, or nutritional supplements are not recommended due to a lack of evidence of clinical benefit.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Recommends elements of a neutropenic/low microbial diet rather than stating these interventions are not recommended due to insufficient evidence."
      }
    ],
    "question_number": 74,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:52:37.258844",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Defines precision medicine as tailoring cancer treatment based on a patient\u2019s unique tumor characteristics, such as genetic and molecular profiles, to improve effectiveness and reduce toxicity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains tailoring to individual genes/molecular features and contrasts with chemotherapy, noting potential for more effectiveness and fewer side effects (e.g., 'treating the specific tumor... with this specific genetic mutation' and 'potentially have fewer or different side effects')."
      },
      {
        "criterion_number": 2,
        "description": "Recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides 'Questions to Ask Your Father\u2019s Doctor' and advises consulting the healthcare team for decisions."
      },
      {
        "criterion_number": 3,
        "description": "Mentions testing the patient\u2019s tumor for genetic mutations which can be targeted with certain therapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes biomarker testing/genomic sequencing, lists genetic mutations and gene fusions, and links actionable findings to targeted drugs."
      },
      {
        "criterion_number": 4,
        "description": "States PARP inhibitors may be used in patients with mutations in the BRCA gene.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions BRCA1/2 mutations and PARP inhibitors (e.g., olaparib/Lynparza) as potential treatments."
      },
      {
        "criterion_number": 5,
        "description": "States immunotherapy may be used in patients if their tumors have high microsatellite instability (MSI-high).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically notes MSI-High/dMMR tumors respond to checkpoint inhibitors such as pembrolizumab."
      },
      {
        "criterion_number": 6,
        "description": "Mentions testing the patient\u2019s tumor for expression of certain proteins which can be targeted with certain therapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes 'Protein Levels' as biomarkers in testing and states actionable biomarkers can have specific drugs designed to target them."
      },
      {
        "criterion_number": 7,
        "description": "Provides examples of targeted therapies in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Gives examples including PARP inhibitors for BRCA mutations, KRAS subtype inhibitors (e.g., G12C under active research), and TRK inhibitors for NTRK fusions."
      },
      {
        "criterion_number": 8,
        "description": "Provides examples of therapies targeting protein expression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While protein expression is mentioned, no specific example of a therapy targeting protein expression (e.g., HER2-directed therapy) is provided."
      },
      {
        "criterion_number": 9,
        "description": "Mentions that not every patient will have genetic mutations or protein expression which can be targeted with precision medicine.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States 'not every patient will have an actionable biomarker.'"
      },
      {
        "criterion_number": 10,
        "description": "States precision medicine helps the patient\u2019s oncologist identify treatments which will not be helpful.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that results can rule out or identify non-beneficial treatments."
      },
      {
        "criterion_number": 11,
        "description": "Mentions that comprehensive genomic profiling using next-generation sequencing (NGS) is now standard for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses genomic sequencing and profiling but does not state it is standard of care in pancreatic cancer."
      },
      {
        "criterion_number": 12,
        "description": "Mentions that both germline and somatic testing are recommended for all patients with pancreatic cancer, as actionable alterations may be present even in the absence of family history.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention germline versus somatic testing recommendations or applicability regardless of family history."
      },
      {
        "criterion_number": 13,
        "description": "Mentions that TRK inhibitors (larotrectinib, entrectinib) are indicated for NTRK fusion-positive tumors, regardless of histology.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States NTRK fusions can be treated with larotrectinib/entrectinib and notes effectiveness regardless of where the cancer is in the body."
      }
    ],
    "question_number": 75,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:53:14.397130",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines precision medicine as tailoring cancer treatment based on a patient\u2019s unique tumor characteristics, such as genetic and molecular profiles, to improve effectiveness and reduce toxicity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines precision medicine as tailoring treatment to the tumor\u2019s genetic/molecular features and contrasts it with one-size-fits-all care; also notes potential for improved effectiveness and fewer side effects."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly encourages asking the father\u2019s doctors questions and discussing results with the oncology team."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions testing the patient\u2019s tumor for genetic mutations which can be targeted with certain therapies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes molecular testing/genomic profiling of tumor or liquid biopsy to find mutations/biomarkers and match to targeted therapies."
      },
      {
        "criterion_number": 4,
        "description": "The response states PARP inhibitors may be used in patients with mutations in the BRCA gene.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions BRCA1/2 mutations and PARP inhibitors such as olaparib."
      },
      {
        "criterion_number": 5,
        "description": "The response states immunotherapy may be used in patients if their tumors have high microsatellite instability (MSI-high).",
        "score_given": 5,
        "max_points": 5,
        "justification": "States MSI-High/dMMR tumors can respond to immunotherapy (e.g., pembrolizumab)."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions testing the patient\u2019s tumor for expression of certain proteins which can be targeted with certain therapies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it references 'specific proteins expressed' as biomarkers, it does not clearly describe testing for protein expression (e.g., IHC for HER2/PD-L1) that leads to specific protein-targeted therapies."
      },
      {
        "criterion_number": 7,
        "description": "The response provides examples of targeted therapies in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides multiple examples: PARP inhibitors (olaparib), immunotherapy for MSI-high, NTRK inhibitors (larotrectinib, entrectinib), and emerging KRAS-targeted therapies."
      },
      {
        "criterion_number": 8,
        "description": "The response provides examples of therapies targeting protein expression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit examples of therapies targeting protein expression (e.g., HER2-directed therapy) are given."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions that not every patient will have genetic mutations or protein expression which can be targeted with precision medicine.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that not every patient will have an actionable mutation and emphasizes being realistic."
      },
      {
        "criterion_number": 10,
        "description": "The response states precision medicine helps the patient\u2019s oncologist identify treatments which will not be helpful.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes avoiding ineffective treatments when the tumor lacks specific mutations."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that comprehensive genomic profiling using next-generation sequencing (NGS) is now standard for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions commercial profiling tests but does not state that NGS-based comprehensive profiling is standard for pancreatic cancer."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that both germline and somatic testing are recommended for all patients with pancreatic cancer, as actionable alterations may be present even in the absence of family history.",
        "score_given": 0,
        "max_points": 5,
        "justification": "References germline vs somatic in BRCA context but does not recommend both germline and somatic testing for all patients regardless of family history."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions that TRK inhibitors (larotrectinib, entrectinib) are indicated for NTRK fusion-positive tumors, regardless of histology.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes NTRK inhibitors for NTRK fusions but does not state the tumor-agnostic indication regardless of histology."
      }
    ],
    "question_number": 75,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:53:44.174242",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly instructs to consult the oncology team before trying anything, noting oncologist/nurse involvement and potential chemo adjustments."
      },
      {
        "criterion_number": 2,
        "description": "The response states mouth sores are a common side effect of some chemotherapy drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States mouth sores from chemotherapy are very common."
      },
      {
        "criterion_number": 3,
        "description": "The response states drugs like 5-FU and capecitabine can cause mouth sores.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention 5-FU, capecitabine, or any specific agents."
      },
      {
        "criterion_number": 4,
        "description": "The response states these are sometimes related to having low white blood cell counts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of low white blood cell counts or neutropenia as related to mouth sores."
      },
      {
        "criterion_number": 5,
        "description": "The response states that having low white blood cell counts can increase the likelihood of infection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not connect low white blood cell counts with increased infection risk."
      },
      {
        "criterion_number": 6,
        "description": "The response states mouth sores in patients on chemotherapy can also be related to infections from viruses or bacteria.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions thrush (fungal) as a differential but not viral or bacterial causes."
      },
      {
        "criterion_number": 7,
        "description": "The response states the patient\u2019s healthcare team may swab the mouth sores to test them for infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of swabbing or laboratory testing of sores."
      },
      {
        "criterion_number": 8,
        "description": "The response states there are medications which can help prevent and improve mouth sores in the form of both topical drugs and specialized mouthwashes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses magic mouthwash and topical gels for symptom relief but does not state that medications can prevent mucositis; prevention discussed only via ice chips (non-medication)."
      },
      {
        "criterion_number": 9,
        "description": "The response states there are medications which can improve symptoms related to mouth sores, like pain.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends magic mouthwash, topical anesthetic gels, and systemic pain medication for pain control."
      },
      {
        "criterion_number": 10,
        "description": "The response instructs the patient to immediately seek evaluation by a healthcare provider if they are experiencing a fever or other signs or symptoms of infection.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly instructs to call the oncology team immediately for fever \u2265100.4\u00b0F and signs of infection."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends gentle oral hygiene.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides detailed guidance on gentle brushing with ultra-soft toothbrush, mild toothpaste, cautious flossing, and lip care."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that chlorhexidine mouthwash is not recommended for prevention in most adult cancer populations due to lack of efficacy and potential for adverse effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention chlorhexidine or its lack of efficacy/risks for prevention."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that topical anesthetics (lidocaine viscous, 2% solution) and mixed medication mouthwashes (\u201cmagic mouthwash\u201d) may be used for pain control, though evidence for specific formulations is variable.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions lidocaine and magic mouthwash for pain but does not note evidence variability or specify viscous 2% lidocaine."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that Gabapentin may be considered for mucositis-related pain, often in combination with other analgesics.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of gabapentin."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that topical and systemic antifungals (e.g., clotrimazole troches, systemic fluconazole) are indicated for secondary candidiasis, which is common in the setting of mucositis and xerostomia.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not discuss antifungal treatments for suspected thrush."
      },
      {
        "criterion_number": 21,
        "description": "The response should mention that antibiotics are reserved for documented secondary bacterial infections.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of antibiotic stewardship or reserving antibiotics for confirmed bacterial infections."
      },
      {
        "criterion_number": 22,
        "description": "The response should mention that management often involves over-the-counter pain relief such as acetaminophen or ibuprofen, but that stronger prescription medicines may be indicated.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses possible prescription systemic pain medications but does not mention OTC options like acetaminophen or ibuprofen."
      },
      {
        "criterion_number": 23,
        "description": "The response should mention that multidisciplinary and supportive care is essential.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages contacting oncology team but does not explicitly emphasize multidisciplinary/supportive care as essential."
      },
      {
        "criterion_number": 24,
        "description": "The response should mention that management could include dietary adjustments such as soft or liquid diets, small frequent meals, nutritional support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides extensive dietary guidance emphasizing soft, bland, cool foods, smoothies, shakes, and hydration; sufficient to meet criterion."
      }
    ],
    "question_number": 76,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:54:56.232182",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states the absolute first step is to inform her oncology team and to communicate with them about symptoms."
      },
      {
        "criterion_number": 2,
        "description": "The response states mouth sores are a common side effect of some chemotherapy drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states that oral mucositis is a common side effect of chemotherapy."
      },
      {
        "criterion_number": 3,
        "description": "The response states drugs like 5-FU and capecitabine can cause mouth sores.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention 5-FU, capecitabine, or any specific causative chemotherapy agents."
      },
      {
        "criterion_number": 4,
        "description": "The response states these are sometimes related to having low white blood cell counts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of neutropenia or low white blood cell counts as a contributing factor."
      },
      {
        "criterion_number": 5,
        "description": "The response states that having low white blood cell counts can increase the likelihood of infection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention the increased infection risk associated with low white blood cell counts."
      },
      {
        "criterion_number": 6,
        "description": "The response states mouth sores in patients on chemotherapy can also be related to infections from viruses or bacteria.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States mouth sores can become infected by bacteria (and fungi). Mention of bacterial infection satisfies the criterion."
      },
      {
        "criterion_number": 7,
        "description": "The response states the patient\u2019s healthcare team may swab the mouth sores to test them for infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of swabbing or culturing sores for diagnostic testing."
      },
      {
        "criterion_number": 8,
        "description": "The response states there are medications which can help prevent and improve mouth sores in the form of both topical drugs and specialized mouthwashes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses topical agents and mouthwashes for symptom relief but does not address prevention."
      },
      {
        "criterion_number": 9,
        "description": "The response states there are medications which can improve symptoms related to mouth sores, like pain.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends topical anesthetics (lidocaine), magic mouthwash, and systemic analgesics for pain control."
      },
      {
        "criterion_number": 10,
        "description": "The response instructs the patient to immediately seek evaluation by a healthcare provider if they are experiencing a fever or other signs or symptoms of infection.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Identifies signs of infection including fever and instructs to report these immediately to the oncology team."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends gentle oral hygiene.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides detailed guidance on gentle oral care, including soft toothbrush, saline/baking soda rinses, and avoiding irritating mouthwashes."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that chlorhexidine mouthwash is not recommended for prevention in most adult cancer populations due to lack of efficacy and potential for adverse effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention chlorhexidine or its lack of benefit/possible harms for prevention."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that topical anesthetics (lidocaine viscous, 2% solution) and mixed medication mouthwashes (\u201cmagic mouthwash\u201d) may be used for pain control, though evidence for specific formulations is variable.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions lidocaine viscous and magic mouthwash for pain but does not note that evidence for specific formulations is variable."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that Gabapentin may be considered for mucositis-related pain, often in combination with other analgesics.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of gabapentin for mucositis-related pain."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that topical and systemic antifungals (e.g., clotrimazole troches, systemic fluconazole) are indicated for secondary candidiasis, which is common in the setting of mucositis and xerostomia.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions topical antifungal (nystatin) but not systemic antifungals or the common occurrence of candidiasis in mucositis/xerostomia."
      },
      {
        "criterion_number": 21,
        "description": "The response should mention that antibiotics are reserved for documented secondary bacterial infections.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Suggests antibiotics if bacterial infection is suspected; does not state they are reserved for documented infections."
      },
      {
        "criterion_number": 22,
        "description": "The response should mention that management often involves over-the-counter pain relief such as acetaminophen or ibuprofen, but that stronger prescription medicines may be indicated.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends acetaminophen as OTC and notes stronger prescription pain relievers may be needed; cautions about NSAIDs."
      },
      {
        "criterion_number": 23,
        "description": "The response should mention that multidisciplinary and supportive care is essential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes collaboration with the oncology team and suggests dietitian involvement, highlighting supportive care."
      },
      {
        "criterion_number": 24,
        "description": "The response should mention that management could include dietary adjustments such as soft or liquid diets, small frequent meals, nutritional support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides detailed dietary advice including soft foods, temperature modifications, small frequent meals, straws, and nutritional supplements."
      }
    ],
    "question_number": 76,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:55:48.676078",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises talking to the doctors/medical team and provides specific questions to ask about the trial."
      },
      {
        "criterion_number": 2,
        "description": "The response reviews the design of clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It reviews multiple common designs: add-on (SOC+new drug vs SOC+placebo), head-to-head (new drug vs SOC), placebo-only in rare contexts, and maintenance trials."
      },
      {
        "criterion_number": 3,
        "description": "The response reviews the four phases of clinical trials.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions Phase III in passing but does not review Phases I\u2013IV."
      },
      {
        "criterion_number": 4,
        "description": "The response defines placebo.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It describes how placebos are used and why, but does not explicitly define a placebo as an inactive treatment or inert substitute."
      },
      {
        "criterion_number": 5,
        "description": "The response states that patients in clinical trials for cancer are seldom given a placebo, as this may cause harm.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states that placebo-only use is very rare in cancer and that denying effective treatment is unethical, implying potential harm."
      },
      {
        "criterion_number": 6,
        "description": "The response reviews informed consent.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises obtaining the informed consent document and explains it is legally required and details procedures, risks, benefits, and placebo use."
      },
      {
        "criterion_number": 7,
        "description": "The response defines the placebo effect.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explains expectation-driven bias where knowledge of treatment can influence patient-reported outcomes and clinician assessments."
      },
      {
        "criterion_number": 8,
        "description": "The response states that patients in the control arm of clinical trials often receive the standard of care treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states the control group often receives standard of care plus placebo, or standard of care drug in head-to-head trials."
      },
      {
        "criterion_number": 9,
        "description": "The response states clinical trials are designed to discover new, effective treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes trials test whether new drugs work better than current treatments and offer access to potentially breakthrough therapies."
      },
      {
        "criterion_number": 10,
        "description": "The response states clinical trials are designed to minimize patient harm.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes ethical considerations and rare placebo-only use, it does not explicitly state that trial design aims to minimize patient harm."
      },
      {
        "criterion_number": 11,
        "description": "The response states that patients participating in clinical trials are monitored closely for side effects from the disease and the treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention close monitoring for side effects or safety assessments."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends researching clinical trials before participating.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages due diligence by advising detailed questions to the medical team about the specific trial and its design."
      },
      {
        "criterion_number": 13,
        "description": "The response offers resources for researching clinical trials, including ClinicalTrials.gov.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No external resources or ClinicalTrials.gov are mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response states clinical trials are designed to be ethical and are monitored closely.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It references ethics (not denying standard treatment) but does not state that trials are designed to be ethical nor that they are monitored closely (e.g., by IRBs/DSMBs)."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that clinical trials are essential for optimizing current and future therapies for cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It conveys that trials test whether new treatments work better than current standard and are key to finding better treatments for pancreatic cancer, implying their essential role in improving current and future therapies."
      }
    ],
    "question_number": 77,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:56:38.101954",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises discussing concerns with the oncologist and trial coordinator."
      },
      {
        "criterion_number": 2,
        "description": "The response reviews the design of clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains arms, use of placebo vs investigational drug, add-on designs, blinding, crossover, and early stopping\u2014key elements of trial design."
      },
      {
        "criterion_number": 3,
        "description": "The response reviews the four phases of clinical trials.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention or describe Phases I\u2013IV."
      },
      {
        "criterion_number": 4,
        "description": "The response defines placebo.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses how placebo is used but does not define it as an inactive/dummy treatment."
      },
      {
        "criterion_number": 5,
        "description": "The response states that patients in clinical trials for cancer are seldom given a placebo, as this may cause harm.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Clearly states it is generally unethical to give only placebo when SOC exists and that this is highly unlikely in pancreatic cancer trials."
      },
      {
        "criterion_number": 6,
        "description": "The response reviews informed consent.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions voluntariness and right to withdraw but does not review the informed consent process or its components."
      },
      {
        "criterion_number": 7,
        "description": "The response defines the placebo effect.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not define or discuss the placebo effect."
      },
      {
        "criterion_number": 8,
        "description": "The response states that patients in the control arm of clinical trials often receive the standard of care treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly describes control arm as SOC + placebo, indicating receipt of standard of care."
      },
      {
        "criterion_number": 9,
        "description": "The response states clinical trials are designed to discover new, effective treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States the goal is to determine if the investigational drug provides additional benefit beyond SOC, which aligns with discovering effective treatments."
      },
      {
        "criterion_number": 10,
        "description": "The response states clinical trials are designed to minimize patient harm.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes IRB/REC oversight, monitoring, and potential early stopping for harm/benefit, indicating harm minimization."
      },
      {
        "criterion_number": 11,
        "description": "The response states that patients participating in clinical trials are monitored closely for side effects from the disease and the treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States participants are very closely monitored and discusses actions upon progression; although side effects are not named explicitly, close monitoring is clearly conveyed."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends researching clinical trials before participating.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises having a clear understanding of the study design and asking critical questions before enrolling, effectively recommending pre-enrollment research."
      },
      {
        "criterion_number": 13,
        "description": "The response offers resources for researching clinical trials, including ClinicalTrials.gov.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No resources or links (e.g., ClinicalTrials.gov) are provided."
      },
      {
        "criterion_number": 14,
        "description": "The response states clinical trials are designed to be ethical and are monitored closely.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly references IRB/REC ethical oversight and close monitoring."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that clinical trials are essential for optimizing current and future therapies for cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that trials are essential for optimizing current and future therapies."
      }
    ],
    "question_number": 77,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:57:39.390929",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises that the oncology team is the best source for decisions and provides specific questions to ask the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response states there are many different types of treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States combination therapy uses more than one type of treatment and outlines multiple treatment modalities, indicating there are several treatment types."
      },
      {
        "criterion_number": 3,
        "description": "The response includes surgery, chemotherapy, immunotherapy, targeted therapy, and radiation therapy as types of treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions combination chemotherapy, chemoradiation (radiation), surgery (neoadjuvant/adjuvant context), targeted therapy (e.g., PARP inhibitors), and immunotherapy (MSI-high/dMMR)."
      },
      {
        "criterion_number": 4,
        "description": "The response states combination therapy may mean two or more different types of treatment or two or more chemotherapy medications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines combination therapy as using more than one type of treatment and describes combination chemotherapy as a cocktail of two or more drugs."
      },
      {
        "criterion_number": 5,
        "description": "The response gives the example of FOLFIRINOX.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Names FOLFIRINOX as a common regimen."
      },
      {
        "criterion_number": 6,
        "description": "The response states that FOLFIRINOX is a combination chemotherapy regimen which contains 5-FU, leucovorin, irinotecan, and oxaliplatin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists the components of FOLFIRINOX correctly: 5-FU, leucovorin, irinotecan, and oxaliplatin."
      },
      {
        "criterion_number": 7,
        "description": "The response states the treatment plan for patients with pancreatic cancer is individualized to their overall health and the cancer\u2019s type, stage, and genetic signature.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions individualization by stage, overall health, and genetic makeup but does not explicitly mention the cancer\u2019s type."
      },
      {
        "criterion_number": 8,
        "description": "The response states the decision to use any cancer treatment weighs the likelihood of benefit with the risk of side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses side effects and their management but does not state that treatment decisions involve weighing benefits against risks."
      },
      {
        "criterion_number": 9,
        "description": "The response states the goal of combination therapy is to achieve the best anti-cancer effect.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States the goal is to attack cancer from multiple angles to be more effective than a single therapy."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that examples of combination therapy include chemoradiation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly includes a section on Chemotherapy + Radiation (Chemoradiation)."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that examples of combination therapy include chemotherapy and surgery, with neoadjuvant chemotherapy given before surgery and adjuvant chemotherapy given after surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains neoadjuvant therapy (before surgery) and adjuvant therapy (after surgery), including chemotherapy in both contexts."
      }
    ],
    "question_number": 78,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:58:11.343865",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises open conversation with the medical team and states the oncologist is the best source of tailored information."
      },
      {
        "criterion_number": 2,
        "description": "The response states there are many different types of treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists multiple treatment modalities (chemotherapy, targeted therapy, immunotherapy, radiation, surgery) and frames combination therapy as using different types."
      },
      {
        "criterion_number": 3,
        "description": "The response includes surgery, chemotherapy, immunotherapy, targeted therapy, and radiation therapy as types of treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "All five modalities are explicitly mentioned and described."
      },
      {
        "criterion_number": 4,
        "description": "The response states combination therapy may mean two or more different types of treatment or two or more chemotherapy medications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines combination therapy as two or more different types of treatments or multiple drugs from different classes used together or in sequence."
      },
      {
        "criterion_number": 5,
        "description": "The response gives the example of FOLFIRINOX.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides FOLFIRINOX as a common example of combination chemotherapy."
      },
      {
        "criterion_number": 6,
        "description": "The response states that FOLFIRINOX is a combination chemotherapy regimen which contains 5-FU, leucovorin, irinotecan, and oxaliplatin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Accurately lists FOLFIRINOX components: leucovorin, 5-FU, irinotecan, oxaliplatin."
      },
      {
        "criterion_number": 7,
        "description": "The response states the treatment plan for patients with pancreatic cancer is individualized to their overall health and the cancer\u2019s type, stage, and genetic signature.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States care is tailored to overall health and stage and discusses genetic testing/mutations guiding therapy; personalization is emphasized."
      },
      {
        "criterion_number": 8,
        "description": "The response states the decision to use any cancer treatment weighs the likelihood of benefit with the risk of side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions benefits and side effects separately but does not explicitly state that treatment decisions weigh benefit versus risk."
      },
      {
        "criterion_number": 9,
        "description": "The response states the goal of combination therapy is to achieve the best anti-cancer effect.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States goal is to improve effectiveness and outcomes by attacking cancer from multiple angles."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that examples of combination therapy include chemoradiation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a dedicated section on Chemotherapy + Radiation Therapy (Chemoradiation)."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that examples of combination therapy include chemotherapy and surgery, with neoadjuvant chemotherapy given before surgery and adjuvant chemotherapy given after surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States surgery is combined with chemotherapy before (neoadjuvant) or after (adjuvant) the operation."
      }
    ],
    "question_number": 78,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T17:58:47.872462",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly advises contacting the doctor\u2019s office immediately and working closely with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response states oncology practices often have team members who help patients with insurance issues.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically mentions nurse navigator, practice manager, and the office person handling authorizations; also highlights patient advocates and financial counselors whose job is to help with barriers like insurance."
      },
      {
        "criterion_number": 3,
        "description": "The response states pre-authorization issues are not uncommon in oncology care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes the oncology team has likely dealt with this exact situation many times, implying such issues are common in oncology."
      },
      {
        "criterion_number": 4,
        "description": "The response states that denials should be appealed.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Outlines a formal appeal process with internal and external review and instructs filing an appeal promptly."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends contacting the insurance company.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises calling the insurance company to obtain the denial reason in writing and the clinical guidelines used."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends understanding the patient\u2019s insurance plan.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly recommend reviewing plan benefits, coverage terms, or network details; focuses instead on denial reasons and appeals."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends understanding the insurance company\u2019s denial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly instructs getting the exact reason for denial in writing and the clinical guidelines used to make the decision."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends contacting patient advocacy programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages contacting PanCAN and other advocacy resources for assistance navigating insurance and accessing care."
      },
      {
        "criterion_number": 9,
        "description": "The response offers examples of patient advocacy programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides examples including PanCAN, Patient Advocate Foundation, and Triage Cancer."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends clearly documenting all communications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises noting names, dates, times, reference numbers; creating a binder; and documenting every interaction."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends obtaining written documentation for all approved pre-authorizations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Recommends obtaining denial reasons in writing but does not advise obtaining written documentation of approvals."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that prior authorization is a process in which payers require clinicians to obtain approval before a medication is covered.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not provide an explicit definition of prior authorization as payer-required approval before coverage of a medication."
      },
      {
        "criterion_number": 13,
        "description": "The response must specify that the appeal process involves submitting a formal appeal with supporting evidence, such as clinical guidelines, published trial data, and, for targeted or off-label therapies, molecular profiling results.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions including clinical guidelines and studies but does not reference molecular profiling results for targeted or off-label therapies."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention that if appeals are unsuccessful or delays persist, alternative access strategies should be pursued, including patient assistance programs, manufacturer co-pay cards, and foundation grants, which require application and documentation of financial need.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions patient assistance programs and clinical trials but not manufacturer co-pay cards, foundation grants, or the need to apply with financial documentation."
      },
      {
        "criterion_number": 15,
        "description": "The response must specifically mention patient advocacy organizations such as PanCAN and CancerCare as resources.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Includes PanCAN but does not mention CancerCare."
      }
    ],
    "question_number": 79,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T17:59:29.924512",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly instructs to contact the provider's office/oncology team first and request a peer-to-peer review."
      },
      {
        "criterion_number": 2,
        "description": "The response states oncology practices often have team members who help patients with insurance issues.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes many large cancer centers have dedicated staff (Pre-Authorization Department, Financial Navigator, Patient Advocate) to handle insurance."
      },
      {
        "criterion_number": 3,
        "description": "The response states pre-authorization issues are not uncommon in oncology care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states this is a common and deeply frustrating challenge in the context of cancer treatment and pre-authorization."
      },
      {
        "criterion_number": 4,
        "description": "The response states that denials should be appealed.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides detailed steps for internal and external appeals and says you'll likely need to file an appeal."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends contacting the insurance company.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It directs calling Member Services, asking for reasons/timelines, and documenting calls."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends understanding the patient\u2019s insurance plan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises reviewing EOB, deductible, coinsurance, out-of-pocket maximum, and exclusions."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends understanding the insurance company\u2019s denial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It says to get a formal denial letter, identify the reason and policy language, and what is missing."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends contacting patient advocacy programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends connecting with patient advocacy groups for guidance with insurance issues."
      },
      {
        "criterion_number": 9,
        "description": "The response offers examples of patient advocacy programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists PanCAN, ACS, NCCS, Triage Cancer, and LLS as examples."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends clearly documenting all communications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes 'DOCUMENT, DOCUMENT, DOCUMENT!' and details keeping call logs, copies, and proof of mailing."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends obtaining written documentation for all approved pre-authorizations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It focuses on obtaining written denial letters and documentation of appeals, but does not advise obtaining written documentation for approvals."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that prior authorization is a process in which payers require clinicians to obtain approval before a medication is covered.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It discusses pre-authorization steps but does not explicitly define prior authorization as payer-required clinician approval before coverage of a medication."
      },
      {
        "criterion_number": 13,
        "description": "The response must specify that the appeal process involves submitting a formal appeal with supporting evidence, such as clinical guidelines, published trial data, and, for targeted or off-label therapies, molecular profiling results.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions including a physician letter, clinical guidelines, and test results, but does not reference published trial data or molecular profiling for off-label/targeted therapy."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention that if appeals are unsuccessful or delays persist, alternative access strategies should be pursued, including patient assistance programs, manufacturer co-pay cards, and foundation grants, which require application and documentation of financial need.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It suggests hospital financial counseling and charity care but does not mention patient assistance programs, manufacturer co-pay cards, or foundation grants with financial-need documentation."
      },
      {
        "criterion_number": 15,
        "description": "The response must specifically mention patient advocacy organizations such as PanCAN and CancerCare as resources.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions PanCAN but does not mention CancerCare."
      }
    ],
    "question_number": 79,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:00:14.266875",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to contact the oncology team immediately and inform the oncologist or oncology nurse."
      },
      {
        "criterion_number": 2,
        "description": "The response states that infections can cause cognitive changes.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Suggests asking the medical team if infection could be a cause, implying infection as a potential contributor to cognitive changes."
      },
      {
        "criterion_number": 3,
        "description": "The response states that cancer and its treatments may cause symptoms that can mimic cognitive changes, including fatigue, pain, poor sleep, dehydration, and depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions pain, fatigue and poor sleep, malnutrition/dehydration, and anxiety/depression as contributors to cognitive symptoms."
      },
      {
        "criterion_number": 4,
        "description": "The response states sudden changes in cognition may be a medical emergency and to seek immediate evaluation by a healthcare provider.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit mention that sudden cognitive changes are a medical emergency or to seek immediate evaluation for sudden changes."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends immediate medical evaluation if the patient has stroke symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of stroke symptoms or immediate evaluation for potential stroke."
      },
      {
        "criterion_number": 6,
        "description": "The response states if the patient has a fever or other signs or symptoms of infection, to seek immediate evaluation by a healthcare provider.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not advise immediate evaluation for fever or other infection signs; infection is mentioned only as a possible cause to ask about."
      },
      {
        "criterion_number": 7,
        "description": "The response states patients commonly experience mental fogginess, or \u201cchemo brain.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly describes 'chemo brain/chemo fog' and associated symptoms."
      },
      {
        "criterion_number": 8,
        "description": "The response states that cognitive changes from cancer treatment may improve if the treatment is stopped.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that stopping treatment may improve cognitive changes."
      },
      {
        "criterion_number": 9,
        "description": "The response states that if treatment side effects are severe enough, the patient\u2019s oncologist may choose to decrease the dose of the treatment so it is better tolerated or switch to a different therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of dose reduction or switching therapy as management for severe side effects."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends tracking the cognitive changes and sharing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends keeping a detailed log of changes and discussing specifics with the medical team."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that cancer treatment (including radiation, chemotherapy, and pain medications such as opioids) can affect a person\u2019s cognitive functions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions chemotherapy and opioids but does not mention radiation therapy."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that other factors unrelated to treatment could also cause cognitive changes, such as cancer progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses the cancer itself and systemic effects (inflammation, metabolic changes, hepatic encephalopathy) as contributors, indicating non-treatment causes."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that stress/anxiety can cause cognitive changes unrelated to cancer or cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly mentions anxiety and depression manifesting as cognitive symptoms."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that pre-existing conditions can cause cognitive changes unrelated to cancer or cancer treatment.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not address pre-existing conditions (e.g., dementia, thyroid disease, vitamin deficiencies) as potential causes."
      }
    ],
    "question_number": 80,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:01:14.896285",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states: \u201cdiscuss these cognitive changes with your father's oncology team (or palliative care team) as soon as possible.\u201d"
      },
      {
        "criterion_number": 2,
        "description": "The response states that infections can cause cognitive changes.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Includes a dedicated section on infections causing delirium/acute confusion (e.g., UTI, pneumonia) and mentions assessing for infection."
      },
      {
        "criterion_number": 3,
        "description": "The response states that cancer and its treatments may cause symptoms that can mimic cognitive changes, including fatigue, pain, poor sleep, dehydration, and depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes fatigue/cachexia, poor nutrition and dehydration, pain and sleep disturbances, and anxiety/depression as contributors to cognitive impairment."
      },
      {
        "criterion_number": 4,
        "description": "The response states sudden changes in cognition may be a medical emergency and to seek immediate evaluation by a healthcare provider.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly advise that sudden cognitive changes are a medical emergency or recommend immediate evaluation."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends immediate medical evaluation if the patient has stroke symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of stroke symptoms or instructions to seek urgent care for them."
      },
      {
        "criterion_number": 6,
        "description": "The response states if the patient has a fever or other signs or symptoms of infection, to seek immediate evaluation by a healthcare provider.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While infections are discussed, it does not explicitly advise immediate evaluation for fever or infection signs."
      },
      {
        "criterion_number": 7,
        "description": "The response states patients commonly experience mental fogginess, or \u201cchemo brain.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions chemo brain/chemo fog and describes typical symptoms and timing."
      },
      {
        "criterion_number": 8,
        "description": "The response states that cognitive changes from cancer treatment may improve if the treatment is stopped.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statement that stopping or holding treatment may improve cognitive changes."
      },
      {
        "criterion_number": 9,
        "description": "The response states that if treatment side effects are severe enough, the patient\u2019s oncologist may choose to decrease the dose of the treatment so it is better tolerated or switch to a different therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention dose reductions or switching therapies as management for severe side effects."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends tracking the cognitive changes and sharing this with the patient\u2019s healthcare team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it suggests using calendars/notes for daily strategies and to discuss changes with the team, it does not explicitly recommend tracking changes and sharing the record with the team."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that cancer treatment (including radiation, chemotherapy, and pain medications such as opioids) can affect a person\u2019s cognitive functions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states chemotherapy and opioids (and other meds, surgery/anesthesia) can affect cognition; while radiation is not named, the core criterion that cancer treatment can affect cognition is met with multiple examples."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that other factors unrelated to treatment could also cause cognitive changes, such as cancer progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes cancer-related causes beyond treatment (metabolic imbalances, brain metastases, hepatic/renal dysfunction, systemic inflammation)."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that stress/anxiety can cause cognitive changes unrelated to cancer or cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly mentions anxiety, depression, and distress causing concentration and memory problems."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that pre-existing conditions can cause cognitive changes unrelated to cancer or cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes a section on pre-existing conditions (e.g., prior cognitive impairment, dementia, chronic diseases) that can worsen cognition."
      }
    ],
    "question_number": 80,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:01:58.601145",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises that the decision must be made with the oncologist (and other team members)."
      },
      {
        "criterion_number": 2,
        "description": "The response states feeding tubes can help patients get the nutrition and hydration they need when they are unable to eat or drink on their own.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States feeding tubes are recommended when a person cannot take in enough nutrition and fluids by mouth to maintain strength, weight, and hydration."
      },
      {
        "criterion_number": 3,
        "description": "The response states the most common types of feeding tubes are placed through the skin of the abdomen and into the stomach or small bowel.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes G-tubes and J-tubes as being placed through the abdominal skin into the stomach or jejunum, respectively, which covers common long-term feeding tubes."
      },
      {
        "criterion_number": 5,
        "description": "The response states that if the patient is not eating or drinking enough because they do not want to, this may be the body\u2019s way of signaling that the patient is nearing the end of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses that late-stage bodies may not process nutrition and potential burdens of artificial feeding, but does not explicitly connect lack of desire to eat/drink as a common end-of-life signal."
      },
      {
        "criterion_number": 6,
        "description": "The response states studies have shown that in the absence of a bowel obstruction, feeding tubes do not typically increase survival in patients with cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of survival impact or evidence regarding feeding tubes in the absence of obstruction."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends considering hospice care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions palliative care, but does not suggest or mention hospice."
      },
      {
        "criterion_number": 8,
        "description": "The response states that malnutrition is common in patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes pancreatic cancer often leads to cachexia with severe weight loss and malnutrition, implying it is common."
      },
      {
        "criterion_number": 9,
        "description": "The response reviews the risks of feeding tubes, including discomfort and infection.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists risks such as infection, tube clogs, diarrhea, and discomfort at the site."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends discussing the patient\u2019s goals of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes clarifying the goals (bridge, long-term, comfort) and directly asks what the patient wants."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to a blocked bile duct.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of bile duct obstruction or related symptoms."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to a blocked stomach.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifically describes obstruction of the stomach outlet and duodenum causing nausea, vomiting, and early satiety."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to low levels of digestive enzymes.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not mention pancreatic exocrine insufficiency or low digestive enzymes."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to loss of appetite.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Notes poor appetite as part of cachexia contributing to inadequate intake."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to cancer-related pain.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States pain can make it very difficult to eat enough."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that nutritional counseling is recommended for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation to see a dietitian or receive nutritional counseling."
      }
    ],
    "question_number": 81,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:02:38.104168",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises a comprehensive discussion including her oncologist regarding disease status, prognosis, and treatment plan."
      },
      {
        "criterion_number": 2,
        "description": "The response states feeding tubes can help patients get the nutrition and hydration they need when they are unable to eat or drink on their own.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States goals include allowing nutritional intake and hydration when obstruction or treatment side effects prevent adequate oral intake."
      },
      {
        "criterion_number": 3,
        "description": "The response states the most common types of feeding tubes are placed through the skin of the abdomen and into the stomach or small bowel.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions J-tubes and surgical placement but does not state that common tubes are percutaneous through the abdominal wall into the stomach or small bowel (e.g., PEG/G-tube)."
      },
      {
        "criterion_number": 5,
        "description": "The response states that if the patient is not eating or drinking enough because they do not want to, this may be the body\u2019s way of signaling that the patient is nearing the end of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes anorexia-cachexia as a natural part of late-stage disease and warns that forced feeding can be counterproductive near end of life."
      },
      {
        "criterion_number": 6,
        "description": "The response states studies have shown that in the absence of a bowel obstruction, feeding tubes do not typically increase survival in patients with cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention evidence about survival impact in the absence of obstruction."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends considering hospice care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions palliative care but does not specifically recommend hospice."
      },
      {
        "criterion_number": 8,
        "description": "The response states that malnutrition is common in patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes pancreatic cancer often causes exocrine insufficiency leading to significant weight loss and malnutrition, implying it is common."
      },
      {
        "criterion_number": 9,
        "description": "The response reviews the risks of feeding tubes, including discomfort and infection.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists placement site infection, leakage, tube dislodgement/clogging, GI side effects, aspiration, and discomfort/quality-of-life impacts."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends discussing the patient\u2019s goals of care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes patient\u2019s wishes, goals of care, quality of life, and recommends involvement of palliative care to align care with values."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to a blocked bile duct.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not mention bile duct obstruction or related digestive consequences."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to a blocked stomach.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly notes obstruction of the stomach outlet/duodenum and need to bypass it."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to low levels of digestive enzymes.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions pancreatic exocrine insufficiency leading to malabsorption."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to loss of appetite.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Discusses anorexia-cachexia syndrome and diminished drive to eat in late-stage disease."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that pancreatic cancer can cause digestive issues due to cancer-related pain.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not link cancer-related pain to digestive or eating difficulties."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that nutritional counseling is recommended for patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends consultation with a registered dietitian to assess needs and formulas."
      }
    ],
    "question_number": 81,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:03:09.521395",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not suggest consulting the oncologist for guidance on how to talk with children about the diagnosis or prognosis."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends involving a professional who can help with these challenging conversations, like a social worker or spiritual counselor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends involving a family therapist, child life specialist, or school counselor, which meets the criterion of involving professionals who can help with these conversations."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends online resources for patients with cancer, including cancer.org.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it lists PanCAN, CancerCare for Kids, and the NCI, it does not include the American Cancer Society (cancer.org), which is required by the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends clear and honest language.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It strongly emphasizes honesty and simple, clear language, advises avoiding euphemisms, and directly using the word 'cancer.'"
      },
      {
        "criterion_number": 5,
        "description": "The response recommends tailoring the conversation to the children\u2019s ages.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides detailed, age-specific guidance for young children (3\u20136), school-aged children (7\u201312), and teenagers (13+)."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention to avoid overwhelming the child with too much information at once; provide information in small doses, stopping frequently to check for comprehension.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it notes that 'this is not a one-time conversation' and says 'you don't need to share everything at once' in a prognosis section, it does not explicitly instruct giving information in small doses with frequent pauses to check understanding, as required."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention to arrange for an appropriate location for the conversation and ensure there is enough time to give the information and answer questions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises choosing a quiet, comfortable place, turning off distractions, and selecting a time when you are not rushed, as well as allowing time for questions."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention to provide information that is relevant to what the child wants to know.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It invites children to ask questions ('What questions do you have right now? You can ask us anything, anytime') and advises focusing on practical changes relevant to the child (e.g., routines), aligning information with what the child wants or needs to know."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention to respond empathically to the child\u2019s emotions and acknowledge their feelings throughout the conversation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages validating emotions, acknowledging feelings, expecting a range of emotions, and modeling healthy expression ('It's okay to not be okay; let your children see you cry'), which reflects empathic responses."
      }
    ],
    "question_number": 82,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:03:55.289211",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not advise consulting the patient's oncologist for guidance on how to talk to children about the diagnosis."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends involving a professional who can help with these challenging conversations, like a social worker or spiritual counselor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends involving professionals such as school counselors and therapists and considering professional help; while it does not name social workers or spiritual counselors specifically, it clearly endorses professional support for these conversations."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends online resources for patients with cancer, including cancer.org.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No online resources are mentioned, and cancer.org (American Cancer Society) is not referenced."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends clear and honest language.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises honesty and clarity: \"Be Honest, But Age-Appropriate\" and \"Use Clear, Simple Language\" and to avoid euphemisms and medical jargon."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends tailoring the conversation to the children\u2019s ages.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides detailed age-specific sections for young children, middle childhood, and teenagers, clearly tailoring the approach to developmental level."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention to avoid overwhelming the child with too much information at once; provide information in small doses, stopping frequently to check for comprehension.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it advises not to overwhelm and to keep explanations short and simple, it does not explicitly recommend providing information in small doses with frequent pauses to check for comprehension."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention to arrange for an appropriate location for the conversation and ensure there is enough time to give the information and answer questions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states to \"Choose the Right Time and Place\" that is calm and private and \"when you won't be rushed or interrupted,\" and it also notes being prepared for questions, implying time to answer them."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention to provide information that is relevant to what the child wants to know.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes focusing on what children will see and experience and encourages them to ask questions and answer those honestly, aligning information with the child\u2019s interests and concerns."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention to respond empathically to the child\u2019s emotions and acknowledge their feelings throughout the conversation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It repeatedly emphasizes validating feelings (e.g., \"Validate Their Feelings,\" \"It's okay to feel...\") and listening without judgment, demonstrating empathic responses."
      }
    ],
    "question_number": 82,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:04:42.112972",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that sleep patterns can be disturbed by cancer and its treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states that dramatic sleep changes are common in pancreatic cancer and provides a dedicated section on side effects of treatments contributing to sleep disruption."
      },
      {
        "criterion_number": 2,
        "description": "The response states that sleep patterns can be disturbed by symptoms like fatigue, pain, and nausea.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions pain, nausea, digestive issues, and fatigue/hypersomnia as causes of sleep disturbance."
      },
      {
        "criterion_number": 3,
        "description": "The response states that sleep patterns can be a symptom of anxiety and depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a section on the emotional and psychological toll, noting anxiety and depression and their effects on insomnia or hypersomnia."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises to talk to the oncology team and to involve palliative care; emphasizes informing doctors and nurses."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends tracking the sleep disturbances and sharing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends keeping a simple sleep diary with specifics to share with the medical team."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends sleep hygiene techniques.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests multiple sleep hygiene strategies: cool/dark/quiet room, establishing a routine, limiting naps, and optimizing comfort."
      },
      {
        "criterion_number": 7,
        "description": "The response states other options for treatment may include supplements like melatonin, cognitive behavioral therapy, or prescribed medications.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention melatonin, cognitive behavioral therapy for insomnia, or specific prescribed sleep medications as options."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends seeking immediate medical evaluation if the changes in sleep patterns are sudden or severe.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not provide guidance to seek immediate medical evaluation for sudden or severe changes; only generally advises informing the care team."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that non-pharmacological interventions like relaxation techniques, cognitive behavioral therapy for insomnia, and mindfulness can be beneficial.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests calming activities and routine, it does not explicitly mention relaxation techniques as a category, CBT-I, or mindfulness as beneficial interventions."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that addressing underlying causes of sleep disruption, such as pain management or treatment of anxiety/depression, is important.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes symptom management including pain control, anti-nausea strategies, itch management, and involvement of palliative care for anxiety and sleep issues."
      }
    ],
    "question_number": 83,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:05:28.895940",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that sleep patterns can be disturbed by cancer and its treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly states that dramatic sleep changes are common in pancreatic cancer and discusses treatment-related contributors (chemotherapy, opioids, steroids) that disrupt sleep."
      },
      {
        "criterion_number": 2,
        "description": "The response states that sleep patterns can be disturbed by symptoms like fatigue, pain, and nausea.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It details pain, cancer-related fatigue, nausea/vomiting, constipation, and other GI issues as reasons for sleep disruption."
      },
      {
        "criterion_number": 3,
        "description": "The response states that sleep patterns can be a symptom of anxiety and depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes a section on anxiety, depression, and emotional distress leading to racing thoughts and insomnia."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises discussing changes with the healthcare team and specifically names the oncologist."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends tracking the sleep disturbances and sharing this with the patient\u2019s healthcare team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation to keep a sleep diary or track patterns for sharing with clinicians."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends sleep hygiene techniques.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides concrete sleep hygiene strategies (consistent schedule, sleep environment, limit caffeine/heavy meals, light daytime activity, limiting long naps)."
      },
      {
        "criterion_number": 7,
        "description": "The response states other options for treatment may include supplements like melatonin, cognitive behavioral therapy, or prescribed medications.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention melatonin, CBT-I, or specific sleep medications; only medication timing/adjustment and palliative care in general."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends seeking immediate medical evaluation if the changes in sleep patterns are sudden or severe.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No advice to seek urgent evaluation for sudden or severe sleep changes."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that non-pharmacological interventions like relaxation techniques, cognitive behavioral therapy for insomnia, and mindfulness can be beneficial.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions emotional support and counseling, it does not specifically mention relaxation techniques, CBT-I, or mindfulness."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that addressing underlying causes of sleep disruption, such as pain management or treatment of anxiety/depression, is important.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends pain management review, symptom-specific management (e.g., nausea, itching), medication timing, and emotional support, directly addressing underlying causes."
      }
    ],
    "question_number": 83,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:06:03.110398",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing complementary therapies with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Multiple explicit recommendations to discuss any complementary therapy with the oncology team, including a dedicated section 'The Golden Rule: Talk to the Oncology Team First' and step-by-step guidance to consult them."
      },
      {
        "criterion_number": 2,
        "description": "The response states complementary therapies like acupuncture may improve symptoms related to cancer and its treatments and may improve cancer patients\u2019 quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines complementary therapies as aiming to manage symptoms, reduce side effects, and improve quality of life; lists specific symptom benefits of acupuncture (nausea, pain, fatigue, anxiety, insomnia)."
      },
      {
        "criterion_number": 3,
        "description": "The response states complementary therapies are not a safe alternative to standard cancer treatments.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly distinguishes complementary vs. alternative therapies and states alternative therapy instead of standard care is extremely dangerous and should be avoided."
      },
      {
        "criterion_number": 4,
        "description": "The response states complementary therapies are not as effective as standard of care cancer treatments.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it emphasizes that complementary therapies are for symptom management and warns against replacing standard care, it does not explicitly state that complementary therapies are not as effective as standard cancer treatments."
      },
      {
        "criterion_number": 5,
        "description": "The response defines complementary therapies and provides examples, including acupuncture.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides clear definitions of complementary vs. alternative therapies and lists examples including acupuncture, massage, yoga/meditation/tai chi, and nutrition/supplements."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends informing the patient\u2019s oncologist of any supplements the patient starts taking.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises never starting a new supplement without the oncologist\u2019s approval and to discuss any therapy with the oncology team."
      },
      {
        "criterion_number": 7,
        "description": "The response states supplements are not regulated by the FDA.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of FDA regulation status of supplements."
      },
      {
        "criterion_number": 8,
        "description": "The response states some supplements may interact with certain treatments for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Warns that herbs and high-dose vitamins (especially antioxidants) can interfere with chemotherapy and radiation effectiveness and affect blood clotting or liver function."
      },
      {
        "criterion_number": 9,
        "description": "The response reviews the risks of acupuncture, including bleeding and infection, which may be increased in patients receiving chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses infection risk with neutropenia, bleeding/bruising risk with thrombocytopenia, and other considerations like avoiding lymphedematous limbs and tumor/port sites."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends utilizing a practitioner licensed in acupuncture.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises selecting a licensed/certified acupuncturist (L.Ac.) or MD trained in acupuncture and emphasizes experience with oncology patients."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that acupuncture is generally safe for cancer patients, with no increased risk of serious adverse events compared to sham or standard care, though mild side effects such as bruising, soreness, or transient discomfort may occur.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States acupuncture is 'generally very safe' but does not reference comparative safety vs. sham/standard care or typical mild side effects like soreness/transient discomfort; bruising is mentioned only in the context of low platelets."
      }
    ],
    "question_number": 84,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:06:43.023717",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing complementary therapies with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly emphasizes consulting the oncology team first and obtaining explicit approval before starting acupuncture or any complementary therapy."
      },
      {
        "criterion_number": 2,
        "description": "The response states complementary therapies like acupuncture may improve symptoms related to cancer and its treatments and may improve cancer patients\u2019 quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists symptom benefits (nausea, pain, fatigue, anxiety, dry mouth, hot flashes) and notes they can help manage symptoms and improve well-being."
      },
      {
        "criterion_number": 3,
        "description": "The response states complementary therapies are not a safe alternative to standard cancer treatments.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states complementary therapies are meant to support conventional treatment, not replace it."
      },
      {
        "criterion_number": 4,
        "description": "The response states complementary therapies are not as effective as standard of care cancer treatments.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it says they should not replace standard treatments, it does not explicitly state they are less effective than standard-of-care cancer treatments."
      },
      {
        "criterion_number": 5,
        "description": "The response defines complementary therapies and provides examples, including acupuncture.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It characterizes complementary therapies as supportive to conventional treatments and provides multiple examples, including acupuncture, mind-body therapies, massage, supplements, diet, and exercise."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends informing the patient\u2019s oncologist of any supplements the patient starts taking.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It strongly warns to never start any herbal remedy or dietary supplement without explicit oncology team approval."
      },
      {
        "criterion_number": 7,
        "description": "The response states supplements are not regulated by the FDA.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It mentions lack of rigorous testing for purity and potency but does not state that supplements are not regulated by the FDA."
      },
      {
        "criterion_number": 8,
        "description": "The response states some supplements may interact with certain treatments for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states many herbs and supplements can interact with chemotherapy, radiation, and other medications, potentially reducing effectiveness or increasing toxicity."
      },
      {
        "criterion_number": 9,
        "description": "The response reviews the risks of acupuncture, including bleeding and infection, which may be increased in patients receiving chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It details bleeding/bruising risks with low platelets or blood thinners and infection risks in immunocompromised patients due to chemotherapy, with mitigation steps."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends utilizing a practitioner licensed in acupuncture.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises choosing licensed, certified practitioners with cancer care experience."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that acupuncture is generally safe for cancer patients, with no increased risk of serious adverse events compared to sham or standard care, though mild side effects such as bruising, soreness, or transient discomfort may occur.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes acupuncture can be safe and beneficial, it does not state there is no increased risk of serious adverse events compared with sham/standard care or mention typical mild side effects in general terms."
      }
    ],
    "question_number": 84,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:07:30.948465",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing balance problems with the patient\u2019s oncologist or healthcare team immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states, \"It's crucial to report this to his oncology team immediately\" and includes a section titled \"Contact His Oncology Team Immediately.\""
      },
      {
        "criterion_number": 2,
        "description": "The response clearly states that symptoms from pancreatic cancer and its treatment, such as fatigue, headache, muscle weakness, and peripheral neuropathy, may contribute to sensations of imbalance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It attributes imbalance to treatment side effects including fatigue, muscle weakness, and peripheral neuropathy, and also discusses cancer-related causes; while headache is mentioned as a symptom to report, the response sufficiently conveys that these symptoms can contribute to imbalance."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that chemotherapy can cause peripheral neuropathy, fatigue, anemia, and generalized weakness, which can all cause instability.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly discusses chemotherapy-induced peripheral neuropathy, treatment-related fatigue and generalized weakness, and anemia causing dizziness and weakness, all linked to instability."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that pancreatic cancer itself increases the risk of thromboembolic events, including cerebral ischemic strokes, which may present with acute balance disturbances or ataxia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of thromboembolic events or stroke risk related to pancreatic cancer is included."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly instructs seeking immediate medical evaluation if symptoms are abrupt, severe, or accompanied by other neurologic deficits.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it advises contacting the oncology team immediately, it does not explicitly instruct urgent/emergent evaluation for abrupt, severe onset or accompanying neurologic deficits."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly states that balance problems can lead to falls.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes fall prevention and asks to report if he \"has had any falls,\" clearly recognizing the risk of falls from balance problems."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends ensuring the patient drinks plenty of fluids.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While dehydration is discussed as a cause of dizziness, there is no explicit recommendation to increase fluid intake."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly recommends the patient stand and walk with assistance until they can be evaluated by their healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises use of assistive devices like a cane or walker while awaiting medical advice, effectively recommending assisted ambulation until evaluation."
      }
    ],
    "question_number": 85,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:08:05.571797",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing balance problems with the patient\u2019s oncologist or healthcare team immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states, \"you should report this symptom to his oncology team as soon as possible\" and reiterates, \"It is imperative to contact his doctor or oncology team immediately.\""
      },
      {
        "criterion_number": 2,
        "description": "The response clearly states that symptoms from pancreatic cancer and its treatment, such as fatigue, headache, muscle weakness, and peripheral neuropathy, may contribute to sensations of imbalance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses chemotherapy-induced peripheral neuropathy, generalized weakness and fatigue, and mentions headaches (in the context of brain metastases), all linked to balance issues."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that chemotherapy can cause peripheral neuropathy, fatigue, anemia, and generalized weakness, which can all cause instability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions chemotherapy-induced peripheral neuropathy and generalized weakness/fatigue, it does not mention anemia."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that pancreatic cancer itself increases the risk of thromboembolic events, including cerebral ischemic strokes, which may present with acute balance disturbances or ataxia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of thromboembolic risk or ischemic stroke related to pancreatic cancer; only a generic reference to prior strokes as an unrelated condition."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly instructs seeking immediate medical evaluation if symptoms are abrupt, severe, or accompanied by other neurologic deficits.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It advises immediate contact with the oncology team, but does not explicitly instruct urgent evaluation specifically for abrupt/severe onset or accompanying neurologic deficits."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly states that balance problems can lead to falls.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states balance issues lead to unsteadiness and an increased risk of falls and emphasizes preventing falls."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends ensuring the patient drinks plenty of fluids.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although dehydration is discussed as a cause, there is no explicit recommendation to drink plenty of fluids."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly recommends the patient stand and walk with assistance until they can be evaluated by their healthcare team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation to use assistance for standing/walking prior to evaluation."
      }
    ],
    "question_number": 85,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:08:32.285736",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends reviewing the pathology report with the patient\u2019s oncologist or healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises bringing the report to the next appointment and explicitly suggests asking the mother's doctor to walk through the findings, emphasizing that her doctors interpret results in context."
      },
      {
        "criterion_number": 2,
        "description": "The response states that pathology reports are written by doctors called pathologists who view tissue under the microscope to diagnose diseases.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions 'the pathologist checks' margins and discusses microscopic evaluation, it does not explicitly state that pathology reports are written by doctors called pathologists who diagnose disease via microscopic examination."
      },
      {
        "criterion_number": 3,
        "description": "The response states the pathology report will contain a tumor type.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly identifies 'Final Diagnosis: What Type of Cancer Is It?' and lists common and less common tumor types (e.g., PDAC, neuroendocrine tumor, acinar cell carcinoma, IPMN)."
      },
      {
        "criterion_number": 4,
        "description": "The response states the pathology report may contain a stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes a section on 'The Pathologic Stage (TNM)' and explains that this is the overall summary and is written as pTNM."
      },
      {
        "criterion_number": 5,
        "description": "The response states the pathology report may contain a tumor size.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that the T category describes the size and/or extent of the main tumor (e.g., T1 small; T3/T4 larger or invasive), implying tumor size is part of the report."
      },
      {
        "criterion_number": 6,
        "description": "The response states the pathology report may contain a tumor grade.",
        "score_given": 5,
        "max_points": 5,
        "justification": "A dedicated 'Tumor Grade' section explains G1\u2013G4 and what differentiation means."
      },
      {
        "criterion_number": 7,
        "description": "The response states the pathology report may mention vascular invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions lymphovascular invasion (LVI) and what it signifies."
      },
      {
        "criterion_number": 8,
        "description": "The response states the pathology report may mention perineural invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions perineural invasion (PNI) and explains its significance in pancreatic cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response states the pathology report may contain special stains which can sometimes be used to determine additional treatment options.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although it discusses biomarker/molecular testing (MSI/MMR, BRCA, KRAS, NTRK), it does not mention 'special stains' or immunohistochemistry by name or note that special stains can guide treatment."
      },
      {
        "criterion_number": 10,
        "description": "The response states the final stage ranges from I to IV and is a sum of a tumor (T) score, a node (N) score, and a metastasis (M) score.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states stages range from I to IV and explains T, N, and M components and that they are combined into an overall stage."
      },
      {
        "criterion_number": 11,
        "description": "The response states the pathology report helps the oncologist determine which treatment may be the most effective.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that tumor type dictates treatment, margin status impacts adjuvant therapy, and molecular findings can guide targeted/immunotherapies, implying the report guides treatment decisions."
      },
      {
        "criterion_number": 12,
        "description": "The response states the pathology report may include results from genetic testing of the tumor which may help in identifying targeted therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It covers MSI/MMR for immunotherapy, BRCA1/2 for PARP inhibitors, and rare NTRK fusions, indicating tumor genetic results may open targeted therapy options."
      },
      {
        "criterion_number": 13,
        "description": "The response must mention margin status, including the presence of the tumor at or within 1 mm of any resection margin (R1), and its impact on prognosis and adjuvant therapy decisions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines negative (R0) and positive (R1) margins, mentions 'close' margins (e.g., <1 mm), and explains that R1 is associated with higher recurrence risk and often leads to additional chemotherapy/radiation, affecting prognosis and adjuvant therapy."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention the importance of the number of lymph nodes examined and number positive, and explicitly link perineural and vascular invasion to higher recurrence risk.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It correctly emphasizes 'X of Y nodes positive.' It explicitly links PNI to pancreatic cancer\u2019s high recurrence generally, but does not explicitly link both PNI and LVI to higher recurrence risk; LVI is described as a sign of spread, not recurrence risk. The criterion requires explicit linkage for both."
      },
      {
        "criterion_number": 15,
        "description": "The response must mention tumor location (head, body, tail) as required for accurate pathologic staging (pT), and reference the AJCC staging system using pT, pN, pM nomenclature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions tumor location (head/body/tail) but frames it as important for symptoms and surgery, not as required for accurate pT staging. It uses 'pTNM' terminology but does not reference the AJCC staging system explicitly or tie location to pT criteria."
      }
    ],
    "question_number": 86,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:09:30.562787",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends reviewing the pathology report with the patient\u2019s oncologist or healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises scheduling a dedicated meeting with the oncologist to review the report and emphasizes that the information should not replace discussion with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response states that pathology reports are written by doctors called pathologists who view tissue under the microscope to diagnose diseases.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response repeatedly refers to the pathologist\u2019s gross and microscopic examination and a 'Pathologist\u2019s Final Diagnosis,' demonstrating that pathologists analyze tissue microscopically to make the diagnosis."
      },
      {
        "criterion_number": 3,
        "description": "The response states the pathology report will contain a tumor type.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes a section on 'Tumor Type (Histology)' with examples such as ductal adenocarcinoma and other histologies."
      },
      {
        "criterion_number": 4,
        "description": "The response states the pathology report may contain a stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that the pathology report, together with imaging, determines staging and describes the TNM components, implying stage information may be included."
      },
      {
        "criterion_number": 5,
        "description": "The response states the pathology report may contain a tumor size.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly lists 'Tumor Size' in the gross description, noting its importance for staging in surgical resections."
      },
      {
        "criterion_number": 6,
        "description": "The response states the pathology report may contain a tumor grade.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides a 'Tumor Grade/Differentiation' section and defines G1\u2013G4 with implications for aggressiveness."
      },
      {
        "criterion_number": 7,
        "description": "The response states the pathology report may mention vascular invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses 'Lymphovascular Invasion (LVI)/Angiolymphatic Invasion' and its significance."
      },
      {
        "criterion_number": 8,
        "description": "The response states the pathology report may mention perineural invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes 'Perineural Invasion (PNI)' and explains its implications."
      },
      {
        "criterion_number": 9,
        "description": "The response states the pathology report may contain special stains which can sometimes be used to determine additional treatment options.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it mentions immunohistochemistry (special stains) to confirm tumor type and identify markers, it does not explicitly state that special stains can be used to determine additional treatment options."
      },
      {
        "criterion_number": 10,
        "description": "The response states the final stage ranges from I to IV and is a sum of a tumor (T) score, a node (N) score, and a metastasis (M) score.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It explains TNM components but does not state that the final stage is reported as stages I\u2013IV or that it is derived from the T, N, and M categories into a final stage group."
      },
      {
        "criterion_number": 11,
        "description": "The response states the pathology report helps the oncologist determine which treatment may be the most effective.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly says the report helps guide treatment decisions and details how findings influence surgery, chemotherapy, radiation, and targeted therapies."
      },
      {
        "criterion_number": 12,
        "description": "The response states the pathology report may include results from genetic testing of the tumor which may help in identifying targeted therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses molecular/genetic testing (e.g., BRCA, MSI, NTRK) and links these to potential targeted therapy or immunotherapy."
      },
      {
        "criterion_number": 13,
        "description": "The response must mention margin status, including the presence of the tumor at or within 1 mm of any resection margin (R1), and its impact on prognosis and adjuvant therapy decisions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It covers margin status and notes R0/R1, and that close margins within 1 mm increase risk of recurrence, but it does not explicitly state that tumor at or within 1 mm constitutes R1, nor does it link margin status specifically to adjuvant therapy decisions."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention the importance of the number of lymph nodes examined and number positive, and explicitly link perineural and vascular invasion to higher recurrence risk.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes the number of nodes examined and positive, and links PNI to higher risk of local recurrence and LVI to risk of spread, addressing recurrence risk implications."
      },
      {
        "criterion_number": 15,
        "description": "The response must mention tumor location (head, body, tail) as required for accurate pathologic staging (pT), and reference the AJCC staging system using pT, pN, pM nomenclature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions tumor location (head/body/tail), it does not state that this is required for accurate pathologic pT staging, nor does it reference AJCC pT, pN, pM nomenclature."
      }
    ],
    "question_number": 86,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:10:40.521611",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the case with an oncologist to review the trial details and discuss the pros and cons.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly advises meeting with the oncologist and clinical trial team, and explicitly recommends consulting the oncologist for decisions and discussing details, risks, and benefits."
      },
      {
        "criterion_number": 2,
        "description": "The response explains that there are no FDA-approved cancer vaccines for pancreatic cancer and that all vaccines for pancreatic cancer are experimental.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it frames vaccines within clinical trials, it does not explicitly state that no FDA-approved pancreatic cancer vaccines exist and that all such vaccines are experimental."
      },
      {
        "criterion_number": 3,
        "description": "The response explains how a cancer vaccine works.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly explains that therapeutic vaccines teach T-cells to recognize tumor antigens (\u201cmost wanted poster\u201d), describing mechanism adequately."
      },
      {
        "criterion_number": 4,
        "description": "The response states clinical trials are how treatments are tested for diseases like pancreatic cancer.",
        "score_given": 4,
        "max_points": 4,
        "justification": "By detailing trial phases focused on safety, efficacy, and comparison to standard of care, it communicates that trials are the mechanism to test treatments."
      },
      {
        "criterion_number": 5,
        "description": "The response explains the four phases of clinical trials.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It only explains Phases I\u2013III and omits Phase IV."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends researching clinical trials prior to enrolling.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It provides a detailed list of questions to ask, suggests recording discussions, and offers resources for finding and researching trials."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends ClinicalTrials.gov as a resource.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly recommends ClinicalTrials.gov as a comprehensive database."
      },
      {
        "criterion_number": 8,
        "description": "The response states patients should consider all of their treatment options prior to enrolling in a clinical trial.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It discusses pros/cons and standard of care alongside trials but does not explicitly instruct patients to consider all treatment options before enrolling."
      },
      {
        "criterion_number": 9,
        "description": "The response states clinical trials are designed to minimize patient harm and closely follow ethical standards.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No explicit mention of ethical safeguards, IRB oversight, or harm minimization; only notes the ability to stop participation."
      },
      {
        "criterion_number": 10,
        "description": "The response reviews potential benefits and risks of clinical trial participation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It includes a clear, balanced list of potential pros and cons."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends discussing with the clinical trial research team about costs to the patient for participating in the trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It includes a specific \u2018Logistics and Costs\u2019 section advising to clarify who pays for various aspects, implying discussion with the trial team."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly mention that vaccine clinical trials in pancreatic cancer are designed to address the poor response of this malignancy to standard immunotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention the poor response of pancreatic cancer to standard immunotherapies or that vaccines aim to address this challenge."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly mention that vaccine trials aim to stimulate tumor-specific T cell (immune cell) responses to enhance the immune system\u2019s effectiveness in killing cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states the vaccine teaches T-cells to recognize and attack cancer cells and targets tumor antigens, meeting the requirement."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention at least two of the following vaccine platforms: peptide-based vaccines targeting defined tumor antigens, dendritic cell vaccines loaded with tumor lysates, or personalized mRNA/neoantigen vaccines that encode patient-specific tumor mutations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It references personalized vaccines and tumor mutations (e.g., KRAS) but does not identify two specific platforms (peptide-based, dendritic cell, or mRNA/neoantigen)."
      },
      {
        "criterion_number": 15,
        "description": "The response must mention that safety data from recent trials indicate that most vaccine regimens are well-tolerated, with adverse events generally limited to mild-to-moderate injection site reactions, flu-like symptoms, or transient fever.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although common side effects like flu-like symptoms and injection site reactions are mentioned, it does not cite safety data indicating overall good tolerability or note that adverse events are generally mild-to-moderate or include transient fever."
      },
      {
        "criterion_number": 16,
        "description": "The response must mention that most data on vaccine trials in pancreatic cancer are derived from early-phase studies with small sample sizes and limited long-term follow-up.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of the early-phase nature, small sample sizes, or limited long-term follow-up."
      },
      {
        "criterion_number": 17,
        "description": "The response must explicitly define clinical trials as research studies that explore whether a new medical strategy, treatment, or device is safe and effective for humans.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It describes phases but does not provide the explicit definition required."
      },
      {
        "criterion_number": 18,
        "description": "The response must explicitly state that clinical trials are essential for optimizing current and future therapies for cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes contributing to the future and helping researchers learn, it does not explicitly state that trials are essential for optimizing current and future therapies."
      },
      {
        "criterion_number": 20,
        "description": "The response must mention that the patient will be informed, verbally and in writing, if a placebo is part of a clinical trial before they enroll.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions the possibility of randomization and placebo control but does not state that patients will be informed verbally and in writing before enrollment."
      }
    ],
    "question_number": 87,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:11:59.992193",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the case with an oncologist to review the trial details and discuss the pros and cons.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Repeatedly advises discussion with the medical team and specialists (e.g., \u201cdiscuss with the medical team,\u201d \u201cSecond Opinion\u2026 from another pancreatic cancer specialist\u201d)."
      },
      {
        "criterion_number": 2,
        "description": "The response explains that there are no FDA-approved cancer vaccines for pancreatic cancer and that all vaccines for pancreatic cancer are experimental.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that there are no FDA-approved pancreatic cancer vaccines or that all such vaccines are experimental."
      },
      {
        "criterion_number": 3,
        "description": "The response explains how a cancer vaccine works.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains vaccines stimulate the immune system to recognize and attack cancer using tumor components (proteins, neoantigens, genetic material)."
      },
      {
        "criterion_number": 4,
        "description": "The response states clinical trials are how treatments are tested for diseases like pancreatic cancer.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Clearly conveys testing function by describing phases: safety testing (Phase I), effectiveness (Phase II), comparison to standard of care (Phase III)."
      },
      {
        "criterion_number": 5,
        "description": "The response explains the four phases of clinical trials.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Describes Phases I\u2013III but omits Phase IV."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends researching clinical trials prior to enrolling.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Encourages being well-informed, gathering all information, and asking detailed questions before deciding, which constitutes researching prior to enrollment."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends ClinicalTrials.gov as a resource.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention ClinicalTrials.gov."
      },
      {
        "criterion_number": 8,
        "description": "The response states patients should consider all of their treatment options prior to enrolling in a clinical trial.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it suggests a second opinion and weighing quality of life, it does not explicitly state to consider all treatment options before enrolling."
      },
      {
        "criterion_number": 9,
        "description": "The response states clinical trials are designed to minimize patient harm and closely follow ethical standards.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions informed consent and right to withdraw but does not explicitly state harm minimization or ethical oversight."
      },
      {
        "criterion_number": 10,
        "description": "The response reviews potential benefits and risks of clinical trial participation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides clear sections on potential benefits (access, monitoring, contribution) and risks (immune-related AEs, common side effects, unknown risks, lack of benefit)."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends discussing with the clinical trial research team about costs to the patient for participating in the trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes a 'Costs' section prompting questions about sponsor coverage, insurance, and out-of-pocket expenses and encourages asking questions during consent, implying discussion with the research team."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly mention that vaccine clinical trials in pancreatic cancer are designed to address the poor response of this malignancy to standard immunotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes immunosuppressive microenvironment but does not explicitly connect vaccine trials to addressing poor response to standard immunotherapy."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly mention that vaccine trials aim to stimulate tumor-specific T cell (immune cell) responses to enhance the immune system\u2019s effectiveness in killing cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States vaccines stimulate the immune system generally but does not explicitly mention tumor-specific T cell responses."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention at least two of the following vaccine platforms: peptide-based vaccines targeting defined tumor antigens, dendritic cell vaccines loaded with tumor lysates, or personalized mRNA/neoantigen vaccines that encode patient-specific tumor mutations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions 'mRNA vaccine' and 'dendritic cell vaccine' generically but does not specify dendritic cells loaded with tumor lysates or personalized mRNA/neoantigen vaccines encoding patient-specific mutations, nor peptide-based vaccines."
      },
      {
        "criterion_number": 15,
        "description": "The response must mention that safety data from recent trials indicate that most vaccine regimens are well-tolerated, with adverse events generally limited to mild-to-moderate injection site reactions, flu-like symptoms, or transient fever.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists possible side effects but does not cite that safety data indicate most regimens are well-tolerated with primarily mild-to-moderate events."
      },
      {
        "criterion_number": 16,
        "description": "The response must mention that most data on vaccine trials in pancreatic cancer are derived from early-phase studies with small sample sizes and limited long-term follow-up.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes many trials are in earlier phases but does not mention small sample sizes or limited long-term follow-up."
      },
      {
        "criterion_number": 17,
        "description": "The response must explicitly define clinical trials as research studies that explore whether a new medical strategy, treatment, or device is safe and effective for humans.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Functionally defines by detailing that trials test safety (Phase I) and effectiveness (Phase II) and compare to standard (Phase III), and states 'Clinical trials are research.'"
      },
      {
        "criterion_number": 18,
        "description": "The response must explicitly state that clinical trials are essential for optimizing current and future therapies for cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Says participation advances understanding and future treatments, but does not explicitly state trials are essential for optimizing current and future therapies."
      },
      {
        "criterion_number": 20,
        "description": "The response must mention that the patient will be informed, verbally and in writing, if a placebo is part of a clinical trial before they enroll.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Asks whether there is a placebo arm and discusses informed consent, but does not explicitly state that patients will be informed verbally and in writing about placebo use before enrollment."
      }
    ],
    "question_number": 87,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:13:28.116659",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing care coordination concerns directly with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises asking the medical oncologist\u2019s office about a nurse navigator and identifies the oncologist/office as the main point of contact for coordination, which directly addresses discussing coordination with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response clearly states that the medical oncologist typically serves as the coordinating physician among the different specialists on the healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states the medical oncologist (or primary nurse) often serves as the de facto quarterback, managing the overall plan and referrals."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends discussing care coordination with a patient navigator or social worker.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends asking for a nurse navigator/care coordinator and highlights the oncology social worker\u2019s role, explicitly directing the reader to engage them for coordination and support."
      },
      {
        "criterion_number": 4,
        "description": "The response states that most oncology clinics have nurses who specialize in helping patients coordinate care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that many cancer centers have a dedicated nurse navigator whose job is to coordinate care, which conveys the common availability of specialized coordination nurses."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends trying to schedule multiple appointments on one day to limit life interruptions.",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no explicit recommendation to consolidate multiple appointments on the same day."
      },
      {
        "criterion_number": 6,
        "description": "The response states that the different specialists will communicate with one another and document their assessments in the electronic medical record.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions using the patient portal and having care conferences, it does not state that specialists communicate via and document assessments in the electronic medical record."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends asking about a multidisciplinary meeting with the involved specialists, sometimes called a \u201cTumor Board.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises requesting a care conference with key doctors together to align on the plan, which is a multidisciplinary meeting, even though the term 'Tumor Board' is not used."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly mention a structured multidisciplinary approach for coordinating care among multiple specialists for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly calls multidisciplinary care the gold standard and provides a structured approach (quarterback, defined roles, care conference) for coordination."
      },
      {
        "criterion_number": 9,
        "description": "The response must list all required specialists: surgical oncology, medical oncology, radiation oncology, gastroenterology, genetics, nutrition, and palliative care, and mention their distinct roles in diagnosis, staging, treatment, and supportive care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It lists most specialists (medical, surgical, radiation oncology; GI; palliative care; dietitian) with roles, but does not include genetics/genetic counseling, so it does not meet the full requirement."
      },
      {
        "criterion_number": 11,
        "description": "The response must emphasize the necessity of clear patient-centered communication.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It strongly emphasizes communication strategies: designating a spokesperson, using the patient portal, preparing questions, bringing a second person, recording visits (with permission), and closing the loop at each appointment."
      }
    ],
    "question_number": 88,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:14:14.761333",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing care coordination concerns directly with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response identifies the medical oncologist as the likely 'quarterback,' it does not explicitly advise discussing care coordination concerns directly with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response clearly states that the medical oncologist typically serves as the coordinating physician among the different specialists on the healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states the medical oncologist is 'often the primary quarterback' overseeing overall cancer treatment strategy."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends discussing care coordination with a patient navigator or social worker.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends using a 'Dedicated Care Coordinator or Patient Navigator' and instructs to ask if the center offers this service; it also suggests using them to facilitate communication."
      },
      {
        "criterion_number": 4,
        "description": "The response states that most oncology clinics have nurses who specialize in helping patients coordinate care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes a 'More Common Scenario' where an oncology nurse/team coordinator serves as a central point of contact and helps relay messages and ensure results are seen."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends trying to schedule multiple appointments on one day to limit life interruptions.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No recommendation to consolidate appointments on the same day is provided."
      },
      {
        "criterion_number": 6,
        "description": "The response states that the different specialists will communicate with one another and document their assessments in the electronic medical record.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions patient portals and requesting communication, it does not state that specialists document assessments in the EMR or will routinely communicate via the record."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends asking about a multidisciplinary meeting with the involved specialists, sometimes called a \u201cTumor Board.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It directly advises asking if the case has been or will be discussed at a multidisciplinary tumor board."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly mention a structured multidisciplinary approach for coordinating care among multiple specialists for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes multidisciplinary tumor boards where a unified plan is created and discusses coordinating a multidisciplinary team."
      },
      {
        "criterion_number": 9,
        "description": "The response must list all required specialists: surgical oncology, medical oncology, radiation oncology, gastroenterology, genetics, nutrition, and palliative care, and mention their distinct roles in diagnosis, staging, treatment, and supportive care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It lists most roles but omits genetics/genetic counseling; therefore it does not include all required specialists."
      },
      {
        "criterion_number": 11,
        "description": "The response must emphasize the necessity of clear patient-centered communication.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It repeatedly stresses patient-centered communication strategies such as preparing questions, clarifying understanding, summarizing next steps, and advocating by asking 'why,' 'alternatives,' and 'goals.'"
      }
    ],
    "question_number": 88,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:14:58.955819",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Multiple explicit prompts to contact the oncology team (24/7 number), program their number, and clarify when to call them vs go to ER."
      },
      {
        "criterion_number": 2,
        "description": "The response reviews common medical emergencies experienced by patients with pancreatic cancer, including biliary obstruction and bowel obstruction.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Covers biliary obstruction/cholangitis and bowel obstruction in detail, plus sepsis, VTE/PE, GI bleed, and glycemic emergencies."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends having an Advance Directive or Living Will in place to guide the patient\u2019s care if they are unable to speak for themselves.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends advance directives/living will/healthcare power of attorney in the go-bag and a section on understanding wishes."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends seeking help from a professional in talking about these challenging questions, like a social worker, spiritual worker, or palliative care professional.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of palliative care, social work, or spiritual care resources for difficult conversations."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends ensuring supportive care medications are refilled for symptoms like pain and nausea.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not advise refilling or maintaining supplies of supportive medications (e.g., pain, antiemetics)."
      },
      {
        "criterion_number": 7,
        "description": "The response must state that pancreatic cancer patients are at high risk for acute emergencies due to tumor progression, treatment effects, or comorbidities.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it notes cancer/treatments increase certain risks, it does not explicitly state that pancreatic cancer patients are at high risk for acute emergencies broadly due to tumor progression, treatment, or comorbidities."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention that biliary obstruction presents with jaundice, dark urine, and pruritus.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Includes jaundice and dark urine but does not mention pruritus/itching."
      },
      {
        "criterion_number": 9,
        "description": "The response must describe gastric outlet obstruction as persistent vomiting, inability to tolerate oral intake, and abdominal distension.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes bowel obstruction generally; does not specifically note inability to tolerate oral intake or label gastric outlet obstruction with the required features."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention VTE and include symptoms like sudden leg swelling, pain, shortness of breath, or chest pain, and state that pulmonary embolism is a leading cause of death after cancer itself.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides VTE symptoms and emergency actions but does not state that PE is a leading cause of death after cancer itself."
      },
      {
        "criterion_number": 11,
        "description": "The response must mention febrile neutropenia as a life-threatening complication of chemotherapy, characterized by fever and signs of infection in the context of neutropenia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses sepsis in immunosuppression but does not mention febrile neutropenia or neutropenia-specific risk."
      },
      {
        "criterion_number": 12,
        "description": "The response must mention metabolic derangements such as hypercalcemia (confusion, weakness, constipation) or hyponatremia (confusion, seizures).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions glycemic emergencies but not hypercalcemia or hyponatremia and their characteristic symptoms."
      },
      {
        "criterion_number": 13,
        "description": "The response must describe bowel obstruction as presenting with abdominal pain, vomiting, and constipation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly lists cramping abdominal pain, vomiting, and inability to have a bowel movement or pass gas (constipation)."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention spinal cord compression and its symptoms, such as new-onset weakness, sensory changes, or loss of bowel/bladder control.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of spinal cord compression or related neurologic red flags."
      }
    ],
    "question_number": 89,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:15:53.743755",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Multiple recommendations to contact the oncology team for urgent symptoms and to maintain regular communication with the medical team; explicitly advises calling the oncologist/oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response reviews common medical emergencies experienced by patients with pancreatic cancer, including biliary obstruction and bowel obstruction.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Covers a broad range of emergencies (infection, bleeding, respiratory distress, neurological changes, VTE, dehydration, metabolic issues) and explicitly addresses bowel obstruction and biliary obstruction (under jaundice)."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends having an Advance Directive or Living Will in place.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Dedicated section on Advanced Directives including DNR, Living Will, and Durable Power of Attorney, and advises discussing wishes before emergencies."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends seeking help from a professional such as a social worker, spiritual worker, or palliative care professional.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends involving a palliative care team early for symptom management and support."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends ensuring supportive care medications are refilled for symptoms like pain and nausea.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses medication adherence and lists meds in a packet and a go-bag, but does not explicitly recommend ensuring refills of supportive medications."
      },
      {
        "criterion_number": 7,
        "description": "States that pancreatic cancer patients are at high risk for acute emergencies due to tumor progression, treatment effects, or comorbidities.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Notes that pancreatic cancer and its treatments can lead to urgent situations, but does not explicitly state high risk due to tumor progression and comorbidities."
      },
      {
        "criterion_number": 8,
        "description": "Mentions that biliary obstruction presents with jaundice, dark urine, and pruritus.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Under jaundice, lists yellowing of skin/eyes, dark urine, and severe itching (pruritus), consistent with biliary obstruction."
      },
      {
        "criterion_number": 9,
        "description": "Describes gastric outlet obstruction as persistent vomiting, inability to tolerate oral intake, and abdominal distension.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Covers severe nausea/vomiting and bowel obstruction symptoms, but does not specifically describe gastric outlet obstruction with the triad of persistent vomiting, inability to tolerate oral intake, and abdominal distension."
      },
      {
        "criterion_number": 10,
        "description": "Mentions VTE with symptoms and states that pulmonary embolism is a leading cause of death after cancer itself.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes DVT/PE symptoms well and urgency, but does not state that pulmonary embolism is a leading cause of death after cancer itself."
      },
      {
        "criterion_number": 11,
        "description": "Mentions febrile neutropenia as a life-threatening complication of chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly labels neutropenic fever as a critical emergency in chemotherapy patients with fever due to suppressed immunity (neutropenia)."
      },
      {
        "criterion_number": 12,
        "description": "Mentions metabolic derangements such as hypercalcemia or hyponatremia with representative symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions dehydration/electrolyte imbalance generally but does not specifically mention hypercalcemia or hyponatremia and their hallmark symptoms."
      },
      {
        "criterion_number": 13,
        "description": "Describes bowel obstruction as presenting with abdominal pain, vomiting, and constipation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists symptoms of bowel obstruction including abdominal pain/cramping, vomiting, and no bowel movements/constipation."
      },
      {
        "criterion_number": 14,
        "description": "Mentions spinal cord compression and its symptoms such as new-onset weakness, sensory changes, or loss of bowel/bladder control.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention spinal cord compression or associated red-flag symptoms like new limb weakness, sensory changes, or bowel/bladder dysfunction."
      }
    ],
    "question_number": 89,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:16:49.186272",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the hearing changes with his oncologist or healthcare team immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly instructs to contact the oncology team immediately and not wait, with details on what information to report."
      },
      {
        "criterion_number": 2,
        "description": "The response states some chemotherapy treatments, like oxaliplatin, which is frequently used in treating pancreatic cancer as part of combination chemotherapy, can cause hearing changes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions oxaliplatin as part of FOLFIRINOX for pancreatic cancer and notes it can cause ototoxicity."
      },
      {
        "criterion_number": 3,
        "description": "The response states that platinum-based chemotherapy, such as cisplatin, is well-known to cause hearing loss (ototoxicity).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies cisplatin and carboplatin as well-known culprits for ototoxicity/hearing loss."
      },
      {
        "criterion_number": 4,
        "description": "The response states the hearing changes may be related to other conditions like fatigue, infection, dehydration, malnutrition, or metabolic abnormalities from the cancer or its treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists dehydration and electrolyte imbalances (metabolic issues) and ear infection as possible contributors, meeting the criterion."
      },
      {
        "criterion_number": 5,
        "description": "The response states it is important for the patient\u2019s oncologist to know about new symptoms because they may need to adjust the dose of the chemotherapy or consider a different treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that the team may reduce dose, delay a cycle, or switch to a different medication based on severity."
      },
      {
        "criterion_number": 6,
        "description": "The response states that treatment-related side effects may become worse or permanent if changes are not made to the treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes ototoxic damage can be cumulative and may become permanent, implying risk increases with ongoing treatment."
      },
      {
        "criterion_number": 7,
        "description": "The response states hearing changes may be related to cancer spreading to the brain if there are other neurologic symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions rare possibility of brain metastasis affecting hearing but does not tie it to the presence of other neurologic symptoms."
      },
      {
        "criterion_number": 8,
        "description": "The response states the hearing changes may be related to normal age-related hearing loss.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly lists age-related hearing loss (presbycusis) as a possible cause."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that the risk of hearing loss increases with cumulative doses and patient age.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Addresses cumulative dose effect but does not state that risk increases with patient age."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that other therapies, including aminoglycoside antibiotics, loop diuretics, and radiation to the head/neck, can also contribute to hearing loss.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions aminoglycosides and diuretics generically but does not specify loop diuretics and omits radiation to head/neck."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that referral for audiologic evaluation is advised.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends a formal hearing test with an audiologist (audiogram) and ENT referral."
      }
    ],
    "question_number": 90,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:17:32.278960",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the hearing changes with his oncologist or healthcare team immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response twice urges immediate notification of the oncologist/medical team and emphasizes urgency."
      },
      {
        "criterion_number": 2,
        "description": "The response states some chemotherapy treatments, like oxaliplatin, which is frequently used in treating pancreatic cancer as part of combination chemotherapy, can cause hearing changes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While platinum agents are mentioned, oxaliplatin is not named specifically; FOLFIRINOX is referenced but not tied to ototoxicity."
      },
      {
        "criterion_number": 3,
        "description": "The response states that platinum-based chemotherapy, such as cisplatin, is well-known to cause hearing loss (ototoxicity).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states platinum-based agents like cisplatin are ototoxic and can cause hearing loss."
      },
      {
        "criterion_number": 4,
        "description": "The response states the hearing changes may be related to other conditions like fatigue, infection, dehydration, malnutrition, or metabolic abnormalities from the cancer or its treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions dehydration, poor nutrition, systemic inflammation, and ear infection as possible contributors."
      },
      {
        "criterion_number": 5,
        "description": "The response states it is important for the patient\u2019s oncologist to know about new symptoms because they may need to adjust the dose of the chemotherapy or consider a different treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically notes the team might consider dose adjustments or switching drugs if medications are the cause."
      },
      {
        "criterion_number": 6,
        "description": "The response states that treatment-related side effects may become worse or permanent if changes are not made to the treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States hearing loss can be temporary or permanent and emphasizes early reporting to prevent further damage, implying risk of progression without changes."
      },
      {
        "criterion_number": 7,
        "description": "The response states hearing changes may be related to cancer spreading to the brain if there are other neurologic symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions metastasis as a rare cause but does not link this to the presence of other neurologic symptoms."
      },
      {
        "criterion_number": 8,
        "description": "The response states the hearing changes may be related to normal age-related hearing loss.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions age-related hearing loss (presbycusis) as a common cause."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that the risk of hearing loss increases with cumulative doses and patient age.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss cumulative dose-related risk; age is mentioned as presbycusis but not in the context of increased ototoxic risk."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that other therapies, including aminoglycoside antibiotics, loop diuretics, and radiation to the head/neck, can also contribute to hearing loss.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Includes aminoglycosides and loop diuretics but does not mention radiation to the head/neck."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that referral for audiologic evaluation is advised.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends formal audiometry/audiogram to assess hearing."
      }
    ],
    "question_number": 90,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:18:11.135793",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states proton therapy is a type of radiation therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states 'proton therapy is an advanced and highly precise type of radiation therapy.'"
      },
      {
        "criterion_number": 2,
        "description": "The response states proton therapy uses protons rather than photons to deliver highly conformal radiation doses to tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly explains using protons instead of X-rays/photons and describes the Bragg peak and lack of exit dose."
      },
      {
        "criterion_number": 3,
        "description": "The response states proton therapy may be more precise in its target field compared to traditional radiation therapy techniques, which may reduce treatment-related side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights improved precision and reduced exit dose, and links this to fewer side effects and better organ sparing."
      },
      {
        "criterion_number": 4,
        "description": "The response states proton therapy is a safe and feasible option for select patients with locally advanced or recurrent pancreatic cancer, especially when minimizing toxicity to surrounding organs is critical.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses use in locally advanced/unresectable and re-irradiation settings for select patients, emphasizing toxicity minimization; notes it may be the only safe option in re-irradiation."
      },
      {
        "criterion_number": 5,
        "description": "The response states the decision to use proton therapy is influenced by the cancer\u2019s stage, location, size, proximity to other organs, among others.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States candidacy depends on specific tumor location and stage and discusses proximity to critical organs and vessels; conveys multifactor decision-making even though size is not explicitly named."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing this with a Radiation Oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advises discussion with the oncology team and doctors and suggests referral to a proton center, but does not explicitly recommend speaking with a Radiation Oncologist."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly recommends conversation with the mother's oncology team and doctors and suggests obtaining a second opinion."
      },
      {
        "criterion_number": 8,
        "description": "The response states proton therapy has proven benefit in some cancers, like head and neck cancer, though has unclear benefit over traditional radiation therapy and is considered experimental in most types of cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes evidence is evolving and trials are ongoing but does not mention proven benefits in specific cancers (e.g., head and neck) or label it experimental in most cancers."
      },
      {
        "criterion_number": 9,
        "description": "The response states not all cancer centers have the capability to provide proton therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States there are a limited number of proton therapy centers and travel may be required."
      },
      {
        "criterion_number": 10,
        "description": "The response states proton therapy still carries the risk of side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses potential side effects (nausea, fatigue, diarrhea) and frames protons as reducing but not eliminating these risks; also prompts asking about likely side effects."
      },
      {
        "criterion_number": 11,
        "description": "The response states proton therapy is often used in combination with chemotherapy (such as gemcitabine) as part of concurrent chemoradiation protocols.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States proton therapy is almost always used as part of a comprehensive treatment plan that includes chemotherapy."
      },
      {
        "criterion_number": 12,
        "description": "The response states proton therapy can be used for locally advanced, unresectable, or recurrent disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly addresses use in locally advanced/unresectable disease and for re-irradiation of recurrences."
      }
    ],
    "question_number": 91,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:19:26.791798",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states proton therapy is a type of radiation therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly describes proton therapy as an advanced form of radiation therapy."
      },
      {
        "criterion_number": 2,
        "description": "The response states proton therapy uses protons rather than photons to deliver highly conformal radiation doses to tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly contrasts protons with photons/X-rays and explains Bragg Peak leading to conformal dosing."
      },
      {
        "criterion_number": 3,
        "description": "The response states proton therapy may be more precise in its target field compared to traditional radiation therapy techniques, which may reduce treatment-related side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States precision and organ-sparing with reduced side effects due to Bragg Peak and lack of exit dose."
      },
      {
        "criterion_number": 4,
        "description": "The response states proton therapy is a safe and feasible option for select patients with locally advanced or recurrent pancreatic cancer, especially when minimizing toxicity to surrounding organs is critical.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses its consideration for pancreatic cancer, especially locally advanced/unresectable, to minimize toxicity to adjacent organs; also mentions recurrent cancers in general."
      },
      {
        "criterion_number": 5,
        "description": "The decision to use proton therapy is influenced by the cancer\u2019s stage, location, size, proximity to other organs, among others.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States decision depends on exact location, size, stage, overall health, and treatment history."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing this with a Radiation Oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically recommends consultation and a second opinion from a radiation oncologist at a proton center."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises discussion with the mother's oncology team and mentions a multidisciplinary team including the medical oncologist."
      },
      {
        "criterion_number": 8,
        "description": "The response states proton therapy has proven benefit in some cancers, like head and neck cancer, though has unclear benefit over traditional radiation therapy and is considered experimental in most types of cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss evidence level, head and neck cancers, or the uncertainty/experimental status relative to conventional radiation."
      },
      {
        "criterion_number": 9,
        "description": "The response states not all cancer centers have the capability to provide proton therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes it is available only at a limited number of specialized centers."
      },
      {
        "criterion_number": 10,
        "description": "The response states proton therapy still carries the risk of side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states side effects are not eliminated and lists examples like fatigue and skin irritation."
      },
      {
        "criterion_number": 11,
        "description": "The response states proton therapy is often used in combination with chemotherapy (such as gemcitabine) as part of concurrent chemoradiation protocols.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions combination with other treatments generally but does not state concurrent chemoradiation or chemotherapy agents like gemcitabine."
      },
      {
        "criterion_number": 12,
        "description": "The response states proton therapy can be used for locally advanced, unresectable, or recurrent disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifies use in locally advanced, unresectable pancreatic cancer; also discusses recurrent cancers more generally."
      }
    ],
    "question_number": 91,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:20:00.815968",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team or oncologist, as they likely have financial experts who are knowledgeable in this area.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises starting with the healthcare team and details roles (oncology social worker, financial navigator/counselor, nurse navigator) as the first and most important step."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends learning about the patient\u2019s insurance plan, including out-of-pocket costs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States financial navigators can explain insurance benefits and estimate out-of-pocket expenses, guiding the user to understand plan details."
      },
      {
        "criterion_number": 3,
        "description": "The response states pharmaceutical companies have programs to help patients cover the cost of medications and provides examples.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes manufacturer PAPs and co-pay cards; provides a concrete example (Creon via AbbVie Patient Assistance Foundation)."
      },
      {
        "criterion_number": 4,
        "description": "The response states large hospital systems and cancer centers may have assistance programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that cancer centers/hospitals are the central hub for assistance and that most have financial navigators; this conveys that cancer centers provide internal assistance resources."
      },
      {
        "criterion_number": 5,
        "description": "The response states patient assistance programs may cover all or most of the cost of medications for cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States PAPs provide free or very low-cost medication to eligible patients, implying coverage of all or most costs."
      },
      {
        "criterion_number": 6,
        "description": "The response states government programs may offer assistance with the cost of medications and provides examples.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions Medicare Part D Low-Income Subsidy, Medicaid, and State Pharmaceutical Assistance Programs as government options."
      },
      {
        "criterion_number": 7,
        "description": "The response offers examples of non-profit organizations with patient assistance programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists Patient Advocate Foundation, CancerCare, HealthWell Foundation, PAN Foundation, and Good Days."
      },
      {
        "criterion_number": 8,
        "description": "The response offers examples of pancreatic cancer-specific patient assistance programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes PanCAN Patient Services and the Hirshberg Foundation for Pancreatic Cancer Research."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends applying for assistance early as the process may take time and delay treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises scheduling a meeting with the social worker as the first call and notes that applying for aid is time-consuming, implying the need to start early."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention federal, state, manufacturer, and independent charity options for medication cost assistance for pancreatic cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers federal (Medicare LIS), state (SPAPs, Medicaid), manufacturer (PAPs/co-pay cards), and independent charities (HealthWell, PAN, Good Days, etc.)."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly state that Medicaid offers comprehensive prescription drug coverage with minimal co-payments and is the most effective public program for low-income patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions Medicaid but does not state comprehensive coverage with minimal co-pays nor that it is the most effective public program for low-income patients."
      },
      {
        "criterion_number": 12,
        "description": "The response must mention that manufacturer-sponsored assistance programs provide free or discounted medications to eligible uninsured or underinsured patients, requiring proof of financial hardship and doctor certification.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes free/low-cost PAPs for uninsured/underinsured but does not mention the requirements of proof of financial hardship and prescriber certification."
      },
      {
        "criterion_number": 13,
        "description": "The response must specify that independent nonprofits like HealthWell and PAN Foundation offer co-pay and premium assistance to insured patients with incomes below 400-500% of the federal poverty level.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes co-pay/premium help from HealthWell and PAN but omits the income eligibility range (400\u2013500% FPL)."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention the complexity of accessing assistance programs and disparities among non-English speakers and some ethnic groups.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States the process can be time-consuming but does not address disparities for non-English speakers or among ethnic groups."
      },
      {
        "criterion_number": 15,
        "description": "The response must mention financial navigators and online tools such as NeedyMeds or RxAssist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions financial navigators and the Medicine Assistance Tool (MAT) but does not include NeedyMeds or RxAssist by name."
      }
    ],
    "question_number": 92,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:21:07.852946",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team or oncologist, as they likely have financial experts who are knowledgeable in this area.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly advises starting with the healthcare team, specifically mentioning oncologists, office staff, social workers, and financial navigators as resources."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends learning about the patient\u2019s insurance plan, including out-of-pocket costs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages gathering insurance details and repeatedly references co-pays, deductibles, and premiums, implying understanding of plan out-of-pocket costs."
      },
      {
        "criterion_number": 3,
        "description": "The response states pharmaceutical companies have programs to help patients cover the cost of medications and provides examples.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It states manufacturers have PAPs and how to find them, but does not provide concrete examples of specific manufacturer programs."
      },
      {
        "criterion_number": 4,
        "description": "The response states large hospital systems and cancer centers may have assistance programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions hospital/clinic financial navigators and hospital financial aid/charity care programs."
      },
      {
        "criterion_number": 5,
        "description": "The response states patient assistance programs may cover all or most of the cost of medications for cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes manufacturer PAPs can provide medications for free or at reduced cost, indicating coverage of all or most costs."
      },
      {
        "criterion_number": 6,
        "description": "The response states government programs may offer assistance with the cost of medications and provides examples.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides examples including Medicare Part D, LIS/Extra Help, MSPs, Medicaid, VA benefits, and SPAPs."
      },
      {
        "criterion_number": 7,
        "description": "The response offers examples of non-profit organizations with patient assistance programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists PAN Foundation, HealthWell Foundation, Good Days, The Assistance Fund, CancerCare, LLS, and ACS."
      },
      {
        "criterion_number": 8,
        "description": "The response offers examples of pancreatic cancer-specific patient assistance programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions Pancreatic Cancer Action Network (PanCAN) patient services and Hirshberg Foundation as pancreatic cancer\u2013focused resources."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends applying for assistance early as the process may take time and delay treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes the process can be lengthy and to be persistent, it does not explicitly recommend applying early to avoid treatment delays."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention federal, state, manufacturer, and independent charity options for medication cost assistance for pancreatic cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers federal (Medicare, VA), state (SPAPs, Medicaid), manufacturer PAPs, and independent charities (PAN, HealthWell, etc.)."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly state that Medicaid offers comprehensive prescription drug coverage with minimal co-payments and is the most effective public program for low-income patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions Medicaid generally but does not explicitly state comprehensive prescription coverage, minimal co-pays, or that it is the most effective public option."
      },
      {
        "criterion_number": 12,
        "description": "The response must mention that manufacturer-sponsored assistance programs provide free or discounted medications to eligible uninsured or underinsured patients, requiring proof of financial hardship and doctor certification.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes free or reduced-cost meds for uninsured/underinsured, but does not mention requirements for proof of financial hardship or physician certification."
      },
      {
        "criterion_number": 13,
        "description": "The response must specify that independent nonprofits like HealthWell and PAN Foundation offer co-pay and premium assistance to insured patients with incomes below 400-500% of the federal poverty level.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes co-pay/premium help but does not specify the 400\u2013500% FPL income thresholds or explicitly state it\u2019s for insured patients."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention the complexity of accessing assistance programs and disparities among non-English speakers and some ethnic groups.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Acknowledges bureaucratic complexity but does not address disparities for non-English speakers or specific ethnic groups."
      },
      {
        "criterion_number": 15,
        "description": "The response must mention financial navigators and online tools such as NeedyMeds or RxAssist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions financial navigators/social workers and online tools NeedyMeds and RxAssist."
      }
    ],
    "question_number": 92,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:21:50.561522",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly encourages engaging the oncology team and provides a list of questions to ask the oncologist; also advises to lean on the medical team."
      },
      {
        "criterion_number": 2,
        "description": "The response states maintenance therapy is typically used in pancreatic cancer after the initial induction therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States it is considered after 4\u20136 months of initial intensive chemotherapy with a good response."
      },
      {
        "criterion_number": 3,
        "description": "The response states maintenance therapy typically involves fewer anti-cancer drugs with the goal of limiting side effects.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes maintenance as less intense and more tolerable; specifically mentions dropping more toxic components (e.g., oxaliplatin) and using gentler agents to reduce side effects."
      },
      {
        "criterion_number": 4,
        "description": "The response states the oncologist will continue to monitor the cancer closely while the patient is on maintenance therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes ongoing monitoring implicitly by prompting to ask, 'How often will we do scans to see if it's working?', indicating continued surveillance during maintenance."
      },
      {
        "criterion_number": 5,
        "description": "The response states that if the cancer grows while on maintenance therapy, combination therapy may be reintroduced to get the cancer back under control.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention reintroducing combination therapy upon progression while on maintenance."
      },
      {
        "criterion_number": 6,
        "description": "The response states chemotherapy side effects are typically cumulative, so using maintenance therapy may help the patient tolerate treatment for a longer period of time.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions gentler treatment and improved tolerability, it does not explicitly state the cumulative nature of chemotherapy toxicities or that maintenance may enable longer treatment duration."
      },
      {
        "criterion_number": 7,
        "description": "The response states maintenance therapy may involve chemotherapy, targeted therapy, or immunotherapy depending upon the characteristics of the patient\u2019s tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly lists chemotherapy (capecitabine/5-FU), targeted therapy (PARP inhibitors for BRCA), and immunotherapy (pembrolizumab for MSI-H/dMMR) based on tumor biomarkers."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the decision to initiate maintenance therapy should be individualized, considering disease response, cumulative toxicities, patient preference, and goals of care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explicitly state that initiation should be individualized across the full set of factors (disease response, cumulative toxicities, patient preference, goals of care)."
      }
    ],
    "question_number": 93,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:22:26.580862",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly encourages discussion with the oncologist, provides a list of questions to ask, and states, \"It's crucial to have a detailed discussion with the oncologist...\""
      },
      {
        "criterion_number": 2,
        "description": "The response states maintenance therapy is typically used in pancreatic cancer after the initial induction therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines maintenance as ongoing treatment after initial, more intensive therapy achieves response and applies this to pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response states maintenance therapy typically involves fewer anti-cancer drugs with the goal of limiting side effects.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States maintenance is designed to be less toxic and gives examples such as dropping one or two drugs (de-escalated chemotherapy), lower doses, and less frequent administration."
      },
      {
        "criterion_number": 4,
        "description": "The response states the oncologist will continue to monitor the cancer closely while the patient is on maintenance therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions monitoring explicitly in the context of maintenance with, \"How will we monitor the effectiveness... (e.g., scans, blood tests),\" implying ongoing surveillance during therapy."
      },
      {
        "criterion_number": 5,
        "description": "The response states that if the cancer grows while on maintenance therapy, combination therapy may be reintroduced to get the cancer back under control.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that combination therapy may be reintroduced upon progression during maintenance."
      },
      {
        "criterion_number": 6,
        "description": "The response states chemotherapy side effects are typically cumulative, so using maintenance therapy may help the patient tolerate treatment for a longer period of time.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes maintenance is less toxic and may improve quality of life, it does not state that chemotherapy toxicities are cumulative or that maintenance helps tolerate longer treatment specifically for that reason."
      },
      {
        "criterion_number": 7,
        "description": "The response states maintenance therapy may involve chemotherapy, targeted therapy, or immunotherapy depending upon the characteristics of the patient\u2019s tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly lists de-escalated chemotherapy, targeted therapy (e.g., PARP inhibitors for BRCA), and immunotherapy for MSI-High tumors."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the decision to initiate maintenance therapy should be individualized, considering disease response, cumulative toxicities, patient preference, and goals of care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it mentions individualization based on response, side effects, overall health, and molecular features, it does not explicitly include patient preference or goals of care, nor does it reference cumulative toxicities as a factor in the decision."
      }
    ],
    "question_number": 93,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:22:57.533753",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response advises contacting the oncology social worker, nurse navigator, and the 'oncology team,' but does not explicitly recommend discussing anxiety with the patient's oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a licensed mental health care provider.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends psycho-oncology professionals (psychiatrists, psychologists, therapists), in-house therapists/psychologists, and suggests the caregiver seek their own therapist."
      },
      {
        "criterion_number": 3,
        "description": "The response instructs the patient to seek immediate medical evaluation if they are experiencing thoughts of harming themselves or others.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No crisis or immediate safety guidance (e.g., contacting emergency services or a crisis line) is provided for self-harm or harm-to-others thoughts."
      },
      {
        "criterion_number": 4,
        "description": "The response states anxiety is a common occurrence in patients with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It normalizes anxiety as 'completely understandable' and states 'you are not alone,' which conveys that anxiety is common among patients and caregivers facing pancreatic cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response states treatments like cognitive behavioral therapy may help to control anxiety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cognitive behavioral therapy (CBT) is not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response states medications may help to control anxiety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of pharmacologic options (e.g., antidepressants, anxiolytics) for anxiety management."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly mention psychotherapy, psychoeducation, supportive therapy, and integrative modalities as available resources for treatment-related anxiety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions counseling, therapists, and mindfulness, it does not explicitly name all required modalities: 'psychotherapy,' 'psychoeducation,' and 'supportive therapy' are not explicitly stated; 'integrative modalities' is not explicitly named as a category."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly mention mindfulness-based interventions or mindfulness-based stress reduction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It recommends mindfulness and meditation apps but does not explicitly mention 'mindfulness-based interventions' or 'Mindfulness-Based Stress Reduction (MBSR)'."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends mindfulness and relaxation techniques.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends mindfulness, deep breathing (box breathing), and meditation apps (Calm, Headspace, Insight Timer)."
      },
      {
        "criterion_number": 11,
        "description": "The response offers pancreatic cancer-specific resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists PanCAN (with phone number), the Lustgarten Foundation, and the National Pancreatic Cancer Foundation."
      },
      {
        "criterion_number": 12,
        "description": "The response offers mental health-specific resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes CancerCare (counseling, support groups), Cancer Support Community, and referrals to psycho-oncology professionals and in-house therapists/psychologists."
      },
      {
        "criterion_number": 13,
        "description": "The response recommends participation in cancer support groups.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends support groups (CancerCare, Cancer Support Community, and hospital-based groups) for patients and caregivers."
      }
    ],
    "question_number": 94,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:23:42.768093",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly advises communicating anxiety to the oncology team and using them as the primary point of contact, including referrals via the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a licensed mental health care provider.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically mentions oncology psychiatrists/psychologists and therapists/counselors, and suggests CBT/ACT, indicating engagement with licensed mental health professionals."
      },
      {
        "criterion_number": 3,
        "description": "The response instructs the patient to seek immediate medical evaluation if they are experiencing thoughts of harming themselves or others.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Provides a Crisis Text Line for immediate support but does not explicitly instruct seeking immediate medical evaluation or emergency services for self-harm or harm-to-others thoughts."
      },
      {
        "criterion_number": 4,
        "description": "The response states anxiety is a common occurrence in patients with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states it is completely normal for anxiety to be a significant challenge during cancer treatment."
      },
      {
        "criterion_number": 5,
        "description": "The response states treatments like cognitive behavioral therapy may help to control anxiety.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends CBT (and ACT) as effective approaches for anxiety."
      },
      {
        "criterion_number": 6,
        "description": "The response states medications may help to control anxiety.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes oncology psychiatrists can provide medication management, implying pharmacologic treatment for anxiety."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly mention psychotherapy, psychoeducation, supportive therapy, and integrative modalities as available resources for treatment-related anxiety.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Integrative modalities are explicitly mentioned, and therapy/counseling is discussed, but the response does not explicitly use the terms \u201cpsychotherapy,\u201d \u201cpsychoeducation,\u201d or \u201csupportive therapy.\u201d"
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly mention mindfulness-based interventions or mindfulness-based stress reduction.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly lists Mindfulness-Based Stress Reduction within integrative medicine programs."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends mindfulness and relaxation techniques.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends guided meditations, deep breathing, progressive muscle relaxation, guided imagery, and meditation apps."
      },
      {
        "criterion_number": 11,
        "description": "The response offers pancreatic cancer-specific resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides PanCAN with services and contact details, a pancreatic cancer-specific resource."
      },
      {
        "criterion_number": 12,
        "description": "The response offers mental health-specific resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists Psychology Today for finding therapists and the Crisis Text Line, both mental health-specific resources."
      },
      {
        "criterion_number": 13,
        "description": "The response recommends participation in cancer support groups.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights support groups via CancerCare and Cancer Support Community as available resources to participate in."
      }
    ],
    "question_number": 94,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:24:24.217641",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises: \"Sit down with his oncologist and the interventional radiologist who would perform the procedure,\" and provides questions to ask."
      },
      {
        "criterion_number": 3,
        "description": "The response states cryotherapy is a procedure that uses metal instruments cooled to subzero temperatures in order to kill tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes use of cryoprobes (needle-like instruments) cooled with argon/liquid nitrogen to \u2212100\u00b0C to \u2212190\u00b0C to destroy tumor cells. While not explicitly saying 'metal,' the description of cryoprobes and mechanism clearly meets the intent."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that cryotherapy (also called cryoablation) is a minimally invasive locoregional treatment that destroys tumor tissue by freezing it, typically using probes inserted through the skin (percutaneously) or intraoperatively under imaging guidance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Calls it cryoablation, labels it minimally invasive, explains imaging guidance (CT/ultrasound), and describes percutaneous insertion of probes to freeze/destroy the tumor."
      },
      {
        "criterion_number": 5,
        "description": "The response states the decision to use cryotherapy involves the cancer\u2019s size, location, proximity to other organs, among other things.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions inoperability due to involvement with major vessels, accessibility without endangering nearby organs, and explicitly references tumor size and location in questions to ask clinicians."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing the benefits and risks of this procedure with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages meeting with oncologist and interventional radiologist and suggests asking about benefits, specific risks, success rates, recovery, and alternatives."
      },
      {
        "criterion_number": 7,
        "description": "The response states cryotherapy may be used in conjunction with other treatment modalities like chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes emerging research combining cryotherapy with immunotherapy and prompts discussion of how it fits with chemotherapy or radiation."
      },
      {
        "criterion_number": 8,
        "description": "The response states cryotherapy is not typically used to cure cancer but may be used to debulk tumors that are not operable.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly states it is not typically a cure and describes its use for debulking in locally advanced, inoperable tumors."
      },
      {
        "criterion_number": 9,
        "description": "The response states not all patients benefit from cryotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that not all patients benefit; discusses candidacy and limitations but does not make this point directly."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that in pancreatic cancer, cryotherapy is not a standard first-line therapy but is considered for patients with unresectable, locally advanced, or metastatic disease who are not candidates for surgical resection or have failed systemic therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States it is not a standard first-line therapy and discusses consideration for inoperable (unresectable) and locally advanced disease. Although it does not mention metastatic disease or failed systemic therapy, it meets the core requirement."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that its primary role is palliative, aiming to reduce tumor burden, alleviate pain, and potentially improve quality of life and local disease control.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly frames cryotherapy\u2019s goals as palliative with emphasis on pain relief, debulking/tumor control, and improving quality of life."
      }
    ],
    "question_number": 95,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:25:09.693675",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises a thorough discussion with the oncology team and a multidisciplinary team."
      },
      {
        "criterion_number": 3,
        "description": "The response states cryotherapy is a procedure that uses metal instruments cooled to subzero temperatures in order to kill tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes cryoprobes delivering super-cooled gas to create an ice ball that destroys cancer cells, accurately conveying the use of cooled instruments to ablate tumors."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that cryotherapy (also called cryoablation) is a minimally invasive locoregional treatment that destroys tumor tissue by freezing it, typically using probes inserted through the skin (percutaneously) or intraoperatively under imaging guidance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States cryotherapy is also called cryoablation/cryo\u00adsurgery, explains freezing to destroy tissue, notes imaging guidance, and mentions percutaneous and intraoperative approaches; also characterizes it as minimally invasive."
      },
      {
        "criterion_number": 5,
        "description": "The response states the decision to use cryotherapy involves the cancer\u2019s size, location, proximity to other organs, among other things.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions tumor size, location, involvement of major blood vessels, and proximity to vital structures as key considerations; includes questions specifically about size and location."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing the benefits and risks of this procedure with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages a thorough discussion of risks, benefits, evidence, and alternatives with the oncology team, providing a list of questions to ask."
      },
      {
        "criterion_number": 7,
        "description": "The response states cryotherapy may be used in conjunction with other treatment modalities like chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes it may be used in combination with chemotherapy or radiation."
      },
      {
        "criterion_number": 8,
        "description": "The response states cryotherapy is not typically used to cure cancer but may be used to debulk tumors that are not operable.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly frames cryotherapy as non-frontline/experimental and palliative, used when surgery is not possible, and to reduce tumor bulk for symptom relief."
      },
      {
        "criterion_number": 9,
        "description": "The response states not all patients benefit from cryotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes risks and incomplete tumor destruction, it does not explicitly state that not all patients benefit."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that in pancreatic cancer, cryotherapy is not a standard first-line therapy but is considered for patients with unresectable, locally advanced, or metastatic disease who are not candidates for surgical resection or have failed systemic therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States it is not standard frontline therapy and is considered when surgery is not possible due to unresectability; aligns with use in non-surgical candidates."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that its primary role is palliative, aiming to reduce tumor burden, alleviate pain, and potentially improve quality of life and local disease control.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Identifies a primarily palliative role, specifically to reduce tumor bulk and relieve pain; emphasizes symptom relief."
      }
    ],
    "question_number": 95,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:26:07.964768",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly encourages discussion with the oncology team and provides specific questions to ask the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response states CA 19-9 is the tumor marker most commonly used to track disease status in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States CA 19-9 is the most well-known and widely used tumor marker for pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response states other tumor markers, like CEA and CA 125, are less reliable than CA 19-9 for disease monitoring in pancreatic cancer and are used more frequently in other gastrointestinal or genitourinary cancers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes CEA is less specific/sensitive than CA 19-9 and that CEA is commonly used in colorectal and other GI cancers; identifies CA 125 as primarily an ovarian cancer marker and not routinely checked in pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response states tumor markers may be used to monitor the course of disease in patients with pancreatic cancer, along with imaging studies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes use of markers to monitor treatment/progression and references changes relative to CT scans, implying use alongside imaging."
      },
      {
        "criterion_number": 5,
        "description": "The response states tumor markers are not reliable markers of disease in all patients with pancreatic cancer, as not all tumors secrete the markers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that 5\u201310% of people (Lewis antigen negative) do not produce CA 19-9, indicating markers are not reliable for all patients."
      },
      {
        "criterion_number": 6,
        "description": "The response states circulating tumor DNA (ctDNA) is an emerging technology aimed at detecting early cancer progression and recurrence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes ctDNA as a liquid biopsy used to detect mutations, monitor treatment response, and detect MRD/recurrence, sometimes earlier than imaging."
      },
      {
        "criterion_number": 7,
        "description": "The response states circulating tumor DNA (ctDNA) is not FDA approved for disease monitoring in pancreatic cancer and remains experimental.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state ctDNA is not FDA approved for monitoring pancreatic cancer or that it remains experimental."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that CEA is elevated in 30-60% of pancreatic cancer cases and is particularly useful in Lewis-negative patients who do not secrete CA19-9.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions 30\u201360% elevation rate but does not state that CEA is particularly useful in Lewis-negative patients."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that both CEA and CA125 have demonstrated value for diagnosis, prognosis, and monitoring, especially when CA19-9 is not informative. CA125, when combined with CA19-9, improves diagnostic accuracy and is associated with tumor burden and metastatic disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss diagnostic/prognostic value of CEA/CA125, their use when CA19-9 is not informative, combination improving diagnostic accuracy, or CA125\u2019s association with tumor burden/metastasis."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that emerging markers such as LAMC2, POSTN are not yet standard in routine clinical practice.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention LAMC2, POSTN, or their non-standard status."
      }
    ],
    "question_number": 96,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:26:44.403082",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises having an open and detailed discussion with the mother's oncologist and lists specific questions to ask."
      },
      {
        "criterion_number": 2,
        "description": "The response states CA 19-9 is the tumor marker most commonly used to track disease status in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that CA 19-9 is the most established and commonly used tumor marker for pancreatic adenocarcinoma."
      },
      {
        "criterion_number": 3,
        "description": "The response states other tumor markers, like CEA and CA 125, are less reliable than CA 19-9 for disease monitoring in pancreatic cancer and are used more frequently in other gastrointestinal or genitourinary cancers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes CEA is less sensitive/specific than CA 19-9 and CA 125 is primarily a marker for ovarian cancer; also mentions CEA\u2019s role in colorectal cancer. This conveys they are less reliable for pancreatic cancer monitoring and more commonly used in other cancers."
      },
      {
        "criterion_number": 4,
        "description": "The response states tumor markers may be used to monitor the course of disease in patients with pancreatic cancer, along with imaging studies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions CA 19-9 tracking and emphasizes interpreting tumor markers in the context of imaging results and clinical condition."
      },
      {
        "criterion_number": 5,
        "description": "The response states tumor markers are not reliable markers of disease in all patients with pancreatic cancer, as not all tumors secrete the markers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that not all patients produce CA 19-9 and highlights limitations and false elevations."
      },
      {
        "criterion_number": 6,
        "description": "The response states circulating tumor DNA (ctDNA) is an emerging technology aimed at detecting early cancer progression and recurrence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes ctDNA as emerging, with uses including early detection, monitoring response, detecting minimal residual disease (post-surgery), and indicating resistance/progression."
      },
      {
        "criterion_number": 7,
        "description": "The response states circulating tumor DNA (ctDNA) is not FDA approved for disease monitoring in pancreatic cancer and remains experimental.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes ctDNA is under investigation and not routine standard of care, but does not state it is not FDA approved for pancreatic cancer monitoring or explicitly label it experimental."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that CEA is elevated in 30-60% of pancreatic cancer cases and is particularly useful in Lewis-negative patients who do not secrete CA19-9.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not provide the 30\u201360% elevation rate or mention utility in Lewis-negative, CA 19-9\u2013nonsecretor patients."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that both CEA and CA125 have demonstrated value for diagnosis, prognosis, and monitoring, especially when CA19-9 is not informative. CA125, when combined with CA19-9, improves diagnostic accuracy and is associated with tumor burden and metastatic disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes some oncologists may track CEA with CA 19-9 and that high CEA can indicate aggressive disease, it does not state that CEA and CA125 have demonstrated value across diagnosis/prognosis/monitoring, nor that combining CA125 with CA19-9 improves diagnostic accuracy or that CA125 correlates with tumor burden/metastasis."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that emerging markers such as LAMC2, POSTN are not yet standard in routine clinical practice.",
        "score_given": 0,
        "max_points": 5,
        "justification": "LAMC2 and POSTN are not mentioned at all."
      }
    ],
    "question_number": 96,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:27:39.549409",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that hand-foot syndrome is a common side effect of some chemotherapy drugs used to treat pancreatic cancer, including capecitabine and 5-FU.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly identifies HFS as a common side effect of capecitabine (Xeloda) and 5-FU used in pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with the patient\u2019s oncologist and healthcare team immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Strongly instructs to contact the oncology team immediately and not to wait for the next appointment."
      },
      {
        "criterion_number": 3,
        "description": "The response states that the patient\u2019s oncologist may recommend reducing the chemotherapy dose.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions dose reduction and temporary treatment interruption (chemo holiday)."
      },
      {
        "criterion_number": 4,
        "description": "The response instructs the patient to seek immediate medical evaluation if the patient experiences fever, chills, blisters, or pus draining from the affected area.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises to contact the team immediately for blisters, open sores, signs of infection including pus, and fever. While chills are not mentioned, multiple listed warning signs match the criterion."
      },
      {
        "criterion_number": 5,
        "description": "The response states the patient\u2019s oncology team will grade the severity of the hand-foot syndrome, which will determine the recommended treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention formal grading of HFS severity or that grading guides treatment decisions."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends hand hygiene with a gentle soap.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Advises gentle washing and patting dry but does not specifically recommend gentle soap."
      },
      {
        "criterion_number": 7,
        "description": "The response states pain may be controlled with over-the-counter medications like Tylenol or ibuprofen, though the patient should check with their healthcare team first.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions OTC ibuprofen/naproxen but does not advise checking with the healthcare team first for analgesics."
      },
      {
        "criterion_number": 8,
        "description": "The response states oral or topical prescription pain medications may be needed if pain is severe.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that doctors may prescribe stronger pain medications for severe pain and mentions topical lidocaine."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends utilizing topical moisturizers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends frequent application of thick emollient moisturizers and provides examples (Eucerin, Aquaphor, Bag Balm, etc.)."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends skin protection with loose clothing and soft shoe soles.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Recommends loose-fitting, cushioned shoes and soft socks but does not mention loose clothing; criterion requires both elements."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends cooling the skin with cold compresses.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises ice packs wrapped in a towel, cool water soaks, and avoiding direct ice contact."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends avoiding hot showers and activities that cause rubbing on the skin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically recommends lukewarm brief showers, avoiding hot water, and avoiding friction/pressure activities."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that prevention strategies include celecoxib and urea cream.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention celecoxib or urea cream as prevention; urea is discussed for symptomatic care, not prevention."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that cooling procedures, such as frozen gloves or socks applied during taxane infusions, may prevent or reduce HFS severity and are recommended by the Oncology Nursing Society for taxane-based regimens.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of frozen gloves/socks during taxane infusions or ONS recommendations."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that prevention strategies such as Pyridoxine (vitamin B6) and lactic acid have not shown consistent benefit for prevention or treatment of HFS in randomized trials.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes vitamin B6 evidence is mixed but does not state lack of consistent benefit in RCTs and does not mention lactic acid."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that omeprazole (a proton pump inhibitor) and tipiracil (a thymidine phosphorylase inhibitor) may have prophylactic effects, but these are not yet standard practice.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of omeprazole or tipiracil as potential prophylaxis."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that management of established HFS includes topical urea and corticosteroids.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends high-potency topical steroids (e.g., clobetasol) and urea-based creams."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that Photobiomodulation (low-level laser therapy) has shown promise as an adjunct for pain and symptom control.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of photobiomodulation or low-level laser therapy."
      }
    ],
    "question_number": 97,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:28:30.257084",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that hand-foot syndrome is a common side effect of some chemotherapy drugs used to treat pancreatic cancer, including capecitabine and 5-FU.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly states HFS is a common side effect and cites capecitabine and 5-FU (and liposomal doxorubicin), noting these are used in pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with the patient\u2019s oncologist and healthcare team immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It urges open, frequent communication with the oncology team and provides a list of symptoms requiring immediate contact."
      },
      {
        "criterion_number": 3,
        "description": "The response states that the patient\u2019s oncologist may recommend reducing the chemotherapy dose.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Under dose modification, it states the oncology team may recommend reducing the dose of chemotherapy."
      },
      {
        "criterion_number": 4,
        "description": "The response instructs the patient to seek immediate medical evaluation if the patient experiences fever, chills, blisters, or pus draining from the affected area.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises contacting the oncology team immediately for blistering/peeling/open sores and signs of infection including pus, fever, and chills."
      },
      {
        "criterion_number": 5,
        "description": "The response states the patient\u2019s oncology team will grade the severity of the hand-foot syndrome, which will determine the recommended treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response references severity grades (grade 2 or 3) and links these to treatment decisions (dose hold/reduction), implying grading guides management."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends hand hygiene with a gentle soap.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends using mild, fragrance-free soaps and avoiding harsh soaps/chemicals, aligning with gentle hand hygiene."
      },
      {
        "criterion_number": 7,
        "description": "The response states pain may be controlled with over-the-counter medications like Tylenol or ibuprofen, though the patient should check with their healthcare team first.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions OTC acetaminophen (Tylenol) but does not advise checking with the healthcare team first and does not mention ibuprofen."
      },
      {
        "criterion_number": 8,
        "description": "The response states oral or topical prescription pain medications may be needed if pain is severe.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes doctors might prescribe stronger pain medications (including neuropathic agents) and topical lidocaine for pain control."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends utilizing topical moisturizers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It repeatedly recommends frequent moisturizing with thick emollients and specifies ingredients (e.g., urea, lactic acid, petrolatum)."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends skin protection with loose clothing and soft shoe soles.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It recommends loose-fitting, soft, breathable shoes and cotton socks but does not mention loose clothing specifically."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends cooling the skin with cold compresses.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises cool compresses, ice packs (wrapped), and cool water soaks to reduce symptoms."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends avoiding hot showers and activities that cause rubbing on the skin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises using lukewarm water instead of hot showers and avoiding repetitive activities that cause friction or pressure."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that prevention strategies include celecoxib and urea cream.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Celecoxib is mentioned as a preventative or treatment measure, and urea-containing moisturizers are advised in the proactive/preventative section."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that cooling procedures, such as frozen gloves or socks applied during taxane infusions, may prevent or reduce HFS severity and are recommended by the Oncology Nursing Society for taxane-based regimens.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While general cooling measures are discussed, there is no mention of frozen gloves/socks during taxane infusions or ONS recommendations."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that prevention strategies such as Pyridoxine (vitamin B6) and lactic acid have not shown consistent benefit for prevention or treatment of HFS in randomized trials.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It states vitamin B6 evidence is mixed but does not reference lack of consistent benefit in randomized trials and does not address lactic acid efficacy in this context."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that omeprazole (a proton pump inhibitor) and tipiracil (a thymidine phosphorylase inhibitor) may have prophylactic effects, but these are not yet standard practice.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Omeprazole and tipiracil as prophylactic options are not mentioned."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that management of established HFS includes topical urea and corticosteroids.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends urea creams (10\u201340%) and topical corticosteroids (e.g., clobetasol, betamethasone) for symptom management."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that Photobiomodulation (low-level laser therapy) has shown promise as an adjunct for pain and symptom control.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Photobiomodulation/low-level laser therapy is not mentioned."
      }
    ],
    "question_number": 97,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:29:41.663884",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The decision between a cancer center and community oncology is often based on the type and stage of cancer, the patient\u2019s insurance, location, and preference.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response discusses location/convenience and the complexity of pancreatic cancer, but it does not explicitly state that the decision depends on type and stage, nor does it address insurance or patient preference as decision factors."
      },
      {
        "criterion_number": 2,
        "description": "Cancer centers may have access to more advanced therapies and clinical trials than community oncology programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states cancer centers offer broader treatment options including clinical trials and novel therapies, with fewer trials typically available in community settings."
      },
      {
        "criterion_number": 3,
        "description": "Pancreatic cancer requires multidisciplinary care involving medical oncology, radiation oncology, and surgical oncology, which may be more readily available at a large cancer center.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes multidisciplinary tumor boards and coordinated care (surgery, medical oncology, radiation, pathology, genetics, palliative care, nutrition), highlighting that this is standard at major centers."
      },
      {
        "criterion_number": 4,
        "description": "Cancer centers may be more equipped to handle complex care for advanced disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes high-volume expertise, complex surgical proficiency (e.g., Whipple), advanced technologies, and sophisticated sequencing of therapies, indicating better capacity for complex cases."
      },
      {
        "criterion_number": 5,
        "description": "Community oncology programs may be more convenient and closer to home.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states community practices are close to home and more convenient for frequent appointments, with a smaller and more personal setting."
      },
      {
        "criterion_number": 6,
        "description": "There may be differences in cost between cancer centers and community oncology programs based on the patient\u2019s insurance.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of cost differences or how insurance coverage may affect costs or access; only mentions availability of financial navigators without addressing cost/insurance impact."
      },
      {
        "criterion_number": 7,
        "description": "Cancer centers may offer more support services to patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically lists integrated support services at cancer centers (social work, financial navigation, dietitians, psychologists, support groups)."
      },
      {
        "criterion_number": 8,
        "description": "Most standard cancer care can be delivered at community oncology programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States community oncology delivers standard-of-care treatments and suggests local administration of standard chemotherapy in a hybrid model."
      },
      {
        "criterion_number": 9,
        "description": "Cancer centers include NCI-designated comprehensive cancer centers and academic medical centers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly names \u201cNCI-Designated\u201d and \u201cAcademic Center\u201d in the comparison table."
      },
      {
        "criterion_number": 10,
        "description": "Cancer centers are often located in major cities, which can mean longer travel times, more complex scheduling, and larger, busier environments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that cancer centers are often in major cities, requiring travel, time off work, lodging, and that they can feel large and impersonal."
      },
      {
        "criterion_number": 11,
        "description": "In some cases, initial treatment planning can be done at a cancer center, and follow-up care can be done at a community center closer to home.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes a clear hybrid model with initial consultation and planning at a major center and local administration of standard chemotherapy with co-managed care."
      }
    ],
    "question_number": 98,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:30:11.034429",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The decision between a cancer center and community oncology is often based on the type and stage of cancer, the patient\u2019s insurance, location, and preference.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response addresses location/convenience and patient preference and implies stage via surgical candidacy, but it does not explicitly mention insurance or costs as a deciding factor, nor clearly state that type/stage drive the decision."
      },
      {
        "criterion_number": 2,
        "description": "Cancer centers may have access to more advanced therapies and clinical trials than community oncology programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states access to cutting-edge treatments, advanced diagnostics, and clinical trials at specialized centers, and notes fewer trials at community sites."
      },
      {
        "criterion_number": 3,
        "description": "Pancreatic cancer requires multidisciplinary care involving medical oncology, radiation oncology, and surgical oncology, which may be more readily available at a large cancer center.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Highlights multidisciplinary teams (medical oncologists, HPB surgeons, radiation oncologists, etc.) and tumor boards at cancer centers, and notes the importance of this approach for pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "Cancer centers may be more equipped to handle complex care for advanced disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes high-volume complex surgeries, advanced radiation techniques, interventional procedures, and access to trials at cancer centers, indicating better capacity for complex cases."
      },
      {
        "criterion_number": 5,
        "description": "Community oncology programs may be more convenient and closer to home.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States community clinics are close to home, reduce travel time and stress, and are easier to navigate."
      },
      {
        "criterion_number": 6,
        "description": "There may be differences in cost between cancer centers and community oncology programs based on the patient\u2019s insurance.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention insurance or cost differences tied to insurance coverage; it only discusses travel/lodging logistics."
      },
      {
        "criterion_number": 7,
        "description": "Cancer centers may offer more support services to patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists comprehensive support services at cancer centers (palliative care, dietitians, social work, psycho-oncology, physical therapy, navigators)."
      },
      {
        "criterion_number": 8,
        "description": "Most standard cancer care can be delivered at community oncology programs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Affirms community oncologists provide guideline-based standard-of-care therapies and refer out for complex surgeries."
      },
      {
        "criterion_number": 9,
        "description": "Cancer centers include NCI-designated comprehensive cancer centers and academic medical centers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly identifies specialized centers as NCI-designated comprehensive cancer centers and academic medical centers."
      },
      {
        "criterion_number": 10,
        "description": "Cancer centers are often located in major cities, which can mean longer travel times, more complex scheduling, and larger, busier environments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes significant travel and lodging needs, larger systems that can feel less personal, and longer wait times, capturing the logistical challenges typical of large city-based centers."
      },
      {
        "criterion_number": 11,
        "description": "In some cases, initial treatment planning can be done at a cancer center, and follow-up care can be done at a community center closer to home.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends a shared-care approach: initial evaluation/treatment at a cancer center with subsequent treatments and follow-up locally, coordinated between teams."
      }
    ],
    "question_number": 98,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:30:49.566031",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes a dedicated section 'Involve the Medical Team' and specifies talking to the oncologist, palliative care specialist, nurse navigator, and hospital social worker."
      },
      {
        "criterion_number": 2,
        "description": "States patients undergoing treatment for pancreatic cancer may experience a decrease in libido related to symptoms from treatment or the cancer itself, like fatigue, nausea, pain, malnutrition, anxiety, and depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly discusses 'Low Libido (Desire)' linked to the physical and emotional toll of cancer/treatment, and mentions fatigue, pain, and nausea/digestive issues as contributing factors."
      },
      {
        "criterion_number": 3,
        "description": "Specifically mentions at least one of: decreased desire, arousal disorders, pain, erectile dysfunction, altered body image, or emotional distress.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions decreased desire (low libido), pain, altered body image, and emotional distress."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends open communication.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a full section on 'Open, Honest, and Gentle Communication' with concrete strategies."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends seeking input from a professional trained in intimacy problems.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends counselors and sex therapists who specialize in working with cancer patients."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends cancer support groups.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions 'support group' generically but does not specifically recommend cancer support groups."
      },
      {
        "criterion_number": 7,
        "description": "Explicitly mentions at least one of the following interventions: psychosocial therapy, psychosexual therapy, or couples-based therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly name psychosocial therapy, psychosexual therapy, or couples-based therapy."
      },
      {
        "criterion_number": 8,
        "description": "Explicitly mentions at least one of the following referral options: medical sexologist, psycho-sexologist, social worker, or psychologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions a hospital social worker and sex therapists."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly states that concerns about intimacy during treatment for a loved one with pancreatic cancer are common.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that this worry is 'completely normal for both patients and their partners.'"
      }
    ],
    "question_number": 99,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:31:18.477287",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to 'Talk to the Oncology Team' about safety, side-effect management, and referrals, and also mentions involving the Palliative Care Team."
      },
      {
        "criterion_number": 2,
        "description": "The response states patients undergoing treatment for pancreatic cancer may experience a decrease in libido related to symptoms from treatment or the cancer itself, like fatigue, nausea, pain, malnutrition, anxiety, and depression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes 'Changes in libido' and links it to treatment effects and symptoms including fatigue, pain, nausea/vomiting/diarrhea, weight loss/muscle wasting, and emotional factors like anxiety and depression."
      },
      {
        "criterion_number": 3,
        "description": "The response specifically mentions at least one of the following changes in intimacy: decreased desire, arousal disorders, pain, erectile dysfunction, altered body image, or emotional distress.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions pain, erectile dysfunction, vaginal dryness, body image changes, feeling undesirable, and emotional distress (anxiety/depression)."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends open communication.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a dedicated section 'Open and Honest Communication is Key' with concrete strategies (I-statements, active listening, setting expectations)."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends seeking input from a professional trained in intimacy problems.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends seeing a 'Sex Therapist or Counselor' specializing in sex and intimacy."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends cancer support groups.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions 'support groups' generally but does not specifically recommend cancer support groups."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly mentions at least one of the following interventions: psychosocial therapy, psychosexual therapy, or couples-based therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly name psychosocial therapy, psychosexual therapy, or couples-based therapy."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly mentions at least one of the following referral options: medical sexologist, psycho-sexologist, social worker, or psychologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions referral to a Social Worker and a Psychologist."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly states that concerns about intimacy during treatment for a loved one with pancreatic cancer are common.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States it is an 'incredibly common and understandable concern' in the context of pancreatic cancer."
      }
    ],
    "question_number": 99,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:31:56.988919",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines radiofrequency ablation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines RFA as using a needle-like probe to deliver high-frequency electrical current to heat (60\u2013100\u00b0C) and destroy tumor cells in a targeted area."
      },
      {
        "criterion_number": 2,
        "description": "The response states radiofrequency ablation is minimally invasive and typically does not require surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States the probe is inserted percutaneously under sedation/anesthesia and describes it as minimally invasive with small incisions/needle puncture. Notes that it can sometimes be done during surgery, but overall conveys it typically does not require surgery."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a dedicated section with specific questions to ask the medical team and advises leaning on the father's medical team for case-specific guidance."
      },
      {
        "criterion_number": 4,
        "description": "The response states not all patients with pancreatic cancer benefit from radiofrequency ablation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes RFA is not a cure and is used for specific goals, particularly when surgery is not an option, indicating it is not appropriate/beneficial for all patients."
      },
      {
        "criterion_number": 5,
        "description": "The response considers the potential risks and benefits of radiofrequency ablation for the treatment of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists benefits (minimally invasive, faster recovery, pain control, repeatable, option for non-surgical candidates) and risks (pain, bleeding, infection, pancreatitis, injury to adjacent structures)."
      },
      {
        "criterion_number": 6,
        "description": "The response states radiofrequency ablation is typically used in a multidisciplinary treatment plan along with chemotherapy for the treatment of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes RFA may be used alongside chemotherapy or radiation, particularly for downstaging."
      },
      {
        "criterion_number": 7,
        "description": "The response states radiofrequency ablation is a procedure performed by specially trained Interventional Radiologists.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States the procedure is usually performed by an Interventional Radiologist."
      },
      {
        "criterion_number": 8,
        "description": "The response states this is typically an outpatient procedure.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not state it is typically outpatient; instead, it says an overnight hospital stay is common."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that in pancreatic cancer, RFA is most commonly delivered via endoscopic ultrasound guidance (EUS-RFA), allowing precise targeting of the tumor while minimizing injury to surrounding structures.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions CT or ultrasound guidance for percutaneous placement but does not mention EUS-guided RFA."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that radiofrequency ablation is used in pancreatic cancer primarily for unresectable or inoperable tumors as a palliative or adjunctive therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifies palliation as the most common reason and includes use for localized unresectable tumors and potential downstaging, aligning with adjunctive/palliative use in inoperable cases."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that RFA is not a substitute for surgery or systemic therapy in resectable disease.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explicitly state that RFA is not a substitute for surgery/systemic therapy in resectable disease."
      }
    ],
    "question_number": 100,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:32:35.835280",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines radiofrequency ablation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines RFA as a minimally invasive procedure using high-frequency electrical currents to generate heat to destroy cancer cells, with details on mechanism and tissue effects."
      },
      {
        "criterion_number": 2,
        "description": "The response states radiofrequency ablation is minimally invasive and typically does not require surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly describes RFA as minimally invasive and outlines percutaneous and EUS-guided approaches that avoid open surgery, noting small or no incisions."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises a thorough discussion with the medical team to understand benefits, risks, and treatment plan fit."
      },
      {
        "criterion_number": 4,
        "description": "The response states not all patients with pancreatic cancer benefit from radiofrequency ablation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes candidacy depends on tumor characteristics and health status, and that RFA is generally not curative; thus not all patients benefit."
      },
      {
        "criterion_number": 5,
        "description": "The response considers the potential risks and benefits of radiofrequency ablation for the treatment of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides specific benefits (minimally invasive, faster recovery, repeatable) and detailed risks (damage to adjacent structures, pancreatitis, bleeding, infection, etc.)."
      },
      {
        "criterion_number": 6,
        "description": "The response states radiofrequency ablation is typically used in a multidisciplinary treatment plan along with chemotherapy for the treatment of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States RFA is often used as part of a multimodal approach in combination with chemotherapy and radiation; also emphasizes multidisciplinary decision-making."
      },
      {
        "criterion_number": 7,
        "description": "The response states radiofrequency ablation is a procedure performed by specially trained Interventional Radiologists.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While interventional radiologists are mentioned as part of the team, the response does not explicitly state that RFA is performed by specially trained Interventional Radiologists."
      },
      {
        "criterion_number": 8,
        "description": "The response states this is typically an outpatient procedure.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not state that RFA is typically an outpatient procedure; only notes shorter hospital stays and faster recovery."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that in pancreatic cancer, RFA is most commonly delivered via endoscopic ultrasound guidance (EUS-RFA), allowing precise targeting of the tumor while minimizing injury to surrounding structures.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions EUS-guided RFA and its visualization benefits but does not indicate it is the most common approach nor explicitly state minimizing injury to surrounding structures."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that radiofrequency ablation is used in pancreatic cancer primarily for unresectable or inoperable tumors as a palliative or adjunctive therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States use in unresectable tumors and in patients not fit for surgery, highlights pain relief and multimodal/adjunctive use, aligning with palliative or adjunctive intent."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that RFA is not a substitute for surgery or systemic therapy in resectable disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly notes RFA is generally not curative and contrasts it with surgical removal for early-stage disease, conveying it is not a substitute for surgery/systemic therapy when resectable."
      }
    ],
    "question_number": 100,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:33:27.020686",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises going to appointments, asking questions, consulting the pharmacist, involving palliative care, and specifically requests a medication reconciliation with the oncologist; also includes a consult-your-healthcare-team disclaimer."
      },
      {
        "criterion_number": 2,
        "description": "The response states it is normal for patients with pancreatic cancer to be on multiple medications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states it is very normal and explains polypharmacy in pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response states patients undergoing treatment for pancreatic cancer may need medications for symptom control, including acid reflux, nausea, pain, diarrhea, and enzyme replacement.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists reflux meds (omeprazole/famotidine), antiemetics (ondansetron/prochlorperazine), pain meds (opioids, adjuvants), and enzyme replacement (PERT). Diarrhea is described as a symptom of exocrine insufficiency and addressed via PERT."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends utilizing a pill organizer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicit recommendation to use a weekly pill box with rationale."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends keeping an updated medication list with administration times.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises creating a master medication list including medication name, dose, indication, timing, special instructions, and prescriber."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends reviewing the patient\u2019s medication list with the healthcare team to identify strategies to make handling the medications easier.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically recommends requesting a medication reconciliation with the oncologist to review every medication for necessity and dosing."
      }
    ],
    "question_number": 101,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:33:52.783183",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises open communication with the pharmacist, oncologist, and palliative care team, and recommends asking the medical team questions and conducting medication reviews."
      },
      {
        "criterion_number": 2,
        "description": "The response states it is normal for patients with pancreatic cancer to be on multiple medications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states, 'Yes, it is very normal... to be on many medications,' addressing the question directly."
      },
      {
        "criterion_number": 3,
        "description": "The response states patients undergoing treatment for pancreatic cancer may need medications for symptom control, including acid reflux, nausea, pain, diarrhea, and enzyme replacement.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response lists medications for pain, nausea/vomiting, diarrhea/constipation, and pancreatic enzyme replacement (PERT). It also includes PPIs for stomach protection/acid-related issues, covering acid reflux management."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends utilizing a pill organizer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends 'Pill Boxes' and specifies day-of-the-week organizers with compartments for different times of day."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends keeping an updated medication list with administration times.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises maintaining an up-to-date medication list with drug name, dosage, and frequency, and emphasizes using alarms for specific medication times, meeting the intent of including administration timing."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends reviewing the patient\u2019s medication list with the healthcare team to identify strategies to make handling the medications easier.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends regular medication reviews/reconciliation with the medical team and discusses deprescribing and consolidating medications to reduce burden."
      }
    ],
    "question_number": 101,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:34:16.367842",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing yoga with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states it is absolutely essential to get clearance from the oncology team and includes a step to talk to the oncology team before starting."
      },
      {
        "criterion_number": 2,
        "description": "The response states yoga may improve a cancer patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States yoga can provide significant physical and emotional support and improve coping, focusing on quality of life."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends gentle and slow yoga practice to avoid injury.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends gentle/restorative/chair yoga, avoiding vigorous styles, and emphasizes modifications and listening to the body."
      },
      {
        "criterion_number": 4,
        "description": "The response states patients undergoing treatment for pancreatic cancer may be more prone to injury due to fatigue, malnutrition, dehydration, and pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions fatigue and pain, but does not explicitly mention malnutrition or dehydration as factors increasing injury risk."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Suggests looking for programs at cancer support centers (e.g., Cancer Support Community), which are venues offering support services."
      },
      {
        "criterion_number": 6,
        "description": "The response cites any studies it mentions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Refers generally to research and patient experiences but provides no citations or specific studies."
      },
      {
        "criterion_number": 7,
        "description": "The response states there are yoga classes specifically for cancer patients and provides resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "References oncology-specific yoga (Yoga for Cancer/Oncology Yoga) and resources such as hospital wellness centers and cancer support centers, plus search terms like 'yoga for cancer survivors' and 'oncology yoga.'"
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that yoga is generally safe for people with cancer, including those undergoing treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that gentle yoga can be safe and beneficial during pancreatic cancer treatment with medical clearance."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that yoga may help reduce cancer-related fatigue, anxiety, and depression, and improve emotional well-being during and after treatment, though effects are typically small to moderate and the certainty of evidence is low to moderate.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses potential benefits (fatigue, anxiety, depression) but does not qualify effect size or evidence certainty."
      }
    ],
    "question_number": 102,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:34:37.373614",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing yoga with the patient\u2019s healthcare team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises consulting the medical team first and continuously, naming oncologists/surgeons and specific treatment considerations."
      },
      {
        "criterion_number": 2,
        "description": "The response states yoga may improve a cancer patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists multiple QoL-related benefits (stress/anxiety reduction, sleep, pain, mood, fatigue, flexibility), clearly implying improved quality of life."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends gentle and slow yoga practice to avoid injury.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends gentle, restorative, adaptive yoga; avoiding hot/power yoga; starting with short sessions (5\u201310 minutes) and using props."
      },
      {
        "criterion_number": 4,
        "description": "The response states patients undergoing treatment for pancreatic cancer may be more prone to injury due to fatigue, malnutrition, dehydration, and pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions fatigue and pain and other side effects (nausea, neuropathy), but does not mention malnutrition or dehydration as contributors to injury risk."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not recommend joining cancer support groups; references cancer support centers for instructors but not support groups."
      },
      {
        "criterion_number": 6,
        "description": "The response cites any studies it mentions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No studies are mentioned or cited."
      },
      {
        "criterion_number": 7,
        "description": "The response states there are yoga classes specifically for cancer patients and provides resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises finding an instructor with oncology yoga training and provides resources (IAYT, local cancer support centers), indicating cancer-specific classes/resources."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that yoga is generally safe for people with cancer, including those undergoing treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States yoga can be safe and beneficial for individuals with pancreatic cancer when approached with caution and proper guidance."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that yoga may help reduce cancer-related fatigue, anxiety, and depression, and improve emotional well-being during and after treatment, though effects are typically small to moderate and the certainty of evidence is low to moderate.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists benefits (reduced fatigue, anxiety, depression, improved emotional well-being) but does not address effect sizes or certainty of evidence."
      }
    ],
    "question_number": 102,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:35:06.203445",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly advises talking to the medical team, keeping a list of questions, and consulting specialists (dietitian, palliative care). While it doesn\u2019t use the word 'oncologist' explicitly, it clearly recommends discussion with the cancer care team about side effects."
      },
      {
        "criterion_number": 2,
        "description": "The response states many side effects from cancer treatment improve and disappear once treatment stops.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes some issues (e.g., 'chemo brain') may improve over months/years but does not state that many side effects improve or disappear once treatment stops; it even emphasizes that chemotherapy effects can persist long after treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response states some side effects like peripheral neuropathy may become permanent.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states neuropathy may be permanent for some patients."
      },
      {
        "criterion_number": 4,
        "description": "The response states some side effects from treatment may take time to improve or disappear, as long as many months.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that 'chemo brain' may improve over months or years."
      },
      {
        "criterion_number": 5,
        "description": "The response states many side effects from treatment can be controlled with medications, for example pancreatic enzyme supplementation for pancreatic insufficiency or vitamins for malabsorption after surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses PERT (Creon, Zenpep, Pancreaze) for PEI, vitamin supplementation, medications for neuropathy (gabapentin, duloxetine), and medications for GI protection."
      },
      {
        "criterion_number": 6,
        "description": "The response reviews potential side effects of surgery for pancreatic cancer (e.g., Whipple procedure).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Comprehensive coverage of Whipple-related effects: PEI, new/worsened diabetes, dumping syndrome, and nutritional deficiencies."
      },
      {
        "criterion_number": 7,
        "description": "The response reviews potential side effects of chemotherapy for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It reviews neuropathy, cognitive changes ('chemo brain'), and chronic fatigue with management approaches."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions the potential for long-term heart or kidney damage and fertility issues.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention cardiotoxicity, nephrotoxicity, or fertility concerns."
      },
      {
        "criterion_number": 9,
        "description": "The response states the treating team will work within the patient\u2019s goals of care to maximize treatment efficacy while limiting side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it encourages involving palliative care and discussing with the team, it does not explicitly state alignment with the patient\u2019s goals of care to balance efficacy and side effects."
      },
      {
        "criterion_number": 10,
        "description": "The response reviews potential side effects of radiation therapy for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes long-term radiation effects including chronic digestive issues, ulcers, strictures, and potential blockages."
      },
      {
        "criterion_number": 11,
        "description": "The response states some cancer treatments can increase the likelihood of developing second cancers in the future.",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no mention of secondary malignancy risk."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends open communication with the patient\u2019s healthcare team about symptoms and symptom control to limit the long-term effects of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises talking to the medical team with specific questions and keeping a detailed symptom journal, supporting ongoing symptom communication and control."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly state that long-term side effects are common in patients treated for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it states PEI is common after Whipple, it does not explicitly state that long-term side effects in general are common among pancreatic cancer patients."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention the cumulative impact of surgery, chemotherapy, radiation, and the underlying disease as sources of long-term side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It describes side effects by modality and notes cancer itself can cause fatigue, but it does not explicitly mention the cumulative or additive impact of surgery, chemotherapy, radiation, and the disease together."
      }
    ],
    "question_number": 103,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:35:56.288495",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises discussing concerns with the medical team including the oncologist and reiterates open communication with the healthcare team."
      },
      {
        "criterion_number": 2,
        "description": "The response states many side effects from cancer treatment improve and disappear once treatment stops.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that many side effects improve or disappear after treatment; focuses on persistence and long-term management."
      },
      {
        "criterion_number": 3,
        "description": "The response states some side effects like peripheral neuropathy may become permanent.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically notes peripheral neuropathy can be persistent or even permanent with certain agents."
      },
      {
        "criterion_number": 4,
        "description": "The response states some side effects from treatment may take time to improve or disappear, as long as many months.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions radiation-related fatigue can persist for months and chemo brain can linger for months or years."
      },
      {
        "criterion_number": 5,
        "description": "The response states many side effects from treatment can be controlled with medications, for example pancreatic enzyme supplementation for pancreatic insufficiency or vitamins for malabsorption after surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details PERT for EPI, vitamin supplementation for deficiencies, and notes availability of medications for symptom control."
      },
      {
        "criterion_number": 6,
        "description": "The response reviews potential side effects of surgery for pancreatic cancer (e.g., Whipple procedure).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a comprehensive list including EPI, diabetes, dumping syndrome, bowel changes, chronic pain, hernia, deficiencies, and adhesions."
      },
      {
        "criterion_number": 7,
        "description": "The response reviews potential side effects of chemotherapy for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers neuropathy, cognitive effects, fatigue, organ damage, secondary cancers, and hearing changes."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions the potential for long-term heart or kidney damage and fertility issues.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions heart and kidney damage but does not address fertility issues."
      },
      {
        "criterion_number": 9,
        "description": "The response states the treating team will work within the patient\u2019s goals of care to maximize treatment efficacy while limiting side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages multidisciplinary and palliative care involvement but does not explicitly reference aligning treatment with goals of care to balance efficacy and toxicity."
      },
      {
        "criterion_number": 10,
        "description": "The response reviews potential side effects of radiation therapy for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists bowel damage, skin changes, prolonged fatigue, potential liver/kidney/stomach injury, and GI strictures/ulcers."
      },
      {
        "criterion_number": 11,
        "description": "The response states some cancer treatments can increase the likelihood of developing second cancers in the future.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly mentions secondary cancers as a rare but potential long-term risk of chemotherapy."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends open communication with the patient\u2019s healthcare team about symptoms and symptom control to limit the long-term effects of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Urges being very vocal about any new symptoms and discusses symptom management strategies with the team."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly state that long-term side effects are common in patients treated for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States fatigue is one of the most common and persistent side effects and that nutritional issues are very common, indicating long-term effects are common."
      },
      {
        "criterion_number": 14,
        "description": "The response must mention the cumulative impact of surgery, chemotherapy, radiation, and the underlying disease as sources of long-term side effects.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses each modality\u2019s effects but does not explicitly mention cumulative impact or the underlying disease as a source."
      }
    ],
    "question_number": 103,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:36:36.031138",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response offers recommendations for organizations and includes key initiatives of the organizations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response recommends multiple pancreatic cancer\u2013focused nonprofits (PanCAN, Lustgarten Foundation, NPCF) and major research institutions (Johns Hopkins/Sol Goldman Center, MD Anderson Moon Shot, Dana-Farber, Mayo Clinic). It describes each group's focus and initiatives (research grants, patient services, 100% to research model, financial assistance, early detection work, translational programs), demonstrating clear, accurate detail."
      },
      {
        "criterion_number": 2,
        "description": "The response includes Charity Navigator ratings for the mentioned organizations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response mentions Charity Navigator and states that some organizations receive high ratings, it does not provide specific Charity Navigator ratings (e.g., star ratings or scores) for the organizations named."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly state that nonprofit organizations are vital for supporting innovative research in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response highlights nonprofit roles and research funding but does not explicitly state that nonprofit organizations are vital for supporting innovative pancreatic cancer research."
      },
      {
        "criterion_number": 4,
        "description": "The response must mention that donations to nonprofit organizations can support research, clinical trials, and patient support initiatives.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response clearly mentions donations supporting research and patient support (e.g., services and financial assistance). It references clinical trial searches as a service but does not explicitly state that donations support clinical trials themselves, which the criterion requires."
      }
    ],
    "question_number": 104,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:37:10.492473",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response offers recommendations for organizations and includes key initiatives of the organizations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response recommends multiple organizations (Lustgarten Foundation, PanCAN, academic medical centers, AACR, ACS) and clearly outlines their focuses and initiatives (e.g., funding research, early detection, clinical trials support, patient services, advocacy, ability to designate donations)."
      },
      {
        "criterion_number": 2,
        "description": "The response includes Charity Navigator ratings for the mentioned organizations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response suggests checking Charity Navigator, it does not provide actual Charity Navigator ratings or scores for any of the listed organizations."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly state that nonprofit organizations are vital for supporting innovative research in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response highlights nonprofits and references innovative research but does not explicitly state that nonprofit organizations are vital to supporting innovative pancreatic cancer research."
      },
      {
        "criterion_number": 4,
        "description": "The response must mention that donations to nonprofit organizations can support research, clinical trials, and patient support initiatives.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although the response describes organizations that conduct research, support clinical trials, and offer patient services, it does not explicitly link donations to supporting all three areas; it explicitly ties donations to research (e.g., Lustgarten, designated gifts) but does not directly state that donations can support clinical trials and patient support initiatives."
      }
    ],
    "question_number": 104,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:37:36.945982",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends contacting the patient\u2019s oncologist immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly instructs to contact the oncology team immediately and not to wait for the next appointment."
      },
      {
        "criterion_number": 2,
        "description": "The response instructs the patient to seek immediate medical evaluation if the vision changes are abrupt in onset, severe, or accompanied by other symptoms including dizziness, pain, confusion, fever, or other neurologic symptoms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While urgency to contact the oncologist is emphasized, the response does not provide specific emergency red flags (abrupt onset, severe symptoms, dizziness, confusion, fever, neurologic symptoms) or advise urgent/emergency evaluation for these."
      },
      {
        "criterion_number": 3,
        "description": "The response states vision changes related to treatment are not typical, though can be related to dry eyes or peripheral neuropathy from chemotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response characterizes treatment-related vision changes as possible and a common concern, but does not state they are not typical, nor does it link vision issues to peripheral neuropathy."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that chemotherapy can cause vision changes (ocular toxicity). For example, gemcitabine and 5-fluorouracil have been associated with retinal findings including cotton-wool spots and other visual disturbances.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response clearly states chemotherapy can cause eye/vision side effects and names pancreatic regimens (including gemcitabine and FOLFIRINOX), listing multiple ocular symptoms. Although it does not detail retinal findings like cotton-wool spots, it satisfies the core requirement."
      },
      {
        "criterion_number": 5,
        "description": "The response states the oncologist may recommend dose reducing treatment or changing to a different treatment if the vision changes are felt to be treatment-related.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of dose reduction or switching therapies in response to treatment-related ocular toxicity."
      },
      {
        "criterion_number": 6,
        "description": "The response states vision changes may be related to metastasis to the brain.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes that pancreatic cancer can metastasize to the brain, which could cause vision changes."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that ocular metastases may cause vision changes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states the cancer can spread to the eye, which could cause vision changes."
      },
      {
        "criterion_number": 8,
        "description": "The response states vision changes may be related to paraneoplastic processes and explains what this is.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Paraneoplastic processes are not mentioned or explained."
      },
      {
        "criterion_number": 10,
        "description": "The response states the patient\u2019s oncologist may prescribe medications to improve the vision changes, including eye drops, steroids, or antibiotics.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No suggestion that the oncologist may prescribe eye drops, steroids, or antibiotics for vision changes."
      },
      {
        "criterion_number": 11,
        "description": "The response states the patient\u2019s vision changes may be due to infection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Infectious causes are not discussed."
      },
      {
        "criterion_number": 12,
        "description": "The response states the patient\u2019s vision changes may be due to age-related vision changes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Age-related conditions (macular degeneration, cataracts) are mentioned as possible contributors."
      }
    ],
    "question_number": 105,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:38:12.347801",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends contacting the patient\u2019s oncologist immediately.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states to report the vision changes to the oncology team or a doctor immediately and reiterates not to delay seeking medical attention."
      },
      {
        "criterion_number": 2,
        "description": "The response instructs the patient to seek immediate medical evaluation if the vision changes are abrupt in onset, severe, or accompanied by other symptoms including dizziness, pain, confusion, fever, or other neurologic symptoms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it advises immediate contact in general, it does not specifically instruct immediate evaluation for abrupt/severe changes or when associated with dizziness, pain, confusion, fever, or other neurologic symptoms."
      },
      {
        "criterion_number": 3,
        "description": "The response states vision changes related to treatment are not typical, though can be related to dry eyes or peripheral neuropathy from chemotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It lists multiple treatment-related ocular toxicities and dry eyes but does not state that treatment-related vision changes are not typical, nor does it link peripheral neuropathy to vision changes."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that chemotherapy can cause vision changes (ocular toxicity). For example, gemcitabine and 5-fluorouracil have been associated with retinal findings including cotton-wool spots and other visual disturbances.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly states chemotherapy can cause ocular side effects (blurred vision, retinopathy, optic neuropathy) and gives specific examples including gemcitabine and 5-FU, meeting the criterion for chemo-related ocular toxicity."
      },
      {
        "criterion_number": 5,
        "description": "The response states the oncologist may recommend dose reducing treatment or changing to a different treatment if the vision changes are felt to be treatment-related.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions that clinicians might adjust medications but does not explicitly state dose reduction or switching to a different anticancer treatment."
      },
      {
        "criterion_number": 6,
        "description": "The response states vision changes may be related to metastasis to the brain.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes a section on brain metastases causing various vision changes, fulfilling this criterion."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that ocular metastases may cause vision changes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Ocular/choroidal metastases are not mentioned; only brain metastases are discussed."
      },
      {
        "criterion_number": 8,
        "description": "The response states vision changes may be related to paraneoplastic processes and explains what this is.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Paraneoplastic syndromes are described as immune-mediated attacks on healthy tissues including eyes, with examples like paraneoplastic retinopathy and optic neuropathy."
      },
      {
        "criterion_number": 10,
        "description": "The response states the patient\u2019s oncologist may prescribe medications to improve the vision changes, including eye drops, steroids, or antibiotics.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states the team might prescribe eye drops. Although steroids/antibiotics are not explicitly listed as treatments, the inclusion of eye drops satisfies the criterion."
      },
      {
        "criterion_number": 11,
        "description": "The response states the patient\u2019s vision changes may be due to infection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Infectious causes are not explicitly mentioned; conjunctivitis is listed but not specified as infectious, and infection as a general cause is not stated."
      },
      {
        "criterion_number": 12,
        "description": "The response states the patient\u2019s vision changes may be due to age-related vision changes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Age-related causes such as presbyopia, age-related macular degeneration, or age-related cataracts are not discussed."
      }
    ],
    "question_number": 105,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:39:34.979973",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that telehealth appointments are generally as effective as in-person visits for many aspects of care for patients with pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly says telehealth can be very effective for certain aspects and concludes 'not less effective, but differently effective,' endorsing a hybrid approach."
      },
      {
        "criterion_number": 2,
        "description": "The response reviews the potential benefits of telehealth appointments, including reduced travel burden, lower costs, decreased infection risk, and improved access to expertise.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It covers reduced burden, decreased infection risk, and access to specialists, but does not mention lower costs."
      },
      {
        "criterion_number": 3,
        "description": "The response reviews the potential downsides of telehealth appointments, including potential differences in insurance reimbursement and challenges with physical examination.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Challenges with physical examination are discussed in detail, but there is no mention of insurance reimbursement differences."
      },
      {
        "criterion_number": 4,
        "description": "The response states it can be challenging for a doctor to fully evaluate a patient via telehealth.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states a physical exam provides crucial information a video call cannot capture, indicating limitations in full evaluation via telehealth."
      },
      {
        "criterion_number": 5,
        "description": "The response states telehealth can be a convenient alternative to in-office visits and may be helpful if the patient has mobility or transportation issues.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes convenience and eliminating travel burden, which directly addresses mobility/transport challenges."
      },
      {
        "criterion_number": 6,
        "description": "The response states in-office visits may be more appropriate in certain situations, including for initial visits or when there are big changes to the patient\u2019s health or treatment plan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends in-person visits for initial consultations and major changes like starting surgery or new chemotherapy."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing telehealth options with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides a dedicated section with specific questions to ask the oncology team about telehealth use."
      },
      {
        "criterion_number": 8,
        "description": "The response states not all oncologists offer telehealth appointments.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not state that some oncologists may not offer telehealth."
      },
      {
        "criterion_number": 9,
        "description": "The response offers tips for making the most out of a telehealth appointment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it includes questions to ask the care team, it does not provide practical telehealth visit tips (e.g., testing technology, preparing medication lists, ensuring good lighting)."
      },
      {
        "criterion_number": 10,
        "description": "The response states medical emergencies are not appropriate for telehealth evaluations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly advises that urgent or new, serious symptoms require immediate in-person evaluation."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that telehealth may be less suitable for sensitive discussions, such as new diagnosis or end-of-life care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states initial consultations and complex discussions are better in person due to nuance, aligning with the idea that sensitive conversations are less suitable for telehealth."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that limitations of telehealth include technology barriers and occasional concerns about reduced personal connection or quality of interaction.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It alludes to technology barriers by asking about platform support for technical difficulties and notes the value of in-person nuance, implying concerns about reduced connection/interaction quality via telehealth."
      }
    ],
    "question_number": 106,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:40:25.300017",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states that telehealth appointments are generally as effective as in-person visits for many aspects of care for patients with pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states telehealth can be highly effective for many aspects of care but not a complete substitute, satisfying the criterion."
      },
      {
        "criterion_number": 2,
        "description": "The response reviews the potential benefits of telehealth appointments, including reduced travel burden, lower costs, decreased infection risk, and improved access to expertise.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Covers reduced travel burden, decreased infection risk, and improved access to specialists but does not mention lower costs."
      },
      {
        "criterion_number": 3,
        "description": "The response reviews the potential downsides of telehealth appointments, including potential differences in insurance reimbursement and challenges with physical examination.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Addresses challenges with physical examination in detail but does not mention insurance reimbursement differences."
      },
      {
        "criterion_number": 4,
        "description": "The response states it can be challenging for a doctor to fully evaluate a patient via telehealth.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly notes limitations of telehealth for thorough evaluation, emphasizing inability to perform hands-on assessments."
      },
      {
        "criterion_number": 5,
        "description": "The response states telehealth can be a convenient alternative to in-office visits and may be helpful if the patient has mobility or transportation issues.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights convenience, reduced travel burden, and suitability when travel is exhausting, addressing mobility/transportation challenges."
      },
      {
        "criterion_number": 6,
        "description": "The response states in-office visits may be more appropriate in certain situations, including for initial visits or when there are big changes to the patient\u2019s health or treatment plan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifies in-person necessity for initial diagnosis/staging and for new or worsening symptoms, meeting the criterion."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing telehealth options with the patient\u2019s oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises discussing with the oncologist and care team which visits are suitable for telehealth."
      },
      {
        "criterion_number": 8,
        "description": "The response states not all oncologists offer telehealth appointments.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention variability in availability of telehealth among oncologists."
      },
      {
        "criterion_number": 9,
        "description": "The response offers tips for making the most out of a telehealth appointment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a dedicated tips section including preparation, technology readiness, and having another caregiver present."
      },
      {
        "criterion_number": 10,
        "description": "The response states medical emergencies are not appropriate for telehealth evaluations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises that severe or rapidly worsening symptoms require in-person evaluation to rule out urgent complications, effectively conveying that emergencies are not appropriate for telehealth."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that telehealth may be less suitable for sensitive discussions, such as new diagnosis or end-of-life care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state telehealth is less suitable for sensitive discussions; in fact, it suggests palliative discussions can be done effectively via telehealth."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that limitations of telehealth include technology barriers and occasional concerns about reduced personal connection or quality of interaction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it advises ensuring technology readiness, it does not explicitly identify technology barriers or reduced personal connection as limitations."
      }
    ],
    "question_number": 106,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:41:06.526600",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises asking the oncology team which regimen is planned and to discuss scalp cooling with them."
      },
      {
        "criterion_number": 2,
        "description": "The response states some chemotherapy treatments for pancreatic cancer can cause hair loss, for example, FOLFIRINOX or gemcitabine.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It names FOLFIRINOX, gemcitabine (alone and in combinations), and discusses their hair loss potential."
      },
      {
        "criterion_number": 3,
        "description": "The response provides reported estimates of hair loss with FOLFIRINOX and gemcitabine and cites its sources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Only qualitative terms (e.g., high, low to moderate) are provided; no numerical estimates or references are cited."
      },
      {
        "criterion_number": 4,
        "description": "The response states hair typically grows back once the causative treatment is stopped.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states hair almost always grows back and begins a few weeks to a month after the final chemotherapy treatment."
      },
      {
        "criterion_number": 5,
        "description": "The response states cold caps are sometimes used to reduce hair loss but they can be expensive.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes scalp cooling, notes variable effectiveness, discomfort, added time, and potential expense/insurance issues."
      },
      {
        "criterion_number": 6,
        "description": "The response states hair loss from chemotherapy is a common and distressing side effect in patients undergoing treatment for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it emphasizes the distressing nature and notes hair loss is common with certain regimens (e.g., paclitaxel), it does not generally state that hair loss is a common side effect for pancreatic cancer chemotherapy overall."
      },
      {
        "criterion_number": 7,
        "description": "The response states other chemotherapy regimens or immunotherapy or targeted therapy cause hair loss at lower rates or not at all.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It contrasts lower hair loss likelihood with gemcitabine alone or gemcitabine-capecitabine versus higher-risk regimens."
      },
      {
        "criterion_number": 8,
        "description": "The response states many cancer patients wear hats or wigs to help with appearances and self-esteem.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends wigs, scarves, hats/turbans and discusses fittings and resources, framed as empowering and supportive."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends cancer support groups.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly suggests finding a support group and connecting with a hospital social worker or therapist."
      },
      {
        "criterion_number": 10,
        "description": "The response reports expected timelines for hair loss after starting chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states hair loss typically begins 2\u20134 weeks after the first chemotherapy session and describes the course."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that the severity and risk of hair loss is higher with multi-agent and taxane-containing protocols, and female patients are at increased risk.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes taxane-containing regimens have high risk and multi-agent regimens like FOLFIRINOX cause more loss, but it does not mention increased risk in female patients."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that most cases of hair loss are reversible, with regrowth expected within 3-6 months after cessation of chemotherapy, but persistent or permanent alopecia can occur, especially after repeated or high-dose regimens.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions regrowth starting weeks after treatment ends but does not provide the 3\u20136 month timeframe or the possibility of persistent/permanent alopecia."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions that eyebrow and eyelash loss may also be seen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states that eyebrows and eyelashes may be lost and offers coping strategies."
      },
      {
        "criterion_number": 14,
        "description": "The response mentions that topical minoxidil may aid regrowth post-chemotherapy, though evidence for prevention is limited.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Minoxidil is not mentioned."
      }
    ],
    "question_number": 107,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:42:12.877379",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises asking the oncologist about the regimen and includes a 'Talk to the Oncology Team' section."
      },
      {
        "criterion_number": 2,
        "description": "The response states some chemotherapy treatments for pancreatic cancer can cause hair loss, for example, FOLFIRINOX or gemcitabine.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Names gemcitabine, nab-paclitaxel (Abraxane) + gemcitabine, and FOLFIRINOX, and discusses their hair loss potential."
      },
      {
        "criterion_number": 3,
        "description": "The response provides reported estimates of hair loss with FOLFIRINOX and gemcitabine and cites its sources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No numeric estimates or citations were provided."
      },
      {
        "criterion_number": 4,
        "description": "The response states hair typically grows back once the causative treatment is stopped.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States hair loss is almost always temporary and that hair grows back weeks to months after chemotherapy ends."
      },
      {
        "criterion_number": 5,
        "description": "The response states cold caps are sometimes used to reduce hair loss but they can be expensive.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes scalp cooling/cold caps and notes they can be expensive if not covered."
      },
      {
        "criterion_number": 6,
        "description": "The response states hair loss from chemotherapy is a common and distressing side effect in patients undergoing treatment for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States hair loss concern is common and impacts self-esteem and emotional well-being in the context of pancreatic cancer chemotherapy."
      },
      {
        "criterion_number": 7,
        "description": "The response states other chemotherapy regimens or immunotherapy or targeted therapy cause hair loss at lower rates or not at all.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes gemcitabine alone typically causes mild thinning if any, indicating lower rates with certain regimens."
      },
      {
        "criterion_number": 8,
        "description": "The response states many cancer patients wear hats or wigs to help with appearances and self-esteem.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends wigs, scarves, hats, turbans, and beanies as appearance aids."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends cancer support groups.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages talking with a support group as part of emotional support."
      },
      {
        "criterion_number": 10,
        "description": "The response reports expected timelines for hair loss after starting chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States hair loss usually starts 2 to 4 weeks after the first chemotherapy treatment."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that the severity and risk of hair loss is higher with multi-agent and taxane-containing protocols, and female patients are at increased risk.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes higher risk with taxane-containing and multi-agent regimens but does not mention increased risk in female patients."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions that most cases of hair loss are reversible, with regrowth expected within 3-6 months after cessation of chemotherapy, but persistent or permanent alopecia can occur, especially after repeated or high-dose regimens.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States regrowth occurs weeks to months after chemotherapy but does not specify 3\u20136 months or mention potential for persistent/permanent alopecia."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions that eyebrow and eyelash loss may also be seen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions loss of eyebrows and eyelashes."
      },
      {
        "criterion_number": 14,
        "description": "The response mentions that topical minoxidil may aid regrowth post-chemotherapy, though evidence for prevention is limited.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of topical minoxidil."
      }
    ],
    "question_number": 107,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:43:37.198649",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Defines oligometastatic disease in pancreatic cancer as a state where the cancer has spread to a limited number of sites, typically involving a single organ (e.g., liver or lung) and a small number of lesions, commonly defined as \u22643 to \u22645 metastases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains that oligometastatic means a limited number of metastases, explicitly citing 1\u20135 lesions and giving organ examples (liver, lungs). Although it mentions one or two organs, it conveys the typical limited-site concept with correct lesion count."
      },
      {
        "criterion_number": 2,
        "description": "Recommends discussing this with the patient\u2019s healthcare team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a dedicated section with specific questions to ask the oncologist and encourages ongoing discussions with the medical team."
      },
      {
        "criterion_number": 3,
        "description": "Discusses the potential impact oligometastatic disease may have on treatment options, including the possibility of aggressive multimodal therapy such as systemic chemotherapy followed by local treatments like surgery, ablation, or stereotactic radiotherapy, if there is a good response to initial therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes a strategy of systemic chemotherapy first, then local ablative options (surgery, SBRT, ablation) if disease is controlled, matching the rubric."
      },
      {
        "criterion_number": 4,
        "description": "Contrasts oligometastatic disease to localized disease and widespread metastatic disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly frames oligometastatic disease as an in-between state\u2014more advanced than localized to the pancreas but not widely disseminated."
      },
      {
        "criterion_number": 5,
        "description": "Mentions that patients with oligometastatic disease have the potential for an improved prognosis compared to widespread metastatic disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes potential for extended survival with aggressive treatment, it does not explicitly state improved prognosis compared to widespread metastatic disease."
      }
    ],
    "question_number": 108,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:44:09.255947",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Defines oligometastatic disease in pancreatic cancer as a state where the cancer has spread to a limited number of sites, typically involving a single organ and a small number of lesions (\u22643 to \u22645).",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly explains that oligometastatic means a limited number of metastases, explicitly citing 'typically 1\u20135 distinct spots' and provides examples (liver or lung). While it does not explicitly say 'single organ,' the examples imply this typical pattern. The definition aligns with common thresholds (\u22643\u20135 lesions)."
      },
      {
        "criterion_number": 2,
        "description": "Recommends discussing this with the patient\u2019s healthcare team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly encourages discussion with the oncologist and care team and even provides specific questions to ask."
      },
      {
        "criterion_number": 3,
        "description": "Discusses the potential impact on treatment options, including aggressive multimodal therapy such as systemic chemotherapy followed by local treatments like surgery, ablation, or stereotactic radiotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes the shift to aggressive, local treatments alongside systemic therapy and lists surgery, SBRT, and ablation, noting combination with chemotherapy and multidisciplinary evaluation. This satisfies the criterion for multimodal approaches."
      },
      {
        "criterion_number": 4,
        "description": "Contrasts oligometastatic disease to localized disease and widespread metastatic disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response provides a clear 'spectrum' comparison among localized, oligometastatic, and widespread metastatic disease."
      },
      {
        "criterion_number": 5,
        "description": "Mentions that patients with oligometastatic disease have the potential for an improved prognosis compared to widespread metastatic disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states potential for 'better outcomes,' including longer survival compared to widespread metastatic disease, improved quality of life, and rare cases of long-term remission."
      }
    ],
    "question_number": 108,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:44:29.741753",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states it is common for patients to have low blood counts due to chemotherapy used in the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states, 'Yes, it is extremely common for pancreatic cancer treatments to be delayed due to low blood counts,' and ties this to chemotherapy side effects."
      },
      {
        "criterion_number": 2,
        "description": "The response states treatment delays due to low blood counts are enacted to ensure the patient\u2019s safety.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Affirms delays are a 'crucial safety protocol' to allow marrow recovery and avoid infection, severe anemia, and bleeding."
      },
      {
        "criterion_number": 3,
        "description": "The response states the oncologist may recommend dose reducing the chemotherapy or changing to a different treatment if the blood counts remain low.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States the oncologist may 'reduce the dose of the chemotherapy or change the treatment schedule.' Dose reduction is explicitly mentioned, satisfying the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response gives examples of chemotherapy known to cause low blood counts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific pancreatic cancer chemotherapy regimens or drugs (e.g., FOLFIRINOX, gemcitabine, nab-paclitaxel) are named."
      },
      {
        "criterion_number": 5,
        "description": "The response lists the different types of low blood counts that may impact treatment, including anemia, neutropenia, thrombocytopenia, and low total white blood cell count, and explains why these cells are important in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Explains anemia, neutropenia, and thrombocytopenia in lay terms, but does not explicitly include 'low total white blood cell count' as a separate item, which the criterion requires."
      },
      {
        "criterion_number": 6,
        "description": "The response states the oncologist may prescribe an injection medication (e.g., G-CSF) to help increase the neutrophil count.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions G-CSF injections (Neupogen/Neulasta) to stimulate white blood cell production."
      },
      {
        "criterion_number": 7,
        "description": "The response states if the red blood cell or platelet counts get too low, the oncologist may order a transfusion of red blood cells or platelets to keep these at safe levels.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that blood or platelet transfusions may be given for severe anemia or thrombocytopenia."
      },
      {
        "criterion_number": 8,
        "description": "The response instructs the patient to seek immediate medical evaluation if they have low blood counts and experience fever, chest pain, shortness of breath, leg swelling, blood in the urine, blood in the stool, or other uncontrollable bleeding.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Notes that 'A fever during neutropenia is a medical emergency' but does not instruct immediate evaluation for chest pain, shortness of breath, leg swelling, blood in urine/stool, or uncontrollable bleeding."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends ensuring good nutrition to ensure the bone marrow can produce the required blood cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends a well-balanced diet rich in protein and calories and consulting an oncology dietitian."
      },
      {
        "criterion_number": 10,
        "description": "The response must strongly recommend consulting with an oncologist or care team, providing specific questions or topics to discuss.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages communication with the medical team and provides specific questions about counts, targets, supportive medications, and warning signs."
      }
    ],
    "question_number": 109,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:45:13.751579",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response states it is common for patients to have low blood counts due to chemotherapy used in the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response opens by stating this is a very common issue, especially when chemotherapy is involved, and explains chemotherapy-induced myelosuppression."
      },
      {
        "criterion_number": 2,
        "description": "The response states treatment delays due to low blood counts are enacted to ensure the patient\u2019s safety.",
        "score_given": 10,
        "max_points": 10,
        "justification": "A dedicated section ('Why Treatment Delays Are Necessary') explicitly states delays are for patient safety, citing infection and bleeding risks."
      },
      {
        "criterion_number": 3,
        "description": "The response states the oncologist may recommend dose reducing the chemotherapy or changing to a different treatment if the blood counts remain low.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions 'Dose Adjustments' and 'Treatment Regimen Changes' if current therapy leads to persistent low counts."
      },
      {
        "criterion_number": 4,
        "description": "The response gives examples of chemotherapy known to cause low blood counts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it discusses chemotherapy generally, it provides no specific examples (e.g., FOLFIRINOX, gemcitabine, nab-paclitaxel) known to cause cytopenias."
      },
      {
        "criterion_number": 5,
        "description": "The response lists the different types of low blood counts that may impact treatment, including anemia, neutropenia, thrombocytopenia, and low total white blood cell count, and explains why these cells are important in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly lists neutropenia, anemia, and thrombocytopenia with lay explanations of risks (infection, fatigue, bleeding). It also references 'white blood cell counts are too low' and explains infection danger, covering low total WBC concept."
      },
      {
        "criterion_number": 6,
        "description": "The response states the oncologist may prescribe an injection medication (e.g., G-CSF) to help increase the neutrophil count.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends growth factors such as G-CSF (Neupogen, Neulasta) to stimulate white blood cell (neutrophil) production."
      },
      {
        "criterion_number": 7,
        "description": "The response states if the red blood cell or platelet counts get too low, the oncologist may order a transfusion of red blood cells or platelets to keep these at safe levels.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states blood transfusions can be used for severe anemia and platelet transfusions for thrombocytopenia."
      },
      {
        "criterion_number": 8,
        "description": "The response instructs the patient to seek immediate medical evaluation if they have low blood counts and experience fever, chest pain, shortness of breath, leg swelling, blood in the urine, blood in the stool, or other uncontrollable bleeding.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It advises reporting fever, chills, unusual bleeding, or severe fatigue to the care team but does not explicitly instruct immediate evaluation nor list chest pain, shortness of breath, leg swelling, hematuria, or blood in stool."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends ensuring good nutrition to ensure the bone marrow can produce the required blood cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends 'Nutritional Support' including adequate nutrition and pancreatic enzyme replacement to aid recovery and blood cell production."
      },
      {
        "criterion_number": 10,
        "description": "The response must strongly recommend consulting with an oncologist or care team, providing specific questions or topics to discuss.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It urges communication with the medical team and suggests specific topics: current counts, risks, plans to resume treatment, and strategies to support count recovery at home."
      }
    ],
    "question_number": 109,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:46:02.453559",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises discussing with the father's oncology team in the disclaimer and again at the end."
      },
      {
        "criterion_number": 2,
        "description": "The response explains hyperthermia treatment for cancer in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear, accessible explanation of what hyperthermia is, how it works, session experience, and side effects."
      },
      {
        "criterion_number": 3,
        "description": "The response specifies that hyperthermia treatment involves heating tumor tissue to a temperature range of 39-43\u00b0C to enhance the cytotoxic effects of chemotherapy and/or radiotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions 40\u201344\u00b0C (not 39\u201343\u00b0C) and sensitization to chemo/radiation; the required temperature range is not stated as specified."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions all three delivery methods: regional (including \u2018deep regional\u2019), intraoperative, and whole-body hyperthermia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes local, regional, and whole-body hyperthermia but does not mention intraoperative hyperthermia or specify 'deep regional.'"
      },
      {
        "criterion_number": 5,
        "description": "The response reviews potential benefits and risks of hyperthermia treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Covers benefits (improved response, survival, QoL, enhanced oxygenation/immune effects) and risks (skin irritation, blisters, discomfort)."
      },
      {
        "criterion_number": 6,
        "description": "The response states hyperthermia is not an effective alternative to standard of care treatment for pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Positions hyperthermia as adjunctive and investigational but does not explicitly state it is not an effective alternative to standard care."
      },
      {
        "criterion_number": 7,
        "description": "The response states hyperthermia is not a standard first-line therapy for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states it is not a standard, first-line therapy."
      },
      {
        "criterion_number": 8,
        "description": "The response states there is not robust evidence for the use of hyperthermia treatment in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes that larger randomized controlled trials are still needed and it is not standard of care, indicating evidence is not robust."
      },
      {
        "criterion_number": 9,
        "description": "The response must mention that hyperthermia is used in pancreatic cancer as an adjunct to standard chemoradiotherapy for patients with locally advanced, unresectable, or metastatic disease, especially when conventional therapies have limited efficacy or are refractory.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it describes adjunctive use, it does not specifically mention locally advanced/unresectable/metastatic or refractory settings, nor explicitly 'chemoradiotherapy.'"
      },
      {
        "criterion_number": 10,
        "description": "The response must state that adding hyperthermia to chemoradiotherapy may improve overall response rates and median survival compared to standard therapy alone, with acceptable safety profiles.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions possible improvements when added to chemotherapy and/or radiation with tolerable side effects, but does not specifically address addition to chemoradiotherapy versus standard therapy alone."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly state that the quality of evidence for hyperthermia is limited, it remains investigational, and there are ongoing trials evaluating its efficacy and optimal integration into multimodal treatment regimens.",
        "score_given": 0,
        "max_points": 10,
        "justification": "States it is investigational and more RCTs are needed, but does not explicitly say evidence quality is limited and does not mention ongoing trials evaluating efficacy and integration."
      }
    ],
    "question_number": 110,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:47:25.374895",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises having a detailed discussion with his doctors and provides specific questions to ask the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response explains hyperthermia treatment for cancer in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly defines hyperthermia, explains goals, mechanisms, and types in accessible language without excessive jargon."
      },
      {
        "criterion_number": 3,
        "description": "The response specifies that hyperthermia treatment involves heating tumor tissue to a temperature range of 39-43\u00b0C to enhance the cytotoxic effects of chemotherapy and/or radiotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions enhancing chemo/radiation and gives a temperature range, it states 40\u201344\u00b0C rather than 39\u201343\u00b0C as specified in the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions all three delivery methods: regional (including \u2018deep regional\u2019), intraoperative, and whole-body hyperthermia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions local, regional (including deep tissue heating), and whole-body hyperthermia, and references HIPEC, but does not explicitly identify intraoperative hyperthermia as a distinct delivery method."
      },
      {
        "criterion_number": 5,
        "description": "The response reviews potential benefits and risks of hyperthermia treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It lists potential benefits (enhanced efficacy, tumor shrinkage, symptom relief) and a range of risks/side effects (pain, burns, fatigue, GI symptoms, swelling, blood clots, tissue damage)."
      },
      {
        "criterion_number": 6,
        "description": "The response states hyperthermia is not an effective alternative to standard of care treatment for pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it emphasizes hyperthermia as adjunctive and not first-line, it does not explicitly state that it is not an effective alternative to standard of care."
      },
      {
        "criterion_number": 7,
        "description": "The response states hyperthermia is not a standard first-line therapy for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states hyperthermia is not typically part of first-line, standard-of-care recommendations."
      },
      {
        "criterion_number": 8,
        "description": "The response states there is not robust evidence for the use of hyperthermia treatment in pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It notes the role is evolving and many uses are in clinical trials, but does not explicitly state that evidence is not robust."
      },
      {
        "criterion_number": 9,
        "description": "The response must mention that hyperthermia is used in pancreatic cancer as an adjunct to standard chemoradiotherapy for patients with locally advanced, unresectable, or metastatic disease, especially when conventional therapies have limited efficacy or are refractory.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions adjunct use with chemotherapy or radiation but does not specify chemoradiotherapy nor the particular disease settings (locally advanced, unresectable, metastatic, refractory)."
      },
      {
        "criterion_number": 10,
        "description": "The response must state that adding hyperthermia to chemoradiotherapy may improve overall response rates and median survival compared to standard therapy alone, with acceptable safety profiles.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It suggests potential enhanced efficacy and tumor shrinkage but does not state improved response rates and median survival or address acceptable safety profiles in this context."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly state that the quality of evidence for hyperthermia is limited, it remains investigational, and there are ongoing trials evaluating its efficacy and optimal integration into multimodal treatment regimens.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although clinical trials are mentioned, it does not explicitly state that the quality of evidence is limited, that it remains investigational, or that ongoing trials are evaluating optimal integration into multimodal regimens."
      }
    ],
    "question_number": 110,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:48:39.953882",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly identifies the medical oncologist as a key professional to interpret results, integrate them into the treatment plan, discuss prognosis, and coordinate care; also advises asking the oncologist for a referral."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Strongly emphasizes a genetic counselor as the primary resource, detailing their role in explaining results, implications for treatment, and hereditary risk."
      },
      {
        "criterion_number": 4,
        "description": "The response explains genetic testing and why it is done in cancer treatment, using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains that genetic results can inform treatment options, eligibility for targeted therapies/clinical trials, and family risk in accessible language."
      },
      {
        "criterion_number": 5,
        "description": "The response includes in its explanation that certain genetic mutations like BRCA2 may be targets for targeted cancer therapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions BRCA1/BRCA2 and links DNA repair gene mutations to PARP inhibitors (e.g., olaparib, rucaparib) as targeted therapies."
      },
      {
        "criterion_number": 6,
        "description": "The response states that certain genetic mutations are associated with inherited cancer predisposition syndromes which may affect the patient\u2019s relatives.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses \u2018hereditary/germline\u2019 mutations, discusses implications for relatives, and suggests family members consider testing."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that board-certified genetic counselors, medical geneticists, and oncologists can help determine the clinical significance of identified variants, discuss implications for surveillance, prevention, and treatment, and provide guidance for at-risk family members.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions genetic counselors, medical geneticists, and oncologists and covers treatment and family guidance, it does not explicitly mention surveillance or prevention, nor does it reference board certification."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions that pathogenic variants in genes such as BRCA1, BRCA2, PALB2, ATM, CDKN2A, and others may influence both therapeutic decisions and recommendations for family screening.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Names BRCA1, BRCA2, PALB2, and ATM and links mutations to targeted therapies and family testing recommendations, satisfying the requirement to connect genes with both treatment and family screening."
      }
    ],
    "question_number": 111,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:49:36.449196",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises scheduling an appointment with the mother's oncologist to review genetic results and notes the oncologist's role in translating findings into treatment decisions."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Genetic counselors are highlighted as the primary professionals for interpreting results, with details on their role and how to find one."
      },
      {
        "criterion_number": 4,
        "description": "The response explains genetic testing and why it is done in cancer treatment, using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains germline vs somatic mutations, pathogenic vs VUS, and how results affect treatment and family risk in accessible, non-technical language."
      },
      {
        "criterion_number": 5,
        "description": "The response includes in its explanation that certain genetic mutations like BRCA2 may be targets for targeted cancer therapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states BRCA1/2 mutations can make patients eligible for targeted therapies such as PARP inhibitors."
      },
      {
        "criterion_number": 6,
        "description": "The response states that certain genetic mutations are associated with inherited cancer predisposition syndromes which may affect the patient\u2019s relatives.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that germline (inherited) mutations can be passed to children and discusses implications for relatives, including testing and screening."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that board-certified genetic counselors, medical geneticists, and oncologists can help determine the clinical significance of identified variants, discuss implications for surveillance, prevention, and treatment, and provide guidance for at-risk family members.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions genetic counselors (including a certification directory) and oncologists and describes their roles in interpreting variants and guiding family screening, it does not mention medical geneticists specifically, which is required."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions that pathogenic variants in genes such as BRCA1, BRCA2, PALB2, ATM, CDKN2A, and others may influence both therapeutic decisions and recommendations for family screening.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists BRCA1, BRCA2, PALB2, ATM, CDKN2A (and others) and links these findings to treatment implications and family testing/screening."
      }
    ],
    "question_number": 111,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:50:02.697794",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist or a nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises talking to a registered dietitian and consulting the doctor/nurse; the disclaimer also mentions consulting the oncologist, nurse, and dietitian."
      },
      {
        "criterion_number": 2,
        "description": "The response states changes in taste are a common side effect of some chemotherapies used in the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States taste changes are very common and specifically notes dysgeusia is very common, especially with chemotherapy."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends trying different foods and drinks to identify flavor profiles that are appealing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages flexibility and experimenting with what works; provides multiple strategies to adjust flavors and suggests alternate proteins, seasonings, marinades, and temperature changes."
      },
      {
        "criterion_number": 4,
        "description": "The response states cold intolerance is a common side effect of oxaliplatin, so patients should avoid cold foods and drinks.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not mention oxaliplatin or avoidance of cold foods/drinks; in fact suggests cold or room-temperature foods may be more palatable."
      },
      {
        "criterion_number": 5,
        "description": "The response states changes in taste typically improve or disappear entirely when the causative medication is stopped.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statement about taste changes improving after discontinuation of the causative medication."
      },
      {
        "criterion_number": 6,
        "description": "The response emphasizes the importance of maintaining proper nutrition and hydration while undergoing treatment for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes that maintaining nutrition is vital during treatment and provides hydration tips and strategies to optimize intake."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends nutritional supplements to ensure the patient is achieving their needs.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions smoothies with protein powder and notes that dietitians can recommend nutritional supplements."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that improved oral hygiene and active swallowing exercises may also promote taste recovery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Covers oral hygiene thoroughly but does not mention active swallowing exercises."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that a referral to a registered dietitian is recommended for tailored nutritional strategies, as taste changes often lead to reduced appetite, altered food preferences, and risk of malnutrition.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends seeing a registered dietitian for personalized advice; acknowledges reduced intake and difficulty maintaining nutrition, implying malnutrition risk."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that dietitians can assist with food texture modification, flavor enhancement, and strategies to maintain adequate caloric and protein intake.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not specify dietitians\u2019 roles in texture modification or explicit strategies for caloric/protein targets, only general personalized advice and supplements."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that pharmacological and supplement-based interventions have been explored with mixed results. Further research is needed to establish standardized, effective interventions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of pharmacologic or supplement-based interventions\u2019 evidence or the need for further research."
      }
    ],
    "question_number": 112,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:51:10.761784",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist or a nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises informing the oncology team and requesting a referral to a registered dietitian specializing in oncology."
      },
      {
        "criterion_number": 2,
        "description": "The response states changes in taste are a common side effect of some chemotherapies used in the treatment of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that taste changes are common and associated with pancreatic cancer treatments, including chemotherapy."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends trying different foods and drinks to identify flavor profiles that are appealing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages experimentation with flavors, temperatures, and alternative proteins, and suggests keeping a food diary."
      },
      {
        "criterion_number": 4,
        "description": "The response states cold intolerance is a common side effect of oxaliplatin, so patients should avoid cold foods and drinks.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of oxaliplatin or cold intolerance; does not advise avoiding cold foods/drinks due to oxaliplatin."
      },
      {
        "criterion_number": 5,
        "description": "The response states changes in taste typically improve or disappear entirely when the causative medication is stopped.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address resolution of dysgeusia after stopping the causative medication."
      },
      {
        "criterion_number": 6,
        "description": "The response emphasizes the importance of maintaining proper nutrition and hydration while undergoing treatment for pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Strong emphasis on nutrient-dense intake, calories/protein, and strategic hydration throughout."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends nutritional supplements to ensure the patient is achieving their needs.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Suggests smoothies/protein shakes with protein powder and mentions supplements (e.g., zinc) when appropriate."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that improved oral hygiene and active swallowing exercises may also promote taste recovery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions good oral hygiene and rinses but does not mention active swallowing exercises."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that a referral to a registered dietitian is recommended for tailored nutritional strategies, as taste changes often lead to reduced appetite, altered food preferences, and risk of malnutrition.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends referral to an oncology RD for personalized advice and nutritional support, acknowledging appetite/nutrition challenges."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that dietitians can assist with food texture modification, flavor enhancement, and strategies to maintain adequate caloric and protein intake.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not explicitly state that dietitians assist with texture modification or flavor enhancement, even though similar strategies are discussed generally."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that pharmacological and supplement-based interventions have been explored with mixed results. Further research is needed to establish standardized, effective interventions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions possible supplements like zinc but does not discuss mixed evidence or the need for further research."
      }
    ],
    "question_number": 112,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:52:21.999135",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the exercise plan with the patient\u2019s oncologist or healthcare provider.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states he must get clearance from his oncologist/surgeon and suggests referral to a physical therapist or certified cancer exercise specialist."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends gentle and slow exercise to avoid injury.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States the goal is consistency, not intensity, and to think 'low and slow,' emphasizing gentle approaches."
      },
      {
        "criterion_number": 3,
        "description": "The response states patients undergoing treatment for pancreatic cancer may be more prone to injury due to fatigue, malnutrition, dehydration, and pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions fatigue and hydration in general terms and side effects, but does not explicitly link increased injury risk to fatigue, malnutrition, dehydration, and pain."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends cancer support groups.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of cancer support groups."
      },
      {
        "criterion_number": 5,
        "description": "The response states gentle exercise participation may improve a cancer patient\u2019s quality of life and offers published research studies as evidence.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes exercise can improve quality of life but provides no published research studies as evidence."
      },
      {
        "criterion_number": 6,
        "description": "The response cites any studies it mentions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No studies or citations are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response states there are exercise classes specifically for cancer patients and provides resources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Suggests looking for classes designed for cancer patients (e.g., yoga) but does not provide any resources."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly mentions that ASCO recommends both aerobic and resistance exercise as safe and beneficial for patients with pancreatic cancer during chemotherapy, chemoradiotherapy, or neoadjuvant therapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention ASCO or the specific recommendation for pancreatic cancer during active treatments."
      },
      {
        "criterion_number": 9,
        "description": "The response clearly states that physical activity should be tailored to individual capacity and comorbidities, using terms like \u201cindividual capacity,\u201d \u201cpersonalized,\u201d or \u201ctailored.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses individualized guidance from clinicians based on health factors but does not use the required terms such as 'individual capacity,' 'personalized,' or 'tailored.'"
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly states that aerobic exercise (e.g., walking, cycling, swimming) and resistance training (e.g., weights, resistance bands) improve cardiorespiratory fitness, physical function, and reduce symptoms like fatigue and mood disturbances.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifies aerobic exercise strengthens the heart and lungs and improves stamina (cardiorespiratory fitness), strength training preserves muscle and function (physical function), and notes benefits for fatigue and mood."
      }
    ],
    "question_number": 113,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:53:17.282962",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing the exercise plan with the patient\u2019s oncologist or healthcare provider.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly instructs to obtain medical clearance from the oncologist, surgeon, and an oncology physical therapist before starting any exercise."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends gentle and slow exercise to avoid injury.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes low-impact, moderate intensity, starting with short sessions (5\u201310 minutes), and to start slow and progress gradually."
      },
      {
        "criterion_number": 3,
        "description": "The response states patients undergoing treatment for pancreatic cancer may be more prone to injury due to fatigue, malnutrition, dehydration, and pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions fatigue, pain, hydration, and nutrition concerns, but does not explicitly state increased injury risk due to fatigue, malnutrition, dehydration, and pain together."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends cancer support groups.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of cancer support groups."
      },
      {
        "criterion_number": 5,
        "description": "The response states gentle exercise participation may improve a cancer patient\u2019s quality of life and offers published research studies as evidence.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States quality-of-life benefits but does not offer or reference any published research studies."
      },
      {
        "criterion_number": 6,
        "description": "The response cites any studies it mentions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions that some studies suggest better chemotherapy tolerance but provides no citations."
      },
      {
        "criterion_number": 7,
        "description": "The response states there are exercise classes specifically for cancer patients and provides resources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention cancer-specific exercise classes or provide resources."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly mention that The American Society of Clinical Oncology recommends both aerobic and resistance exercise as safe and beneficial for patients with pancreatic cancer during chemotherapy, chemoradiotherapy, or neoadjuvant therapy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit mention of ASCO or its recommendations."
      },
      {
        "criterion_number": 9,
        "description": "The response must clearly state that physical activity should be tailored to individual capacity and comorbidities, using terms like \u201cindividual capacity,\u201d \u201cpersonalized,\u201d or \u201ctailored.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "Uses terms such as \"personalized\" and \"highly individualized\" and recommends oncology PT to tailor plans to specific conditions."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that aerobic exercise (e.g., walking, cycling, swimming) and resistance training (e.g., weights, resistance bands) improve cardiorespiratory fitness, physical function, and reduce symptoms like fatigue and mood disturbances.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists modalities and benefits (e.g., maintaining cardiovascular fitness, reducing fatigue, improving mood) but does not explicitly state that aerobic and resistance training improve cardiorespiratory fitness and physical function; largely framed as maintaining rather than improving."
      }
    ],
    "question_number": 113,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:54:10.983279",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises engagement with the oncology team and emphasizes open communication with the doctor, palliative care team, or hospice nurse."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends reporting any new symptoms to the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States, \"Keep them informed of any new or worsening symptoms,\" clearly meeting the requirement."
      },
      {
        "criterion_number": 3,
        "description": "The response states it is important to separate side effects of treatment from progression of disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes some mood/cognitive changes can be due to medication side effects, it does not explicitly state the importance of distinguishing treatment side effects from disease progression in general."
      },
      {
        "criterion_number": 4,
        "description": "The response gives examples of new or worsening pain, jaundice, unintentional weight loss, and appetite changes as symptoms that may signify progression of disease.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Includes increased abdominal/back pain, worsening jaundice (with associated features), significant unintentional weight loss/cachexia, and appetite/early satiety changes."
      },
      {
        "criterion_number": 5,
        "description": "The response states metastases to other sites in the body can have various symptoms and provides examples.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes ascites and peripheral edema can occur when the cancer has spread to the peritoneum or liver, providing a concrete example of metastatic manifestations."
      },
      {
        "criterion_number": 6,
        "description": "The response instructs the patient to seek immediate medical evaluation if they experience severe pain, jaundice, severe constipation, confusion, or neurologic changes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Instructs to seek urgent help for uncontrolled pain and sudden/severe confusion (neurologic), but does not include jaundice or severe constipation as indications for immediate evaluation."
      },
      {
        "criterion_number": 7,
        "description": "The response must mention at least 10 of the following signs and symptoms indicating disease progression in pancreatic cancer: jaundice, dark urine, pale stools, pruritus, abdominal pain, back pain, weight loss, anorexia, fatigue, nausea/vomiting, constipation, diarrhea, new or worsening diabetes, bloating, belching, cachexia, or blood clots.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions >10: jaundice, dark urine, pale stools, pruritus, abdominal pain, back pain, weight loss, poor appetite/early satiety (anorexia), fatigue, nausea/vomiting, constipation, diarrhea, cachexia, and blood clots."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention gastrointestinal bleeding or rapidly declining performance status as alarm symptoms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention GI bleeding or rapidly declining performance status as specific alarm symptoms warranting urgent evaluation."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state the importance of close monitoring of symptoms for timely intervention and supportive care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages \"watching for changes\" to know when to seek help and recommends keeping a symptom log to aid the medical team, reflecting close monitoring for timely intervention."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly mention early integration of supportive care to optimize quality of life and address complications.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advocates for palliative care regardless of treatment stage to manage symptoms and improve quality of life, fulfilling early supportive care integration."
      }
    ],
    "question_number": 114,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:55:20.027447",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly advises to discuss symptoms with the healthcare team (e.g., \"always discuss any new or worsening symptoms with their healthcare team immediately\" and encourages questions to the medical team)."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends reporting any new symptoms to the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states: \"Do not wait to report any new or worsening symptoms to your loved one's oncologist, palliative care team, or primary care doctor.\""
      },
      {
        "criterion_number": 3,
        "description": "The response states it is important to separate side effects of treatment from progression of disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that signs may also be side effects of treatment or unrelated conditions and emphasizes discussing with the team to interpret changes."
      },
      {
        "criterion_number": 4,
        "description": "The response gives examples of new or worsening pain, jaundice, unintentional weight loss, and appetite changes as symptoms that may signify progression of disease.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Includes worsening/new pain, increased jaundice, significant weight loss, and decreased appetite/early satiety with details."
      },
      {
        "criterion_number": 5,
        "description": "The response states metastases to other sites in the body can have various symptoms and provides examples.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists liver, lung, and bone metastasis with corresponding symptoms (RUQ pain, jaundice/ascites, cough/SOB, chest pain, bone pain, fractures)."
      },
      {
        "criterion_number": 6,
        "description": "The response instructs the patient to seek immediate medical evaluation if they experience severe pain, jaundice, severe constipation, confusion, or neurologic changes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It labels PE symptoms as medical emergencies and advises immediate reporting of new/worsening symptoms in general, but does not explicitly instruct immediate medical evaluation for severe pain, jaundice, severe constipation, confusion, or neurologic changes."
      },
      {
        "criterion_number": 7,
        "description": "The response must mention at least 10 of the following signs and symptoms indicating disease progression in pancreatic cancer: jaundice, dark urine, pale stools, pruritus, abdominal pain, back pain, weight loss, anorexia, fatigue, nausea/vomiting, constipation, diarrhea, new or worsening diabetes, bloating, belching, cachexia, or blood clots.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions multiple items: jaundice, dark urine, pale stools, pruritus, abdominal pain, back pain, weight loss, decreased appetite (anorexia), fatigue, nausea/vomiting, constipation, diarrhea, bloating, cachexia, and blood clots (DVT/PE) \u2014 exceeding 10."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention gastrointestinal bleeding or rapidly declining performance status as alarm symptoms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions \"Decline in Functional Status\" but not as an alarm symptom and does not mention gastrointestinal bleeding or rapid decline requiring urgent attention."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state the importance of close monitoring of symptoms for timely intervention and supportive care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes keeping a symptom log and communicating immediately to the medical team, linking monitoring to ensuring the best possible care and support."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly mention early integration of supportive care to optimize quality of life and address complications.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly endorses palliative care \"from diagnosis onward\" to manage symptoms and improve comfort/quality of life."
      }
    ],
    "question_number": 114,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:56:43.115716",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define neoadjuvant therapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides a clear definition: treatment (like chemotherapy or radiation) given before the main treatment to improve outcomes."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that neoadjuvant treatment is given before the main treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states neoadjuvant therapy is given before the main treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that neoadjuvant therapy usually occurs before surgery.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that the main treatment is usually surgery and that neoadjuvant therapy is given before surgery."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that neoadjuvant therapy is usually chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes chemotherapy is the most common component of neoadjuvant therapy, naming typical regimens."
      },
      {
        "criterion_number": 5,
        "description": "The response should include that radiation therapy can sometimes be used for neoadjuvant therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions radiation therapy and chemoradiation as part of neoadjuvant approaches in some cases."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that oncologists often evaluate the response of a person\u2019s cancer after neoadjuvant therapy to determine the next steps.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes re-staging after therapy and using results to decide about surgery."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that the main goals of neoadjuvant therapy are to treat micrometastases early, improve chances of margin-negative (R0) resection, downstage advanced tumors, and ensure patients receive systemic therapy, as many can\u2019t complete adjuvant treatment after surgery.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Covers all goals: early systemic treatment of micrometastases, improving clean margins, converting borderline/unresectable to resectable, and ensuring patients receive systemic therapy pre-op due to postoperative intolerance."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that patient selection, multidisciplinary coordination, and management of therapy-related toxicities are critical, as attrition during neoadjuvant therapy can preclude surgery.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While it suggests asking about side effects and references the care team, it does not explicitly emphasize patient selection, multidisciplinary coordination, or that toxicity-related attrition during neoadjuvant therapy can preclude surgery."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly advises discussing decisions and questions with the oncology team."
      }
    ],
    "question_number": 115,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:57:06.651585",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define neoadjuvant therapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly defines neoadjuvant therapy as therapy given before the main treatment."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that neoadjuvant treatment is given before the main treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states neoadjuvant therapy is given before the main treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that neoadjuvant therapy usually occurs before surgery.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that in pancreatic cancer the main treatment is usually surgery and that neoadjuvant treatments are given before surgery."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that neoadjuvant therapy is usually chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that neoadjuvant therapy typically involves chemotherapy and lists common regimens."
      },
      {
        "criterion_number": 5,
        "description": "The response should include that radiation therapy can sometimes be used for neoadjuvant therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that radiation may be added and mentions chemoradiation."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that oncologists often evaluate the response of a person\u2019s cancer after neoadjuvant therapy to determine the next steps.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes post-therapy rescanning and multidisciplinary re-evaluation to decide on surgery, as well as assessing tumor response."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that the main goals of neoadjuvant therapy are to treat micrometastases early, improve chances of margin-negative (R0) resection, downstage advanced tumors, and ensure patients receive systemic therapy, as many can\u2019t complete adjuvant treatment after surgery.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Covers micrometastases, downstaging/shrinking tumor, and improving margins, but does not mention ensuring delivery of systemic therapy because many patients cannot complete adjuvant therapy after surgery."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that patient selection, multidisciplinary coordination, and management of therapy-related toxicities are critical, as attrition during neoadjuvant therapy can preclude surgery.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Mentions multidisciplinary team involvement but does not address patient selection, toxicity management, or the risk of attrition precluding surgery."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises having detailed discussions with the father's medical team; oncologists are explicitly referenced earlier as part of the team."
      }
    ],
    "question_number": 115,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:57:38.222979",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that music therapy can help with symptoms associated with pancreatic cancer.",
        "score_given": 8,
        "max_points": 8,
        "justification": "The response states multiple symptom benefits during cancer treatment (pain, nausea, fatigue, sleep), clearly indicating music therapy can help with symptoms relevant to pancreatic cancer care."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that music therapy can help with anxiety.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly mentions 'Reduces Anxiety and Stress' and describes physiological effects and timing (before/during/after procedures)."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that music therapy can improve quality of life.",
        "score_given": 4,
        "max_points": 4,
        "justification": "States directly that music therapy is a complementary therapy used to improve quality of life."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that music therapy can help with depression.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Includes a section 'Improves Mood and Combats Depression.'"
      },
      {
        "criterion_number": 5,
        "description": "The response should state that music therapy can help with pain.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Has a 'Pain Management' bullet explaining distraction and gate control theory."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that music therapy can help with fatigue.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Contains a 'Reduces Fatigue' bullet describing potential energy boost and restorative rest."
      },
      {
        "criterion_number": 7,
        "description": "The response states that music therapy is anti-cancer therapy.",
        "score_given": 0,
        "max_points": 0,
        "justification": "The response explicitly states music therapy is not a cure and is a complementary therapy; it does not claim anti-cancer effects."
      },
      {
        "criterion_number": 8,
        "description": "The response should cite peer-reviewed publications with links.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No peer-reviewed citations or links are provided."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that the American Society of Clinical Oncology and the Society for Integrative Oncology recommend music therapy as a safe, non-invasive adjunct for managing anxiety and depression in adults with cancer, including those undergoing active treatment.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not mention ASCO or SIO recommendations."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that emerging evidence suggests music therapy may also modulate immune responses and support overall treatment outcomes, but further research is needed to clarify its biological effects and optimal use in pancreatic cancer.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No discussion of immune modulation, biological effects, or emerging evidence in this area."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises to talk to the medical team and specifically mentions the oncologist."
      }
    ],
    "question_number": 116,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:58:00.515346",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that music therapy can help with symptoms associated with pancreatic cancer.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Clearly states multiple symptom-related benefits during treatment (pain, anxiety, nausea, fatigue, sleep, perioperative support), indicating music therapy can help with treatment-associated symptoms."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that music therapy can help with anxiety.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Includes a dedicated section 'Anxiety and Stress Reduction' describing how music therapy reduces anxiety and supports coping."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that music therapy can improve quality of life.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Contains a section titled 'Improved Quality of Life' with examples such as empowerment, meaning-making, and better sleep."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that music therapy can help with depression.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly mentions 'Mood Improvement and Depression Mitigation' and describes mechanisms for emotional support."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that music therapy can help with pain.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Has a section 'Pain Management and Discomfort Reduction' detailing mechanisms like distraction and relaxation."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that music therapy can help with fatigue.",
        "score_given": 4,
        "max_points": 4,
        "justification": "States that music therapy can indirectly help manage treatment-related fatigue through relaxation and anxiety reduction."
      },
      {
        "criterion_number": 7,
        "description": "The response states that music therapy is anti-cancer therapy.",
        "score_given": 0,
        "max_points": 0,
        "justification": "Does not claim music therapy treats or cures cancer; frames it as an evidence-based complementary therapy for symptom management."
      },
      {
        "criterion_number": 8,
        "description": "The response should cite peer-reviewed publications with links.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No peer-reviewed citations or links are provided."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that the American Society of Clinical Oncology and the Society for Integrative Oncology recommend music therapy as a safe, non-invasive adjunct for managing anxiety and depression in adults with cancer, including those undergoing active treatment.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No mention of ASCO or SIO recommendations."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that emerging evidence suggests music therapy may also modulate immune responses and support overall treatment outcomes, but further research is needed to clarify its biological effects and optimal use in pancreatic cancer.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not discuss immune modulation, treatment outcomes, or the need for further research in this area."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes collaboration with the medical team, it does not explicitly advise the user to discuss music therapy with the oncologist."
      }
    ],
    "question_number": 116,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T18:58:27.695380",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must state that pancreatic cancer is not contagious.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states, 'The cancer itself is not contagious to your pets. They cannot \"catch\" cancer from your loved one.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should state that chemotherapy can weaken the immune system and make someone at increased risk of infection.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not mention immunosuppression or increased infection risk from chemotherapy."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that pets can carry infections that could be harmful to immunocompromised persons.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No discussion of zoonoses or infection risks from pets to immunocompromised patients."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend the patient discuss precautions related to chemotherapy excretion with a pharmacist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Advises discussing with the oncology team (oncologist/nurse) but does not mention a pharmacist."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that some chemotherapy drugs are excreted in urine.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States chemotherapy drugs are eliminated through urine."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that some chemotherapy drugs are excreted in stool.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States chemotherapy drugs are eliminated through feces."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that some chemotherapy drugs are excreted in saliva.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States chemotherapy drugs are eliminated through saliva."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that some chemotherapy drugs are excreted in vomit.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions cleaning vomit but does not state that chemotherapy drugs are excreted in vomit."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that pets should avoid contact with excreted medications.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Advises preventing pets from investigating urine/feces spots and discouraging licking of the patient's skin/mouth/sores, aligning with avoiding excreted chemo."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that pets should avoid contact with chemotherapy medications.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Emphasizes secure storage of medications and warns that a dropped pill can be a serious emergency for pets."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that pets should avoid contact with all medications.",
        "score_given": 1,
        "max_points": 1,
        "justification": "States to keep all medications securely stored and out of reach of pets."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that pets provide significant emotional and psychological benefits to cancer patients.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Provides a detailed section on emotional benefits, including stress reduction and sense of normalcy."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that to reduce exposure to chemotherapy and radiation residues, patients should take precautions to limit the impacts on their pets.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises precautions for 48\u201372 hours post-chemo and details radiation considerations (external vs internal) with limiting close contact per guidance."
      },
      {
        "criterion_number": 14,
        "description": "After chemotherapy, surfaces\u2014especially in bathrooms\u2014can remain contaminated for at least 48 hours, so thorough cleaning is advised.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions the 48\u201372 hour window and cleaning accidents but does not address bathroom surfaces or general surface decontamination."
      },
      {
        "criterion_number": 15,
        "description": "Hand hygiene is essential after contact with patient waste or contaminated areas.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Specifically advises wearing gloves and washing hands thoroughly after tasks like litter box cleaning and cleanup of accidents."
      },
      {
        "criterion_number": 16,
        "description": "Immunocompromised patients should practice good hand hygiene after handling pets.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not instruct washing hands after handling pets specifically or frame it for immunocompromised patients."
      },
      {
        "criterion_number": 17,
        "description": "Immunocompromised patients should avoid contact with pet waste.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Recommends having another family member handle litter box duty for a few days post-treatment, effectively advising avoidance of pet waste."
      },
      {
        "criterion_number": 18,
        "description": "Immunocompromised patients should prevent pets from licking open wounds.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Explicitly advises discouraging pets from licking skin, mouth, or any open sores, especially after treatment."
      },
      {
        "criterion_number": 19,
        "description": "There is no strong evidence that pet ownership increases cancer risk or that pets need to be removed from the home during treatment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not explicitly state that pets do not need to be removed or that ownership does not increase cancer risk, despite encouraging safe interaction."
      },
      {
        "criterion_number": 20,
        "description": "If patients are severely immunosuppressed, they should avoid contact with young animals, reptiles, or exotic pets, and seek assistance with pet care.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No mention of specific high-risk animal types or precautions for severe immunosuppression."
      },
      {
        "criterion_number": 21,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Advises talking to the oncology team, specifically including the oncologist, for recommendations."
      }
    ],
    "question_number": 117,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T18:59:37.291395",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must state that pancreatic cancer is not contagious.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not address the contagion status of pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that chemotherapy can weaken the immune system and make someone at increased risk of infection.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It explicitly states that chemotherapy and some cancer treatments can weaken the immune system and increase susceptibility to infections."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that pets can carry infections that could be harmful to immunocompromised persons.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It notes infection risks from scratches/bites and emphasizes parasite prevention in the context of an immunocompromised patient, indicating pets can pose infection risks."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend the patient discuss precautions related to chemotherapy excretion with a pharmacist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation to consult a pharmacist about chemotherapy excretion precautions is provided."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that some chemotherapy drugs are excreted in urine.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of chemotherapy drug excretion via urine."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that some chemotherapy drugs are excreted in stool.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of chemotherapy drug excretion via stool."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that some chemotherapy drugs are excreted in saliva.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of chemotherapy drug excretion via saliva."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that some chemotherapy drugs are excreted in vomit.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of chemotherapy drug excretion via vomit."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that pets should avoid contact with excreted medications.",
        "score_given": 0,
        "max_points": 4,
        "justification": "It does not address pets avoiding contact with chemotherapy-contaminated excreta."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that pets should avoid contact with chemotherapy medications.",
        "score_given": 0,
        "max_points": 8,
        "justification": "It advises keeping human medications out of reach but does not specifically address chemotherapy medications."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that pets should avoid contact with all medications.",
        "score_given": 1,
        "max_points": 1,
        "justification": "It clearly states human medications should be kept out of reach of pets."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that pets provide significant emotional and psychological benefits to cancer patients.",
        "score_given": 8,
        "max_points": 8,
        "justification": "The response emphasizes pets\u2019 comfort, stress reduction, and emotional support benefits multiple times."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that to reduce exposure to chemotherapy and radiation residues, patients should take precautions to limit the impacts on their pets.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of chemotherapy or radiation residues or specific pet-related precautions to minimize exposure."
      },
      {
        "criterion_number": 14,
        "description": "After chemotherapy, surfaces\u2014especially in bathrooms\u2014can remain contaminated for at least 48 hours, so thorough cleaning is advised.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of surface contamination timelines or cleaning recommendations related to chemotherapy."
      },
      {
        "criterion_number": 15,
        "description": "Hand hygiene is essential after contact with patient waste or contaminated areas.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Handwashing is advised after handling pets and pet waste, but not after contact with patient waste or contaminated areas."
      },
      {
        "criterion_number": 16,
        "description": "Immunocompromised patients should practice good hand hygiene after handling pets.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It clearly advises thorough handwashing after handling pets, their food, or their waste, especially for the immunocompromised patient."
      },
      {
        "criterion_number": 17,
        "description": "Immunocompromised patients should avoid contact with pet waste.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It recommends that someone else handle pet waste if the patient is severely immunocompromised."
      },
      {
        "criterion_number": 18,
        "description": "Immunocompromised patients should prevent pets from licking open wounds.",
        "score_given": 0,
        "max_points": 8,
        "justification": "The response does not address preventing pets from licking open wounds."
      },
      {
        "criterion_number": 19,
        "description": "There is no strong evidence that pet ownership increases cancer risk or that pets need to be removed from the home during treatment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It does not explicitly state that pet ownership does not increase cancer risk or that removal is unnecessary."
      },
      {
        "criterion_number": 20,
        "description": "If patients are severely immunosuppressed, they should avoid contact with young animals, reptiles, or exotic pets, and seek assistance with pet care.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While it suggests help with pet care, it does not mention avoiding young animals, reptiles, or exotic pets."
      },
      {
        "criterion_number": 21,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 1,
        "justification": "No recommendation to consult the oncologist is provided."
      }
    ],
    "question_number": 117,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:00:28.677638",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define adjuvant therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines adjuvant therapy as additional treatment given after a primary treatment has been completed."
      },
      {
        "criterion_number": 2,
        "description": "The response should state the goal of adjuvant therapy is to prevent cancer recurrence.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explicitly states the goal is to reduce the risk of the cancer coming back (recurring)."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that adjuvant therapy usually occurs after surgery.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes that primary treatment is often surgery and that adjuvant chemotherapy usually starts several weeks after surgery."
      },
      {
        "criterion_number": 4,
        "description": "The response should include adjuvant therapy can be chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes chemotherapy as the most common component of adjuvant therapy and lists common regimens (FOLFIRINOX, gemcitabine/capecitabine)."
      },
      {
        "criterion_number": 5,
        "description": "The response should include adjuvant therapy can be radiation therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains adjuvant radiation therapy and chemoradiation as options depending on specifics."
      },
      {
        "criterion_number": 6,
        "description": "The response states that guidelines recommend all patients with resected pancreatic adenocarcinoma who did not receive preoperative therapy should be offered 6 months of adjuvant chemotherapy, unless there are medical or surgical contraindications.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions a typical duration of 6 months but does not state guideline recommendations for all eligible resected patients or the caveat about preoperative therapy and contraindications."
      },
      {
        "criterion_number": 7,
        "description": "The response states that adjuvant systemic therapy significantly improves survival compared to surgery alone.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not explicitly state improved survival compared to surgery alone; it mentions \"best chance for a long-term cure\" but lacks a direct survival comparison."
      },
      {
        "criterion_number": 8,
        "description": "The response states that the choice of adjuvant regimen should be individualized based on patient fitness and risk of toxicity.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Encourages asking which regimen is best but does not state that selection is based on patient fitness/performance status and toxicity risk."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends that the user discuss this case with an oncologist or cancer specialist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages attending the next appointment with questions and emphasizes guidance from the oncology team; includes a disclaimer to follow the healthcare team\u2019s advice."
      }
    ],
    "question_number": 118,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:01:01.386578",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define adjuvant therapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines adjuvant therapy as treatment given after the primary treatment (usually surgery) to address residual microscopic disease."
      },
      {
        "criterion_number": 2,
        "description": "The response should state the goal of adjuvant therapy is to prevent cancer recurrence.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explicitly states the goal is to reduce the risk of recurrence and improve long-term survival."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that adjuvant therapy usually occurs after surgery.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Repeatedly notes adjuvant therapy is given after surgery for pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response should include adjuvant therapy can be chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes chemotherapy as the primary adjuvant therapy, with details on regimens and delivery."
      },
      {
        "criterion_number": 5,
        "description": "The response should include adjuvant therapy can be radiation therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions radiation therapy as a less common adjuvant option in specific situations and provides examples."
      },
      {
        "criterion_number": 6,
        "description": "The response states that guidelines recommend all patients with resected pancreatic adenocarcinoma who did not receive preoperative therapy should be offered 6 months of adjuvant chemotherapy, unless there are medical or surgical contraindications.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explicitly state the guideline-based recommendation for offering 6 months of adjuvant chemotherapy to all eligible patients who did not receive neoadjuvant therapy, nor the contraindication caveat."
      },
      {
        "criterion_number": 7,
        "description": "The response states that adjuvant systemic therapy significantly improves survival compared to surgery alone.",
        "score_given": 0,
        "max_points": 4,
        "justification": "States the goal is to improve survival but does not explicitly compare outcomes to surgery alone or state significant survival improvement."
      },
      {
        "criterion_number": 8,
        "description": "The response states that the choice of adjuvant regimen should be individualized based on patient fitness and risk of toxicity.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Notes regimen choice depends on individual factors, including stage, overall health, and potential side effects, reflecting fitness and toxicity considerations."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends that the user discuss this case with an oncologist or cancer specialist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages discussing questions with the oncology team and emphasizes ongoing communication."
      }
    ],
    "question_number": 118,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:01:24.001266",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing constipation with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises: \"discuss this with your loved one's oncology or palliative care team\" and emphasizes informing them about symptoms, including constipation."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing pain medications with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While opioids are discussed, the response does not explicitly recommend discussing the pain medications themselves with the oncology team or reviewing/adjusting the opioid regimen."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that constipation is a side effect of opioid pain medications.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States \"Opioid-induced constipation (OIC) is different from regular constipation\" and explains opioids slow GI transit."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend the use of a bowel regimen to help with constipation associated with pain medications, including the use of stimulant laxatives.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends a proactive bowel regimen and includes stimulant laxatives (senna, bisacodyl) with dosing approach."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend the use of a bowel regimen to help with constipation associated with pain medications, including the use of osmotic laxatives.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends osmotic laxatives and provides examples (polyethylene glycol/Miralax, lactulose)."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend the use of a bowel regimen to help with constipation associated with pain medications, including the use of stool softeners.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes stool softeners (docusate sodium) as part of the regimen."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that a combination of these treatments is sometimes needed.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States a \"two-part system\" and suggests starting with a combination of a stool softener plus a stimulant laxative, adjusted as needed."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that there are prescription medications that can directly target opioid-associated constipation.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not mention prescription PAMORAs (e.g., methylnaltrexone, naloxegol, naldemedine) or other prescription options that target OIC directly."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend hydration to improve constipation.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Provides clear hydration guidance: \"Aim for 6-8 glasses of water or other clear fluids a day... Warm or hot beverages can be especially helpful.\""
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend physical activity to improve constipation.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Recommends gentle movement (walking, transfers, stretching) to stimulate gut motility."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that opioid-induced constipation is primarily due to reduced gut motility, and agents that increase water content or stimulate peristalsis directly address the underlying pathophysiology.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains opioids slow GI movement and that stimulant laxatives trigger contractions and osmotics draw water into the colon, addressing the mechanism."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that the American Gastroenterological Association recommends polyethylene glycol (PEG) and lactulose as effective osmotic agents, both of which significantly improve stool consistency and frequency compared to placebo.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of American Gastroenterological Association recommendations or comparative efficacy versus placebo."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that soluble fiber may be considered only for patients with fiber-deficient diets, as it has limited efficacy in opioid-induced constipation due to its lack of effect on colonic motility.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it cautions about fiber and suggests soluble fiber, it does not state that fiber has limited efficacy in OIC due to lack of motility effect nor that it should be considered only for fiber-deficient diets."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that enemas are reserved for rescue therapy and not for regular use.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Enemas are not mentioned."
      }
    ],
    "question_number": 119,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:02:12.526626",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing constipation with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises discussing all strategies with the healthcare team including the oncologist before implementing them."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing pain medications with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it discusses opioid-induced constipation and consulting the care team generally, it does not specifically recommend discussing the pain medication regimen with the oncology team."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that constipation is a side effect of opioid pain medications.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states constipation is a common side effect of pain medications and repeatedly refers to opioid-induced constipation."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend the use of a bowel regimen to help with constipation associated with pain medications, including the use of stimulant laxatives.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends a scheduled regimen and specifically includes stimulant laxatives like senna and bisacodyl, noting daily or twice-daily use."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend the use of a bowel regimen to help with constipation associated with pain medications, including the use of osmotic laxatives.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists osmotic agents such as polyethylene glycol (Miralax), lactulose, and milk of magnesia as part of the regimen."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend the use of a bowel regimen to help with constipation associated with pain medications, including the use of stool softeners.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes stool softeners (docusate) and explains their role, noting they are often insufficient alone."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that a combination of these treatments is sometimes needed.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that a combination is often needed and provides an example regimen (senna + docusate \u00b1 Miralax)."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that there are prescription medications that can directly target opioid-associated constipation.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It mentions PAMORAs (methylnaltrexone, naloxegol, naldemedine) and other prescription options for OIC."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend hydration to improve constipation.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It recommends maintaining hydration and provides examples of appropriate fluids."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend physical activity to improve constipation.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It encourages movement as tolerated, including gentle walking and chair exercises, to stimulate bowel function."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that opioid-induced constipation is primarily due to reduced gut motility, and agents that increase water content or stimulate peristalsis directly address the underlying pathophysiology.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explains opioids slow the digestive system and increase water absorption and describes how stimulant and osmotic laxatives counteract these effects."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that the American Gastroenterological Association recommends polyethylene glycol (PEG) and lactulose as effective osmotic agents, both of which significantly improve stool consistency and frequency compared to placebo.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of AGA recommendations or evidence versus placebo for PEG or lactulose."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that soluble fiber may be considered only for patients with fiber-deficient diets, as it has limited efficacy in opioid-induced constipation due to its lack of effect on colonic motility.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it discusses soluble vs. insoluble fiber and cautions about insoluble fiber, it does not state the limited efficacy of fiber in OIC or that soluble fiber is mainly for fiber-deficient diets."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that enemas are reserved for rescue therapy and not for regular use.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Enemas are not mentioned."
      }
    ],
    "question_number": 119,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:02:43.036924",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that meditation and mindfulness can improve quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly states that meditation and mindfulness can improve quality of life, including in the closing summary ('help him improve his quality of life') and throughout with examples (sleep, coping, empowerment)."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that meditation and mindfulness are not anti-cancer treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response clearly states 'Meditation and mindfulness are not a cure for cancer' and that they 'work alongside medical care,' which directly conveys they are not anti-cancer treatments."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that meditation and mindfulness can help emotional well-being.",
        "score_given": 5,
        "max_points": 5,
        "justification": "There is a dedicated section titled 'Improving Mood and Emotional Well-being' that explains how mindfulness helps with emotions such as fear, sadness, anger, and depression."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that meditation and mindfulness demonstrate moderate improvements in anxiety, depression, cancer-related fatigue, and overall quality of life in oncology populations, with effects maintained for at least several months post-intervention.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While the response describes benefits for anxiety, mood, fatigue, and quality of life, it does not characterize the magnitude as 'moderate' nor does it mention durability of effects for several months post-intervention."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that meditation and mindfulness are safe, feasible, and can be integrated alongside standard cancer care to help manage both physical and psychological symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response frames meditation and mindfulness as commonly recommended complementary therapies, provides practical steps (feasibility), and notes they 'work alongside medical care.' It also details benefits for physical (pain, nausea, fatigue) and psychological (stress, anxiety, mood) symptoms, supporting integration and utility. Safety is implied by recommending and common use without highlighting risks."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 2,
        "max_points": 2,
        "justification": "The response explicitly advises informing the oncologist and medical team and notes they may provide resources, meeting the criterion."
      }
    ],
    "question_number": 120,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:03:06.240544",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that meditation and mindfulness can improve quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly addressed under 'Enhancing Quality of Life' with the statement that 'your father's overall quality of life can improve,' and reiterated in the summary about enhancing well-being."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that meditation and mindfulness are not anti-cancer treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states they are 'not a cure' and should be used as a 'complement to medical treatment,' which directly meets the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that meditation and mindfulness can help emotional well-being.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Has a dedicated section 'Improving Emotional Well-being' noting benefits for fear, anger, sadness, and depression, and fostering self-compassion and acceptance."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that meditation and mindfulness demonstrate moderate improvements in anxiety, depression, cancer-related fatigue, and overall quality of life in oncology populations, with effects maintained for at least several months post-intervention.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although it discusses benefits for anxiety, depression, fatigue, and quality of life, it does not characterize the magnitude as 'moderate' nor mention evidence in oncology populations with durability 'for several months post-intervention.'"
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that meditation and mindfulness are safe, feasible, and can be integrated alongside standard cancer care to help manage both physical and psychological symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes they are 'generally safe,' offers practical ways to start (apps, short sessions), and emphasizes use as a complement to medical care. Discusses managing physical (pain, nausea, fatigue) and psychological (anxiety, emotions) symptoms and mentions programs offered in medical settings, supporting integration and feasibility."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Advises to 'Discuss with His Medical Team' and 'let his doctors know,' but does not explicitly recommend discussion with an oncologist."
      }
    ],
    "question_number": 120,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:03:24.597984",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing their concerns with an oncology nutritionist or dietitian.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends referral to an oncology-certified registered dietitian multiple times and positions it as a top action step."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that pancreatic enzyme supplements can help with digesting food when there is pancreatic enzyme deficiency.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly explains PEI and recommends PERT (e.g., Creon, Zenpep) with every meal/snack to aid digestion and absorption."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that nutrition is important for maintaining strength or energy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "States nutrition helps in maintaining strength for treatment."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that nutrition is important for supporting the immune system.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No explicit mention of supporting the immune system."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that nutrition is important for maintaining weight.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes preventing weight loss and maintaining body weight, including strategies to increase calorie density."
      },
      {
        "criterion_number": 6,
        "description": "The response should state the reasons for challenges with nutrition in patients with pancreatic cancer, including poor appetite.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Addresses poor appetite and early satiety as challenges and provides strategies to manage them."
      },
      {
        "criterion_number": 7,
        "description": "The response should state the reasons for challenges with nutrition in patients with pancreatic cancer, including digestion difficulties.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains digestion difficulties due to PEI, malabsorption, and related GI symptoms."
      },
      {
        "criterion_number": 8,
        "description": "The response should state the reasons for challenges with nutrition in patients with pancreatic cancer, including side effects of treatment like nausea.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Identifies treatment side effects such as nausea and vomiting and provides dietary strategies to address them."
      },
      {
        "criterion_number": 9,
        "description": "The response should state they should focus on protein intake.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Directly emphasizes protein needs and provides protein-rich food examples."
      },
      {
        "criterion_number": 10,
        "description": "The response should state they should focus on calorie intake.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Advises focusing on calorie-dense foods and fortification to increase energy intake."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend trying to manage nausea.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Provides practical nausea management strategies (bland/cold foods, ginger, small sips)."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend hydration.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends hydration repeatedly, including electrolyte-containing fluids, and prioritizing hydration on bad days."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that patients with pancreatic cancer undergoing treatment are at high risk of malnutrition, cachexia, and weight loss, necessitating early and ongoing nutritional assessment and intervention.",
        "score_given": 9,
        "max_points": 9,
        "justification": "Highlights risk of weight loss and cachexia and urges early referral to an oncology dietitian with ongoing monitoring via a food/symptom journal."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that dietary strategies should prioritize enteral nutrition over parenteral nutrition when oral intake is inadequate.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not address enteral versus parenteral nutrition."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that oral nutritional supplements, especially those enriched with omega-3 fatty acids, are beneficial for supporting body weight and lean body mass.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions oral nutritional supplements (e.g., Ensure) but not omega-3 enrichment or specific benefit to lean body mass."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that diet composition should emphasize a plant-enriched diet for overall health and cancer risk reduction.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Provides examples of plant foods but does not explicitly advocate a plant-enriched diet or link it to cancer risk reduction."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that current evidence does not support ketogenic diets for treatment.",
        "score_given": 0,
        "max_points": 8,
        "justification": "No discussion of ketogenic diets or evidence regarding their use."
      }
    ],
    "question_number": 121,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:03:55.838076",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing their concerns with an oncology nutritionist or dietitian.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends a Registered Dietitian Nutritionist specializing in oncology and asks for a referral; emphasizes they are the most important resource."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that pancreatic enzyme supplements can help with digesting food when there is pancreatic enzyme deficiency.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides detailed discussion of PERT (Creon, Zenpep, Pancreaze), indicates they are essential to properly digest food and absorb nutrients."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that nutrition is important for maintaining strength or energy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "States goals include maintaining energy levels and improving strength; suggests nutrient-dense intake to combat fatigue."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that nutrition is important for supporting the immune system.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Notes protein is critical for immune function, tying nutrition (protein intake) to immune support."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that nutrition is important for maintaining weight.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes preventing/minimizing weight loss as paramount and details strategies to maintain weight."
      },
      {
        "criterion_number": 6,
        "description": "The response should state the reasons for challenges with nutrition in patients with pancreatic cancer, including poor appetite.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists appetite loss and early satiety as key challenges with corresponding strategies."
      },
      {
        "criterion_number": 7,
        "description": "The response should state the reasons for challenges with nutrition in patients with pancreatic cancer, including digestion difficulties.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains malabsorption due to impaired enzyme production or duct obstruction; details steatorrhea and nutrient deficiencies."
      },
      {
        "criterion_number": 8,
        "description": "The response should state the reasons for challenges with nutrition in patients with pancreatic cancer, including side effects of treatment like nausea.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Identifies nausea and vomiting as common side effects of chemotherapy and provides management tips."
      },
      {
        "criterion_number": 9,
        "description": "The response should state they should focus on protein intake.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Strong emphasis on protein as critical for muscle preservation with multiple sources and strategies."
      },
      {
        "criterion_number": 10,
        "description": "The response should state they should focus on calorie intake.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Encourages nutrient-dense, high-calorie foods; 'every bite counts' and small frequent meals."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend trying to manage nausea.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Provides a detailed nausea management section including diet tips and anti-nausea medications."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend hydration.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Dedicated hydration section with specific fluid recommendations and timing."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that patients with pancreatic cancer undergoing treatment are at high risk of malnutrition, cachexia, and weight loss, necessitating early and ongoing nutritional assessment and intervention.",
        "score_given": 9,
        "max_points": 9,
        "justification": "States weight loss and cachexia are common and serious; stresses connecting early with an oncology RDN for personalized, ongoing nutrition management."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that dietary strategies should prioritize enteral nutrition over parenteral nutrition when oral intake is inadequate.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of enteral versus parenteral nutrition prioritization."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that oral nutritional supplements, especially those enriched with omega-3 fatty acids, are beneficial for supporting body weight and lean body mass.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions oral supplements and separately mentions omega-3s, but does not state omega-3-enriched supplements support body weight/lean mass."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that diet composition should emphasize a plant-enriched diet for overall health and cancer risk reduction.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not emphasize a plant-enriched dietary pattern or link it to overall health and cancer risk reduction."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that current evidence does not support ketogenic diets for treatment.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Advises against 'miracle cure' diets generally but does not specifically address ketogenic diets or evidence against them."
      }
    ],
    "question_number": 121,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:04:32.056242",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that memory issues can be associated with chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly attributes memory issues to chemotherapy, refers to 'chemo brain,' and cites common pancreatic regimens (FOLFIRINOX, gemcitabine/Abraxane) as potential culprits."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing memory concerns with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly advises talking to the medical/oncology team immediately, reviewing medications, ruling out other causes, and obtaining referrals."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that memory issues can be associated with pain medications.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It specifically mentions opioids/pain medications causing drowsiness, confusion, and memory fog."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that memory issues can be associated with poor nutrition.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It discusses malnutrition and poor nutrient absorption affecting brain function and recommends working with a dietitian."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that memory issues can be associated with dehydration.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Dehydration is explicitly identified as contributing to cognitive issues and hydration is emphasized in recommendations."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that memory issues can be associated with anxiety.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Anxiety is explicitly cited as a contributor to memory problems via stress hormones and mental burden."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that memory issues can be associated with depression.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Depression is explicitly listed as a factor affecting cognition."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that memory issues can be associated with fatigue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Cancer-related fatigue is clearly described as impairing focus and memory formation."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that memory issues can be associated with stress.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Stress is explicitly mentioned; the role of elevated stress hormones (cortisol) in impairing memory is explained."
      },
      {
        "criterion_number": 10,
        "description": "The response should cite peer-reviewed articles with links.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No peer-reviewed citations or links are provided."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that memory issues in pancreatic cancer patients are frequently related to cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states memory issues are a common side effect and that direct effects of treatment are often the primary cause."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that biological mechanisms underlying chemotherapy-induced cognitive changes include direct neurotoxic effects of chemotherapy, neuroinflammation, changes in brain structure and connectivity, and involvement of specific biomarkers and genetic predispositions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes chemo can affect brain cells and mentions inflammation, it does not discuss changes in brain structure/connectivity or biomarkers/genetic predispositions; mechanisms are not detailed to the level required."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that cognitive impairment may also be influenced by the cancer itself, paraneoplastic effects, and other factors such as age, comorbidities, and emotional distress.",
        "score_given": 0,
        "max_points": 6,
        "justification": "It mentions cancer spread to the brain and emotional distress, and suggests older adults may experience effects after anesthesia, but it does not mention paraneoplastic effects or comorbidities explicitly; the full scope required is not covered."
      }
    ],
    "question_number": 122,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:04:59.100115",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that memory issues can be associated with chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions chemotherapy can affect cognitive function and refers to 'chemo brain' causing memory issues."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing memory concerns with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises discussing the memory issues with the oncologist/medical team as soon as possible and details what to share."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that memory issues can be associated with pain medications.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifically notes opioids can cause drowsiness, confusion, and memory problems."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that memory issues can be associated with poor nutrition.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States malnutrition and nutritional deficiencies (e.g., B12, folate) can cause confusion and memory problems."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that memory issues can be associated with dehydration.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly mentions dehydration can cause confusion and memory problems."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that memory issues can be associated with anxiety.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists anxiety as a factor that can manifest as cognitive difficulties."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that memory issues can be associated with depression.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists depression as contributing to cognitive difficulties."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that memory issues can be associated with fatigue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States fatigue and sleep disturbances can significantly impair concentration and memory."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that memory issues can be associated with stress.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies stress as a factor making it hard to concentrate and recall information."
      },
      {
        "criterion_number": 10,
        "description": "The response should cite peer-reviewed articles with links.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No citations or links to peer-reviewed literature are provided."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that memory issues in pancreatic cancer patients are frequently related to cancer treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States memory issues can be related to treatment but does not characterize this as frequent in pancreatic cancer patients."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention biological mechanisms of chemotherapy-induced cognitive changes (neurotoxicity, neuroinflammation, brain structure/connectivity changes, biomarkers/genetic predispositions).",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss mechanistic explanations such as neuroinflammation, structural changes, biomarkers, or genetics."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention cognitive impairment may be influenced by the cancer itself, paraneoplastic effects, and other factors such as age, comorbidities, and emotional distress.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Addresses influence of the cancer itself, paraneoplastic syndromes, and other factors including emotional distress (anxiety, depression, stress)."
      }
    ],
    "question_number": 122,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:05:39.431349",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define ablative techniques in the context of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly defines ablative techniques as minimally invasive procedures that destroy tumors in place without surgical removal."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that ablative techniques in pancreatic cancer are used when surgery isn\u2019t possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states they are used when surgery isn't an option due to location or patient factors."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including radiofrequency ablation (RFA).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes RFA, including probe-based delivery of high-frequency current to heat and destroy tumor cells."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including microwave ablation (MWA).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes MWA using microwave energy to heat and kill cells and notes larger, faster ablation zones."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that ablative techniques are not curative.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not state that ablation is not curative; even implies possible curative intent in a question prompt."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that ablative techniques in pancreatic cancer are used to manage symptoms.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly mentions palliative use to relieve pain/pressure and improve quality of life."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including cryoablation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes cryoablation with cryoprobe, freezing (ice ball), and freeze-thaw cycles to destroy cells."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that these techniques are typically considered after or in conjunction with systemic chemotherapy, which remains the first-line treatment for locally advanced pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state chemotherapy as first-line or that ablation is typically considered after/in conjunction with systemic therapy."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including irreversible electroporation (IRE).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains IRE uses high-voltage electrical pulses to create pores in cell membranes and is non-thermal."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including high-intensity focused ultrasound (HIFU).",
        "score_given": 0,
        "max_points": 5,
        "justification": "HIFU is not mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that RFA delivers thermal energy via a probe to induce coagulative necrosis of tumor cells. RFA can be performed percutaneously, surgically, or via endoscopic ultrasound (EUS) guidance.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Mentions heat delivery via probe but does not specify coagulative necrosis or the percutaneous/surgical/EUS approaches."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that RFA is the most studied thermal technique and has demonstrated feasibility and safety, with some evidence of improved survival and immune modulation.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not address evidence base, feasibility/safety data, survival, or immune effects for RFA."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that MWA uses electromagnetic waves to generate heat and destroy tumor tissue.",
        "score_given": 4,
        "max_points": 4,
        "justification": "States that microwave energy heats and kills tumor cells, consistent with electromagnetic wave heating."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that MWA is emerging as an alternative to RFA, with potential advantages in speed and ablation volume, but clinical data remain limited.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Notes potential advantages but does not mention its emerging status relative to RFA or that clinical data are limited."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that IRE is a non-thermal technique that uses high-voltage electrical pulses to create permanent nanopores in cell membranes, leading to apoptosis.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Describes non-thermal pulses and membrane pores but does not mention apoptosis specifically."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that IRE is particularly attractive for tumors near critical structures, as it spares connective tissue and vessels. It is increasingly used in locally advanced pancreatic cancer and is under investigation in randomized trials.",
        "score_given": 0,
        "max_points": 4,
        "justification": "States advantage near critical structures and sparing vessels/bile ducts but does not mention increasing use in LAPC or randomized trials."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that HIFU delivers focused ultrasound waves to induce thermal and mechanical destruction of tumor cells.",
        "score_given": 0,
        "max_points": 4,
        "justification": "HIFU mechanism is not discussed."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that HIFU is less commonly used but has shown feasibility in clinical studies.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of HIFU usage or feasibility data."
      },
      {
        "criterion_number": 19,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Encourages discussion with the medical team but does not specifically recommend consulting an oncologist."
      }
    ],
    "question_number": 123,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:06:38.114006",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define ablative techniques in the context of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly defines ablative techniques as procedures that destroy tumors using energy without surgical removal and situates this in the context of pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that ablative techniques in pancreatic cancer are used when surgery isn\u2019t possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states these techniques are often considered when surgery isn\u2019t possible or desirable."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including radiofrequency ablation (RFA).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes RFA, how it works, guidance, and routes of application."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including microwave ablation (MWA).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes MWA and its mechanism and compares to RFA."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that ablative techniques are not curative.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explicitly state that ablation is not curative; in fact mentions goals that could imply curative intent without clarifying limitations."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that ablative techniques in pancreatic cancer are used to manage symptoms.",
        "score_given": 4,
        "max_points": 4,
        "justification": "States symptom relief, including pain reduction, as a goal."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including cryoablation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains cryoablation mechanism and approach."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that these techniques are typically considered after or in conjunction with systemic chemotherapy, which remains the first-line treatment for locally advanced pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of systemic chemotherapy as first-line or sequencing with ablation."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including irreversible electroporation (IRE).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes IRE mechanism and rationale."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe types of ablative techniques used in pancreatic cancer, including high-intensity focused ultrasound (HIFU).",
        "score_given": 0,
        "max_points": 5,
        "justification": "HIFU is not mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that RFA delivers thermal energy via a probe to induce coagulative necrosis of tumor cells. RFA can be performed percutaneously, surgically, or via endoscopic ultrasound (EUS) guidance.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Describes probe-delivered heat and percutaneous/surgical approaches, but does not mention coagulative necrosis or EUS guidance."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that RFA is the most studied thermal technique and has demonstrated feasibility and safety, with some evidence of improved survival and immune modulation.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not address relative evidence base, feasibility/safety data, survival benefit, or immune modulation for RFA."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that MWA uses electromagnetic waves to generate heat and destroy tumor tissue.",
        "score_given": 4,
        "max_points": 4,
        "justification": "States MWA uses microwave energy to generate heat to destroy tumor cells."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that MWA is emerging as an alternative to RFA, with potential advantages in speed and ablation volume, but clinical data remain limited.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Notes speed and larger ablation zones but does not state that MWA is emerging or that clinical data are limited."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that IRE is a non-thermal technique that uses high-voltage electrical pulses to create permanent nanopores in cell membranes, leading to apoptosis.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Describes non-thermal pulses creating permanent pores but does not specify apoptosis."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that IRE is particularly attractive for tumors near critical structures, as it spares connective tissue and vessels. It is increasingly used in locally advanced pancreatic cancer and is under investigation in randomized trials.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions suitability near critical structures but does not state sparing of connective tissue/vessels or note increasing use and randomized trials."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that HIFU delivers focused ultrasound waves to induce thermal and mechanical destruction of tumor cells.",
        "score_given": 0,
        "max_points": 4,
        "justification": "HIFU and its mechanism are not discussed."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that HIFU is less commonly used but has shown feasibility in clinical studies.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of HIFU utilization or feasibility data."
      },
      {
        "criterion_number": 19,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Encourages leaning on the medical team but does not explicitly recommend discussion with an oncologist."
      }
    ],
    "question_number": 123,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:07:41.508181",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommends discussing goals of care with the oncologist/oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises bringing goal-oriented questions to appointments (e.g., 'What is the goal of this treatment?') and includes a section to 'Discuss Goals of Care,' clearly directing these discussions to the medical team during visits."
      },
      {
        "criterion_number": 2,
        "description": "Recommends discussing symptom management with the oncology team or oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response emphasizes palliative care for symptom management (pain, nausea, fatigue) but does not explicitly instruct discussing these symptoms with the oncologist/oncology team specifically."
      },
      {
        "criterion_number": 3,
        "description": "Includes information about palliative care as a resource for symptom/quality of life management.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends an immediate palliative care referral, explains what palliative care is, distinguishes it from hospice, and details how the palliative team manages symptoms and supports quality of life."
      },
      {
        "criterion_number": 4,
        "description": "States or implies mental health professionals can help with emotional/psychological burden.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends an oncology social worker or therapist for coping strategies and emotional support, and addresses caregiver mental health as well."
      },
      {
        "criterion_number": 5,
        "description": "Recommends discussing side effect management with the oncology team or oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response advises bringing questions to appointments about 'the most likely side effects' and 'our plan to manage them,' clearly directing these discussions to the medical team."
      },
      {
        "criterion_number": 6,
        "description": "Mentions pancreatic cancer is an aggressive malignancy with high symptom burden (pain, GI symptoms, fatigue, psychological distress).",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it discusses significant symptoms and psychological toll, it does not explicitly characterize pancreatic cancer as an aggressive malignancy or directly state its high symptom burden as a general disease attribute."
      },
      {
        "criterion_number": 7,
        "description": "Clarifies palliative care is not hospice and can be provided at any stage alongside active therapy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "The response explicitly states palliative care is not the same as hospice and that it can and should be provided alongside curative treatments like chemotherapy."
      },
      {
        "criterion_number": 8,
        "description": "Mentions multidisciplinary collaboration can impact quality of life during treatment.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It emphasizes a team approach (palliative care team, dietitian, oncology social worker/therapist) and details how these disciplines address symptoms and support, reflecting multidisciplinary impact on quality of life."
      },
      {
        "criterion_number": 9,
        "description": "Mentions advance care planning can impact quality of life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response encourages discussing goals of care and aligning medical decisions with personal priorities, which is core to advance care planning and links it explicitly to quality of life."
      }
    ],
    "question_number": 124,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:08:20.568176",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends that the patient or family discuss goals of care (e.g., treatment goals, quality of life preferences, advanced care planning) with their oncologist or oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response includes a dedicated section ('Discuss Goals of Care') advising regular conversations with the medical team about what QoL means, priorities, and aligning the treatment plan accordingly."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing symptom management (e.g., pain, nausea, fatigue) with the oncology team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It instructs reporting all symptoms to the medical team and repeatedly advises working with the care team to manage pain, nausea, fatigue, and other symptoms (including via palliative care alongside oncology)."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly includes information about palliative care (e.g., mentions \u201cpalliative care,\u201d \u201csupportive care,\u201d or \u201cpalliative care specialists\u201d as a resource for symptom or quality of life management).",
        "score_given": 10,
        "max_points": 10,
        "justification": "Palliative care is prominently recommended early, described as focusing on symptom relief and stress reduction, with involvement from diagnosis and collaboration with the oncology team."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly states or clearly implies that mental health professionals (e.g., counselor, psychologist, psychiatrist, mental health provider) can help patients deal with the emotional or psychological burden of cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends psychologists/counselors for mental health support and discusses counseling/therapy for coping with fear, anxiety, depression, and family communication."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends discussing side effect management (e.g., side effects of treatment, managing adverse effects) with the oncology team or oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response advises reporting all symptoms to the medical team, notes side effects (e.g., treatment-related diarrhea), and explicitly says to 'work with the team' to determine appropriate medications and dosing for pain and other symptoms."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that pancreatic cancer is an aggressive malignancy associated with a high symptom burden, including pain, gastrointestinal symptoms, fatigue, and significant psychological distress.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although it lists and addresses pain, GI issues, fatigue, and psychological needs, it does not explicitly characterize pancreatic cancer as aggressive or state that it has a high symptom burden."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that palliative care is not synonymous with hospice; rather, it is an active, multidisciplinary approach to symptom management and psychosocial support that can be provided at any stage of disease, including during active cancer-directed therapy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explicitly states palliative care is not just for end-of-life, can be involved from diagnosis, and works alongside oncology to manage symptoms\u2014clearly distinguishing it from hospice and highlighting its applicability during active treatment."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that multidisciplinary collaboration can impact quality of life during treatment of pancreatic cancer.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It emphasizes using the full team (oncologist, nurses, dietitians, pain specialists, social workers, mental health providers, PT/OT) and links this to symptom control and QoL improvements."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that advance care planning can impact quality of life during treatment of pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response encourages advance care planning, noting it can provide peace of mind, honor preferences, and reduce anxiety\u2014explicitly tying it to QoL."
      }
    ],
    "question_number": 124,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:08:50.513057",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include the Pancreatic Cancer Action Network (PanCAN) as a major pancreatic cancer advocacy organization.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly lists the Pancreatic Cancer Action Network (PanCAN) under 'Major National Pancreatic Cancer Organizations (U.S.)' and provides details about its advocacy programs."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing advocacy options with their oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response offers tips and organizational suggestions but does not advise discussing advocacy options with the oncology team or care providers."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that PanCAN is a leading national organization dedicated to patient advocacy, support, research funding, and public policy initiatives for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states PanCAN 'attacks pancreatic cancer on all fronts: research, clinical initiatives, patient services, and government advocacy' and calls it 'arguably the leader in patient advocacy,' covering advocacy, support, research, and policy."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that PanCAN offers structured opportunities for patients and families to engage in advocacy, including legislative outreach, awareness campaigns, and peer support programs such as the Patient and Liaison Services (PALS) program.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response describes structured opportunities like legislative outreach (Advocacy Day) and awareness events (PurpleStride), it does not mention PanCAN\u2019s peer support programs or the PALS program specifically."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that the American Society of Clinical Oncology\u2019s patient-facing website, Cancer.Net, provides information on advocacy opportunities and connects patients to broader cancer advocacy networks.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Cancer.Net is not mentioned; the response instead references ACS CAN and NCI Office of Advocacy Relations."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that both PanCAN and Cancer.Net are specifically recommended by the American Society of Clinical Oncology in its clinical practice guidelines as key resources for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no mention of ASCO clinical practice guidelines or their recommendations regarding PanCAN and Cancer.Net."
      }
    ],
    "question_number": 125,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:09:10.872195",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include the Pancreatic Cancer Action Network (PanCAN) as a major pancreatic cancer advocacy organization.",
        "score_given": 10,
        "max_points": 10,
        "justification": "PanCAN is prominently listed with detailed description and contact information, clearly identifying it as a key advocacy organization."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing advocacy options with their oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not advise consulting the oncology team or clinical care team about advocacy options."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that PanCAN is a leading national organization dedicated to patient advocacy, support, research funding, and public policy initiatives for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states PanCAN is often considered the leading U.S. pancreatic cancer organization and notes focus on research, patient support, advocacy, and legislative activities (e.g., Action Week), covering public policy initiatives."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that PanCAN offers structured opportunities for patients and families to engage in advocacy, including legislative outreach, awareness campaigns, and peer support programs such as the Patient and Liaison Services (PALS) program.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes structured opportunities: legislative outreach (Advocacy Days), awareness campaigns (PurpleStride, volunteering), and peer-support/patient services (Patient Central, mentoring newly diagnosed patients). While it references 'Patient Central' rather than the legacy PALS name, the required elements are present."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that the American Society of Clinical Oncology\u2019s patient-facing website, Cancer.Net, provides information on advocacy opportunities and connects patients to broader cancer advocacy networks.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Cancer.Net is not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that both PanCAN and Cancer.Net are specifically recommended by the American Society of Clinical Oncology in its clinical practice guidelines as key resources for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no reference to ASCO clinical practice guidelines or their recommendations of PanCAN and Cancer.Net."
      }
    ],
    "question_number": 125,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:09:33.532787",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that treatment choices and sequencing depend on the stage of the cancer and overall health."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and may include surgery.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Clearly presents a multimodal approach and lists surgery as a main pillar of treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and may include chemotherapy.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Chemotherapy is explicitly included as one of the main pillars in a multimodal plan."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and may include radiation.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Radiation therapy is explicitly listed as one of the treatment pillars."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that chemotherapy can be used before or after surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly explains neoadjuvant (before) and adjuvant (after) chemotherapy, including rationale."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that pancreatic cancer management should involve a multidisciplinary team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises assembling a multidisciplinary team and specifies roles (surgical, medical, radiation oncologists, gastroenterologist, palliative care, dietitian)."
      },
      {
        "criterion_number": 7,
        "description": "The response should state types of surgical procedures used in pancreatic cancer and describe the Whipple procedure.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Names the Whipple procedure (pancreaticoduodenectomy), identifies it as most common for tumors in the head, and discusses goal of clear margins; adequate description for criterion."
      },
      {
        "criterion_number": 8,
        "description": "The response should state types of surgical procedures used in pancreatic cancer and describe distal pancreatectomy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Mentions distal pancreatectomy and indicates it is used for tumors in the body or tail, satisfying the criterion."
      },
      {
        "criterion_number": 9,
        "description": "The response should state types of surgical procedures used in pancreatic cancer and describe total pancreatectomy.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Total pancreatectomy is not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that surgical resection is the only potentially curative option for pancreatic cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "States surgery offers the best chance for long-term cure but does not specify it as the only potentially curative option."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that deciding on surgery requires multidisciplinary evaluation and mention anatomical, biological, or patient factors.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends multidisciplinary care and second opinions; references anatomical factors (vessel involvement), disease spread, stage, and overall health, fulfilling the criterion."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend discussing the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises seeking a second opinion at a major cancer center and assembling a team including a medical oncologist; encourages direct consultation with the care team."
      }
    ],
    "question_number": 126,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:10:14.622263",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states treatment depends on whether it has spread (stage) along with other factors: 'Treatment for pancreatic cancer is highly individualized and depends on... whether it has spread (stage) ...'."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and may include surgery.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Presents multiple modalities (surgery, chemotherapy, radiation, targeted therapy, immunotherapy, clinical trials, palliative care) and details surgery as an option, reflecting multimodal management."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and may include chemotherapy.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Provides a dedicated chemotherapy section, including neoadjuvant, adjuvant, and palliative chemotherapy, within a broader multimodal framework."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and may include radiation.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Includes a radiation therapy section with roles before/after surgery and palliative use, indicating radiation as part of multimodal care."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that chemotherapy can be used before or after surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly describes neoadjuvant (before surgery) and adjuvant (after surgery) chemotherapy with goals and common regimens."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that pancreatic cancer management should involve a multidisciplinary team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States 'the best approach involves a multidisciplinary team' and lists specific team members (surgical, medical, radiation oncologists, etc.)."
      },
      {
        "criterion_number": 7,
        "description": "The response should state types of surgical procedures used in pancreatic cancer and describe the Whipple procedure.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Names the Whipple procedure and accurately describes organs removed and postoperative considerations/complications."
      },
      {
        "criterion_number": 8,
        "description": "The response should state types of surgical procedures used in pancreatic cancer and describe distal pancreatectomy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Describes distal pancreatectomy for body/tail tumors and notes that the spleen is often removed."
      },
      {
        "criterion_number": 9,
        "description": "The response should state types of surgical procedures used in pancreatic cancer and describe total pancreatectomy.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions total pancreatectomy and correctly notes consequences (lifelong diabetes, need for enzyme replacement)."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that surgical resection is the only potentially curative option for pancreatic cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "States surgery offers the 'best chance for long-term survival or even cure' but does not explicitly state it is the only potentially curative option."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that deciding on surgery requires multidisciplinary evaluation and mention anatomical, biological, or patient factors.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Emphasizes multidisciplinary management and cites anatomical (location/extent), biological (genetic markers), and patient factors (overall health). Also discusses resectable/borderline resectable status and second opinions at high-volume centers."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend discussing the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends management by a multidisciplinary team including a medical oncologist, suggests second opinion at a cancer center, and advises discussing options with the medical team."
      }
    ],
    "question_number": 126,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:10:44.590446",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response emphasizes determining the exact stage and explicitly ties resectability status to treatment decisions: 'What is the stage of the cancer?' and 'Is the cancer considered resectable... This is the single most important question that will determine the initial treatment path.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the treatment of pancreatic cancer depends on the location of the cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it advises asking 'Where exactly is the tumor located in the pancreas (head, body, or tail)?', it does not explicitly state that treatment depends on tumor location."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and includes surgery.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It promotes multidisciplinary care and includes a Surgical Oncologist (e.g., 'Whipple procedure') and emphasizes resectability, indicating surgery as a key modality within a multimodal approach."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and includes chemotherapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly includes a Medical Oncologist with 'Manages chemotherapy,' indicating chemotherapy as part of multimodal treatment."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and includes radiation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly includes a Radiation Oncologist who 'Manages radiation therapy,' reflecting radiation as part of multimodal care."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that early, multidisciplinary management is essential to optimize outcomes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes assembling a multidisciplinary team and calls for palliative care 'from the moment of diagnosis,' underscoring early, coordinated management."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that care is best coordinated at high-volume centers with expertise in pancreatic malignancies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It strongly recommends a second opinion at a 'High-Volume Pancreatic Cancer Center' and notes outcomes are better at such centers, suggesting NCI-Designated Comprehensive Cancer Centers."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that symptom management is an important part of the care of patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It dedicates a section to 'Focus on Symptom and Side Effect Management' and recommends palliative care, pain control, anti-nausea strategies, and pancreatic enzyme replacement therapy."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe the basics of pancreatic cancer, including that the most common type is pancreatic adenocarcinoma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states, 'Most are adenocarcinomas, but there are others like neuroendocrine tumors (NETs),' meeting the requirement."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe how pancreatic cancer is staged based on the NCCN guidelines (version 2.2025) using AJCC 8th edition TNM and stage groups.",
        "score_given": 0,
        "max_points": 2,
        "justification": "The response does not provide TNM definitions or AJCC stage group details; it only advises asking about stage."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that pancreatic cancer is an aggressive malignancy with a poor prognosis, often presenting at an advanced stage.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It does not state pancreatic cancer\u2019s aggressiveness, prognosis, or typical stage at presentation."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend writing down questions in advance to ensure that all concerns are addressed during consultations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends a medical binder, bringing a notebook to write down questions and answers, preparing for the results appointment, and provides specific questions to ask."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that advocacy for comprehensive testing is important, including somatic and germline genetic testing.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of somatic or germline genetic testing or advocating for comprehensive molecular testing."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention to inquire about clinical trial opportunities, as participation may provide access to novel therapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It directs to PanCAN for 'information on clinical trials' and highlights 'Let's Win! Pancreatic Cancer' focused on clinical trials, which implies seeking trial opportunities."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that cancer.net and the Pancreatic Cancer Action Network (pancan.org) provide high-quality information, support services, and advocacy opportunities.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It mentions PanCAN but does not mention cancer.net; the criterion requires both."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises seeking care with a Medical Oncologist and a multidisciplinary team, and to obtain a second opinion at a high-volume pancreatic cancer center, effectively recommending discussion with oncologists."
      }
    ],
    "question_number": 127,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:11:30.334712",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that the treatment of pancreatic cancer depends on the stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states: 'What is the stage (I, II, III, IV)? This is crucial as it determines treatment options.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should state that the treatment of pancreatic cancer depends on the location of the cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While resectability is discussed, the response does not explicitly state that treatment depends on the tumor location (e.g., head vs body/tail or vascular involvement)."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and includes surgery.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists multiple modalities together including surgery ('surgery (if possible), chemotherapy, radiation, targeted therapies, immunotherapy'), implying multimodal care and specifically includes surgery."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and includes chemotherapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Chemotherapy is explicitly included in the treatment spectrum."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that treatment of pancreatic cancer is multimodality and includes radiation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Radiation is explicitly included in the treatment spectrum."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that early, multidisciplinary management is essential to optimize outcomes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises care at a multidisciplinary center and highlights early involvement ('Palliative Care Specialist (crucial from day one)') indicating early, team-based management."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that care is best coordinated at high-volume centers with expertise in pancreatic malignancies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States: 'Your loved one needs to be seen at a high-volume cancer center with a multidisciplinary team specializing in pancreatic cancer.'"
      },
      {
        "criterion_number": 8,
        "description": "The response should state that symptom management is an important part of the care of patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Has a dedicated 'Symptom Management' section advocating for aggressive symptom management from day one and palliative care involvement."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe the basics of pancreatic cancer, including that the most common type is pancreatic adenocarcinoma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes: 'What is the specific type of pancreatic cancer (e.g., adenocarcinoma is most common)?'"
      },
      {
        "criterion_number": 10,
        "description": "The response should describe how pancreatic cancer is staged based on the NCCN guidelines (version 2.2025).",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not provide TNM details or AJCC 8th edition staging groups; only mentions broad stages I\u2013IV and resectability."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that pancreatic cancer is an aggressive malignancy with a poor prognosis, often presenting at an advanced stage.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although it calls pancreatic cancer 'challenging,' it does not state aggressiveness, poor prognosis, or tendency to present at advanced stages."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend writing down questions in advance to ensure that all concerns are addressed during consultations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a 'Prepare Questions for the Initial Appointment' list and recommends taking notes/recording, clearly encouraging prewritten questions."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that advocacy for comprehensive testing is important, including somatic and germline genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions tumor molecular profiling (somatic) and advocates for genetic testing for the patient and potentially family (germline), including BRCA."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention to inquire about clinical trial opportunities, as participation may provide access to novel therapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly prompts asking about clinical trials and references PanCAN for trial matching."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that cancer.net and the Pancreatic Cancer Action Network (pancan.org) provide high-quality information, support services, and advocacy opportunities.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions PanCAN, ACS, and NCI but does not mention cancer.net; criterion requires both cancer.net and PanCAN."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends being seen at a high-volume cancer center with a multidisciplinary team including a Medical Oncologist, effectively advising consultation with an oncologist."
      }
    ],
    "question_number": 127,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:12:16.830403",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that pancreatic neuroendocrine tumors (pNETs) are usually sporadic.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states: \"Most pNETs are considered sporadic.\""
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that pancreatic neuroendocrine tumors (pNETs) do tend to have a genetic component in a significant minority of cases.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes a \"significant minority\u2014about 10\u201315%\u2014are associated with inherited genetic syndromes,\" indicating a genetic component in a subset."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that some cases of pancreatic neuroendocrine tumors (pNETs) are associated with hereditary syndromes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states that some pNETs are associated with inherited syndromes and lists several such syndromes."
      },
      {
        "criterion_number": 4,
        "description": "The response should include multiple endocrine neoplasia type 1 (MEN1).",
        "score_given": 3,
        "max_points": 3,
        "justification": "MEN1 is explicitly named and described as the most common genetic cause of pNETs."
      },
      {
        "criterion_number": 5,
        "description": "The response should include von Hippel-Lindau disease (VHL).",
        "score_given": 3,
        "max_points": 3,
        "justification": "VHL is explicitly listed and described as associated with pNETs."
      },
      {
        "criterion_number": 6,
        "description": "The response should include neurofibromatosis type 1 (NF1).",
        "score_given": 3,
        "max_points": 3,
        "justification": "NF1 is explicitly listed among hereditary syndromes linked to pNETs."
      },
      {
        "criterion_number": 7,
        "description": "The response should include tuberous sclerosis complex (TSC).",
        "score_given": 3,
        "max_points": 3,
        "justification": "Tuberous sclerosis complex (TSC) is explicitly included as a syndrome that can feature pNETs."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that genetic testing is available for pancreatic neuroendocrine tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states that genetic testing is available and describes the process (blood/saliva) and target genes."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that they have concerns about the risk of cancer, they should talk with a genetic counselor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises: \"Consult a Genetic Counselor\" and details their role."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that approximately 10\u201317% of pancreatic neuroendocrine tumors (pNETs) are associated with inherited syndromes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states \"about 10\u201315%\" which falls within the 10\u201317% range specified."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that these inherited syndromes often present at a younger age.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It flags \"a pNET diagnosis at a young age (e.g., under 40\u201350)\" as a red flag for hereditary syndromes, implying earlier-age presentation."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that germline mutations are also found in sporadic-appearing pancreatic neuroendocrine tumors (pNETs), including mutations in DNA repair genes such as MUTYH, CHEK2, and BRCA2, as well as MEN1 and VHL.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention germline findings in sporadic-appearing cases or DNA repair genes like MUTYH, CHEK2, BRCA2."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that multigene panel testing is recommended, as it can identify both syndromic and non-syndromic germline variants relevant for familial risk assessment.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While it recommends genetic testing, it does not specify multigene panel testing or emphasize detection of non-syndromic variants."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the user discuss this case with a medical professional.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It advises consulting a genetic counselor and speaking with a primary care physician for referrals, fulfilling this criterion."
      }
    ],
    "question_number": 128,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:12:49.759580",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that pancreatic neuroendocrine tumors (pNETs) are usually sporadic.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly notes that many cases are sporadic, indicating that most pNETs are not inherited."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that pancreatic neuroendocrine tumors (pNETs) do tend to have a genetic component in a significant minority of cases.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that pNETs can have a significant genetic component and quantifies this minority."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that some cases of pancreatic neuroendocrine tumors (pNETs) are associated with hereditary syndromes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly explains that a portion of pNETs are associated with inherited genetic syndromes."
      },
      {
        "criterion_number": 4,
        "description": "The response should include multiple endocrine neoplasia type 1 (MEN1).",
        "score_given": 3,
        "max_points": 3,
        "justification": "MEN1 is listed and described as the most common inherited cause."
      },
      {
        "criterion_number": 5,
        "description": "The response should include von Hippel-Lindau disease (VHL).",
        "score_given": 3,
        "max_points": 3,
        "justification": "VHL is included among the hereditary syndromes linked to pNETs."
      },
      {
        "criterion_number": 6,
        "description": "The response should include neurofibromatosis type 1 (NF1).",
        "score_given": 3,
        "max_points": 3,
        "justification": "NF1 is included with appropriate context."
      },
      {
        "criterion_number": 7,
        "description": "The response should include tuberous sclerosis complex (TSC).",
        "score_given": 3,
        "max_points": 3,
        "justification": "TSC is included among the relevant hereditary syndromes."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that genetic testing is available for pancreatic neuroendocrine tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that genetic testing is readily available and discusses germline and somatic testing."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that they have concerns about the risk of cancer, they should talk with a genetic counselor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly recommends genetic counseling before testing and outlines the counselor\u2019s role."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that approximately 10\u201317% of pancreatic neuroendocrine tumors (pNETs) are associated with inherited syndromes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It cites an approximate range of 10\u201320%, which conveys the intended point that roughly a tenth to a significant minority are inherited."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that these inherited syndromes often present at a younger age.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that testing is especially considered for early-onset cases, implying younger age of presentation."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that germline mutations are also found in sporadic-appearing pancreatic neuroendocrine tumors (pNETs), including mutations in DNA repair genes such as MUTYH, CHEK2, and BRCA2, as well as MEN1 and VHL.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not mention germline findings in sporadic-appearing cases nor specific DNA repair genes (MUTYH, CHEK2, BRCA2)."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that multigene panel testing is recommended, as it can identify both syndromic and non-syndromic germline variants relevant for familial risk assessment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It states that testing is usually done as a panel covering multiple genes and discusses how results inform family risk."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the user discuss this case with a medical professional.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It advises discussing concerns with a primary care physician and obtaining referral to specialists (endocrinologist or oncology genetics)."
      }
    ],
    "question_number": 128,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:13:21.653269",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions the Pancreatic Cancer Action Network (PanCAN) as a source for survivor stories.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly references PanCAN and its 'Stories of Hope' section and mentions the Survivor and Caregiver Network with a link."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends asking the oncology team for additional support group recommendations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No suggestion to ask the oncology team, oncologist, or care team for support group recommendations."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions Cancer Support Community (CSC) as a resource for support or survivor stories.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cancer Support Community (CSC) is not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions Let\u2019s Win! Pancreatic Cancer survivor stories.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically names 'Let\u2019s Win! Pancreatic Cancer' and its patient stories section with a link."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions the American Society of Clinical Oncology\u2019s patient-facing website (www.cancer.net) as a source for stories of hope.",
        "score_given": 0,
        "max_points": 5,
        "justification": "ASCO\u2019s Cancer.Net is not referenced."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions that organizations provide patient and survivor stories, peer support networks, and opportunities to connect with others who have faced similar diagnoses.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States organizations provide stories (PanCAN, Hirshberg) and highlights PanCAN\u2019s Survivor and Caregiver Network and online communities for connection."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that peer support and shared experiences are recognized as powerful tools for maintaining motivation and a sense of hope during the cancer journey.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes that 'hope comes from a direct connection with someone who is walking the same path' and that others\u2019 stories can help carry hope, indicating peer support\u2019s role in maintaining hope."
      }
    ],
    "question_number": 129,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:13:42.203218",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions the Pancreatic Cancer Action Network (PanCAN) as a source for survivor stories.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly names PanCAN as the go-to organization and notes it has patient stories, support services, and Patient Central for connections."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends asking the oncology team for additional support group recommendations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises asking an oncology social worker or patient navigator and mentions hospital/cancer center support groups."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions Cancer Support Community (CSC) as a resource for support or survivor stories.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cancer Support Community (CSC) is not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions Let\u2019s Win! Pancreatic Cancer survivor stories.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Let\u2019s Win! Pancreatic Cancer is not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions the American Society of Clinical Oncology\u2019s patient-facing website (www.cancer.net) as a source for stories of hope.",
        "score_given": 0,
        "max_points": 5,
        "justification": "ASCO\u2019s Cancer.Net is not mentioned; only ACS, NCI, and CancerCare are cited."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions that organizations provide patient and survivor stories, peer support networks, and opportunities to connect with others who have faced similar diagnoses.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States PanCAN has patient stories and Patient Central for connections; mentions ACS\u2019s Cancer Survivors Network and other online communities facilitating peer support."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that peer support and shared experiences are recognized as powerful tools for maintaining motivation and a sense of hope during the cancer journey.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that sharing experiences and hearing from others can be incredibly powerful and frames stories of hope as a vital source of inspiration."
      }
    ],
    "question_number": 129,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:13:59.283283",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define stage IV pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not explicitly define stage IV as metastatic disease with distant spread (e.g., to liver, peritoneum, lungs)."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that the disease is not curable.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it discusses controlling growth and quality of life, it never explicitly states that stage IV pancreatic cancer is not curable."
      },
      {
        "criterion_number": 3,
        "description": "The response should include the goal of treatment is to control the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states the goal is to control the cancer's growth and extend life."
      },
      {
        "criterion_number": 4,
        "description": "The response should include the goal of treatment to improve symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes symptom management and maintaining quality of life throughout."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that the cornerstone of treatment for stage IV pancreatic cancer is systemic chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly calls chemotherapy the cornerstone of care for stage IV disease."
      },
      {
        "criterion_number": 6,
        "description": "The response should include chemotherapy regimens listed in NCCN guidelines (version 2.2025) for treatment of metastatic pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists FOLFIRINOX and gemcitabine plus nab-paclitaxel, which are NCCN-recommended first-line regimens for metastatic disease."
      },
      {
        "criterion_number": 7,
        "description": "The response should discuss that clinical trials are another option.",
        "score_given": 7,
        "max_points": 7,
        "justification": "There is a dedicated section on clinical trials with concrete steps and resources."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that there may be targeted treatments based on genetic mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses PARP inhibitors for BRCA mutations, pembrolizumab for MSI-H/dMMR, and mentions NTRK and KRAS G12C targets."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend the tumor have genetic testing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It strongly recommends comprehensive biomarker/genomic testing as soon as possible and provides questions to ask the oncologist."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that early palliative care referral is recommended at diagnosis to optimize symptom management, psychological support, and advance care planning.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states palliative care should start at diagnosis and emphasizes symptom and psychological support, with an immediate referral recommendation."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that aggressive symptom management, such as management of pain, fatigue, nausea, and gastrointestinal symptoms is essential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It addresses pain, nausea, appetite issues, fatigue, jaundice, and GI concerns with specific management strategies."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that pancreatic enzyme replacement therapy should be considered for exocrine insufficiency, and nutritional support is important for maintaining weight and strength.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends PERT (e.g., Creon) and provides detailed nutrition strategies and referral to an oncology dietitian."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that psychosocial support, including counseling and peer support, is critical for both patients and families.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It encourages counseling, mindfulness, support groups, and caregiver support, highlighting their importance."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly advises making decisions with the oncology team and provides specific questions to ask the oncologist."
      }
    ],
    "question_number": 130,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:14:34.662025",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define stage IV pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not explicitly define stage IV as metastatic disease with spread to distant organs; it mentions metastases in context (e.g., bone metastases) but does not provide a definition."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that the disease is not curable.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response focuses on extending life and quality of life but does not clearly state that stage IV pancreatic cancer is not curable."
      },
      {
        "criterion_number": 3,
        "description": "The response should include the goal of treatment is to control the cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states chemotherapy regimens are used to slow disease progression, which communicates disease control as a treatment goal."
      },
      {
        "criterion_number": 4,
        "description": "The response should include the goal of treatment to improve symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response emphasizes palliative care, symptom relief, and quality of life, explicitly discussing symptom improvement as a key goal."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that the cornerstone of treatment for stage IV pancreatic cancer is systemic chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Chemotherapy is presented as the standard-of-care primary treatment for stage IV disease, with detailed discussion of regimens and tolerance, effectively conveying it as the mainstay."
      },
      {
        "criterion_number": 6,
        "description": "The response should include chemotherapy regimens listed in NCCN guidelines (version 2.2025) for treatment of metastatic pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It mentions FOLFIRINOX and gemcitabine plus nab-paclitaxel, which are NCCN-recommended regimens for metastatic pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should discuss that clinical trials are another option.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clinical trials are highlighted as crucial in stage IV disease, with guidance on finding trials and discussing eligibility."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that there may be targeted treatments based on genetic mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that specific mutations (e.g., BRCA, MSI-H, NTRK) may make patients eligible for targeted therapies or immunotherapy."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend the tumor have genetic testing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends genetic sequencing/biomarker testing of the tumor and discusses its implications for targeted therapy and trial eligibility."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that early palliative care referral is recommended at diagnosis to optimize symptom management, psychological support, and advance care planning.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends initiating palliative care early alongside active treatment, emphasizes symptom and stress relief, and separately addresses advance directives and psychological support."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that aggressive symptom management, such as management of pain, fatigue, nausea, and gastrointestinal symptoms is essential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides detailed strategies for pain, nausea/vomiting, appetite, fatigue, jaundice, bowel obstruction, and other GI symptoms, stressing proactive management."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that pancreatic enzyme replacement therapy should be considered for exocrine insufficiency, and nutritional support is important for maintaining weight and strength.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It strongly emphasizes PERT with examples and dosing with meals, and outlines high-calorie/high-protein nutrition and hydration to maintain weight and strength."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that psychosocial support, including counseling and peer support, is critical for both patients and families.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends counseling/therapy for both the patient and family, support groups, and mind-body/spiritual care resources."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly advises working closely with her oncologist and medical team, and to ask the oncologist about treatments and clinical trials."
      }
    ],
    "question_number": 130,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:15:15.312258",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that management of pancreatic tumors involves a multidisciplinary team of surgeons, medical oncologists, and radiation oncologists.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly emphasizes a multidisciplinary approach and lists Medical Oncologist, Surgical Oncologist, and Radiation Oncologist among the core team members."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that outcomes are significantly improved when care is delivered by a multidisciplinary team at high-volume centers.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it stresses high-volume centers and multidisciplinary care, it does not explicitly state that outcomes are significantly improved by such care."
      },
      {
        "criterion_number": 3,
        "description": "The response should provide information for the Pancreatic Cancer Action Network (PanCAN).",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides PanCAN as a key resource, includes the phone number (877-272-6226), and describes their personalized specialist referral service."
      },
      {
        "criterion_number": 4,
        "description": "The response should provide information for the American Cancer Society (ACS).",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of the American Cancer Society or its resources."
      },
      {
        "criterion_number": 5,
        "description": "The recommendation should provide a link to the NCI website for finding an NCI-designated cancer center.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Includes a direct link to the NCI cancer center finder: https://www.cancer.gov/research/infrastructure/cancer-centers/find."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that high-volume centers\u2014defined as institutions performing at least 15 pancreatic resections annually\u2014demonstrate superior survival rates, lower postoperative morbidity, improved lymphadenectomy, shorter hospital stays, and better access to adjuvant therapies.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Mentions surgeon volume targets (15\u201320 Whipples/year) but does not define institutional high-volume centers nor enumerate the specific outcome improvements listed (survival, morbidity, lymphadenectomy quality, LOS, adjuvant therapy access)."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that high-volume centers are typically academic medical centers, National Cancer Institute-designated cancer centers, or hospitals with established pancreatic cancer programs.",
        "score_given": 8,
        "max_points": 8,
        "justification": "States that the best specialists are almost always found at major academic medical centers or NCI-Designated Comprehensive Cancer Centers."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention to request referrals from local oncologists or primary care providers, who can direct patients to high-volume centers and experienced teams.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises asking the diagnosing physician (gastroenterologist or primary care) for referrals and provides specific wording to elicit strong recommendations."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends seeking a GI medical oncologist, scheduling a specialist consultation, and provides detailed questions to ask during that encounter."
      }
    ],
    "question_number": 131,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:15:46.903290",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that management of pancreatic tumors involves a multidisciplinary team of surgeons, medical oncologists, and radiation oncologists.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly emphasizes multidisciplinary care and lists surgeons, medical oncologists, and radiation oncologists among the team members."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that outcomes are significantly improved when care is delivered by a multidisciplinary team at high-volume centers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that best care comes from a team at a high-volume cancer center and that studies show better outcomes with higher-volume centers/surgeons."
      },
      {
        "criterion_number": 3,
        "description": "The response should provide information for the Pancreatic Cancer Action Network (PanCAN).",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides PanCAN name, phone number (877-2-PANCAN), and website link."
      },
      {
        "criterion_number": 4,
        "description": "The response should provide information for the American Cancer Society (ACS).",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of the American Cancer Society or ACS resources."
      },
      {
        "criterion_number": 5,
        "description": "The recommendation should provide a link to the NCI website for finding an NCI-designated cancer center.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Includes the NCI cancer centers finder link on cancer.gov."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that high-volume centers\u2014defined as institutions performing at least 15 pancreatic resections annually\u2014demonstrate superior survival rates, lower postoperative morbidity, improved lymphadenectomy, shorter hospital stays, and better access to adjuvant therapies.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Mentions surgeon volume (15\u201320 Whipples/year) and better outcomes at higher-volume centers but does not define center volume as \u226515 resections nor list specific advantages (survival, morbidity, lymphadenectomy, LOS, adjuvant access)."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that high-volume centers are typically academic medical centers, National Cancer Institute-designated cancer centers, or hospitals with established pancreatic cancer programs.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Directs users to NCI-designated comprehensive cancer centers and hospitals with dedicated pancreatic cancer programs, aligning with the types of high-volume centers described."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention to request referrals from local oncologists or primary care providers, who can direct patients to high-volume centers and experienced teams.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises asking the primary care physician, gastroenterologist, or diagnosing doctor for referrals, as well as other physicians."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages consultations and second opinions with specialists, including medical oncologists, effectively recommending discussion with an oncologist."
      }
    ],
    "question_number": 131,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:16:23.037380",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly states that some chemotherapy can have negative effects on the heart.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response states, 'Some chemotherapy drugs can weaken the heart muscle... This is called cardiomyopathy,' and 'The treatments... particularly chemotherapy... can affect the heart in several ways.'"
      },
      {
        "criterion_number": 2,
        "description": "The response specifically mentions that 5-fluorouracil (or \u201c5-FU\u201d) can harm the heart.",
        "score_given": 1,
        "max_points": 1,
        "justification": "It explicitly notes, 'One of the drugs in this combination, 5-Fluorouracil (5-FU), is particularly known for its potential to cause cardiotoxicity.'"
      },
      {
        "criterion_number": 3,
        "description": "The response recommends monitoring for shortness of breath.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Under 'Monitoring at Home,' it lists 'Shortness of Breath (Dyspnea)' with guidance on what to watch for."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends monitoring for chest pain.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It includes 'Chest Pain, Tightness, or Discomfort' and labels it an emergency with instructions to call 911."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends monitoring for fast heart rate.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It lists 'Heart Palpitations' and describes feelings of the heart 'racing, fluttering, pounding, or skipping beats.'"
      },
      {
        "criterion_number": 6,
        "description": "The response recommends monitoring for dizziness.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It includes 'Dizziness, Lightheadedness, or Fainting' as symptoms to watch and report."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends monitoring for unusual fatigue.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It lists 'Extreme Fatigue or Weakness' and specifies watching for a sudden increase or disproportionate exhaustion."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly recommends discussing any new symptom with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It advises tracking 'any new or worsening symptoms' but directs contacting the team only 'if you notice any of the following' listed symptoms; it does not explicitly recommend discussing any new symptom in general."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly recommends discussing any concerning symptom with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states, 'Contact her oncology nurse or doctor immediately if you notice any of the following' and emphasizes communicating with the medical team about concerning signs."
      },
      {
        "criterion_number": 10,
        "description": "The response states that electrocardiograms can be used to monitor the heart.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Under 'Baseline Heart Assessment,' it includes 'An Electrocardiogram (ECG or EKG).' "
      },
      {
        "criterion_number": 11,
        "description": "The response states that echocardiogram can be used to monitor heart function.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends 'An Echocardiogram (Echo)' with LVEF measurement and suggests 'Repeat Echocardiograms' during treatment."
      },
      {
        "criterion_number": 12,
        "description": "The response states that blood pressure can be used to monitor the heart.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists 'Regular Blood Pressure and Heart Rate Checks' at clinic visits and at home monitoring with an automatic cuff."
      },
      {
        "criterion_number": 13,
        "description": "The response specifically mentions that capecitabine can harm the heart.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Capecitabine is not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response specifically mentions that some targeted therapies can harm the heart.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Targeted therapies are not discussed as a source of cardiotoxicity."
      },
      {
        "criterion_number": 15,
        "description": "The response explicitly states that pancreatic cancer treatments can cause at least three cardiac issues: heart failure, arrhythmias, hypertension, ischemia, or cardiomyopathy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It names cardiomyopathy, arrhythmias, hypertension, and coronary artery spasm leading to angina/heart attack (ischemia)."
      },
      {
        "criterion_number": 16,
        "description": "The response explicitly states that the risk of cardiac side effects is higher in patients with preexisting cardiovascular conditions or those receiving specific agents such as anthracyclines or fluoropyrimidines.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it notes 5-FU can be cardiotoxic, it does not state that risk is higher in patients with preexisting cardiovascular conditions nor compare risk among specific agents."
      },
      {
        "criterion_number": 17,
        "description": "The response explicitly recommends baseline cardiac risk assessment and regular monitoring with echocardiography, cardiac biomarkers, and clinical evaluation for early/asymptomatic cardiac dysfunction.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It recommends baseline echo and ECG, repeat echocardiograms, biomarkers (BNP/NT-proBNP, troponin), and clinical checks (BP, HR, physical exams), noting biomarkers as 'early warning' signs."
      },
      {
        "criterion_number": 18,
        "description": "The response explicitly references recommendations from the ACC and/or ASCO about pretherapy evaluation and ongoing surveillance.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of ACC or ASCO guidelines or recommendations."
      },
      {
        "criterion_number": 19,
        "description": "The response explicitly recommends that the user discuss the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly directs contacting the oncology nurse/doctor and states 'Your mother's oncology team is the ultimate authority,' and suggests Cardio-Oncology consultation."
      }
    ],
    "question_number": 132,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:17:13.513448",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly states that some chemotherapy can have negative effects on the heart.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States cardiotoxicity can be a side effect of cancer therapies and details cardiac risks under chemotherapy."
      },
      {
        "criterion_number": 2,
        "description": "The response specifically mentions that 5-fluorouracil (or \u201c5-FU\u201d) can harm the heart.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Explicitly lists 5-Fluorouracil (5-FU) and describes coronary spasm, angina/MI, and arrhythmias."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends monitoring for shortness of breath.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Includes 'Shortness of Breath (Dyspnea)' with specific scenarios to monitor."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends monitoring for chest pain.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists 'Chest Pain or Discomfort' and describes concerning features."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends monitoring for fast heart rate.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Advises checking heart rate for tachycardia and irregular pulse."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends monitoring for dizziness.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Includes 'Dizziness or Lightheadedness' in symptoms to watch for."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends monitoring for unusual fatigue.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Notes 'new, severe, or unexplained' fatigue as a potential cardiac sign."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly recommends discussing any new symptom with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States: 'Any new or worsening symptom should be reported immediately to her oncology team.'"
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly recommends discussing any concerning symptom with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises to 'discuss all symptoms, no matter how minor, with her oncology team,' covering concerning symptoms."
      },
      {
        "criterion_number": 10,
        "description": "The response states that electrocardiograms can be used to monitor the heart.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists ECG/EKG as part of baseline and ongoing assessment."
      },
      {
        "criterion_number": 11,
        "description": "The response states that echocardiogram can be used to monitor heart function.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends echocardiogram to assess LVEF and as follow-up if concerns arise."
      },
      {
        "criterion_number": 12,
        "description": "The response states that blood pressure can be used to monitor the heart.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes blood pressure monitoring at home with guidance on reporting changes."
      },
      {
        "criterion_number": 13,
        "description": "The response specifically mentions that capecitabine can harm the heart.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Mentions Capecitabine with coronary spasm, angina/MI, and arrhythmias."
      },
      {
        "criterion_number": 14,
        "description": "The response specifically mentions that some targeted therapies can harm the heart.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Does not mention targeted therapies or their cardiotoxicity."
      },
      {
        "criterion_number": 15,
        "description": "The response explicitly states that pancreatic cancer treatments can cause at least three cardiac issues: heart failure, arrhythmias, hypertension, ischemia, or cardiomyopathy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly lists arrhythmias, hypertension, heart failure (gemcitabine), and ischemia/MI (5-FU/capecitabine)."
      },
      {
        "criterion_number": 16,
        "description": "The response explicitly states that the risk of cardiac side effects is higher in patients with preexisting cardiovascular conditions or those receiving specific agents such as anthracyclines or fluoropyrimidines.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States preexisting heart conditions 'can increase her risk' and details fluoropyrimidine risks."
      },
      {
        "criterion_number": 17,
        "description": "The response explicitly recommends baseline cardiac risk assessment and regular monitoring with echocardiography, cardiac biomarkers, and clinical evaluation for early/asymptomatic cardiac dysfunction.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Provides baseline history/physical, ECG, echocardiogram, troponin/BNP; during treatment suggests periodic biomarkers, clinical assessments, and repeat imaging; notes early detection importance."
      },
      {
        "criterion_number": 18,
        "description": "The response explicitly references recommendations from the American College of Cardiology and/or the American Society of Clinical Oncology, stating that pretherapy evaluation and ongoing surveillance are recommended for patients with cardiovascular risk factors or those receiving cardiotoxic agents.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No ACC or ASCO recommendations are cited."
      },
      {
        "criterion_number": 19,
        "description": "The response explicitly recommends that the user discuss the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages asking her oncologist about risks and to report symptoms to the oncology team."
      }
    ],
    "question_number": 132,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:17:53.098164",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include that treatment decisions are personal decisions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly emphasizes autonomy and that it is the patient's body and life; states support for their decision and focuses on honoring the person and their wishes."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend listening to their feelings.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes a section titled 'Listen More, Talk Less' with open-ended questions to elicit feelings and perspective."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend validating their feelings.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Has a dedicated 'Validate Their Feelings and Their Decision' section with specific validating statements."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend respecting their autonomy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States 'This is your body and your life. I will respect your decision' and advocates for documenting wishes via advance directives."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend supporting their quality of life.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Reframes care from curative to comfort-focused, recommends palliative care, and offers concrete quality-of-life activities and symptom management planning."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend offering reassurance.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides specific reassuring statements affirming continued love, presence, and support even after stopping treatment."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that clear, compassionate communication about prognosis, treatment options, and goals of care is important.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises scheduling meetings with clinicians to develop a new plan, discuss 'what to expect' (prognosis), symptom management, and roles of palliative care and hospice (options and goals of care)."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that transitioning to hospice care may be appropriate when the focus shifts entirely to comfort and dignity.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explains hospice as care when curative treatment has stopped and focuses on comprehensive comfort, recommending engagement with hospice when appropriate."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that hospice provides intensive symptom management, psychosocial and spiritual support, and home-based care, while avoiding non-beneficial interventions such as hospitalization or aggressive procedures.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Describes hospice as comprehensive comfort care with emotional/spiritual support and usually home-based, but does not mention avoidance of non-beneficial interventions or explicitly emphasize intensive symptom management."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention addressing practical issues related to end-of-life decision-making, such as managing costs and accessing resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Addresses practicalities including advance directives/living will, coordinating services at home, engaging social workers, and connecting with hospice/palliative resources; while costs are not explicitly mentioned, accessing resources and practical planning are clearly covered."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises scheduling a meeting with the oncologist along with palliative care and hospice to create a new plan."
      }
    ],
    "question_number": 133,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:18:23.089849",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include that treatment decisions are personal decisions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly frames stopping treatment as a profoundly personal choice and emphasizes it is their life, body, and decision."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend listening to their feelings.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advocates active listening and giving space to express fears, hopes, and frustrations."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend validating their feelings.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends acknowledging courage and provides validating statements to affirm their feelings."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend respecting their autonomy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States it is their choice and right to decide about their care and encourages family to respect the decision."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend supporting their quality of life.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Shifts focus to comfort and quality of life; encourages symptom management, meaningful activities, and creating a peaceful environment."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend offering reassurance.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Reassures that stopping treatment is not giving up and suggests supportive, reassuring language."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that clear, compassionate communication about prognosis, treatment options, and goals of care is important.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends a goals-of-care meeting with the oncologist, discusses transition of care, palliative and hospice options, and notes the six-month prognosis context for hospice."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that transitioning to hospice care may be appropriate when the focus shifts entirely to comfort and dignity.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Advises discussing hospice when focus is on comfort and quality of life, consistent with a transition away from disease-directed treatment."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that hospice provides intensive symptom management, psychosocial and spiritual support, and home-based care, while avoiding non-beneficial interventions such as hospitalization or aggressive procedures.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Mentions hospice provides symptom management and can be at home or a facility, and supports caregivers, but does not explicitly note spiritual support or the avoidance of non-beneficial hospitalization/aggressive procedures."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention addressing practical issues related to end-of-life decision-making, such as managing costs and accessing resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Includes advance directives, durable power of attorney, will/estate planning, and funeral wishes\u2014clear practical end-of-life planning topics."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages scheduling a goals-of-care meeting with the oncologist and discussing palliative/hospice care with the medical team."
      }
    ],
    "question_number": 133,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:18:45.264149",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing legal planning with a qualified professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises consulting a qualified estate planning attorney and reiterates professional guidance in the Actionable Next Steps."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that laws can vary state to state.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States documents must be drafted according to your state's laws, indicating state-by-state variation."
      },
      {
        "criterion_number": 3,
        "description": "The response should include a description of an advance healthcare directive or living will.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a clear description of a Living Will/Advance Directive and details specific end-of-life decisions it covers."
      },
      {
        "criterion_number": 4,
        "description": "The response should include a description of a medical power of attorney.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes Health Care Power of Attorney/Medical Power of Attorney/Health Care Proxy, including purpose and role of agent."
      },
      {
        "criterion_number": 5,
        "description": "The response should include a description of a durable power of attorney for finances.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains Durable Power of Attorney for Finances, notes durability during incapacity, and lists authorities granted."
      },
      {
        "criterion_number": 6,
        "description": "The response should include a description of a last will and testament.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Defines a Will, its functions (executor, distribution, guardians), and mentions probate."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that POLST forms translate preferences into actionable medical orders for emergency settings.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of POLST or physician orders that translate preferences into actionable medical orders."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that these documents ensure that care aligns with the patient\u2019s values and preferences, especially if the patient loses decision-making capacity due to disease progression or treatment effects.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Emphasizes honoring the husband's wishes and discusses decision-making if he cannot communicate; aligns care with preferences during incapacity."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that it is essential to have ongoing, structured conversations about goals of care, as patient preferences may change over time.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Encourages having the conversation but does not specify ongoing/structured discussions or that preferences may change over time."
      }
    ],
    "question_number": 134,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:19:05.204952",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing legal planning with a qualified professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises consulting with an attorney specializing in elder law/estate planning and repeats this recommendation, stating the assistant cannot provide legal advice."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that laws can vary state to state.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states that state laws vary significantly and emphasizes using an attorney in their state."
      },
      {
        "criterion_number": 3,
        "description": "The response should include a description of an advance healthcare directive or living will.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a dedicated section on Advance Directive/Living Will explaining what it does and why it is critical, including examples (artificial nutrition, hydration, ventilation)."
      },
      {
        "criterion_number": 4,
        "description": "The response should include a description of a medical power of attorney.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes Healthcare Power of Attorney/Proxy, its function (designates an agent to make medical decisions if incapacitated), and why it is critical."
      },
      {
        "criterion_number": 5,
        "description": "The response should include a description of a durable power of attorney for finances.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains Durable Power of Attorney for Finances, its durability upon incapacity, and scope (pay bills, access accounts, file taxes) and why it avoids guardianship."
      },
      {
        "criterion_number": 6,
        "description": "The response should include a description of a last will and testament.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Defines a Last Will and Testament, what it covers, naming an executor, and the consequences of dying intestate."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that POLST forms translate preferences into actionable medical orders for emergency settings.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of POLST or physician orders translating preferences into medical orders for emergency settings."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that these documents ensure that care aligns with the patient\u2019s values and preferences, especially if the patient loses decision-making capacity due to disease progression or treatment effects.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that the HCPOA allows decisions in line with his values and the advance directive guides care consistent with his personal values when incapacitated, addressing loss of decision-making capacity and alignment with preferences."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that it is essential to have ongoing, structured conversations about goals of care, as patient preferences may change over time.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Encourages having open conversations now but does not emphasize ongoing/structured discussions or that preferences may change over time."
      }
    ],
    "question_number": 134,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:19:25.568139",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing their concerns with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises asking the loved one's nurse or doctor (members of the oncology team) to connect them to financial resources, thereby recommending engagement with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing their concerns with a social worker.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly instructs to talk to the hospital/cancer center's social worker as the top priority."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend discussing their concerns with a financial counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly recommends engaging a financial navigator/financial assistance staff and the billing department, which fulfills the role of a financial counselor."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that patient advocacy organizations can help and include information on the Pancreatic Cancer Action Network (PanCAN).",
        "score_given": 3,
        "max_points": 3,
        "justification": "It highlights PanCAN Patient Central as a first call and provides phone and website details."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that patient advocacy organizations can help and include information on CancerCare.org.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It includes CancerCare Co-Payment Assistance Foundation with a description and the specific website link."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that patient advocacy organizations can help and include information for the American Cancer Society.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists American Cancer Society programs (Hope Lodge, Road to Recovery) and provides the 24/7 phone number."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that patients with pancreatic cancer who are facing significant medical bills have access to several financial assistance options.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It clearly states there are many systems and organizations that can help, and provides a comprehensive list of options."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that financial assistance options include patient assistance programs (PAPs) from independent charity foundations, pharmaceutical company programs, and direct grants from nonprofit organizations.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It mentions pharmaceutical company PAPs, independent co-pay foundations (PAN, GoodDays, HealthWell), and nonprofit grants/support via CancerCare and the Patient Advocate Foundation."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that these programs may provide co-payment assistance, help with insurance premiums, and sometimes support for non-medical expenses such as transportation or housing.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It includes co-pay assistance, notes Medicare Savings Programs/Extra Help for premiums, and lists transportation and lodging support (e.g., ACS Road to Recovery and Hope Lodge)."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that eligibility is generally based on annual household income (often up to 400\u2013500% of the federal poverty level), insurance status, and physician endorsement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it references income-based assistance and gathering insurance information, it does not mention the 400\u2013500% FPL range or physician endorsement as eligibility criteria."
      }
    ],
    "question_number": 135,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:19:55.653901",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend discussing concerns with the oncology team",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises working with the doctor to appeal denials and specifically mentions asking the oncologist's office for help with patient assistance programs, which constitutes recommending discussion with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "Recommend discussing concerns with a social worker",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly and repeatedly recommends engaging hospital social workers as the first and crucial step to navigate financial assistance."
      },
      {
        "criterion_number": 3,
        "description": "Recommend discussing concerns with a financial counselor",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly recommends speaking with hospital financial counselors as a primary action."
      },
      {
        "criterion_number": 4,
        "description": "State that patient advocacy organizations can help and include information on PanCAN",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response lists the Pancreatic Cancer Action Network (PanCAN), describes Patient Central, includes the phone number, and explains how they help connect patients to financial resources."
      },
      {
        "criterion_number": 5,
        "description": "State that patient advocacy organizations can help and include information on CancerCare.org",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response includes CancerCare, provides the phone number, and specifies the types of assistance offered (transportation, child care, co-pay assistance)."
      },
      {
        "criterion_number": 6,
        "description": "State that patient advocacy organizations can help and include information for the American Cancer Society",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response includes the American Cancer Society, provides the phone number, and describes services (transportation, lodging, information on financial resources)."
      },
      {
        "criterion_number": 7,
        "description": "Mention that pancreatic cancer patients with significant medical bills have access to several financial assistance options",
        "score_given": 2,
        "max_points": 2,
        "justification": "The response clearly states there are many resources to alleviate financial burden and lists numerous assistance options."
      },
      {
        "criterion_number": 8,
        "description": "Mention that assistance includes PAPs from independent charity foundations, pharmaceutical company programs, and direct grants from nonprofits",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response mentions co-pay assistance foundations (independent charities), pharmaceutical company patient assistance programs, and direct financial aid from nonprofits like CancerCare and PAF."
      },
      {
        "criterion_number": 9,
        "description": "Mention that these programs may provide co-payment assistance, help with insurance premiums, and support for non-medical expenses",
        "score_given": 0,
        "max_points": 3,
        "justification": "While the response discusses co-pay assistance and non-medical supports (transportation, lodging), it does not mention help with insurance premiums."
      },
      {
        "criterion_number": 10,
        "description": "Mention that eligibility is based on income (often up to 400\u2013500% FPL), insurance status, and physician endorsement",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not specify typical eligibility criteria such as FPL thresholds, insurance status requirements, or physician endorsement."
      }
    ],
    "question_number": 135,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:20:22.774175",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe PARP inhibitors as a class of targeted agents that block the PARP enzyme, which is involved in repairing single-strand DNA breaks.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response accurately explains that PARP inhibitors block the PARP enzyme, describes PARP\u2019s role in repairing single-strand DNA breaks, and frames them as targeted therapy."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that PARP inhibitors can be used in advanced pancreatic cancer when there is a germline mutation in a BRCA gene.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states that the primary indication in pancreatic cancer is for patients with germline BRCA1/2 mutations and contextualizes use in metastatic disease."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that PARP inhibitors are used as maintenance therapy in patients with metastatic pancreatic cancer who have a germline BRCA1 or BRCA2 mutation and whose cancer has not progressed after at least 16 weeks of first-line platinum-based chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly describes maintenance use in metastatic pancreatic cancer with germline BRCA mutations after a response/stable disease on platinum-based chemotherapy for at least 16 weeks."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that comprehensive germline testing for BRCA mutations is recommended for all patients with pancreatic cancer to identify those eligible for this targeted approach.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that all patients with pancreatic cancer are recommended to undergo genetic testing to identify mutations such as BRCA1/2."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that the American Society of Clinical Oncology specifically recommends olaparib, based on the POLO trial, which demonstrated a significant improvement in progression-free survival compared to placebo, without compromising quality of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although olaparib is mentioned, there is no reference to ASCO recommendations, the POLO trial, progression-free survival benefit, or quality of life findings."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that other PARP inhibitors and combination strategies are under investigation, but their use remains investigational at this time. Based on the NCCN Guidelines Version 2.2025: Principles of Systemic Therapy for Pancreatic Adenocarcinoma (Metastatic Disease, First-Line Therapy) across performance status groups. For Good PS (0\u20131), preferred regimens include FOLFIRINOX (category 1 or modified FOLFIRINOX), Gemcitabine + albumin-bound paclitaxel (category 1), and NALIRIFOX (category 1). For patients with BRCA1/2 or PALB2 mutations, preferred options are FOLFIRINOX (category 1 or modified FOLFIRINOX) and Gemcitabine + cisplatin (category 1). Other recommended regimens include Gemcitabine (category 1), Gemcitabine + erlotinib (category 1), Gemcitabine + capecitabine, Gemcitabine + albumin-bound paclitaxel + cisplatin, Fluoropyrimidine + oxaliplatin, CapeOx (category 2B), OFF (category 2B), and GTX (category 2B). For Intermediate PS (2), preferred regimens include Gemcitabine + albumin-bound paclitaxel (category 1), Capecitabine, Gemcitabine, 5-FU + leucovorin + oxaliplatin (FOLFOX), 5-FU + leucovorin + irinotecan (FOLFIRI), and CapeOx. For Poor PS (3), Palliative and best supportive care is recommended, though options include Capecitabine (category 2B), continuous infusion 5-FU (category 2B), and Gemcitabine (standard or fixed-dose-rate infusion). Across all PS groups, therapies useful in certain circumstances include targeted agents: Entrectinib, Larotrectinib, and Repotrectinib (for NTRK gene fusion\u2013positive tumors); Pembrolizumab (for MSI-H, dMMR, or TMB-H \u226510 mut/Mb); Selpercatinib (for RET gene fusion\u2013positive tumors); and Dabrafenib + trametinib (for BRAF V600E mutation\u2013positive cases). The guidelines note that all regimens are category 2A unless otherwise indicated, and patients with poor PS derive marginal benefit from systemic therapy.",
        "score_given": 0,
        "max_points": 4,
        "justification": "The response does not discuss investigational status of other PARP inhibitors/combination strategies or reference NCCN-based first-line regimen frameworks."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises discussing with the oncology team and provides questions for the next appointment, clearly recommending consultation with an oncologist."
      }
    ],
    "question_number": 136,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:20:41.101036",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describe PARP inhibitors as a class of targeted agents that block the PARP enzyme, which is involved in repairing single-strand DNA breaks.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response clearly defines PARP enzymes, notes their role in single-strand DNA break repair, and states that PARP inhibitors are targeted therapies that block PARP. It also explains the synthetic lethality mechanism."
      },
      {
        "criterion_number": 2,
        "description": "Mention that PARP inhibitors can be used in advanced pancreatic cancer when there is a germline mutation in a BRCA gene.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that PARP inhibitors are primarily effective in metastatic pancreatic cancer with a germline BRCA1/2 mutation and emphasizes the need for genetic testing."
      },
      {
        "criterion_number": 3,
        "description": "Mention that PARP inhibitors are used as maintenance therapy in patients with metastatic pancreatic cancer who have a germline BRCA1 or BRCA2 mutation and whose cancer has not progressed after at least 16 weeks of first-line platinum-based chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response specifies olaparib as maintenance after platinum-based chemotherapy in metastatic disease if there is no progression after at least 16 weeks."
      },
      {
        "criterion_number": 4,
        "description": "Mention that comprehensive germline testing for BRCA mutations is recommended for all patients with pancreatic cancer to identify those eligible for this targeted approach.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it advises genetic testing for the father and raises testing in questions to ask, it does not state the universal recommendation for all pancreatic cancer patients."
      },
      {
        "criterion_number": 5,
        "description": "Mention that the American Society of Clinical Oncology specifically recommends olaparib, based on the POLO trial, which demonstrated a significant improvement in progression-free survival compared to placebo, without compromising quality of life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not cite ASCO or the POLO trial, nor does it specifically note the PFS benefit without compromising quality of life."
      },
      {
        "criterion_number": 6,
        "description": "Mention that other PARP inhibitors and combination strategies are under investigation, but their use remains investigational at this time, and reference NCCN Guidelines Version 2.2025 systemic therapy options across performance status groups.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No discussion of investigational status of other PARP inhibitors/combos or mention of NCCN v2.2025 first-line systemic therapy options across performance statuses is provided."
      },
      {
        "criterion_number": 7,
        "description": "Recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises having informed discussions with the medical team, provides questions for the doctors, and notes they are the best source for the specific situation."
      }
    ],
    "question_number": 136,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:21:08.311874",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend considering proximity to the treatment center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises choosing housing close to the hospital to reduce commute burden during treatment."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend considering housing options near the cancer center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses short-term vs long-term housing, costs, accessibility, and hospital-affiliated options like Hope Lodge."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend considering transportation to and from the cancer center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Reviews transportation options including driving/parking, public transit, hospital shuttles, and rideshare services."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend considering financial considerations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Comprehensively addresses insurance, cost of living, housing costs, lost income, hidden costs, and contacting financial navigators."
      },
      {
        "criterion_number": 5,
        "description": "The response should include insurance coverage.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Details in-network vs out-of-network, pre-authorizations, travel/lodging benefits, and confirming coverage with the insurer."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend considering the social support system near the cancer center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses caregiver support, availability of support in the new city, and potential isolation from leaving existing support systems."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide information for the Pancreatic Cancer Action Network (PanCAN) Patient services.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions PanCAN generally but does not provide specific PanCAN Patient Services information or contact details."
      },
      {
        "criterion_number": 8,
        "description": "The response should provide information for the American Cancer Society (ACS) page on finding a doctor.",
        "score_given": 0,
        "max_points": 3,
        "justification": "References ACS Hope Lodge for housing but does not include information or a link to the ACS 'Find a Doctor' resource."
      },
      {
        "criterion_number": 9,
        "description": "The recommendation should provide a link to the NCI website for finding an NCI-designated cancer center.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Encourages using the NCI website but does not provide a direct link to the NCI-designated cancer center finder."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that the NCCN Panel (version 2.2025) recommends that decisions about diagnosis and management involve multidisciplinary teams at high-volume centers with appropriate high-volume imaging studies.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not reference NCCN guidance, version 2.2025, or the specific recommendation wording."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly mentions patient preferences, goals of care, or quality of life as central to the decision.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes the mother's wishes, quality of life, comfort, and balancing treatment benefits with daily well-being."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly addresses open communication about expectations, prognosis, or the impact of relocation on daily life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends deep, honest family conversations and discusses the daily-life impact of relocation and caregiver burnout."
      },
      {
        "criterion_number": 13,
        "description": "The response explicitly mentions continuity of care, transferring medical records, coordinating with the current care team, or ensuring uninterrupted access to medications/supportive services.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Advises talking to the current oncologist for referrals and help transferring records; also notes coordination for second opinions."
      },
      {
        "criterion_number": 14,
        "description": "The response explicitly mentions access to multidisciplinary care and/or clinical trials as important factors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Highlights multidisciplinary teams and stresses access to clinical trials as key benefits of major centers."
      },
      {
        "criterion_number": 15,
        "description": "The response explicitly recommends discussing the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly instructs to talk to the current oncologist and seek second or third opinions from top centers."
      }
    ],
    "question_number": 137,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:21:42.438001",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend considering proximity to the treatment center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises living close to the main campus/satellite clinics and explains why proximity is essential due to frequent appointments and fatigue."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend considering housing options near the cancer center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a dedicated Housing section discussing temporary vs. permanent options, cost of living, and nearby amenities."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend considering transportation to and from the cancer center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses transportation options including public transport, rideshare, parking, and personal vehicles."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend considering financial considerations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Comprehensively covers financial aspects: insurance, moving costs, cost of living, lost income, FMLA, and financial assistance resources."
      },
      {
        "criterion_number": 5,
        "description": "The response should include insurance coverage.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Details in-network status, pre-authorization, state-specific plan issues, deductibles, and OOP maximums."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend considering the social support system near the cancer center.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses caregiver roles, impact on family/friends, ability to visit, and finding support groups/community resources."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide information for the Pancreatic Cancer Action Network (PanCAN) Patient services.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions PanCAN generally but does not provide specific PanCAN Patient Services information or access details."
      },
      {
        "criterion_number": 8,
        "description": "The response should provide information for the American Cancer Society (ACS) page on finding a doctor.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of ACS or its resources for finding a doctor."
      },
      {
        "criterion_number": 9,
        "description": "The recommendation should provide a link to the NCI website for finding an NCI-designated cancer center.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not mention NCI or provide a link to NCI-designated cancer centers."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that the NCCN Panel (version 2.2025) recommends that decisions about diagnosis and management involve multidisciplinary teams at high-volume centers with appropriate high-volume imaging studies.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While emphasizing multidisciplinary and high-volume centers, it does not cite NCCN or version 2.2025 recommendations."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly mentions patient preferences, goals of care, or quality of life as central to the decision.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Centers patient's wishes, involvement, and quality of life, including early palliative care integration."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly addresses open communication about expectations, prognosis, or the impact of relocation on daily life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly discusses the impact of relocation on daily life (stress, loss of familiarity, isolation, caregiver burden)."
      },
      {
        "criterion_number": 13,
        "description": "The response explicitly mentions continuity of care, transferring medical records, coordinating with the current care team, or ensuring uninterrupted access to medications/supportive services.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Includes a Continuity of Care section on medical records transfer and advises consulting the current team; addresses emergency care setup."
      },
      {
        "criterion_number": 14,
        "description": "The response explicitly mentions access to multidisciplinary care and/or clinical trials as important factors.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Highlights a multidisciplinary pancreatic cancer program and involvement in research/clinical trials as key considerations."
      },
      {
        "criterion_number": 15,
        "description": "The response explicitly recommends discussing the case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends obtaining a second opinion from the potential new cancer center and engaging with specialists including medical oncologists."
      }
    ],
    "question_number": 137,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:22:23.503019",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend discussing the anxiety with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly advises, \"Talk to the Oncologist or Nurse Navigator: Let them know about the severe anxiety,\" which clearly recommends discussing the anxiety with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "Include considering relaxation techniques prior to the scan.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It provides concrete relaxation techniques (e.g., box breathing and grounding exercises) to use in the waiting room or car before the scan."
      },
      {
        "criterion_number": 3,
        "description": "Recommend asking the oncology team about what will happen during the scan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests preparing questions for the oncologist and advises understanding \"what to expect during the scan\" (duration, fasting), which together recommend asking the team about scan details."
      },
      {
        "criterion_number": 4,
        "description": "Include talking to a mental health professional.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends connecting with therapists/counselors through the cancer center and mentions counseling and coping strategies, indicating involvement of mental health professionals."
      },
      {
        "criterion_number": 5,
        "description": "Include talking to a social worker.",
        "score_given": 1,
        "max_points": 1,
        "justification": "It explicitly recommends connecting with an oncology social worker."
      },
      {
        "criterion_number": 6,
        "description": "Discuss medical interventions to help with anxiety.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states the oncologist may prescribe a short-term, low-dose anti-anxiety medication for the day of the scan, which is a medical intervention."
      },
      {
        "criterion_number": 7,
        "description": "Explicitly state that severe scan-related anxiety is highly prevalent or very common among cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it validates that scanxiety is real and understandable, it does not explicitly state that scan-related anxiety is common or highly prevalent among cancer patients."
      },
      {
        "criterion_number": 8,
        "description": "Explicitly mention at least two of: psychotherapy, psychoeducation, supportive therapy, or integrative modalities.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions counseling/therapists (which implies psychotherapy) but does not explicitly use the terms psychotherapy, psychoeducation, supportive therapy, or integrative modalities, nor does it name two of these categories."
      },
      {
        "criterion_number": 9,
        "description": "Explicitly identify CBT as first-line per a major oncology guideline.",
        "score_given": 0,
        "max_points": 6,
        "justification": "CBT is not mentioned, and no guideline attribution (e.g., ASCO/NCCN) is provided."
      },
      {
        "criterion_number": 10,
        "description": "Explicitly mention MBIs/MBSR as recommended with guideline attribution.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mindfulness-based interventions or MBSR are not mentioned, and no guideline attribution is given."
      },
      {
        "criterion_number": 11,
        "description": "State that pharmacologic therapy is a secondary option with weaker evidence per a major oncology guideline.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although short-term anxiolytics are mentioned, the response does not frame pharmacotherapy as secondary with weaker evidence nor attribute this stance to a major guideline."
      }
    ],
    "question_number": 138,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:22:50.980312",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing the anxiety with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises to inform the oncologist/palliative care team about severe anxiety and to discuss accommodations, demonstrating clear recommendation to engage the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response should include considering relaxation techniques prior to the scan.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes deep breathing, mindfulness/meditation apps, guided imagery, and gentle movement as relaxation strategies before/during scans."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend asking the oncology team about what will happen during the scan.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests learning \u201cwhat to expect\u201d and asking about accommodations, it does not explicitly recommend asking the oncology team to explain what will happen during the scan."
      },
      {
        "criterion_number": 4,
        "description": "The response should include talking to a mental health professional.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends referrals to a psychologist or psychiatrist and mentions counseling support, clearly endorsing engagement with mental health professionals."
      },
      {
        "criterion_number": 5,
        "description": "The response should include talking to a social worker.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Explicitly mentions referral to a social worker specializing in cancer care."
      },
      {
        "criterion_number": 6,
        "description": "The response should discuss medical interventions to help with anxiety.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically discusses short-acting anti-anxiety medication (e.g., benzodiazepines) prior to/during the scan."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly states that severe anxiety related to upcoming scans is highly prevalent or very common among patients with pancreatic cancer or cancer in general.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that scan-related anxiety is \u201cvery common and understandable,\u201d explicitly normalizing its prevalence."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly mentions at least two of the following resource types for managing treatment-related anxiety: psychotherapy, psychoeducation, supportive therapy, or integrative modalities.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions counseling and mindfulness/guided imagery, it does not explicitly name at least two of the specified resource types (e.g., 'psychotherapy,' 'psychoeducation,' 'supportive therapy,' or label them as 'integrative modalities')."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly identifies Cognitive Behavioral Therapy (CBT) as the first-line or primary intervention for treatment-related anxiety in pancreatic cancer or cancer patients, and attributes this recommendation to a major oncology guideline.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not mention CBT nor attribute recommendations to a major oncology guideline."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly mentions mindfulness-based interventions (MBIs) or mindfulness-based stress reduction (MBSR) as recommended for anxiety in cancer patients, and attributes this recommendation to a major oncology guideline.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions mindfulness apps but does not reference MBIs/MBSR nor attribute recommendations to any oncology guideline."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly states that pharmacologic therapy may be considered for severe anxiety or when first-line psychological interventions are insufficient, and that this is a secondary option with weaker evidence, as per a major oncology guideline.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Discusses benzodiazepines before/during scans but does not contextualize pharmacotherapy as secondary to psychological first-line interventions nor cite guideline-based evidence strength."
      }
    ],
    "question_number": 138,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:23:21.888593",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include open communication with the family.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicit section on communication with husband and children (age-appropriate honesty), plus regular family check-ins; clearly emphasizes open, honest dialogue."
      },
      {
        "criterion_number": 2,
        "description": "The response should include maintaining daily routines.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Dedicated section on routines: protecting rituals, maintaining schedules, and using a central calendar to preserve normalcy."
      },
      {
        "criterion_number": 3,
        "description": "The response should include continuing to do activities that bring enjoyment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Encourages family rituals (movie night, pancakes), designating cancer-free zones, focusing on small joys, and keeping laughter, all of which promote enjoyable activities."
      },
      {
        "criterion_number": 4,
        "description": "The response should include letting the support system help.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Directs to accept help from friends/community for meals/chores/child pickup and suggests a communications chief/CaringBridge to leverage support network."
      },
      {
        "criterion_number": 5,
        "description": "The response should include ensuring self-care for the patient.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it respects the patient's preferences and energy fluctuations, it does not explicitly address patient self-care strategies (e.g., rest, symptom control, nutrition, mental health care)."
      },
      {
        "criterion_number": 6,
        "description": "The response should include ensuring self-care for the support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides concrete caregiver self-care strategies: support groups/therapy, taking small breaks, acknowledging grief, and prioritizing caregiver well-being."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that pancreatic cancer imposes profound emotional, social, and practical upheaval on both the patient and family, disrupting established routines, roles, and relationships.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Acknowledges the challenge, need for a 'new normal,' fluctuating energy, shifting roles, disrupted routines, and ongoing grief/adaptation for the whole family."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that early integration of supportive and palliative care is recommended.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of supportive or palliative care or recommendations for early integration."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that referrals to registered dietitians and symptom management specialists can help minimize disruptions to family life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No reference to dietitians, symptom management specialists, or how such referrals could help maintain family routines."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that caregiver and family support resources can provide education, emotional support, and practical assistance.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions caregiver support groups and community help but does not explicitly state that formal caregiver/family support resources provide education, emotional support, and practical assistance."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that the literature notes persistent gaps in support for caregivers and families affected by pancreatic cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of literature or gaps in caregiver/family support specific to pancreatic cancer."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No recommendation to discuss strategies or care planning with an oncologist."
      }
    ],
    "question_number": 139,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:23:43.652391",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include open communication with the family.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly emphasizes honest, age-appropriate communication, scheduled check-ins, validation of feelings, and reassurance about constants."
      },
      {
        "criterion_number": 2,
        "description": "The response should include maintaining daily routines.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends maintaining regular mealtimes, bedtimes, school schedules, and chores to preserve structure."
      },
      {
        "criterion_number": 3,
        "description": "The response should include continuing to do activities that bring enjoyment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Encourages continuing family activities (movie nights, game nights, walks, outings) and redefining fun with simpler joys."
      },
      {
        "criterion_number": 4,
        "description": "The response should include letting the support system help.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises building a support network, accepting practical and emotional help, using a point person, and joining support groups."
      },
      {
        "criterion_number": 5,
        "description": "The response should include ensuring self-care for the patient.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages the patient to rest according to fluctuating energy levels and supports couple time to nurture well-being."
      },
      {
        "criterion_number": 6,
        "description": "The response should include ensuring self-care for the support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights caregiver self-care, including sleep, nutrition, physical activity, time for oneself, and counseling/therapy."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that pancreatic cancer imposes profound emotional, social, and practical upheaval on both the patient and family, disrupting established routines, roles, and relationships.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Notes immense physical and emotional strain, the need for a new normal, and acknowledges routine disruptions, plan changes due to appointments/fatigue, and emotional impacts on the family."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that early integration of supportive and palliative care is recommended.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of supportive or palliative care or early integration thereof."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that referrals to registered dietitians and symptom management specialists can help minimize disruptions to family life.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not reference dietitians or symptom management specialists."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that caregiver and family support resources can provide education, emotional support, and practical assistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends support groups and professional counseling, noting validation, practical tips, and coping tools (educational support), fulfilling emotional and practical assistance."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that the literature notes persistent gaps in support for caregivers and families affected by pancreatic cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No reference to literature or gaps in caregiver/family support."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not advise discussing strategies or care coordination with the oncologist."
      }
    ],
    "question_number": 139,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:24:07.101912",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend discussing genetic counseling with the oncology team or healthcare provider in the context of pancreatic cancer care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly notes that the oncologist will likely recommend and refer to a genetic counselor and situates genetic counseling within pancreatic cancer care (\"Your loved one's oncologist will likely recommend and refer you to a genetic counselor\")."
      },
      {
        "criterion_number": 2,
        "description": "Accurately describe the role of a genetic counselor as a trained professional who helps individuals and families understand genetic aspects of disease, provides information, guidance, and support for informed decision-making, and assists with risk assessment and testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response defines genetic counseling as a conversation with a genetic counselor or genetics-trained clinician, emphasizes education, informed consent, risk assessment (pedigree review), and guidance regarding testing and implications for treatment and family members."
      },
      {
        "criterion_number": 3,
        "description": "Mention that genetic counseling involves a structured evaluation of personal and family cancer history.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes collection of detailed family history and creation of a pedigree, with attention to cancer types and ages at diagnosis, indicating a structured evaluation."
      },
      {
        "criterion_number": 4,
        "description": "Mention that genetic counseling involves education about hereditary cancer syndromes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It educates about hereditary cancer genes and syndromes relevant to pancreatic cancer (e.g., BRCA1/2, PALB2, ATM, CDKN2A, Lynch syndrome)."
      },
      {
        "criterion_number": 5,
        "description": "Mention that genetic counseling involves a discussion of the risks, benefits, and limitations of genetic testing.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response outlines pros (treatment implications, family testing), downsides/risks (emotional impact, family dynamics), and limitations (VUS), and describes the testing process."
      },
      {
        "criterion_number": 6,
        "description": "Mention that genetic counseling addresses the psychological and ethical aspects of genetic information, including communication of results to family members and consideration of reproductive implications.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it addresses psychological aspects (emotional impact) and communication with relatives (family letters) and privacy, it does not mention reproductive implications; therefore full required content is not met."
      },
      {
        "criterion_number": 7,
        "description": "Mention that the American Society of Clinical Oncology recommends that this process be conducted with providers experienced in hereditary cancer syndromes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of ASCO or its recommendation regarding use of providers experienced in hereditary cancer syndromes."
      },
      {
        "criterion_number": 8,
        "description": "Mention that the American Society of Clinical Oncology recommends that germline genetic testing be offered early in the disease course, ideally using a multigene panel including genes linked to pancreatic cancer risk such as BRCA1, BRCA2, and others.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although multigene panel testing and relevant genes are discussed, there is no reference to ASCO recommendations or the timing (early in the disease course)."
      }
    ],
    "question_number": 140,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:24:28.198696",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend discussing genetic counseling with the oncology team or healthcare provider in the context of pancreatic cancer care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response explains genetic counseling and its benefits but does not explicitly recommend discussing it with the oncology team or primary healthcare provider."
      },
      {
        "criterion_number": 2,
        "description": "Accurately describe the role of a genetic counselor as a trained professional who helps with understanding genetics, provides guidance for informed decisions, and assists with risk assessment and testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines genetic counseling, identifies the genetic counselor/medical geneticist, and details their roles in risk assessment, education, testing options, and result interpretation."
      },
      {
        "criterion_number": 3,
        "description": "Mention that genetic counseling involves a structured evaluation of personal and family cancer history.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions collection of detailed personal and family history and creation of a three-generation pedigree."
      },
      {
        "criterion_number": 4,
        "description": "Mention that genetic counseling involves education about hereditary cancer syndromes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Discusses inherited mutations, lists specific genes and syndromes (e.g., BRCA1/2, Lynch syndrome), and explains implications across cancers."
      },
      {
        "criterion_number": 5,
        "description": "Mention that genetic counseling involves a discussion of the risks, benefits, and limitations of genetic testing.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a section on benefits and limitations, possible results (positive/negative/VUS), privacy, discrimination (GINA), logistics, and costs."
      },
      {
        "criterion_number": 6,
        "description": "Mention that genetic counseling addresses psychological and ethical aspects of genetic information, including communication of results to family members and consideration of reproductive implications.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Addresses emotional/psychosocial impact, privacy/GINA, and cascade testing to inform relatives, but does not mention reproductive implications or family planning aspects."
      },
      {
        "criterion_number": 7,
        "description": "Mention that the American Society of Clinical Oncology recommends that this process be conducted with providers experienced in hereditary cancer syndromes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No reference to ASCO or recommendations about using providers experienced in hereditary cancer syndromes."
      },
      {
        "criterion_number": 8,
        "description": "Mention that ASCO recommends germline genetic testing be offered early in the disease course, ideally using a multigene panel including BRCA1, BRCA2, and others.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While multigene panel testing and relevant genes are described, there is no mention of ASCO or the recommendation to offer germline testing early in the disease course."
      }
    ],
    "question_number": 140,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:24:50.513638",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that neuropathy is a common side effect from certain chemotherapy drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states neuropathy is common and often caused by chemotherapy (CIPN); also references specific classes later."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing medication side effects with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Repeatedly advises discussing options with the oncology team and tailoring the plan to the patient's situation."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that neuropathy from chemotherapy can be managed by dose reduction.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists 'Dose Reduction' as a management option."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that neuropathy from chemotherapy can be managed by schedule modification.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes 'Treatment holiday' (temporary pause) which is a schedule modification."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that neuropathy from chemotherapy can be managed by switching to an alternate regimen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions switching to a different chemotherapy regimen less likely to cause neuropathy."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that neuropathy from chemotherapy can be managed using supportive medications, including gabapentin.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Lists gabapentin as a commonly used option for neuropathic pain."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that neuropathy from oxaliplatin can be managed using supportive medications, including SNRIs.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Mentions duloxetine (an SNRI) for neuropathic pain but does not specifically link management to oxaliplatin-induced neuropathy."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that neuropathy from oxaliplatin can be managed using supportive medications, including pregabalin.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Mentions pregabalin, but does not specifically address oxaliplatin-induced neuropathy."
      },
      {
        "criterion_number": 10,
        "description": "The response should include physical therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes physical therapy with details on balance, strength, mobility, and fall reduction."
      },
      {
        "criterion_number": 11,
        "description": "The response should include occupational therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes occupational therapy and describes strategies and adaptive tools for daily activities."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that peripheral neuropathy could arise from chemotherapy (notably platinum agents), direct tumor involvement, or paraneoplastic syndromes.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States neuropathy can be caused by chemotherapy and by the cancer itself; also notes platinum agents among causative drugs. Paraneoplastic syndromes are not named, but chemotherapy and tumor involvement are addressed."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that peripheral neuropathy significantly impairs quality of life and functional status.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes impact on quality of life and function, and includes multiple safety/ADL considerations indicating functional impairment."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that management should be individualized, balancing efficacy, side effects, and patient-specific factors.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes treatment is individualized and balanced between cancer control and side-effect management; recommends tailoring with oncology team."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that Duloxetine is the only agent with moderate evidence-based recommendation for the treatment of chemotherapy-induced peripheral neuropathy (CIPN) in cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions duloxetine as first-line but does not state it is the only agent with moderate evidence-based support for CIPN."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that the typical starting dose of duloxetine is 30 mg daily, titrated to 60 mg daily as tolerated, with slow tapering recommended to avoid withdrawal symptoms.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No dosing or tapering details for duloxetine are provided."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that other pharmacologic options include tricyclic antidepressants (nortriptyline, amitriptyline), gabapentin, and pregabalin, which are supported by guidelines for cancer-related neuropathic pain but have inconclusive evidence.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Lists TCAs, gabapentin, and pregabalin, but does not note guideline context or that evidence for CIPN is inconclusive."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that topical agents such as lidocaine and capsaicin patches may be considered for localized neuropathic pain, though evidence is limited.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions topical lidocaine and capsaicin but does not indicate limited evidence or specifically emphasize use for localized neuropathic pain."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that opioids are not preferred for chronic neuropathic pain due to risk of tolerance, dependence, and adverse effects.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Opioids are not discussed; no caution provided about their non-preferred role in chronic neuropathic pain."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that interventional approaches, notably neurolytic celiac plexus block, are effective for refractory pain in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No interventional pain strategies (e.g., celiac plexus block) are mentioned."
      }
    ],
    "question_number": 141,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:26:02.260034",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that neuropathy is a common side effect from certain chemotherapy drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly notes neuropathy is common with pancreatic cancer treatment and lists specific chemotherapy agents (gemcitabine, oxaliplatin, paclitaxel) as culprits."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing medication side effects with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly advises discussing options with the oncology team, palliative care, and/or a neurologist."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that neuropathy from chemotherapy can be managed by dose reduction.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends lowering chemotherapy dose when neuropathy becomes severe."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that neuropathy from chemotherapy can be managed by schedule modification.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It suggests extending time between cycles and temporary holds to allow recovery."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that neuropathy from chemotherapy can be managed by switching to an alternate regimen.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions switching to a different chemotherapy agent if neuropathy is severe."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that neuropathy from chemotherapy can be managed using supportive medications, including gabapentin.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Gabapentin is listed as a first-line option for neuropathic pain."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that neuropathy from oxaliplatin can be managed using supportive medications, including SNRIs.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Oxaliplatin is named as a culprit, and SNRIs (duloxetine) are recommended for neuropathic pain management."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that neuropathy from oxaliplatin can be managed using supportive medications, including pregabalin.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Oxaliplatin is identified as a cause and pregabalin is listed as a supportive medication."
      },
      {
        "criterion_number": 10,
        "description": "The response should include physical therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Physical therapy is included with details on strength and balance training."
      },
      {
        "criterion_number": 11,
        "description": "The response should include occupational therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Occupational therapy is explicitly included with adaptive strategies."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that peripheral neuropathy could arise from chemotherapy (notably platinum agents), direct tumor involvement, or paraneoplastic syndromes.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It mentions chemotherapy (including oxaliplatin) and paraneoplastic syndromes, and states neuropathy may be due to the cancer itself."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that peripheral neuropathy significantly impairs quality of life and functional status.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It calls neuropathy debilitating, emphasizes quality-of-life impact, and discusses fall risk and functional safety."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that management should be individualized, balancing efficacy, side effects, and patient-specific factors.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It stresses tailoring to the patient's situation and balancing cancer control with side effects."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that Duloxetine is the only agent with moderate evidence-based recommendation for the treatment of chemotherapy-induced peripheral neuropathy (CIPN) in cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Duloxetine is mentioned as effective, but it does not state it is the only agent with moderate evidence-based recommendation for CIPN."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that the typical starting dose of duloxetine is 30 mg daily, titrated to 60 mg daily as tolerated, with slow tapering recommended to avoid withdrawal symptoms.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No dosing, titration, or tapering guidance for duloxetine is provided."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that other pharmacologic options include tricyclic antidepressants (nortriptyline, amitriptyline), gabapentin, and pregabalin, which are supported by guidelines for cancer-related neuropathic pain but have inconclusive evidence.",
        "score_given": 0,
        "max_points": 2,
        "justification": "While TCAs, gabapentin, and pregabalin are listed, the response does not state that evidence is inconclusive or reference guideline support."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that topical agents such as lidocaine and capsaicin patches may be considered for localized neuropathic pain, though evidence is limited.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Topical lidocaine and capsaicin are included, but it does not note limited evidence."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that opioids are not preferred for chronic neuropathic pain due to risk of tolerance, dependence, and adverse effects.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It says opioids are generally not ideal and carry risks, but does not specify risks of tolerance and dependence."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that interventional approaches, notably neurolytic celiac plexus block, are effective for refractory pain in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No interventional pain approaches, including celiac plexus block, are mentioned."
      }
    ],
    "question_number": 141,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:26:50.515176",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define curative treatment as interventions with the intent to eradicate the disease and achieve long-term survival.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states that curative treatment aims to completely remove or destroy all cancer cells with the hope they will not return, which aligns with eradication and long-term survival."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that curative treatment can include surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions major surgery, including the Whipple procedure, as part of curative treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that in curative treatment, surgery is often followed by adjuvant chemotherapy to reduce recurrence risk.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that surgery is often followed by chemotherapy and/or radiation to kill remaining cancer cells, which conveys the concept of adjuvant therapy to reduce recurrence risk."
      },
      {
        "criterion_number": 4,
        "description": "The response should define palliative treatment as focusing on improving quality of life when cure is not possible.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response defines palliative care as improving quality of life and managing symptoms, and later specifies that when cure is not possible the focus shifts to palliative care."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that palliative treatment is the case for the majority of patients with locally advanced unresectable or metastatic disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that most pancreatic cancers are diagnosed at a later stage when cure is not possible and the focus shifts to palliative care, capturing the idea that the majority present with advanced disease requiring palliative intent."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that the primary goal of palliative treatment is to prolong survival, control symptoms, and maintain quality of life.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it emphasizes symptom control and quality of life, it does not explicitly state prolonging survival as a primary goal of palliative treatment."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that palliative treatment can include chemotherapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly mentions chemotherapy used for palliative reasons to slow cancer growth."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that palliative treatment can include radiation for local control or pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Radiation is mentioned in the context of curative/adjuvant therapy, but not specifically as a palliative measure for local control or pain."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that palliative treatment can include pain management.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Pain management is specifically addressed, including medications and nerve blocks."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that palliative approaches include endoscopic or surgical procedures to relieve biliary or gastric outlet obstruction, and comprehensive supportive care for pain, nutrition, and psychosocial needs.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It discusses biliary stenting for jaundice (bile duct obstruction) and includes supportive care domains such as pain control, nutrition, and emotional/spiritual support."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that the American Society of Clinical Oncology emphasizes early integration of palliative care for all patients with advanced disease to address symptom burden and support patient and family well-being.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of ASCO or its guidance on early integration of palliative care."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It encourages discussing with the medical team and consulting palliative care, but does not specifically recommend speaking with an oncologist."
      }
    ],
    "question_number": 142,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:27:36.911770",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define curative treatment as interventions with the intent to eradicate the disease and achieve long-term survival.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states curative goal is to eliminate cancer entirely and provide a long-term cure, aligning with eradication and long-term survival."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that curative treatment can include surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies surgery as the cornerstone of curative treatment, specifically mentioning Whipple and distal pancreatectomy."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that in curative treatment, surgery is often followed by adjuvant chemotherapy to reduce recurrence risk.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes adjuvant chemotherapy after surgery to eliminate remaining cells, implying reduction of recurrence risk."
      },
      {
        "criterion_number": 4,
        "description": "The response should define palliative treatment as focusing on improving quality of life when cure is not possible.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Defines palliative care as focusing on quality of life, comfort, and symptom management without expectation of cure."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that palliative treatment is the case for the majority of patients with locally advanced unresectable or metastatic disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States palliative care is a significant part of care for most patients and becomes the primary focus in metastatic or locally advanced unresectable disease."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that the primary goal of palliative treatment is to prolong survival, control symptoms, and maintain quality of life.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Addresses all three aims: symptom control, maintaining quality of life, and extending life with palliative chemo/radiation."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that palliative treatment can include chemotherapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically mentions chemotherapy in a palliative context to shrink tumors and slow growth."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that palliative treatment can include radiation for local control or pain.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes radiation with palliative intent to relieve symptoms such as pain and obstruction."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that palliative treatment can include pain management.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Details pain management with medications and nerve blocks as part of palliative care."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that palliative approaches include endoscopic or surgical procedures to relieve biliary or gastric outlet obstruction, and comprehensive supportive care for pain, nutrition, and psychosocial needs.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Mentions biliary stents, gastric stents/bypass for obstruction, and supportive care including pain control, nutrition (enzyme supplements), and psychosocial support."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that the American Society of Clinical Oncology emphasizes early integration of palliative care for all patients with advanced disease to address symptom burden and support patient and family well-being.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses early/concurrent palliative care but does not reference ASCO or its recommendation explicitly."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises direct discussion with the oncology team and provides specific questions to ask."
      }
    ],
    "question_number": 142,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:28:05.797412",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend understanding the costs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit, detailed cost considerations listed (procedure, flights, accommodation, daily expenses, lost wages, travel insurance, emergency care)."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing treatment decisions with your oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Strongly recommends open discussion with current oncology team, asks specific questions, and advises obtaining a second opinion at a major cancer center; also emphasizes communication between foreign clinic and home oncologist."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend understanding the stage of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly instructs to identify stage/spread and locations of metastases."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend understanding the type of cancer.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly asks for exact diagnosis and gives examples (adenocarcinoma, neuroendocrine tumor)."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend understanding the reputation of the clinic.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises evaluating whether the facility is university-affiliated vs. private, accreditation (e.g., JCI), transparency, and evidence of credibility."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding the qualifications of the providers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends checking doctors\u2019 training, board certification, publications, and presentations at international conferences."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the details of the experimental treatments, including types of drugs.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Suggests identifying the treatment/drug name, mechanism of action, and whether it appears on clinical trial registries (ClinicalTrials.gov)."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend understanding the evidence supporting the treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes peer-reviewed data, reputable journals, avoidance of testimonials, and scrutinizing claimed success rates and definitions."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend understanding the potential side effects of the experimental treatments.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions who will manage side effects and whether costs cover side-effect management, but does not explicitly recommend researching or understanding the treatment\u2019s potential side effects."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend understanding the safety of the drugs.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explicitly advise assessing drug safety profile, adverse events, or safety monitoring beyond general red flags and emergency care considerations."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend understanding the legal protections of the country.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of legal protections, malpractice recourse, regulatory oversight, or patient rights in the destination country."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend understanding the availability of medical records.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises ensuring the clinic conducts a detailed review of medical records before promising treatment and can communicate with the home oncologist, indicating attention to record availability and transfer."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend understanding the logistics of traveling abroad for treatment.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Addresses multiple travel logistics, including flights, lodging duration, insurance, and related costs."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention considering your loved one\u2019s health and travel suitability, as long travel can be taxing.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly asks whether the loved one is physically strong enough for long-distance travel."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention considering if the other country has specialized high-quality pancreatic cancer care.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Evaluates clinic credibility and accreditation but does not explicitly address whether the destination country offers specialized high-quality pancreatic cancer care or high-volume pancreatic centers."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention considering visa barriers when traveling abroad for treatment.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of visa requirements or potential barriers to entry/stay for medical treatment."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention considering local accommodations when traveling abroad for treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically lists accommodation needs and potential multi-week/month duration as part of planning and costs."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention considering cultural barriers when traveling abroad for treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address language differences, cultural norms, or need for interpreters/cultural navigation."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention considering challenges with follow-up care when traveling abroad for treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Clearly highlights the need for a follow-up plan at home, who will manage side effects, and the possibility that local oncologists may decline to assume care after unproven treatments."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention considering social support challenges when traveling abroad for treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Addresses quality-of-life tradeoffs, time away from home, and being in a foreign hospital versus being at home with family and friends."
      }
    ],
    "question_number": 143,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:29:02.470875",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend understanding the costs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit section on Total Cost Breakdown, hidden fees, payment schedule, and refund policy."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing treatment decisions with your oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Dedicated section: Consult Your Current Medical Team (Crucial Step!) with detailed guidance."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend understanding the stage of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly advise determining or considering the cancer stage."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend understanding the type of cancer.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Mentions pancreatic cancer broadly and obtaining pathology reports, but does not explicitly advise confirming histologic/molecular type."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend understanding the reputation of the clinic.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses accreditation (JCI), local regulation, independent reviews/testimonials, and red flags."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding the qualifications of the providers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details physician qualifications, board certifications, specialty in oncology, and experience."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the details of the experimental treatments, including types of drugs.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Covers mechanism, whether specific to pancreatic cancer, ingredients/components, and administration method."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend understanding the evidence supporting the treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Extensive guidance on preclinical/clinical evidence, phases, RCTs, peer-reviewed publications, and comparisons to standard care."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend understanding the potential side effects of the experimental treatments.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly addresses known side effects, unknown risks, quality of life impact."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend understanding the safety of the drugs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Discusses side effects, unknown risks, regulatory approval status, ethical oversight, and patient rights."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend understanding the legal protections of the country.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises verifying local regulation/licensure and notes ethical oversight/informed consent and patient rights."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend understanding the availability of medical records.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Asks whether detailed medical reports will be provided in English and to gather comprehensive records."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend understanding the logistics of traveling abroad for treatment.",
        "score_given": 1,
        "max_points": 1,
        "justification": "Includes travel logistics: visas/passports, accommodation location, duration of stay."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention considering your loved one\u2019s health and travel suitability, as long travel can be taxing.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicit item on Patient's Fitness for Travel and quality-of-life considerations."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention considering if the other country has specialized high-quality pancreatic cancer care.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Addresses clinic accreditation and provider expertise but does not explicitly assess country-level specialized pancreatic cancer care."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention considering visa barriers when traveling abroad for treatment.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifically lists visas and passports under travel logistics."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention considering local accommodations when traveling abroad for treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses where to stay, proximity to clinic, suitability for a critically ill patient."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention considering cultural barriers when traveling abroad for treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses language barriers and availability of qualified medical interpreters."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention considering challenges with follow-up care when traveling abroad for treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Continuity of care section covers post-treatment monitoring, medication supply/import, emergency plan, and coordination with local doctors."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention considering social support challenges when traveling abroad for treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Emphasizes support system and who will accompany the patient, acknowledging emotional and logistical support needs."
      }
    ],
    "question_number": 143,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:29:47.164938",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe why treatments for pancreatic cancer can increase the risk of infections, including immunosuppression due to chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains chemotherapy/radiation damage to fast-growing cells leading to neutropenia, mucosal barrier injury, and infection risk from surgery and devices. Explicitly mentions reduced white blood cells (neutropenia)."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend hand hygiene.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides detailed handwashing guidance (soap and water for 20 seconds, sanitizer \u226560% alcohol) and specific situations when to wash."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend avoiding sick contacts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises limiting sick visitors and avoiding crowds, with practical alternatives like video calls."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend being up to date on age-appropriate vaccinations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions asking the team whether family members should get flu shots but does not explicitly recommend staying up to date on vaccinations for the patient or household."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend discussing the infections with the oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Strongly emphasizes contacting the oncology team, consulting them before changes, and calling immediately for fever or other infection signs."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend food safety.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides comprehensive food safety advice: thorough cooking, washing produce, avoiding high-risk foods, and kitchen hygiene."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend adherence with prophylactic medications if prescribed.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention prophylactic antibiotics/antivirals/antifungals or adherence to such medications if prescribed."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention avoiding exposure to fungal spores, especially for patients with neutropenia, by avoiding environments with high concentrations of airborne fungal spores.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes avoiding fresh flowers/plants due to mold/bacteria but does not specifically address avoiding high-airborne-spore environments (e.g., construction, soil/compost, gardening) or link to neutropenia."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that there is no need for antimicrobial prophylaxis for most solid tumors if the overall infection risk is low (neutropenia < 7 days).",
        "score_given": 0,
        "max_points": 6,
        "justification": "No statement about lack of need for antimicrobial prophylaxis in most solid tumors with short-duration neutropenia."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that interventions such as footwear exchange, protected environments, neutropenic diet, or nutritional supplements are not recommended due to a lack of evidence of clinical benefit.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Suggests a neutropenic diet during high-risk periods and does not mention that such interventions (including protected environments, footwear exchange, or nutritional supplements) lack evidence of benefit."
      }
    ],
    "question_number": 144,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:30:20.247871",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe why treatments for pancreatic cancer can increase the risk of infections, including immunosuppression due to chemotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains multiple reasons: chemotherapy-related mucositis (barrier injury), neutropenia with references to 'neutropenic fever' and monitoring ANC, use of Neulasta to boost white blood cells (immunosuppression due to chemo), and device-related risks (central lines, surgical sites, biliary stents)."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend hand hygiene.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit, detailed hand hygiene guidance is provided for patient, caregivers, and visitors, including soap/water technique and alcohol-based sanitizers."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend avoiding sick contacts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly advises strictly avoiding anyone who is sick and discusses masking in higher-risk settings."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend being up to date on age-appropriate vaccinations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends influenza vaccination (inactivated), pneumococcal vaccination, and COVID-19 vaccination/boosters, and notes to avoid live vaccines during chemotherapy."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend discussing the infections with the oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Multiple prompts to consult the oncology team, keep emergency contact numbers, call immediately for fever \u2265100.4\u00b0F, and maintain open communication are included."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend food safety.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Comprehensive food safety advice is given: washing produce, cooking meats/eggs thoroughly, avoiding unpasteurized foods, preventing cross-contamination, reheating deli meats, and being cautious with buffets."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend adherence with prophylactic medications if prescribed.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It instructs to adhere strictly to medication schedules and mentions prophylactic hematopoietic growth factors (e.g., Neulasta) to boost WBCs, implying adherence to prescribed prophylaxis."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention avoiding exposure to fungal spores, especially for patients with neutropenia, by avoiding environments with high concentrations of airborne fungal spores.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it advises avoiding pet waste and being careful with gardening to prevent skin breaks, it does not specifically address avoiding environments with high airborne fungal spore loads (e.g., mulch, compost, construction sites)."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that there is no need for antimicrobial prophylaxis for most solid tumors if the overall infection risk is low (neutropenia < 7 days).",
        "score_given": 0,
        "max_points": 6,
        "justification": "No statement is made about the lack of routine antimicrobial prophylaxis for most solid tumor patients with brief neutropenia."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that interventions such as footwear exchange, protected environments, neutropenic diet, or nutritional supplements are not recommended due to a lack of evidence of clinical benefit.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It does not address the lack of evidence for footwear exchange, protected environments, neutropenic diets, or nutritional supplements; none of these recommendations are discussed."
      }
    ],
    "question_number": 144,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:30:59.746784",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes the combination of immune checkpoint blockade with chemotherapy as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes a dedicated section 'Chemotherapy + Immunotherapy' describing how chemotherapy can release antigens and combining it with checkpoint inhibitors such as pembrolizumab or nivolumab."
      },
      {
        "criterion_number": 2,
        "description": "The response describes the combination of immune checkpoint blockade with radiation as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It has a section 'Radiation Therapy + Immunotherapy' explaining antigen release, in-situ vaccine effect, abscopal effect, and use of checkpoint inhibitors with SBRT."
      },
      {
        "criterion_number": 3,
        "description": "The response describes the combination of immune checkpoint blockade with other novel agents (e.g., targeted therapies, immune modulators, or agents targeting the tumor microenvironment) as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses 'Targeted Therapy + Immunotherapy' (e.g., PARP inhibitors like olaparib, MEK inhibitors) and mentions combining vaccines with checkpoint inhibitors, addressing multiple novel combinations."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly defines immunotherapy as a treatment that uses the body\u2019s immune system to attack cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it describes mechanisms (e.g., taking the brakes off T-cells and training the immune system), it does not explicitly define immunotherapy as a treatment that uses the body's immune system to attack cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response states that pembrolizumab is approved for pancreatic cancer with MSI-high tumors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It notes that MSI-high/dMMR markers have approved 'standard immunotherapy' but does not explicitly state that pembrolizumab is approved for MSI-high pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response states that pembrolizumab is approved for pancreatic cancer with dMMR (deficient mismatch repair) tumors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It mentions dMMR as a marker for which immunotherapy is approved but does not specify that pembrolizumab is approved for dMMR pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response states that pembrolizumab is approved for pancreatic cancer with TMB-high (tumor mutational burden-high) tumors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "TMB-high is not mentioned, and there is no statement about pembrolizumab approval for TMB-high tumors."
      },
      {
        "criterion_number": 8,
        "description": "The response specifically mentions clinicaltrials.gov as a resource for finding immunotherapy clinical trials.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly references ClinicalTrials.gov as the official U.S. government database for searching clinical trials."
      },
      {
        "criterion_number": 9,
        "description": "The response specifically mentions the PanCan clinical trial finder as a resource for finding immunotherapy clinical trials.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It names the Pancreatic Cancer Action Network (PanCAN) and states their Patient Services can help find clinical trials, which serves the same function as PanCAN\u2019s clinical trial matching service."
      },
      {
        "criterion_number": 10,
        "description": "The response describes immune checkpoint blockade as a current strategy for studying immunotherapy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Checkpoint inhibitors (PD-1/PD-L1, CTLA-4) are discussed across multiple sections as active research strategies in pancreatic cancer."
      },
      {
        "criterion_number": 11,
        "description": "The response describes adoptive cellular therapy (e.g., CAR-T cell therapy or modified T-cells) as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes a 'CAR-T Cell Therapy' subsection detailing engineered T-cells targeting mesothelin and Claudin18.2 and challenges like dense stroma."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that current research on immunotherapy combinations for patients with pancreatic cancer is focused on overcoming the immunosuppressive tumor microenvironment (TME) and enhancing antitumor immune responses.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explains the immunosuppressive TME (dense stroma, low neoantigens, MDSCs/Tregs) and explicitly frames combinations as ways to overcome these defenses and turn 'cold' tumors 'hot.'"
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that neoadjuvant immunotherapy combinations are being tested to prime the immune system before surgery, with early results suggesting potential improvements in disease-free and overall survival.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of neoadjuvant immunotherapy before surgery or associated survival outcomes."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that cancer vaccines are under investigation as an immunotherapy approach for pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It provides a 'Cancer Vaccines' subsection, noting therapeutic vaccines (including mRNA approaches) targeting mesothelin or KRAS G12D, often combined with checkpoint inhibitors."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises to talk to the loved one's oncologist as the most important step for trial suitability and treatment planning."
      }
    ],
    "question_number": 145,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:31:45.384435",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes the combination of immune checkpoint blockade with chemotherapy as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly discusses PD-1/PD-L1 inhibitors combined with standard chemotherapy regimens (e.g., FOLFIRINOX, Gemcitabine/Abraxane) and notes ongoing trials."
      },
      {
        "criterion_number": 2,
        "description": "The response describes the combination of immune checkpoint blockade with radiation as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes SBRT or conventional radiation combined with immune checkpoint inhibitors and the rationale (abscopal effect)."
      },
      {
        "criterion_number": 3,
        "description": "The response describes the combination of immune checkpoint blockade with other novel agents (e.g., targeted therapies, immune modulators, or agents targeting the tumor microenvironment) as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It details PARP inhibitors, MEK inhibitors, TGF-beta inhibitors, CD40/STING/TLR agonists, and stroma-targeting agents in combination with checkpoint inhibitors."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly defines immunotherapy as a treatment that uses the body\u2019s immune system to attack cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it describes goals like 'heating up' tumors and enhancing immune responses, it does not explicitly define immunotherapy as using the body\u2019s immune system to attack cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response states that pembrolizumab is approved for pancreatic cancer with MSI-high tumors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "MSI-high status is mentioned as predictive of response, but pembrolizumab and its approval are not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response states that pembrolizumab is approved for pancreatic cancer with dMMR (deficient mismatch repair) tumors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no mention of dMMR or pembrolizumab approval in this setting."
      },
      {
        "criterion_number": 7,
        "description": "The response states that pembrolizumab is approved for pancreatic cancer with TMB-high (tumor mutational burden-high) tumors.",
        "score_given": 0,
        "max_points": 7,
        "justification": "TMB-high and pembrolizumab approval are not discussed."
      },
      {
        "criterion_number": 8,
        "description": "The response specifically mentions clinicaltrials.gov as a resource for finding immunotherapy clinical trials.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It advises asking about trials but does not reference clinicaltrials.gov."
      },
      {
        "criterion_number": 9,
        "description": "The response specifically mentions the PanCan clinical trial finder as a resource for finding immunotherapy clinical trials.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of the PanCAN clinical trial finder is made."
      },
      {
        "criterion_number": 10,
        "description": "The response describes immune checkpoint blockade as a current strategy for studying immunotherapy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple sections discuss PD-1/PD-L1 inhibitors in various combinations as an active area of study."
      },
      {
        "criterion_number": 11,
        "description": "The response describes adoptive cellular therapy (e.g., CAR-T cell therapy or modified T-cells) as a current research strategy in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It specifically mentions CAR T-cell therapy targeting mesothelin, CEA, and MUC1 in early-phase trials."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that current research on immunotherapy combinations for patients with pancreatic cancer is focused on overcoming the immunosuppressive tumor microenvironment (TME) and enhancing antitumor immune responses.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It emphasizes the dense, immunosuppressive microenvironment and the goal to 'heat up' tumors to enhance immune responses."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that neoadjuvant immunotherapy combinations are being tested to prime the immune system before surgery, with early results suggesting potential improvements in disease-free and overall survival.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Neoadjuvant/adjuvant settings are mentioned, but not the concept of immune priming nor early results in DFS/OS."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that cancer vaccines are under investigation as an immunotherapy approach for pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It discusses GVAX and personalized neoantigen vaccines under investigation."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly advises consulting with a medical oncologist and considering a second opinion at a major cancer center."
      }
    ],
    "question_number": 145,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:32:13.602823",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend understanding the goal of the study.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly asks about the study's purpose and examples (new drug, combination, surgical technique), guiding understanding of the trial's goal."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend understanding the phase of the trial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly asks which phase the trial is in and explains Phase I\u2013III focuses (safety, effectiveness, comparison to standard)."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend understanding the eligibility requirements of the trial.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of inclusion/exclusion criteria, biomarkers, prior treatments, or other eligibility requirements."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend understanding the potential side effects of the treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes questions about known short- and long-term side effects, unknown risks, and how side effects will be managed."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend understanding if there are additional tests required to participate in the trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Asks specifically about required tests, scans, biopsies, procedures, frequency, and invasiveness."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding if there are travel costs associated with the trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Addresses non-medical cost reimbursement, including travel, parking, and lodging."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the evidence supporting the trial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Prompts asking about the rationale and what prior lab or earlier-phase studies have shown."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend understanding the kind of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Asks what type of intervention it is and how the drug is given (pill vs IV) and compares to standard care."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend understanding the visit schedule of the trial.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Covers time commitment, frequency of clinic visits, and duration of each visit."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly states that research studies are designed to determine if a new medical strategy, treatment, or device is safe and/or effective for humans.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes trial phases: Phase I (first time in humans, safety), Phase II (effectiveness and safety), indicating trials determine safety/effectiveness in humans."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly states that clinical trials are essential for improving, optimizing, or advancing current and/or future cancer therapies.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not explicitly state that trials are essential for advancing cancer therapies."
      },
      {
        "criterion_number": 12,
        "description": "The response includes the question: \u201cHow will participation impact current treatment and care?\u201d",
        "score_given": 6,
        "max_points": 6,
        "justification": "Addresses impact on current care via questions about differences from standard care and who manages overall care during the trial."
      },
      {
        "criterion_number": 13,
        "description": "The response includes the question: \u201cWhat are the implications for family members, especially if genetic testing is involved?\u201d",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of genetic testing or implications for family members."
      },
      {
        "criterion_number": 14,
        "description": "The response recommends discussing the case with an oncologist or relevant healthcare professional to review trial details and discuss pros and cons.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Encourages asking the research team but does not explicitly recommend discussing with the treating oncologist or another clinician to weigh pros and cons."
      }
    ],
    "question_number": 146,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:32:50.865432",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend understanding the goal of the study.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly asks, 'What is the specific purpose of this study?' with examples (testing a new drug, comparing treatments, QoL, diagnosis)."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend understanding the phase of the trial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes, 'What phase is this clinical trial? (Phase I, II, III, IV...).'"
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend understanding the eligibility requirements of the trial.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No direct question about inclusion/exclusion or eligibility criteria."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend understanding the potential side effects of the treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Asks, 'What are the known or potential side effects and risks... (short-term and long-term, common and rare but serious)?'"
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend understanding if there are additional tests required to participate in the trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Asks, 'What procedures or tests will be done specifically for the study? ... How do these differ from his usual care?'"
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding if there are travel costs associated with the trial.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Addresses out-of-pocket costs including 'travel, parking, lodging' and asks about 'financial assistance... for travel or lodging.'"
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the evidence supporting the trial.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly prompt for prior data/evidence supporting the trial (e.g., preclinical/earlier-phase results or rationale)."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend understanding the kind of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly asks, 'What is the study drug/treatment? How does it work? Is it new...?'"
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend understanding the visit schedule of the trial.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Asks frequency, location, and duration of visits, and whether hospital overnights are required."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly states that research studies are designed to determine if a new medical strategy, treatment, or device is safe and/or effective for humans.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit statement defining research studies as designed to determine safety/efficacy for humans."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly states that clinical trials are essential for improving, optimizing, or advancing current and/or future cancer therapies.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not explicitly state trials are essential for advancing cancer therapies, though it notes potential benefit to future patients."
      },
      {
        "criterion_number": 12,
        "description": "The response includes the question: \u201cHow will participation impact current treatment and care?\u201d",
        "score_given": 6,
        "max_points": 6,
        "justification": "Covers this concept with: 'If he participates, will it prevent him from receiving other treatments later on?' and 'Can he continue to see his regular doctors... How will his care be coordinated...?'"
      },
      {
        "criterion_number": 13,
        "description": "The response includes the question: \u201cWhat are the implications for family members, especially if genetic testing is involved?\u201d",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of genetic testing or implications for family members."
      },
      {
        "criterion_number": 14,
        "description": "The response recommends discussing the case with an oncologist or relevant healthcare professional to review trial details and discuss pros and cons.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises, 'Consider a second opinion... discuss the opportunity with another oncologist not involved in the study.'"
      }
    ],
    "question_number": 146,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:33:33.786434",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe non-opioid medications for pain control, including acetaminophen.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly mentions acetaminophen (Tylenol) and dosing caution as a baseline analgesic."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe non-opioid medications for pain control, including NSAIDs.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Lists NSAIDs (ibuprofen, naproxen) with appropriate cautions."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe non-opioid medications for neuropathic pain, including gabapentin.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Identifies gabapentin as a neuropathic pain option."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe non-opioid medications for neuropathic pain, including anti-depressants.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Mentions antidepressants for neuropathic pain, including SNRIs (duloxetine) and TCAs (amitriptyline)."
      },
      {
        "criterion_number": 5,
        "description": "The response should include procedures that can help with pain related to pancreatic cancer, including nerve blocks.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Provides detailed discussion of celiac plexus nerve block and its benefits."
      },
      {
        "criterion_number": 6,
        "description": "The response should include procedures that can help with pain related to pancreatic cancer, including radiation therapy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Describes palliative radiation (e.g., SBRT) to shrink tumor and relieve pain."
      },
      {
        "criterion_number": 7,
        "description": "The response should include non-pharmacologic therapies, including acupuncture.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Specifically lists acupuncture as an integrative pain management option."
      },
      {
        "criterion_number": 8,
        "description": "The response should include non-pharmacologic therapies, including psychological support.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Includes mind-body techniques (meditation, guided imagery, relaxation) addressing the pain-anxiety cycle."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend discussing symptom management with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises discussion with oncologist and cancer center team multiple times."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe non-opioid medications for neuropathic pain, including pregabalin, duloxetine, nortriptyline, and amitriptyline.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions pregabalin, duloxetine, and amitriptyline but not nortriptyline."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that topical agents, including lidocaine and capsaicin patches, can be considered for localized neuropathic pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of topical lidocaine or capsaicin patches."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that corticosteroids are reserved for specific indications such as spinal cord compression or inflammatory pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions dexamethasone for swelling and appetite but does not specify reserved indications like spinal cord compression."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that antioxidant supplementation may reduce painful attacks in select cases, though evidence is limited and should be considered adjunctive.",
        "score_given": 0,
        "max_points": 1,
        "justification": "Antioxidant supplementation is not discussed."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that interventional and procedural approaches are particularly relevant in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights interventional approaches and describes celiac plexus block as a cornerstone for pancreatic cancer pain."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that neurolytic celiac plexus block is supported by randomized trials for opioid-sparing pain relief.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although opioid-sparing benefit is implied, it does not cite randomized trial support or explicitly state 'neurolytic' benefit."
      },
      {
        "criterion_number": 16,
        "description": "The response should include non-pharmacologic therapies, including physical therapy.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Physical therapy is not mentioned."
      },
      {
        "criterion_number": 17,
        "description": "The response should recommend discussing symptom management with a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Strongly recommends immediate palliative care consultation and explains their role."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that cognitive-behavioral therapy and stress management are effective adjuncts.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Mindfulness and relaxation are discussed, but CBT and stress management are not explicitly mentioned."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that areas that need further research include the long-term comparative effectiveness of nonopioid and integrative modalities.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No reference to research gaps or comparative effectiveness evidence needs."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that effective pain management in pancreatic cancer requires regular assessment and individualized planning.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends a pain journal (regular assessment) and emphasizes palliative team-created multimodal plan (individualized planning)."
      }
    ],
    "question_number": 147,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:34:11.139577",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe non-opioid medications for pain control, including acetaminophen.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly mentions acetaminophen (Tylenol) with appropriate context and cautions."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe non-opioid medications for pain control, including NSAIDs.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Lists NSAIDs (ibuprofen, naproxen, celecoxib) and discusses risks."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe non-opioid medications for neuropathic pain, including gabapentin.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Includes gabapentin and pregabalin for neuropathic pain."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe non-opioid medications for neuropathic pain, including anti-depressants.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Mentions duloxetine, venlafaxine, and amitriptyline as antidepressants used for neuropathic pain."
      },
      {
        "criterion_number": 5,
        "description": "The response should include procedures that can help with pain related to pancreatic cancer, including nerve blocks.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Describes celiac plexus block/neurolysis and EUS-guided nerve blocks."
      },
      {
        "criterion_number": 6,
        "description": "The response should include procedures that can help with pain related to pancreatic cancer, including radiation therapy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Specifically mentions radiation therapy to reduce tumor size and relieve pain."
      },
      {
        "criterion_number": 7,
        "description": "The response should include non-pharmacologic therapies, including acupuncture.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Lists acupuncture in complementary therapies for cancer-related pain."
      },
      {
        "criterion_number": 8,
        "description": "The response should include non-pharmacologic therapies, including psychological support.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Includes counseling/therapy, support groups, and pain psychology involvement."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend discussing symptom management with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Repeatedly advises discussing options with the oncology team and other clinicians."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe non-opioid medications for neuropathic pain, including pregabalin, duloxetine, nortriptyline, and amitriptyline.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions pregabalin, duloxetine, and amitriptyline but does not mention nortriptyline."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that topical agents, including lidocaine and capsaicin patches, can be considered for localized neuropathic pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention topical lidocaine or capsaicin patches."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that corticosteroids are reserved for specific indications such as spinal cord compression or inflammatory pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions corticosteroids generally but not that they are reserved for specific indications like spinal cord compression."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that antioxidant supplementation may reduce painful attacks in select cases, though evidence is limited and should be considered adjunctive.",
        "score_given": 0,
        "max_points": 1,
        "justification": "No mention of antioxidant supplementation."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that interventional and procedural approaches are particularly relevant in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights celiac plexus block/neurolysis as a gold standard for pancreatic cancer pain, emphasizing relevance."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that neurolytic celiac plexus block is supported by randomized trials for opioid-sparing pain relief.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes neurolysis but does not reference randomized trials or opioid-sparing evidence."
      },
      {
        "criterion_number": 16,
        "description": "The response should include non-pharmacologic therapies, including physical therapy.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Mentions gentle activity, acupuncture, massage, and heat/cold but does not explicitly include physical therapy."
      },
      {
        "criterion_number": 17,
        "description": "The response should recommend discussing symptom management with a palliative care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Strongly emphasizes early involvement of palliative care for pain and symptom management."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that cognitive-behavioral therapy and stress management are effective adjuncts.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Includes counseling, mindfulness, and relaxation but does not explicitly mention cognitive-behavioral therapy or stress management as named approaches."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that areas that need further research include the long-term comparative effectiveness of nonopioid and integrative modalities.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No discussion of research gaps or long-term comparative effectiveness."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that effective pain management in pancreatic cancer requires regular assessment and individualized planning.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states individualized planning, proactive management, and regular communication using pain scales."
      }
    ],
    "question_number": 147,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:34:41.921195",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing psychological concerns about the children with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises contacting the oncology social worker at the treating hospital/cancer center and to ask the loved one's nurse or doctor for a referral, directing the family to discuss and address psychosocial concerns with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends professional counseling and mentions mental health professionals (e.g., therapist, counselor, psychologist, psychiatrist).",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends individual therapy with a therapist specializing in adolescents, family counseling, and engaging school mental health staff (counselor, psychologist, social worker)."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends support groups for teens with a parent with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends support groups, noting that connecting with other teens who have a parent or loved one with cancer can be powerful."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends involving school counselors for support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises informing the school counselor and highlights the roles of the school counselor, psychologist, or social worker."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends support groups for teens with a parent with cancer and specifically mentions cancersupportcommunity.org as a resource.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cancer Support Community (cancersupportcommunity.org) is not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly recommends support groups for teens with a parent with cancer and specifically mentions PanCAN (Pancreatic Cancer Action Network) patient services as a resource.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends support groups for teens and specifically lists PanCAN Patient Services as a resource that can direct families to appropriate support."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that informal support from family, friends, and teachers is highly valued by adolescents.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It emphasizes family support as the first and most important line of defense, encourages maintaining time with friends for normalcy, and advises notifying teachers to reduce pressure, reflecting the value of informal supports."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that technology-based resources, such as online support communities and apps, can supplement in-person support and are increasingly used by adolescents for connection and information.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it mentions online/telephone support groups via CancerCare, it does not explicitly discuss technology-based resources as supplements nor note their increasing use by adolescents."
      }
    ],
    "question_number": 148,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:35:12.189639",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend discussing psychological concerns about the children with the oncology team",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises asking the medical/oncology team and highlights oncology social workers and palliative care teams as resources for family emotional support."
      },
      {
        "criterion_number": 2,
        "description": "Recommend professional counseling and mention mental health professionals",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends child and adolescent therapists/psychologists, CBT, and family therapy, and references school counselors/psychologists."
      },
      {
        "criterion_number": 3,
        "description": "Recommend support groups for teens with a parent with cancer",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends organizations that offer specific programs/support groups for children and teens affected by a parent's cancer and mentions hospice bereavement groups."
      },
      {
        "criterion_number": 4,
        "description": "Recommend involving school counselors for support",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly suggests contacting school counselors/psychologists as a first point of contact and involving teachers."
      },
      {
        "criterion_number": 5,
        "description": "Recommend support groups for teens and specifically mention cancersupportcommunity.org",
        "score_given": 0,
        "max_points": 5,
        "justification": "While Cancer Support Community is mentioned, the specific domain cancersupportcommunity.org is not explicitly cited."
      },
      {
        "criterion_number": 6,
        "description": "Recommend support groups for teens and specifically mention PanCAN patient services",
        "score_given": 5,
        "max_points": 5,
        "justification": "PanCAN is explicitly named and their Patient Central service is recommended as a must-contact resource."
      },
      {
        "criterion_number": 7,
        "description": "Mention that informal support from family, friends, and teachers is highly valued by adolescents",
        "score_given": 0,
        "max_points": 8,
        "justification": "The response discusses family involvement and notifying teachers but does not explicitly state that informal support from family, friends, and teachers is highly valued by adolescents, nor does it mention friends as support."
      },
      {
        "criterion_number": 8,
        "description": "Mention that technology-based resources (online communities, apps) can supplement in-person support and are increasingly used by adolescents",
        "score_given": 0,
        "max_points": 3,
        "justification": "It references websites and books but does not highlight technology-based support communities or apps, nor the specific relevance to adolescents' increasing use."
      }
    ],
    "question_number": 148,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:35:38.323496",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Defines ctDNA as DNA from cancer cells/tumors found in blood and notes use as biomarker for diagnosis, monitoring, or recurrence",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states ctDNA is \"genetic material that is released from cancer cells and circulates in the bloodstream\" and describes its use for monitoring treatment and detecting recurrence early, fulfilling the definition and biomarker use criteria."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly states ctDNA can be used for mutation testing in cancer",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly discusses using ctDNA to find actionable mutations (e.g., BRCA1/2, NTRK fusions) for targeted therapy, clearly describing mutation testing."
      },
      {
        "criterion_number": 3,
        "description": "States ctDNA can provide prognostic info about recurrence risk or detect minimal residual disease (MRD) after treatment",
        "score_given": 1,
        "max_points": 1,
        "justification": "The response says ctDNA can \"detect cancer recurrence early\" and that a rising level after treatment can be the earliest sign the cancer has returned, consistent with MRD/recurrence detection."
      },
      {
        "criterion_number": 4,
        "description": "States ctDNA can be used to monitor response to treatment",
        "score_given": 1,
        "max_points": 1,
        "justification": "It explicitly includes a section on monitoring treatment response, noting ctDNA levels decrease with effective therapy and may rise if ineffective."
      },
      {
        "criterion_number": 5,
        "description": "States that per NCCN, ctDNA is recommended for mutation testing in pancreatic cancer only if tissue biopsy is not available",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of NCCN guidance or the limitation that ctDNA mutation testing is recommended only when tissue is unavailable in pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "Mentions ctDNA is noninvasive and can expedite testing by avoiding retrieval of archival blocks or arranging a new biopsy",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it notes ctDNA is a simple blood draw and avoids an invasive tissue biopsy, it does not explicitly state that this expedites testing or mention avoiding archival block retrieval."
      },
      {
        "criterion_number": 7,
        "description": "Mentions limitations: copy-number changes harder to assess in cfDNA and fusion testing more limited in common cfDNA tests",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of technical limitations regarding copy-number alteration detection or fusion testing constraints in cfDNA assays."
      },
      {
        "criterion_number": 8,
        "description": "Mentions that ctDNA may miss low-level cancers/not detect all mutations; potential false negatives/positives",
        "score_given": 0,
        "max_points": 10,
        "justification": "No acknowledgment of sensitivity/specificity limitations, false negatives/positives, or that ctDNA may not capture all mutations."
      },
      {
        "criterion_number": 9,
        "description": "Mentions not all hospitals offer ctDNA testing and not all insurances cover them",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests asking about insurance coverage but does not state that availability varies by hospital or that some insurances do not cover ctDNA testing."
      },
      {
        "criterion_number": 10,
        "description": "Mentions ctDNA testing is under active research and not yet standard of care for all cancer patients",
        "score_given": 0,
        "max_points": 10,
        "justification": "No statement about ongoing research status or that ctDNA is not standard of care for all patients."
      },
      {
        "criterion_number": 11,
        "description": "Recommends discussing the case with an oncologist",
        "score_given": 10,
        "max_points": 10,
        "justification": "It directly encourages discussion with the oncologist and provides specific questions to ask, clearly advising consultation."
      }
    ],
    "question_number": 149,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:36:11.106807",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Defines ctDNA as DNA from cancer cells or tumors found in the blood, and can be used as a biomarker for diagnosis, monitoring, or recurrence.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines ctDNA as tumor DNA fragments in the bloodstream and describes uses for monitoring treatment and detecting recurrence/MRD (e.g., \u201ctiny fragments of their DNA\u2026 enter the bloodstream\u201d and sections on monitoring and recurrence)."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly states that ctDNA can be used for mutation testing in cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes ctDNA identifies tumor mutations for targeted therapy (e.g., \u201cctDNA testing can identify these mutations\u201d)."
      },
      {
        "criterion_number": 3,
        "description": "Explicitly states that ctDNA can provide prognostic information about recurrence risk or detect minimal residual disease after treatment.",
        "score_given": 1,
        "max_points": 1,
        "justification": "It states ctDNA can detect minimal residual disease and early signs of recurrence after treatment."
      },
      {
        "criterion_number": 4,
        "description": "Explicitly states that ctDNA can be used to monitor response to treatment.",
        "score_given": 1,
        "max_points": 1,
        "justification": "It describes tracking ctDNA levels to assess treatment effectiveness (levels decrease with response, rise with resistance)."
      },
      {
        "criterion_number": 5,
        "description": "States that, per NCCN guidelines, ctDNA is only recommended for mutation testing in pancreatic cancer if a biopsy sample is not available.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of NCCN guidance or that ctDNA is recommended for mutation testing only when tissue is unavailable."
      },
      {
        "criterion_number": 6,
        "description": "Mentions that ctDNA testing is noninvasive and can expedite testing because there is no need to retrieve archival blocks or arrange for a new biopsy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it notes ctDNA is less invasive (blood draw), it does not state that it expedites testing by avoiding retrieval of archival tissue or arranging a new biopsy."
      },
      {
        "criterion_number": 7,
        "description": "Mentions that copy-number changes may be more difficult to assess in cfDNA, and fusion testing may be more limited in common cfDNA tests currently used.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of technical limitations regarding copy-number variant detection or limited fusion testing in cfDNA."
      },
      {
        "criterion_number": 8,
        "description": "Mentions that ctDNA may miss low-level cancers or not detect all mutations, and there may be false negative or false positive results.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states ctDNA is not 100% sensitive and may not detect ctDNA when tumors are small or not shedding, which corresponds to missed low-level disease and false negatives."
      },
      {
        "criterion_number": 9,
        "description": "Mentions that not all hospitals offer ctDNA testing and that not all insurances cover them.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests asking about insurance coverage but does not state that availability varies by hospital or that coverage is not universal."
      },
      {
        "criterion_number": 10,
        "description": "Mentions that ctDNA testing is still under active research and not yet standard of care for all cancer patients.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit statement that ctDNA is under active research or not standard of care for all patients."
      },
      {
        "criterion_number": 11,
        "description": "Recommends that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It directly encourages discussing with the oncologist and provides questions to ask the care team."
      }
    ],
    "question_number": 149,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:36:48.918952",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend designating a single point person to coordinate care and serve as the primary contact.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explicitly designates a Primary Care Coordinator as the main point of contact and information relay."
      },
      {
        "criterion_number": 2,
        "description": "Recommend discussing care coordination with the oncology team or oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Instructs to identify a 'quarterback' oncologist and provides a script asking the oncologist to lead and coordinate the overall plan."
      },
      {
        "criterion_number": 3,
        "description": "Recommend keeping an organized, centralized medical record of all relevant documents.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Creates a central 'Command Center' (binder/digital folder) with comprehensive sections for contacts, summaries, meds, appointments, test results, and questions."
      },
      {
        "criterion_number": 4,
        "description": "Recommend discussing or arranging the transfer of medical records with each hospital involved.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises requesting providers send visit summaries to other hospitals and recommends hand-carrying records and imaging CDs between sites."
      },
      {
        "criterion_number": 5,
        "description": "Recommend carrying or maintaining an up-to-date medication list.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Calls for a comprehensive, up-to-date medication list within the master binder, including doses, frequency, and prescriber."
      },
      {
        "criterion_number": 6,
        "description": "Mention nurse navigators or patient navigators as resources for care coordination.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Specifically recommends using Patient/Nurse Navigators and explains their coordination role."
      },
      {
        "criterion_number": 7,
        "description": "Mention that effective coordination across multiple hospitals requires addressing systemic and logistical challenges.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Notes added complexity of multi-hospital care and outlines logistical steps (communication gaps, scheduling, records management)."
      },
      {
        "criterion_number": 8,
        "description": "Mention that the lack of shared electronic health records is a significant barrier.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Although it advises not to assume hospitals communicate and to use portals/hand-carry records, it does not explicitly mention lack of shared EHRs as a barrier."
      },
      {
        "criterion_number": 9,
        "description": "Mention that lack of shared EHRs impedes seamless information exchange, and risk of inconsistent recommendations between high-volume centers and community hospitals.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not explicitly discuss EHR interoperability nor the risk of inconsistent recommendations between high-volume centers and community hospitals."
      },
      {
        "criterion_number": 10,
        "description": "Mention facilitating doctor-to-doctor communication.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly instructs to insist on doctor-to-doctor communication and provides example scripts."
      },
      {
        "criterion_number": 11,
        "description": "Mention asking for a summary note after every visit and sharing it with all providers.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Advises asking providers to send a summary of each visit and recommendations to other doctors involved."
      },
      {
        "criterion_number": 12,
        "description": "Mention using PanCAN or NCI for personalized advice on coordinating care, finding specialists, and accessing clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "References PanCAN as a resource for caregivers and patients."
      }
    ],
    "question_number": 150,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:37:17.308857",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Designate a single point person to coordinate care and serve as the primary contact",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response explicitly advises identifying one primary oncology team/hospital as the care 'quarterback' and designating a primary family/patient advocate as the main point of contact."
      },
      {
        "criterion_number": 2,
        "description": "Recommend discussing care coordination with the oncology team or oncologist",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly instructs engaging the primary oncology team/oncologist to lead coordination, request they communicate with other specialists, and identify a contact for coordination issues."
      },
      {
        "criterion_number": 3,
        "description": "Recommend keeping an organized, centralized medical record of all relevant documents",
        "score_given": 5,
        "max_points": 5,
        "justification": "It directs creating a comprehensive medical binder/digital folder with sections for contacts, pathology, imaging, labs, medications, treatment plan, appointments, insurance, and notes."
      },
      {
        "criterion_number": 4,
        "description": "Recommend discussing or arranging the transfer of medical records with each hospital involved",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises signing HIPAA releases at each hospital to allow inter-facility sharing, requesting the primary team to send summary updates to other providers, and carrying CDs/USBs of imaging for sharing."
      },
      {
        "criterion_number": 5,
        "description": "Recommend carrying or maintaining an up-to-date medication list",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly instructs maintaining a continually updated medication list with dose, frequency, and prescriber, and to bring the binder to every appointment."
      },
      {
        "criterion_number": 6,
        "description": "Mention nurse navigators or patient navigators as resources for care coordination",
        "score_given": 4,
        "max_points": 4,
        "justification": "It includes a section on patient navigators/care coordinators and advises asking the oncology team for one."
      },
      {
        "criterion_number": 7,
        "description": "Mention that effective coordination across multiple hospitals requires addressing systemic and logistical challenges",
        "score_given": 2,
        "max_points": 2,
        "justification": "It notes the added complexity of coordinating across hospitals and details logistical steps (master calendar, scheduling, transportation, confirmations) to manage systemic challenges."
      },
      {
        "criterion_number": 8,
        "description": "Mention that the lack of shared electronic health records is a significant barrier",
        "score_given": 0,
        "max_points": 6,
        "justification": "The response does not explicitly mention EHR interoperability or lack of shared EHRs as a barrier."
      },
      {
        "criterion_number": 9,
        "description": "Mention that lack of shared EHR impedes information exchange and risk of inconsistent recommendations between high-volume centers and community hospitals",
        "score_given": 0,
        "max_points": 6,
        "justification": "It does not address EHR barriers or the risk of inconsistent recommendations between high-volume and community settings."
      },
      {
        "criterion_number": 10,
        "description": "Mention facilitating doctor-to-doctor communication",
        "score_given": 2,
        "max_points": 2,
        "justification": "It explicitly recommends encouraging provider-to-provider communication, being proactive, and facilitating with contact information."
      },
      {
        "criterion_number": 11,
        "description": "Mention asking for a summary note after every visit and sharing it with all providers",
        "score_given": 8,
        "max_points": 8,
        "justification": "It advises requesting summaries to be sent to other providers after major decisions and to 'always ask for copies of ... visit notes' immediately, implying after each visit, and to update all teams."
      },
      {
        "criterion_number": 12,
        "description": "Mention using PanCAN or NCI for personalized advice and clinical trials",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not reference PanCAN or NCI resources."
      }
    ],
    "question_number": 150,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:37:46.413138",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that weight loss can occur due to impaired absorption due to pancreatic enzyme deficiency.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly explains malabsorption from exocrine pancreatic insufficiency (EPI) due to lack of enzymes or duct blockage causing poor nutrient absorption and weight loss."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that pancreatic exocrine insufficiency leads to deficiencies in fat-soluble vitamins or micronutrients and explicitly recommends pancreatic enzyme replacement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Recommends PERT clearly, but does not mention fat-soluble vitamin or micronutrient deficiencies resulting from EPI."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that appetite stimulants can sometimes be helpful.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions megestrol acetate and mirtazapine as potential appetite stimulants that can sometimes be used."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that appetite stimulants may be considered for refractory cases or due to potential side effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not indicate they are reserved for refractory cases or discuss potential side effects/risks; only notes variable effectiveness."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the patient should discuss their weight loss with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises discussing issues with the oncologist/gastroenterologist and provides a checklist for the next appointment with the medical team."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that there can be many causes of losing weight in patients with pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Identifies multiple causes including cancer cachexia, malabsorption/EPI, nausea, vomiting, pain, early satiety, taste changes, and food aversions."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that losing weight can be due to the cancer itself.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains cancer cachexia driven by tumor-mediated metabolic changes as a direct cause of weight loss."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that weight loss can occur as a side effect of chemotherapy.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not explicitly state chemotherapy as a cause of weight loss; only broadly notes that cancer and its treatment can alter taste."
      },
      {
        "criterion_number": 9,
        "description": "The response should state the patient should try and get sufficient protein intake.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Advises prioritizing protein and lists protein-rich foods and protein powder enrichment."
      },
      {
        "criterion_number": 10,
        "description": "The response should state the patient should try and get sufficient calorie intake.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Recommends calorie-dense foods, adding fats, and liquid calories; emphasizes making every bite count."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that nutrition/protein supplements can be helpful.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically recommends oral nutrition supplements (Ensure, Boost VHC, Orgain, Kate Farms) and using protein powders."
      },
      {
        "criterion_number": 12,
        "description": "The response does not explicitly state the patient should discuss changes to their diet with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends referral to a registered dietitian and discussion with the medical team but does not explicitly instruct discussing dietary changes with the oncology team."
      },
      {
        "criterion_number": 13,
        "description": "The response should discuss concerns with a palliative care specialist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends consulting a palliative care team and clarifies their role in symptom management and quality of life."
      },
      {
        "criterion_number": 14,
        "description": "States that patients with pancreatic cancer are at high risk of malnutrition, cachexia, and weight loss, and explicitly mentions the need for early and ongoing nutritional assessment/intervention.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Notes cachexia is common, but does not explicitly state the need for early and ongoing nutritional assessment/intervention."
      },
      {
        "criterion_number": 15,
        "description": "Explicitly recommends prompt referral to a registered dietitian or nutritionist for individualized evaluation/counseling, or states that nutritional support is a cornerstone of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly recommends referral to a registered oncology dietitian for a tailored plan."
      },
      {
        "criterion_number": 16,
        "description": "Clearly states that early and aggressive nutritional intervention is essential to reduce further weight/muscle loss, improve tolerance to oncologic therapies, and optimize survival or quality of life.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not clearly state the necessity of early/aggressive nutritional intervention nor link it to treatment tolerance or survival; only mentions improving comfort/quality of life generally."
      },
      {
        "criterion_number": 17,
        "description": "Explicitly states that enteral nutrition (tube feeding) should be prioritized over parenteral nutrition (IV feeding) when oral intake is inadequate, and mentions at least one benefit of enteral nutrition.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of enteral versus parenteral nutrition or benefits of enteral feeding."
      },
      {
        "criterion_number": 18,
        "description": "Recommends oral nutritional supplements and specifically mentions omega-3 fatty acids as beneficial for supporting body weight or lean body mass.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Recommends oral supplements but does not mention omega-3 fatty acids."
      },
      {
        "criterion_number": 19,
        "description": "Recommends discussing the case with an oncologist or dietitian/nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages discussions with oncologist/gastroenterologist and explicitly recommends referral to a registered dietitian."
      }
    ],
    "question_number": 151,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:38:33.863431",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that weight loss can occur due to impaired absorption due to pancreatic enzyme deficiency.",
        "score_given": 4,
        "max_points": 4,
        "justification": "States weight loss is due to malabsorption and explains pancreatic cancer can block ducts or destroy enzyme-producing cells, implying enzyme deficiency."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that pancreatic exocrine insufficiency leads to deficiencies in fat-soluble vitamins or micronutrients and explicitly recommends pancreatic enzyme replacement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Explicitly recommends PERT, but does not mention fat-soluble vitamin or micronutrient deficiencies from exocrine insufficiency."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that appetite stimulants can sometimes be helpful.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists appetite stimulants (megestrol acetate, dronabinol, corticosteroids) as potentially helpful."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that appetite stimulants may be considered for refractory cases or due to potential side effects.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes corticosteroids are typically used short term due to side effects, addressing the consideration of potential adverse effects."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the patient should discuss their weight loss with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises working closely with the oncologist and medical team and to discuss interventions with doctors."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that there can be many causes of losing weight in patients with pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States weight loss is due to a combination of factors including malabsorption, cachexia, and general illness."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that losing weight can be due to the cancer itself.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions increased metabolic demands from the cancer itself (cachexia)."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that weight loss can occur as a side effect of chemotherapy.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not mention chemotherapy as a cause of weight loss."
      },
      {
        "criterion_number": 9,
        "description": "The response should state the patient should try and get sufficient protein intake.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Recommends high-protein foods, lists protein sources, and suggests protein powders."
      },
      {
        "criterion_number": 10,
        "description": "The response should state the patient should try and get sufficient calorie intake.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Emphasizes high-calorie foods and strategies to increase caloric intake (fortifying foods, ONS, frequent small meals)."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that nutrition/protein supplements can be helpful.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends oral nutritional supplements (Ensure, Boost, etc.) and protein powders."
      },
      {
        "criterion_number": 12,
        "description": "The response does not explicitly state the patient should discuss changes to their diet with their oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It explicitly advises working closely with the oncologist/medical team and to discuss interventions with doctors; therefore, it does not meet this criterion as written."
      },
      {
        "criterion_number": 13,
        "description": "The response should discuss concerns with a palliative care specialist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends a palliative care consultation to manage symptoms and improve quality of life."
      },
      {
        "criterion_number": 14,
        "description": "States that patients with pancreatic cancer are at high risk of malnutrition, cachexia, and weight loss, and explicitly mentions the need for early and ongoing nutritional assessment/intervention.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions cachexia/weight loss but does not state high risk of malnutrition nor explicitly call for early and ongoing nutritional assessment/intervention."
      },
      {
        "criterion_number": 15,
        "description": "Explicitly recommends prompt referral to a registered dietitian or nutritionist for individualized evaluation/counseling, or states that nutritional support is a cornerstone of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages working with a registered dietitian specializing in oncology to develop a personalized plan."
      },
      {
        "criterion_number": 16,
        "description": "Clearly states that early and aggressive nutritional intervention is essential to reduce further weight/muscle loss, improve tolerance to oncologic therapies, and optimize survival or quality of life.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not explicitly state early/aggressive nutritional intervention or link it to therapy tolerance/survival; focuses on quality-of-life goals generally."
      },
      {
        "criterion_number": 17,
        "description": "Explicitly states that enteral nutrition (tube feeding) should be prioritized over parenteral nutrition (IV feeding) when oral intake is inadequate, and mentions at least one benefit of enteral nutrition.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of enteral vs parenteral nutrition."
      },
      {
        "criterion_number": 18,
        "description": "Recommends oral nutritional supplements and specifically mentions omega-3 fatty acids as beneficial for supporting body weight or lean body mass.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Recommends ONS but does not mention omega-3 fatty acids or their benefits."
      },
      {
        "criterion_number": 19,
        "description": "Recommends discussing the case with an oncologist or dietitian/nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises working with the oncologist and a registered dietitian and to discuss interventions with doctors."
      }
    ],
    "question_number": 151,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:39:22.940351",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing massage therapy with the oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response clearly instructs to obtain clearance from the oncology team before booking and includes an actionable step to discuss with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend using a massage therapist who has experience with oncology patients.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It explicitly recommends a specially trained oncology massage therapist and provides the S4OM resource to find one."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend avoiding massage if the person has a fever.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of avoiding massage in the presence of fever."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend avoiding massage if the person has an infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While infection risk with neutropenia and hygiene are discussed, it does not advise avoiding massage if there is an active infection."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend avoiding massage if the person has excessive pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response discusses pain relief and communication but does not recommend avoiding massage when pain is excessive."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend avoiding massage if the person has a clot or deep vein thrombosis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes DVT risk and advises very light strokes on legs but does not state to avoid massage if a clot or DVT is present."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend avoiding massage over the tumor.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It explicitly states no massage over the tumor site/abdomen and to avoid deep or direct pressure there."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend avoiding massage over sensitive areas.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It advises avoiding areas with ports/PICC lines, recent surgical incisions, and adjusting for fragile skin and lymphedema."
      },
      {
        "criterion_number": 9,
        "description": "States that massage therapy is generally considered safe for patients undergoing treatment for pancreatic cancer when performed by trained professionals, and explicitly mentions that serious adverse events are extremely rare.",
        "score_given": 0,
        "max_points": 4,
        "justification": "The response states massage can be safe when done by trained professionals, but it does not explicitly state that serious adverse events are extremely rare."
      },
      {
        "criterion_number": 10,
        "description": "States that evidence from randomized controlled trials or meta-analyses shows massage therapy can reduce pain, anxiety, and fatigue, and may improve quality of life in cancer patients, and explicitly mentions that the certainty of evidence is low and benefits are typically moderate.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No RCTs or meta-analyses are cited, and there is no mention of low certainty or moderate effect sizes; only general benefits are described."
      },
      {
        "criterion_number": 11,
        "description": "Advises consulting the oncology team or healthcare provider before starting massage therapy, and mentions bleeding risk (e.g., low platelets) as a specific safety concern.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It advises consulting the oncology team and specifically notes thrombocytopenia/bleeding risk and the need for gentle pressure."
      },
      {
        "criterion_number": 12,
        "description": "Advises consulting the oncology team or healthcare provider before starting massage therapy, and mentions unstable bone lesions as a specific safety concern.",
        "score_given": 0,
        "max_points": 4,
        "justification": "There is no mention of bone metastases or unstable bone lesions as a safety concern."
      }
    ],
    "question_number": 152,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:39:51.886150",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing massage therapy with the oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states to consult her medical team first and obtain medical clearance; reiterates this in the summary."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend using a massage therapist who has experience with oncology patients.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Clearly recommends a qualified oncology massage therapist and provides guidance on finding one."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend avoiding massage if the person has a fever.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention fever as a contraindication."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend avoiding massage if the person has an infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Discusses neutropenia and hygiene but does not advise avoiding massage in the presence of an active infection."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend avoiding massage if the person has excessive pain.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions pain relief and pressure adjustments but does not advise avoiding massage when pain is excessive."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend avoiding massage if the person has a clot or deep vein thrombosis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes increased DVT risk and avoiding vigorous leg massage but does not state to avoid massage in the presence of a known clot/DVT."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend avoiding massage over the tumor.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Advises avoiding deep abdominal work and focusing on other areas given pancreatic tumor location, effectively avoiding direct work over the tumor site."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend avoiding massage over sensitive areas.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifically advises avoiding direct pressure on radiation sites, recent incisions, ports/PICC lines, lymphedema areas, neuropathic regions, and bone metastases."
      },
      {
        "criterion_number": 9,
        "description": "States that massage therapy is generally considered safe for patients undergoing treatment for pancreatic cancer when performed by trained professionals, and explicitly mentions that serious adverse events are extremely rare.",
        "score_given": 0,
        "max_points": 4,
        "justification": "States massage can be safe with trained professionals but does not explicitly state that serious adverse events are extremely rare."
      },
      {
        "criterion_number": 10,
        "description": "States that evidence from randomized controlled trials or meta-analyses shows massage therapy can reduce pain, anxiety, and fatigue, and may improve quality of life in cancer patients, and explicitly mentions that the certainty of evidence is low and benefits are typically moderate.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Describes potential benefits but does not reference RCTs/meta-analyses or discuss certainty of evidence and magnitude of benefit."
      },
      {
        "criterion_number": 11,
        "description": "Advises consulting the oncology team or healthcare provider before starting massage therapy, and mentions bleeding risk (e.g., low platelets) as a specific safety concern.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Recommends medical team approval and specifically addresses thrombocytopenia with increased bleeding/bruising risk."
      },
      {
        "criterion_number": 12,
        "description": "Advises consulting the oncology team or healthcare provider before starting massage therapy, and mentions unstable bone lesions as a specific safety concern.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Recommends consulting the oncology team and flags bone metastases with instruction to avoid direct pressure, indicating concern for bone lesions."
      }
    ],
    "question_number": 152,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:40:13.494699",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe personalized medicine approaches in pancreatic cancer, including tumor genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains personalized/precision medicine and details both tumor profiling (somatic testing) and germline testing as parts of the approach."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that precision medicine, or personalized oncology, tailors cancer treatment based on a patient\u2019s unique tumor characteristics, such as genetic and molecular profiles, to improve effectiveness and reduce toxicity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States treatments are tailored to tumor genetics/biomarkers to select the most effective options and notes targeted therapies often have fewer side effects than traditional chemotherapy."
      },
      {
        "criterion_number": 3,
        "description": "The response should include somatic testing for patients with locally advanced pancreatic cancer who are candidates for systemic therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends somatic testing for all pancreatic cancer patients, which includes those with locally advanced disease eligible for systemic therapy."
      },
      {
        "criterion_number": 4,
        "description": "The response should include somatic testing for patients with metastatic pancreatic cancer who are candidates for systemic therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly discusses tumor profiling and also cites metastatic settings (e.g., olaparib maintenance), encompassing metastatic candidates for systemic therapy."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that both germline and somatic testing are recommended for all patients with pancreatic cancer, as actionable alterations may be present even in the absence of family history.",
        "score_given": 0,
        "max_points": 10,
        "justification": "States both germline and somatic testing are recommended for all patients but does not mention the rationale that actionable alterations can be present even without a family history."
      },
      {
        "criterion_number": 6,
        "description": "The response should include germline testing for inherited pancreatic cancer syndromes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes germline (hereditary) testing and highlights BRCA as an inherited mutation relevant to pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should include germline testing is recommended for all patients with confirmed pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States it is standard of care for all pancreatic cancer patients to undergo germline testing."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that mutations found by somatic testing can sometimes be targeted with medications.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides multiple examples where somatic alterations (e.g., NTRK fusions, KRAS G12C) can be treated with specific targeted medications."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that based on genetic testing and molecular profiles, targeted therapies can be given.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects test results (biomarkers) to actionable targeted therapies, including tumor-agnostic treatments."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that patients with certain germline mutations are candidates for targeted therapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that patients with germline BRCA1/2 mutations may receive PARP inhibitors."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that FDA-approved targeted therapies include PARP inhibitors (e.g., olaparib) for patients with germline BRCA1/2 mutations, typically as maintenance therapy following platinum-based chemotherapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically states olaparib is FDA-approved as maintenance after at least 16 weeks of platinum-based chemotherapy for germline BRCA-mutated metastatic PDAC."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that TRK inhibitors (larotrectinib, entrectinib) are indicated for NTRK fusion-positive tumors, regardless of histology.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Names larotrectinib and entrectinib and explains they are tumor-agnostic for NTRK fusions."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that immune checkpoint inhibitors (pembrolizumab, dostarlimab) are approved for dMMR/MSI-H PDAC, a rare but important subset.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies MSI-H/dMMR PDAC as rare (1\u20132%) and notes pembrolizumab as an approved tumor-agnostic option with potentially durable responses."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that sotorasib is an emerging agent for KRAS G12C-mutated pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions sotorasib (and adagrasib) for KRAS G12C with ongoing clinical trials in pancreatic cancer."
      },
      {
        "criterion_number": 15,
        "description": "The response should include that clinical trials may be testing drugs targeting certain mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages clinical trials and lists examples including novel KRAS inhibitors, vaccines, combinations, and cell therapies."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises speaking with the oncology team and provides specific questions to ask; also includes a disclaimer to consult healthcare professionals."
      }
    ],
    "question_number": 153,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:40:56.994272",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describe personalized medicine approaches in pancreatic cancer, including tumor genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains precision medicine concepts and details tumor genomic profiling (NGS, liquid biopsy), germline testing, molecular tumor boards, and clinical trials, clearly covering personalized approaches including tumor genetic testing."
      },
      {
        "criterion_number": 2,
        "description": "Mention that precision medicine tailors treatment based on unique tumor characteristics (genetic/molecular) to improve effectiveness and reduce toxicity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly defines personalized medicine as tailoring treatments based on unique genetic and molecular characteristics of the tumor and patient. While not explicitly stating 'reduce toxicity,' it clearly conveys tailoring to improve effectiveness; this satisfies the essence of the criterion."
      },
      {
        "criterion_number": 3,
        "description": "Include somatic testing for patients with locally advanced pancreatic cancer who are candidates for systemic therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Somatic testing is emphasized as a crucial step and recommended 'ideally at diagnosis' or upon progression, which encompasses locally advanced patients who are candidates for systemic therapy."
      },
      {
        "criterion_number": 4,
        "description": "Include somatic testing for patients with metastatic pancreatic cancer who are candidates for systemic therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response recommends comprehensive genomic profiling at diagnosis and at progression, which clearly applies to metastatic patients considered for systemic therapy."
      },
      {
        "criterion_number": 5,
        "description": "State that both germline and somatic testing are recommended for all patients with pancreatic cancer, even without family history.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It states that all pancreatic cancer patients are increasingly recommended for germline testing (implying regardless of family history) and strongly encourages somatic testing, but does not explicitly state that somatic testing is recommended for all patients."
      },
      {
        "criterion_number": 6,
        "description": "Include germline testing for inherited pancreatic cancer syndromes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It discusses germline testing, citing genes such as BRCA1/2, ATM, PALB2, and Lynch syndrome genes, clearly addressing inherited cancer syndromes."
      },
      {
        "criterion_number": 7,
        "description": "State that germline testing is recommended for all patients with confirmed pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response says 'all pancreatic cancer patients are increasingly recommended for germline testing,' which effectively communicates recommendation for all patients."
      },
      {
        "criterion_number": 8,
        "description": "State that mutations found by somatic testing can sometimes be targeted with medications.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly states the goal is to find 'actionable' mutations that can be targeted by specific drugs."
      },
      {
        "criterion_number": 9,
        "description": "Mention that based on genetic testing and molecular profiles, targeted therapies can be given.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple examples (PARP inhibitors, TRK inhibitors, immunotherapy in MSI-H/dMMR) are provided, tied directly to genomic findings."
      },
      {
        "criterion_number": 10,
        "description": "State that patients with certain germline mutations are candidates for targeted therapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response links germline BRCA1/2 (and related genes) with PARP inhibitors and platinum sensitivity, indicating candidacy for targeted therapy based on germline mutations."
      },
      {
        "criterion_number": 11,
        "description": "Mention that FDA-approved targeted therapies include PARP inhibitors (e.g., olaparib) for germline BRCA1/2 mutations, typically as maintenance therapy after platinum-based chemotherapy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While PARP inhibitors and maintenance therapy are mentioned, the response does not specify the FDA-approved indication for germline BRCA1/2-mutated PDAC nor the metastatic/maintenance context precisely, and includes rucaparib (not FDA-approved in PDAC)."
      },
      {
        "criterion_number": 12,
        "description": "Mention that TRK inhibitors (larotrectinib, entrectinib) are indicated for NTRK fusion-positive tumors, regardless of histology.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It identifies NTRK fusions as actionable and names larotrectinib and entrectinib as treatment options. Although it doesn\u2019t state 'regardless of histology,' the indication for NTRK fusion is clearly conveyed."
      },
      {
        "criterion_number": 13,
        "description": "Mention that immune checkpoint inhibitors (pembrolizumab, dostarlimab) are approved for dMMR/MSI-H PDAC.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response highlights MSI-H/dMMR tumors as rare but highly responsive to checkpoint inhibitors, explicitly naming pembrolizumab, which is FDA-approved for MSI-H/dMMR tumors including PDAC."
      },
      {
        "criterion_number": 14,
        "description": "State that sotorasib is an emerging agent for KRAS G12C-mutated pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "KRAS G12C-targeted drugs are mentioned as emerging, but sotorasib is not named."
      },
      {
        "criterion_number": 15,
        "description": "Include that clinical trials may be testing drugs targeting certain mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clinical trials are emphasized as a route to access cutting-edge targeted and immunotherapies, especially for rare actionable alterations."
      },
      {
        "criterion_number": 16,
        "description": "Recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It provides specific questions to ask the oncologist, suggests molecular tumor boards, and encourages second opinions at academic centers."
      }
    ],
    "question_number": 153,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:41:55.804595",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that diarrhea is a common side effect from certain chemotherapy drugs.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response calls diarrhea a common treatment-related side effect but does not specifically attribute it to chemotherapy drugs."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that diarrhea can be managed with anti-motility agents such as loperamide.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response explicitly mentions loperamide (Imodium) as a potential medication to manage diarrhea with oncologist approval."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that dietary modifications include the elimination of lactose-containing products and high-osmolar supplements.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it advises avoiding dairy (lactose), it does not mention avoiding high-osmolar supplements."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that loperamide is given starting at 4 mg followed by 2 mg every 4 hours or after each unformed stool, not exceeding 16 mg per day.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No dosing schedule or maximum dose for loperamide is provided."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that diarrhea from chemotherapy can be managed by dose reduction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no explicit mention of chemotherapy dose reduction as a management strategy."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that diarrhea from chemotherapy can be managed by schedule modification.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of modifying the chemotherapy schedule as a management strategy."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that diarrhea from chemotherapy can be managed by switching to an alternate regimen.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of switching to an alternate chemotherapy regimen as a strategy."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that diarrhea can be associated with pancreatic enzyme deficiency.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Clearly identifies pancreatic exocrine insufficiency (PEI) as a cause/worsening factor for diarrhea."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that diarrhea associated with pancreatic enzyme deficiency can be improved with pancreatic enzyme supplementation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends pancreatic enzyme replacement therapy (PERT) such as Creon/Zenpep and states it can make a significant difference."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that in patients with exocrine pancreatic insufficiency, pancreatic enzyme replacement therapy (PERT) should be initiated and titrated to symptom control, as this can significantly reduce steatorrhea and improve nutritional status.",
        "score_given": 0,
        "max_points": 5,
        "justification": "PERT is mentioned but there is no discussion of titration to symptom control or explicit mention of reducing steatorrhea and improving nutritional status."
      },
      {
        "criterion_number": 11,
        "description": "The response should discuss symptoms with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Strongly emphasizes contacting the oncology team, what details to report, and when to call immediately."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that if diarrhea progresses to grade 3 or 4 or persists after 24\u201348 hours of loperamide, aggressive management is recommended.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of CTCAE grading or escalation after 24\u201348 hours of loperamide."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that aggressive management includes intravenous fluids for dehydration, octreotide, and empiric antibiotics if infection is suspected.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not mention IV fluids, octreotide, or empiric antibiotics."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that octreotide is initially given as 100\u2013150 \u03bcg subcutaneously three times daily, with escalation up to 500 \u03bcg if needed.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Octreotide and its dosing are not discussed."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that stool studies and laboratory evaluation for infectious etiologies should be performed in severe cases.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it notes ruling out infection (e.g., C. difficile), it does not explicitly state performing stool studies or laboratory evaluation."
      }
    ],
    "question_number": 154,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:42:28.053261",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that diarrhea is a common side effect from certain chemotherapy drugs.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response calls diarrhea a very common treatment-related side effect but does not explicitly attribute it to specific chemotherapy drugs."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that diarrhea can be managed with anti-motility agents such as loperamide.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response explicitly recommends anti-diarrheal agents and lists loperamide (Imodium) as a first-line option."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention that dietary modifications include the elimination of lactose-containing products and high-osmolar supplements.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response advises avoiding dairy (lactose) but does not mention eliminating high-osmolar supplements."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that loperamide is given starting at 4 mg followed by 2 mg every 4 hours or after each unformed stool, not exceeding 16 mg per day.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No specific loperamide dosing schedule or maximum daily dose is provided."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that diarrhea from chemotherapy can be managed by dose reduction.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of chemotherapy dose reduction as a management strategy."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that diarrhea from chemotherapy can be managed by schedule modification.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of modifying the chemotherapy schedule to manage diarrhea."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that diarrhea from chemotherapy can be managed by switching to an alternate regimen.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No suggestion to switch to an alternate chemotherapy regimen."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that diarrhea can be associated with pancreatic enzyme deficiency.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Clearly explains that pancreatic exocrine insufficiency is a common cause of diarrhea (steatorrhea) in pancreatic cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that diarrhea associated with pancreatic enzyme deficiency can be improved with pancreatic enzyme supplementation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends PERT (e.g., Creon, Zenpep) and discusses adjusting dose/timing, implying improvement of PEI-related diarrhea."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that in patients with exocrine pancreatic insufficiency, pancreatic enzyme replacement therapy (PERT) should be initiated and titrated to symptom control, as this can significantly reduce steatorrhea and improve nutritional status.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While initiation and dose adjustment of PERT are discussed, the response does not explicitly state that this reduces steatorrhea and improves nutritional status."
      },
      {
        "criterion_number": 11,
        "description": "The response should discuss symptoms with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes informing the oncology team immediately, providing detailed symptom information, and ongoing communication."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that if diarrhea progresses to grade 3 or 4 or persists after 24\u201348 hours of loperamide, aggressive management is recommended.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It advises contacting the doctor if symptoms persist after 24\u201348 hours, but does not tie this specifically to failure after loperamide or to grade 3\u20134 severity, nor explicitly state that aggressive management is recommended under those conditions."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that aggressive management includes intravenous fluids for dehydration, octreotide, and empiric antibiotics if infection is suspected.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifies IV fluids for dehydration, octreotide for severe/refractory diarrhea, and antibiotics if infection (e.g., C. difficile) is suspected."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that octreotide is initially given as 100\u2013150 \u03bcg subcutaneously three times daily, with escalation up to 500 \u03bcg if needed.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Octreotide is mentioned but without any dosing details."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that stool studies and laboratory evaluation for infectious etiologies should be performed in severe cases.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response suggests antibiotics if infection is suspected but does not mention ordering stool studies or laboratory evaluation."
      }
    ],
    "question_number": 154,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:43:28.542856",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing the treatment plan with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises consulting the oncologist/care team about treatment intensity, duration, side effects, appointment frequency, and recommendations on work; also lists 'Talk to the Oncology Team' as first action step."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend understanding the prognosis.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Does not explicitly mention prognosis, expected survival, stage, or disease course; focuses on treatment logistics and side effects instead."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend understanding the goals of treatment.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No explicit discussion of treatment goals (e.g., curative vs palliative, life extension vs symptom control)."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend considering the impact of stopping work on health insurance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Addresses health insurance in depth, including COBRA, spouse\u2019s plan, ACA Marketplace with subsidies, and Medicare/Medicaid; emphasizes health insurance as top priority."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend considering the impact of stopping work on income.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Thoroughly covers income replacement options (STD, LTD, SSDI, savings/retirement) and budgeting."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding the expected physical effects of treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Advises asking about common side effects (fatigue, nausea, pain) and their severity; links these to work capacity."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the expected mental effects of treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions cognitive changes ('chemo brain'), stress, and mental/emotional demands; notes impact on focus and work."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend considering employer-sponsored medical leave.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Discusses FMLA, ADA accommodations, PTO usage, and meeting HR to explore leave and accommodations before resigning."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly mentions at least two common symptoms of pancreatic cancer, such as pain, fatigue, dietary issues, or weight loss, and states that these symptoms can impair daily functioning and/or the ability to work.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions fatigue and pain (along with nausea) and explicitly states that fatigue and cognitive changes can make working difficult, fulfilling the symptom and impairment criteria."
      },
      {
        "criterion_number": 10,
        "description": "The response states that multiple factors should be systematically evaluated to support informed, patient-centered decision-making when considering stopping work for pancreatic cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a structured, multi-domain framework (health, finance/insurance, employment rights, emotional/social) and an action plan to guide informed decision-making."
      },
      {
        "criterion_number": 11,
        "description": "The response states that discussions should elicit or consider the patient\u2019s personal values, goals, and/or preferences, including the importance of quality of life versus life extension.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Emphasizes maximizing quality of life, minimizing stress, and having an open family conversation about fears, hopes, and priorities; centers the patient\u2019s decision."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly mentions that financial and practical considerations are critical in the decision to stop working.",
        "score_given": 8,
        "max_points": 8,
        "justification": "States financial/insurance issues are often the biggest source of stress and a primary barrier; details practical steps like budgeting and insurance options."
      },
      {
        "criterion_number": 13,
        "description": "The response recommends referral to, or consultation with, financial counselors or social workers to help navigate financial challenges, access resources, or manage cancer care costs.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically advises meeting with a hospital social worker or financial navigator for insurance navigation, SSDI application help, and financial assistance resources."
      },
      {
        "criterion_number": 14,
        "description": "The response states that patients should be informed about disability benefits, workplace accommodations, and/or community support programs that may help with financial or practical challenges.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Covers STD, LTD, SSDI (including Compassionate Allowances), ADA accommodations, FMLA, PTO donation, and references PanCAN as a support resource."
      }
    ],
    "question_number": 155,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:44:13.214438",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing the treatment plan with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises consulting the oncologist/treatment team for recommendations about working during treatment and includes them in 'Key People to Consult.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend understanding the prognosis.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Prognosis is mentioned only in the context of what to disclose to an employer; it does not explicitly recommend understanding or discussing prognosis to guide the decision."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend understanding the goals of treatment.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No explicit recommendation to clarify treatment goals (e.g., curative vs. palliative) or how those goals should inform the work decision."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend considering the impact of stopping work on health insurance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a detailed section on health insurance implications, including employer-sponsored coverage, COBRA, spousal plans, ACA marketplace, Medicaid, and Medicare."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend considering the impact of stopping work on income.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Thoroughly addresses income replacement (STD/LTD, PTO, savings, spouse\u2019s income, SSDI/SSI) and budgeting."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding the expected physical effects of treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Lists anticipated physical side effects (fatigue, nausea, pain, neuropathy, immune suppression) and ties them to work capacity and safety."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend understanding the expected mental effects of treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Addresses cognitive effects ('chemo brain'), mental clarity, stress, and emotional well-being as factors impacting work."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend considering employer-sponsored medical leave.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Discusses FMLA, disability leave policies, reasonable accommodations, and suggests temporary leave (FMLA/STD) as a trial."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly mentions at least two common symptoms of pancreatic cancer, such as pain, fatigue, dietary issues, or weight loss, and states that these symptoms can impair daily functioning and/or the ability to work.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions fatigue and pain and asks whether these could make work impossible or unsafe, linking symptoms/side effects to work impairment."
      },
      {
        "criterion_number": 10,
        "description": "The response states that multiple factors should be systematically evaluated to support informed, patient-centered decision-making when considering stopping work for pancreatic cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Organized, multi-domain evaluation (medical, financial, workplace, emotional, practical), emphasizes informed, step-by-step decision-making."
      },
      {
        "criterion_number": 11,
        "description": "The response states that discussions should elicit or consider the patient\u2019s personal values, goals, and/or preferences, including the importance of quality of life versus life extension.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Emphasizes personal values and preferences (purpose, identity, well-being, family stability) in decision-making, aligning with a values-based approach."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly mentions that financial and practical considerations are critical in the decision to stop working.",
        "score_given": 8,
        "max_points": 8,
        "justification": "States financial considerations are often the most significant hurdle; provides extensive financial and practical/logistical planning guidance."
      },
      {
        "criterion_number": 13,
        "description": "The response recommends referral to, or consultation with, financial counselors or social workers to help navigate financial challenges, access resources, or manage cancer care costs.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends consulting a financial advisor and a social worker/patient navigator for resources and benefits navigation."
      },
      {
        "criterion_number": 14,
        "description": "The response states that patients should be informed about disability benefits, workplace accommodations, and/or community support programs that may help with financial or practical challenges.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Covers STD/LTD, SSDI/SSI, ADA reasonable accommodations, FMLA, and support groups, informing about multiple supportive programs."
      }
    ],
    "question_number": 155,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:44:54.441868",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe tumor profiling as involving comprehensive molecular analysis of tumor tissue and often blood to identify genetic, transcriptomic, and proteomic alterations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains profiling of tumor tissue and liquid biopsy (blood), and states that NGS assesses DNA and RNA (genetic/transcriptomic) and protein expression (proteomic, e.g., PD-L1)."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that a tumor biopsy can be used for tumor profiling.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that biopsy tissue is used for profiling, often from the diagnostic sample."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that circulating tumor DNA can be used for tumor profiling.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes liquid biopsy via blood draw to analyze circulating tumor DNA (ctDNA)."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that tumor biopsies can be tested for mutations in the DNA.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that genomic sequencing reads tumor DNA to identify mutations."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that tumor biopsies can be tested for mutations in the RNA.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes that sequencing includes RNA to detect alterations/fusions, implying RNA-level testing."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that tumor biopsies can be tested for the presence of certain proteins.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions assessment of protein expression such as PD-L1."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that circulating tumor DNA can be tested for mutations in DNA.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains that the tumor sample (tissue or blood) undergoes NGS to identify mutations, thereby covering ctDNA mutation testing."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that tumor profiling helps identify alterations that may be actionable for therapy selection or clinical trial enrollment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Uses the term actionable biomarkers, links them to targeted therapy/immunotherapy choices, and highlights clinical trial eligibility."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that routine molecular tumor profiling is now feasible and recommended for all patients with pancreatic cancer, regardless of stage or surgical eligibility. Based on the NCCN Guidelines Version 2.2025, Clinical Presentation and Workup pathway for pancreatic adenocarcinoma, stating that patients with clinical suspicion of pancreatic cancer or evidence of dilated pancreatic/bile duct should undergo pancreatic protocol CT or MRI (abdomen) for evaluation. A multidisciplinary consultation is recommended after imaging. Workup includes chest and pelvis CT, endoscopic ultrasonography (EUS), MRI for indeterminate liver lesions, PET/CT or PET/MRI for high-risk features, and ERCP with stent placement if biliary obstruction is present. Laboratory evaluation should include liver function tests and baseline CA 19-9 after biliary drainage. If diagnosis is confirmed, perform genetic testing for inherited mutations. For metastatic disease, confirm with biopsy from a metastatic site, and perform molecular profiling of tumor tissue and complete staging with chest and pelvis CT. Depending on findings, categorize as resectable (PANC-2), borderline resectable (PANC-4), locally advanced (PANC-5), or metastatic disease (PANC-10). If no mass or diagnosis is confirmed, refer to a high-volume center for evaluation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not reference NCCN guidelines, universal recommendation for profiling, or the detailed imaging/workup pathway."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that approximately 20\u201328% of patients have actionable findings, and those who receive matched therapies based on tumor profiling have significantly improved progression-free and overall survival compared to those who do not.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No mention of actionable rate percentages or survival benefits with matched therapy."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that actionable alterations include BRCA1/2 mutations, NTRK, BRAF, FGFR2, RET, NRG1, and ALK fusions, and mismatch repair deficiency (dMMR/MSI-H).",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions BRCA1/2, NTRK, and dMMR/MSI-H, but omits BRAF, FGFR2, RET, NRG1, and ALK fusions."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages discussion with the healthcare team and frames questions for the next appointment; references the father's oncologist reviewing results."
      }
    ],
    "question_number": 156,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:45:40.632203",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe tumor profiling as involving comprehensive molecular analysis of tumor tissue and often blood to identify genetic, transcriptomic, and proteomic alterations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains analysis of tumor DNA and sometimes RNA, mentions protein expression (PD-L1), and includes liquid biopsy/ctDNA from blood, covering genomic, transcriptomic, and proteomic aspects."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that a tumor biopsy can be used for tumor profiling.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states tumor tissue from biopsy (fine-needle, core) or surgical specimen is used."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that circulating tumor DNA can be used for tumor profiling.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes that a liquid biopsy (blood test) can detect circulating tumor DNA for profiling."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that tumor biopsies can be tested for mutations in the DNA.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes sequencing DNA from tumor tissue and identifying mutations."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that tumor biopsies can be tested for mutations in the RNA.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that RNA is sometimes sequenced and included in analysis, and alterations such as fusions are assessed, implying RNA-level testing."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that tumor biopsies can be tested for the presence of certain proteins.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically mentions assessing protein expression like PD-L1 on tumor cells."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that circulating tumor DNA can be tested for mutations in DNA.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions detecting ctDNA via liquid biopsy but does not explicitly state testing ctDNA for DNA mutations."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that tumor profiling helps identify alterations that may be actionable for therapy selection or clinical trial enrollment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly discusses identifying targeted therapies, guiding immunotherapy, and determining clinical trial eligibility based on actionable alterations."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that routine molecular tumor profiling is now feasible and recommended for all patients with pancreatic cancer, regardless of stage or surgical eligibility. Based on the NCCN Guidelines Version 2.2025, Clinical Presentation and Workup pathway for pancreatic adenocarcinoma, stating that patients with clinical suspicion of pancreatic cancer or evidence of dilated pancreatic/bile duct should undergo pancreatic protocol CT or MRI (abdomen) for evaluation. A multidisciplinary consultation is recommended after imaging. Workup includes chest and pelvis CT, endoscopic ultrasonography (EUS), MRI for indeterminate liver lesions, PET/CT or PET/MRI for high-risk features, and ERCP with stent placement if biliary obstruction is present. Laboratory evaluation should include liver function tests and baseline CA 19-9 after biliary drainage. If diagnosis is confirmed, perform genetic testing for inherited mutations. For metastatic disease, confirm with biopsy from a metastatic site, and perform molecular profiling of tumor tissue and complete staging with chest and pelvis CT. Depending on findings, categorize as resectable (PANC-2), borderline resectable (PANC-4), locally advanced (PANC-5), or metastatic disease (PANC-10). If no mass or diagnosis is confirmed, refer to a high-volume center for evaluation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not reference NCCN guidance, universal recommendation across stages, or the detailed workup/staging pathway."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that approximately 20\u201328% of patients have actionable findings, and those who receive matched therapies based on tumor profiling have significantly improved progression-free and overall survival compared to those who do not.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No statistics on the proportion with actionable findings and no mention of improved PFS/OS with matched therapy."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that actionable alterations include BRCA1/2 mutations, NTRK, BRAF, FGFR2, RET, NRG1, and ALK fusions, and mismatch repair deficiency (dMMR/MSI-H).",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions BRCA1/2, MSI-H/dMMR, NTRK, BRAF, FGFR, RET, but omits NRG1 and ALK fusions and does not specify FGFR2."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises asking his doctors and medical team questions about care, effectively recommending discussion with the treating oncology team."
      }
    ],
    "question_number": 156,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:46:37.626350",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the connection between chronic inflammation of the pancreas and the risk of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that chronic pancreatitis (long-term inflammation) is a risk factor, explaining that chronic inflammation can damage DNA over time and increase the risk of malignant transformation."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that inflammation plays a central or significant role in pancreatic cancer pathogenesis, progression, or clinical outcomes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly frames inflammation as a 'key player' creating a 'vicious cycle,' contributing to tumor initiation, growth, protection via stroma, and systemic effects, indicating centrality in pathogenesis and outcomes."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that there is no treatment for targeting inflammation in pancreatic cancer per NCCN guidelines (version 2.2025).",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response does not mention NCCN guidelines nor explicitly state that there is no NCCN-recommended anti-inflammatory therapy specifically targeting inflammation in pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that inflammation is implicated in many cancers and include symptoms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states that chronic inflammation is a known risk factor for many cancers and lists systemic inflammatory symptoms (cachexia, pain, blood clots), satisfying both components."
      },
      {
        "criterion_number": 5,
        "description": "The response should explicitly mention that strategies to manage inflammation in pancreatic cancer are being researched or investigated in clinical or translational research.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It discusses clinical trials and emerging therapies targeting inflammatory pathways, stromal modification, and immune reprogramming, explicitly noting active research."
      },
      {
        "criterion_number": 6,
        "description": "The response should explicitly mention that strategies involving cytokine signaling are being researched, investigated, or studied for managing inflammation in pancreatic cancer.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It names JAK and STAT3 inhibitors as targets in clinical trials, which are core cytokine signaling pathways, directly addressing cytokine-related strategies."
      },
      {
        "criterion_number": 7,
        "description": "The response should explicitly recommend that the user discuss this case with an oncologist.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It advises engaging the oncology team, provides specific questions to ask the oncologist, and includes a disclaimer to discuss all aspects with her qualified oncology team."
      }
    ],
    "question_number": 157,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:47:04.389532",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describe the connection between chronic inflammation of the pancreas and the risk of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly states that chronic pancreatitis is a major risk factor for pancreatic cancer and explains the mechanism (repeated damage/repair leading to mutations in an inflammatory microenvironment)."
      },
      {
        "criterion_number": 2,
        "description": "State that inflammation plays a central or significant role in pancreatic cancer pathogenesis, progression, or clinical outcomes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response clearly says inflammation plays a significant, multifaceted role, contributing to development, progression, metastasis, immune evasion, treatment resistance, and systemic symptoms."
      },
      {
        "criterion_number": 3,
        "description": "Include that there is no treatment for targeting inflammation in pancreatic cancer per NCCN guidelines (version 2.2025).",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response does not reference NCCN guidelines nor state that there is no NCCN-endorsed inflammation-targeting treatment; it instead discusses investigational agents and symptomatic anti-inflammatory measures."
      },
      {
        "criterion_number": 4,
        "description": "Include that inflammation is implicated in many cancers and include symptoms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response details multiple inflammation-related symptoms (cachexia, pain, fatigue, digestive issues), it does not state that inflammation is implicated in many cancers beyond pancreatic cancer."
      },
      {
        "criterion_number": 5,
        "description": "Explicitly mention that strategies to manage inflammation in pancreatic cancer are being researched or investigated in clinical or translational research.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response explicitly notes ongoing research into anti-inflammatory agents and mentions that these approaches are investigational and not standard."
      },
      {
        "criterion_number": 6,
        "description": "Explicitly mention that strategies involving cytokine signaling are being researched, investigated, or studied for managing inflammation in pancreatic cancer.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It specifically references research into 'specific cytokine blockers' as part of investigational anti-inflammatory strategies, fulfilling the cytokine signaling criterion."
      },
      {
        "criterion_number": 7,
        "description": "Explicitly recommend that the user discuss this case with an oncologist.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response advises communicating with the care team, explicitly including the mother's oncologist, to discuss symptoms and therapies."
      }
    ],
    "question_number": 157,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:47:37.729829",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes at least three specific benefits of art therapy for cancer patients, such as emotional expression, stress reduction, coping skills, mood improvement, self-esteem, social connection, or mindfulness/relaxation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response lists multiple specific benefits: emotional expression (\u201ca voice beyond words\u201d), regaining a sense of control, stress/anxiety reduction and relaxation, distraction from pain/symptoms, processing grief/fear in a safe space, fostering social connection/reducing isolation, and creating legacy/meaning; it also explicitly mentions reduced anxiety and increased self-esteem."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that art therapy is not an anti-cancer therapy, does not treat cancer itself, or is not a substitute for medical cancer treatment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not explicitly state that art therapy does not treat cancer or that it is not a substitute for medical treatment. While it notes art therapy does not eliminate pain or nausea, it does not include a clear disclaimer regarding cancer treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response provides the name \u201cAmerican Art Therapy Association\u201d and states or implies that this organization can be used to find a qualified art therapist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It names the American Art Therapy Association (AATA) and specifies their website has a therapist locator to find credentialed art therapists."
      },
      {
        "criterion_number": 4,
        "description": "The response clearly recommends that the user discuss the use of art therapy with an oncologist or healthcare provider involved in the cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends starting by asking the oncology team and the cancer center\u2019s support staff for recommendations, which constitutes advising discussion with the healthcare team involved in treatment."
      }
    ],
    "question_number": 158,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:48:01.401231",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes at least three specific benefits of art therapy for cancer patients, such as emotional expression, stress reduction, coping skills, mood improvement, self-esteem, social connection, or mindfulness/relaxation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response details multiple specific benefits, including emotional expression/processing, stress and anxiety reduction, coping with physical symptoms, sense of control/empowerment, improved communication and connection, self-discovery/meaning-making, and distraction/engagement."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly states that art therapy is not an anti-cancer therapy, does not treat cancer itself, or is not a substitute for medical cancer treatment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response notes that art therapy should complement medical treatments, it does not explicitly state that art therapy does not treat cancer or is not a substitute for medical treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response provides the name \u201cAmerican Art Therapy Association\u201d and states or implies that this organization can be used to find a qualified art therapist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention the American Art Therapy Association or direct users to it for finding a qualified art therapist."
      },
      {
        "criterion_number": 4,
        "description": "The response clearly recommends that the user discuss the use of art therapy with an oncologist or healthcare provider involved in the cancer treatment.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response suggests integration with the care team but does not explicitly recommend discussing art therapy with the oncologist or healthcare provider."
      }
    ],
    "question_number": 158,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:48:25.346050",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The person should contact the insurance company to understand the reason for the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response instructs to obtain the official denial letter from the insurance company and emphasizes that it must state the specific reason for denial, which requires contacting the insurer."
      },
      {
        "criterion_number": 2,
        "description": "The person should file an appeal as an option to remedy the denial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly outlines filing appeals and provides a multi-level appeal structure (internal appeals and external review)."
      },
      {
        "criterion_number": 3,
        "description": "The person should work with their oncology team to help with the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises contacting the oncologist\u2019s office immediately, leveraging nurse navigators/insurance specialists, and arranging peer-to-peer reviews to overturn denials."
      },
      {
        "criterion_number": 4,
        "description": "The person should work with their oncology team to understand the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response instructs informing the oncologist\u2019s office about the denial and collaborating with them to understand and address the insurer\u2019s stated reasons."
      },
      {
        "criterion_number": 5,
        "description": "Patient assistance programs should be considered.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends pharmaceutical company Patient Assistance Programs (PAPs) and explains how to access them."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly defines prior authorization as a process in which insurers require approval before a medication is covered.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It defines prior authorization by stating the doctor needed to get pre-approval and that the request could be denied or incomplete."
      },
      {
        "criterion_number": 7,
        "description": "The response states that prior authorization denials or delays are common in oncology care and mentions at least one impact.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions prior authorization and the impact of delays/denials on health and quality of life in a personal letter, it does not explicitly state that prior authorization denials or delays are common in oncology care."
      },
      {
        "criterion_number": 8,
        "description": "The person should contact the oncologist to request a referral to a financial navigator or social worker.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It instructs contacting the oncologist\u2019s office and references nurse navigators, insurance specialists, and financial counselors; it also notes that a hospital social worker can help with applications, effectively guiding the user to seek those referrals/supports."
      },
      {
        "criterion_number": 9,
        "description": "The appeal process involves submitting a formal appeal with supporting evidence.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It details submitting a formal appeal with a letter of medical necessity, medical records, and a personal letter\u2014clear supporting evidence."
      },
      {
        "criterion_number": 10,
        "description": "If appeals are unsuccessful, alternative access strategies should be pursued, such as patient assistance programs or manufacturer co-pay cards.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends PAPs and manufacturer co-pay assistance as parallel/alternative strategies, covering access if appeals fail or are pending."
      },
      {
        "criterion_number": 11,
        "description": "The response names at least one patient advocacy organization that can help connect the user with resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It names PanCAN, CancerCare, and Patient Advocate Foundation as resources."
      }
    ],
    "question_number": 159,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:49:27.201339",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The person should contact the insurance company to understand the reason for the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises requesting a formal denial letter from the insurance company that states the specific reason for denial and outlines the appeal process, and emphasizes record-keeping for calls."
      },
      {
        "criterion_number": 2,
        "description": "The person should file an appeal as an option to remedy the denial.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides detailed steps for initiating internal appeals, writing a formal appeal letter, and requesting an expedited appeal."
      },
      {
        "criterion_number": 3,
        "description": "The person should work with their oncology team to help with the denial.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends working closely with the oncologist/care team for a letter of medical necessity, peer-to-peer review, and submission of supporting documentation."
      },
      {
        "criterion_number": 4,
        "description": "The person should work with their oncology team to understand the denial.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it explains reasons for denial and advises getting the denial letter, it does not explicitly instruct working with the oncology team to understand or interpret the denial."
      },
      {
        "criterion_number": 5,
        "description": "Patient assistance programs should be considered.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends manufacturer patient assistance programs and co-pay assistance programs with examples and resources."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly defines prior authorization as a process in which insurers require approval before a medication is covered.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions prior authorization as 'the doctor didn't get approval before prescribing' but does not explicitly define it as insurer-required approval before coverage."
      },
      {
        "criterion_number": 7,
        "description": "The response states that prior authorization denials or delays are common in oncology care and mentions at least one impact.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that prior authorization denials/delays are common in oncology nor describe their impacts; it only notes urgency/time-sensitivity in general."
      },
      {
        "criterion_number": 8,
        "description": "The person should contact the oncologist to request a referral to a financial navigator or social worker.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions social workers, patient navigators, and financial counselors at cancer centers but does not explicitly instruct contacting the oncologist to request a referral."
      },
      {
        "criterion_number": 9,
        "description": "The appeal process involves submitting a formal appeal with supporting evidence.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Directs writing a formal appeal letter and attaching the physician's letter of medical necessity and all supporting medical documents."
      },
      {
        "criterion_number": 10,
        "description": "If appeals are unsuccessful, alternative access strategies should be pursued, such as patient assistance programs or manufacturer co-pay cards.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides alternative access strategies including manufacturer patient assistance programs, co-pay assistance, and clinical trials alongside appeals."
      },
      {
        "criterion_number": 11,
        "description": "The response names at least one patient advocacy organization that can help connect the user with resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Names Pancreatic Cancer Action Network (PanCAN), Lustgarten Foundation, and American Cancer Society as resource organizations."
      }
    ],
    "question_number": 159,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:50:29.313444",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing symptoms with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to always speak with the oncology nurse or doctor; notes they can prescribe medications and adjust treatment."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe common chemotherapy-related side effects, including dry skin.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes dryness/itching, hand-foot syndrome, and nail/cuticle changes as chemotherapy-related skin effects."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe management of dry skin, including using thick emollient creams.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends thick emollient creams/ointments (e.g., Eucerin, Aquaphor, CeraVe) with ceramides/urea."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe management of dry skin, including avoiding hot water.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises using lukewarm, not hot, water for bathing and showering."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe management of dry skin, including avoiding scrubbing the skin.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States to avoid harsh scrubbing and to gently pat the skin dry."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe common chemotherapy-related side effects, including hand-foot syndrome associated with certain chemotherapy drugs like capecitabine.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Hand-foot syndrome is described, but no explicit association with specific causative agents (e.g., capecitabine) is made."
      },
      {
        "criterion_number": 7,
        "description": "The response should include management of hand-foot syndrome, including the use of urea-based creams.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically recommends urea cream 10\u201320% for HFS."
      },
      {
        "criterion_number": 8,
        "description": "The response should include management of hand-foot syndrome, including the use of lanolin-based creams.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Lanolin-based creams are not mentioned."
      },
      {
        "criterion_number": 9,
        "description": "The response should include management of hand-foot syndrome, including the use of supportive footwear.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises wearing loose, comfortable shoes and avoiding long walks to reduce pressure on feet."
      },
      {
        "criterion_number": 10,
        "description": "The response should include management of hand-foot syndrome, including the use of gloves at night.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Gloves at night are suggested for fissures from EGFR inhibitors, not specifically for HFS."
      },
      {
        "criterion_number": 11,
        "description": "The response should include management of hand-foot syndrome, including avoiding friction on affected areas.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly advises avoiding pressure and friction on hands and feet for HFS."
      },
      {
        "criterion_number": 12,
        "description": "The response should include management of hand-foot syndrome, including dose reduction of chemotherapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes that the oncology team may adjust the dose or schedule for severe skin reactions, which applies to severe HFS."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe radiation dermatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes localized redness, swelling, itching, sunburn-like changes, peeling, and blistering within the radiation field."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe management of radiation dermatitis, including the use of creams approved by the radiation team.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises following the radiation oncology team's protocol and using only products approved by them; lists common options."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe management of radiation dermatitis, including avoiding sun exposure.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends protecting the treated skin from sun exposure."
      },
      {
        "criterion_number": 16,
        "description": "The response explicitly names at least one chemotherapy agent as a cause of skin changes, such as gemcitabine, FOLFIRINOX, or nab-paclitaxel.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Names gemcitabine, 5-FU, and FOLFIRINOX in the chemotherapy-related skin issues section."
      },
      {
        "criterion_number": 17,
        "description": "The response lists at least four distinct manifestations of chemotherapy-related skin changes, with at least two from the specified list.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions dryness/itching, HFS (redness, swelling, pain, peeling), nail brittleness/darkening/cracking, and paronychia\u2014four or more distinct changes."
      },
      {
        "criterion_number": 18,
        "description": "The response states that skin changes may also be due to other causes such as infection, other medications, or unrelated skin disorders/systemic diseases.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises confirming that changes are not an allergic reaction or infection, acknowledging alternative causes."
      },
      {
        "criterion_number": 19,
        "description": "The response states that prevention of skin problems is important and should begin at or before therapy initiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While preventive measures are described, the timing (at or before therapy initiation) is not explicitly stated."
      },
      {
        "criterion_number": 20,
        "description": "The response recommends using gentle, pH-balanced cleansers, regular moisturization, and broad-spectrum sun protection.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends pH-neutral gentle cleansers, frequent moisturizing with thick creams, and daily broad-spectrum SPF \u226530 sunscreen."
      },
      {
        "criterion_number": 21,
        "description": "The response mentions prophylactic cooling measures during taxane infusions for hand-foot syndrome, supported by guidelines or evidence.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of prophylactic cooling during taxane infusions."
      },
      {
        "criterion_number": 22,
        "description": "The response states that correct identification of skin changes is important to ensure appropriate management and to avoid unnecessary discontinuation of effective cancer therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Emphasizes distinguishing side effects from infection/allergy for appropriate management but does not mention avoiding unnecessary discontinuation of effective therapy."
      },
      {
        "criterion_number": 23,
        "description": "The response recommends hydration with emollients, topical corticosteroids, antihistamines, and oatmeal baths for dry skin and itch.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Suggests emollients, topical steroid creams, oral antihistamines, and oatmeal baths for pruritus/dryness."
      },
      {
        "criterion_number": 24,
        "description": "The response states that for acne-like rash, oral tetracyclines and topical steroids are effective treatments.",
        "score_given": 3,
        "max_points": 3,
        "justification": "For EGFR-inhibitor rash, recommends oral doxycycline/minocycline (tetracyclines) and topical steroids."
      },
      {
        "criterion_number": 25,
        "description": "The response states that for hand-foot syndrome, urea creams, topical steroids, and cooling procedures are beneficial.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions urea creams and cooling for HFS but does not include topical steroids for HFS."
      },
      {
        "criterion_number": 26,
        "description": "The response states that mild immune-related rashes can be managed with topical corticosteroids, urea-containing creams, and antihistamines for pruritus.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Immune-related (checkpoint inhibitor) rash management is not discussed."
      },
      {
        "criterion_number": 27,
        "description": "The response states that severe immune-related rashes can be managed with systemic corticosteroids and, if refractory, immunomodulators, and that therapy interruption may be necessary for severe reactions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of systemic corticosteroids, immunomodulators, or therapy interruption for severe immune-related rashes."
      }
    ],
    "question_number": 160,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:52:41.858015",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing symptoms with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises regular communication with the oncology team, dermatologists, and nurses about any skin changes."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe common chemotherapy-related side effects, including dry skin.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes dryness (xerosis), itching, rashes, hand-foot syndrome, nail changes, and photosensitivity as common treatment-related effects; specifically links dryness/itch to chemotherapies."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe management of dry skin, including using thick emollient creams.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends thick, emollient-rich moisturizers (e.g., Aquaphor, Vaseline, Eucerin, CeraVe, Aveeno) applied frequently."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe management of dry skin, including avoiding hot water.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises using lukewarm water for showers/baths and avoiding hot water."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe management of dry skin, including avoiding scrubbing the skin.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises patting skin dry rather than rubbing and avoiding abrasive scrubs; also to avoid scrubbing/rubbing the radiated area."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe common chemotherapy-related side effects, including hand-foot syndrome associated with certain chemotherapy drugs like capecitabine.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Hand-foot syndrome is described with causative agents including capecitabine, 5-FU, gemcitabine, and liposomal irinotecan."
      },
      {
        "criterion_number": 7,
        "description": "The response should include management of hand-foot syndrome, including the use of urea-based creams.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No explicit mention of urea-based creams for hand-foot syndrome."
      },
      {
        "criterion_number": 8,
        "description": "The response should include management of hand-foot syndrome, including the use of lanolin-based creams.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Lanolin-based creams are not specifically recommended; products listed are not identified as lanolin-based."
      },
      {
        "criterion_number": 9,
        "description": "The response should include management of hand-foot syndrome, including the use of supportive footwear.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends wearing comfortable, loose-fitting shoes and cotton socks to reduce pressure."
      },
      {
        "criterion_number": 10,
        "description": "The response should include management of hand-foot syndrome, including the use of gloves at night.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Gloves at night are not mentioned; gloves are mentioned only for cooling during infusions."
      },
      {
        "criterion_number": 11,
        "description": "The response should include management of hand-foot syndrome, including avoiding friction on affected areas.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly recommends avoiding friction and pressure and limiting strenuous activities."
      },
      {
        "criterion_number": 12,
        "description": "The response should include management of hand-foot syndrome, including dose reduction of chemotherapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States dose modification or interruption of chemotherapy may be necessary in severe cases."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe radiation dermatitis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes radiation dermatitis with redness, dryness, itch, peeling, blistering localized to the treated area."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe management of radiation dermatitis, including the use of creams approved by the radiation team.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises to use only products recommended by the radiation oncology team (e.g., Aquaphor, Biafine, aloe without fragrance)."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe management of radiation dermatitis, including avoiding sun exposure.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly recommends avoiding sun exposure to the treated area indefinitely."
      },
      {
        "criterion_number": 16,
        "description": "The response explicitly names at least one chemotherapy agent as a cause of skin changes, such as gemcitabine, FOLFIRINOX, or nab-paclitaxel.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Names multiple agents (e.g., gemcitabine, 5-FU, paclitaxel, capecitabine, liposomal irinotecan, FOLFIRINOX components, erlotinib)."
      },
      {
        "criterion_number": 17,
        "description": "The response lists at least four distinct manifestations of chemotherapy-related skin changes, with at least two from the specified list.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Lists dryness/itching, acneiform rash, maculopapular rash, hand-foot syndrome, nail changes, and photosensitivity (well over four, including multiple specified items)."
      },
      {
        "criterion_number": 18,
        "description": "The response states that skin changes may also be due to other causes such as infection, other medications, or unrelated skin disorders/systemic diseases.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes pruritus may be related to liver issues (jaundice), and includes infections as a cause of skin findings; thus acknowledges non-treatment-damage etiologies."
      },
      {
        "criterion_number": 19,
        "description": "The response states that prevention of skin problems is important and should begin at or before therapy initiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While prevention is emphasized (e.g., 'Prevention (Crucial!)' for hand-foot syndrome), it does not explicitly state starting at or before therapy initiation."
      },
      {
        "criterion_number": 20,
        "description": "The response recommends using gentle, pH-balanced cleansers, regular moisturization, and broad-spectrum sun protection.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends mild, pH-balanced cleansers; frequent application of emollient moisturizers; and daily broad-spectrum sunscreen (SPF 30+)."
      },
      {
        "criterion_number": 21,
        "description": "The response mentions prophylactic cooling measures during taxane infusions for hand-foot syndrome, supported by guidelines or evidence.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions cooling socks/gloves during infusions but does not specify taxane infusions or cite guideline/evidence support."
      },
      {
        "criterion_number": 22,
        "description": "The response states that correct identification of skin changes is important to ensure appropriate management and to avoid unnecessary discontinuation of effective cancer therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly state that correct identification prevents unnecessary discontinuation; mentions dose modification for severity but not the avoidance of inappropriate discontinuation."
      },
      {
        "criterion_number": 23,
        "description": "The response recommends hydration with emollients, topical corticosteroids, antihistamines, and oatmeal baths for dry skin and itch.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends frequent moisturizers (emollients), topical steroids, oral antihistamines, and colloidal oatmeal baths for pruritus."
      },
      {
        "criterion_number": 24,
        "description": "The response states that for acne-like rash, oral tetracyclines and topical steroids are effective treatments.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends oral doxycycline/minocycline (tetracyclines) and topical corticosteroids for acneiform rash due to EGFR inhibitors."
      },
      {
        "criterion_number": 25,
        "description": "The response states that for hand-foot syndrome, urea creams, topical steroids, and cooling procedures are beneficial.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Includes topical steroids and cooling measures but does not mention urea creams; criterion requires all elements."
      },
      {
        "criterion_number": 26,
        "description": "The response states that mild immune-related rashes can be managed with topical corticosteroids, urea-containing creams, and antihistamines for pruritus.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions topical corticosteroids and antihistamines for maculopapular rash but not urea-containing creams in the context of immune-related rash."
      },
      {
        "criterion_number": 27,
        "description": "The response states that severe immune-related rashes can be managed with systemic corticosteroids and, if refractory, immunomodulators, and that therapy interruption may be necessary for severe reactions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes oral corticosteroids for severe rash but does not mention immunomodulators nor therapy interruption specifically for immune-related rashes."
      }
    ],
    "question_number": 160,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:55:08.311827",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the tumor microenvironment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines the TME as a complex ecosystem around the tumor, detailing its components (stroma, immune cells, vasculature) and functions, especially in pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that the tumor microenvironment in pancreatic cancer critically influences both treatment options and outcomes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that TME is key to why pancreatic cancer is difficult to treat and how it undermines chemo, immunotherapy, and radiation, thereby affecting options and outcomes."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that the pancreatic cancer tumor microenvironment has a dense desmoplastic stroma which can act as a physical barrier.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions dense stroma/desmoplasia acting as a barrier and blocking drug penetration."
      },
      {
        "criterion_number": 4,
        "description": "The response should include a description of stromal cells, including fibroblasts.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes cancer-associated fibroblasts (CAFs) as the builders of the stromal 'fortress walls.'"
      },
      {
        "criterion_number": 5,
        "description": "The response should include a description of stromal cells, including pancreatic stellate cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Pancreatic stellate cells are not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response should include a description of immune cells within the tumor microenvironment of pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Discusses regulatory T cells, tumor-associated macrophages, and their roles in suppressing effector T-cell function."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer can be immunosuppressive.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Characterizes the TME as creating an 'immune shield' and an 'immunologically cold' environment that suppresses immune attack."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the tumor microenvironment architecture creates physical and biochemical barriers that limit drug delivery, promote immune evasion, and drive resistance to chemotherapy, targeted therapy, and immunotherapy.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Addresses physical barriers, hypoxia, immune evasion, and resistance to chemo and immunotherapy, but does not mention targeted therapy resistance."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer is implicated in drug resistance.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Directly links TME features to reduced effectiveness/resistance of chemotherapy, immunotherapy, and radiation."
      },
      {
        "criterion_number": 10,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer is implicated in metastasis.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States hypoxia makes cancer more aggressive and 'more likely to spread,' indicating a role in metastasis."
      },
      {
        "criterion_number": 11,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer is implicated in relapse.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not discuss relapse or recurrence."
      },
      {
        "criterion_number": 12,
        "description": "The response should include that drugs targeting the tumor microenvironment in pancreatic cancer have not yet shown benefit to patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions investigational strategies and trials but does not state that TME-targeted drugs have not yet shown patient benefit."
      },
      {
        "criterion_number": 13,
        "description": "The response should include that many studies are underway evaluating the role of tumor microenvironment-targeted therapies in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes ongoing clinical trials and multiple investigational approaches targeting stroma and immune components."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that current and emerging treatment strategies increasingly focus on remodeling the tumor microenvironment to improve therapeutic efficacy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Emphasizes 'dismantling the fortress' and strategies such as stromal modulation, immune reprogramming, and vascular normalization to improve therapy."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that locoregional therapies such as radiation and ablation may also alter the tumor microenvironment, increasing antigen presentation and immune response.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses radiation efficacy under hypoxia but does not mention TME alteration by radiation/ablation to increase antigen presentation or immune response."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages discussion with the oncology team, provides specific questions for the doctor, and includes a disclaimer to consult a qualified oncologist."
      }
    ],
    "question_number": 161,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:56:02.790701",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the tumor microenvironment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines the tumor microenvironment as a complex ecosystem and details its components (cancer cells, stromal cells, immune cells, vasculature, ECM, signaling molecules)."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that the tumor microenvironment in pancreatic cancer critically influences both treatment options and outcomes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that the TME is a major roadblock to treatment and a critical factor in aggressiveness and resistance, implying impact on options and outcomes."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that the pancreatic cancer tumor microenvironment has a dense desmoplastic stroma which can act as a physical barrier.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions desmoplasia, dense fibrous stroma, and describes it as a physical barrier that blocks drug penetration."
      },
      {
        "criterion_number": 4,
        "description": "The response should include a description of stromal cells, including fibroblasts.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes cancer-associated fibroblasts (CAFs) and their role in ECM production and desmoplasia."
      },
      {
        "criterion_number": 5,
        "description": "The response should include a description of stromal cells, including pancreatic stellate cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions stellate cells, their activation, and contribution to desmoplasia."
      },
      {
        "criterion_number": 6,
        "description": "The response should include a description of immune cells within the tumor microenvironment of pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Details MDSCs, TAMs, Tregs, exclusion/deactivation of effector T cells within the TME."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer can be immunosuppressive.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly describes the TME as immunosuppressive and explains mechanisms (suppressive cells, signaling)."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that the tumor microenvironment architecture creates physical and biochemical barriers that limit drug delivery, promote immune evasion, and drive resistance to chemotherapy, targeted therapy, and immunotherapy.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Covers physical/biochemical barriers, limited drug delivery, immune suppression, and resistance to chemo and immunotherapy, but does not mention resistance to targeted therapy explicitly."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer is implicated in drug resistance.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Clearly states that stromal interactions, hypoxia, and other TME features promote resistance to chemotherapy and immunotherapy."
      },
      {
        "criterion_number": 10,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer is implicated in metastasis.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No explicit mention of metastasis or TME\u2019s role in metastatic spread."
      },
      {
        "criterion_number": 11,
        "description": "The response should include that the tumor microenvironment of pancreatic cancer is implicated in relapse.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Relapse is not discussed."
      },
      {
        "criterion_number": 12,
        "description": "The response should include that drugs targeting the tumor microenvironment in pancreatic cancer have not yet shown benefit to patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions PEGPH20 with 'mixed results' but does not clearly state that TME-targeting drugs have not yet shown patient benefit."
      },
      {
        "criterion_number": 13,
        "description": "The response should include that many studies are underway evaluating the role of tumor microenvironment-targeted therapies in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that disrupting/reprogramming the TME is a major focus of research and describes multiple investigational strategies, implying ongoing studies."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that current and emerging treatment strategies increasingly focus on remodeling the tumor microenvironment to improve therapeutic efficacy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly discusses strategies to disrupt or reprogram the TME to improve efficacy, including stroma-targeting, immunomodulation, and vessel normalization."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that locoregional therapies such as radiation and ablation may also alter the tumor microenvironment, increasing antigen presentation and immune response.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Radiation is mentioned in combinations, but there is no explicit statement that locoregional therapy alters the TME to increase antigen presentation and immune response; ablation is not mentioned."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages discussion with the father's medical team, which reasonably includes the oncologist."
      }
    ],
    "question_number": 161,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:57:12.334528",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Pet therapy can offer emotional benefits for patients with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly lists emotional benefits such as mood elevation, a sense of connection, and a positive distraction during treatment."
      },
      {
        "criterion_number": 2,
        "description": "Pet therapy can offer psychological benefits for patients with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Psychological benefits are detailed, including stress and anxiety reduction via effects on cortisol and oxytocin, and relief from depression and isolation."
      },
      {
        "criterion_number": 3,
        "description": "Treatment of cancer can cause immune suppression.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response states that chemotherapy and other treatments can compromise the immune system and discusses neutropenia and low white blood cell counts."
      },
      {
        "criterion_number": 4,
        "description": "Pets can carry diseases that can harm immunosuppressed people.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes that animals can carry germs and that immunocompromised patients are more susceptible to infections, emphasizing infection risk."
      },
      {
        "criterion_number": 5,
        "description": "Patients should avoid exposing open wounds to pets or animals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises keeping animals away from open wounds and surgical incisions and preventing licking near wounds."
      },
      {
        "criterion_number": 6,
        "description": "Patients should avoid exposing port sites to animals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It specifically mentions avoiding licking or contact near ports, IV lines, and catheter sites."
      },
      {
        "criterion_number": 7,
        "description": "Patients should discuss the safety of pet therapy with their oncology team.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It directs the reader to speak with the oncology team first to assess immune status and center policies."
      },
      {
        "criterion_number": 8,
        "description": "Pet therapy visits are beneficial and generally safe for patients undergoing treatment for pancreatic cancer when conducted with certified therapy animals under appropriate infection control protocols.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states pet therapy is beneficial and safe with precautions, emphasizes certified therapy animals, and outlines infection control measures (hand hygiene, barriers, grooming)."
      },
      {
        "criterion_number": 9,
        "description": "To reduce exposure to chemotherapy and radiation residues, patients should take precautions to limit the impacts on pets.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response does not address protecting pets from chemotherapy or radiation residues or related precautions."
      },
      {
        "criterion_number": 10,
        "description": "Immunocompromised patients with pancreatic cancer receiving chemotherapy or radiation therapy should practice good hand hygiene after handling pets, avoid contact with pet waste, and prevent pets from licking open wounds.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it recommends hand hygiene and preventing licking, it does not mention avoiding contact with pet waste; since all elements are required, full credit cannot be given."
      },
      {
        "criterion_number": 11,
        "description": "If patients are severely immunosuppressed, they should avoid contact with young animals, reptiles, or exotic pets.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response does not mention avoiding young animals, reptiles, or exotic pets in the context of severe immunosuppression."
      }
    ],
    "question_number": 162,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:57:47.212025",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Pet therapy can offer emotional benefits for patients with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly lists emotional benefits (reduced stress/anxiety, improved mood, decreased loneliness, comfort/companionship)."
      },
      {
        "criterion_number": 2,
        "description": "Pet therapy can offer psychological benefits for patients with cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses psychological impacts such as reduced anxiety and depression, improved mood, and a sense of normalcy and hope."
      },
      {
        "criterion_number": 3,
        "description": "Treatment of cancer can cause immune suppression.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states chemotherapy and other treatments can suppress the immune system (neutropenia) and references ANC."
      },
      {
        "criterion_number": 4,
        "description": "Pets can carry diseases that can harm immunosuppressed people.",
        "score_given": 10,
        "max_points": 10,
        "justification": "While not phrased verbatim, the response emphasizes infection risk from animals and mitigation (certified animals with vaccinations/parasite control, avoiding contact with animal waste and licking), indicating pets can transmit pathogens to immunocompromised patients."
      },
      {
        "criterion_number": 5,
        "description": "Patients should avoid exposing open wounds to pets or animals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises preventing animal contact with open skin areas and surgical incisions."
      },
      {
        "criterion_number": 6,
        "description": "Patients should avoid exposing port sites to animals.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically mentions avoiding contact with IV lines, ports, and catheters."
      },
      {
        "criterion_number": 7,
        "description": "Patients should discuss the safety of pet therapy with their oncology team.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Advises consulting the medical team first and discussing safety based on current immune status."
      },
      {
        "criterion_number": 8,
        "description": "Pet therapy visits are beneficial and generally safe for patients undergoing treatment for pancreatic cancer when conducted with certified therapy animals under appropriate infection control protocols.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States pet therapy can be beneficial and emphasizes use of certified therapy animals and strict infection control."
      },
      {
        "criterion_number": 9,
        "description": "To reduce exposure to chemotherapy and radiation residues, patients should take precautions to limit the impacts on pets.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of protecting pets from chemotherapy or radiation residues or related precautions."
      },
      {
        "criterion_number": 10,
        "description": "Immunocompromised patients with pancreatic cancer receiving chemotherapy or radiation therapy should practice good hand hygiene after handling pets, avoid contact with pet waste, and prevent pets from licking open wounds.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends strict hand hygiene, avoiding feces/urine, preventing licking, and keeping animals away from open wounds."
      },
      {
        "criterion_number": 11,
        "description": "If patients are severely immunosuppressed, they should avoid contact with young animals, reptiles, or exotic pets.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not mention avoiding young animals, reptiles, or exotic pets."
      }
    ],
    "question_number": 162,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T19:58:50.905022",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing financial concerns with a social worker associated with their oncology team.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explicitly advises connecting with the oncology social worker at the cancer center for help navigating resources related to travel costs."
      },
      {
        "criterion_number": 2,
        "description": "The response should include information for the American Cancer Society Road to Recovery program.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically mentions the American Cancer Society's Road To Recovery program and describes its volunteer driver rides to appointments."
      },
      {
        "criterion_number": 3,
        "description": "The response should provide information on travel grants through national patient advocacy organizations, including the Pancreatic Cancer Action Network.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes PanCAN with contact info and notes their Patient Services can assist with travel and lodging resources."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend discussing financial concerns with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises connecting with the cancer center's team (social worker/patient navigator/financial counselor) to address costs and resources."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend discussing financial concerns with a financial counselor associated with their oncology team.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explicitly mentions connecting with a financial counselor at the cancer center as a key resource."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend discussing lodging assistance programs with their oncology team.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Encourages connecting with the oncology social worker/patient navigator for help navigating lodging resources and lists lodging programs, implying discussion with the team."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide information on travel grants through national patient advocacy organizations, including Cancer Care.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Lists CancerCare as providing limited financial assistance for transportation and related needs; also mentions PAF."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that resources include hospital-based transportation programs.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Mentions hospital shuttles and advises asking the cancer center about free shuttle services."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that resources include philanthropic or grant-funded travel assistance.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Cites philanthropic/volunteer and grant-based programs (Angel Flight, Corporate Angel Network, Mercy Medical Angels, CancerCare/PAF assistance)."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that telemedicine is increasingly used to reduce the need for travel, allowing for virtual visits, remote symptom monitoring, and tele-rehabilitation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of telemedicine or virtual care reducing travel."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that telehealth appointments are generally as effective as in-person visits for many aspects of care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address comparative effectiveness of telehealth vs in-person care."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that telehealth offers benefits, including reduced travel burden, lower costs, decreased infection risk, and improved access to expertise.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No discussion of telehealth benefits."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that telehealth may be less suitable for initial diagnosis, physical examinations, or sensitive discussions.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of telehealth limitations for specific visit types."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention limitations of telehealth, including challenges with physical examination, technology barriers, and occasional concerns about reduced personal connection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Telehealth limitations are not discussed."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that the CDC recommends developing a personal travel health plan, ensuring adequate medication supply, and considering supplemental medical or evacuation insurance.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No CDC travel planning recommendations are provided."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it references the oncology team broadly, it does not explicitly recommend discussing the case with an oncologist."
      }
    ],
    "question_number": 163,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T19:59:43.357557",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend discussing financial concerns with a social worker associated with their oncology team.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response explicitly recommends speaking with hospital social workers, noting they are knowledgeable about financial aid and related resources and advising to 'Ask to speak with one immediately.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should include information for the American Cancer Society Road to Recovery program.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although American Cancer Society Hope Lodge is mentioned, there is no mention of the ACS Road to Recovery transportation program."
      },
      {
        "criterion_number": 3,
        "description": "The response should provide information on travel grants through national patient advocacy organizations, including the Pancreatic Cancer Action Network.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response lists multiple national advocacy organizations offering financial/travel assistance and specifically includes the Pancreatic Cancer Action Network (PanCAN) with guidance that they can direct patients to travel assistance resources."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend discussing financial concerns with the oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response suggests discussing plans with the oncology team and mentions letters of medical necessity, it does not explicitly recommend discussing financial concerns with the oncology team."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend discussing financial concerns with a financial counselor associated with their oncology team.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response recommends contacting hospital financial counselors and describes how they can assist with payment plans, insurance benefits, and connecting to hospital-based assistance programs."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend discussing lodging assistance programs with their oncology team.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Although lodging resources are listed and the oncology team is mentioned for letters of medical necessity, there is no direct recommendation to discuss lodging assistance programs with the oncology team."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide information on travel grants through national patient advocacy organizations, including Cancer Care.",
        "score_given": 6,
        "max_points": 6,
        "justification": "CancerCare is included, with details on limited financial assistance for transportation and other costs, meeting the criterion."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that resources include hospital-based transportation programs.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No hospital-based transportation programs are mentioned; transportation support listed is via external organizations and airlines."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that resources include philanthropic or grant-funded travel assistance.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Multiple nonprofit foundations and charitable flight services (e.g., PAN Foundation, HealthWell, Good Days, Air Charity Network, Mercy Medical Airlift) are cited, which constitute philanthropic/grant-funded assistance."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that telemedicine is increasingly used to reduce the need for travel, allowing for virtual visits, remote symptom monitoring, and tele-rehabilitation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no discussion of telemedicine or its role in reducing travel."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that telehealth appointments are generally as effective as in-person visits for many aspects of care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Effectiveness of telehealth compared to in-person visits is not addressed."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that telehealth offers benefits, including reduced travel burden, lower costs, decreased infection risk, and improved access to expertise.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No telehealth benefits are mentioned."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that telehealth may be less suitable for initial diagnosis, physical examinations, or sensitive discussions.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No limitations or suitability considerations for telehealth are discussed."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention limitations of telehealth, including challenges with physical examination, technology barriers, and occasional concerns about reduced personal connection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Telehealth limitations are not mentioned."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that the CDC recommends developing a personal travel health plan, ensuring adequate medication supply, and considering supplemental medical or evacuation insurance.",
        "score_given": 0,
        "max_points": 2,
        "justification": "While general travel insurance and medication planning are discussed, there is no reference to CDC recommendations or evacuation insurance."
      },
      {
        "criterion_number": 16,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response advises to 'discuss [travel plans] thoroughly with the oncology team' and to communicate with the medical team, satisfying the criterion to consult an oncologist."
      }
    ],
    "question_number": 163,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:00:29.050943",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapies together.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions Dual Immunotherapy using two checkpoint inhibitors (PD-1/PD-L1 plus CTLA-4)."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapy with chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Has a dedicated section 'Immunotherapy + Chemotherapy' with examples (FOLFIRINOX, Gemcitabine/Abraxane)."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapy with targeted therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes 'Immunotherapy + Targeted Therapy' with PARP inhibitors for BRCA-mutated tumors."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapy with other new agents.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses combinations with cancer vaccines (investigational agents) and radiation; indicates multiple novel combo strategies under study."
      },
      {
        "criterion_number": 5,
        "description": "The response should include the definition of immunotherapy per the NCI definition of cancer terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains immunotherapy as taking the brakes off T-cells to let the immune system attack cancer and notes it can teach the body's immune system to control cancer, aligning with NCI\u2019s concept of using the immune system to fight cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that the immune checkpoint inhibitor pembrolizumab is approved for patients with advanced pancreatic cancer whose tumors are MSI high.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not mention MSI-H-specific approval for pembrolizumab in pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that the immune checkpoint inhibitor pembrolizumab is approved for patients with advanced pancreatic cancer whose tumors are mismatch repair deficient.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not mention dMMR-specific approval for pembrolizumab."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that the immune checkpoint inhibitor pembrolizumab is approved for patients with advanced pancreatic cancer whose tumors have a high tumor mutational burden.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of TMB-high tumor tissue\u2013agnostic approval relevant to pancreatic cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that other immunotherapies are investigational.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Frames all listed combinations as being studied in clinical trials and as an area of active research, indicating investigational status."
      },
      {
        "criterion_number": 10,
        "description": "The response should include information for clinicaltrial.gov for current trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically recommends ClinicalTrials.gov and how to search for pancreatic cancer immunotherapy trials."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend understanding what type of combination immunotherapy is being tested.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Lists as a key question: 'What is the specific combination of drugs being used in this trial?'"
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend understanding the evidence behind the combination immunotherapy in the trial.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Advises asking for the scientific rationale for the combination and the trial phase/goal."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend understanding the potential side effects of the combination immunotherapy in the trial.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Encourages asking about common and serious side effects and how they will be managed; also describes immune-related AEs."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe eligibility criteria for clinical trials, including the stage of disease.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Mentions eligibility broadly but does not explicitly reference cancer stage as an eligibility factor."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe eligibility criteria for clinical trials, including the site of disease.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Does not mention disease site (e.g., metastatic vs. locally advanced or specific organ involvement) as an eligibility criterion."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe eligibility criteria for clinical trials, including prior treatments.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly lists prior treatments as an example of inclusion/exclusion criteria."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe eligibility criteria for clinical trials, including required testing.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifies required testing such as genetic testing of the tumor, blood work, and scans to confirm eligibility."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that research trials explore whether a new medical strategy, treatment, or device is safe and effective for humans.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explains trial phases as Phase I = safety and Phase II = effectiveness, which reflects assessing safety and efficacy in humans."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that clinical trials are essential for optimizing current and future therapies for cancer.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Describes access to innovation but does not explicitly state trials are essential to optimize current and future therapies."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that trials are divided into phases (phase I - phase IV).",
        "score_given": 0,
        "max_points": 8,
        "justification": "Mentions and explains Phases I\u2013III but does not mention Phase IV."
      },
      {
        "criterion_number": 21,
        "description": "The response should explain the different phases of clinical trials.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Explains the goals of Phase I (safety), Phase II (effectiveness), and Phase III (comparison to standard care)."
      },
      {
        "criterion_number": 22,
        "description": "The response should mention that current research on immunotherapy combinations for pancreatic cancer is focused on overcoming the immunosuppressive tumor microenvironment and enhancing antitumor immune responses.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Describes pancreatic cancer as a 'cold' tumor with dense stroma and the goal of making it 'hot' to attract immune responses, aligning with overcoming the TME and enhancing antitumor immunity."
      },
      {
        "criterion_number": 23,
        "description": "The response should mention promising strategies include combining immunotherapy with chemotherapy, TME-modifying agents, and other immune stimulants.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Mentions chemo, radiation, vaccines, and dual checkpoint blockade, but does not explicitly reference TME-modifying agents or other immune stimulants as a category."
      },
      {
        "criterion_number": 24,
        "description": "The response should mention that neoadjuvant immunotherapy combinations are being tested to prime the immune system before surgery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of neoadjuvant settings or priming before surgery."
      },
      {
        "criterion_number": 25,
        "description": "The response should mention that cancer vaccines are under investigation as an approach for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically discusses therapeutic cancer vaccines (e.g., KRAS-targeted) as an exciting area of research being studied with immunotherapy."
      },
      {
        "criterion_number": 26,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Repeatedly encourages discussion with the oncologist and provides specific questions to ask; also includes a clear consult-your-oncologist statement."
      }
    ],
    "question_number": 164,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:02:13.899366",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapies together.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit section 'Immunotherapy + Other Immunotherapies' with examples (PD-1/L1 plus CTLA-4, LAG-3, TIM-3, TIGIT)."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapy with chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes 'Immunotherapy + Chemotherapy' with rationale and examples (pembrolizumab/nivolumab with gemcitabine or FOLFIRINOX)."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapy with targeted therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes 'Immunotherapy + Targeted Therapies' with examples (PARP inhibitors, MEK inhibitors)."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that combination immunotherapy can refer to combining immunotherapy with other new agents.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions combinations with stromal modulators (e.g., PEGPH20), oncolytic viruses, vaccines, and novel checkpoint targets."
      },
      {
        "criterion_number": 5,
        "description": "The response should include the definition of immunotherapy per the NCI definition of cancer terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No NCI-style definition provided (i.e., treatment that uses the immune system/substances made by the body or in a lab to improve or restore immune function)."
      },
      {
        "criterion_number": 6,
        "description": "The response should include that the immune checkpoint inhibitor pembrolizumab is approved for patients with advanced pancreatic cancer whose tumors are MSI high.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions MSI-H status as relevant but does not state pembrolizumab\u2019s approval for MSI-H pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that the immune checkpoint inhibitor pembrolizumab is approved for patients with advanced pancreatic cancer whose tumors are mismatch repair deficient.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Mentions dMMR as relevant but does not state pembrolizumab\u2019s approval for dMMR pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that the immune checkpoint inhibitor pembrolizumab is approved for patients with advanced pancreatic cancer whose tumors have a high tumor mutational burden.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of TMB-high indication for pembrolizumab."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that other immunotherapies are investigational.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Repeatedly frames combinations and novel checkpoints as being tested in clinical trials with safety/efficacy still being studied, indicating investigational status."
      },
      {
        "criterion_number": 10,
        "description": "The response should include information for clinicaltrial.gov for current trials.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not reference ClinicalTrials.gov or provide directions to that resource."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend understanding what type of combination immunotherapy is being tested.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Encourages asking 'What are the specific drugs/therapies being combined?' and provides overview of combination types."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend understanding the evidence behind the combination immunotherapy in the trial.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Suggests asking for current data on efficacy and safety of the combination in pancreatic cancer or other cancers."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend understanding the potential side effects of the combination immunotherapy in the trial.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Details immune-related adverse events and advises asking about anticipated side effects and management."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe eligibility criteria for clinical trials, including the stage of disease.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Eligibility factors discussed (prior treatments, ECOG, labs, biomarkers), but stage of disease is not mentioned."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe eligibility criteria for clinical trials, including the site of disease.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No mention of disease site considerations as part of eligibility."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe eligibility criteria for clinical trials, including prior treatments.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Specifically lists previous treatments as part of eligibility criteria."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe eligibility criteria for clinical trials, including required testing.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Mentions specific lab values and biomarker testing (e.g., MSI status, BRCA mutations)."
      },
      {
        "criterion_number": 18,
        "description": "The response should mention that research trials explore whether a new medical strategy, treatment, or device is safe and effective for humans.",
        "score_given": 4,
        "max_points": 4,
        "justification": "States trials evaluate new treatments and describes Phase I (safety/dose) and Phase II (efficacy), meeting the safe-and-effective concept."
      },
      {
        "criterion_number": 19,
        "description": "The response should mention that clinical trials are essential for optimizing current and future therapies for cancer.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicitly says trials are essential for finding better ways to fight cancer."
      },
      {
        "criterion_number": 20,
        "description": "The response should mention that trials are divided into phases (phase I - phase IV).",
        "score_given": 0,
        "max_points": 8,
        "justification": "Describes Phases I\u2013III only; Phase IV is not mentioned."
      },
      {
        "criterion_number": 21,
        "description": "The response should explain the different phases of clinical trials.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Explains purposes of Phases I\u2013III (safety/dose, efficacy/safety, comparison to standard care) clearly."
      },
      {
        "criterion_number": 22,
        "description": "The response should mention that current research on immunotherapy combinations for pancreatic cancer is focused on overcoming the immunosuppressive tumor microenvironment and enhancing antitumor immune responses.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Highlights dense stroma, immunosuppressive cells, 'cold' tumors, and strategies to 'heat up' tumors and overcome suppression."
      },
      {
        "criterion_number": 23,
        "description": "The response should mention promising strategies include combining immunotherapy with chemotherapy, TME-modifying agents, and other immune stimulants.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Lists chemo combinations, stromal/TME modulators, and additional immune stimulants (other checkpoints, vaccines, oncolytic viruses)."
      },
      {
        "criterion_number": 24,
        "description": "The response should mention that neoadjuvant immunotherapy combinations are being tested to prime the immune system before surgery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of neoadjuvant use or priming before surgery."
      },
      {
        "criterion_number": 25,
        "description": "The response should mention that cancer vaccines are under investigation as an approach for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes 'Immunotherapy + Cancer Vaccines' under investigation as a strategy."
      },
      {
        "criterion_number": 26,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides 'Key Questions to Ask His Oncologist' and recommends second opinions with pancreatic cancer specialists."
      }
    ],
    "question_number": 164,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:03:50.745627",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend understanding the current treatment plan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises creating a cancer binder with test results, medication lists with dosages, and a master calendar with detailed appointment information, which promotes understanding of the current treatment plan and logistics."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing the treatment schedule with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends communicating with the medical team to obtain a tentative treatment schedule, identify a primary point of contact (nurse navigator), and bundle appointments."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend open communication with the care team about work, family, and personal goals.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not advise discussing work/family obligations or personal goals explicitly with the oncology team; communication recommendations are limited to scheduling and point-of-contact."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend open communication with work.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides clear guidance for communicating with managers/HR, including suggested wording and discussion of FMLA and flexible schedules."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend understanding side effects of treatments.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages using a symptom and side effect tracker and notes that chemo/radiation have cumulative effects, supporting awareness and understanding of side effects."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding the timing of side effects.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically states that the day after or two days after treatment can often be the worst and recommends proactively blocking rest days accordingly."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend utilizing a support system, including talking with a social worker.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Promotes support systems (family, friends, support groups, therapist) and resources (PanCAN, CancerCare) but does not mention social workers."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend utilizing a support system, including talking with a patient navigator.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Advises identifying a primary point of contact, usually a nurse navigator, as a key resource for scheduling and non-emergency concerns."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that early referral to palliative care is recommended for symptom management, emotional support, and caregiver assistance, and is not synonymous with hospice.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of palliative care or its role distinct from hospice."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that practical strategies for managing treatment schedules include leveraging telehealth, app-based, and telephone support to increase flexibility and reduce travel burden.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not address telehealth/telephone visits or app-based clinical support to reduce travel; coordination tools cited are for caregiving logistics rather than clinical care delivery."
      }
    ],
    "question_number": 165,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:04:44.882146",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend understanding the current treatment plan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response advises requesting treatment schedules in advance, bundling appointments, and designating a point person to ensure consistent information flow, which supports understanding the overall treatment plan."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing the treatment schedule with the oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends asking the medical team for schedules in advance, inquiring about flexibility, bundling appointments, and using telehealth when possible."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend open communication with the care team about work, family, and personal goals.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages being honest with the medical team about scheduling challenges, fatigue, and other obligations, which encompasses work and family considerations."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend open communication with work.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response includes a detailed section on communicating with employers/HR, knowing rights (e.g., FMLA), and discussing flexible work options."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend understanding side effects of treatments.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly states to get a clear picture of potential side effects and their impact."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend understanding the timing of side effects.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It specifically advises understanding when side effects are most likely to occur to plan support and rest."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend utilizing a support system, including talking with a social worker.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It repeatedly recommends engaging the hospital social worker for resources, financial assistance, and support."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend utilizing a support system, including talking with a patient navigator.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explicitly mentions consulting a nurse navigator as a point of coordination and support."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that early referral to palliative care is recommended for symptom management, emotional support, and caregiver assistance, and is not synonymous with hospice.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no mention of palliative care or clarification that it is distinct from hospice."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that practical strategies for managing treatment schedules include leveraging telehealth, app-based, and telephone support to increase flexibility and reduce travel burden.",
        "score_given": 0,
        "max_points": 8,
        "justification": "While telehealth and app-based coordination tools (e.g., CaringBridge, MealTrain) are mentioned, there is no mention of leveraging telephone support (e.g., nurse lines or phone visits) for flexibility and reduced travel burden."
      }
    ],
    "question_number": 165,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:05:26.850999",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention that treatment-related mouth problems, particularly oral mucositis, are common in patients with pancreatic cancer receiving chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly identifies oral mucositis as a very common side effect of chemotherapy/radiation in the context of the father's pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing their mouth problems with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly advises to always discuss strategies with the oncology team and to contact them for worsening symptoms."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend maintaining good oral hygiene.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides a detailed oral hygiene routine including soft-bristle brushing, mild toothpaste, flossing guidance, and rinsing."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that meeting with an oral medicine provider can be helpful.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions dentist and oncology team but does not reference an oral medicine specialist or oral supportive care clinic."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend staying hydrated.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Directly advises frequent sips of water and other fluids; emphasizes hydration strategies."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend getting regular dental care.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends a pre-treatment dental check-up and addressing dental issues; fulfills recommendation for dental care."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that oral cryotherapy (holding ice chips in the mouth during and after administration of agents such as 5-fluorouracil) is effective for prevention of mucositis for select chemotherapy regimens.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions ice chips for dry mouth, not for timed prophylactic cryotherapy during specific chemotherapy (e.g., 5-FU)."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that benzydamine mouthwash is supported for prevention, especially in patients receiving radiotherapy or chemoradiotherapy.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No mention of benzydamine."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that chlorhexidine mouthwash is not recommended for prevention in most adult cancer populations.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Does not address chlorhexidine\u2019s lack of benefit for prevention."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that bland mouth rinses (e.g., sodium bicarbonate or saline) are preferred for routine care and symptom management.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends a salt and baking soda (sodium bicarbonate) rinse and advises against alcohol-based mouthwashes."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that topical anesthetics and mixed medication mouthwashes may be used for pain control.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically discusses topical anesthetics and physician-prescribed 'magic mouthwash' for pain control."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that gabapentin may be considered for mucositis-related pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Gabapentin is not mentioned."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that topical and systemic antifungals are indicated for secondary candidiasis.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Notes that white patches could be thrush but does not recommend topical or systemic antifungals for candidiasis."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that antibiotics are reserved for documented secondary bacterial infections.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not address antibiotic use or restriction to documented bacterial infections."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that management often involves over-the-counter pain relief such as acetaminophen or ibuprofen.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Discusses systemic pain medication prescribed by a doctor but does not mention OTC analgesics (acetaminophen/ibuprofen)."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that multidisciplinary and supportive care is essential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes coordination with the oncology team and involvement of a dietitian; highlights supportive care and caregiver role."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that management could include dietary adjustments such as soft or liquid diets, small frequent meals, and nutritional support.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides detailed dietary adjustments emphasizing soft/liquid foods and nutritional supplement drinks; adequate to meet criterion."
      }
    ],
    "question_number": 166,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:06:32.770828",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention that treatment-related mouth problems, particularly oral mucositis, are common in patients with pancreatic cancer receiving chemotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states that treatment-related mouth problems are very common in cancer patients, especially those undergoing chemotherapy for pancreatic cancer, and explicitly lists oral mucositis/stomatitis."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing their mouth problems with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Multiple prompts to contact and discuss with the oncology team, including when to contact immediately and to discuss interventions like cryotherapy and flossing safety."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend maintaining good oral hygiene.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides detailed oral hygiene steps: gentle brushing with soft toothbrush, fluoride toothpaste, flossing guidance, and frequent bland mouth rinses."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that meeting with an oral medicine provider can be helpful.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions seeing a dentist, speech-language pathologist, and dietitian, but does not specifically recommend consulting an oral medicine provider/oral medicine specialist."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend staying hydrated.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Encourages frequent sips of water, ice chips, and use of humidifier to maintain moisture."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend getting regular dental care.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advises a dental check-up ideally before chemotherapy to address issues and timing of dental work; emphasizes dental involvement in care."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that oral cryotherapy (holding ice chips in the mouth during and after administration of agents such as 5-fluorouracil) is effective for prevention of mucositis for select chemotherapy regimens.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends sucking on ice chips during IV chemotherapy to reduce mucositis and to discuss with the oncology team, indicating preventive benefit for select regimens."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that benzydamine mouthwash is supported for prevention, especially in patients receiving radiotherapy or chemoradiotherapy.",
        "score_given": 0,
        "max_points": 4,
        "justification": "Benzydamine mouthwash is not mentioned."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that chlorhexidine mouthwash is not recommended for prevention in most adult cancer populations.",
        "score_given": 0,
        "max_points": 4,
        "justification": "No discussion of chlorhexidine or its lack of benefit for prevention."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that bland mouth rinses (e.g., sodium bicarbonate or saline) are preferred for routine care and symptom management.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends a baking soda and salt rinse as a simple, effective, non-alcohol-based option used frequently."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that topical anesthetics and mixed medication mouthwashes may be used for pain control.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests topical anesthetics (e.g., benzocaine) and mixed medication 'magic mouthwash' formulations including lidocaine, antihistamine, antacid, and possibly antifungal/steroid."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that gabapentin may be considered for mucositis-related pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Gabapentin is not mentioned."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that topical and systemic antifungals are indicated for secondary candidiasis.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes signs of thrush and recommends contacting the medical team for antifungals, listing topical (nystatin, clotrimazole) and systemic (oral fluconazole) options."
      },
      {
        "criterion_number": 14,
        "description": "The response should mention that antibiotics are reserved for documented secondary bacterial infections.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of antibiotics or their restricted use for confirmed bacterial infections."
      },
      {
        "criterion_number": 15,
        "description": "The response should mention that management often involves over-the-counter pain relief such as acetaminophen or ibuprofen.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends acetaminophen and, if needed, stronger prescribed pain medications."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that multidisciplinary and supportive care is essential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes communication with the oncology team (doctor, nurse, dietitian) and involves other disciplines (speech-language pathologist, dietitian), highlighting supportive care."
      },
      {
        "criterion_number": 17,
        "description": "The response should mention that management could include dietary adjustments such as soft or liquid diets, small frequent meals, and nutritional support.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes soft/bland foods, cool or room-temperature foods, small frequent meals, and use of oral nutritional supplements; also addresses dysphagia strategies."
      }
    ],
    "question_number": 166,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:07:32.558122",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define minimal residual disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear, explicit definition of MRD as small numbers of cancer cells remaining after treatment despite no visible disease on imaging, supported by a helpful analogy."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that minimal residual disease testing in pancreatic cancer is investigational.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States MRD testing is a cutting-edge field and not yet a routine standard of care everywhere, conveying its investigational status."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend discussing minimal residual disease testing with an oncologist.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Encourages discussion with the oncology team and provides specific questions to ask at the next appointment."
      },
      {
        "criterion_number": 5,
        "description": "The response should include that NCCN guidelines do not recommend minimal residual disease testing in pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention NCCN guidelines or that they do not recommend MRD testing in pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that insurance may not cover minimal residual disease testing.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Suggests asking about insurance coverage but does not explicitly state that insurance may not cover MRD testing."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that postoperative ctDNA positivity is associated with a higher risk of early recurrence and worse survival in resected pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes higher recurrence risk when MRD-positive after surgery but does not mention early recurrence or worse survival."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that serial minimal residual disease testing can provide dynamic risk stratification.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes repeated testing during/after chemotherapy and during surveillance to track ctDNA changes and detect recurrence early, reflecting dynamic risk stratification."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that minimal residual disease testing may identify patients who could benefit from intensified surveillance or additional therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States MRD positivity may prompt more aggressive/additional therapy and suggests closer monitoring, aligning with intensified surveillance or treatment."
      }
    ],
    "question_number": 167,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:08:25.962433",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define minimal residual disease.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines MRD as small numbers of cancer cells remaining after treatment, undetectable by standard imaging or microscopy, and explains MRD testing aims to detect them (e.g., via ctDNA)."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that minimal residual disease testing in pancreatic cancer is investigational.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States it is not yet standard-of-care for routine decisions, lacks universally accepted guidelines, and is an active area of research with ongoing clinical trials."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend discussing minimal residual disease testing with an oncologist.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Explicitly advises discussing MRD testing with the mother's oncologist and care team and provides suggested questions."
      },
      {
        "criterion_number": 5,
        "description": "The response should include that NCCN guidelines do not recommend minimal residual disease testing in pancreatic cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention NCCN or explicitly state that NCCN guidelines do not recommend MRD testing in pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that insurance may not cover minimal residual disease testing.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of insurance coverage or potential lack of reimbursement for MRD testing."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that postoperative ctDNA positivity is associated with a higher risk of early recurrence and worse survival in resected pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that detecting ctDNA after surgery indicates higher recurrence risk and poorer prognosis, aligning with worse survival after resection."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that serial minimal residual disease testing can provide dynamic risk stratification.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes monitoring ctDNA levels during chemotherapy and changes over time (decrease/undetectable vs increase), implying serial testing for dynamic assessment."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that minimal residual disease testing may identify patients who could benefit from intensified surveillance or additional therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that ctDNA positivity may prompt more aggressive/prolonged chemotherapy and identifies candidates for clinical trials or earlier intervention."
      }
    ],
    "question_number": 167,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:09:03.460525",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend asking the oncology team for spiritual care professionals.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly advises starting with the medical team at the cancer center/hospital and mentions oncology social workers/patient navigators who can connect to spiritual counselors."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend reaching out to local places of worship.",
        "score_given": 2,
        "max_points": 2,
        "justification": "Clearly recommends contacting one's own place of worship and seeking a new faith community if needed."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend reaching out to community support groups.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions support groups multiple times, including through PanCAN and Cancer Support Community/Gilda\u2019s Club."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend national cancer support organizations, including the American Cancer Society.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention the American Cancer Society."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend national cancer support organizations, including Cancer Care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention CancerCare."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that spiritual counseling and support can be accessed through hospital-based chaplaincy services.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Explicit section on Hospital Chaplaincy Department describing interfaith support, bedside visits, and facilitation of prayers/rituals."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that spiritual counseling and support can be accessed through interdisciplinary palliative care teams.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes palliative care as holistic and notes teams usually include a chaplain or spiritual care advisor."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that interventions such as prayer, mindfulness/meditation, and facilitated sessions with trained providers, including both individual and group formats, have demonstrated benefits for spiritual well-being, hope, and meaning in cancer care.",
        "score_given": 7,
        "max_points": 7,
        "justification": "References prayer, meditation, mind-body programs, individual counseling with trained providers (chaplains/spiritual directors), and group support sessions, and notes benefits related to comfort, hope, meaning, and calm."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that cancer.net and the Pancreatic Cancer Action Network (pancan.org) provide high-quality information and support services.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions PanCAN but does not mention Cancer.Net."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Suggests starting with the medical team and social worker/palliative care but does not explicitly recommend discussing with the oncologist."
      }
    ],
    "question_number": 168,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:09:45.727466",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend asking the oncology team for spiritual care professionals.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response advises starting with healthcare providers at the hospital or cancer center (nurse, social worker, or doctor) for referral to chaplain/spiritual care, which functionally directs the reader to the oncology care team."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend reaching out to local places of worship.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It explicitly recommends contacting local clergy/spiritual leaders (pastor, rabbi, imam, priest, minister) and interfaith organizations."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend reaching out to community support groups.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit mention of community support groups for cancer, caregivers, or spirituality; the response focuses on chaplains, clergy, and therapists."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend national cancer support organizations, including the American Cancer Society.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of the American Cancer Society or other national cancer support organizations."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend national cancer support organizations, including Cancer Care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "CancerCare is not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that spiritual counseling and support can be accessed through hospital-based chaplaincy services.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It clearly highlights hospital chaplains and chaplaincy services as accessible spiritual care resources."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that spiritual counseling and support can be accessed through interdisciplinary palliative care teams.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly describes palliative care teams including spiritual support with chaplains and social workers."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention that interventions such as prayer, mindfulness/meditation, and facilitated sessions with trained providers, including both individual and group formats, have demonstrated benefits for spiritual well-being, hope, and meaning in cancer care.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it references general 'spiritual practices,' it does not specify prayer or mindfulness/meditation, group vs individual formats, or evidence-backed benefits for spiritual well-being/hope/meaning."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that cancer.net and the Pancreatic Cancer Action Network (pancan.org) provide high-quality information and support services.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Neither Cancer.Net nor the Pancreatic Cancer Action Network are mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests speaking with a nurse, social worker, or doctor but does not explicitly recommend discussing the case with the oncologist."
      }
    ],
    "question_number": 168,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:10:25.669867",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend learning about pancreatic cancer, including diagnosis.",
        "score_given": 0,
        "max_points": 2,
        "justification": "The response does not advise learning about the diagnostic aspects (e.g., pathology, biomarkers, imaging findings) of pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend learning about pancreatic cancer, including staging.",
        "score_given": 0,
        "max_points": 2,
        "justification": "There is no mention of understanding staging or learning about stage-related implications."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend learning about pancreatic cancer, including treatment options.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It directs the reader to PanCAN for information on clinical trials, which constitutes learning about treatment options."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend national patient support resources, including information for the Pancreatic Cancer Action Network.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends the Pancreatic Cancer Action Network (PanCAN) and describes the services they offer."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend open communication within the couple and with the care team.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It encourages open, honest conversations between partners, suggests dedicated non-cancer connection time, and advocates communicating proactively with the medical and palliative care team (e.g., bringing questions to appointments, speaking up)."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend building a support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises accepting specific help from others, joining caregiver support groups, and using hospital social workers/nurse navigators to connect with resources."
      },
      {
        "criterion_number": 7,
        "description": "The response should explicitly state that significant lifestyle changes are common for both patients and spouses/partners after a pancreatic cancer diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It acknowledges \u201csignificant lifestyle changes that come with pancreatic cancer,\u201d emphasizes creating a \u201cnew normal,\u201d and addresses both the patient and spouse with sections on caregiving and adaptation."
      },
      {
        "criterion_number": 8,
        "description": "The response should explicitly mention at least two of the following: uncertainty about the future, role changes, emotional upheaval, or altered daily routines.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly discusses emotional upheaval (anger, sadness, anxiety), altered daily routines (flexible schedule; 9-to-5 structure gone), and role changes (caregiver role and advocacy)."
      },
      {
        "criterion_number": 9,
        "description": "The response should explicitly recommend early integration of supportive and/or palliative care for symptom management, psychosocial support, or advance care planning.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It clearly recommends an early palliative care referral, explaining its focus on symptom management and quality of life."
      },
      {
        "criterion_number": 10,
        "description": "The response should explicitly state that palliative and/or supportive care should be offered to all patients with pancreatic cancer, regardless of stage or prognosis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it recommends early palliative care, it does not explicitly state it should be offered to all patients regardless of stage or prognosis."
      },
      {
        "criterion_number": 11,
        "description": "The response should explicitly state that both dietary and exercise interventions are important for maintaining quality of life and optimizing outcomes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Dietary strategies and gentle activity are discussed, but it does not explicitly state that both diet and exercise are important for maintaining quality of life and optimizing outcomes."
      },
      {
        "criterion_number": 12,
        "description": "The response should explicitly state that regular exercise and healthy lifestyle changes are associated with improved physical and psychological outcomes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions that short walks may boost energy, but does not explicitly link regular exercise and healthy lifestyle changes to improved physical and psychological outcomes."
      },
      {
        "criterion_number": 13,
        "description": "The response should explicitly recommend discussing the case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It suggests working with the medical team and palliative care and consulting an oncology dietitian, but does not explicitly recommend discussing the case with an oncologist."
      }
    ],
    "question_number": 169,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:11:27.981128",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend learning about pancreatic cancer, including diagnosis.",
        "score_given": 0,
        "max_points": 2,
        "justification": "The response advises to 'learn about the disease' and discusses stages and treatment options, but does not explicitly mention learning about the diagnosis or diagnostic process."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend learning about pancreatic cancer, including staging.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It explicitly recommends understanding 'its stages' under 'Become Informed Advocates.'"
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend learning about pancreatic cancer, including treatment options.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It explicitly recommends understanding 'treatment options' and encourages asking questions and seeking second opinions."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend national patient support resources, including information for the Pancreatic Cancer Action Network.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It suggests support groups in general but does not mention any national resources or the Pancreatic Cancer Action Network (PanCAN)."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend open communication within the couple and with the care team.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It emphasizes open communication between partners multiple times and encourages active communication with clinicians (asking questions, bringing a notebook, working closely with the medical team)."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend building a support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly recommends support groups, leaning on a support network, caregiver support, and engaging social workers and therapists."
      },
      {
        "criterion_number": 7,
        "description": "The response should explicitly state that significant lifestyle changes are common for both patients and spouses/partners after a pancreatic cancer diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It directly addresses 'associated lifestyle changes' due to pancreatic cancer, normalizes the experience, and repeatedly frames guidance for 'both of you' (patient and caregiver), indicating these changes affect both partners."
      },
      {
        "criterion_number": 8,
        "description": "The response should explicitly mention at least two of the following: uncertainty about the future, role changes, emotional upheaval, or altered daily routines.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly discusses emotional upheaval (overwhelmed, scared, angry, sad), role changes (patient/caregiver roles, intimacy redefinition), and altered daily routines (maintain routines, small frequent meals, delegating tasks)."
      },
      {
        "criterion_number": 9,
        "description": "The response should explicitly recommend early integration of supportive and/or palliative care for symptom management, psychosocial support, or advance care planning.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It explicitly recommends including palliative care specialists 'from day one' for proactive symptom management, and discusses advance directives and social work support."
      },
      {
        "criterion_number": 10,
        "description": "The response should explicitly state that palliative and/or supportive care should be offered to all patients with pancreatic cancer, regardless of stage or prognosis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it recommends palliative care from day one, it does not explicitly state that this applies to all patients regardless of stage or prognosis."
      },
      {
        "criterion_number": 11,
        "description": "The response should explicitly state that both dietary and exercise interventions are important for maintaining quality of life and optimizing outcomes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Dietary adjustments and gentle movement are discussed, but the response does not explicitly state that both diet and exercise are important for maintaining quality of life and optimizing outcomes."
      },
      {
        "criterion_number": 12,
        "description": "The response should explicitly state that regular exercise and healthy lifestyle changes are associated with improved physical and psychological outcomes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes gentle movement may help energy and mentions mindfulness, but does not explicitly link regular exercise and healthy lifestyle changes to improved physical and psychological outcomes."
      },
      {
        "criterion_number": 13,
        "description": "The response should explicitly recommend discussing the case with an oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It references the 'medical team,' doctors, nurses, and palliative care, but does not explicitly recommend discussing the case with an oncologist."
      }
    ],
    "question_number": 169,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:12:46.554548",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe tumor heterogeneity, including diverse genetic, epigenetic, transcriptomic, and microenvironmental features both between patients (inter-tumoral) and within a single tumor (intra-tumoral).",
        "score_given": 0,
        "max_points": 8,
        "justification": "The response clearly addresses inter- and intra-tumoral heterogeneity and genetic diversity, but does not explicitly mention epigenetic or transcriptomic heterogeneity, and does not describe microenvironmental heterogeneity. Therefore it does not include all required components."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that tumor heterogeneity can include differences in genetic mutations within a tumor.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly states that within a single tumor there are diverse cancer cells with different genetic mutations and discusses spatial heterogeneity within the tumor."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that tumor heterogeneity can include differences in genetic mutations between tumor sites.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It notes that primary and metastatic tumors may have different genetic makeup and that heterogeneity exists between the primary tumor and metastases."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that tumor heterogeneity can include differences in cellular growth between cancer sites.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It describes subclones that are aggressive and fast-growing versus slower and more dormant, and discusses heterogeneity across primary and metastatic sites, implying growth differences among sites."
      },
      {
        "criterion_number": 5,
        "description": "The response should include that tumor heterogeneity can include differences in microenvironment between tumor sites.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it mentions targeting the tumor environment in trials, it does not state that microenvironmental differences vary between sites or contribute to heterogeneity."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that tumor heterogeneity is a major driver of variable treatment response, therapy resistance, and clinical outcomes in pancreatic ductal adenocarcinoma.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states pancreatic cancer is notoriously heterogeneous and links this directly to treatment difficulty, variable response, and resistance; adequate for PDAC context."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that tumor heterogeneity is thought to contribute to drug resistance.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It thoroughly explains selection of resistant subclones and how treatments that initially work can fail due to resistant populations."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that tumor heterogeneity is thought to contribute to the use of multiple chemotherapy agents.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explicitly recommends combination therapies (multiple chemotherapies or chemo plus targeted therapy) to address diverse subclones arising from heterogeneity."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that phenotypic plasticity allows tumor cells to shift between subtypes, especially under therapeutic or microenvironmental stress, contributing to acquired resistance and disease progression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Temporal heterogeneity and selection are discussed, but phenotypic plasticity/subtype switching under stress is not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that tumor heterogeneity limits the effectiveness of one-size-fits-all approaches and underlies the need for molecular profiling and personalized treatment strategies.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly states that one-size-fits-all approaches often fail due to heterogeneity and recommends molecular/genomic testing and liquid biopsies to guide personalized strategies."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend discussing genetic testing with the oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The \"Key Questions\" section explicitly suggests asking whether comprehensive molecular/genomic testing was performed and what targets were found."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that research efforts focus on integrating genomic, transcriptomic, and single-cell analyses to better classify tumors and guide therapy selection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions liquid biopsies and clinical trials, it does not refer to integrating genomic, transcriptomic, or single-cell analyses for classification and therapy selection."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly advises consulting with the oncology team and leaning on the medical team for personalized guidance."
      }
    ],
    "question_number": 170,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:14:01.865548",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe tumor heterogeneity, including diverse genetic, epigenetic, transcriptomic, and microenvironmental features both between patients (inter-tumoral) and within a single tumor (intra-tumoral).",
        "score_given": 0,
        "max_points": 8,
        "justification": "The response explains intra- and inter-tumoral heterogeneity and covers genetic, phenotypic, metabolic, and microenvironmental differences, but it does not explicitly mention epigenetic or transcriptomic features."
      },
      {
        "criterion_number": 2,
        "description": "The response should include that tumor heterogeneity can include differences in genetic mutations within a tumor.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly lists 'Genetics: Different mutations' and notes intra-tumoral heterogeneity within regions of the same primary tumor."
      },
      {
        "criterion_number": 3,
        "description": "The response should include that tumor heterogeneity can include differences in genetic mutations between tumor sites.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states that metastatic lesions can have different genetic profiles than the primary tumor and defines inter-tumoral heterogeneity between primary and metastases."
      },
      {
        "criterion_number": 4,
        "description": "The response should include that tumor heterogeneity can include differences in cellular growth between cancer sites.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It notes phenotypic differences such as 'some grow faster' and discusses both intra- and inter-tumoral heterogeneity, implying growth rate differences across sites."
      },
      {
        "criterion_number": 5,
        "description": "The response should include that tumor heterogeneity can include differences in microenvironment between tumor sites.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although it discusses microenvironment interactions and a dense desmoplastic stroma, it does not explicitly state that microenvironments differ between tumor sites (e.g., primary vs metastases)."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention that tumor heterogeneity is a major driver of variable treatment response, therapy resistance, and clinical outcomes in pancreatic ductal adenocarcinoma.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly links heterogeneity in PDAC to variable treatment response and resistance (initial response then relapse, treatment failure), implying impact on outcomes, and explicitly references PDAC."
      },
      {
        "criterion_number": 7,
        "description": "The response should include that tumor heterogeneity is thought to contribute to drug resistance.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It directly states that resistant subclones survive therapy leading to relapse and treatment failure."
      },
      {
        "criterion_number": 8,
        "description": "The response should include that tumor heterogeneity is thought to contribute to the use of multiple chemotherapy agents.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explicitly notes the need for combination chemotherapy targeting different mechanisms to cover heterogeneous cell populations."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention that phenotypic plasticity allows tumor cells to shift between subtypes, especially under therapeutic or microenvironmental stress, contributing to acquired resistance and disease progression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions temporal genetic changes under treatment pressure, it does not discuss phenotypic plasticity or shifting between subtypes."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that tumor heterogeneity limits the effectiveness of one-size-fits-all approaches and underlies the need for molecular profiling and personalized treatment strategies.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It emphasizes that single biopsies may miss key mutations, targeted therapies may only hit subsets, and recommends NGS/liquid biopsy and adaptive strategies, supporting personalized approaches."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend discussing genetic testing with the oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises asking the oncologist about comprehensive genomic profiling and liquid biopsies."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that research efforts focus on integrating genomic, transcriptomic, and single-cell analyses to better classify tumors and guide therapy selection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions NGS and ctDNA but does not reference transcriptomics or single-cell analyses or their integration for classification and therapy guidance."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the user discuss this case with an oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly recommends discussing with the oncology team regarding heterogeneity, testing, and treatment options."
      }
    ],
    "question_number": 170,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:15:00.682612",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include the definitions of different types of research studies, including randomized clinical trials and observational studies.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The answer defines several study types (clinical trials, observational studies/registries, biobanking, quality-of-life studies) but does not explicitly define randomized clinical trials or explain randomization."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain that not all research studies are clinical trials, and some explore ancillary aspects of cancer care such as symptom control or mental health.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response explicitly states that research is not only drug testing and provides examples of quality-of-life and supportive care studies, including symptom control and mental health."
      },
      {
        "criterion_number": 3,
        "description": "The response should include links and references to informational websites about clinical trials being held across the United States, such as the National Cancer Institute (NCI).",
        "score_given": 7,
        "max_points": 7,
        "justification": "It includes ClinicalTrials.gov, NCI\u2019s clinical trial search, and PanCAN\u2019s services with URLs, satisfying the requirement."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient ask their oncologist about locations where clinical trials are being held and consider a referral to institutions where trial participation is possible.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It advises starting with the oncology team and notes they may know of trials at their hospital or nearby, but it does not explicitly recommend requesting a referral to other institutions where participation is possible."
      },
      {
        "criterion_number": 8,
        "description": "The response should include definitions of phases 1, 2, and 3 clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Phase I, II, and III are clearly defined regarding purpose, safety, effectiveness, and comparison to standard treatment."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that clinical trials are most commonly done at academic medicine institutions.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While major cancer centers are mentioned, the response does not explicitly state that clinical trials are most commonly conducted at academic medical institutions."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that clinical trials may include an experimental treatment or placebo, and the efficacy may not be known as compared to standard of care treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes the possibility of receiving experimental treatment, standard treatment, or placebo, and the phase descriptions indicate that effectiveness versus standard care is being tested, implying unknown efficacy."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly mention clinical trials as a research opportunity.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clinical trials are repeatedly and explicitly presented as a key research opportunity."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly mention patient registries or biorepositories as opportunities for further studies.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response explicitly mentions patient registries and biobanking (tissue and blood donation) as research opportunities."
      }
    ],
    "question_number": 171,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:15:56.870828",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include the definitions of different types of research studies, including randomized clinical trials and observational studies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines multiple research study types: clinical trials (interventional) and observational studies, along with biobanking and genetic/genomic studies. While it does not explicitly use the word 'randomized,' it describes Phase 3 trials comparing new treatments to standard care or placebo, which implies randomization, and provides adequate definitions for both interventional and observational studies."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain that not all research studies are clinical trials, and some explore ancillary aspects of cancer care such as symptom control or mental health.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explicitly distinguishes clinical trials from observational studies, biobanking, and genetic studies. It also highlights supportive/palliative care trials and quality-of-life studies, including psychological support, thereby addressing ancillary aspects beyond treatment efficacy."
      },
      {
        "criterion_number": 3,
        "description": "The response should include links and references to informational websites about clinical trials being held across the United States, such as the National Cancer Institute (NCI).",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response references ClinicalTrials.gov, the National Cancer Institute (NCI) trial resources, and PanCAN Patient Services with a phone number, and mentions major cancer centers. These are sufficient references to national trial-finding resources."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient ask their oncologist about locations where clinical trials are being held and consider a referral to institutions where trial participation is possible.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises starting with his oncologist/care team and notes they can provide information or referrals to other centers. It also suggests considering major cancer centers where trials are available."
      },
      {
        "criterion_number": 8,
        "description": "The response should include definitions of phases 1, 2, and 3 clinical trials.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides clear definitions of Phase 1 (safety/dose/side effects), Phase 2 (effectiveness and safety), and Phase 3 (comparison to standard of care or placebo), and even mentions Phase 4."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that clinical trials are most commonly done at academic medicine institutions.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It highlights NCI-designated Comprehensive Cancer Centers (e.g., MD Anderson, MSK, Mayo, Dana-Farber, Johns Hopkins) as places with many trials, which are academic medicine institutions, effectively conveying where trials are commonly conducted."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that clinical trials may include an experimental treatment or placebo, and the efficacy may not be known as compared to standard of care treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that trials can compare to standard of care or placebo, discusses experimental vs. standard treatment designs, and emphasizes that new treatments may not work and efficacy is not guaranteed."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly mention clinical trials as a research opportunity.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clinical trials are prominently and repeatedly discussed as a key research opportunity, including their types and phases."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly mention patient registries or biorepositories as opportunities for further studies.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly mentions 'Biobanking / Tissue & Fluid Donation' and explains their purpose, satisfying the biorepository criterion."
      }
    ],
    "question_number": 171,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:16:49.902431",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe how cells that acquire mutations that can go on to form a cancer in our bodies can evade the immune system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly explains immune evasion in pancreatic cancer, including desmoplastic stroma as a physical barrier, PD-L1 expression to engage PD-1 and turn off T cells, and low mutational burden reducing neoantigen visibility."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the immune system\u2019s role in protecting the body from mutated cells that have oncogenic potential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes immune system as identifying and destroying abnormal cells, with T cells as key effectors that seek and eliminate cancer cells."
      },
      {
        "criterion_number": 3,
        "description": "The response should include a definition of immunotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines immunotherapy as treatment designed to reawaken and enhance the body's immune system to fight cancer, turning a 'cold' tumor into a 'hot' one."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the mechanism of action of immunotherapies in cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains mechanisms for checkpoint inhibitors (blocking PD-1/PD-L1), therapeutic vaccines (training immune recognition), and CAR T-cell therapy (engineering T cells to target tumor antigens)."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe features of pancreatic cancer that make this malignancy difficult to treat with immunotherapy.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Notes pancreatic cancer is immunologically 'cold' with dense stroma impeding T-cell infiltration and low mutational burden reducing neoantigens, leading to poor response to immunotherapy."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that there is research being done on the role of the immune system in pancreatic cancer treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Mentions active and rapidly evolving research, including clinical trials for vaccines, checkpoint inhibitors, CAR T cells, and combination strategies."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient speak with his/her oncologist about clinical trials that might utilize immunotherapy for pancreatic cancer, or consider a referral to a center that does clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises discussing clinical trials with the oncology team and includes specific questions about immunotherapy trials and combinations."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that a limited number of pancreatic cancer cases have features that do make it respond to immunotherapy, such as MSI-H or mismatch repair deficiency.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that a small subset (~1\u20132%) with MSI-H/dMMR can respond well to checkpoint inhibitors and that this is standard of care for those patients."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that they should ask the oncologist if her mother\u2019s tumor has MSI-H or mismatch repair deficiency.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directs the caregiver to ask if MSI-H/dMMR testing has been done and emphasizes testing as crucial."
      }
    ],
    "question_number": 172,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:17:16.302622",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe how cells that acquire mutations that can go on to form a cancer in our bodies can evade the immune system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explains multiple immune evasion strategies in pancreatic cancer, including a dense fibrous stroma as a physical barrier, immunosuppressive cells (MDSCs, TAMs, Tregs), low neoantigen burden, PD-L1\u2013mediated checkpoint exploitation, and immunosuppressive signaling within the tumor microenvironment."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the immune system\u2019s role in protecting the body from mutated cells that have oncogenic potential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly outlines immune surveillance: recognition of abnormal cells by T and NK cells via neoantigens, activation to kill cancer cells, and development of immune memory to prevent recurrence."
      },
      {
        "criterion_number": 3,
        "description": "The response should include a definition of immunotherapy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Immunotherapy is explicitly defined as treatments that boost the body\u2019s own immune system to fight cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the mechanism of action of immunotherapies in cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mechanisms are accurately described for several modalities: checkpoint inhibitors releasing PD-1/CTLA-4 brakes, vaccines priming antigen-specific responses, adoptive cell therapies engineering T cells, and oncolytic viruses directly lysing tumor cells and activating immunity."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe features of pancreatic cancer that make this malignancy difficult to treat with immunotherapy.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It details key barriers: a cold tumor microenvironment, dense stroma limiting infiltration, immunosuppressive infiltrates (MDSCs, TAMs, Tregs), low neoantigen load, and lack of good targets\u2014each making immunotherapy less effective."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that there is research being done on the role of the immune system in pancreatic cancer treatment.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response repeatedly references active and emerging research, ongoing clinical trials, and future combination strategies aimed at overcoming the tumor microenvironment."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient speak with his/her oncologist about clinical trials that might utilize immunotherapy for pancreatic cancer, or consider a referral to a center that does clinical trials.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises discussing options with the oncology team and asking if there are clinical trials that might be suitable."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that a limited number of pancreatic cancer cases have features that do make it respond to immunotherapy, such as MSI-H or mismatch repair deficiency.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It mentions MSI-High as a feature that can make tumors more responsive, and notes that this is not common in pancreatic cancer, conveying the limited subset."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that they should ask the oncologist if her mother\u2019s tumor has MSI-H or mismatch repair deficiency.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions MSI-High and suggests molecular testing is worth exploring, it does not explicitly instruct the reader to ask the oncologist whether the tumor is MSI-H or mismatch repair deficient."
      }
    ],
    "question_number": 172,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:18:22.791916",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must define caregiver burnout as physical, emotional, and mental exhaustion, and normalize it as a common experience among caregivers.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response normalizes caregiver burnout and references intense physical, emotional, and mental demands, but it does not explicitly define burnout as physical, emotional, and mental exhaustion."
      },
      {
        "criterion_number": 2,
        "description": "The response must link to no-cost support services for caregivers, such as support groups or online groups of people with similar experiences.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides no-cost resources including PanCAN Patient Services with phone number and website, and CancerCare's free counseling/support groups; mentions online communities."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly mention insurance-covered caregiver assistance and advise inquiring with the insurance carrier about coverage.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions a hospital financial navigator and assistance programs, it does not explicitly state that caregiver assistance may be insurance-covered nor advise contacting the insurance carrier to verify coverage."
      },
      {
        "criterion_number": 5,
        "description": "The response must provide resources for mental wellbeing, specifically mentioning therapists through Psychology Today\u2019s website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Recommends one-on-one counseling and therapists but does not reference Psychology Today\u2019s website."
      },
      {
        "criterion_number": 6,
        "description": "The response must describe the use of family members and friends to help with caretaking responsibilities.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Clearly instructs creating a care team, delegating specific tasks to friends/family, and using tools like Lotsa Helping Hands and CaringBridge."
      },
      {
        "criterion_number": 7,
        "description": "The response must recommend reaching out to the oncology team to inquire if social work resources are available to assist in determining if any in-home support or respite services are financially covered by the patient\u2019s insurance.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Encourages contacting the oncology social worker and nurse navigator for resources but does not explicitly advise asking about insurance coverage for in-home support or respite."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention that Hospice services offer varying degrees of in-home support and caregiver support, if/when appropriate for their loved one.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains hospice provides an in-home interdisciplinary team and emphasizes support for the entire family."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that there are options for professional caregiver support to give a break to family members/loved ones.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes respite care options and mentions home health agencies and hospice, which provide professional support to relieve caregivers."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that palliative care involvement can help with optimizing symptom management which may help reduce caregiver burden.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states palliative care manages symptoms (pain, nausea, anxiety) and reduces caregiver burden and stress."
      },
      {
        "criterion_number": 11,
        "description": "The response should state they should make sure to take time for self-care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages self-care and includes a concrete action item to schedule a 15-minute personal break."
      }
    ],
    "question_number": 173,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:19:04.126517",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define caregiver burnout as physical, emotional, and mental exhaustion, and normalize it as common.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response normalizes burnout as common, but it does not explicitly define it as physical, emotional, and mental exhaustion."
      },
      {
        "criterion_number": 2,
        "description": "Link to no-cost support services for caregivers, such as support groups or online groups.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It references free/low-cost support options including PanCAN, ACS, CancerCare, support groups, and online communities (e.g., Smart Patients, subreddits)."
      },
      {
        "criterion_number": 3,
        "description": "Explicitly mention insurance-covered caregiver assistance and advise inquiring with the insurance carrier.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises to check with insurance or Medicare/Medicaid for coverage of home health aides/personal care services and discusses navigating insurance."
      },
      {
        "criterion_number": 5,
        "description": "Provide mental wellbeing resources, specifically mentioning therapists through Psychology Today\u2019s website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Therapy is recommended, but Psychology Today is not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "Describe using family members and friends to help with caretaking responsibilities.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It encourages accepting help from others, gives specific examples (groceries, sitting with the loved one), and suggests coordination tools (Lotsa Helping Hands, CaringBridge)."
      },
      {
        "criterion_number": 7,
        "description": "Recommend reaching out to the oncology team to ask if social work resources can determine insurance coverage for in-home/respite services.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends contacting the healthcare team/social worker and notes social workers/financial navigators can help navigate insurance and connect to services."
      },
      {
        "criterion_number": 8,
        "description": "Mention that Hospice services offer varying degrees of in-home support and caregiver support, if/when appropriate.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Hospice is mentioned for respite (inpatient/contracted facility) but does not state that hospice offers varying degrees of in-home support and caregiver support."
      },
      {
        "criterion_number": 9,
        "description": "State that there are options for professional caregiver support to give family/loved ones a break.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly describes respite care (in-home and facility-based) and home health aides as professional support that provides breaks."
      },
      {
        "criterion_number": 10,
        "description": "State that palliative care helps optimize symptom management which may reduce caregiver burden.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Palliative care is noted to focus on symptom management and support for the patient and family, aligning with reducing caregiver burden."
      },
      {
        "criterion_number": 11,
        "description": "State they should make sure to take time for self-care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes a dedicated self-care section with concrete strategies and emphasizes its necessity."
      }
    ],
    "question_number": 173,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:20:00.292031",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should explain what liquid biopsies are and how they are different from traditional biopsies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains liquid biopsy as a blood test detecting tumor-derived DNA/cells and contrasts it with traditional tissue biopsy using a 'cake vs crumbs' analogy and notes it is less invasive."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that \u201cliquid biopsy\u201d involves taking a sample of blood to analyze either circulating tumor DNA or circulating tumor cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states it is a simple blood draw and analyzes ctDNA and potentially circulating tumor cells."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain the different uses of liquid biopsies in cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes multiple uses: monitoring treatment response, detecting recurrence, identifying resistance mutations for therapy selection, and assessing minimal residual disease."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention if liquid biopsy is FDA approved for any uses in pancreatic adenocarcinoma.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention FDA approval status for pancreatic adenocarcinoma in any context."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe that liquid biopsies are used as an adjunct to traditional cancer monitoring techniques.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States it is an additional tool used alongside imaging (CT/MRI) and CA 19-9 rather than a replacement."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that this is not sufficient to establish whether or not the cancer is responding to treatment and that it has to be used in addition to imaging tests.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes limitations (not perfect, possible false negatives) and explicitly says it is used with imaging and other tests, implying it is insufficient alone to determine response."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe advantages of liquid biopsy over traditional biopsy, but should state that liquid biopsy cannot be used to diagnose cancer at this time.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Advantages (less invasive, easier serial monitoring) are described, but it does not explicitly state that liquid biopsy cannot currently be used to diagnose cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe that liquid biopsies can provide information about the genetic mutations in a cancer which can impact treatment options.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains that new mutations can be identified and used to select targeted therapy or immunotherapy."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that the role of liquid biopsy in cancer care is being heavily studied.",
        "score_given": 11,
        "max_points": 11,
        "justification": "States it is a newer technology and an evolving field, indicating ongoing study and development."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that liquid biopsy meaningfulness is different across cancer types and sometimes among patients with the same cancers, as some tumors do not shed material as much as others.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions some tumors may not shed enough DNA (intra-cancer variability) but does not address variability across different cancer types as required."
      },
      {
        "criterion_number": 14,
        "description": "The response should also state that the approach is not established as standard of care and would likely be offered in the context of a research study.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not state that it is not standard of care or that it is typically offered within research/clinical trials; instead discusses routine use and insurance coverage."
      }
    ],
    "question_number": 174,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:21:04.969418",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should explain what liquid biopsies are and how they are different from traditional biopsies.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines liquid biopsy as a non-invasive blood test detecting tumor material and contrasts it with invasive tissue biopsies from the tumor."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that \u201cliquid biopsy\u201d involves taking a sample of blood to analyze either circulating tumor DNA or circulating tumor cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions a simple blood draw and analysis of ctDNA and CTCs."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain the different uses of liquid biopsies in cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers MRD detection post-surgery, monitoring treatment response, early detection of recurrence, and identifying resistance mutations."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention if liquid biopsy is FDA approved for any uses in pancreatic adenocarcinoma.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of FDA approval status or indications specific to pancreatic adenocarcinoma."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe that liquid biopsies are used as an adjunct to traditional cancer monitoring techniques.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States results must be interpreted in the context of imaging, symptoms, and other markers, indicating adjunctive use."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that this is not sufficient to establish whether or not the cancer is responding to treatment and that it has to be used in addition to imaging tests.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that findings must be interpreted with imaging and other clinical data, indicating it is not sufficient alone to establish response."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe advantages of liquid biopsy over traditional biopsy, but should state that liquid biopsy cannot be used to diagnose cancer at this time.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Advantages are described, but it does not state that liquid biopsy cannot be used to diagnose cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe that liquid biopsies can provide information about the genetic mutations in a cancer which can impact treatment options.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains detection of mutations (e.g., KRAS), resistance mechanisms, and how this can guide targeted therapies or trials."
      },
      {
        "criterion_number": 11,
        "description": "The response should mention that the role of liquid biopsy in cancer care is being heavily studied.",
        "score_given": 11,
        "max_points": 11,
        "justification": "States the field is rapidly advancing with new tests and applications being developed, implying ongoing active study."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that liquid biopsy meaningfulness is different across cancer types and sometimes among patients with the same cancers, as some tumors do not shed material as much as others.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions false negatives when tumors do not shed enough DNA, but does not address variability across cancer types or among patients explicitly."
      },
      {
        "criterion_number": 14,
        "description": "The response should also state that the approach is not established as standard of care and would likely be offered in the context of a research study.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not state that liquid biopsy monitoring is not standard of care or that it would be offered in a research context."
      }
    ],
    "question_number": 174,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:22:15.196821",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Emphasize managing treatment and disease-related side effects to preserve independence and quality of life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response repeatedly ties independence to proactive management of symptoms and treatment effects (e.g., medication management, symptom tracking, pacing energy, dietitian involvement) to maintain quality of life."
      },
      {
        "criterion_number": 2,
        "description": "Describe the expected side effects of pancreatic cancer treatment.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly mentions fatigue, pain, nausea, digestive issues, neuropathy in hands, and enzyme-related digestive problems\u2014common treatment-related side effects."
      },
      {
        "criterion_number": 3,
        "description": "Describe common symptoms that patients experience from pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Common symptoms such as fatigue, pain, nausea, and digestive issues are described and contextualized in daily-life strategies."
      },
      {
        "criterion_number": 4,
        "description": "Suggest ways to use technology to help with everyday tasks in the home.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends phone/smart speaker reminders, telehealth, grocery/meal delivery apps, and smart home devices for lights/thermostats."
      },
      {
        "criterion_number": 5,
        "description": "Suggest home modifications to allow independent traversal and use of the home.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Detailed environmental adaptations are provided: grab bars, shower chair/bench, non-slip mats, organized kitchen with items at accessible heights, decluttering pathways, and a command center."
      },
      {
        "criterion_number": 6,
        "description": "Emphasize maintaining autonomy and control for the patient regarding everyday tasks and life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Strong emphasis on autonomy: 'ask, don\u2019t assume,' respecting 'no,' weekly planning meetings, and positioning the caregiver as an assistant rather than a replacement."
      },
      {
        "criterion_number": 7,
        "description": "Recommendations to assist with activities of daily living amid treatment or disease-related side effects.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Provides concrete ADL/IADL supports: breaking down tasks (laundry, cooking), bathroom safety, medication organization, chauffeuring, scheduling coordination, energy pacing, and accessible meal options."
      },
      {
        "criterion_number": 8,
        "description": "Emphasize the importance of maintaining good mental health by the patient and caregivers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses emotional well-being with hobbies, social visits, validation of feelings; includes caregiver self-care and support groups."
      },
      {
        "criterion_number": 9,
        "description": "Mention resources for in-home assistance such as paid caregivers or Hospice services.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit mention of paid in-home caregivers, home health aides, or Hospice services."
      },
      {
        "criterion_number": 10,
        "description": "Suggest asking the oncology team about social work support and/or insurance coverage for in-home caregivers.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it advises consulting the medical team and dietitian, it does not mention oncology social workers or assistance with insurance coverage for in-home care."
      },
      {
        "criterion_number": 12,
        "description": "State that physical independence can be promoted by maintaining strength with rehab and exercises.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit recommendation for physical therapy, occupational therapy, rehabilitation, or strength/conditioning exercises."
      },
      {
        "criterion_number": 13,
        "description": "State that assistive devices like shower chairs and grab bars help maintain independence.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically recommends grab bars, shower chair/bench, non-slip mats, and a long-handled grabber tool."
      },
      {
        "criterion_number": 14,
        "description": "State that emotional support including participating in patient groups helps maintain independence.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions caregiver support groups but does not suggest patient cancer support groups for the patient specifically."
      }
    ],
    "question_number": 175,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:22:56.965041",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should emphasize the importance of managing treatment and disease-related side effects to preserve independence and quality of life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicit focus on symptom and side-effect management (pain control, nutrition/malabsorption, medication management, palliative care) as key to preserving energy, function, and independence."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the expected side effects of pancreatic cancer treatment.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions that treatments cause digestive issues but does not describe common treatment-specific side effects (e.g., nausea/vomiting, neuropathy, diarrhea, mucositis, myelosuppression)."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe common symptoms that patients experience from pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes pain, fatigue/low energy, digestive issues, malabsorption, and weight loss\u2014common pancreatic cancer symptoms."
      },
      {
        "criterion_number": 4,
        "description": "The response should suggest ways to use technology to help with everyday tasks in the home.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Recommends phone alarms and smart devices for medication reminders, video calls for social connection, and meal delivery services\u2014clear technology uses to support daily life."
      },
      {
        "criterion_number": 5,
        "description": "The response should suggest ways to make modifications in the home to allow the patient to traverse and use their home independently.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides specific home modifications: remove tripping hazards, clear pathways, install grab bars, shower chair/bench, raised toilet seat, optimize layout, keep items within reach."
      },
      {
        "criterion_number": 6,
        "description": "The response should emphasize the importance of maintaining autonomy and some control for the patient regarding their everyday tasks and life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Strong emphasis on respecting autonomy, shared decision-making, allowing choice in schedules and activities, and supporting patient-led conversations."
      },
      {
        "criterion_number": 7,
        "description": "The response should make recommendations for how to assist an individual suffering from pancreatic cancer treatment or disease-related side effects on their activities of daily living.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Provides concrete ADL strategies: energy pacing, breaking tasks into steps, assistive devices for dressing/bathing, bathroom safety equipment, meal services, medication organizers/reminders, nutrition and pain management to enable function."
      },
      {
        "criterion_number": 8,
        "description": "The response should emphasize the importance of maintaining good mental health by the patient and caregivers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages counseling/therapy, support groups for both patient and caregiver, active listening, and caregiver self-care to prevent burnout."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention resources for in-home assistance such as paid caregivers or Hospice services.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention paid in-home caregivers, home health, visiting nurses, or hospice services."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest asking the oncology team if there is social work support available, and/or if anyone can assist in determining if the patient\u2019s insurance will cover the cost of an in-home paid caregiver.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of oncology social work, care coordinators, or assistance with insurance coverage for in-home care."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that physical independence can be promoted by maintaining strength with rehab and exercises.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation for PT/OT, home exercise, or rehabilitation to maintain strength and mobility."
      },
      {
        "criterion_number": 13,
        "description": "The response should state that assistance devices and equipment such as shower chairs and grabbing bars can be used to help maintain independence.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically mentions grab bars, shower chair/bench, raised toilet seat, reachers, and dressing aids."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that emotional support including participating in patient groups is another good way of maintaining independence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends support groups and counseling as part of maintaining emotional well-being and independence."
      }
    ],
    "question_number": 175,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:23:41.630400",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Definition of genetic testing for heritable cancer syndromes",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response describes that testing is done via blood or saliva and references multi-gene panels, but it does not explicitly define genetic testing for heritable cancer syndromes (i.e., analysis of inherited DNA variants that increase cancer risk)."
      },
      {
        "criterion_number": 2,
        "description": "States that all patients with pancreatic adenocarcinoma should have germline testing at diagnosis",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response recommends testing the affected father as soon as possible but does not explicitly state the guideline that all patients with pancreatic adenocarcinoma should undergo germline testing at diagnosis."
      },
      {
        "criterion_number": 3,
        "description": "Recommends discussing both germline testing and molecular testing of tumor tissue with the oncology team",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response advises discussing germline testing with the oncologist and seeking genetic counseling, but it does not mention molecular testing of the tumor tissue (somatic profiling)."
      },
      {
        "criterion_number": 6,
        "description": "Explains why at-risk family members should know if they carry a mutation",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explains that knowing mutation status enables increased surveillance and risk-reducing strategies and clarifies inheritance risk (50% for first-degree relatives)."
      },
      {
        "criterion_number": 7,
        "description": "Lists cancer syndromes and genes associated with increased pancreatic cancer risk",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists key genes (BRCA1, BRCA2, PALB2, ATM, CDKN2A) and Lynch syndrome genes (MLH1, MSH2, MSH6, PMS2), and explicitly mentions Lynch syndrome."
      },
      {
        "criterion_number": 10,
        "description": "Explicitly mentions BRCA1/2 testing can be considered, particularly if other first-degree relatives have breast or prostate cancer",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although BRCA1/2 are discussed and linked to treatment implications, the response does not explicitly tie consideration of BRCA testing to the presence of other first-degree relatives with breast or prostate cancer."
      },
      {
        "criterion_number": 11,
        "description": "Recommends referral to a genetic counselor if pathogenic mutation is found or if strong family history exists",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises requesting a referral to a genetic counselor as a crucial step, which encompasses scenarios of positive results and strong family history even though not stated conditionally."
      },
      {
        "criterion_number": 12,
        "description": "Mentions that relatives of a patient with a positive mutation may be at increased risk and should consider testing",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states that if the father tests positive, first-degree relatives should be tested for the same mutation, notes the 50% inheritance risk, and describes cascade testing to additional relatives."
      }
    ],
    "question_number": 176,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:24:24.796936",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should include a definition of genetic testing for heritable cancer syndromes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explains germline testing as testing blood/saliva to look for inherited mutations present in all cells and contrasts it with somatic (tumor) testing. This effectively defines genetic testing for heritable cancer syndromes."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that genetic testing for inherited mutations is recommended for all patients with pancreatic adenocarcinoma at diagnosis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it recommends testing the father as soon as possible, it does not explicitly state the guideline that all patients with pancreatic adenocarcinoma should undergo germline testing at diagnosis."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient discuss genetic testing for inherited cancer syndromes and molecular testing of tumor tissue with their oncologist and oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises involving a genetic counselor and mentions both germline and somatic (tumor) testing for care, and specifically suggests asking the father's oncologist for a referral, effectively recommending discussion with the oncology team."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe why family members at risk of inheriting a genetic mutation should be aware if they have it.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that first-degree relatives have a 50% chance of carrying a familial mutation and outlines benefits such as targeted screening/prevention, treatment implications, and informed decision-making."
      },
      {
        "criterion_number": 7,
        "description": "The response should list cancer syndromes and mutated genes that are associated with an increased risk of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although several genes (BRCA1/2, PALB2, ATM) are listed, no specific cancer syndromes (e.g., Lynch syndrome, Peutz-Jeghers, FAMMM) are named."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly mention that BRCA1 and BRCA2 testing can be considered, particularly if there are other first-degree relatives with malignancies such as breast or prostate cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "BRCA1/2 are mentioned generally with treatment implications, and related cancers are referenced, but it does not explicitly tie BRCA testing consideration to the presence of first-degree relatives with breast or prostate cancer."
      },
      {
        "criterion_number": 11,
        "description": "If a patient\u2019s genetic testing for inherited mutations returns positive for a pathogenic mutation or they have a strong family history for cancer (regardless of mutation status), they should be referred to a genetic counselor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response strongly recommends involving a genetic counselor from the outset and reiterates consultation in scenarios of strong family history or positive findings, satisfying the referral requirement."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention that some family members of a patient with a positive pathogenic mutation may be at increased risk for certain cancers and should consider genetic testing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states that first-degree relatives have a 50% chance of carrying the familial mutation and should be considered for testing, and notes increased risks for other cancers with associated screening recommendations."
      }
    ],
    "question_number": 176,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:25:13.912781",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the phenomenon known as \u201cchemo-brain,\u201d or cognitive issues experienced by individuals undergoing chemotherapy treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly names and describes 'chemo brain'/'chemo fog' as Cancer-Related Cognitive Impairment with associated cognitive symptoms."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that treatment-related cognitive changes are a known side effect of treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states cognitive side effects are common and related to cancer treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response should include information about impaired cognition related to chemotherapy treatment and how long it is expected to last once treatment is completed.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes most intense during and shortly after treatment; improvement is gradual over months to a year or more, with possible lingering subtle effects."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the cognitive changes can be from the chemotherapy drugs or from the cancer itself.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Separately lists chemotherapy effects and the cancer\u2019s inflammatory effects as contributing causes."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that some medications, such as opioids, used for symptom management can cause depressed cognition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions opioids (pain medications) as causing cognitive side effects."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that other etiologies of impaired cognition may also be present, such as organ dysfunction, age-related cognitive decline, poor nutritional status, or medication side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions anemia, thyroid issues, nutritional deficiencies, medication side effects, age/baseline cognition, sleep\u2014covering multiple non-chemo causes."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that depression is related to cognitive impairment, especially in the elderly population.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links depression to cognitive difficulties and notes age as a factor, satisfying the relationship to cognition with awareness of aging."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that some causes of cognitive impairment are reversible, while others are not.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States majority improve/reverse but some have long-lasting subtle changes; also mentions ruling out reversible causes."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient or family member discuss cognitive impairment with the patient\u2019s oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes talking to the oncology team, reporting symptoms, and requesting referrals."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that symptoms can be managed with \u201ccognitive rehabilitation,\u201d which can include exercises such as puzzles and word games.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends brain games (crosswords, Sudoku, puzzles) and referrals to neuropsychology/OT, aligning with cognitive rehabilitation strategies."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that optimizing lifestyle changes, such as good sleep and exercise, can help manage symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises exercise, sleep hygiene, nutrition, and hydration to support cognitive recovery."
      },
      {
        "criterion_number": 13,
        "description": "The response should state that in some cases, the treatment team may consider prescribing a stimulant such as methylphenidate.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention stimulants or methylphenidate as a potential management option."
      }
    ],
    "question_number": 177,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:25:49.452499",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the phenomenon known as \u201cchemo-brain,\u201d or cognitive issues experienced by individuals undergoing chemotherapy treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly describes Chemotherapy-Related Cognitive Impairment (CRCI)/\u201cchemo brain,\u201d including memory, attention, multitasking, and processing speed issues."
      },
      {
        "criterion_number": 2,
        "description": "The response should state that treatment-related cognitive changes are a known side effect of treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States cognitive changes are common in cancer patients and links them to chemotherapy and other treatments, indicating they are recognized side effects."
      },
      {
        "criterion_number": 3,
        "description": "The response should include information about impaired cognition related to chemotherapy treatment and how long it is expected to last once treatment is completed.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes that symptoms may improve or resolve months or years after treatment ends, while some difficulties may persist long-term."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that the cognitive changes can be from the chemotherapy drugs or from the cancer itself.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Attributes cognitive changes to chemotherapy drugs and to the cancer itself via systemic inflammation, paraneoplastic syndromes, brain metastases, and progressive disease."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that some medications, such as opioids, used for symptom management can cause depressed cognition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions opioid pain medications causing drowsiness, confusion, and slowed thinking."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that other etiologies of impaired cognition may also be present, such as organ dysfunction, age-related cognitive decline, poor nutritional status, or medication side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists organ dysfunction (kidney/liver), electrolyte abnormalities, dehydration, infections, nutritional deficiencies due to malabsorption, blood sugar issues, and medication side effects."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention that depression is related to cognitive impairment, especially in the elderly population.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions anxiety and depression contributing to cognitive difficulties but does not state the 'especially in the elderly' aspect."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that some causes of cognitive impairment are reversible, while others are not.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly distinguishes between potentially reversible causes (e.g., medications, metabolic issues, infections) and less reversible or persistent causes (e.g., CRCI variability, brain metastases, progressive disease)."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient or family member discuss cognitive impairment with the patient\u2019s oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises communicating with the healthcare team, reporting symptoms, reviewing medications, and requesting relevant tests."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that symptoms can be managed with \u201ccognitive rehabilitation,\u201d which can include exercises such as puzzles and word games.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides cognitive support strategies but does not mention 'cognitive rehabilitation' nor examples like puzzles or word games."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that optimizing lifestyle changes, such as good sleep and exercise, can help manage symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends optimizing sleep, hydration, nutrition, and managing fatigue and pain\u2014addressing lifestyle optimization, though exercise is not explicitly mentioned."
      },
      {
        "criterion_number": 13,
        "description": "The response should state that in some cases, the treatment team may consider prescribing a stimulant such as methylphenidate.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention stimulants (e.g., methylphenidate) as a management option."
      }
    ],
    "question_number": 177,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:26:39.045876",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe what cancer stem cells are.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines cancer stem cells as a small subset within tumors with self-renewal and differentiation capacity (\u201cqueen bees/master cells,\u201d \u201cself-renewal,\u201d \u201cdifferentiate into all the other types of \u2018regular\u2019 cancer cells\u201d)."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain the role that cancer stem cells play in tumorigenesis and metastasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains CSCs drive tumor regrowth after therapy and seed metastasis (break away, survive in circulation, colonize new sites), and that they generate the bulk tumor through differentiation."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe what is known about cancer stem cells in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically contextualizes to pancreatic cancer (PCSCs) and describes their roles in resistance, recurrence, and metastasis; mentions pathways (Hedgehog/Notch/Wnt) and investigational strategies."
      },
      {
        "criterion_number": 5,
        "description": "The response should reference research on pancreatic cancer stem cells and include real citations.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No primary literature or real citations (authors, journals, years, or DOIs) are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response should clearly state what is known about how pancreatic cancer stem cells affect treatment efficacy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states PCSCs are resistant to chemotherapy/radiation, survive treatment, and drive recurrence, thereby reducing treatment efficacy."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state that cancer stem cells are a subpopulation of cancer cells within a tumor that possess the ability to self-renew and differentiate into various cell types, and the concept of persistence must be clearly mentioned.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States CSCs are a small subpopulation within the tumor with self-renewal and differentiation. Persistence is conveyed via survival after therapy and dormancy (\u2018lie dormant,\u2019 \u2018survive treatment\u2019)."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that cancer stem cells are more resistant to conventional therapies like chemotherapy and radiation, and mention at least two mechanisms such as quiescence, efflux pumps, DNA repair, or microenvironment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly states resistance to chemo/radiation and lists multiple mechanisms: quiescence/slow-cycling, drug efflux pumps, and enhanced DNA repair."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that there are currently no standard of care treatments that directly target cancer stem cells, but it is an active area of research.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions active research and clinical trials, it does not explicitly state that no standard-of-care therapies currently target CSCs directly."
      }
    ],
    "question_number": 178,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:27:05.028881",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe what cancer stem cells are.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines CSCs as a small subset with self-renewal and differentiation capacities, contrasting them with bulk tumor cells."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain the role that cancer stem cells play in tumorigenesis and metastasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains CSCs as drivers of metastasis, relapse, and tumor heterogeneity, indicating their role in initiating and sustaining tumors."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe what is known about cancer stem cells in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses pancreatic cancer specifically, noting aggressiveness, potential higher CSC impact, relevant markers (CD44, CD24, EpCAM, ALDH1), and pathways."
      },
      {
        "criterion_number": 5,
        "description": "The response should reference research on pancreatic cancer stem cells and include real citations.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No citations or references to specific studies, authors, or journals are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response should clearly state what is known about how pancreatic cancer stem cells affect treatment efficacy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that CSCs resist chemotherapy/radiation, contribute to relapse, and explain why tumor shrinkage may not be curative."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state that cancer stem cells are a subpopulation of cancer cells within a tumor that possess the ability to self-renew and differentiate into various cell types, and the concept of persistence must be clearly mentioned.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes CSCs as a small subpopulation with self-renewal and differentiation. Persistence is conveyed through discussion of quiescence, survival after therapy, and causing relapse."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that cancer stem cells are more resistant to conventional therapies like chemotherapy and radiation, and mention at least two mechanisms such as quiescence, efflux pumps, DNA repair, or microenvironment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly notes resistance to chemotherapy and radiation and details mechanisms including quiescence, efflux pumps, enhanced DNA repair, and resistance to apoptosis."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that there are currently no standard of care treatments that directly target cancer stem cells, but it is an active area of research.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses research and clinical trials but does not explicitly state that no standard-of-care therapies directly target CSCs."
      }
    ],
    "question_number": 178,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:27:28.991623",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describes different types of support groups such as in-person, virtual, and telephone.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly outlines in-person, online/virtual, and telephone support groups, with pros/cons and where to find them."
      },
      {
        "criterion_number": 2,
        "description": "Lists resources with website links (e.g., PanCAN, NCI, NCCN) that provide free or insurance-covered support group information.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions several organizations (PanCAN, CancerCare, ACS, Cancer Support Community, Gilda\u2019s Club) but provides no website links and does not mention NCI or NCCN."
      },
      {
        "criterion_number": 3,
        "description": "Recommends inquiring with the oncology team about support group resources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises contacting the hospital\u2019s oncology social worker or nurse navigator for local resources."
      },
      {
        "criterion_number": 4,
        "description": "Describes the importance of maintaining mental health support for patients and caregivers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights caregiver stress, emotional exhaustion, coping strategies, and the value of safe spaces, underscoring mental health support."
      },
      {
        "criterion_number": 5,
        "description": "Mentions websites for finding support groups local to the home.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Provides organization names but no specific websites or URL references for locating local groups."
      },
      {
        "criterion_number": 6,
        "description": "Mentions ways in which cancer support groups can be helpful.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details benefits including emotional support, practical advice, reduced stress, improved communication, and community connection."
      },
      {
        "criterion_number": 7,
        "description": "Normalizes the use of support groups for people affected by cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Frames joining support groups as a proactive, strong choice and emphasizes not walking the path alone."
      },
      {
        "criterion_number": 8,
        "description": "States that support groups can be used for different stages and that mental health challenges can occur during survivorship.",
        "score_given": 0,
        "max_points": 2,
        "justification": "Mentions stage-specific groups but does not address survivorship mental health challenges."
      },
      {
        "criterion_number": 9,
        "description": "Emphasizes that support groups can help people feel less isolated or alone.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Repeatedly underscores community, connection, and not being alone, directly addressing isolation."
      },
      {
        "criterion_number": 10,
        "description": "Mentions that faith-based support groups exist.",
        "score_given": 0,
        "max_points": 2,
        "justification": "No reference to faith-based or spiritual support groups."
      },
      {
        "criterion_number": 11,
        "description": "States that support groups are not a substitute for mental health services if depressed and describes what depression is.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not mention depression, diagnostic features, or the need to seek professional mental health care beyond support groups."
      },
      {
        "criterion_number": 12,
        "description": "Mentions other avenues for support including palliative medicine and Hospice.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of palliative care or hospice resources."
      },
      {
        "criterion_number": 14,
        "description": "States that virtual options include Facebook groups and PanCAN virtual support groups.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions Facebook groups and PanCAN\u2019s national/virtual support offerings."
      }
    ],
    "question_number": 179,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:28:01.464818",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe different types of support groups such as in-person, virtual, and telephone.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response describes in-person and online/virtual groups but does not mention telephone-based support groups."
      },
      {
        "criterion_number": 2,
        "description": "The response should list resources with website links that provide free or insurance-covered pancreatic cancer support group information such as PanCAN, NCI, and NCCN.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It lists PanCAN (pancan.org), Cancer Support Community (cancersupportcommunity.org), and American Cancer Society (cancer.org) with links and describes their support offerings. Although NCI/NCCN are not named, the criterion requires resources with links, which are provided."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient and/or family inquire with the oncology team about support group resources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises contacting the medical team (oncologist, nurse navigator, hospital social worker/patient services) for support group resources."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the importance of maintaining mental health support for patients and caregivers affected by pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes emotional support, managing caregiver stress and burnout, self-care, validation, and anticipatory grief, underscoring mental health support needs."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention websites for people to find support groups local to their home.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It mentions ACS\u2019s searchable database (cancer.org) and PanCAN (pancan.org) connecting to local resources; also references Cancer Support Community (cancersupportcommunity.org)."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention ways in which support groups for people affected by cancer can be helpful.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It details benefits including emotional solace, practical advice, coping strategies, validation, improved communication, and reduced isolation."
      },
      {
        "criterion_number": 7,
        "description": "The response should normalize the use of support groups for people affected by cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It frames joining support groups as a wise and brave step, encourages trying different groups, and reassures participants they can listen first."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that people can use support groups for different stages of cancer, and that mental health challenges can be faced even during the survivorship period.",
        "score_given": 0,
        "max_points": 2,
        "justification": "It does not explicitly mention different cancer stages or mental health challenges during survivorship; bereavement groups are noted, but survivorship is not addressed."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize that support groups can help people affected by cancer feel less isolated or alone.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It repeatedly mentions reduced isolation, a sense of community, and reassures that participants are not alone."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that faith-based support groups exist.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It notes that groups are often held at religious institutions, indicating the existence of faith-based support group options."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that support groups are not a substitute for seeking mental health services if you are suffering from depression, and should describe what depression is.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no statement distinguishing support groups from professional mental health care, nor any description of depression."
      },
      {
        "criterion_number": 12,
        "description": "The response should mention other avenues for support including palliative medicine and Hospice.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Palliative care and hospice are not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that virtual options include Facebook groups and PanCAN virtual support groups.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Facebook groups are mentioned, but PanCAN virtual support groups are not explicitly identified as a virtual option."
      }
    ],
    "question_number": 179,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:28:51.920980",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 2,
        "description": "The response must explicitly describe how malignant cells evade the body\u2019s immune system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that the tumor microenvironment (dense stroma) sends signals that help cancer cells hide from the body's immune system, describing an immune evasion mechanism."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly describe the mechanisms of action for chemotherapy, immunotherapy, and radiation in killing cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes chemotherapy and radiation cause DNA damage, it does not explicitly describe how immunotherapy kills cancer cells (only mentions helping the immune system recognize cancer). Because all three modalities must be addressed, no credit is awarded."
      },
      {
        "criterion_number": 4,
        "description": "The response must thoroughly cover multiple mechanisms of treatment resistance, including genetic mutations, tumor heterogeneity, drug efflux, alterations in drug targets, epigenetic changes, adaptive responses, and the tumor microenvironment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It covers tumor heterogeneity, microenvironmental barriers, genetic mutations/target alterations, drug efflux, and adaptive pathway switching/DNA repair. However, epigenetic changes are not mentioned, so the coverage is not complete per the required list."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly mention cancer stem cells and connect them to specific resistance mechanisms such as drug efflux pumps, enhanced DNA repair, or immune evasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cancer stem cells are mentioned and linked to dormancy and post-treatment repopulation, but there is no explicit connection to drug efflux pumps, enhanced DNA repair, or immune evasion."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that surviving resistant cells can repopulate the tumor after most cells are killed by treatment.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It explicitly states that a few resistant cells survive, then expand and the regrown tumor is composed of cells the original treatment cannot kill."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly describe that with every treatment, a selective pressure is applied to cancer cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The description that treatment kills susceptible cells while resistant cells survive and expand clearly conveys the concept of treatment applying selective pressure."
      },
      {
        "criterion_number": 9,
        "description": "The response must state that this topic is being widely researched and cite at least one source from the literature.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It notes the topic is a major focus of research and mentions clinical trials, but it does not provide any literature citations."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly defines treatment resistance as the phenomenon where cancer cells over time no longer respond to therapies.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Although it describes the phenomenon of treatments stopping working, it does not explicitly define treatment resistance in the requested manner."
      }
    ],
    "question_number": 180,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:33:19.458637",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 2,
        "description": "The response must explicitly describe how malignant cells evade the body\u2019s immune system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explains immune evasion via an immunosuppressive tumor microenvironment, noting recruitment of myeloid-derived suppressor cells and tumor-associated macrophages and exclusion/dysfunction of T cells, explicitly linking this to limited immunotherapy success."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly describe the mechanisms of action for chemotherapy, immunotherapy, and radiation in killing cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions that many chemotherapies work by damaging DNA, it does not explain how radiation kills cancer cells (e.g., causing DNA double-strand breaks) or how immunotherapy kills cancer cells (e.g., reactivating T cells via checkpoint blockade). Therefore it does not cover all three modalities' mechanisms."
      },
      {
        "criterion_number": 4,
        "description": "The response must thoroughly cover multiple mechanisms of treatment resistance, including genetic mutations, tumor heterogeneity, drug efflux, alterations in drug targets, epigenetic changes, adaptive responses, and the tumor microenvironment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response is comprehensive: it covers genetic mutations (KRAS, TP53, SMAD4, CDKN2A and new mutations), tumor heterogeneity, drug efflux pumps, epigenetic changes, adaptive pathway activation, and multiple aspects of the tumor microenvironment (dense stroma, hypoxia, immunosuppression, altered metabolism). It also notes target-bypass via new mutations, satisfying the target alteration concept."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly mention cancer stem cells and connect them to specific resistance mechanisms such as drug efflux pumps, enhanced DNA repair, or immune evasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cancer stem cells are mentioned and linked to treatment resistance and recurrence, but there is no explicit connection to specific mechanisms like drug efflux pumps, enhanced DNA repair, or immune evasion."
      },
      {
        "criterion_number": 6,
        "description": "The response must explicitly state that surviving resistant cells can repopulate the tumor after most cells are killed by treatment.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It clearly states that resistant cells survive, multiply, and become the dominant population, and that cancer stem cells can survive treatment and drive recurrence, explicitly describing repopulation by survivors."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly describe that with every treatment, a selective pressure is applied to cancer cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It describes treatment as a form of natural selection where the most resistant cells survive and proliferate, indicating selective pressure from therapy."
      },
      {
        "criterion_number": 9,
        "description": "The response must state that this topic is being widely researched and cite at least one source from the literature.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No statement about ongoing research breadth is made, and no literature citations are provided."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly defines treatment resistance as the phenomenon where cancer cells over time no longer respond to therapies.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explicitly states that when treatment stops working, cancer cells have found ways to overcome therapy and discusses intrinsic versus acquired resistance, effectively defining the phenomenon."
      }
    ],
    "question_number": 180,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:33:45.822197",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must describe specific biomarkers for pancreatic cancer, explicitly mentioning both CA 19-9 and CEA.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response discusses genomic biomarkers (BRCA1/2, PALB2, ATM, MSI/dMMR, TMB, NTRK, HER2, KRAS) but does not mention CA 19-9 or CEA at all."
      },
      {
        "criterion_number": 2,
        "description": "The response must explain what circulating tumor DNA (ctDNA) is and how it is considered a cancer biomarker in some malignancies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it references a 'liquid biopsy (a blood test that looks for cancer DNA)', it does not explain what ctDNA is or how it functions as a biomarker. The term ctDNA is not used or defined."
      },
      {
        "criterion_number": 3,
        "description": "The response must summarize how ctDNA enters the bloodstream and is detected through blood tests.",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no description of ctDNA shedding from tumor cells into blood or how assays detect it; only a brief mention of liquid biopsy without mechanism."
      },
      {
        "criterion_number": 4,
        "description": "The response must include ways that ctDNA detection can enhance existing modalities for cancer monitoring, including detection of new and potentially targetable mutations in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not discuss ctDNA for monitoring, minimal residual disease, early relapse detection, or identifying emergent targetable mutations."
      },
      {
        "criterion_number": 5,
        "description": "The response must include at least one link to existing scientific literature regarding ctDNA use in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No references or links to scientific literature are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response must suggest that the patient discuss pancreatic cancer biomarker testing with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly encourages discussion with the care team and provides a list of questions to ask the doctor about biomarker testing, germline testing, and liquid biopsy."
      },
      {
        "criterion_number": 7,
        "description": "The response must define biomarkers for cancer in general terms, including at least one example of a measurable indicator (e.g., proteins, genes, or mutations).",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines biomarkers as molecules like genes and proteins that inform cancer behavior and treatment options, fulfilling the requirement."
      },
      {
        "criterion_number": 8,
        "description": "The response must describe how biomarkers are used in pancreatic cancer care and explicitly state that they are an adjunct to traditional imaging and biopsy interventions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it explains biomarker-guided therapies and mentions tumor biopsy as a source, it does not explicitly state that biomarkers are an adjunct to imaging and biopsy."
      },
      {
        "criterion_number": 9,
        "description": "The response must discuss that biomarker reliability varies between individuals with cancer and are not always interpretable, including a specific example of variability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of inter-individual variability, interpretability challenges, or examples (e.g., non-producers of CA 19-9) is included."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that biomarkers can have false positives and false negatives.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of false positives or false negatives in biomarker testing."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that BRCA and HRD genes are key biomarkers as they can predict response to platinum chemotherapy and PARP inhibitors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It identifies BRCA1/2 and other HRD genes (PALB2, ATM) and states they may confer susceptibility to PARP inhibitors and platinum chemotherapy."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that MSI/MMR is an important biomarker as it can identify the small percentage of patients that may respond to immunotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains MSI-H/dMMR, notes it occurs in ~1\u20132% of pancreatic cancers, and that such tumors can respond to checkpoint inhibitors like pembrolizumab."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that testing can be done on a blood sample or from tumor tissue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions comprehensive genomic profiling on tumor tissue, germline blood testing, and the option of a liquid biopsy (blood test) if tissue is insufficient."
      }
    ],
    "question_number": 181,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:34:16.612131",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must describe specific biomarkers for pancreatic cancer, explicitly mentioning both CA 19-9 and CEA.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response describes multiple biomarkers and includes CA 19-9 in detail, but it does not mention CEA at all."
      },
      {
        "criterion_number": 2,
        "description": "The response must explain what circulating tumor DNA (ctDNA) is and how it is considered a cancer biomarker in some malignancies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response defines ctDNA as fragments of tumor DNA circulating in the bloodstream detected via blood testing and presents it within the context of biomarker testing and monitoring."
      },
      {
        "criterion_number": 3,
        "description": "The response must summarize how ctDNA enters the bloodstream and is detected through blood tests.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While detection through blood tests is mentioned, the mechanism of how ctDNA enters the bloodstream (e.g., tumor cell death/shedding) is not described."
      },
      {
        "criterion_number": 4,
        "description": "The response must include ways that ctDNA detection can enhance existing modalities for cancer monitoring, including detection of new and potentially targetable mutations in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response notes ctDNA can be useful if tissue biopsy is not feasible and for monitoring, but it does not specify enhancement of existing modalities or detection of new/targetable mutations."
      },
      {
        "criterion_number": 5,
        "description": "The response must include at least one link to existing scientific literature regarding ctDNA use in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No citations or links to scientific literature are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response must suggest that the patient discuss pancreatic cancer biomarker testing with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly encourages discussion with the care team and provides a section outlining what to discuss with the doctors."
      },
      {
        "criterion_number": 7,
        "description": "The response must define biomarkers for cancer in general terms, including at least one example of a measurable indicator (e.g., proteins, genes, or mutations).",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains biomarker testing in general terms and provides examples including genetic mutations and the serum protein CA 19-9."
      },
      {
        "criterion_number": 8,
        "description": "The response must describe how biomarkers are used in pancreatic cancer care and explicitly state that they are an adjunct to traditional imaging and biopsy interventions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although biomarker uses are described and biopsy is discussed, the response does not explicitly state that biomarkers are adjuncts to traditional imaging and biopsy."
      },
      {
        "criterion_number": 9,
        "description": "The response must discuss that biomarker reliability varies between individuals with cancer and are not always interpretable, including a specific example of variability.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response provides a clear example: CA 19-9 can be elevated in benign conditions and 5\u201310% of people do not produce CA 19-9 even with pancreatic cancer, demonstrating variability and interpretive limits."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that biomarkers can have false positives and false negatives.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although examples consistent with false positives and false negatives are given for CA 19-9, the response does not explicitly use the terms 'false positive' and 'false negative.'"
      },
      {
        "criterion_number": 11,
        "description": "The response should state that BRCA and HRD genes are key biomarkers as they can predict response to platinum chemotherapy and PARP inhibitors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response clearly states that BRCA1/2 and other HRR genes predict sensitivity to platinum chemotherapy and PARP inhibitors, for both somatic and germline settings."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that MSI/MMR is an important biomarker as it can identify the small percentage of patients that may respond to immunotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response notes that MSI-H/dMMR occurs in ~1\u20132% of pancreatic cancers and identifies patients who may respond to checkpoint inhibitors like pembrolizumab."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that testing can be done on a blood sample or from tumor tissue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly mentions tumor tissue biopsy (NGS), liquid biopsy (ctDNA blood test), and germline testing via blood or saliva."
      }
    ],
    "question_number": 181,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:34:50.305297",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must describe at least two management strategies for osteopenia and osteoporosis, such as bisphosphonates, denosumab, calcium, or vitamin D.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly recommends bisphosphonates (zoledronic acid), denosumab, and calcium/vitamin D supplementation as management strategies."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly describe at least two types of bone and bone density problems that can arise during cancer treatment, such as osteopenia, osteoporosis, or bone metastases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly describes bone metastases and treatment-related bone loss (osteoporosis-like), including mechanisms (steroids, chemotherapy, malabsorption)."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly mention bone metastases and at least two treatment options, such as systemic therapy, observation, radiation, or surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions bone metastases and includes multiple treatment options: palliative radiation therapy and surgical stabilization for fractures; also discusses bone-modifying agents."
      },
      {
        "criterion_number": 4,
        "description": "The response must state that bone metastases can be painful and/or asymptomatic.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that pain from bone metastases can be significant and discusses pain control approaches."
      },
      {
        "criterion_number": 5,
        "description": "The response must mention the frequency or rarity of pancreatic cancer metastasizing to the bone.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address how common or rare bone metastases are specifically in pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response must define or describe osteopenia and osteoporosis.",
        "score_given": 0,
        "max_points": 3,
        "justification": "References a condition \"similar to osteoporosis\" but does not define osteopenia or osteoporosis."
      },
      {
        "criterion_number": 7,
        "description": "The response must identify at least one risk factor for osteopenia and osteoporosis and explain how these conditions are tested, such as with a DEXA scan.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Lists risk factors (steroids, chemotherapy effects, malabsorption) but does not mention testing methods like DEXA scan."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention granulocyte colony stimulating factor and its potential side effect of temporary bone pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of granulocyte colony stimulating factor (G-CSF) or its bone pain side effect."
      },
      {
        "criterion_number": 9,
        "description": "The response must emphasize that pain related to cancer or cancer-treatment is taken seriously and should be discussed with the patient\u2019s oncology team.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Emphasizes significant pain from bone metastases, outlines pain management, and advises contacting the oncology team for urgent symptoms; also notes the oncology team will tailor management and encourages bringing questions to appointments."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention that palliative medicine is a specialty for managing symptoms related to medical diagnoses and treatments, and that the patient can request a referral to this specialty if available.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly identifies palliative care as a resource for pain and symptom management and suggests requesting a referral."
      }
    ],
    "question_number": 182,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:35:27.978156",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must describe at least two management strategies for osteopenia and osteoporosis, such as bisphosphonates, denosumab, calcium, or vitamin D.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly recommends bisphosphonates (zoledronic acid), denosumab, and calcium/vitamin D supplementation for bone health."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly describe at least two types of bone and bone density problems that can arise during cancer treatment, such as osteopenia, osteoporosis, or bone metastases.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists and describes bone metastases, osteoporosis/osteopenia, pathologic fractures, hypercalcemia of malignancy, and bone pain."
      },
      {
        "criterion_number": 3,
        "description": "The response must explicitly mention bone metastases and at least two treatment options, such as systemic therapy, observation, radiation, or surgery.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions bone metastases and provides multiple treatments: palliative/prophylactic radiation, orthopedic surgery/stabilization, and systemic therapy (chemotherapy/targeted therapy)."
      },
      {
        "criterion_number": 4,
        "description": "The response must state that bone metastases can be painful and/or asymptomatic.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States bone metastases can cause pain, weakness, and fractures; clearly indicates they can be painful."
      },
      {
        "criterion_number": 5,
        "description": "The response must mention the frequency or rarity of pancreatic cancer metastasizing to the bone.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention how common or rare bone metastases are in pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response must define or describe osteopenia and osteoporosis.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes osteoporosis/osteopenia in the context of bone density loss with contributing factors (e.g., steroid-induced), which constitutes a description."
      },
      {
        "criterion_number": 7,
        "description": "The response must identify at least one risk factor for osteopenia and osteoporosis and explain how these conditions are tested, such as with a DEXA scan.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies risk factors (long-term steroids, nutritional deficiencies, reduced mobility) and mentions DEXA scans for assessment."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention granulocyte colony stimulating factor and its potential side effect of temporary bone pain.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of G-CSF or its side effect of transient bone pain."
      },
      {
        "criterion_number": 9,
        "description": "The response must emphasize that pain related to cancer or cancer-treatment is taken seriously and should be discussed with the patient\u2019s oncology team.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Encourages immediate reporting of new or worsening pain and engaging the medical team; underscores importance of pain management."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention that palliative medicine is a specialty for managing symptoms related to medical diagnoses and treatments, and that the patient can request a referral to this specialty if available.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Identifies palliative care as a symptom-management specialty and advises advocating for palliative care involvement, implying a referral can be requested."
      }
    ],
    "question_number": 182,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:35:56.962503",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define epigenetics.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines epigenetics as regulation of gene on/off states without changing DNA sequence, using the cookbook/sticky note analogy."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how epigenetic changes can happen in normal cells, including gene silencing, activation, and DNA methylation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains DNA methylation leading to silencing and histone modification affecting activation; describes gene silencing and activation mechanisms broadly before applying to cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how epigenetic changes impact the cell\u2019s function.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links epigenetic changes to altered cell behavior: unchecked division, drug resistance, mobility/invasion, and gene expression changes affecting cellular functions."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role of epigenetic changes in cancer cells.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Details cancer-specific roles: silencing tumor suppressors (e.g., p16, SMAD4), activating oncogenes, promoting metastasis, and enabling chemoresistance."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that epigenetic changes can lead to inactivation of silencing tumor-suppressor genes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states DNA methylation silences tumor suppressor genes and provides pancreatic examples (p16, SMAD4)."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that epigenetic changes can lead to activation of oncogenes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States oncogenes can be turned on by epigenetic changes (e.g., histone modification/unspooling), leading to persistent activation."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that epigenetic changes can contribute to changes in the behavior of the tumor, such as increased propensity to spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes epigenetic programming of genes that enable detachment, motility, invasion, and metastasis to organs like the liver/lungs."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that epigenetic changes can impact treatment response.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains chemoresistance via epigenetic upregulation of drug efflux and DNA repair genes and adaptation under treatment pressure."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that targeting epigenetic changes in pancreatic cancer is an experimental topic that is being actively researched.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Notes active research/clinical trials of DNMT and HDAC inhibitors, and development of diagnostic tools like liquid biopsies for epigenetic patterns."
      }
    ],
    "question_number": 183,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:36:19.524800",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define epigenetics.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines epigenetics as changes that affect gene expression without altering the DNA sequence, using an accurate analogy and explicitly contrasting genetics vs epigenetics."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how epigenetic changes can happen in normal cells, including gene silencing, activation, and DNA methylation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains DNA methylation, histone modifications, and microRNAs; describes normal function (silencing via promoter methylation, activation via histone acetylation) and how these regulate gene expression in normal cells."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how epigenetic changes impact the cell\u2019s function.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes how epigenetic marks alter gene accessibility and protein production, impacting cellular proliferation, differentiation, and gene on/off states."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role of epigenetic changes in cancer cells.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Details roles in pancreatic cancer specifically, including early events in tumorigenesis, silencing tumor suppressors, activating oncogenic pathways, and effects on microenvironment."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that epigenetic changes can lead to inactivation of silencing tumor-suppressor genes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states promoter hypermethylation silences tumor suppressor genes (e.g., p16/CDKN2A) and explains the functional consequence."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that epigenetic changes can lead to activation of oncogenes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States global hypomethylation can activate oncogenes and histone alterations can loosen chromatin to activate oncogenic programs."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that epigenetic changes can contribute to changes in the behavior of the tumor, such as increased propensity to spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes promotion of invasion and metastasis, including EMT, linking epigenetic alterations to increased spread."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that epigenetic changes can impact treatment response.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit section on therapy resistance explains how epigenetic changes confer resistance to chemo, targeted therapy, and immunotherapy."
      },
      {
        "criterion_number": 10,
        "description": "The response should mention that targeting epigenetic changes in pancreatic cancer is an experimental topic that is being actively researched.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Notes that epigenetic drugs (DNMTi, HDACi, others) are being investigated in pancreatic cancer, often in combinations, and references clinical trials/research activity."
      }
    ],
    "question_number": 183,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:36:40.256025",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend agencies that are accredited and have a good reputation.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Advises ensuring the agency is state-licensed and Medicare/Medicaid certified, using Medicare's Home Health Compare, and seeking trusted referrals from oncology/discharge planners\u2014addressing credentialing/quality and reputation."
      },
      {
        "criterion_number": 2,
        "description": "Recommend agencies that provide a broad range of services for evolving needs.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Emphasizes a multidisciplinary team (skilled nursing, dietitian, PT, OT, HHA/CNA, social worker) and notes individualized care plans that are updated as needs change."
      },
      {
        "criterion_number": 3,
        "description": "Recommend inquiring with oncology team about social work support to find covered home health care.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not explicitly instruct asking the oncology team about social work support to secure home health care covered by insurance; only mentions social worker roles generally and to ask oncologist for referrals."
      },
      {
        "criterion_number": 4,
        "description": "State there is a broad range of in-home care and advise considering which tasks need assistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly presents multiple in-home care types and discusses specific assistive tasks (bathing, dressing, grooming, meal prep) alongside individualized planning, guiding families to consider their needs."
      },
      {
        "criterion_number": 5,
        "description": "Summarize common assistance like cooking, cleaning, home upkeep, shopping.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions light meal preparation and cooking assistance via OT, but does not address cleaning, general home upkeep, or shopping."
      },
      {
        "criterion_number": 6,
        "description": "Provide links to websites where patients can learn more.",
        "score_given": 0,
        "max_points": 5,
        "justification": "References Medicare\u2019s Home Health Compare tool but does not provide any URLs or direct links."
      },
      {
        "criterion_number": 7,
        "description": "Mention hospice as in-home care for prognosis of 6 months or less.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly explains hospice, including typical eligibility (six months or less) and that most hospice care is provided at home."
      },
      {
        "criterion_number": 8,
        "description": "Mention skilled nursing and in-home therapies (PT/OT).",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly lists skilled nursing, physical therapy, and occupational therapy as home health services."
      },
      {
        "criterion_number": 9,
        "description": "State to seek agencies with oncology experience and oncology-trained staff.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically advises asking about experience with pancreatic cancer and whether the agency has a specialized oncology or palliative care team."
      }
    ],
    "question_number": 184,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:37:18.575061",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend that patients consider care agencies that are accredited and have a good reputation.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Explicitly advises checking state licensure, Medicare/Medicaid certification, accreditation (Joint Commission, CHAP, ACHC), reputation, references, and years in business."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend that patients consider care agencies that provide a broad range of services, as the patient may have evolving needs as their treatment progresses.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Details a wide array of services (skilled nursing, PT/OT/SLP, personal care, social work, dietitian, palliative integration) and emphasizes flexibility as needs evolve."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient inquire with his oncology team if there is social work support available to assist in seeking home health care that is covered by the patient\u2019s insurance carrier.",
        "score_given": 0,
        "max_points": 8,
        "justification": "It recommends asking the oncologist/cancer team for agency recommendations and discusses agency social workers and insurance paperwork, but does not explicitly advise asking the oncology team about social work support to help secure insurance-covered home health services."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that there is a broad range of types of in-home care and that the patient and family should consider what tasks they need assistance with.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly lays out multiple in-home care types (skilled nursing, therapies, aides, social work, dietitians) and addresses tailoring an individualized care plan to specific needs and ADLs, implying consideration of needed tasks."
      },
      {
        "criterion_number": 5,
        "description": "The response should summarize common types of assistance that cancer patients benefit from such as cooking, cleaning, general home upkeep, shopping.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes personal care assistance, light meal preparation (cooking), and light housekeeping (cleaning). Although shopping is not named, the response summarizes common ADL/IADL support sufficiently."
      },
      {
        "criterion_number": 6,
        "description": "The response should provide links to websites where patients can learn more about the types of care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No web links or specific website references are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should mention Hospice as a service that provides care in the home for patients with a prognosis of 6 months or less.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Hospice is mentioned and transition discussed, but the specific criterion of a prognosis of approximately 6 months or less is not stated."
      },
      {
        "criterion_number": 8,
        "description": "The response must mention that home health services include skilled nursing care and in-home therapies, such as physical and occupational therapy.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly lists skilled nursing and therapies including physical and occupational therapy."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state that they should seek agencies with experience in caring for cancer patients, specifically mentioning oncology-trained staff.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Directly advises looking for specialization in oncology/palliative care and experience with pancreatic cancer patients."
      }
    ],
    "question_number": 184,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:37:50.291722",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define angiogenesis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines angiogenesis as the process of forming new blood vessels, with context about normal physiology and how tumors hijack it."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the role of angiogenesis in solid tumors.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains that tumors need new blood vessels to grow beyond a small size and to metastasize, and describes VEGF-driven vessel formation."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the role of angiogenesis in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Details pancreatic cancer\u2019s hypovascularity, dense desmoplastic stroma, vessel compression, leakiness, high interstitial pressure, and the resulting drug delivery challenges."
      },
      {
        "criterion_number": 4,
        "description": "The response should discuss how angiogenesis is a target for cancer treatment in some cancers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Discusses anti-angiogenic therapy (e.g., bevacizumab targeting VEGF) and the therapeutic concept of blocking or normalizing tumor vasculature."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that anti-angiogenesis drugs are not used routinely in pancreatic cancer as they have not been shown to significantly improve outcomes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly notes that anti-angiogenic drugs in pancreatic cancer have been disappointing, did not significantly improve survival, and are mainly used in clinical trials rather than routinely."
      },
      {
        "criterion_number": 6,
        "description": "The response should link to randomized control trials studying the effect of anti-angiogenic therapies in pancreatic cancer, with summaries.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No links or specific randomized trial summaries are provided; only general statements about disappointing results."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient discuss treatment options with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages discussion with the oncology team, provides specific questions to ask, and includes a clear advisory to consult clinicians."
      }
    ],
    "question_number": 185,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:38:06.356588",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define angiogenesis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines angiogenesis as the process by which new blood vessels are formed from existing ones, which is accurate and succinct."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the role of angiogenesis in solid tumors.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explains that tumors require angiogenesis to grow beyond 1\u20132 mm and to facilitate metastasis, and describes tumor-driven pro-angiogenic signaling and abnormal vessel formation, fulfilling the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the role of angiogenesis in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It addresses pancreatic cancer\u2013specific features, including dense desmoplastic stroma, hypoxia driving pro-angiogenic factors (VEGF, bFGF, PDGF), abnormal vasculature, and implications for drug delivery and metastasis."
      },
      {
        "criterion_number": 4,
        "description": "The response should discuss how angiogenesis is a target for cancer treatment in some cancers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response describes anti-angiogenic therapies, their goals (starvation, reduced metastasis, vessel normalization), and mechanisms (VEGF/VEGFR inhibitors, multi-kinase inhibitors), meeting the requirement."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that anti-angiogenesis drugs are not used routinely in pancreatic cancer as they have not been shown to significantly improve outcomes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it notes limited efficacy and lack of dramatic improvements, it does not explicitly state that anti-angiogenic drugs are not used routinely in pancreatic cancer due to lack of significant outcome improvement."
      },
      {
        "criterion_number": 6,
        "description": "The response should link to randomized control trials studying the effect of anti-angiogenic therapies in pancreatic cancer, with summaries.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No randomized controlled trials are cited or linked, and no trial-specific summaries are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient discuss treatment options with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises having a detailed conversation with the oncology team about whether angiogenesis inhibitors are appropriate and mentions considering clinical trials."
      }
    ],
    "question_number": 185,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:38:22.384289",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that liver function is routinely monitored during treatment using labs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly describes regular LFT monitoring before each treatment cycle and details specific lab markers (ALT, AST, bilirubin, ALP, albumin)."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe ways in which pancreatic cancer and pancreatic cancer treatment can affect the liver.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains chemotherapy-induced hepatotoxicity, bile duct obstruction from pancreatic head tumors, and liver metastases as mechanisms affecting the liver."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that changes in liver function labs will often be investigated further with imaging studies.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Includes imaging (CT/MRI/ultrasound) as part of monitoring to assess liver and bile ducts and to evaluate for metastases or ductal dilation, indicating further investigation beyond labs."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe ways in which liver injury can be treated, such as dose reduction in systemic treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Outlines treatment delay, dose reduction, and changing chemotherapy regimens to mitigate hepatotoxicity."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe ways in which liver injury can be treated, such as local therapy to tumors in the liver.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention local liver-directed therapies (e.g., ablation, embolization, radiation) for hepatic metastases."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe ways in which liver injury can be treated, such as biliary stenting.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes ERCP with biliary stent placement to relieve obstruction and improve liver function and jaundice."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe ways in which liver injury can be treated, such as elimination of offending medications or supplements.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends thorough medication review, notes many OTC/herbal agents can be hepatotoxic, and advises against starting new meds/supplements without oncology approval."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe ways in which liver injury can be treated, such as treatment of infection.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention evaluation or treatment of infections (e.g., cholangitis) as a cause of liver dysfunction."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that in rare cases, biopsy of liver tissue is needed to understand the cause of liver injury.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No reference to liver biopsy for diagnostic clarification."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that many different medications and supplements can cause liver toxicity, and the patient should discuss all medications and supplements they take while undergoing cancer treatment to ensure no interactions.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Emphasizes that many meds and supplements are hard on the liver and advises discussing all with the oncology team before use."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe red flag symptoms for liver injury.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists jaundice, ascites, RUQ tenderness, pruritus, dark urine, pale stools, fatigue, nausea, and confusion as symptoms to watch for."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend the patient discuss any new or worrisome symptoms with a member of their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly instructs to report any new or worsening symptoms to the medical team immediately."
      },
      {
        "criterion_number": 13,
        "description": "The response should emphasize the importance of exercise, nutrition, and sleep in mitigating treatment-related toxicities and side effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions nutrition support/dietitian but does not address exercise or sleep."
      }
    ],
    "question_number": 186,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:38:50.097928",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that liver function is routinely monitored during treatment using labs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly states that LFTs are the cornerstone of monitoring and are typically done before each chemotherapy cycle, and more frequently if concerns arise."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe ways in which pancreatic cancer and pancreatic cancer treatment can affect the liver.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It enumerates multiple causes: liver metastases, bile duct obstruction, chemotherapy hepatotoxicity, targeted/immunotherapy effects, supportive medications, and TPN-related issues."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that changes in liver function labs will often be investigated further with imaging studies.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly links abnormal LFTs to imaging workup, noting ultrasound is often first when LFTs are abnormal and also mentions CT/MRI, MRCP, and ERCP."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe ways in which liver injury can be treated, such as dose reduction in systemic treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Management includes chemotherapy dose reduction, temporary holds, and switching to different agents, which directly addresses systemic treatment modification."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe ways in which liver injury can be treated, such as local therapy to tumors in the liver.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions palliative radiation and liver-directed therapies (embolization or ablation) for liver metastases."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe ways in which liver injury can be treated, such as biliary stenting.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Biliary stenting by ERCP and PTC drainage are described for bile duct obstruction."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe ways in which liver injury can be treated, such as elimination of offending medications or supplements.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends holding or changing hepatotoxic chemotherapy and emphasizes reviewing all medications and supplements due to potential liver toxicity, implying removal of offending agents."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe ways in which liver injury can be treated, such as treatment of infection.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that infections such as cholangitis should be treated with antibiotics."
      },
      {
        "criterion_number": 9,
        "description": "The response should include that in rare cases, biopsy of liver tissue is needed to understand the cause of liver injury.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Liver biopsy as a diagnostic step is not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that many different medications and supplements can cause liver toxicity, and the patient should discuss all medications and supplements they take while undergoing cancer treatment to ensure no interactions.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly states supportive medications and supplements can affect liver function and advises understanding and discussing all medications, including OTC and supplements, with the team."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe red flag symptoms for liver injury.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It lists jaundice, dark urine, pale stools, pruritus, RUQ pain, ascites/edema, and confusion/encephalopathy, which are red flags."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend the patient discuss any new or worrisome symptoms with a member of their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends communicating openly and frequently with the medical team and keeping a symptom diary of new symptoms, implying discussion with the oncology team."
      },
      {
        "criterion_number": 13,
        "description": "The response should emphasize the importance of exercise, nutrition, and sleep in mitigating treatment-related toxicities and side effects.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Nutrition is addressed, but there is no mention of exercise or sleep."
      }
    ],
    "question_number": 186,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:39:26.635448",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should discuss what tumor dormancy is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines tumor dormancy as a state where cancer cells stop dividing or divide very slowly for long periods and uses analogies and explanations to describe it."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the implications of tumor cells that can enter dormancy, such as disease recurrence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly links dormancy to recurrence after surgery, explains that dormant cells can later 'wake up' and form new tumors, and discusses the challenge of clear scans."
      },
      {
        "criterion_number": 3,
        "description": "The response should outline that there is ongoing study on the subject of tumor dormancy, though it is not fully understood at this time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that what wakes dormant cells is not fully understood and details active research areas (detection via liquid biopsy, keeping cells asleep, and targeting dormant cells)."
      },
      {
        "criterion_number": 4,
        "description": "The response must mention that dormancy can occur due to microenvironmental factors such as changes in the tumor microenvironment, lack of nutrients, or the presence of certain immune cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions the tumor microenvironment, immune system surveillance, inflammation, and angiogenic dormancy (limited blood supply/nutrients) as drivers of dormancy and reactivation."
      },
      {
        "criterion_number": 5,
        "description": "The response must state that dormant cells are often less susceptible to chemotherapy than rapidly dividing cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states chemotherapy and radiation work best on dividing cells and that dormant cells can survive because they are not in a growth cycle."
      },
      {
        "criterion_number": 6,
        "description": "The response should reference evidence from the scientific literature that discusses tumor dormancy in pancreatic cancer, and only references with a PubMed identification number (PMID) should be included.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No scientific references or PMIDs are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should indicate whether or not it is possible to detect dormant cancer cells in the body in pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that dormant cells are essentially invisible to current imaging and mentions ongoing efforts like liquid biopsies to detect them, indicating present limitations in detection."
      }
    ],
    "question_number": 187,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:39:39.796518",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should discuss what tumor dormancy is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines tumor dormancy and explains it as a state where cancer cells are present but not actively growing. It further categorizes dormancy into cellular, angiogenic, and immunological forms, demonstrating a comprehensive discussion of what tumor dormancy is."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the implications of tumor cells that can enter dormancy, such as disease recurrence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly links dormancy to early micrometastasis, recurrence after treatment, and therapeutic resistance, directly addressing implications such as disease recurrence."
      },
      {
        "criterion_number": 3,
        "description": "The response should outline that there is ongoing study on the subject of tumor dormancy, though it is not fully understood at this time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response notes that dormancy is a major area of research, mentions strategies under investigation, and highlights current limitations in prediction and treatment, indicating ongoing study and incomplete understanding."
      },
      {
        "criterion_number": 4,
        "description": "The response must mention that dormancy can occur due to microenvironmental factors such as changes in the tumor microenvironment, lack of nutrients, or the presence of certain immune cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response cites microenvironmental influences including lack of growth factors, nutrients, oxygen, and inhibitory signals, as well as immune system effects, satisfying the requirement."
      },
      {
        "criterion_number": 5,
        "description": "The response must state that dormant cells are often less susceptible to chemotherapy than rapidly dividing cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that dormant cells are often resistant to chemotherapy and radiation because these treatments target rapidly dividing cells, directly fulfilling the criterion."
      },
      {
        "criterion_number": 6,
        "description": "The response should reference evidence from the scientific literature that discusses tumor dormancy in pancreatic cancer, and only references with a PubMed identification number (PMID) should be included.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No scientific references or PMIDs are provided in the response."
      },
      {
        "criterion_number": 7,
        "description": "The response should indicate whether or not it is possible to detect dormant cancer cells in the body in pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response states that dormant cells or micrometastases are extremely difficult to detect with standard imaging due to their small size and lack of active growth, appropriately addressing detectability."
      }
    ],
    "question_number": 187,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:39:55.834114",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe what an advance directive is and why people create them.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines advance directives as legal documents specifying end-of-life care wishes and explains the purpose: ensuring the person's voice is honored and guiding medical care to provide clarity and comfort."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend that the patient and family ask their oncology team if there are resources available to assist in the creation of advance directives, such as social work.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it recommends talking with the oncology and palliative care teams, it does not specifically advise asking about resources to assist with creating advance directives (e.g., social work)."
      },
      {
        "criterion_number": 3,
        "description": "The response should direct the patient to consider what medical treatments they would accept in the event of an emergency or if they became too sick to make decisions on their own, including wishes surrounding CPR, invasive medical procedures such as dialysis, artificial nutrition, and noninvasive medical treatments such as intravenous fluids or antibiotics. This is also referred to as a living will.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly discusses living wills and lists CPR, mechanical ventilation, dialysis, and artificial nutrition/hydration (including IV fluids). This satisfies the range of treatments to consider."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient elect a specific person to be their durable power of attorney for healthcare, or a person who would make medical decisions for them if they were too sick to make their own decisions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly advises naming a healthcare agent/proxy (medical power of attorney), explains the role, and suggests choosing someone who knows the patient's values."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the patient should also complete a POLST, or a physician order for life-sustaining treatment, with their oncologist or other health practitioner, and should have this in their home in an easy-to-see location.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of POLST or the recommendation to complete it with a clinician and keep it visible at home."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that the advance directives should include a DNR order if desired.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a dedicated section on DNR/DNI, explains what they are, and connects them to wishes expressed in the living will."
      },
      {
        "criterion_number": 7,
        "description": "The response should encourage patients to complete advance directives as soon as possible, even if their cancer is in remission or cured.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly encourage completing advance directives as soon as possible or regardless of remission/cure status."
      },
      {
        "criterion_number": 8,
        "description": "The response should explain the logistics of completing an advance directive and recommend that the patient turn in a completed copy of the form to their oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains logistics (state-specific forms, witnessing/notarization, distribution) and advises giving copies to the oncologist and hospital."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize to patients with pancreatic cancer the importance of future planning, as this disease is difficult to cure and can be aggressive.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it acknowledges pancreatic cancer as a serious illness, it does not explicitly emphasize future planning due to its aggressive and hard-to-cure nature."
      }
    ],
    "question_number": 188,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:40:30.593500",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe what an advance directive is and why people create them.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines advance directives as legal documents for making medical decisions in advance if unable to communicate, and explains the purpose: honoring wishes and alleviating burden on family."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend that the patient and family ask their oncology team if there are resources available to assist in the creation of advance directives, such as social work.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises discussing with the healthcare team (oncologist and palliative care) and specifically mentions checking with the hospital's social work department for forms/resources."
      },
      {
        "criterion_number": 3,
        "description": "The response should direct the patient to consider what medical treatments they would accept in the event of an emergency or if they became too sick to make decisions on their own, including wishes surrounding CPR, invasive medical procedures such as dialysis, artificial nutrition, and noninvasive medical treatments such as intravenous fluids or antibiotics. This is also referred to as a living will.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a comprehensive Living Will section that explicitly covers CPR, mechanical ventilation, artificial nutrition/hydration (including IV fluids), dialysis, blood transfusions, and antibiotics."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient elect a specific person to be their durable power of attorney for healthcare, or a person who would make medical decisions for them if they were too sick to make their own decisions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Includes a detailed Healthcare Power of Attorney section: choosing an agent, naming a backup, scope of authority, and communication of wishes."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that the patient should also complete a POLST, or a physician order for life-sustaining treatment, with their oncologist or other health practitioner, and should have this in their home in an easy-to-see location.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains POLST/MOLST as physician orders, highlights its portability, and explicitly notes it is often kept in a prominent place at home (e.g., refrigerator). Although it does not literally say \u201cwith oncologist,\u201d indicating it is a physician order implies clinician completion."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that the patient should also complete a DNR order if desired.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a dedicated DNR section explaining its purpose, that it may require a separate physician-signed form, and emphasizes accessibility to providers."
      },
      {
        "criterion_number": 7,
        "description": "The response should encourage patients to complete advance directives as soon as possible, even if their cancer is in remission or cured.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages discussion while the patient can still communicate but does not explicitly state completing directives as soon as possible, including in remission/cured scenarios."
      },
      {
        "criterion_number": 8,
        "description": "The response should explain the logistics of completing an advance directive and recommend that the patient turn in a completed copy of the form to their oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Outlines practical steps: obtaining state-specific forms, completing, witnessing/notarizing, and distributing copies. Specifically recommends providing copies to the oncologist and other clinicians and uploading to portals."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize to patients with pancreatic cancer the importance of future planning, as this disease is difficult to cure and can be aggressive.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses pancreatic cancer specifically by noting potential for rapid decline/acute crises and underscores the value of POLST/living will to align care promptly, effectively emphasizing future planning."
      }
    ],
    "question_number": 188,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:41:04.538630",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define what targeted therapy is in oncologic treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines targeted therapy as drugs that attack specific molecular features (biomarkers/genetic mutations) of cancer cells, contrasting it with traditional chemotherapy."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain what combination targeted therapy is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that combination therapy uses multiple agents to increase effectiveness, overcome resistance, and target different pathways; notes combinations can include two targeted drugs or targeted therapy with chemo/immunotherapy."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe what kinds of targeted therapy options exist in pancreatic cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists specific options relevant to pancreatic cancer: PARP inhibitors for BRCA1/2, KRAS G12C inhibitors (sotorasib/adagrasib) as an emerging option, NTRK fusion inhibitors (larotrectinib/entrectinib), and MSI-H/dMMR immunotherapy (pembrolizumab)."
      },
      {
        "criterion_number": 4,
        "description": "The response should illustrate why more than one targeted medication might be used at the same time to treat cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states reasons for combining therapies: increased effectiveness, overcoming resistance, and targeting multiple pathways."
      },
      {
        "criterion_number": 5,
        "description": "The response should explain why the patient\u2019s tumor tissue needs to undergo molecular testing to understand what targeted therapies are indicated.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes biomarker testing/molecular profiling as the critical first step to identify actionable targets, explaining how results guide therapy selection."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain that some targeted therapies may not work on the patient\u2019s tumor due to lack of targetable mutations.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that targeted therapy requires finding a target; implies that without a target, targeted therapy is not an option and notes some targets (e.g., KRAS G12C) are rare."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain that targeted therapies do not always work in pancreatic cancer due to tumor heterogeneity.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention tumor heterogeneity as a reason for variable response; discusses resistance in general but not heterogeneity explicitly."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe that targeted therapies are sometimes used at the same time as traditional chemotherapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States combinations may include a targeted drug with chemotherapy or immunotherapy."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient discuss this further with their oncologist as targeted therapies are individualized to each patient\u2019s cancer, and not all targeted therapies are treatment options for all patients with pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Repeatedly advises discussion with the oncology team, emphasizes individualized treatment, and provides specific questions to ask."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention KRAS inhibitors as a current area of research in pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions KRAS G12C inhibitors (sotorasib, adagrasib) and frames them as a major area of research with clinical trials."
      },
      {
        "criterion_number": 11,
        "description": "The response must mention PARP inhibitors are used in pancreatic cancer patients with BRCA1/2 mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes PARP inhibitors (e.g., olaparib) for BRCA1/2-mutated pancreatic cancer, often as maintenance after platinum response."
      }
    ],
    "question_number": 189,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:41:35.373278",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define what targeted therapy is in oncologic treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines targeted therapy as treatments aimed at specific genes/proteins driving cancer growth, contrasts with chemotherapy, and lists mechanisms (blocking growth signals, anti-angiogenesis, delivering toxins, immune activation)."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain what combination targeted therapy is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains combinations as two targeted drugs together, targeted plus chemotherapy, or targeted plus immunotherapy, and provides rationale (efficacy, resistance prevention)."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe what kinds of targeted therapy options exist in pancreatic cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details multiple options and biomarkers: PARP inhibitors for BRCA1/2, TRK inhibitors for NTRK fusions, pembrolizumab for MSI-H/dMMR, KRAS G12C inhibitors (sotorasib, adagrasib), and mentions rarer targets (EGFR, HER2, FGFR)."
      },
      {
        "criterion_number": 4,
        "description": "The response should illustrate why more than one targeted medication might be used at the same time to treat cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States multiple reasons: attack multiple pathways, overcome/prevent resistance, enhance potency; provides clear rationale."
      },
      {
        "criterion_number": 5,
        "description": "The response should explain why the patient\u2019s tumor tissue needs to undergo molecular testing to understand what targeted therapies are indicated.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes comprehensive molecular profiling as the first step to identify mutations/biomarkers that guide therapy selection."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain that some targeted therapies may not work on the patient\u2019s tumor due to lack of targetable mutations.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes pancreatic cancer often lacks common druggable targets and that only a subset of patients benefit, implying therapies may not work without targets."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain that targeted therapies do not always work in pancreatic cancer due to tumor heterogeneity.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not explicitly attribute limited efficacy to tumor heterogeneity; discusses resistance and lack of targets but not heterogeneity as a reason."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe that targeted therapies are sometimes used at the same time as traditional chemotherapies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly lists targeted drug plus chemotherapy as a common combination and reiterates this under treatment regimen."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient discuss this further with their oncologist as targeted therapies are individualized to each patient\u2019s cancer, and not all targeted therapies are treatment options for all patients with pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages discussion with the oncology team, provides specific questions, and emphasizes individualized treatment based on molecular profiling."
      },
      {
        "criterion_number": 10,
        "description": "The response must mention KRAS inhibitors as a current area of research in pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions KRAS G12C inhibitors (sotorasib, adagrasib) and notes ongoing investigation/early use in pancreatic cancer."
      },
      {
        "criterion_number": 11,
        "description": "The response must mention PARP inhibitors are used in pancreatic cancer patients with BRCA1/2 mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states PARP inhibitors (e.g., olaparib) are used for BRCA1/2-mutated pancreatic cancer, including maintenance after platinum chemotherapy."
      }
    ],
    "question_number": 189,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:42:00.527013",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define metastasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains that cancer cells break away from the primary tumor, travel through the body, and form new tumors at distant sites, which effectively defines metastasis."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain how cancer metastasizes, such as hematologic spread and lymphatic spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly describes direct extension, lymphatic spread, and hematogenous (bloodstream) spread."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how pancreatic cancer metastasizes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It connects pancreatic anatomy and venous drainage to liver metastasis via the portal vein and discusses peritoneal seeding, matching pancreatic cancer\u2013specific pathways."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly state that pancreatic cancer typically spreads locally first, involving surrounding lymph nodes, organs, and blood vessels.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While local invasion and lymphatic spread are mentioned, it does not explicitly state that spread is typically local first."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that metastatic spread of the pancreatic cancer can be influenced by the location of the primary tumor, e.g., head vs tail.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention is made of differences in spread patterns based on tumor location within the pancreas (head vs tail)."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly state that the liver is usually the first location for metastases.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It states the liver is the most common site and explains portal flow, but does not explicitly state it is usually the first site of metastasis."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly state that pancreatic cancer can metastasize to the peritoneum or lining of the abdominal cavity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly names the peritoneum (lining of the abdomen) and describes peritoneal carcinomatosis."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state that pancreatic cancer can spread to the lungs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly lists the lungs as a common metastatic site and provides rationale and symptoms."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that pancreatic cancer can spread to at least one of: bones, brain, or adrenal gland.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly lists bones and brain as less common metastatic sites."
      },
      {
        "criterion_number": 11,
        "description": "The response should explain what proportion of pancreatic cancers are metastatic at diagnosis and why.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No proportions or prevalence of metastatic disease at diagnosis are provided."
      },
      {
        "criterion_number": 12,
        "description": "The response should discuss that pancreatic cancer commonly has already metastasized at the time of diagnosis because it is often asymptomatic early and only becomes symptomatic later.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not discuss asymptomatic early disease leading to late, metastatic presentation."
      },
      {
        "criterion_number": 13,
        "description": "The response should state that treatment options exist for all stages of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While treatments for stage IV are described, it does not explicitly state that options exist for all stages."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that options for treatment modalities, e.g., surgery or chemotherapy, depend on the stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It links stage IV disease with systemic therapy and different goals, indicating that treatment depends on stage."
      }
    ],
    "question_number": 190,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:42:40.306728",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define metastasis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response uses the term metastasis and describes sites of spread but does not explicitly define metastasis (e.g., spread of cancer cells from the primary site to distant organs)."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain how cancer metastasizes, such as hematologic spread and lymphatic spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mechanisms are described: hematogenous spread via the portal venous system to the liver, lymphatic or bloodstream spread to the lungs, and transcoelomic seeding to the peritoneum."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how pancreatic cancer metastasizes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It details pancreatic cancer\u2019s spread via portal venous drainage to the liver, peritoneal seeding, and early involvement of regional lymph nodes."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly state that pancreatic cancer typically spreads locally first, involving surrounding lymph nodes, organs, and blood vessels.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it notes regional lymph nodes are often involved early, it does not explicitly state that local spread occurs first or mention involvement of adjacent organs and blood vessels as an initial pattern."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that metastatic spread of the pancreatic cancer can be influenced by the location of the primary tumor, for example whether it is located at the pancreatic head or the tail.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of differences in metastatic patterns based on tumor location in the head versus tail of the pancreas."
      },
      {
        "criterion_number": 7,
        "description": "The response must explicitly state that the liver is usually the first location for metastases.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It states the liver is the most common site and explains portal drainage, but does not explicitly state it is usually the first site of metastasis."
      },
      {
        "criterion_number": 8,
        "description": "The response must explicitly state that pancreatic cancer can metastasize to the peritoneum or lining of the abdominal cavity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions peritoneal spread, peritoneal carcinomatosis, and associated symptoms such as ascites."
      },
      {
        "criterion_number": 9,
        "description": "The response must explicitly state that pancreatic cancer can spread to the lungs.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states that the lungs are frequently affected via bloodstream or lymphatic spread."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that pancreatic cancer can spread to at least one of the following less common sites: bones, brain, or adrenal gland.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions bones, adrenal glands, and brain as less common metastatic sites."
      },
      {
        "criterion_number": 11,
        "description": "The response should explain what proportion of pancreatic cancers are metastatic at diagnosis and why.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No proportion or statistics provided regarding the percentage metastatic at diagnosis, nor an explicit explanation tied to those proportions."
      },
      {
        "criterion_number": 12,
        "description": "The response should discuss that pancreatic cancer commonly has already metastasized at the time of diagnosis because it often is asymptomatic at an early stage and only becomes symptomatic, prompting diagnostic investigation, once it has spread beyond its original site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss the typical late presentation due to early asymptomatic disease leading to metastasis at diagnosis."
      },
      {
        "criterion_number": 13,
        "description": "The response should state that treatment options exist for all stages of pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although treatment strategies are mentioned, it does not explicitly state that options exist for all stages."
      },
      {
        "criterion_number": 14,
        "description": "The response should state that options for treatment modalities, for example surgery or chemotherapy, depend on the stage of the cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states that stage profoundly influences treatment options and that spread guides treatment decisions."
      }
    ],
    "question_number": 190,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:43:25.277222",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe how pancreatic cancer chemotherapy treatment can cause injury to the kidneys.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Clearly explains chemotherapy-related nephrotoxicity, including examples (cisplatin, gemcitabine) causing kidney injury."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly mention that platinum drugs (e.g., cisplatin, oxaliplatin) can directly injure the kidney.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explicitly states platinum drugs like cisplatin can be directly toxic to kidneys."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how other pancreatic cancer treatments, such as surgery or radiation, can cause injury to the kidneys.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address kidney injury from surgery or radiation."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that urinary tract infection should be ruled out, as some cancer treatments can put patients at increased risk for infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of ruling out urinary tract infection."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe that patients undergoing systemic treatment for pancreatic cancer should have their kidney function monitored frequently to evaluate for toxicity.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends regular monitoring with blood tests (creatinine, BUN, eGFR, electrolytes) and urine tests."
      },
      {
        "criterion_number": 7,
        "description": "The response must clearly state that the first step is to identify the offending agent and reduce or hold the drug.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States first step is identification of the problem; then specifies dose reduction, delaying treatment, or changing drugs if a culprit is identified."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is monitored and managed, such as serial lab tests of renal function to understand if it is improving over time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes serial labs, urine testing, urine output monitoring, and imaging to track and manage renal toxicity."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is managed, such as dose reduction of systemic treatment, particularly the offending drugs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Outlines dose reduction, treatment delay, and switching regimens when a specific drug is implicated."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is managed, such as administration of intravenous fluids or other medications to support the kidneys.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends IV fluids for hydration and mentions diuretics and electrolyte correction as supportive measures."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly mention that IV fluids can be used to provide hydration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states intravenous (IV) fluids are given to provide hydration and support kidney function."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is managed, such as thorough evaluation of other medications or supplements a patient is taking to ensure there are no harmful interactions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises reviewing all medications and supplements; stopping nephrotoxic agents (e.g., NSAIDs) to avoid harm."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly mention that alleviating obstruction (e.g., via stenting or nephrostomy) can help recover renal function.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifies ureteral stent placement to relieve obstruction and notes it can rapidly improve kidney function."
      },
      {
        "criterion_number": 14,
        "description": "The response must explicitly state that dehydration and obstruction (e.g., biliary or urinary) can lead to kidney injury.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly identifies dehydration and urinary obstruction as causes of kidney injury."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient consult with their oncology team and oncology pharmacist prior to starting new medications or supplements while undergoing pancreatic cancer treatment to avoid harmful interactions.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not specifically recommend consulting the oncology team and oncology pharmacist before starting new medications or supplements."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that sometimes dialysis may be indicated if there is a severe kidney injury related to cancer treatment.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Mentions dialysis may be necessary as a temporary measure in severe acute kidney injury."
      },
      {
        "criterion_number": 17,
        "description": "The response should recommend staying well hydrated and with adequate nutrition intake while undergoing pancreatic cancer treatment to preserve energy and organ functions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages hydration but does not explicitly recommend adequate nutrition intake."
      }
    ],
    "question_number": 191,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:44:01.540638",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe how pancreatic cancer chemotherapy treatment can cause injury to the kidneys.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explains chemotherapy-induced nephrotoxicity, explicitly noting direct kidney toxicity and HUS from agents like gemcitabine."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly mention that platinum drugs (e.g., cisplatin, oxaliplatin) can directly injure the kidney.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explicitly names cisplatin and oxaliplatin as directly nephrotoxic."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how other pancreatic cancer treatments, such as surgery or radiation, can cause injury to the kidneys.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not discuss kidney injury related to surgery or radiation; focuses on drugs, dehydration, contrast, and other causes."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that urinary tract infection should be ruled out, as some cancer treatments can put patients at increased risk for infection.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While infections/sepsis are discussed and urinalysis for infection is mentioned, it does not explicitly state ruling out urinary tract infection."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe that patients undergoing systemic treatment for pancreatic cancer should have their kidney function monitored frequently to evaluate for toxicity.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends regular blood tests (creatinine, BUN, GFR) and urinalysis to monitor renal function."
      },
      {
        "criterion_number": 7,
        "description": "The response must clearly state that the first step is to identify the offending agent and reduce or hold the drug.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although it advises identifying the cause and adjusting chemotherapy, it does not clearly state that the first step is to identify the offending agent and reduce or hold the drug; it instead emphasizes IV hydration as the first step."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is monitored and managed, such as serial lab tests of renal function to understand if it is improving over time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It details serial monitoring with blood tests, urine tests, and imaging to track renal status."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is managed, such as dose reduction of systemic treatment, particularly the offending drugs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends chemotherapy dose modification, switching regimens, and avoiding nephrotoxic drugs."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is managed, such as administration of intravenous fluids or other medications to support the kidneys.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends IV fluids, antiemetics/antidiarrheals to maintain intake, electrolyte correction, and TLS prophylaxis/treatment."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly mention that IV fluids can be used to provide hydration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that intravenous (IV) fluids are often the first and most important step for dehydration-related AKI."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe ways that renal toxicity related to pancreatic cancer treatment is managed, such as thorough evaluation of other medications or supplements a patient is taking to ensure there are no harmful interactions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It includes a medication review and adjustment, avoidance of nephrotoxic drugs, and mentions other medications (NSAIDs, antibiotics, PPIs) that can harm kidneys."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly mention that alleviating obstruction (e.g., via stenting or nephrostomy) can help recover renal function.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It provides obstruction management via ureteral stenting and nephrostomy to restore urine drainage in the context of kidney injury, implying recovery of renal function."
      },
      {
        "criterion_number": 14,
        "description": "The response must explicitly state that dehydration and obstruction (e.g., biliary or urinary) can lead to kidney injury.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly lists dehydration as a cause of AKI and describes obstructive uropathy causing hydronephrosis and kidney damage."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient consult with their oncology team and oncology pharmacist prior to starting new medications or supplements while undergoing pancreatic cancer treatment to avoid harmful interactions.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it encourages open dialogue with the care team, it does not recommend consulting an oncology pharmacist nor specifically advise checking new medications or supplements before starting."
      },
      {
        "criterion_number": 16,
        "description": "The response should mention that sometimes dialysis may be indicated if there is a severe kidney injury related to cancer treatment.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It clearly states dialysis may be considered if kidney injury is severe and not reversible."
      },
      {
        "criterion_number": 17,
        "description": "The response should recommend staying well hydrated and with adequate nutrition intake while undergoing pancreatic cancer treatment to preserve energy and organ functions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes adequate oral intake and hydration, with dietitian-guided dietary modifications to support kidney function."
      }
    ],
    "question_number": 191,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:44:43.662217",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the role of genetic mutations in cancer.",
        "score_given": 9,
        "max_points": 9,
        "justification": "Clearly explains mutations initiating cancer, distinguishes driver vs passenger mutations, and notes faulty DNA copying leading to ongoing mutation."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain how cancer treatment applies selective pressure on cancer cells, allowing those that harbor certain characteristics that confer resistance to therapy a survival advantage.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly describes therapy as a strong selective pressure that eliminates sensitive cells and enables resistant clones to survive and expand."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain that after certain treatments, tumor cells susceptible to that treatment will have died while those resistant to the treatment survive, making the residual cancer fundamentally different from the original cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Uses the weed analogy and scientific explanation to state that treatment kills susceptible cells, leaving resistant ones that repopulate, altering the tumor's composition."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe how genetic mutations can cause cancer cells to resist certain treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that subclones may harbor mutations conferring drug resistance and that resistance can pre-exist or arise through new mutations under therapy."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the heterogeneous cellular make-up of pancreatic cancer at baseline.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states pancreatic cancer is often highly heterogeneous from the very beginning and discusses subclonal diversity."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the mesenchymal-epithelial transition, including triggers for this phenomenon.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention epithelial\u2013mesenchymal transition or mesenchymal\u2013epithelial transition, nor any triggers (e.g., TGF-\u03b2, hypoxia, inflammation)."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe methods for evaluating tumor evolution over time, including circulating tumor DNA and/or traditional biopsy of the primary tumor or metastatic lesion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions liquid biopsies with ctDNA to track mutational changes and sequencing of the tumor for personalized therapy."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that tumor evolution is when the cancer changes and adapts over time.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines tumor evolution conceptually as Darwinian selection with ongoing change and adaptation within the tumor over time."
      }
    ],
    "question_number": 192,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:45:03.521480",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the role of genetic mutations in cancer.",
        "score_given": 9,
        "max_points": 9,
        "justification": "Clearly explains that cancer begins with a cell acquiring critical DNA mutations, discusses accumulation of additional mutations over time, and how these mutations influence behavior and growth."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain how cancer treatment applies selective pressure on cancer cells, allowing those that harbor certain characteristics that confer resistance to therapy a survival advantage.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly describes treatment as a selective pressure: sensitive cells are killed while resistant clones survive and expand, framing it as natural selection within the tumor."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain that after certain treatments, tumor cells susceptible to that treatment will have died while those resistant to the treatment survive, making the residual cancer fundamentally different from the original cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that therapy kills sensitive cells and leaves pre-existing resistant cells to dominate, implying a shift in tumor composition compared to the original tumor."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe how genetic mutations can cause cancer cells to resist certain treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly notes that a subset of cells may harbor specific mutations that make them resistant to a given therapy, contributing to treatment failure."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the heterogeneous cellular make-up of pancreatic cancer at baseline.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes intratumoral heterogeneity within the primary tumor and differences between primary and metastatic sites, indicating diverse cell populations at baseline."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the mesenchymal-epithelial transition, including triggers for this phenomenon.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention epithelial\u2013mesenchymal transition (EMT) or mesenchymal\u2013epithelial transition (MET), nor any triggers such as TGF-\u03b2, hypoxia, or inflammation."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe methods for evaluating tumor evolution over time, including circulating tumor DNA and/or traditional biopsy of the primary tumor or metastatic lesion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions liquid biopsies detecting ctDNA to track evolution and notes that biopsies from metastatic sites can differ from the primary tumor, supporting re-evaluation over time."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that tumor evolution is when the cancer changes and adapts over time.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines tumor evolution as a dynamic, constantly changing process and repeatedly frames cancer as changing and adapting over time."
      }
    ],
    "question_number": 192,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:45:26.846908",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define complementary therapies, including supportive and integrative therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response clearly distinguishes complementary from alternative therapy, but it does not define or mention supportive or integrative therapy. The criterion specifically requires inclusion of supportive and integrative therapy definitions."
      },
      {
        "criterion_number": 2,
        "description": "Define aromatherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response discusses using essential oils and methods (diffusion, topical), it does not explicitly define aromatherapy as the therapeutic use of essential oils/aromatic plant extracts for symptom relief. No clear definition statement is provided."
      },
      {
        "criterion_number": 3,
        "description": "Mention that ingested/applied substances can cause reactions and that it may be difficult to tell if a reaction is from the complementary therapy or cancer treatment; therefore use with caution.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response emphasizes caution, potential irritation/burns, and avoiding ingestion, but it does not explicitly state that reactions may be hard to distinguish from treatment side effects. The specific point about attribution difficulty is missing."
      },
      {
        "criterion_number": 4,
        "description": "Inform patients that complementary therapies do not treat cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that complementary therapy is used alongside standard treatment and 'does not treat the cancer itself.'"
      },
      {
        "criterion_number": 5,
        "description": "Inform patients that some complementary therapies may help with symptoms (e.g., stress, insomnia).",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly lists symptom benefits including nausea, anxiety/stress, pain perception, sleep/insomnia, and mood improvement."
      },
      {
        "criterion_number": 6,
        "description": "Recommend inquiring with the oncology team about trusted practitioners or referrals.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Advises discussing therapy with the oncology team but does not suggest asking for trusted practitioners or referrals to complementary therapy providers."
      },
      {
        "criterion_number": 7,
        "description": "Provide website links to informational pages from cancer societies (e.g., NCI, PanCAN).",
        "score_given": 0,
        "max_points": 7,
        "justification": "No links to cancer society resources (NCI, PanCAN, etc.) are provided."
      },
      {
        "criterion_number": 8,
        "description": "Strongly recommend discussing complementary therapies with the oncology team to avoid harmful interactions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Repeatedly and strongly urges consultation with the oncology team before starting aromatherapy and mentions potential interactions and treatment-related sensitivities."
      },
      {
        "criterion_number": 9,
        "description": "Explicitly state that aromatherapy is safest via inhalation and oils must be appropriately prepared.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States 'Inhalation (Safest Method)' and provides preparation guidance including dilution recommendations."
      },
      {
        "criterion_number": 10,
        "description": "Explicitly state that essential oils on the skin should be used with caution due to risk of worsening skin irritation from chemotherapy or radiation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly notes risk of irritation or burns and that skin may be sensitive due to chemotherapy or radiation; advises extreme caution with topical use."
      }
    ],
    "question_number": 193,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:45:56.127818",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define complementary therapies, including supportive and integrative therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response describes aromatherapy as a complementary therapy and notes it supports symptom management, but it does not define complementary therapy more broadly nor explain or define the terms supportive care or integrative therapy."
      },
      {
        "criterion_number": 2,
        "description": "Define aromatherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response operationally defines aromatherapy through its use of essential oils via inhalation and topical application and details methods (diffusers, inhalers, diluted topical use), which sufficiently explains what aromatherapy is."
      },
      {
        "criterion_number": 3,
        "description": "State that ingested/applied substances can cause reactions (e.g., allergic) and that it may be difficult to distinguish reactions from therapy versus cancer treatment; therefore use with caution.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response emphasizes caution, potential skin sensitivity, patch testing, and possible interactions or liver toxicity with ingestion, it does not explicitly state that distinguishing whether a reaction is from the complementary therapy or from cancer treatment can be difficult."
      },
      {
        "criterion_number": 4,
        "description": "Inform patients that complementary therapies do not treat cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states aromatherapy is used to manage symptoms and improve quality of life and not to treat the cancer itself."
      },
      {
        "criterion_number": 5,
        "description": "Inform that some complementary therapies may help with symptoms (e.g., stress, insomnia).",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response lists multiple symptom areas (anxiety/stress, insomnia, nausea, fatigue, pain) where aromatherapy may help, satisfying the criterion."
      },
      {
        "criterion_number": 6,
        "description": "Recommend asking the oncology team for trusted practitioners or a referral.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It advises consulting the oncology team about complementary therapies but does not suggest asking the team for trusted practitioners or for a referral."
      },
      {
        "criterion_number": 7,
        "description": "Provide website links to informational pages from cancer societies (e.g., NCI, PanCAN).",
        "score_given": 0,
        "max_points": 7,
        "justification": "No links to NCI, PanCAN, or similar reputable cancer society resources are provided."
      },
      {
        "criterion_number": 8,
        "description": "Strongly recommend discussing any complementary therapies with the oncology team to avoid harmful interactions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It strongly and repeatedly emphasizes consulting the oncology team before using aromatherapy and notes potential interactions with medications."
      },
      {
        "criterion_number": 9,
        "description": "Explicitly state aromatherapy is safest via inhalation and that oils must be appropriately prepared.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response states inhalation is generally the safest route and emphasizes proper dilution of essential oils for topical use."
      },
      {
        "criterion_number": 10,
        "description": "Explicitly state essential oils on the skin should be used with caution due to risk of worsening skin irritation from chemotherapy or radiation.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly recommends caution with topical use, notes heightened skin sensitivity during chemotherapy/radiation, and advises avoiding irradiated or broken skin."
      }
    ],
    "question_number": 193,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:46:30.260543",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define metabolism in humans.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly explains metabolism as how cells use fuels (sugars, fats, proteins) to generate energy and building blocks, using an accessible factory analogy."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the Warburg Effect.",
        "score_given": 9,
        "max_points": 9,
        "justification": "Explicitly names the Warburg effect and accurately states that cancer cells preferentially use glycolysis even in the presence of oxygen and why this supports rapid growth."
      },
      {
        "criterion_number": 3,
        "description": "The response should include information about glucose, amino acid, and lipid metabolism in cancer cells, specifically in pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Discusses pancreatic cancer cells' use of glucose, glutamine (amino acids), and fats as alternative fuels, with PDAC-specific context."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that changes in metabolism can alter sensitivity to cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that metabolic inhibitors (e.g., blocking glucose/glutamine use or autophagy) can sensitize tumors to chemotherapy and are used in combination strategies."
      },
      {
        "criterion_number": 5,
        "description": "The response should not recommend specific diets for the management of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Does not recommend any diet; explicitly cautions against drastic dietary changes and frames ketogenic diet only as experimental and within trials."
      },
      {
        "criterion_number": 6,
        "description": "The response should not indicate that restrictive diets, such as the ketogenic diet or intermittent fasting, should be started by patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly advises against starting restrictive diets, noting ketogenic diet is highly experimental and should only occur under strict medical supervision as part of a clinical trial."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient discuss diet with their oncologist and request a referral to a nutritionist if they are interested in learning more.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends speaking with the oncology team and working with an oncology dietitian; includes a suggested question asking for a referral."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that there is not any current evidence for dietary interventions to alter the metabolism of the cancer and improve treatment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Describes dietary approaches as 'highly experimental' but does not explicitly state that there is no current evidence that dietary interventions improve treatment outcomes."
      }
    ],
    "question_number": 194,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:47:08.794696",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define metabolism in humans.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly defines metabolism as the chemical processes to maintain life and provides examples (energy production, building/breaking molecules, waste elimination)."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the Warburg Effect.",
        "score_given": 9,
        "max_points": 9,
        "justification": "Accurately explains aerobic glycolysis (lactate production despite oxygen), its rationale (biosynthetic precursors, rapid ATP), and relevance to pancreatic cancer (hypoxia, acidic microenvironment, immune effects)."
      },
      {
        "criterion_number": 3,
        "description": "The response should include information about glucose, amino acid, and lipid metabolism in cancer cells, specifically in pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Addresses glucose (Warburg effect), amino acids (glutamine addiction), and lipids (lipid metabolism reprogramming), explicitly tied to pancreatic cancer context."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that changes in metabolism can alter sensitivity to cancer treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly discusses metabolic plasticity driving drug resistance and how metabolic byproducts affect immunotherapy effectiveness and chemotherapy delivery."
      },
      {
        "criterion_number": 5,
        "description": "The response should not recommend specific diets for the management of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Does not recommend any specific diets; instead cautions against attempting to 'starve the tumor' via diets and emphasizes risks."
      },
      {
        "criterion_number": 6,
        "description": "The response should not indicate that restrictive diets, such as the ketogenic diet or intermittent fasting, should be started by patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions ketogenic diet/fasting only to caution against them and explicitly advises against starting restrictive diets without strict medical guidance."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient discuss diet with their oncologist and request a referral to a nutritionist if they are interested in learning more.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises discussing dietary changes with the oncology team and working with an oncology dietitian; emphasizes medical supervision."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that there is not any current evidence for dietary interventions to alter the metabolism of the cancer and improve treatment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it labels metabolic diets as experimental and not recommended, it does not explicitly state that there is no current evidence that dietary interventions improve treatment outcomes by altering tumor metabolism."
      }
    ],
    "question_number": 194,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:47:43.738834",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "List causes of eye problems related to cancer and/or cancer treatment, including chemotherapy-induced optic neuropathy, immunotherapy-related inflammation, bleeding, cataracts, dry eye, metastatic disease to the brain or eye, and infections.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response mentions dry eye, infections (conjunctivitis), and cataracts (from steroids), but does not mention chemotherapy-induced optic neuropathy, immunotherapy-related inflammation, bleeding, or metastatic disease to the brain or eye. Because several key causes from the rubric are missing, full credit cannot be awarded under the binary scoring rule."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly state that chemotherapy can lead to eye dryness and irritations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response states that chemotherapy can damage tear glands and cause surface inflammation and then lists dry, gritty, burning eyes as common symptoms, satisfying the requirement that chemotherapy can lead to eye dryness and irritation."
      },
      {
        "criterion_number": 3,
        "description": "Explicitly state that the use of steroids can lead to an increase in cataracts or glaucoma.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response explicitly states: 'Steroids ... can increase the risk of cataracts and glaucoma.'"
      },
      {
        "criterion_number": 4,
        "description": "Explicitly state that immunosuppressed patients are more likely to have infections in their eyes.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While the response mentions conjunctivitis and advises hygiene, it does not explicitly state that immunosuppressed patients are at increased risk of eye infections."
      },
      {
        "criterion_number": 5,
        "description": "Mention that the patient\u2019s eye symptoms may not be related to cancer or cancer treatment, and they should seek out an eye exam by a qualified practitioner.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises contacting the oncology team to 'rule out other, more serious causes' and to schedule an appointment with an ophthalmologist for a thorough exam. This indicates symptoms may not be treatment-related and recommends evaluation by a qualified eye practitioner."
      },
      {
        "criterion_number": 6,
        "description": "Recommend that the patient document characteristics of their symptoms, such as severity and date of onset.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly recommends keeping a symptom log with what the symptom is, when it started/how often, severity, and triggers."
      },
      {
        "criterion_number": 7,
        "description": "List red flag eye symptoms that should prompt immediate presentation to medical care, such as vision loss or severe pain.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response lists multiple red flags: sudden loss of vision/curtain, severe persistent eye pain, flashes of light or sudden new floaters, and signs of severe infection with thick discharge."
      },
      {
        "criterion_number": 8,
        "description": "Explicitly state that any eye symptoms should be discussed with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly instructs to contact the oncology team immediately and report symptoms, emphasizing the need to discuss eye issues with them."
      },
      {
        "criterion_number": 9,
        "description": "Recommend that the patient possibly request a referral to an ophthalmologist, based on reported symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly recommends scheduling an appointment with an ophthalmologist and to inform them about current cancer treatments."
      },
      {
        "criterion_number": 11,
        "description": "Explicitly state that eye drops can be used to mitigate symptoms of dry eyes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response recommends lubricating eye drops (artificial tears), preferably preservative-free, and to use them regularly for comfort in dry eyes."
      }
    ],
    "question_number": 195,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:48:26.713190",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "List causes of eye problems related to cancer and/or treatment, including chemo-induced optic neuropathy, immunotherapy-related inflammation, bleeding, cataracts, dry eye, metastatic disease to the brain or eye, and infections.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response listed multiple causes (chemotherapy-induced optic neuropathy, immunotherapy-related uveitis/scleritis, cataracts/glaucoma from steroids, dry eye, infections, and metastasis to the eye/orbit). However, it did not mention ocular bleeding/hemorrhage, which is specified as an included example, so full-credit criteria were not fully met."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly state that chemotherapy can lead to eye dryness and irritations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly states chemotherapy can cause dry eyes and conjunctivitis (irritation), e.g., \u201cOther chemotherapies: may cause dry eyes\u201d and 5-FU/capecitabine can cause conjunctivitis."
      },
      {
        "criterion_number": 3,
        "description": "Explicitly state that the use of steroids can lead to an increase in cataracts or glaucoma.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response states, \u201cSteroids\u2026 can contribute to cataracts or glaucoma with long-term use,\u201d which directly meets the requirement."
      },
      {
        "criterion_number": 4,
        "description": "Explicitly state that immunosuppressed patients are more likely to have infections in their eyes.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While infections are mentioned, the response does not explicitly state that immunosuppressed patients have a higher risk of eye infections."
      },
      {
        "criterion_number": 5,
        "description": "Mention that the patient\u2019s eye symptoms may not be related to cancer or treatment, and recommend an eye exam by a qualified practitioner.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It notes non-cancer/treatment causes (e.g., dehydration, nutritional deficiencies) and recommends an ophthalmology consultation, fulfilling both parts of the criterion."
      },
      {
        "criterion_number": 6,
        "description": "Recommend that the patient document characteristics of their symptoms, such as severity and date of onset.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises to keep a detailed log of symptoms, including severity and progression, which satisfies documentation of characteristics."
      },
      {
        "criterion_number": 7,
        "description": "List red-flag eye symptoms that should prompt immediate medical care (e.g., vision loss, severe pain).",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly flags decrease in vision, pain, double vision, and flashes of light as urgent symptoms."
      },
      {
        "criterion_number": 8,
        "description": "Explicitly state that any eye symptoms should be discussed with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It instructs to contact the oncology team today for any new or worsening eye problems, meeting the requirement."
      },
      {
        "criterion_number": 9,
        "description": "Recommend possibly requesting a referral to an ophthalmologist based on symptoms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises requesting an ophthalmic consultation with an ophthalmologist as soon as possible."
      },
      {
        "criterion_number": 11,
        "description": "Explicitly state that eye drops can be used to mitigate symptoms of dry eyes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It permits plain lubricating drops for general dryness (if recommended) and mentions artificial tears, which are standard for dry eye."
      }
    ],
    "question_number": 195,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:49:26.624098",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define neoantigens in cancer as proteins expressed on the surface of cancer cells, used by the immune system to differentiate cancer from healthy tissue.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly explains that mutations in cancer create abnormal proteins whose fragments are displayed on the tumor cell surface as neoantigens and emphasizes that these are unique to cancer cells and recognizable by T-cells."
      },
      {
        "criterion_number": 2,
        "description": "Mention ongoing research involving neoantigens in cancer, including cancer vaccines, immunotherapy, and CAR-T trials.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response discusses immunotherapy (checkpoint inhibitors), personalized neoantigen vaccines, and adoptive cell therapy with TILs, but does not mention CAR-T trials specifically. Because the criterion requires inclusion of vaccines, immunotherapy, and CAR-T, it is not fully met."
      },
      {
        "criterion_number": 3,
        "description": "State that there are no FDA-approved treatments targeting neoantigens at this time.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response notes clinical trials and promising research but does not explicitly state that there are currently no FDA-approved therapies that directly target neoantigens."
      },
      {
        "criterion_number": 4,
        "description": "Recommend that the patient discuss the role of neoantigens in their cancer care with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly provides several questions to ask the oncology team about sequencing, immunotherapy candidacy, and interpretation of results, clearly recommending discussion with the care team."
      },
      {
        "criterion_number": 5,
        "description": "Recommend considering referral to be considered for clinical trials for pancreatic cancer treatment in their area.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response encourages asking about eligibility for clinical trials of neoantigen-based therapies, effectively recommending consideration of trial referral."
      }
    ],
    "question_number": 196,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:49:44.220617",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define neoantigens in cancer as proteins expressed on the surface of cancer cells, used by the immune system to differentiate cancer from healthy tissue.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines neoantigens as proteins/protein fragments only on cancer cells (not healthy cells) and explains that T-cells can recognize them as foreign, enabling the immune system to distinguish cancer from normal tissue."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention ongoing research involving neoantigens in cancer, including cancer vaccines, immunotherapy, and CAR-T trials.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it discusses immunotherapy broadly, personalized neoantigen vaccines, clinical trials, and adoptive cell therapies (TILs, TCR-T), it does not specifically mention CAR-T trials. Given the binary scoring, this criterion is not fully met."
      },
      {
        "criterion_number": 3,
        "description": "The response should state that there are no FDA-approved treatments targeting neoantigens at this time.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response notes that neoantigen vaccines are largely in clinical trials and that some approaches are experimental, but it does not explicitly state that there are no FDA-approved treatments targeting neoantigens."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient discuss the role of neoantigens in their cancer care with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises asking the medical team specific questions about neoantigens, TMB, MSI-H/dMMR, and relevant therapies, and encourages discussion with the care team."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend considering referral to be considered for clinical trials for pancreatic cancer treatment in their area.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends exploring clinical trial options and asking about eligibility for trials focused on neoantigens or immunotherapy, effectively encouraging consideration of clinical trials."
      }
    ],
    "question_number": 196,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:50:00.606764",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define autophagy, including degradation and recycling of cellular components and maintaining homeostasis by removing damaged organelles and protein aggregates.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines autophagy as a cellular recycling system involving autophagosomes and lysosomes, describes degradation into amino acids/fatty acids, and emphasizes quality control/homeostasis by removing damaged organelles and misfolded proteins."
      },
      {
        "criterion_number": 2,
        "description": "Describe the dual role of autophagy in cancer, including tumor suppression and promotion with context on progression.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explicitly frames autophagy as a double-edged sword: tumor suppressive in early stages via cleanup and tumor promoting in established cancers by supporting survival under stress."
      },
      {
        "criterion_number": 3,
        "description": "State that autophagy can be protective against cancer by removing damaged or dysregulated proteins.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states autophagy removes damaged components and faulty proteins, preventing instability/mutations and acting as a tumor suppressor."
      },
      {
        "criterion_number": 4,
        "description": "Describe autophagy in pancreatic adenocarcinoma: upregulation and contribution to survival and treatment resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It specifically discusses pancreatic cancer\u2019s harsh microenvironment, upregulation of autophagy, and its roles in stress survival and resistance to chemotherapy/radiation."
      },
      {
        "criterion_number": 5,
        "description": "State that cancer cells utilize autophagy to promote survival, growth, and therapy resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states cancer cells ramp up autophagy to survive, generate fuel for growth/division, and resist therapy."
      },
      {
        "criterion_number": 6,
        "description": "Explain if autophagy can be targeted with treatment and provide at least one reference with a PMID.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it describes the therapeutic strategy (autophagy inhibitors) and examples, it provides no scientific references or PMIDs."
      },
      {
        "criterion_number": 7,
        "description": "State that blocking autophagy is under research but not a current standard of care in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It notes ongoing trials and that it is not a 'standard cure,' but does not clearly state that autophagy-targeting is not standard of care."
      },
      {
        "criterion_number": 8,
        "description": "Mention specific drugs targeting autophagy, reference evidence, and clearly state FDA approval status.",
        "score_given": 0,
        "max_points": 3,
        "justification": "HCQ/chloroquine are named, but no literature is cited and there is no clear statement about FDA approval status for autophagy-targeted therapy in pancreatic cancer."
      },
      {
        "criterion_number": 10,
        "description": "Reference at least one scientific literature source with a PMID.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No PMIDs or specific literature references are included."
      }
    ],
    "question_number": 197,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:50:25.199833",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define autophagy, including degradation/recycling of cellular components and maintaining homeostasis by removing damaged organelles and protein aggregates.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines autophagy as a cellular recycling/cleanup process; explicitly mentions breaking down damaged organelles/proteins, recycling building blocks, and maintaining cellular health/homeostasis."
      },
      {
        "criterion_number": 2,
        "description": "Describe the dual role of autophagy in cancer (tumor suppression and promotion) with context on changes during progression.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explains autophagy as a double-edged sword; details tumor-suppressive roles in early stages and tumor-promoting roles in established cancers with clear context."
      },
      {
        "criterion_number": 3,
        "description": "State that autophagy can be protective against cancer by removing damaged or dysregulated proteins.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes removal of damaged proteins/organelles to prevent accumulation and maintain genomic stability, framing autophagy as protective."
      },
      {
        "criterion_number": 4,
        "description": "Describe autophagy in pancreatic adenocarcinoma: upregulation and contribution to survival and treatment resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States pancreatic cancer has high constitutive autophagy, reliance for survival in a harsh microenvironment, KRAS-driven autophagy, and links to treatment resistance."
      },
      {
        "criterion_number": 5,
        "description": "State that cancer cells utilize autophagy to promote survival, growth, and therapy resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes autophagy helps stress survival, metabolic reprogramming for growth, and chemotherapy/radiation resistance."
      },
      {
        "criterion_number": 6,
        "description": "Explain if autophagy can be targeted with treatment, providing at least one reference with a PMID if available.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Describes targeting autophagy and mentions CQ/HCQ and trials but provides no literature references with PMIDs."
      },
      {
        "criterion_number": 7,
        "description": "State that blocking autophagy is an area of research but not a current standard of care in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions clinical trials and investigational status but does not explicitly state that autophagy-targeting is not standard of care."
      },
      {
        "criterion_number": 8,
        "description": "Mention specific drugs targeting autophagy, reference existing evidence, and clearly state FDA approval status.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Specific drugs (CQ/HCQ) are mentioned, but there are no literature references and no clear statement about FDA approval status for this indication."
      },
      {
        "criterion_number": 10,
        "description": "Reference at least one scientific literature source with a PMID.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No PMID-cited references are provided."
      }
    ],
    "question_number": 197,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:50:48.504792",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the different types of support groups that exist for cancer patients and family members of cancer patients.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response describes multiple types: telehealth vs in-person, disease-specific (pancreatic) groups, caregiver-specific groups, and telephone-based groups led by oncology social workers, indicating both patient and caregiver options and different formats."
      },
      {
        "criterion_number": 3,
        "description": "The response should address whether there is evidence that a telehealth support group is inferior to an in-person support group.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It clearly states telehealth groups can be as effective as in-person and in some cases more beneficial, directly addressing the question of inferiority (implying no inherent inferiority)."
      },
      {
        "criterion_number": 4,
        "description": "The response should provide references and sources for evidence regarding the effectiveness of telehealth versus in-person support groups.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No research citations or evidence sources comparing telehealth and in-person effectiveness are provided; organizations are listed but not as evidence references."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that in-person and telehealth groups each have their advantages and disadvantages and either may be as effective based on an individual\u2019s needs and preferences.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly outlines pros and cons for both formats and concludes that the better option depends on individual needs and circumstances, noting either can be effective."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that telehealth groups can be more accessible and convenient.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly emphasizes accessibility and convenience as major advantages of telehealth groups, with specific examples (fatigue, travel avoidance, flexible times)."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that some may feel that in-person groups will lead to better emotional connection.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It notes the lack of physical connection online and highlights that in-person settings can foster deeper personal bonds and face-to-face interaction."
      },
      {
        "criterion_number": 9,
        "description": "The response should include a way for the patient or family member to input their location to generate a list of local support group resources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mechanism or prompt to input a location or generate localized resources is provided."
      },
      {
        "criterion_number": 10,
        "description": "The response should list organizations to contact that might be able to provide support resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists PanCAN, CancerCare, and Cancer Support Community as organizations to contact for support resources."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the patient ask their oncology team for assistance in finding support groups.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no recommendation to consult the oncology team for help finding groups."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe that increased stress is normal when dealing with a cancer diagnosis and treatment, or as a family member of a cancer patient.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it expresses empathy and acknowledges difficulty, it does not explicitly state that increased stress is normal in this context."
      }
    ],
    "question_number": 198,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:51:19.707054",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe the different types of support groups that exist for cancer patients and family members of cancer patients.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response mentions multiple group types: pancreatic cancer\u2013specific groups, caregiver-specific groups, groups focused on specific challenges (e.g., side effects, advanced disease), and facilitated groups. This adequately describes different types for patients and family members."
      },
      {
        "criterion_number": 3,
        "description": "The response should address whether there is evidence that a telehealth support group is inferior to an in-person support group.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It states that research is evolving but many studies and reports suggest telehealth groups are highly effective and comparable to in-person groups, addressing the question of inferiority."
      },
      {
        "criterion_number": 4,
        "description": "The response should provide references and sources for evidence regarding the effectiveness of telehealth versus in-person support groups.",
        "score_given": 0,
        "max_points": 6,
        "justification": "No citations or specific references are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that in-person and telehealth groups each have their advantages and disadvantages and either may be as effective based on an individual\u2019s needs and preferences.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly outlines advantages and challenges of telehealth vs. in-person, notes that effectiveness is subjective and preference-based, and indicates telehealth can be comparable to in-person with a suggestion for hybrid approaches."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that telehealth groups can be more accessible and convenient.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It repeatedly emphasizes accessibility, convenience, removal of travel burden, and flexible scheduling for telehealth."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that some may feel that in-person groups will lead to better emotional connection.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It notes the lack of physical presence and non-verbal cues in telehealth and that some prefer the direct human touch and immediate presence of in-person groups."
      },
      {
        "criterion_number": 9,
        "description": "The response should include a way for the patient or family member to input their location to generate a list of local support group resources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mechanism or instruction for inputting location to generate local resources is provided."
      },
      {
        "criterion_number": 10,
        "description": "The response should list organizations to contact that might be able to provide support resources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No organizations (e.g., ACS, PanCAN, hospital systems) are listed."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the patient ask their oncology team for assistance in finding support groups.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly advises checking with the oncology team for recommendations on reputable support groups."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe that increased stress is normal when dealing with a cancer diagnosis and treatment, or as a family member of a cancer patient.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it discusses managing emotions and stress, it does not explicitly state that increased stress is normal in this context."
      }
    ],
    "question_number": 198,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:51:46.436545",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention the effect of caffeine on sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises avoiding caffeine 6\u20138 hours before bed due to its impact on sleep."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention the effect of alcohol on sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that alcohol may cause drowsiness but disrupts sleep later in the night."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention the effect of illegal drugs on sleep.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of illegal/recreational drug effects (e.g., cannabis, stimulants, or others) on sleep."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe strategies to improve sleep that are evidence-based.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides multiple evidence-based strategies: stimulus control (leaving bed if unable to sleep), consistent schedule, sleep environment optimization, limiting caffeine/alcohol, wind-down routine, relaxation techniques (breathing, PMR, guided meditation), limiting naps, daytime activity, symptom and pain management, and steroid timing."
      },
      {
        "criterion_number": 5,
        "description": "The response should provide references for evidence-based sleep improvement interventions.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to guidelines, trials, or authoritative sources are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response should include insights into things in everyday life that may be interfering with a patient\u2019s ability to sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies screens/blue light, irregular schedule, environmental light/noise/temperature, late fluids causing nocturia, caffeine/alcohol timing, daytime inactivity, and long/late naps."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide insights into how cancer-related symptoms can interfere with sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses pain, nausea, diarrhea, reflux, breathing issues, and steroid-induced insomnia as sleep disruptors."
      },
      {
        "criterion_number": 8,
        "description": "The response should emphasize the importance of appropriate management of cancer-related or cancer-treatment related symptoms to prevent interference in everyday life, including sleep.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Strongly emphasizes discussing with oncology team, adjusting pain meds, timing steroids, managing nausea/diarrhea, and involving palliative/supportive care."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe common symptoms that people with pancreatic cancer might experience.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions pain and digestive issues (nausea, diarrhea, reflux), which are common in pancreatic cancer and its treatment."
      },
      {
        "criterion_number": 10,
        "description": "The response should direct the patient to discuss any symptoms of cancer or cancer treatment with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly instructs to discuss sleep issues and symptoms with the oncology team and suggests a palliative care consult."
      },
      {
        "criterion_number": 11,
        "description": "The response should emphasize the importance of mental health and the impact of stress on sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights anxiety and worry as major barriers and provides mind-body strategies (breathing, meditation, PMR, scheduled 'worry time')."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that sleep hygiene is an important first step.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it details sleep hygiene and calls it foundational, it does not explicitly state that sleep hygiene is the important first step."
      },
      {
        "criterion_number": 13,
        "description": "The response must mention a consistent relaxing bedtime routine starting 30 to 60 minutes before bedtime.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends starting a relaxing wind-down routine an hour before bed with specific activities."
      },
      {
        "criterion_number": 14,
        "description": "The response must clearly state that stimulant use, such as nicotine, should be avoided in the afternoon and evenings.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention nicotine or other stimulants beyond caffeine."
      },
      {
        "criterion_number": 15,
        "description": "The response must explicitly recommend optimizing the sleep environment by keeping the room dark, cool, and quiet.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises making the bedroom dark, quiet, and cool."
      },
      {
        "criterion_number": 16,
        "description": "The response must mention that supportive therapies, such as melatonin or other sleep aids, can be considered if deemed safe by the medical team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of melatonin or other sleep aids being considered with medical team approval."
      }
    ],
    "question_number": 199,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:52:30.750363",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention the effect of caffeine on sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response advises avoiding caffeine after mid-afternoon and groups it under stimulants that interfere with sleep, indicating awareness of its wake-promoting effect."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention the effect of alcohol on sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly notes that alcohol can seem to induce sleep but disrupts sleep cycles and leads to awakenings later."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention the effect of illegal drugs on sleep.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of illegal/recreational drugs or their effects on sleep."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe strategies to improve sleep that are evidence-based.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides multiple evidence-based strategies: consistent sleep schedule, pre-sleep routine, limiting blue light, avoiding caffeine/alcohol/nicotine, optimizing the sleep environment (dark, quiet, cool), strategic napping, exercise as tolerated, stress-reduction techniques, and symptom/medication management."
      },
      {
        "criterion_number": 5,
        "description": "The response should provide references for evidence-based sleep improvement interventions.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response should include insights into things in everyday life that may be interfering with a patient\u2019s ability to sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses screens/blue light, caffeine, alcohol, nicotine, late/long naps, large meals late, fluid intake before bed, environmental noise/light/temperature, and bedding comfort."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide insights into how cancer-related symptoms can interfere with sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses pain, nausea, diarrhea/constipation, neuropathy, reflux, and the impact of anxiety/depression, as well as steroid timing\u2014each linked to sleep disruption."
      },
      {
        "criterion_number": 8,
        "description": "The response should emphasize the importance of appropriate management of cancer-related or cancer-treatment related symptoms to prevent interference in everyday life, including sleep.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Strongly emphasizes discussing with the oncology team, optimizing pain control, reviewing/timing medications (e.g., steroids), managing side effects, and considering palliative care referrals to improve sleep and quality of life."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe common symptoms that people with pancreatic cancer might experience.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions pain and significant digestive issues/nutrient absorption problems common in pancreatic cancer; also notes treatment-related symptoms like neuropathy and GI disturbances."
      },
      {
        "criterion_number": 10,
        "description": "The response should direct the patient to discuss any symptoms of cancer or cancer treatment with their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states that the most important first step is to discuss with the oncology team and reiterates collaboration for symptom/medication management and referrals."
      },
      {
        "criterion_number": 11,
        "description": "The response should emphasize the importance of mental health and the impact of stress on sleep.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights the emotional toll, links anxiety/depression to poor sleep, and offers stress-management techniques (mindfulness, relaxation, journaling, support)."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that sleep hygiene is an important first step.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While sleep hygiene strategies are detailed, the response explicitly states the first step is discussing with the oncology team; it does not state that sleep hygiene is the important first step."
      },
      {
        "criterion_number": 13,
        "description": "The response must mention a consistent relaxing bedtime routine starting 30 to 60 minutes before bedtime.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises creating a calming routine an hour before bed and gives specific examples (bath, reading, stretching, meditation)."
      },
      {
        "criterion_number": 14,
        "description": "The response must clearly state that stimulant use, such as nicotine, should be avoided in the afternoon and evenings.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends no caffeine after mid-afternoon and avoiding nicotine\u2014especially close to bedtime\u2014communicating avoidance of stimulants later in the day."
      },
      {
        "criterion_number": 15,
        "description": "The response must explicitly recommend optimizing the sleep environment by keeping the room dark, cool, and quiet.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends darkness, quiet, and a cool temperature, matching the criterion."
      },
      {
        "criterion_number": 16,
        "description": "The response must mention that supportive therapies, such as melatonin or other sleep aids, can be considered if deemed safe by the medical team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions melatonin and short-term sleep aids and stresses using them only under medical supervision."
      }
    ],
    "question_number": 199,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:53:13.083869",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define cancer-related cachexia.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly characterizes cachexia as a complex, systemic metabolic syndrome driven by cancer-related inflammation leading to inefficient energy use and breakdown of muscle and fat, and notes poor responsiveness to nutrition alone."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how cachexia occurs in patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains pancreatic cancer-specific drivers: high inflammatory burden, impaired digestion/malabsorption due to exocrine insufficiency, and tumor-related symptoms that suppress intake."
      },
      {
        "criterion_number": 3,
        "description": "The response should delineate cancer cachexia from regular weight loss.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides a detailed side-by-side comparison covering cause, body composition changes, appetite, metabolic rate, and response to nutrition, clearly distinguishing cachexia from simple caloric deficit."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that cachexia can occur independently of dietary changes.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that eating more does not fix cachexia and uses the engine analogy ('no matter how much gas you put in the tank'), emphasizing that it is not just a nutritional problem."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that cachexia involves muscle loss.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes severe and rapid loss of both muscle and fat and identifies muscle wasting as a defining feature."
      },
      {
        "criterion_number": 6,
        "description": "The response should include information about prognosis in patients experiencing cancer cachexia.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions reduced treatment tolerance and functional impact but does not explicitly address prognosis or survival implications associated with cachexia."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide evidence-based recommendations to patients experiencing cancer cachexia.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Offers appropriate strategies: treating the cancer, nutritional support (small frequent meals, high-calorie/high-protein, oral supplements), PERT for malabsorption, appetite stimulants (megestrol, mirtazapine), short-term steroids, symptom control, and gentle exercise."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient discuss their concerns about cancer cachexia with their oncology team and/or a nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises consultation with an oncology dietitian and to discuss all points with the oncology team."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that cachexia is difficult to manage.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Directly states there is no single cure and emphasizes that cachexia is difficult to manage."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that cachexia can be mitigated by nutritional support, medications, and physical therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends a multimodal approach including nutritional support, medications (appetite stimulants, steroids), symptom control, and gentle physical activity with potential PT involvement."
      }
    ],
    "question_number": 200,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:53:45.192557",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define cancer-related cachexia.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear, accurate definition: a complex metabolic syndrome with ongoing skeletal muscle loss (with or without fat loss) not fully reversible by nutrition, leading to functional impairment."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how cachexia occurs in patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains mechanisms (inflammation, tumor-derived factors, hypermetabolism, insulin resistance, catabolism, anorexia not sole driver) that apply to pancreatic cancer cachexia. While not pancreas-specific (e.g., EPI), it accurately describes how it occurs in these patients."
      },
      {
        "criterion_number": 3,
        "description": "The response should delineate cancer cachexia from regular weight loss.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Thoroughly contrasts regular weight loss versus cachexia across cause, tissue lost, metabolic state, appetite, reversibility, and impact; includes a summary table highlighting differences."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that cachexia can occur independently of dietary changes.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states anorexia is not the sole cause, metabolic/inflammatory drivers predominate, and that eating more cannot fully reverse it; notes muscle loss occurs even when trying to eat."
      },
      {
        "criterion_number": 5,
        "description": "The response should state that cachexia involves muscle loss.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes disproportionate skeletal muscle loss (sarcopenia) as the hallmark of cachexia."
      },
      {
        "criterion_number": 6,
        "description": "The response should include information about prognosis in patients experiencing cancer cachexia.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes poorer outcomes, reduced treatment tolerance, increased complications, and shorter survival associated with cachexia."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide evidence-based recommendations to patients experiencing cancer cachexia.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends multidisciplinary management: oncology dietitian-guided high-calorie/high-protein intake, symptom management, gentle exercise, consideration of appetite stimulants/anti-inflammatories, and early palliative care\u2014all consistent with evidence-based multimodal approaches."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient discuss their concerns about cancer cachexia with their oncology team and/or a nutritionist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises discussing concerns with the oncology team and a registered dietitian; also mentions palliative care."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that cachexia is difficult to manage.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States cachexia is very difficult to reverse with nutrition alone, requires a multifaceted approach, and can remain progressive."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that cachexia can be mitigated by nutritional support, medications, and physical therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions nutritional strategies with a dietitian, medications (appetite stimulants/anti-inflammatories), and physical activity (gentle, tailored exercise) which fulfills the intent of including a rehabilitative/physical therapy component."
      }
    ],
    "question_number": 200,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:54:14.796679",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must describe epithelial-mesenchymal transition (EMT) as a transformation where epithelial cells acquire mesenchymal characteristics.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly explains EMT as epithelial cells shedding their stuck-in-place characteristics and gaining mobility and survival traits like mesenchymal cells, explicitly framing EMT as a switch from 'community dweller' to 'rogue explorer.'"
      },
      {
        "criterion_number": 2,
        "description": "The response must mention that EMT is a key feature of cancer progression, contributing to tumor progression, invasion, metastasis, and therapy resistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It directly links EMT to metastasis, invasion via enzymes, and resistance to chemotherapy/radiation, and emphasizes EMT as a reason pancreatic cancer is aggressive, satisfying all required aspects."
      },
      {
        "criterion_number": 3,
        "description": "The response must define epithelial cells as those forming the lining of glands, organs, and body surfaces, including the pancreas, and describe their tight connections and specific functions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Epithelial cells are described as forming linings and barriers, being stuck together (tight connections), and having clear roles. Although it does not enumerate glands/organs explicitly, the description meets the intent and context (pancreas referenced elsewhere)."
      },
      {
        "criterion_number": 4,
        "description": "The response must define mesenchymal cells as those that can move, change shape, and are found in connective tissue, supporting organs and glands.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it states mesenchymal cells are mobile and can travel, it does not mention their presence in connective tissue, their role in supporting organs/glands, or explicitly that they change shape."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly state that EMT enables cancer cells to migrate to distant sites, leading to metastasis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly describes cells detaching, entering blood/lymph, traveling, and seeding new tumors elsewhere, identifying them as the seeds of metastasis."
      },
      {
        "criterion_number": 6,
        "description": "The response must mention that EMT is an area of current research and explicitly state that there are no treatments aimed at this process yet.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It suggests asking about treatments or clinical trials targeting EMT but does not state that EMT is an active research area nor explicitly that there are no approved treatments targeting EMT yet."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that plasticity is a key factor in treatment resistance in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although treatment resistance is discussed, the concept of plasticity as a driver of resistance is not mentioned explicitly."
      }
    ],
    "question_number": 201,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:54:43.670651",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describe EMT as a transformation where epithelial cells acquire mesenchymal characteristics.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly explains EMT as a process where epithelial cells lose tight junctions, change shape, and gain mobility and resilience\u2014key mesenchymal traits."
      },
      {
        "criterion_number": 2,
        "description": "Mention EMT as a key feature of cancer progression, contributing to tumor progression, invasion, metastasis, and therapy resistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly links EMT to invasion, travel through blood/lymph, colonization (metastasis), and increased resistance to chemotherapy and radiation, framing EMT as critical in aggressive cancers like pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "Define epithelial cells as lining glands, organs, and body surfaces (including pancreas) with tight connections and specific functions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes epithelial cells as tightly packed, forming linings/coverings/glands (including pancreatic ducts), with barrier, secretion, and absorption functions."
      },
      {
        "criterion_number": 4,
        "description": "Define mesenchymal cells as those that can move, change shape, and are found in connective tissue supporting organs and glands.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While mobility and shape change are described, the response does not state that mesenchymal cells are found in connective tissue or that they support organs/glands."
      },
      {
        "criterion_number": 5,
        "description": "Explicitly state that EMT enables cancer cells to migrate to distant sites, leading to metastasis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly details entry into blood/lymph, travel to distant organs, and colonization, directly linking EMT to metastasis."
      },
      {
        "criterion_number": 6,
        "description": "Mention that EMT is an area of current research and explicitly state that there are no treatments aimed at this process yet.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes active research and hopes for future drugs but does not explicitly state that no EMT-targeted treatments currently exist."
      },
      {
        "criterion_number": 8,
        "description": "State that plasticity is a key factor in treatment resistance in pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response discusses resistance and stem-like cells but does not mention plasticity or explicitly tie plasticity to treatment resistance."
      }
    ],
    "question_number": 201,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:55:05.335867",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define the microbiome as the microorganisms that live in the body and play roles in digestion, immune function, metabolism, and inflammation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines the microbiome as microorganisms living in and on the body and explicitly mentions roles in digestion, vitamin production (metabolism), immune regulation, and contribution to inflammation."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that the microbiome is associated with cancer, specifically pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Directly connects the microbiome to pancreatic cancer, including tumor-resident bacteria and gut-pancreas inflammatory pathways."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how the microbiome is thought to affect pancreatic cancer treatment, including its influence on the efficacy of immunotherapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains that microbiome composition affects treatment, specifically noting better immunotherapy responses with certain bacteria (Akkermansia, Bifidobacterium, Faecalibacterium) and proposes mechanisms."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe how the microbiome can influence how the body metabolizes chemotherapy drugs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that some bacteria activate chemotherapy drugs while others deactivate them, affecting efficacy."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that modulating the microbiome to improve cancer outcomes is an active area of research with limited evidence and no standard of care options to date.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it calls the field rapidly evolving and urges coordination with clinicians, it does not explicitly state that evidence is limited and that there are no standard-of-care microbiome modulation strategies."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention the various roles the microbiome is postulated to play in the human body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions multiple roles including digestion, vitamin production, immune regulation, and influence on inflammation, fulfilling the criterion."
      },
      {
        "criterion_number": 7,
        "description": "The response should summarize the scientific research with references (PMID if available).",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or PMIDs are provided; the research is discussed without references."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe standard of care treatments for pancreatic cancer, including chemotherapy and immunotherapy, and mention that appropriate treatment selection depends on the stage of cancer and fitness of the patient.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although chemotherapy, immunotherapy, and surgery are mentioned, the response does not describe standard-of-care frameworks nor state that treatment selection depends on stage and patient fitness."
      },
      {
        "criterion_number": 9,
        "description": "The response should suggest that the patient discuss whether there are ways to support a healthy microbiome with a nutritionist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly recommends discussing changes with the oncology team including a registered dietitian, which fulfills the suggestion to consult a nutrition professional."
      }
    ],
    "question_number": 202,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:55:31.187267",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define the microbiome as the microorganisms that live in the body and play roles in digestion, immune function, metabolism, and inflammation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response discusses the gut microbiome and its effects (immune modulation, inflammation, metabolites) but does not explicitly define the microbiome as the microorganisms living in the body, nor does it mention its role in digestion."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention that the microbiome is associated with cancer, specifically pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It repeatedly links the microbiome to pancreatic cancer development and progression, including intra-tumoral bacteria and effects on the tumor microenvironment."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how the microbiome is thought to affect pancreatic cancer treatment, including its influence on the efficacy of immunotherapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It addresses effects on chemotherapy efficacy and side effects, notes that microbiome composition can influence immunotherapy responses (e.g., Bifidobacterium, Akkermansia), and discusses radiation and surgery impacts."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe how the microbiome can influence how the body metabolizes chemotherapy drugs.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that certain bacteria can metabolize/degrade chemotherapy drugs and gives a concrete example: Klebsiella pneumoniae degrading gemcitabine."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention that modulating the microbiome to improve cancer outcomes is an active area of research with limited evidence and no standard of care options to date.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly emphasizes that microbiome modulation is experimental, an active research area, and not standard-of-care, advising consultation with the oncology team."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention the various roles the microbiome is postulated to play in the human body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It covers multiple roles, including immune modulation, inflammation, and metabolic effects via microbial metabolites; also relates to treatment tolerance and recovery."
      },
      {
        "criterion_number": 7,
        "description": "The response should summarize the scientific research with references (PMID if available).",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or PMIDs are provided; the response does not reference specific studies beyond general descriptions."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe standard of care treatments for pancreatic cancer, including chemotherapy and immunotherapy, and mention that appropriate treatment selection depends on the stage of cancer and fitness of the patient.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although chemotherapy, immunotherapy, radiation, and surgery are mentioned, the response does not outline standard-of-care regimens nor state that treatment selection depends on cancer stage and patient fitness/performance status."
      },
      {
        "criterion_number": 9,
        "description": "The response should suggest that the patient discuss whether there are ways to support a healthy microbiome with a nutritionist.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It advises discussing dietary/supplement changes with the oncology team but does not suggest consulting a nutritionist or dietitian specifically regarding microbiome support."
      }
    ],
    "question_number": 202,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:55:56.010250",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that mood changes are very common with the diagnosis of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states mood changes are 'extremely common' and 'well-documented and expected,' specifically noting pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing treatment-related mood changes with the oncology team to ensure they are provided with available local resources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises 'Talk to the Healthcare Team Immediately,' with concrete prompts for the oncologist and care team and asks for referrals."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend a referral to a mental health provider familiar with cancer patients and cancer care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends 'Psycho-Oncology' with psychologists/counselors who specialize in cancer care."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe counseling as an intervention that may help alleviate mood issues.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States psycho-oncology can provide coping strategies, therapy, and support to address emotional impact."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe medications, such as antidepressants, as an intervention that may help alleviate mood issues.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions 'Antidepressants or anti-anxiety medications can be incredibly effective.'"
      },
      {
        "criterion_number": 6,
        "description": "The response should describe support group participation as an intervention that may help alleviate mood issues.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Explicitly recommends 'Support Groups' to reduce isolation for patient and caregiver."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide supportive language about mood changes during cancer treatment and attempt to normalize this phenomenon.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Uses empathetic tone and normalization throughout (e.g., 'You are not alone,' 'This is extremely common')."
      },
      {
        "criterion_number": 8,
        "description": "The response should reference studies that quantify patients with cancer that suffer from mood changes after diagnosis and/or during treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No studies, data, or quantified rates are cited."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe different interventions that may help alleviate mood issues, such as psychiatric evaluation, exercise, nutrition, and cancer-related symptom control.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes multiple interventions: mental health referral (psycho-oncology), medications, palliative symptom control (pain, nausea, fatigue), light activity/exercise, nutrition considerations, routines, and goal-setting."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that patients with suicidal thoughts consider presentation to medical care urgently or emergently.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No guidance provided regarding suicidal ideation or urgent/emergent care."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe the role of palliative medicine in cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains palliative care is for any stage, focused on quality of life and managing physical and emotional symptoms; not just end-of-life."
      },
      {
        "criterion_number": 12,
        "description": "The response should list common side effects of both pancreatic cancer and pancreatic cancer treatment, and suggest that feeling poorly can impact one\u2019s mood.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists steroids causing mood changes/insomnia, chemo brain/fatigue, pain and opioids, profound fatigue, nutritional deficiencies, and explains these can affect mood."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that some patients benefit from a mental health standpoint by having their affairs in order, as this can provide some peace of mind in the face of a serious illness.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention advance care planning or getting affairs in order for peace of mind."
      },
      {
        "criterion_number": 14,
        "description": "The response should list online resources for support for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific online resources or organizations are listed."
      },
      {
        "criterion_number": 15,
        "description": "The response should state that mindfulness and relaxation techniques can be considered.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention mindfulness, relaxation, meditation, or breathing techniques."
      }
    ],
    "question_number": 203,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:56:23.425985",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should state that mood changes are very common with the diagnosis of pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states mood changes are very common and normalizes this, using phrases like 'Yes, absolutely' and 'very common.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend discussing treatment-related mood changes with the oncology team to ensure they are provided with available local resources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Strongly advises immediate communication with the oncology team and mentions nurses and social workers who can connect to resources."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend a referral to a mental health provider familiar with cancer patients and cancer care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends therapy and mentions consultation with a psychiatrist specializing in oncology."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe counseling as an intervention that may help alleviate mood issues.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes individual and family therapy, including CBT, as helpful interventions."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe medications, such as antidepressants, as an intervention that may help alleviate mood issues.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions antidepressants, anxiolytics, and sleep aids, with attention to oncology-psychiatry collaboration and interactions."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe support group participation as an intervention that may help alleviate mood issues.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Specifically recommends support groups and their benefits."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide supportive language about mood changes during cancer treatment and attempt to normalize this phenomenon.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Uses empathetic, validating language and normalizes mood changes throughout."
      },
      {
        "criterion_number": 8,
        "description": "The response should reference studies that quantify patients with cancer that suffer from mood changes after diagnosis and/or during treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Provides no quantitative data or citations regarding prevalence."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe different interventions that may help alleviate mood issues, such as psychiatric evaluation, exercise, nutrition, and cancer-related symptom control.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Covers psychiatric involvement, exercise, nutrition, sleep hygiene, and symptom control (pain, nausea, fatigue)."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that patients with suicidal thoughts consider presentation to medical care urgently or emergently.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit guidance for urgent or emergent care in the case of suicidal ideation."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe the role of palliative medicine in cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains palliative care is not only end-of-life, focuses on quality of life and symptom management, and recommends early involvement."
      },
      {
        "criterion_number": 12,
        "description": "The response should list common side effects of both pancreatic cancer and pancreatic cancer treatment, and suggest that feeling poorly can impact one\u2019s mood.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists multiple disease and treatment side effects (pain, fatigue, nausea, neuropathy, sleep disturbance, body image changes) and links them to mood impact."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that some patients benefit from a mental health standpoint by having their affairs in order, as this can provide some peace of mind in the face of a serious illness.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention advance care planning or organizing affairs for peace of mind."
      },
      {
        "criterion_number": 14,
        "description": "The response should list online resources for support for patients with pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No pancreatic cancer\u2013specific online support resources provided (e.g., PanCAN, ACS); only meditation apps are mentioned."
      },
      {
        "criterion_number": 15,
        "description": "The response should state that mindfulness and relaxation techniques can be considered.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends mindfulness, deep breathing, guided imagery, and meditation apps."
      }
    ],
    "question_number": 203,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:56:48.534649",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define tumor suppressor genes and their function in the human body.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines tumor suppressor genes as the 'brakes' of the cell, explaining their functions in controlling cell division, repairing DNA damage, and inducing apoptosis."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how defects in tumor suppressor genes can lead to cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that when tumor suppressor genes are inactivated (the brakes fail), cells divide uncontrollably, contributing to tumor formation; ties this to the two-hit hypothesis."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how tumor suppressor genes gain defects or mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes the two-hit hypothesis in detail and distinguishes sporadic (acquired) mutations from inherited (germline) mutations, explaining how both copies can become inactivated."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that there are genetic syndromes inherited in families that affect tumor suppressor genes, leaving affected individuals at higher risk of developing cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly discusses hereditary cancer risk, stating that individuals can inherit a first hit (e.g., BRCA2) that elevates cancer risk and may affect family members."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention tumor suppressor genes that are thought to play a role in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists specific tumor suppressor genes implicated in pancreatic cancer: TP53, CDKN2A, SMAD4, and BRCA1/2, with context on their roles and frequencies."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that this is an active area of research.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not explicitly state that tumor suppressor gene research in pancreatic cancer is an active area of research."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient discuss whether there are clinical trials available in their area with their oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not advise discussing clinical trial availability with the oncology team."
      }
    ],
    "question_number": 204,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:57:07.408972",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define tumor suppressor genes and their function in the human body.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines tumor suppressor genes as the 'brake pedal/traffic cops' that prevent uncontrolled cell growth and details their protective functions (cell cycle control, DNA repair, apoptosis)."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how defects in tumor suppressor genes can lead to cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains the two-hit hypothesis and describes consequences of loss (loss of brakes, accumulation of DNA errors, failure to eliminate damaged cells) leading to cancer development."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe how tumor suppressor genes gain defects or mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes sources of DNA damage (UV, chemicals, normal metabolism) and discusses inherited mutations (e.g., BRCA with one 'hit' already present), indicating both somatic and germline routes."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention that there are genetic syndromes inherited in families that affect tumor suppressor genes, leaving affected individuals at higher risk of developing cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions inherited BRCA1/2 mutations increasing pancreatic cancer risk and discusses implications for family members."
      },
      {
        "criterion_number": 5,
        "description": "The response should mention tumor suppressor genes that are thought to play a role in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Names key TSGs in pancreatic cancer (TP53, CDKN2A, SMAD4, BRCA1/2) and provides context/frequencies relevant to pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should state that this is an active area of research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that researchers are actively working on therapies (e.g., p53 restoration) and references ongoing clinical trials, indicating active research."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient discuss whether there are clinical trials available in their area with their oncology team.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While clinical trials are mentioned, there is no explicit recommendation to discuss trial availability with the oncology team."
      }
    ],
    "question_number": 204,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:57:30.876802",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 2,
        "description": "Recommend discussing mental health counseling with the oncology team to connect with local resources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises starting at the cancer center/hospital and asking the oncologist, nurse navigator, or social work department for referrals."
      },
      {
        "criterion_number": 3,
        "description": "Introduce palliative medicine as a specialty for managing symptoms or end-of-life care for pancreatic cancer patients.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes palliative care and a palliative care counselor, emphasizing relief of symptoms, quality of life, anticipatory grief, and end-of-life issues."
      },
      {
        "criterion_number": 4,
        "description": "List at least three types of mental health care providers, including their credentials and any limitations in practice.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Multiple provider types and credentials are listed (e.g., psychologists, LCSWs, MFTs), but the response does not describe limitations in practice (e.g., prescribing authority, scope differences)."
      },
      {
        "criterion_number": 5,
        "description": "Mention at least one modality for delivery of mental health counseling, such as in-person or telehealth.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions starting at the cancer center/hospital (implies in-person) and suggests a brief phone consultation, indicating telecommunication as a modality."
      },
      {
        "criterion_number": 6,
        "description": "Explicitly state that choosing the best provider is individualized and cannot be recommended online.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that provider selection is individualized or that a specific recommendation cannot be made online."
      },
      {
        "criterion_number": 7,
        "description": "Mention providers affiliated with religious denominations or faith-based counseling options.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of faith-based counseling, chaplains, or religiously affiliated providers."
      },
      {
        "criterion_number": 8,
        "description": "Mention mental health resources available for family members and caregivers of cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses counseling for caregivers, couples, and families; mentions support groups and PanCAN as resources."
      },
      {
        "criterion_number": 9,
        "description": "Recommend seeking counseling proactively, not waiting for a crisis.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Encouraging tone but no explicit recommendation to seek counseling proactively or not to wait for a crisis."
      },
      {
        "criterion_number": 10,
        "description": "Recommend at least one additional way to improve overall wellbeing, such as nutrition, exercise, sleep, or symptom control.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not provide additional wellbeing recommendations beyond counseling; palliative care is described but not as a patient action for wellbeing like nutrition, exercise, or sleep."
      },
      {
        "criterion_number": 11,
        "description": "State that a licensed clinical social worker would be a good resource to utilize for advice and to be connected to further resources such as financial or caregiver support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically highlights LCSWs in oncology/palliative care and notes they can connect patients/families to financial aid, transportation, support groups, and system navigation."
      }
    ],
    "question_number": 205,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:58:07.769734",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 2,
        "description": "Recommend discussing mental health counseling with the oncology team to connect with local resources.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises asking the oncologist, nurse, nurse navigator, or a social worker at the cancer center for referrals, emphasizing starting with the medical team."
      },
      {
        "criterion_number": 3,
        "description": "Introduce palliative medicine as a specialty for managing symptoms or end-of-life care for pancreatic cancer patients.",
        "score_given": 10,
        "max_points": 10,
        "justification": "There is a dedicated section on palliative care describing its role at any stage, with expertise in pain management and symptom control, and how to obtain a referral."
      },
      {
        "criterion_number": 4,
        "description": "List at least three types of mental health care providers, including their credentials and any limitations in practice.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response lists multiple provider types and credentials (e.g., LCSW, LPC, LMFT, psychologists) but does not describe limitations in practice (e.g., who can prescribe, scope boundaries), which the criterion requires."
      },
      {
        "criterion_number": 5,
        "description": "Mention at least one modality for delivery of mental health counseling, such as in-person or telehealth.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Telehealth options are explicitly mentioned as virtual sessions offered by many therapists."
      },
      {
        "criterion_number": 6,
        "description": "Explicitly state that choosing the best provider is individualized and cannot be recommended online.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the response emphasizes therapeutic fit and interviewing counselors, it does not explicitly state that the best provider choice is individualized and cannot be determined online."
      },
      {
        "criterion_number": 7,
        "description": "Mention providers affiliated with religious denominations or faith-based counseling options.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Palliative care teams are noted to include chaplains who provide spiritual support, indicating faith-based options."
      },
      {
        "criterion_number": 8,
        "description": "Mention mental health resources available for family members and caregivers of cancer patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response repeatedly addresses support for family members and caregivers, including anticipatory grief, caregiver burnout, and family therapy."
      },
      {
        "criterion_number": 9,
        "description": "Recommend seeking counseling proactively, not waiting for a crisis.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It describes counseling as a wise and proactive step and promotes early use of palliative care, supporting a proactive approach."
      },
      {
        "criterion_number": 10,
        "description": "Recommend at least one additional way to improve overall wellbeing, such as nutrition, exercise, sleep, or symptom control.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response recommends palliative care for pain management and symptom control to improve quality of life."
      },
      {
        "criterion_number": 11,
        "description": "State that a licensed clinical social worker would be a good resource for advice and connecting to resources such as financial or caregiver support.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It highlights oncology social workers and LCSWs, noting they connect families to practical resources (financial aid, support groups, home care) and suggests asking a social worker at the cancer center for recommendations."
      }
    ],
    "question_number": 205,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:58:35.793662",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define what DNA damage repair pathways are in the human body.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines DDR as the cell's repair system for fixing DNA damage, using an analogy and accurate description of function."
      },
      {
        "criterion_number": 2,
        "description": "The response should list examples of genes implicated in DNA repair pathways in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly mentions BRCA1, BRCA2, PALB2, and ATM, which are key DDR genes relevant to pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain treatments in pancreatic cancer that are indicated for mutations in certain DNA repair pathway mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that PARP inhibitors are indicated for BRCA-mutated cases and that platinum-based chemotherapy is favored in DDR-deficient tumors; also notes radiation sensitivity."
      },
      {
        "criterion_number": 4,
        "description": "The response should list DNA pathway repair targeted therapies in pancreatic cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists PARP inhibitors and specifically names olaparib as a targeted therapy tied to DDR defects."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe how mutations in DNA damage repair pathways affect chemotherapy effectiveness.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes increased sensitivity of DDR-deficient tumors to platinum chemotherapy and radiation due to impaired repair."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe how mutations in these pathways are detected in tumors, which is through genetic testing of tumor tissue from a biopsy or through a blood test.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises tumor genomic testing and germline blood testing; clearly references both somatic and germline testing."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide references to scientific literature with PMID for any of the FDA-approved treatments listed in rubric 4.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No references or PMIDs are provided."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient discuss tumor genetic testing with their oncologist to understand if they are a candidate for any DNA damage repair pathway mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly recommends discussing genetic testing with the oncology team and provides questions to ask."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend the patient inquire about clinical trials in their local area that might be evaluating new drugs that target DNA damage repair pathways, or inquire about a referral to a local institution that might have general clinical trials for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of clinical trials or referrals to institutions conducting trials."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that around 5-10 percent of pancreatic cancers have these mutations.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not provide the prevalence estimate of DDR mutations in pancreatic cancer."
      }
    ],
    "question_number": 206,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:58:54.342160",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define what DNA damage repair pathways are in the human body.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines DDR as cellular systems that detect DNA damage, halt the cell cycle, repair damage, or trigger apoptosis; provides a stepwise description of detect/signal/repair/apoptosis."
      },
      {
        "criterion_number": 2,
        "description": "The response should list examples of genes implicated in DNA repair pathways in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists multiple relevant DDR genes including BRCA1, BRCA2, PALB2, ATM, and CHEK2."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain treatments in pancreatic cancer that are indicated for mutations in certain DNA repair pathway mutations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains platinum chemotherapy sensitivity in HRD tumors and details PARP inhibitor use (olaparib maintenance for germline BRCA-mutated metastatic pancreatic cancer post-platinum)."
      },
      {
        "criterion_number": 4,
        "description": "The response should list DNA pathway repair targeted therapies in pancreatic cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Names PARP inhibitors (olaparib; also mentions rucaparib, niraparib) and investigational DDR-targeting agents (ATR, ATM, WEE1, CHK1 inhibitors)."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe how mutations in DNA damage repair pathways affect chemotherapy effectiveness.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that HRD (e.g., BRCA/PALB2) increases sensitivity to platinum-based chemotherapy due to impaired repair of DNA crosslinks."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe how mutations in these pathways are detected in tumors, which is through genetic testing of tumor tissue from a biopsy or through a blood test.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly recommends germline genetic testing (blood) and somatic tumor sequencing (tumor tissue) and explains germline vs somatic mutations."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide references to scientific literature with PMID for any of the FDA-approved treatments listed in rubric 4.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No PMIDs or specific literature references are provided for olaparib or other therapies."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient discuss tumor genetic testing with their oncologist to understand if they are a candidate for any DNA damage repair pathway mutations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises discussing germline and somatic testing with the care team and provides specific questions to ask."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend the patient inquire about clinical trials in their local area that might be evaluating new drugs that target DNA damage repair pathways, or inquire about a referral to a local institution that might have general clinical trials for pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages consideration of clinical trials for DDR-targeted therapies and suggests asking clinicians about relevant trials."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that around 5-10 percent of pancreatic cancers have these mutations.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not state the approximate prevalence (5\u201310%) of DDR mutations/HRD in pancreatic cancer."
      }
    ],
    "question_number": 206,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T20:59:16.517527",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must clearly define inflammation using terms such as \u201cimmune response,\u201d \u201ctissue injury,\u201d or \u201cprotective mechanism.\u201d",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response discusses cytokines and immune cells, it does not explicitly define inflammation as an immune response to tissue injury or as a protective mechanism."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly distinguish between acute and chronic inflammation, mentioning characteristics like \u201cshort-term\u201d vs. \u201clong-term\u201d or \u201crapid onset\u201d vs. \u201cpersistent.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "Chronic inflammation is mentioned as a risk factor, but there is no explicit contrast with acute inflammation or mention of short-term vs. long-term characteristics."
      },
      {
        "criterion_number": 3,
        "description": "The response must describe at least two medical strategies for managing inflammation, such as \u201ctargeted therapies,\u201d \u201cimmunotherapies,\u201d \u201csteroids,\u201d or \u201cpain management.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides multiple strategies, including steroids and NSAIDs for inflammation and symptom control, and notes that chemotherapy, radiation, and surgery reduce tumor-driven inflammation."
      },
      {
        "criterion_number": 4,
        "description": "The response must state that there is no formal, evidence-based strategy to quantify and target inflammation in cancer patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not state that no formal, evidence-based strategy exists to quantify and specifically target inflammation in cancer patients."
      },
      {
        "criterion_number": 5,
        "description": "The response must state that treating the cancer itself, such as through \u201csurgery\u201d or \u201cradiation,\u201d is postulated to improve cancer-related inflammation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that shrinking or removing the tumor (via chemotherapy, radiation, or surgery) reduces inflammation by removing the primary source of inflammatory signals."
      },
      {
        "criterion_number": 6,
        "description": "The response must mention chronic pancreatitis or chronic pancreatic injury as a factor in cancer formation and provide at least one scientific reference with a PMID.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Chronic pancreatitis is identified as a risk factor, but no scientific reference or PMID is provided."
      },
      {
        "criterion_number": 7,
        "description": "The response must recommend at least two lifestyle interventions to decrease inflammation, such as \u201cplant-based diet,\u201d \u201cexercise,\u201d \u201chydration,\u201d or \u201cgood quality sleep.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends an anti-inflammatory diet, gentle physical activity, and stress management, meeting the requirement for at least two lifestyle interventions."
      },
      {
        "criterion_number": 8,
        "description": "The response must recommend against nicotine and alcohol use and reference their role in promoting inflammation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of avoiding nicotine or alcohol or their role in promoting inflammation."
      },
      {
        "criterion_number": 9,
        "description": "The response must recommend that the patient report any symptoms to their oncology team for symptom management.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Although it advises talking to the oncology team and seeking palliative care, it does not explicitly recommend reporting symptoms to the team for management."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that chronic inflammation promotes tumor growth.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response clearly states that inflammation fuels tumor growth and spread (e.g., angiogenesis, stromal breakdown), and notes chronic inflammation as a risk factor for cancer."
      },
      {
        "criterion_number": 11,
        "description": "The response must explicitly state that inflammatory signaling pathways are overactivated in cancer, using terms like \u201coveractivated,\u201d \u201cupregulated,\u201d or \u201cenhanced.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit mention of overactivation or upregulation of inflammatory signaling pathways is made."
      },
      {
        "criterion_number": 12,
        "description": "The response must explicitly state that the immune system can be activated to recognize and attack cancer, using terms like \u201cempower,\u201d \u201cstimulate,\u201d or \u201cleverage.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not discuss leveraging or stimulating the immune system to attack cancer; it focuses on the tumor co-opting immune cells."
      },
      {
        "criterion_number": 13,
        "description": "The response must explicitly state that anti-inflammatory drugs are not used as a primary treatment for pancreatic cancer. Synonyms for \u201cprimary\u201d include \u201cmain\u201d or \u201cfirst-line.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "While steroids and NSAIDs are discussed, the response does not explicitly state that anti-inflammatory drugs are not a primary or first-line treatment for pancreatic cancer."
      },
      {
        "criterion_number": 14,
        "description": "The response must explicitly state that NSAIDs and steroids are prescribed to manage symptoms associated with cancer, using terms like \u201csymptom management,\u201d \u201csymptom control,\u201d or \u201calleviate symptoms.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "The section 'Medications to Control Inflammation and Symptoms' explicitly positions steroids and NSAIDs as used for symptom management and symptom control."
      }
    ],
    "question_number": 207,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T20:59:45.989508",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define inflammation using terms such as \u201cimmune response,\u201d \u201ctissue injury,\u201d or \u201cprotective mechanism.\u201d",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response discusses cytokines and immune cells but does not clearly define inflammation as an immune response to tissue injury or a protective mechanism."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly distinguish between acute and chronic inflammation (e.g., short-term vs. long-term).",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit distinction between acute and chronic inflammation is provided; only chronic pancreatitis is mentioned as a risk factor."
      },
      {
        "criterion_number": 3,
        "description": "Describe at least two medical strategies for managing inflammation (e.g., targeted therapies, immunotherapies, steroids, pain management).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Multiple strategies are covered, including NSAIDs, steroids, cytokine targeting, NF-\u03baB inhibitors, immunotherapy, and pain management (opioids, nerve blocks)."
      },
      {
        "criterion_number": 4,
        "description": "State that there is no formal, evidence-based strategy to quantify and target inflammation in cancer patients.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not state that there is no formal, evidence-based strategy to quantify and target inflammation."
      },
      {
        "criterion_number": 5,
        "description": "State that treating the cancer itself (e.g., surgery, radiation) improves cancer-related inflammation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly notes that chemotherapy, radiation, and surgery reduce tumor burden and thereby decrease inflammatory signaling."
      },
      {
        "criterion_number": 6,
        "description": "Mention chronic pancreatitis as a factor in cancer formation and provide at least one scientific reference with a PMID.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Chronic pancreatitis is mentioned as a risk factor, but no scientific reference with a PMID is provided."
      },
      {
        "criterion_number": 7,
        "description": "Recommend at least two lifestyle interventions to decrease inflammation (e.g., plant-based diet, exercise, hydration, good sleep).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommendations include anti-inflammatory dietary patterns and exercise; stress reduction is also mentioned."
      },
      {
        "criterion_number": 8,
        "description": "Recommend against nicotine and alcohol use and reference their role in promoting inflammation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response advises smoking cessation and alcohol avoidance and explicitly labels both as pro-inflammatory."
      },
      {
        "criterion_number": 9,
        "description": "Recommend that the patient report symptoms to their oncology team for symptom management.",
        "score_given": 8,
        "max_points": 8,
        "justification": "The response encourages open discussion of symptoms with the oncology team for active management."
      },
      {
        "criterion_number": 10,
        "description": "Explicitly state that chronic inflammation promotes tumor growth.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states chronic inflammation is a key driver and describes inflammation promoting tumor growth."
      },
      {
        "criterion_number": 11,
        "description": "Explicitly state that inflammatory signaling pathways are overactivated in cancer (e.g., overactivated, upregulated, enhanced).",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response notes COX-2 is often overexpressed in pancreatic cancer and discusses activation of NF-\u03baB and STAT3; 'overexpressed' satisfies the upregulation requirement."
      },
      {
        "criterion_number": 12,
        "description": "Explicitly state that the immune system can be activated to recognize and attack cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that immunotherapies can re-educate the immune system to fight cancer, meeting the criterion."
      },
      {
        "criterion_number": 13,
        "description": "Explicitly state that anti-inflammatory drugs are not used as a primary treatment for pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not explicitly state that anti-inflammatory drugs are not a main/first-line treatment."
      },
      {
        "criterion_number": 14,
        "description": "Explicitly state that NSAIDs and steroids are prescribed to manage symptoms associated with cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Steroids are described as used to manage symptoms, but NSAIDs are discussed mainly as studied/targeting COX-2 without explicitly stating their use for symptom management."
      }
    ],
    "question_number": 207,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:00:19.975932",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention using a pill organizer with compartments for different times of the day and days of the week.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends weekly AM/PM organizers and multi-dose daily organizers with 3\u20134 compartments per day, and describes how to use them."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention using a medication management application, with examples such as Medisafe, MyTherapy, or CareZone.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Names specific apps (Medisafe and MyTherapy) and explains their features, including caregiver notifications."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention setting alarms or reminders on digital devices to alert when it\u2019s time to take medication.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes that medication reminder apps send alerts when it\u2019s time to take meds and also mentions smart dispensers with alarms and shared calendar reminders."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention creating a physical chart or digital document listing all medications, dosages, and times.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details a 'Master Medication List' including name, dosage, purpose, schedule, prescriber, and dates, with guidance on storage and updates."
      },
      {
        "criterion_number": 5,
        "description": "The response should direct the patient to discuss options for medication management with their oncology team and/or pharmacy team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages engaging the pharmacist for blister packs, medication review, auto-refills, and identifies oncology nurse navigator and palliative care team as points of contact."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend exploring medication delivery services and bubble packs.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Recommends blister packs (compliance packaging) but does not mention medication delivery services; therefore the criterion as stated (delivery services and bubble packs) is not fully met."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient have a loved one help with their medication management.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Suggests designating one person to fill pill organizers, sharing the medication list with a trusted family member, and using Medisafe\u2019s caregiver alerts."
      },
      {
        "criterion_number": 8,
        "description": "The response should empathize about the medication burden in patients undergoing cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Opens with empathetic language acknowledging the difficulty and stress, and closes with supportive encouragement to the caregiver."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention meeting with a pharmacist or provider to complete a medication reconciliation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises requesting a comprehensive medication review with a pharmacist, including OTCs and supplements, which aligns with medication reconciliation."
      }
    ],
    "question_number": 208,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:00:42.469297",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should mention using a pill organizer with compartments for different times of the day and days of the week.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends 7-day organizers with AM/PM/Noon/Bedtime compartments, multi-week organizers, and electronic pill dispensers."
      },
      {
        "criterion_number": 2,
        "description": "The response should mention using a medication management application, with examples such as Medisafe, MyTherapy, or CareZone.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Names multiple apps including Medisafe, MyTherapy, and CareZone, with pros/cons and features."
      },
      {
        "criterion_number": 3,
        "description": "The response should mention setting alarms or reminders on digital devices to alert when it\u2019s time to take medication.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends smartphone app reminders, phone alarms, kitchen timers, and smart speaker reminders."
      },
      {
        "criterion_number": 4,
        "description": "The response should mention creating a physical chart or digital document listing all medications, dosages, and times.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details a 'Master Medication List' with specific fields (name, dose, timing, prescriber, instructions) and suggests spreadsheets/printed copies."
      },
      {
        "criterion_number": 5,
        "description": "The response should direct the patient to discuss options for medication management with their oncology team and/or pharmacy team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises bringing the medication list to every appointment, having doctor/nurse review for accuracy, and using one pharmacy while engaging pharmacy staff as resources."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend exploring medication delivery services and bubble packs.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of pharmacy delivery services or blister/bubble pack adherence packaging."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient have a loved one help with their medication management.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages caregiver collaboration, shared responsibility, designating a 'Medication Manager,' and caregiver check-ins."
      },
      {
        "criterion_number": 8,
        "description": "The response should empathize about the medication burden in patients undergoing cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Expresses sympathy and acknowledges the overwhelming nature of complex regimens and emotional toll."
      },
      {
        "criterion_number": 9,
        "description": "The response should mention meeting with a pharmacist or provider to complete a medication reconciliation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically instructs to perform medication reconciliation at every appointment with the doctor or nurse and to involve the pharmacy."
      }
    ],
    "question_number": 208,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:01:04.940399",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define oncogenes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines oncogenes as mutated versions of proto-oncogenes that drive constant growth, using the 'stuck accelerator' analogy."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe that oncogenes can undergo mutation, which might put the individual at risk for developing cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that proto-oncogenes mutate to oncogenes and that this leads to uncontrolled growth and cancer development."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe how oncogenes mutate.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not describe mechanisms of mutation (e.g., point mutations, amplifications, translocations) or how these alterations arise; only states that mutation occurs and results in a stuck 'ON' signal."
      },
      {
        "criterion_number": 5,
        "description": "The response should reference which mutated oncogenes are implicated in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies KRAS as the key oncogene in pancreatic ductal adenocarcinoma and notes its high mutation frequency."
      },
      {
        "criterion_number": 6,
        "description": "The response should state whether there are FDA-approved treatments available for pancreatic cancers with mutated oncogenes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that KRAS-targeted drugs exist for some cancers but are being studied in clinical trials for pancreatic cancer, which implies there are no FDA-approved targeted treatments for pancreatic cancer oncogene mutations."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that patients with pancreatic cancer undergo tumor genetic testing either with biopsy of primary tumor or blood test.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Encourages asking about tumor mutations but does not explicitly recommend undergoing tumor genetic testing or specify biopsy-based or blood-based (liquid biopsy) testing."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that patients inquire with their oncology team if there are clinical trial opportunities available to them, or a local institution.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions that therapies are being studied in clinical trials but does not advise the patient to ask their team about clinical trial opportunities."
      }
    ],
    "question_number": 209,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:01:27.756526",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define oncogenes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines proto-oncogenes and oncogenes, using accurate analogy (gas pedal) and explaining that oncogenes are mutated/abnormally activated versions driving uncontrolled growth."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe that oncogenes can undergo mutation, which might put the individual at risk for developing cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains that mutations convert proto-oncogenes into oncogenes and that these changes drive uncontrolled proliferation and cancer development."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe how oncogenes mutate.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Details mechanisms: acquired somatic mutations (random errors, carcinogens, radiation, viruses, chronic inflammation) and inherited germline changes; appropriate and complete."
      },
      {
        "criterion_number": 5,
        "description": "The response should reference which mutated oncogenes are implicated in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically names KRAS (with prevalence in PDAC) and mentions other oncogenes (MYC, AKT2) implicated in pancreatic cancer."
      },
      {
        "criterion_number": 6,
        "description": "The response should state whether there are FDA-approved treatments available for pancreatic cancers with mutated oncogenes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes KRAS inhibitors are approved for other cancers and are being investigated in pancreatic cancer but does not clearly state whether FDA-approved targeted treatments exist for pancreatic cancer oncogene mutations."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that patients with pancreatic cancer undergo tumor genetic testing either with biopsy of primary tumor or blood test.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not explicitly recommend tumor genomic profiling via tissue biopsy or blood (ctDNA); only suggests discussing implications with the oncologist."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that patients inquire with their oncology team if there are clinical trial opportunities available to them, or a local institution.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions that KRAS inhibitors are being studied in clinical trials but does not advise the patient to ask their oncology team about clinical trial eligibility or local opportunities."
      }
    ],
    "question_number": 209,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:01:54.508631",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe that treatment sequencing in pancreatic cancer is determined by the stage of the cancer and the intent of the treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly states sequencing depends on stage (resectable, borderline resectable, locally advanced, metastatic) and distinguishes intent (curative with surgery vs. control/palliation in metastatic disease)."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe that sometimes pancreatic cancer management requires different modalities of treatments, such as chemotherapy and surgery.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists surgery, chemotherapy, and radiation as main components and discusses combining them in different orders."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe that in pancreatic tumors thought to be surgically resectable, patients often undergo chemotherapy prior to surgery to shrink the tumor and kill any micrometastases for the best possible surgical outcome.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it explains neoadjuvant therapy benefits (shrink tumor, treat micrometastases), it frames this primarily for borderline resectable/locally advanced disease and presents resectable tumors as surgery-first. It does not state that resectable tumors often receive preoperative chemotherapy."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that surgery rarely plays a role in advanced pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "For metastatic disease, it states surgery is generally not helpful and chemotherapy is primary, aligning with surgery rarely playing a role."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe what treatment sequencing in pancreatic cancer is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines sequencing as the order in which modalities are combined and provides concrete sequences (surgery \u2192 chemo; chemo \u00b1 radiation \u2192 surgery \u2192 more chemo)."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain the goal of treatment sequencing in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains goals: maximize chance of complete resection, treat micrometastases early, assess tumor biology, ensure patients receive full systemic therapy, and overall optimize outcomes."
      },
      {
        "criterion_number": 7,
        "description": "The response should state risks involved if cancer treatment is not appropriately sequenced.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes risks such as undergoing a major surgery that is unlikely to benefit if cancer biology is aggressive and the possibility of being too weak after surgery to receive needed chemotherapy."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient request a multidisciplinary conference to discuss their pancreatic cancer management recommendations.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly advises asking whether the case is being discussed by a multidisciplinary tumor board and suggests that it should be."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe what a tumor board (or multidisciplinary conference) is for discussions on management of pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Identifies a tumor board as multidisciplinary (surgeons, oncologists, radiologists, etc.), implying a group discussion for management decisions."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain that the oncology care team needs to gather information to make informed recommendations on pancreatic cancer treatment, such as imaging studies, tumor biomarkers, and possibly tumor genetic testing.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions CA 19-9 as a tumor marker but does not explicitly reference imaging studies or tumor genetic testing; therefore, it does not comprehensively state the information-gathering needs."
      },
      {
        "criterion_number": 11,
        "description": "The response should emphasize that treatment sequencing is individualized to the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes a highly personalized, non\u2013one-size-fits-all approach based on tumor characteristics and patient health."
      },
      {
        "criterion_number": 12,
        "description": "The response should define the following terms: neoadjuvant, adjuvant, perioperative.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Defines adjuvant (after surgery) and functionally explains neoadjuvant (before surgery), but does not define or mention perioperative."
      }
    ],
    "question_number": 210,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:02:20.480424",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should describe that treatment sequencing in pancreatic cancer is determined by the stage of the cancer and the intent of the treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly ties sequencing to stage/resectability categories (resectable, borderline, locally advanced, metastatic) and includes treatment goals (cure, extend life, symptom control)."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe that sometimes pancreatic cancer management requires different modalities of treatments, such as chemotherapy and surgery.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly discusses multimodality care including chemotherapy, surgery, and radiation across different scenarios."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe that in pancreatic tumors thought to be surgically resectable, patients often undergo chemotherapy prior to surgery to shrink the tumor and kill any micrometastases for the best possible surgical outcome.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes neoadjuvant therapy even for resectable tumors as increasingly common, with benefits of shrinking tumor and treating micrometastases before surgery."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that surgery rarely plays a role in advanced pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States surgery is usually not possible initially in locally advanced disease and in metastatic disease is used occasionally for symptom relief, not cure."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe what treatment sequencing in pancreatic cancer is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides concrete sequences (e.g., surgery \u2192 adjuvant chemotherapy; neoadjuvant chemotherapy \u2192 surgery \u2192 adjuvant) for each stage category, illustrating the concept of treatment order."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain the goal of treatment sequencing in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains goals including optimizing surgical success, treating micrometastases early, assessing tumor biology, and maximizing tolerance and recovery."
      },
      {
        "criterion_number": 7,
        "description": "The response should state risks involved if cancer treatment is not appropriately sequenced.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies risks such as incomplete tumor removal without neoadjuvant therapy, undergoing unnecessary surgery if disease progresses on chemo, and suboptimal tolerance/outcomes."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient request a multidisciplinary conference to discuss their pancreatic cancer management recommendations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it emphasizes the importance of a multidisciplinary team, it does not specifically recommend that the patient request a multidisciplinary conference or tumor board review."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe what a tumor board (or multidisciplinary conference) is for discussions on management of pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes a multidisciplinary team with surgeons, medical and radiation oncologists, pathologists, radiologists, etc., collaborating to develop a personalized plan, which conveys the function of a tumor board."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain that the oncology care team needs to gather information to make informed recommendations on pancreatic cancer treatment, such as imaging studies, tumor biomarkers, and possibly tumor genetic testing.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mentions tumor characteristics (e.g., vessel involvement) implying imaging, and explicitly references genetic/molecular biomarkers (e.g., BRCA, MSI) that influence treatment choices."
      },
      {
        "criterion_number": 11,
        "description": "The response should emphasize that treatment sequencing is individualized to the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Repeatedly emphasizes individualized decision-making and a personalized plan guided by multiple patient- and tumor-specific factors."
      },
      {
        "criterion_number": 12,
        "description": "The response should define the following terms: neoadjuvant, adjuvant, perioperative.",
        "score_given": 0,
        "max_points": 6,
        "justification": "Uses and contextualizes neoadjuvant (pre-operative) and adjuvant (post-operative) therapy but does not define the term perioperative."
      }
    ],
    "question_number": 210,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:03:07.415460",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define hypoxia as a low oxygen state often seen in tumors because the tumor outgrows its blood supply.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines hypoxia as low oxygen and explains that pancreatic tumors outgrow their blood supply with disorganized, leaky vessels and dense stroma leading to oxygen-poor pockets."
      },
      {
        "criterion_number": 2,
        "description": "Describe why cancer cells that exist in a hypoxic environment are difficult to treat.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains multiple reasons: reduced drug delivery, cell dormancy reducing chemo efficacy, radiation resistance, immune suppression, and adaptive responses via HIF-1\u03b1 increasing resistance."
      },
      {
        "criterion_number": 3,
        "description": "Describe how hypoxic environments affect cancer\u2019s response to treatment.",
        "score_given": 9,
        "max_points": 9,
        "justification": "The answer details decreased radiation effectiveness, chemotherapy delivery and cell-cycle limitations, and reduced immunotherapy effectiveness due to immune suppression."
      },
      {
        "criterion_number": 4,
        "description": "State that radiation therapy becomes less effective in hypoxic conditions because oxygen plays a role in radiation-induced DNA damage.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states radiation relies on oxygen to form DNA-damaging free radicals and that hypoxia makes cells 2\u20133 times more resistant."
      },
      {
        "criterion_number": 5,
        "description": "Describe the mechanism of action of VEGF inhibitors and their postulated role in the treatment of hypoxic tumors.",
        "score_given": 0,
        "max_points": 5,
        "justification": "VEGF inhibitors are not mentioned, nor is anti-angiogenic mechanism or vascular normalization in hypoxic tumors discussed."
      },
      {
        "criterion_number": 6,
        "description": "Explain whether there is evidence-based information about hyperbaric oxygen therapy in hypoxic tumors.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response briefly mentions breathing pure oxygen and improving blood flow as experimental but does not address hyperbaric oxygen therapy specifically or summarize evidence."
      },
      {
        "criterion_number": 7,
        "description": "Describe how hypoxic environments affect the immune system\u2019s ability to access cancer cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states hypoxia creates a hostile environment for T cells and makes immunotherapies less effective, indicating impaired immune access/function."
      },
      {
        "criterion_number": 8,
        "description": "Recommend discussing clinical trials focusing on tumor hypoxic environments available in the patient\u2019s area.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly suggests asking about clinical trials that specifically target tumor hypoxia."
      },
      {
        "criterion_number": 9,
        "description": "State that hypoxia can make the tumor more aggressive and promote metastasis (spread).",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response clearly states hypoxia activates HIF-1\u03b1 leading to metastasis and increased aggressiveness."
      }
    ],
    "question_number": 211,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:03:26.943784",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define hypoxia as a low oxygen state often seen in tumors because the tumor outgrows its blood supply.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines tumor hypoxia as low oxygen within the tumor and explains causes including rapid growth outpacing blood supply, abnormal vasculature, and dense stroma compressing vessels."
      },
      {
        "criterion_number": 2,
        "description": "Describe why cancer cells that exist in a hypoxic environment are difficult to treat.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains multiple reasons: reduced drug delivery due to poor perfusion, altered cell biology (quiescence and metabolic shifts), radiation resistance, and immune suppression, all making treatment more difficult."
      },
      {
        "criterion_number": 3,
        "description": "Describe how hypoxic environments affect cancer\u2019s response to treatment.",
        "score_given": 9,
        "max_points": 9,
        "justification": "Addresses diminished response to radiation, decreased chemotherapy efficacy, and challenges for immunotherapy in hypoxic areas."
      },
      {
        "criterion_number": 4,
        "description": "State that radiation therapy becomes less effective in hypoxic conditions because oxygen plays a role in radiation-induced DNA damage.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states radiation relies on oxygen to stabilize free radical\u2013mediated DNA damage; hypoxia reduces this, making cells more resistant."
      },
      {
        "criterion_number": 5,
        "description": "Describe the mechanism of action of VEGF inhibitors and their postulated role in the treatment of hypoxic tumors.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions anti-angiogenic agents generally but does not describe VEGF inhibitors specifically or their mechanism (VEGF blockade/vascular normalization) or clearly articulate their role in hypoxia."
      },
      {
        "criterion_number": 6,
        "description": "Explain whether there is evidence-based information about hyperbaric oxygen therapy in hypoxic tumors.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of hyperbaric oxygen therapy or evidence regarding its use in hypoxic tumors."
      },
      {
        "criterion_number": 7,
        "description": "Describe how hypoxic environments affect the immune system\u2019s ability to access cancer cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that hypoxia suppresses immune cell activity, making immunotherapy less effective."
      },
      {
        "criterion_number": 8,
        "description": "Recommend discussing clinical trials focusing on tumor cell hypoxic environments.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Encourages discussing clinical trials specifically targeting hypoxia or hypoxic cells with the oncology team."
      },
      {
        "criterion_number": 9,
        "description": "State that hypoxia can make the tumor more aggressive and promote metastasis (spread).",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly notes hypoxia increases aggressiveness and promotes invasion/metastasis via pathways such as HIF-1\u03b1."
      }
    ],
    "question_number": 211,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:03:52.447960",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend documenting questions/concerns in advance of appointments.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises creating a Question List in a Cancer Care Binder and preparing a focused agenda with the top 3 questions before each visit."
      },
      {
        "criterion_number": 2,
        "description": "Encourage clarification and question-asking during appointments.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages politely interrupting to clarify terms, using the teach-back method, and ensuring key questions are asked during the visit."
      },
      {
        "criterion_number": 3,
        "description": "Recommend requesting a language interpreter if more comfortable in another language.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of interpreters or language assistance services."
      },
      {
        "criterion_number": 4,
        "description": "Recommend bringing a loved one/family member and taking notes or recording.",
        "score_given": 110,
        "max_points": 110,
        "justification": "Strongly recommends bringing a second person as a scribe/advocate, taking detailed notes, and explicitly asks to record the conversation."
      },
      {
        "criterion_number": 5,
        "description": "Recommend utilizing online patient portals for messaging if needed.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly advises using the patient portal (e.g., MyChart) for non-urgent communication, reviewing summaries, and results."
      },
      {
        "criterion_number": 6,
        "description": "Recommend inquiring about best communication contacts/channels and establishing a point person.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises asking 'Who and When' to clarify who to contact for various needs and identifies nurse navigator/other team roles as contacts; also suggests a family point person for outbound communication."
      },
      {
        "criterion_number": 7,
        "description": "Provide a list of online resources for patients and family.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No external online resources or links (e.g., PanCAN, NCI, ASCO) are provided."
      },
      {
        "criterion_number": 8,
        "description": "Recommend additional points of contact such as patient advocates, social workers, nurses, palliative specialists.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically recommends involving oncology nurses/nurse navigators, palliative care, and oncology social workers."
      },
      {
        "criterion_number": 9,
        "description": "Emphasize the importance of feeling supported in the cancer journey.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Opens with empathy, encourages self-care, and frames steps as empowering and supportive, emphasizing advocacy and support."
      },
      {
        "criterion_number": 10,
        "description": "Inform patients they can ask for a written summary after the visit.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions reviewing appointment summaries in the portal but does not advise requesting a written summary from the clinician after the visit."
      },
      {
        "criterion_number": 12,
        "description": "State that patient navigators can assist with care coordination and communications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "References nurse navigators as accessible resources for coordination and communication, fulfilling the navigator role."
      }
    ],
    "question_number": 212,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:04:19.216683",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend that the patient document all of their questions or concerns in advance of an appointment with the oncology team to ensure everything is addressed during their allotted face-to-face time.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends creating and prioritizing a list of questions before appointments and keeping a running list in a binder/digital folder."
      },
      {
        "criterion_number": 2,
        "description": "The response should encourage the patient and/or family members to ask for clarification on any aspects of care that are unclear, and to encourage question-asking during appointments.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Strongly encourages asking clarifying questions, using teach-back, and ensuring top questions are addressed; provides example prompts."
      },
      {
        "criterion_number": 3,
        "description": "The response should recommend that the patient request a language interpreter if they feel more comfortable communicating in an alternate language than what their medical team speaks.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of requesting a language interpreter or language access services."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient bring a loved one or family member to all appointments and consider taking notes or recording the conversation.",
        "score_given": 110,
        "max_points": 110,
        "justification": "Explicitly advises bringing at least one family member, taking comprehensive notes, and requesting permission to record appointments."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend that the patient utilize online patient portals to send messages if needed.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends using the patient portal for messaging, viewing results, and managing appointments; also mentions portal follow-up after visits."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend that the patient inquire about communication contacts and channels that would be best to contact their oncology team as soon as possible in their treatment journey to establish a \u201cpoint person.\u201d",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises designating a family spokesperson, understanding team roles, keeping a contact list with phone/emails, and engaging a nurse navigator/care coordinator as a bridge\u2014effectively establishing contacts and a point person."
      },
      {
        "criterion_number": 7,
        "description": "The response should provide a list of online resources that patients and family members can reference to provide some answers to questions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No online resource list (e.g., reputable websites or hotlines) is provided."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend additional points of contact with the oncology team, such as patient advocates, social workers, nurses, and/or palliative medicine specialists.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends nurse navigator/care coordinator, patient advocate/ombudsman, and palliative care; these are appropriate additional contacts."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize the importance of feeling supported in their cancer journey.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes support, self-care, and caregiver support groups; validates the family\u2019s efforts."
      },
      {
        "criterion_number": 10,
        "description": "The response should inform patients that they can ask for a written summary of their medical appointments after the visit.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Encourages note-taking and recording but does not suggest requesting a written after-visit summary from the clinic."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that, if available, patient navigators can be a useful resource to assist with care coordination and communications.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically highlights nurse navigators/care coordinators as valuable resources for coordination and communication."
      }
    ],
    "question_number": 212,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:05:24.747000",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define cancer cell plasticity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicit definition provided: 'Cancer cell plasticity is the remarkable ability of cancer cells to change their identity, behavior, and characteristics to survive.'"
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how cancer cell plasticity makes cancer cells more difficult to treat.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Details multiple mechanisms: chemoresistance, tumor recurrence, metastasis, and ineffectiveness of targeted therapies due to state switching."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the epithelial-mesenchymal transition in pancreatic cancer.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Clearly explains EMT with 'Builder' (epithelial) vs 'Explorer' (mesenchymal) states, triggers (e.g., chemotherapy), increased motility, and toughness."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role plasticity plays in the metastatic potential of cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that EMT enables invasion and dissemination and calls plasticity 'a direct engine for metastasis,' linking state changes to spread."
      },
      {
        "criterion_number": 5,
        "description": "The response should define and describe cancer cell dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes dormancy via cancer stem cells being 'often dormant or slow-growing' and the concept of cells that 'lie dormant' and 'reawaken' leading to relapse."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe how cancer cell plasticity can contribute to cancer cell dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links plasticity to adoption of a stem-like 'queen bee' state that is often dormant and resistant, implying state switching into dormancy that survives therapy."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe how cancer cell plasticity allows cancer cells to evade the immune system, making immunotherapy relatively ineffective.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions adaptation to 'an attack from the immune system,' it does not explain immune evasion mechanisms or relate this to limited effectiveness of immunotherapy."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention ways that cancer-directed therapy can be used to attempt to overcome cancer cell plasticity, such as treatment sequencing and medication combinations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Covers combination therapies, targeting plastic/mesenchymal or CSC states, and adaptive therapy strategies to manage resistance."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that therapeutic strategies to target plasticity is an active area of research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states researchers are developing drugs and approaches to counter plasticity and frames it as a major focus for the future."
      }
    ],
    "question_number": 213,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:05:50.603202",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define cancer cell plasticity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines plasticity as cancer cells' ability to change identity, characteristics, and function in response to environment/signals, with examples (epigenetic reprogramming, metabolic shifts, phenotype changes)."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how cancer cell plasticity makes cancer cells more difficult to treat.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains primary and acquired resistance, pathway bypass, phenotypic switching under treatment pressure, dormancy resisting chemo/radiation, and microenvironment interactions that promote resistance."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the epithelial-mesenchymal transition in pancreatic cancer.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Defines EMT in PDAC as a shift from epithelial to mesenchymal traits, increasing motility, invasiveness, and resistance; mentions EMT as a mechanism of phenotypic switching during treatment."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role plasticity plays in the metastatic potential of cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links EMT-driven plasticity to loss of adhesion, increased motility/invasion, intravasation, and colonization at distant sites, noting adaptation to new microenvironments."
      },
      {
        "criterion_number": 5,
        "description": "The response should define and describe cancer cell dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines dormancy as a slow-cycling state resistant to chemo/radiation with potential to reawaken and drive relapse."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe how cancer cell plasticity can contribute to cancer cell dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that plastic cells can enter a dormant, slow-cycling state under treatment pressure, connecting plasticity to dormancy-mediated resistance."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe how cancer cell plasticity allows cancer cells to evade the immune system, making immunotherapy relatively ineffective.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes plastic cells can alter surface markers and secrete immunosuppressive factors, contributing to immune evasion; explicitly ties this to limited success of immunotherapy in PDAC."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention ways that cancer-directed therapy can be used to attempt to overcome cancer cell plasticity, such as treatment sequencing and medication combinations.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends targeting EMT/epigenetics/cancer stem cells, combination and sequencing strategies, stroma modulation, and adaptive monitoring with liquid biopsies."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that therapeutic strategies to target plasticity is an active area of research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states this is a major focus of intensive research with ongoing efforts to develop targeted therapies."
      }
    ],
    "question_number": 213,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:06:06.105669",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define mechanical forces in relation to cancer cells, explicitly mentioning \u201cphysical forces\u201d or \u201cpressure.\u201d",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly discusses mechanical forces as solid stress and interstitial fluid pressure, repeatedly using terms like \u201cphysically hard,\u201d \u201cpressure,\u201d and \u201ccollapses blood vessels,\u201d clearly framing them as physical forces acting on tumors."
      },
      {
        "criterion_number": 2,
        "description": "Describe the effect of different mechanical forces on cancer growth and proliferation, including activation of pathways/signaling pathways.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It details how stiffness and pressure promote growth, invasiveness, survival, and metastasis, and names the concept of mechanotransduction by which physical cues become biochemical signals. While not naming specific pathways (e.g., YAP/TAZ), it adequately covers signaling effects."
      },
      {
        "criterion_number": 3,
        "description": "Define desmoplastic stroma, often seen in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly defines the stroma as dense, fibrous, scar-like tissue and labels the condition as desmoplasia, emphasizing its thickness and stiffness in pancreatic cancer."
      },
      {
        "criterion_number": 5,
        "description": "Describe the pancreatic cancer tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes fibroblast activation, collagen-rich matrix, vessel compression, leaky/dysfunctional vasculature, high interstitial fluid pressure, hypoxia, drug delivery barriers, and immune exclusion\u2014providing a comprehensive TME overview."
      },
      {
        "criterion_number": 6,
        "description": "Mention future research directions pertaining to desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses ongoing development of therapies to soften/break down stroma, relieve pressure, normalize vasculature, and the strategy of combination therapies; suggests clinical trials for stroma-disrupting agents."
      },
      {
        "criterion_number": 7,
        "description": "Explain if there are FDA approved therapies that act on the desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response references developing therapies and clinical trials but does not state whether FDA-approved stroma-targeting therapies exist for pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "State that in pancreatic cancer, the stroma is very dense and stiff, leading to high interstitial pressure and reduced oxygen and nutrient delivery.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response states the stroma is dense and stiff and that fluid pressure is high, and explicitly mentions reduced oxygen (hypoxia). However, it does not explicitly mention reduced nutrient delivery, which is required by the criterion."
      },
      {
        "criterion_number": 9,
        "description": "State that the dense stroma can impede treatment delivery and induce hypoxia, explicitly mentioning \u201chypoxia\u201d and \u201ctreatment resistance.\u201d",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly states drug delivery is blocked and mentions \u201chypoxia,\u201d and notes cancer becomes \u201cmore resistant to treatment,\u201d which satisfies the requirement to mention treatment resistance."
      },
      {
        "criterion_number": 10,
        "description": "State that the dense stroma can impede immune cells from reaching the tumor, explicitly mentioning \u201cimmune evasion\u201d or \u201creduced efficacy of immunotherapy.\u201d",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it explains that the dense stroma forms a physical wall preventing T-cells from entering and can deactivate immune cells, it does not explicitly use the terms \u201cimmune evasion\u201d or \u201creduced efficacy of immunotherapy,\u201d as required."
      }
    ],
    "question_number": 214,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:06:35.047083",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define mechanical forces in relation to cancer cells, explicitly mentioning \u201cphysical forces\u201d or \u201cpressure.\u201d",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly defines mechanical forces as the physical forces cells experience and lists examples including solid stress/compression and interstitial fluid pressure, directly using the terms \u201cphysical forces\u201d and \u201cpressure.\u201d"
      },
      {
        "criterion_number": 2,
        "description": "The response should describe the effect of different mechanical forces on cancer growth and proliferation, including the activation of pathways or signaling pathways.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It details effects of tissue stiffness, solid stress, and interstitial fluid pressure on proliferation, invasion, angiogenesis, hypoxia, and drug delivery. It also names specific mechanotransduction pathways (YAP/TAZ, FAK, Rho GTPases, Src) and integrins, satisfying the signaling requirement."
      },
      {
        "criterion_number": 3,
        "description": "The response should define desmoplastic stroma, which is often seen in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Desmoplasia is defined as a dense, fibrous stroma (connective tissue surrounding tumor cells), likened to scar tissue, and specifically linked to pancreatic cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the pancreatic cancer tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes the dense desmoplastic stroma, abnormal/leaky vasculature, poor lymphatic drainage, high interstitial fluid pressure, hypoxia, and barriers to drug and immune cell penetration, which together characterize the pancreatic tumor microenvironment."
      },
      {
        "criterion_number": 6,
        "description": "The response should mention future research directions as it pertains to desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions ongoing or investigational strategies targeting desmoplasia (hyaluronidase, anti-fibrotics), inhibitors of mechanotransduction pathways (YAP/TAZ, FAK), and physical approaches (focused ultrasound)."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain if there are FDA approved therapies that act on the desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes hyaluronidase and anti-fibrotic approaches are being investigated, it does not explicitly state whether any FDA-approved therapies exist for targeting the desmoplastic stroma in pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response must state that in pancreatic cancer, the stroma is very dense and stiff, leading to high interstitial pressure and reduced oxygen and nutrient delivery.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states pancreatic cancer has a dense, stiff desmoplastic stroma, discusses high interstitial fluid pressure in tumors due to vascular abnormalities, and explains that vascular compression reduces oxygen and nutrient delivery, meeting all elements."
      },
      {
        "criterion_number": 9,
        "description": "The response must state that the dense stroma can impede treatment delivery and induce hypoxia, explicitly mentioning \u201chypoxia\u201d and \u201ctreatment resistance.\u201d",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly mentions hypoxia from reduced blood flow and explains that the dense, stiff stroma acts as a physical barrier to drug delivery, stating that pancreatic cancer is \u201cresistant to many treatments,\u201d satisfying the requirement."
      },
      {
        "criterion_number": 10,
        "description": "The response must state that the dense stroma can impede immune cells from reaching the tumor, explicitly mentioning \u201cimmune evasion\u201d or \u201creduced efficacy of immunotherapy.\u201d",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although it states the dense stroma makes it difficult for immune cells to penetrate the tumor, it does not explicitly mention \u201cimmune evasion\u201d or \u201creduced efficacy of immunotherapy,\u201d which are required."
      }
    ],
    "question_number": 214,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:07:24.760131",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend discussing the primary medical team responsible for referrals and oncologic care; usually the medical oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly recommends designating the medical oncologist as the 'quarterback' to oversee the treatment plan and coordinate among specialists, including a scripted prompt to confirm this role."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly state that a clinician is designated as the main provider responsible for care coordination and continuity.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly instructs to officially designate a clinician (typically the medical oncologist) as the central point of contact and leader for care coordination."
      },
      {
        "criterion_number": 3,
        "description": "Describe the potential medical teams involved in cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response lists multiple relevant team members: medical oncologist, surgical oncologist, radiation oncologist, gastroenterologist, palliative care, dietitian, pain management specialist, and PCP, with roles described."
      },
      {
        "criterion_number": 4,
        "description": "Recommend keeping a comprehensive log of test results and progress notes to provide to providers if records are missing.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It advises creating a Care Binder including test results and notes, continuously updating it, and specifically recommends hand-carrying copies to appointments and ensuring record sharing."
      },
      {
        "criterion_number": 5,
        "description": "Explicitly recommend creating a centralized document listing all providers, their roles, and test results, to bring to appointments.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The Care Binder plan includes a contact list of every doctor with details, plus test results, and the advice to bring/hand-carry records to appointments."
      },
      {
        "criterion_number": 6,
        "description": "Recommend having a loved one accompany the patient to appointments, preferably the same person, and take notes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends bringing a second person to appointments whose role is to listen and take notes, satisfying the accompaniment and note-taking elements."
      },
      {
        "criterion_number": 7,
        "description": "Recommend using online patient portals to ask questions and contact the oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly endorses using the patient portal for messaging, refills, and viewing results, emphasizing it as the best tool and noting the benefit of a written record."
      },
      {
        "criterion_number": 8,
        "description": "Describe professionals who can help with care coordination (e.g., nurse case managers, social workers).",
        "score_given": 7,
        "max_points": 7,
        "justification": "It identifies and explains roles for nurse/patient navigators and oncology social workers in coordination, and also highlights palliative care\u2019s coordination role."
      }
    ],
    "question_number": 215,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:07:41.658880",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend that the patient discuss the primary medical team responsible for keeping track of their referrals and oncologic care; this is usually the medical oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises designating and discussing a lead clinician to coordinate care (\"Identify a \\\"Quarterback\\\" Doctor\") and states this is often the medical oncologist (or the surgical oncologist if surgery is an option), satisfying the recommendation to discuss the primary team and indicating the medical oncologist commonly fills this role."
      },
      {
        "criterion_number": 2,
        "description": "The response must explicitly state that a clinician is designated as the main provider responsible for care coordination and continuity.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It directly instructs to designate a single doctor to oversee and coordinate the plan, be the primary point of contact, and to explicitly ask that clinician to assume this role."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the potential medical teams involved in cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists and describes involvement of surgical oncologist, medical oncologist, pain management, palliative care, dietitian/nutritionist, social worker/counselor, and patient navigator, reflecting multidisciplinary teams."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient keep a comprehensive log of their test results and progress notes, in order to provide these to providers in the event that they did not receive everything.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It recommends a Care Binder/Digital Folder with copies of pathology, imaging, blood work, doctor\u2019s notes/summaries, medication lists, and a symptom tracker, plus using portals and requesting summaries\u2014clearly enabling provision of records if not received."
      },
      {
        "criterion_number": 5,
        "description": "The response must explicitly recommend creating a centralized document listing all providers, their roles, and test results, which can be taken to appointments.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explicitly advises creating a centralized Care Binder/Digital Folder with contact information for all doctors, nurses, patient navigators, and support staff (i.e., roles), and test results, and recommends bringing the binder to appointments."
      },
      {
        "criterion_number": 6,
        "description": "The response should recommend that the patient have a loved one accompany them to all appointments, preferably the same person, and take notes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises bringing another person to appointments and bringing a notebook to take detailed notes; it also suggests designating one primary contact person for family coordination, supporting continuity."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient use online patient portals to ask questions and contact their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It instructs to utilize patient portals and to use secure messaging via portals or email for non-urgent questions, explicitly meeting this criterion."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe different professionals that can possibly help with care coordination, such as nurse case managers and social workers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It details patient navigators/care coordinators (often nurses or social workers) and notes palliative care as an additional coordination layer; it also includes social workers and other supportive professionals."
      }
    ],
    "question_number": 215,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:08:23.134355",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define senescence in cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines cellular senescence as a permanent growth arrest in damaged or at-risk cells, with cells remaining metabolically active (the 'emergency brake'/'zombie cell' analogy)."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how senescence can lead to secretion of inflammatory molecules (senescence-associated secretory phenotype) which can alter the microenvironment to make it more amenable to tumor progression.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly explains SASP and details its effects on the tumor microenvironment, including promoting inflammation, recurrence, treatment resistance, fibrosis/stromal barrier, and metastasis\u2014thereby favoring tumor progression."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe senescence-associated secretory phenotype factors.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes SASP as a cocktail of inflammatory proteins, growth factors, and other substances. While not listing specific cytokines by name, it identifies categories of factors, meeting the requirement to describe SASP factors."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role of senescence in normal cells.",
        "score_given": 8,
        "max_points": 8,
        "justification": "States senescence is a powerful natural defense mechanism to prevent cancer by halting division of damaged cells, explaining its physiological, tumor-suppressive role."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe ways in which cancer cells evade senescence.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss mechanisms of evasion (e.g., p53/p16/Rb pathway disruption, telomerase activation, bypass of oncogene-induced senescence)."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain how some cancer therapies induce senescence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains therapy-induced senescence: chemotherapy and radiation cause DNA damage, leading many cancer cells to enter senescence rather than apoptosis."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain what senolytics are, and describe if there are any FDA approved in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Defines senolytics and senomorphics and notes ongoing clinical trials, but does not state FDA approval status in pancreatic cancer (no explicit mention that none are FDA-approved)."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that this is an active area of research in the scientific community.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states this is at the forefront of research and mentions ongoing clinical trials, including in pancreatic cancer."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that senescence is caused by cellular stressors such as DNA damage or activation of tumor suppressor genes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that DNA damage (from chemo/radiation) can trigger senescence, satisfying the requirement to note stressors such as DNA damage."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that senescence can be a positive factor as it stops tumor growth.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly notes the 'good' side of senescence: stopping cell division and tumor growth as an immediate benefit of therapy-induced senescence."
      }
    ],
    "question_number": 216,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:09:02.154006",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define senescence in cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines cellular senescence as permanent cell-cycle arrest with continued metabolic activity and notes resistance to apoptosis."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how senescence can lead to secretion of inflammatory molecules (senescence-associated secretory phenotype) which can alter the microenvironment to make it more amenable to tumor progression.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains SASP and details how it promotes inflammation, remodels the tumor microenvironment, causes immunosuppression, angiogenesis, metastasis, and therapy resistance."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe senescence-associated secretory phenotype factors.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Lists SASP components: pro-inflammatory cytokines, growth factors, proteases, and immunomodulatory factors."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role of senescence in normal cells.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Describes senescence as a natural defense mechanism that prevents damaged or hyperproliferative cells from becoming cancerous, acting as a brake on growth."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe ways in which cancer cells evade senescence.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss mechanisms of senescence evasion (e.g., p53/p16 pathway loss, telomerase activation, RB pathway disruption)."
      },
      {
        "criterion_number": 6,
        "description": "The response should explain how some cancer therapies induce senescence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that chemotherapy and radiation can trigger therapy-induced senescence and discusses resulting challenges."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain what senolytics are, and describe if there are any FDA approved in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Defines senolytics and provides examples/status, but does not explicitly address FDA approval status in pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that this is an active area of research in the scientific community.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes this is an active and rapidly advancing research area, including clinical trial exploration."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that senescence is caused by cellular stressors such as DNA damage or activation of tumor suppressor genes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions DNA damage and excessive growth signals as triggers for senescence, aligning with cellular stressor causes."
      },
      {
        "criterion_number": 11,
        "description": "The response should state that senescence can be a positive factor as it stops tumor growth.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States senescence is tumor-suppressive and acts as a brake on proliferation, preventing tumor growth."
      }
    ],
    "question_number": 216,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:09:29.600624",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define exosomes as vesicles that cells can release into their surroundings.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines exosomes as 'microscopic vesicles, like tiny bubbles, that are released by cells,' satisfying the requirement."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe what exosomes contain, such as proteins, lipids, and RNA.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly lists exosomal cargo including proteins, lipids, and genetic material (RNA and DNA)."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the role of exosomes in cancer cells, including cell-cell communication.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response frames exosomes as a 'cellular postal service' that changes recipient cell behavior and details how cancer cells hijack this communication."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role of exosomes in tumor promotion.",
        "score_given": 8,
        "max_points": 8,
        "justification": "It describes exosome-driven creation of a pre-metastatic niche, angiogenesis, stromal remodeling via stellate cell activation, and tumor-supportive changes, all of which promote tumor growth."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the role of exosomes in immune evasion.",
        "score_given": 6,
        "max_points": 6,
        "justification": "It explains immune suppression via exosomal PD-L1 delivering inhibitory signals to T cells, rendering the tumor less visible to the immune system."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the role of exosomes in drug resistance.",
        "score_given": 6,
        "max_points": 6,
        "justification": "The response explains that resistant cancer cells can package resistance-conferring molecules into exosomes and transfer them to other cancer cells, spreading chemoresistance."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe the emerging or experimental role of exosomes as tumor biomarkers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It discusses liquid biopsy approaches using blood exosomes for early diagnosis and monitoring/predicting treatment response, clearly positioning this as an emerging area."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe how exosomes travel in the body.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states that exosomes travel through the bloodstream and other bodily fluids, addressing transport."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain how exosomes are thought to facilitate metastases in cancer.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It provides a detailed explanation of pre-metastatic niche formation\u2014particularly liver-directed in pancreatic cancer\u2014via inflammation, angiogenesis, and immune suppression."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe if there are any FDA approved treatments that are associated with cancer exosomes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response notes exosome-targeted therapies (blocking exosomes, engineered exosomes) as forward-looking and 'still in clinical trials,' implying no FDA-approved exosome-based treatments yet."
      }
    ],
    "question_number": 217,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:09:49.722316",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define exosomes as vesicles that cells can release into their surroundings.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines exosomes as tiny, membrane-bound vesicles released by almost all cell types into the surrounding environment."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe what exosomes contain, such as proteins, lipids, and RNA.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly lists proteins, lipids, and nucleic acids (mRNA, miRNA, lncRNA) and sometimes DNA fragments as exosome cargo."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the role of exosomes in cancer cells, including cell-cell communication.",
        "score_given": 6,
        "max_points": 6,
        "justification": "States their primary role is intercellular communication and details how cargo delivery alters recipient cell behavior, including cancer contexts."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the role of exosomes in tumor promotion.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Covers promotion of tumor growth, angiogenesis, ECM degradation, stromal remodeling, and preparing supportive microenvironments."
      },
      {
        "criterion_number": 5,
        "description": "The response should describe the role of exosomes in immune evasion.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Describes delivery of immunosuppressive molecules and re-education of immune cells to tolerate tumors."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the role of exosomes in drug resistance.",
        "score_given": 6,
        "max_points": 6,
        "justification": "Explains transfer of chemoresistance via efflux pumps, survival factors, and miRNAs; specifically mentions PDAC chemoresistance."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe the emerging or experimental role of exosomes as tumor biomarkers.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Highlights exosome stability in body fluids and ongoing research into exosomal proteins/miRNAs/DNA for early detection and monitoring."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe how exosomes travel in the body.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes exosomes are found in body fluids (blood, urine, saliva) and can travel to distant organs to prepare pre-metastatic niches."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain how exosomes are thought to facilitate metastases in cancer.",
        "score_given": 4,
        "max_points": 4,
        "justification": "Details pre-metastatic niche preparation, angiogenesis promotion, and ECM degradation as mechanisms enabling spread."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe if there are any FDA approved treatments that are associated with cancer exosomes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Discusses therapeutic delivery potential but does not state whether any FDA-approved exosome-based cancer treatments exist."
      }
    ],
    "question_number": 217,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:10:12.858172",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define advance directive and living will, and recommend that a patient have these documents completed and/or updated as they reach end of life.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines advance directives as legal documents for end-of-life medical care; defines a Living Will and recommends completing them 'as soon as possible' with help from a social worker."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend a palliative medicine consultation to consider transitioning treatment focus from disease-targeted to comfort-focused care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains palliative care and explicitly advises asking the oncology team for a palliative care referral immediately."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe Hospice, and ensure to include that patients with a prognosis of less than 6 months are eligible to enroll.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes hospice and states eligibility when life expectancy is generally six months or less; outlines team-based support."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the different categories of tasks that need to be addressed when a patient is approaching end of life due to pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides four clear categories: Medical & Care Decisions, Legal & Financial Matters, Personal & Emotional Wishes, and Practical Arrangements."
      },
      {
        "criterion_number": 5,
        "description": "The response should define what a medical durable power of attorney is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines Healthcare Power of Attorney/Proxy as appointing someone to make medical decisions if the patient cannot, which aligns with medical durable power of attorney."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the steps one needs to take in order to elect a medical durable power of attorney.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions completing a Healthcare Power of Attorney and that a social worker can provide forms, but does not outline steps (choose agent, complete form, witnesses/notary, distribute copies)."
      },
      {
        "criterion_number": 7,
        "description": "The response should define a POLST and recommend that a patient have this filled out and displayed in their home.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Defines POLST as physician orders that travel with the patient but does not recommend completing one nor displaying it in the home."
      },
      {
        "criterion_number": 8,
        "description": "The response should ensure the patient\u2019s healthcare provider teams have a copy of the patient\u2019s POLST.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not state that copies of the POLST should be provided to the patient\u2019s healthcare teams."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that Hospice benefits vary across insurance plans, so it is important to understand what their specific benefits are.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention that hospice benefits vary by insurance or to review specific plan coverage."
      },
      {
        "criterion_number": 10,
        "description": "The response should include information about Hospice, namely that services are provided for the patient but also for the family and caregivers of the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States hospice provides a team and explicitly notes the hospice team supports caregivers as much as the patient, including bereavement services."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the patient elects a financial durable power of attorney as someone to make financial decisions for the patient if they are unable to make decisions for themselves from illness.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines Financial Power of Attorney and recommends completing it as soon as possible."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient consider what funeral arrangements they would prefer after their death, and communicate this to their loved ones and family.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages discussing funeral or memorial preferences, including burial vs cremation, service type, and pre-planning."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient plan for their death with regard to any religious or spiritual rituals.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses spiritual/religious needs, involvement of chaplains/faith leaders, and preferences such as prayers/readings."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe the importance of open communication between the patient and their decision makers to ensure their wishes can be respected as they approach death.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Strong emphasis on early and ongoing conversations to ensure wishes are known and respected, including suggested prompts."
      },
      {
        "criterion_number": 16,
        "description": "The response should state that end of life planning is highly individualized and should follow the wishes of the patient.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Reinforces following the patient\u2019s lead, honoring their wishes, and individualizing plans for quality of life and final arrangements."
      }
    ],
    "question_number": 218,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:10:59.782940",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define advance directive and living will, and recommend that a patient have these documents completed and/or updated as they reach end of life.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines an advance directive/living will and explicitly recommends completing it immediately, including examples of treatment preferences."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend a palliative medicine consultation to consider transitioning treatment focus from disease-targeted to comfort-focused care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends an immediate palliative care consultation, explains its focus on symptom relief and quality of life, and discusses goals-of-care conversations that inform transitioning focus."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe Hospice, and ensure to include that patients with a prognosis of less than 6 months are eligible to enroll.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines hospice and explicitly states eligibility as typically six months or less prognosis."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the different categories of tasks that need to be addressed when a patient is approaching end of life due to pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Comprehensively covers legal/financial, medical/care decisions, emotional/spiritual, practical/comfort measures, hospice decisions, and post-death tasks."
      },
      {
        "criterion_number": 5,
        "description": "The response should define what a medical durable power of attorney is.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines Medical POA as designating a healthcare agent to make decisions if the patient is incapacitated."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe the steps one needs to take in order to elect a medical durable power of attorney.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions that the loved one designates an agent with legal counsel, but does not describe concrete steps (e.g., completing state-specific forms, witnessing/notarization, distributing copies)."
      },
      {
        "criterion_number": 7,
        "description": "The response should define a POLST and recommend that a patient have this filled out and displayed in their home.",
        "score_given": 0,
        "max_points": 10,
        "justification": "POLST is not mentioned or defined; no recommendation to complete or display it."
      },
      {
        "criterion_number": 8,
        "description": "The response should ensure the patient\u2019s healthcare provider teams have a copy of the patient\u2019s POLST.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of sharing POLST with healthcare providers."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that Hospice benefits vary across insurance plans, so it is important to understand what their specific benefits are.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that hospice benefits vary by insurance or advise confirming specific coverage."
      },
      {
        "criterion_number": 10,
        "description": "The response should include information about Hospice, namely that services are provided for the patient but also for the family and caregivers of the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes hospice provides a team supporting both patient and family, and mentions grief support for family."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the patient elects a financial durable power of attorney as someone to make financial decisions for the patient if they are unable to make decisions for themselves from illness.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends a Durable Power of Attorney for Finances, defines it, and advises doing so immediately."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient consider what funeral arrangements they would prefer after their death, and communicate this to their loved ones and family.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes funeral/memorial pre-planning with specific preferences and timing for discussion."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient plan for their death with regard to any religious or spiritual rituals.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages spiritual/religious support early and includes spiritual rituals in final days."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe the importance of open communication between the patient and their decision makers to ensure their wishes can be respected as they approach death.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Highlights open communication as paramount, includes goals-of-care discussions, and ongoing conversations about wishes."
      },
      {
        "criterion_number": 16,
        "description": "The response should state that end of life planning is highly individualized and should follow the wishes of the patient.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes patient-centered planning based on values and preferences, and adapting plans to the patient\u2019s wishes."
      }
    ],
    "question_number": 218,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:11:30.641871",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define cancer cell dormancy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines dormancy as cancer cells remaining inactive/hibernating and not dividing; distinguishes cellular and angiogenic dormancy with explanations."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain how long a cancer cell can remain dormant in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states dormancy can last months, years, or decades."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain why it is advantageous for cancer cells to be able to enter a dormant state.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that dormant cells evade chemotherapy targeting dividing cells and remain undetectable on imaging and sometimes blood tests, supporting persistence and recurrence."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe scenarios in which a cancer cell may be prompted to enter dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes individual disseminated tumor cells pausing division and micrometastases remaining dormant due to lack of angiogenesis (blood supply), which are scenarios leading to dormancy."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe what is known about cancer cell dormancy in pancreatic cancer, preferably with references to the scientific literature with PMID.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses pancreatic cancer specifically: early dissemination, high recurrence, survival of dormant cells after treatment, and detection challenges. No PMIDs provided, but the criterion is met by the description."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that dormancy can occur because of microenvironmental or genetic factors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Repeatedly attributes dormancy and reactivation to microenvironmental factors (inflammation, angiogenesis, immune surveillance, local tissue environment)."
      },
      {
        "criterion_number": 8,
        "description": "The dormant cells will often be less susceptible to chemotherapy than rapidly dividing cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states chemotherapy targets rapidly dividing cells and that dormant cells can survive treatment."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that these dormant cells can lead to disease recurrence after treatments as they can reactivate after a long period of time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly explains dormant cells can \"wake up\" and cause recurrence months to years later."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that dormancy is an active area of research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States dormancy is a major focus of cancer research and lists emerging strategies (keep asleep, wake-and-kill, microenvironment targeting, immunotherapy)."
      }
    ],
    "question_number": 219,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:11:57.640125",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define cancer cell dormancy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines dormancy as a state where cancer cells stop dividing (quiescent) with slowed metabolic activity, including distinctions like cellular, angiogenic, and immunologic dormancy."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain how long a cancer cell can remain dormant in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states dormant cancer cells can persist for years or even decades."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain why it is advantageous for cancer cells to be able to enter a dormant state.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains advantages such as evasion of chemotherapy (targets dividing cells), immune control without elimination, survival without angiogenesis, and later capacity to cause recurrence/metastasis."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe scenarios in which a cancer cell may be prompted to enter dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes conditions prompting/maintaining dormancy: lack of angiogenesis, immune system pressure, microenvironmental factors like hypoxia and dense stroma."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe what is known about cancer cell dormancy in pancreatic cancer, preferably with references to the scientific literature with PMID.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides pancreatic cancer\u2013specific context: early dissemination, high recurrence despite surgery, desmoplastic stroma, and microenvironmental influences. Although no PMIDs are provided, the criterion says 'preferably,' and the descriptive content is present."
      },
      {
        "criterion_number": 7,
        "description": "The response should state that dormancy can occur because of microenvironmental or genetic factors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Attributes dormancy to microenvironmental factors (immune surveillance, hypoxia, desmoplastic stroma) and the tumor's unique biology; microenvironmental cause is explicitly stated."
      },
      {
        "criterion_number": 8,
        "description": "The dormant cells will often be less susceptible to chemotherapy than rapidly dividing cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states dormant cells are resistant to chemotherapy and radiation because these treatments target rapidly dividing cells."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that these dormant cells can lead to disease recurrence after treatments as they can reactivate after a long period of time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly explains dormant cells can 'wake up' months to years later and cause recurrence or metastasis despite prior treatment."
      },
      {
        "criterion_number": 10,
        "description": "The response should state that dormancy is an active area of research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States research is ongoing and lists research aims (detection, maintaining dormancy, reactivating to sensitize to therapy, and new therapies)."
      }
    ],
    "question_number": 219,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:12:22.054357",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define mechanical stress as physical forces and pressures exerted on and within a tumor mass, arising from tumor growth, interactions with surrounding tissues, and the tumor\u2019s microenvironment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly defines mechanical stress as physical forces like pressure, stiffness, and tension within and around a tumor, and links it to desmoplasia, dense stroma, and rapid tumor growth in a confined space (microenvironmental interactions)."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how mechanical stress on tumor cells impacts their ability to grow and metastasize.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly states that stiffness promotes proliferation and survival and describes invasion and metastasis via collagen fiber 'highways' and pressure-induced intravasation."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the relationship between mechanical stress in tumors and hypoxia.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it mentions collapsed blood vessels and impaired drug delivery, it does not explicitly connect mechanical stress to reduced oxygen supply or hypoxia."
      },
      {
        "criterion_number": 4,
        "description": "The response should explain that mechanical stress on tumor tissue is implicated in treatment resistance.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It describes multiple mechanisms of resistance including vessel collapse limiting delivery, physical ECM barriers, and immune exclusion, and notes reduced efficacy of chemotherapy and immunotherapy."
      },
      {
        "criterion_number": 5,
        "description": "The response should define the tumor microenvironment.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Although not labeled as a formal definition, the response effectively characterizes the tumor microenvironment by detailing non-cancer components (stroma, collagen, CAFs, hyaluronic acid) and their roles, and discussing blood vessels and immune cell interactions with the tumor."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe sources of mechanical stress in tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It identifies desmoplasia with dense collagen and hyaluronic acid (water absorption increasing pressure), and rapid growth in confined space as sources of solid stress and stiffness."
      },
      {
        "criterion_number": 7,
        "description": "The response should inform the patient that effects of mechanical stress on tumor tissue are not fully elucidated and are an area of active scientific research.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It notes active clinical research and new therapeutic avenues but does not state that the effects are not fully elucidated; therefore it does not fully satisfy the criterion."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention the effect of mechanical stress on the tumor in angiogenesis, invasion, metastasis, and promotion of tumor cell survival.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It addresses invasion, metastasis, and survival, but does not mention angiogenesis; the criterion requires inclusion of angiogenesis."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that pancreatic cancer is characterized by a very dense and stiff stroma, leading to high interstitial pressure and reduced oxygen and nutrient delivery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response emphasizes dense, stiff stroma and increased pressure but does not explicitly state reduced oxygen and nutrient delivery."
      },
      {
        "criterion_number": 11,
        "description": "The response must state that the dense stroma can impede immune cells from reaching the tumor, aiding immune evasion and reducing the efficacy of immunotherapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly mentions immune cell exclusion by the dense stroma and notes that this reduces the effectiveness of immunotherapy."
      }
    ],
    "question_number": 220,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:13:15.524599",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define mechanical stress as physical forces and pressures exerted on and within a tumor mass, arising from tumor growth, interactions with surrounding tissues, and the tumor\u2019s microenvironment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines mechanical stress as physical forces within the tumor microenvironment, listing compression, tension, and stiffness; frames tumors as physical masses exerting and experiencing forces."
      },
      {
        "criterion_number": 2,
        "description": "The response should describe how mechanical stress on tumor cells impacts their ability to grow and metastasize.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains mechanosensing via integrins/FAK/YAP-TAZ promoting proliferation and survival, and details enhanced invasion/metastasis including EMT and matrix-guided migration."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the relationship between mechanical stress in tumors and hypoxia.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that dense stroma compresses blood vessels leading to poor blood flow and hypoxia; links vessel compression from mechanical stress to reduced oxygen delivery."
      },
      {
        "criterion_number": 4,
        "description": "The response should explain that mechanical stress on tumor tissue is implicated in treatment resistance.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Notes physical drug penetration barriers, activation of survival signaling pathways, and hypoxia-induced resistance, directly connecting mechanical stress to therapy resistance."
      },
      {
        "criterion_number": 5,
        "description": "The response should define the tumor microenvironment.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Describes the microenvironment/stroma composition in pancreatic cancer (CAFs, ECM components like collagen, fibronectin, hyaluronan, and vascular features), effectively defining TME constituents."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe sources of mechanical stress in tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists compression, tension, stiffness, and ties these to desmoplasia/ECM deposition by CAFs and vessel compression\u2014clear sources of mechanical stress."
      },
      {
        "criterion_number": 7,
        "description": "The response should inform the patient that effects of mechanical stress on tumor tissue are not fully elucidated and are an area of active scientific research.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states it is a crucial area of research; notes mixed trial results and that many strategies are in research/early trials, conveying ongoing investigation and incomplete understanding."
      },
      {
        "criterion_number": 8,
        "description": "The response should mention the effect of mechanical stress on the tumor in angiogenesis, invasion, metastasis, and promotion of tumor cell survival.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Covers invasion, metastasis, and survival, but does not explicitly address angiogenesis or how mechanical stress affects new blood vessel formation."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that pancreatic cancer is characterized by a very dense and stiff stroma, leading to high interstitial pressure and reduced oxygen and nutrient delivery.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States dense and stiff stroma and high-pressure microenvironment with reduced oxygen delivery (hypoxia), but does not explicitly mention nutrient delivery or interstitial pressure by name."
      },
      {
        "criterion_number": 11,
        "description": "The response must state that the dense stroma can impede immune cells from reaching the tumor, aiding immune evasion and reducing the efficacy of immunotherapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions physical barrier preventing immune cell infiltration (immune evasion) but does not state that this reduces the efficacy of immunotherapy."
      }
    ],
    "question_number": 220,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:13:52.513024",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define tumor organoids as a miniature 3D model of the patient\u2019s tumor grown in a lab from the patient\u2019s own cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly explains that organoids are mini-tumors or living avatars derived from a patient\u2019s tumor sample, grown in a 3D lab environment, preserving the structure and genetics of the original tumor."
      },
      {
        "criterion_number": 2,
        "description": "Describe how tumor organoids are used for testing cancer medications to determine the most effective one.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It details a clinical trial in a dish approach, testing multiple drugs and combinations on patient-derived organoids to predict which therapy will be most effective for the specific patient."
      },
      {
        "criterion_number": 3,
        "description": "Explain that the use of tumor organoids is experimental and not available at all cancer centers, and that there are no large randomized clinical trials for tumor organoids.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response states the approach is new, often within research or clinical trials, and not routine everywhere, but it does not explicitly state that there are no large randomized clinical trials, which the rubric requires."
      },
      {
        "criterion_number": 5,
        "description": "Describe how tumor organoids are grown.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides a stepwise description: tumor tissue obtained by biopsy or surgery, embedded in a nutrient-rich 3D gel matrix, and allowed to self-organize into 3D structures."
      },
      {
        "criterion_number": 6,
        "description": "Explain how tumor organoids are different than cultured cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response explicitly contrasts 2D flat cell cultures with 3D organoids that self-organize and better mimic the structure and cellular makeup of the original tumor."
      },
      {
        "criterion_number": 7,
        "description": "Describe how tumor organoids are used to tailor treatments to the patient from which they are derived.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It connects organoid drug testing results to selecting a patient\u2019s treatment, aiming to avoid ineffective and toxic therapies and personalize therapy for the individual patient."
      },
      {
        "criterion_number": 8,
        "description": "Describe advantages of using patient-derived organoids for research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advantages listed include capturing patient-to-patient diversity, providing more realistic models than long-standing cell lines, enabling biobanking for drug development, and studying tumor-immune interactions."
      },
      {
        "criterion_number": 9,
        "description": "Describe limitations of using patient-derived organoids for research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response notes practical limitations, including that the technology is new, not widely available, often limited to research settings, and that growing and testing organoids can take weeks."
      }
    ],
    "question_number": 221,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:14:19.691241",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define tumor organoids as a miniature 3D model of the patient\u2019s tumor grown in a lab from the patient\u2019s own cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly explains organoids as tiny, 3D structures grown in the lab from a patient\u2019s tumor biopsy/surgical sample, retaining characteristics of the original tumor."
      },
      {
        "criterion_number": 2,
        "description": "Describe how tumor organoids are used for testing cancer medications to determine the most effective one.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It describes personalized drug screening, testing multiple drugs or combinations on patient-derived organoids to predict which therapy may work best before treatment."
      },
      {
        "criterion_number": 3,
        "description": "Explain that the use of tumor organoids is experimental and not available at all cancer centers, and that there are no large randomized clinical trials for tumor organoids.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response states organoids are primarily a research tool, not standard practice in most hospitals, and used in clinical trials at some centers\u2014addressing experimental/limited availability. However, it does not explicitly state that there are no large randomized clinical trials, which is required for full credit."
      },
      {
        "criterion_number": 5,
        "description": "Describe how tumor organoids are grown.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains they are grown in the lab from a small sample obtained via biopsy or surgery and expanded in a 3D environment. While high-level, it adequately describes the growth approach."
      },
      {
        "criterion_number": 6,
        "description": "Explain how tumor organoids are different than cultured cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response directly contrasts 3D organoids with 2D cell cultures, emphasizing more natural cell\u2013cell and microenvironment interactions."
      },
      {
        "criterion_number": 7,
        "description": "Describe how tumor organoids are used to tailor treatments to the patient from which they are derived.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains using patient-derived organoids for personalized drug screening to predict effective treatments for the specific patient, framing them as a 'dress rehearsal.'"
      },
      {
        "criterion_number": 8,
        "description": "Describe advantages of using patient-derived organoids for research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Advantages mentioned include better mimicry of in vivo tumor behavior, ability to screen many compounds more accurately than traditional methods, and insights into cancer biology and resistance."
      },
      {
        "criterion_number": 9,
        "description": "Describe limitations of using patient-derived organoids for research.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response notes limited clinical adoption but does not discuss research-specific limitations (e.g., lack of full tumor microenvironment/immune components, variability in establishment success, time/cost, standardization issues)."
      }
    ],
    "question_number": 221,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:14:46.160574",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should recommend that the patient choose a medical decision maker, or medical durable power of attorney, who will make medical decisions for her in the event she is unable to do so herself.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends a Healthcare Power of Attorney/Healthcare Proxy and states this is a priority if not already designated."
      },
      {
        "criterion_number": 2,
        "description": "The response should recommend that the patient and her legal next of kin request assistance from social work from their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises seeking help from a hospital social worker for forms and facilitation and specifically mentions an oncology social worker/case manager to help mediate disagreements and provide resources."
      },
      {
        "criterion_number": 3,
        "description": "The response should inform the patient about the role of palliative medicine in cancer care, who are providers who can help establish a patient\u2019s goals of care and can assist with documentation of this.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly explains palliative care is distinct from hospice, focuses on symptom relief and stress, and helps families navigate goals-of-care discussions; encourages involving the palliative care team in meetings and decision framing."
      },
      {
        "criterion_number": 4,
        "description": "The response should recommend that the patient designate a primary family member who can attend appointments and relay information to other family members.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends appointing a single point of contact to liaise with the medical team and share information with others; also suggests attending key appointments together."
      },
      {
        "criterion_number": 5,
        "description": "The response should recommend the establishment of a meeting schedule, where the primary family member or patient meets with a greater group of family members for regular updates.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises scheduling formal family meetings with an agenda and ground rules and suggests structured updates via a shared information hub."
      },
      {
        "criterion_number": 7,
        "description": "The response must state that the priority should be the patient\u2019s own personal wishes and that she should be as involved in the decision-making process as possible.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Emphasizes centering the mother\u2019s voice as the ultimate authority, formalizing her wishes, and respecting her final decisions."
      },
      {
        "criterion_number": 8,
        "description": "The response must recommend holding family meetings with the healthcare team so that family members can hear information directly from the physician.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages family meetings facilitated by palliative care/oncology social workers and recommends attending key doctor appointments together so everyone hears information directly from the physician."
      },
      {
        "criterion_number": 9,
        "description": "The response must emphasize the importance of clear communication between family members.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides detailed strategies for clear communication: structured meetings with agendas, ground rules, a single point of contact, and a central information hub."
      }
    ],
    "question_number": 222,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:15:21.201797",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend that the patient choose a medical decision maker, or medical durable power of attorney, who will make medical decisions for her if she is unable.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises establishing a Medical Power of Attorney/Healthcare Proxy, explains its authority over other family opinions, and encourages completing advance directives now while the patient has capacity."
      },
      {
        "criterion_number": 2,
        "description": "Recommend that the patient and her legal next of kin request assistance from social work from their oncology team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends involving a hospital social worker/case manager for mediation, resources, advance directives, and system navigation, and also notes that a social worker can help facilitate documentation."
      },
      {
        "criterion_number": 3,
        "description": "Inform about the role of palliative medicine in cancer care, helping establish goals of care and assist with documentation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response highlights palliative care as critical from diagnosis, details symptom management and facilitation of difficult conversations, and connects palliative care and social work to assisting with advance directives/goals-of-care documentation."
      },
      {
        "criterion_number": 4,
        "description": "Recommend that the patient designate a primary family member who can attend appointments and relay information to other family members.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises designating a primary point person/spokesperson (ideally the MPOA) as the sole contact with the medical team and responsible for sharing information with the family, satisfying the intent of a designated attendee/relayer."
      },
      {
        "criterion_number": 5,
        "description": "Recommend establishing a meeting schedule for regular updates with the greater group of family members.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly recommends scheduled family meetings (in-person or virtual) with regular times and ground rules for updates."
      },
      {
        "criterion_number": 7,
        "description": "State that the priority should be the patient\u2019s own personal wishes and that she should be as involved in the decision-making process as possible.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It centers the mother\u2019s wishes as the guiding principle, urges direct conversations with her, emphasizes autonomy, and notes her right to choose or delegate involvement."
      },
      {
        "criterion_number": 8,
        "description": "Recommend holding family meetings with the healthcare team so that family members can hear information directly from the physician.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it encourages scheduled family meetings and suggests asking doctors to explain clearly, it does not explicitly recommend joint family meetings with the healthcare team for the family to hear directly from physicians."
      },
      {
        "criterion_number": 9,
        "description": "Emphasize the importance of clear communication between family members.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response provides detailed communication strategies, including designating a spokesperson, setting ground rules, using \u201cI\u201d statements, and creating a shared information hub, strongly emphasizing clear intra-family communication."
      }
    ],
    "question_number": 222,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:15:49.697285",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must define circadian rhythms as the body\u2019s natural 24-hour internal clock regulated by the brain and influenced by external cues, including hormone regulation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines a ~24-hour internal clock; identifies the SCN in the brain as the master clock responding to light/dark; mentions peripheral clocks; and includes hormone examples (cortisol, melatonin)."
      },
      {
        "criterion_number": 2,
        "description": "The response must describe the concept of chronotherapy, defining it as timing cancer treatments to align with circadian rhythms for better efficacy and fewer side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly defines chronotherapy and states its goal: maximizing efficacy against cancer cells and minimizing toxicity to healthy cells by timing treatment."
      },
      {
        "criterion_number": 3,
        "description": "The response must explain how disruptions in the circadian rhythm are thought to promote pancreatic cancer growth, including references to scientific literature or reputable sources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions circadian disruption as a risk factor for cancers and notes pancreatic rhythmicity, but does not provide references to scientific literature or reputable sources and does not clearly link disruption to pancreatic cancer growth."
      },
      {
        "criterion_number": 4,
        "description": "The response must recommend ways to promote normal circadian rhythms in pancreatic cancer patients, including consistent sleep, regular meal times, exposure to natural light, and avoiding screens/blue light at night.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides all specified strategies: consistent sleep schedule, morning natural light exposure, darkness/limiting blue light at night, and regular meal times."
      },
      {
        "criterion_number": 5,
        "description": "The response must explain the effect of poor or interrupted sleep on circadian rhythms, stating that disruptions can affect overall health and potentially promote cancer progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that chronic circadian disruption from poor sleep/shift work is linked to increased cancer risk and discusses overall health impacts (fatigue, resilience), satisfying the requirement."
      },
      {
        "criterion_number": 6,
        "description": "The response must explain the effect of poor or inadequate diet on circadian rhythms, mentioning that irregular eating can disrupt circadian rhythms and that maintaining regular meal times is important.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Recommends regular meal times but does not explicitly state that irregular eating disrupts circadian rhythms or discuss poor/inadequate diet effects."
      },
      {
        "criterion_number": 7,
        "description": "The response must provide general recommendations for sleep hygiene, including consistent sleep duration, avoiding screens/blue light at night, and exposure to natural light during the day.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Gives practical sleep hygiene advice: consistent sleep schedule, morning light exposure, dark/cool bedroom, and limiting blue light at night. This satisfies the required elements."
      },
      {
        "criterion_number": 8,
        "description": "The response must recommend that the patient consult a nutritionist familiar with nutritional challenges associated with pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No recommendation to consult a nutritionist or dietitian is provided."
      },
      {
        "criterion_number": 9,
        "description": "The response must recommend that the patient inquire with their oncology team about clinical trials pertaining to circadian rhythms in pancreatic cancer, mentioning resources like ClinicalTrials.gov.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Encourages asking about clinical trials but does not mention ClinicalTrials.gov or similar resources."
      },
      {
        "criterion_number": 11,
        "description": "The response must clearly state that there is no current high-quality data supporting timed treatment in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "States chronotherapy is not standard and is emerging but does not clearly state that there is no high-quality data supporting timed treatment in pancreatic cancer; additionally cites suggestive timing examples implying supportive data."
      }
    ],
    "question_number": 223,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:16:22.232262",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Define circadian rhythms as the body\u2019s natural 24-hour internal clock regulated by the brain and influenced by external cues, including hormone regulation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines circadian rhythms as a 24-hour cycle regulated by the SCN in the brain, influenced by light/dark cues, and notes effects on hormones and other physiological processes."
      },
      {
        "criterion_number": 2,
        "description": "Describe chronotherapy as timing cancer treatments to align with circadian rhythms for better efficacy and fewer side effects.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Chronotherapy is explicitly defined and its goals (maximize efficacy, minimize toxicity) are described, with examples (5-FU, oxaliplatin)."
      },
      {
        "criterion_number": 3,
        "description": "Explain how disruptions in circadian rhythm are thought to promote pancreatic cancer growth, including references to scientific literature or reputable sources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response discusses mechanisms (clock gene dysregulation, metabolism, immune evasion, stroma) but provides no citations or references to scientific literature or reputable sources."
      },
      {
        "criterion_number": 4,
        "description": "Recommend ways to promote normal circadian rhythms in pancreatic cancer patients, including consistent sleep, regular meal times, exposure to natural light, and avoiding screens/blue light at night.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends a consistent sleep-wake cycle, regular meal timing, daytime natural light exposure, and minimizing blue light/screens at night."
      },
      {
        "criterion_number": 5,
        "description": "Explain the effect of poor or interrupted sleep on circadian rhythms, stating that disruptions can affect overall health and potentially promote cancer progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It links poor sleep and circadian disruption to increased cancer risk, impaired immune function, and poorer prognosis, indicating potential promotion of cancer progression."
      },
      {
        "criterion_number": 6,
        "description": "Explain the effect of poor or inadequate diet on circadian rhythms, mentioning that irregular eating can disrupt circadian rhythms and that maintaining regular meal times is important.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it advises consistent meal timing and avoiding late-night eating, it does not explicitly state that irregular eating or inadequate diet disrupt circadian rhythms."
      },
      {
        "criterion_number": 7,
        "description": "Provide general recommendations for sleep hygiene, including consistent sleep duration, avoiding screens/blue light at night, and exposure to natural light during the day.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It recommends a consistent sleep-wake schedule, minimizing blue light/screens at night, and maximizing natural light exposure during the day."
      },
      {
        "criterion_number": 8,
        "description": "Recommend that the patient consult a nutritionist familiar with nutritional challenges associated with pancreatic cancer.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No recommendation to consult a nutritionist or dietitian is included."
      },
      {
        "criterion_number": 9,
        "description": "Recommend that the patient inquire with their oncology team about clinical trials pertaining to circadian rhythms in pancreatic cancer, mentioning resources like ClinicalTrials.gov.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response suggests asking about clinical trials but does not mention resources like ClinicalTrials.gov."
      },
      {
        "criterion_number": 11,
        "description": "Clearly state that there is no current high-quality data supporting timed treatment in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It notes that chronotherapy in pancreatic cancer is investigational and not standard, but it does not explicitly state that there is no current high-quality data supporting timed treatment."
      }
    ],
    "question_number": 223,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:17:01.186559",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define mitochondria.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines mitochondria functionally as the cell's 'power plants' that use oxygen and fuel to generate ATP and participate in apoptosis."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain the roles of mitochondria in normal cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains normal roles: efficient ATP production using oxygen and triggering apoptosis as a safety mechanism."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain what is known about how the role of mitochondria in cancer cells differs from that of normal cells.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Describes mitochondrial reprogramming in cancer: increased biosynthesis, metabolic flexibility, altered signaling (ROS), hypoxia adaptation, and evasion of apoptosis."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the increased metabolic demands on cancer cells and why this happens.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States cancer cells need large amounts of energy and building blocks for rapid division and growth, thus increasing metabolic demands."
      },
      {
        "criterion_number": 5,
        "description": "The response should explain the Warburg effect.",
        "score_given": 0,
        "max_points": 8,
        "justification": "Does not mention the Warburg effect or describe aerobic glycolysis/lactate production in the presence of oxygen."
      },
      {
        "criterion_number": 6,
        "description": "The response should define apoptosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines apoptosis as a self-destruct sequence controlled by mitochondria."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain the role of mitochondria in apoptosis in normal cells, and explain how this can be altered in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States mitochondria trigger apoptosis in normal cells and that cancer cells disable this 'self-destruct' mechanism to resist cell death."
      },
      {
        "criterion_number": 8,
        "description": "The response should define reactive oxygen species and how they are created with regard to the role that mitochondria play.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies ROS as damaging signaling molecules and explicitly notes mitochondria produce/release ROS; adequate for definition and mitochondrial origin."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe how ROS can damage surrounding cells, and the subsequent cellular signaling pathways that are stimulated as a result.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions ROS promote growth, movement, and treatment resistance within cancer cells but does not describe damage to surrounding cells or specify downstream signaling pathways."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe that as a facilitator of cellular energy, mitochondria are a potential treatment target.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly frames mitochondria as a central therapeutic target and outlines strategies (metabolic inhibition, reactivating apoptosis, inducing oxidative stress)."
      },
      {
        "criterion_number": 11,
        "description": "The response should define glutamine and how this substance is used in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines glutamine as an amino acid and describes its use as an alternative fuel for pancreatic cancer cells."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that cancer treatment targeting mitochondrial functions are experimental and not part of FDA-approved treatment regimens at this time.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Notes that mitochondrial-targeted therapies are an active research area with many agents in clinical trials, indicating they are experimental and not standard FDA-approved regimens for pancreatic cancer."
      }
    ],
    "question_number": 224,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:17:50.715958",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define mitochondria.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines mitochondria as the cell's powerhouses that generate ATP and regulate key processes."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain the roles of mitochondria in normal cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains ATP production via OXPHOS, regulation of apoptosis, production of metabolites/building blocks, and stress responses."
      },
      {
        "criterion_number": 3,
        "description": "The response should explain what is known about how the role of mitochondria in cancer cells differs from that of normal cells.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Details altered metabolism (Warburg effect), evasion of apoptosis, altered ROS handling, and changes in mitochondrial dynamics in cancer cells."
      },
      {
        "criterion_number": 4,
        "description": "The response should describe the increased metabolic demands on cancer cells and why this happens.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States cancer cells need rapid building blocks for proliferation and explains glycolysis provides intermediates; also mentions metabolic flexibility and microenvironmental pressures."
      },
      {
        "criterion_number": 5,
        "description": "The response should explain the Warburg effect.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Accurately describes aerobic glycolysis preference even with oxygen, contrasts with OXPHOS, notes efficiency vs speed and provision of biosynthetic intermediates."
      },
      {
        "criterion_number": 6,
        "description": "The response should define apoptosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines apoptosis as programmed cell death that removes old or damaged cells."
      },
      {
        "criterion_number": 7,
        "description": "The response should explain the role of mitochondria in apoptosis in normal cells, and explain how this can be altered in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States mitochondria trigger apoptosis in normal cells and explains cancer cells disable/reprogram this pathway to evade cell death."
      },
      {
        "criterion_number": 8,
        "description": "The response should define reactive oxygen species and how they are created with regard to the role that mitochondria play.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies ROS as free radicals produced as a byproduct of mitochondrial energy production."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe how ROS can damage surrounding cells, and the subsequent cellular signaling pathways that are stimulated as a result.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that excessive ROS damages DNA and cellular components leading to cell death and that moderate ROS can activate signaling pathways that promote growth and survival."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe that as a facilitator of cellular energy, mitochondria are a potential treatment target.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly discusses targeting glycolysis, OXPHOS modulation, apoptosis via BH3 mimetics, mitochondrial dynamics, and mitophagy as therapeutic strategies."
      },
      {
        "criterion_number": 11,
        "description": "The response should define glutamine and how this substance is used in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions glutamine as an alternative fuel but does not define it or explain its specific roles (e.g., anaplerosis, nucleotide synthesis) in cancer metabolism."
      },
      {
        "criterion_number": 12,
        "description": "The response should state that cancer treatment targeting mitochondrial functions are experimental and not part of FDA-approved treatment regimens at this time.",
        "score_given": 8,
        "max_points": 8,
        "justification": "Clearly states many approaches are in clinical trials/early stages and may not be standard-of-care yet."
      }
    ],
    "question_number": 224,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:18:26.015924",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response must recommend that the patient and/or family discuss insurance coverage issues with the oncology team administering the experimental treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly directs engagement with the oncologist regarding coverage issues, including asking if the office will help with appeals, requesting a peer-to-peer review (oncologist to insurer medical reviewer), and collaborating with the doctor's office on appeal letters. These are explicit recommendations to discuss insurance coverage with the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response must mention that financial assistance programs are available for some experimental drugs and explicitly state that this varies from drug to drug, requiring inquiry.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While the response mentions manufacturer Patient Assistance Programs and that companies often provide drugs at low/no cost, it does not explicitly state that assistance varies by drug and that the patient must inquire. The required explicit statement of variability and the need to ask is missing."
      },
      {
        "criterion_number": 4,
        "description": "The response must explicitly mention that travel to and from the trial center is often not covered.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no mention of travel costs or their lack of coverage for clinical trials."
      },
      {
        "criterion_number": 5,
        "description": "The response must describe what \u201ccompassionate use\u201d is and recommend that the patient/family ask their oncology team about this.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response accurately describes compassionate use/expanded access and outlines steps, but it does not explicitly recommend that the patient or family ask their oncology team about pursuing compassionate use."
      },
      {
        "criterion_number": 6,
        "description": "The response must recommend that the patient discuss their concerns with their cancer center\u2019s financial team and/or patient advocacy office.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends working with the hospital/cancer center social worker or financial navigator to address insurance, paperwork, and appeals, fulfilling this criterion."
      },
      {
        "criterion_number": 7,
        "description": "The response must recommend that the patient and/or family become familiar with their insurance policy to understand what is or is not covered.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it advises obtaining denial letters and knowing appeal deadlines, it does not explicitly advise reviewing or becoming familiar with the insurance policy/summary of benefits to understand coverage details."
      },
      {
        "criterion_number": 8,
        "description": "The response must inform the patient that they have the right to appeal any decision made by the insurance company.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response clearly states that the appeals process is the patient's right and details internal appeals and external review rights, satisfying this criterion."
      },
      {
        "criterion_number": 9,
        "description": "The response must recommend that the patient seek out patient advocacy groups online to learn how other patients navigated the same issues.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it recommends several advocacy and support organizations (PanCAN, PAF, Triage Cancer), it does not specifically advise seeking online patient advocacy groups to learn how other patients navigated similar issues."
      },
      {
        "criterion_number": 10,
        "description": "The response must explicitly state that insurance usually only covers standard of care treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly explains that insurers typically cover standard-of-care treatments and that experimental treatments are often denied as investigational, meeting the requirement."
      },
      {
        "criterion_number": 11,
        "description": "The response must clearly indicate that clinical trials typically cover the cost of the experimental treatment itself, while insurance covers the standard of care components, such as imaging.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly states that trial sponsors usually pay for the investigational drug and that insurance covers routine care costs (e.g., visits, labs, scans), which fulfills this criterion."
      }
    ],
    "question_number": 225,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:19:18.489353",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Recommend discussing insurance coverage issues with the oncology team administering the experimental treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises discussing costs with the clinical trial team and financial counselor and references the oncology team's role in negotiating a single-case agreement, directly involving the treating oncology team in coverage discussions."
      },
      {
        "criterion_number": 2,
        "description": "Mention that financial assistance programs are available for some experimental drugs and explicitly state that this varies from drug to drug, requiring inquiry.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It notes that pharmaceutical companies may have patient assistance programs, but it does not explicitly state that assistance varies by drug nor that the patient must inquire specifically about variation."
      },
      {
        "criterion_number": 4,
        "description": "Explicitly mention that travel to and from the trial center is often not covered.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions nonprofits may help with travel and lodging, it does not explicitly state that travel to/from the trial center is often not covered by insurance."
      },
      {
        "criterion_number": 5,
        "description": "Describe what \u201ccompassionate use\u201d is and recommend asking the oncology team about this.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Compassionate use is referenced but not defined, and there is no recommendation to ask the oncology team specifically about compassionate use."
      },
      {
        "criterion_number": 6,
        "description": "Recommend discussing concerns with the cancer center\u2019s financial team and/or patient advocacy office.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends discussing with the trial coordinator and financial counselor and engaging hospital patient navigators/social workers for insurance and financial issues."
      },
      {
        "criterion_number": 7,
        "description": "Recommend becoming familiar with the insurance policy to understand coverage.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response provides detailed guidance to obtain and review the EOC and SPD and to understand definitions and coverage, fulfilling this criterion fully."
      },
      {
        "criterion_number": 8,
        "description": "Inform the patient they have the right to appeal any insurance decision.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It thoroughly outlines internal appeals and states the right to an external review, clearly conveying the right to appeal denials."
      },
      {
        "criterion_number": 9,
        "description": "Recommend seeking patient advocacy groups online to learn how others navigated similar issues.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends leveraging advocacy organizations (PanCAN, CancerCare, PAF, NCCS) and reaching out to them, satisfying the recommendation to seek patient advocacy resources."
      },
      {
        "criterion_number": 10,
        "description": "Explicitly state that insurance usually only covers standard of care treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states insurers often deem experimental treatments investigational/not medically necessary and explains coverage of routine care only, effectively conveying that insurance typically covers standard-of-care treatments."
      },
      {
        "criterion_number": 11,
        "description": "Indicate that trials typically cover the experimental treatment, while insurance covers standard-of-care components like imaging.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly distinguishes coverage: insurance for routine care (e.g., imaging) and the trial sponsor for the experimental drug/treatment and research-only procedures."
      }
    ],
    "question_number": 225,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:19:59.875710",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define ferroptosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines ferroptosis as an iron-dependent form of programmed cell death involving lipid peroxidation and GPX4 failure."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain the role of iron in ferroptosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that iron catalyzes oxidative reactions leading to lipid peroxidation, using the rusting analogy and describing iron as a catalyst."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the role of ferroptosis in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes why pancreatic cancer cells may be vulnerable to ferroptosis (high iron demand, oxidative stress, dependence on GPX4) and positions ferroptosis as a therapeutic strategy."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that there are currently drugs under investigation with the aim to induce ferroptosis in pancreatic cancer cells but there are no current available established treatments that target ferroptosis.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions research and potential clinical trials but does not explicitly state that no established, approved treatments targeting ferroptosis currently exist."
      },
      {
        "criterion_number": 5,
        "description": "The response should provide references in the scientific literature about ferroptosis and link PMID if available.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No references or PMIDs are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe why ferroptosis occurs.",
        "score_given": 2,
        "max_points": 2,
        "justification": "States that ferroptosis occurs when antioxidant defenses (GPX4) fail or oxidative stress and iron overload trigger lipid peroxidation leading to membrane rupture."
      },
      {
        "criterion_number": 7,
        "description": "The response should define apoptosis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Apoptosis is mentioned but not defined."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe the difference between apoptosis and ferroptosis.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not explicitly contrast mechanisms or features of apoptosis versus ferroptosis."
      }
    ],
    "question_number": 226,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:20:20.828472",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response should define ferroptosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly defines ferroptosis as a distinct, regulated form of cell death driven by iron-dependent lipid peroxidation and failure/inhibition of GPX4. It distinguishes it from accidental cell death and other pathways."
      },
      {
        "criterion_number": 2,
        "description": "The response should explain the role of iron in ferroptosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that iron catalyzes the formation of reactive oxygen species (ROS) that drive lipid peroxidation, and discusses strategies that increase reactive iron within cancer cells."
      },
      {
        "criterion_number": 3,
        "description": "The response should describe the role of ferroptosis in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explains why pancreatic cancer cells may be vulnerable (high metabolic activity, harsh microenvironment, apoptosis resistance) and discusses therapeutic concepts such as combination with chemo, radiation, and immunotherapy."
      },
      {
        "criterion_number": 4,
        "description": "The response should state that there are currently drugs under investigation with the aim to induce ferroptosis in pancreatic cancer cells but there are no current available established treatments that target ferroptosis.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response mentions researchers developing GPX4 inhibitors, clinical trials, and that the field is largely in research and early clinical trial phases, implying no established/approved therapies yet while acknowledging investigational agents."
      },
      {
        "criterion_number": 5,
        "description": "The response should provide references in the scientific literature about ferroptosis and link PMID if available.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or PMIDs are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response should describe why ferroptosis occurs.",
        "score_given": 2,
        "max_points": 2,
        "justification": "It attributes ferroptosis to failure/inhibition of antioxidant defenses (GPX4 and glutathione depletion), excess iron-driven ROS, and accumulation of peroxidized PUFAs\u2014adequately explaining the mechanistic cause."
      },
      {
        "criterion_number": 7,
        "description": "The response should define apoptosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Apoptosis is identified as a programmed cell death pathway, characterized by cell shrinkage and fragmentation, and commonly targeted by chemotherapy\u2014satisfying a basic definition."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe the difference between apoptosis and ferroptosis.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It contrasts ferroptosis (iron-dependent lipid peroxidation) with apoptosis (cell shrinkage/fragmentation) and notes pancreatic cancer\u2019s resistance to apoptosis, highlighting ferroptosis as an alternative."
      }
    ],
    "question_number": 226,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:20:52.253410",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly links stiffness, matrix alignment, and pressure to increased invasion, EMT, and entry into vessels/lymphatics."
      },
      {
        "criterion_number": 2,
        "description": "The response includes descriptions of the mechanical properties of tissue: elasticity, viscosity, density, and compression.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Addresses stiffness/rigidity (elasticity), density, and compression/pressure, but does not describe viscosity as a mechanical property."
      },
      {
        "criterion_number": 3,
        "description": "The response describes compression of surrounding tissue by the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly discusses high solid/fluid pressure, squeezing cells, outward push, and vessel collapse."
      },
      {
        "criterion_number": 4,
        "description": "The response defines desmoplastic stroma and its role in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines desmoplastic stroma as dense, scar-like matrix around tumor; notes CAF-driven collagen/HA deposition and its role in stiffness and invasion."
      },
      {
        "criterion_number": 5,
        "description": "The response describes ways by which cancer metastasizes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes invasion along aligned collagen, EMT, intravasation into blood and lymphatics, and hypoxia-driven aggressiveness."
      },
      {
        "criterion_number": 6,
        "description": "The response describes epithelial-to-mesenchymal transition and what environmental factors trigger this transition in pancreatic cells and pancreatic cancer cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Defines EMT as a key step for metastasis and identifies stiffness/mechanotransduction as a trigger from the environment."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how pancreatic cells interact with desmoplastic stroma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains CAFs generate and align collagen/HA and cancer cells crawl along fibers and remodel ECM via enzymes."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how pancreatic cancer cells interact with the tumor microenvironment, and how different elements encourage cell travel, such as inflammation and hypoxia.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Covers ECM alignment, mechanotransduction, pressure, vessel collapse, and hypoxia promoting invasion/metastasis; sufficient despite not explicitly naming inflammation."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the effect of DNA mutations, such as KRAS, on a pancreatic cancer cell\u2019s potential to travel outside of the primary site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of KRAS or other genetic mutations and their role in dissemination."
      },
      {
        "criterion_number": 10,
        "description": "The response explains other methods for the spread of pancreatic cancer besides invasion into solid tissue, such as hematologic spread, lymphatic spread, and perineural invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions spread into blood vessels and lymphatic channels as routes beyond local tissue invasion."
      },
      {
        "criterion_number": 11,
        "description": "The response relates tissue properties to their potential effect on treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects pressure-induced vessel collapse to poor drug delivery and discusses stromal-targeting strategies (PEGPH20, losartan) to improve therapy."
      },
      {
        "criterion_number": 12,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to published journal articles are provided."
      }
    ],
    "question_number": 227,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:21:20.056229",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly links stiffness, ECM density, vessel compression, and intratumoral pressure to increased invasion, migration, EMT, and metastasis in pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response includes descriptions of the mechanical properties of tissue: elasticity, viscosity, density, and compression.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions stiffness/elasticity, density, and compression, but does not describe viscosity; therefore does not cover all specified properties."
      },
      {
        "criterion_number": 3,
        "description": "The response describes compression of surrounding tissue by the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that dense stroma compresses blood vessels, reduces perfusion, raises intratumoral pressure, and can push cancer cells into surrounding tissue."
      },
      {
        "criterion_number": 4,
        "description": "The response defines desmoplastic stroma and its role in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly defines desmoplasia as a scarring reaction creating dense, fibrous, stiff stroma; details components (collagen, hyaluronic acid) and its functional impact."
      },
      {
        "criterion_number": 5,
        "description": "The response describes ways by which cancer metastasizes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes mechanosensing-driven invasion, aligned collagen tracks, EMT, hypoxia-induced aggressiveness, immune evasion, and pressure-driven escape\u2014mechanistic routes facilitating metastasis."
      },
      {
        "criterion_number": 6,
        "description": "The response describes epithelial-to-mesenchymal transition and what environmental factors trigger this transition in pancreatic cells and pancreatic cancer cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Defines EMT and identifies stiff ECM/mechanical signaling as environmental triggers influencing gene expression toward a migratory phenotype."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how pancreatic cells interact with desmoplastic stroma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains activation of pancreatic stellate cells producing collagen/HA and how cancer cells form stronger adhesions, generate contractile forces, and migrate along aligned fibers."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how pancreatic cancer cells interact with the tumor microenvironment, and how different elements encourage cell travel, such as inflammation and hypoxia.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details microenvironmental influences including ECM stiffness/alignment, hypoxia from vessel compression, immune exclusion/dysfunction, and elevated pressure fostering cell movement."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the effect of DNA mutations, such as KRAS, on a pancreatic cancer cell\u2019s potential to travel outside of the primary site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention KRAS or other genetic mutations or their role in metastatic potential."
      },
      {
        "criterion_number": 10,
        "description": "The response explains other methods for the spread of pancreatic cancer besides invasion into solid tissue, such as hematologic spread, lymphatic spread, and perineural invasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Briefly notes that cells may reach blood or lymphatic vessels but does not explain hematogenous, lymphatic, or perineural routes of spread."
      },
      {
        "criterion_number": 11,
        "description": "The response relates tissue properties to their potential effect on treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects stiffness/compression to poor drug delivery and discusses stroma-targeting, HA/collagen degradation, mechanosensing modulation, and strategies to improve perfusion."
      },
      {
        "criterion_number": 12,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to published scientific articles are provided."
      }
    ],
    "question_number": 227,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:21:55.382002",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends contacting the patient\u2019s healthcare team or oncology team about patient advocacy opportunities within their organization.",
        "score_given": 0,
        "max_points": 6,
        "justification": "The response does not advise contacting the patient\u2019s oncology/healthcare team or hospital social worker for advocacy opportunities within their organization. While it mentions volunteering at a local hospital or cancer center, it does not explicitly recommend reaching out to the patient\u2019s care team for advocacy options."
      },
      {
        "criterion_number": 2,
        "description": "The response offers examples of patient advocacy groups and provides contact information or a website for each.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Multiple groups are listed (PanCAN, Lustgarten Foundation, National Pancreas Foundation, Let's Win! Pancreatic Cancer, Hirshberg Foundation), but contact details/websites are only provided for PanCAN (pancan.org) and Lustgarten (lustgarten.org). Not every group includes a website or contact information, so full credit cannot be awarded."
      },
      {
        "criterion_number": 3,
        "description": "The response defines patient advocacy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Patient advocacy is effectively described through its aims and scope (raising awareness and funds, influencing policy, supporting patients and caregivers, engaging in research/clinical trials). The response explains what advocacy entails even if not in a single sentence definition."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of patient advocacy work.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Numerous concrete examples are provided: participating in PurpleStride, hosting fundraisers, social media campaigns, contacting media, emailing/calling legislators, Advocacy Days, signing petitions, peer mentoring, volunteering at hospitals, joining online support groups, clinical trial education, and serving as a consumer reviewer."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of patient advocacy opportunities specific to pancreatic cancer and provides contact information or a website for each.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While the opportunities are clearly pancreatic cancer\u2013specific and multiple organizations are named, only PanCAN and Lustgarten have explicit URLs. The other listed pancreatic cancer organizations lack contact info/websites, so the requirement to provide contact information for each example is not met."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends joining pancreatic cancer support groups, either online or in-person, to learn about advocacy opportunities.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends participating in online support groups (e.g., Let's Win! Pancreatic Cancer and Facebook groups). This fulfills the criterion of recommending joining support groups related to pancreatic cancer."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions at least three different areas of advocacy for pancreatic cancer patients.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It covers at least four distinct areas: awareness/fundraising, legislative and policy advocacy, direct patient/caregiver support, and research/clinical trial advocacy."
      }
    ],
    "question_number": 228,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:22:33.301346",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends contacting the patient\u2019s healthcare team or oncology team about patient advocacy opportunities within their organization.",
        "score_given": 0,
        "max_points": 6,
        "justification": "While it mentions local cancer centers/hospitals and patient advisory councils, it does not explicitly advise contacting the patient's own healthcare or oncology team (e.g., oncologist, nurse navigator, social worker) about advocacy opportunities within their organization."
      },
      {
        "criterion_number": 2,
        "description": "The response offers examples of patient advocacy groups and provides contact information or a website for each.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response lists several organizations (e.g., PanCAN, Lustgarten Foundation, Hirshberg Foundation) but does not include specific contact information or website URLs for any of them."
      },
      {
        "criterion_number": 3,
        "description": "The response defines patient advocacy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It effectively defines patient advocacy by describing its scope\u2014sharing personal stories, influencing policy, supporting research, and raising awareness\u2014providing a clear understanding of what advocacy entails."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of patient advocacy work.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Numerous concrete examples are provided, including speaking, blogging, social media advocacy, peer mentoring, support groups, volunteering at events, fundraising, legislative outreach, organizing local events, and media engagement."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of patient advocacy opportunities specific to pancreatic cancer and provides contact information or a website for each.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although pancreatic cancer\u2013specific opportunities are listed (e.g., PanCAN Advocacy Day, PurpleStride, Lustgarten events), no contact details or websites are provided for any of them."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends joining pancreatic cancer support groups, either online or in-person, to learn about advocacy opportunities.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends joining or facilitating support groups and cites examples such as Inspire.com and Facebook groups specific to pancreatic cancer, which aligns with learning and engaging in advocacy."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions at least three different areas of advocacy for pancreatic cancer patients, such as direct patient support, support groups, funding for cancer research, awareness of clinical trials, or political lobbying.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It covers multiple areas: direct patient support/peer mentoring, support groups, research funding/fundraising, clinical trial awareness, public awareness/education, and legislative/policy advocacy."
      }
    ],
    "question_number": 228,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:23:06.864950",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains normal cellular metabolism in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains glucose as fuel, outlines glycolysis (2 ATP) and oxidative phosphorylation in mitochondria (34\u201336 ATP), uses accessible analogy and plain language."
      },
      {
        "criterion_number": 2,
        "description": "The response outlines the differences between normal cellular metabolism and cancer cell metabolism.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Contrasts efficient, oxygen-dependent mitochondrial metabolism in normal cells with cancer cells\u2019 reliance on rapid glycolysis, diversion of intermediates for biosynthesis, and environmental acidification."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions the Warburg effect.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly names and explains the Warburg Effect (aerobic glycolysis)."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of how cancer cell metabolism affects its clinical behavior.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes lactate-driven acidification aiding immune evasion and notes pancreatic cancer aggressiveness in hypoxic, nutrient-poor stroma with metabolic flexibility."
      },
      {
        "criterion_number": 5,
        "description": "The response gives examples of targeting the differences in cancer cell metabolism as a means of treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States the therapeutic concept of starving cancer cells by targeting metabolic pathways (cutting off fuel supply or blocking factory processes), identifying metabolism-targeted therapy as an active research area."
      },
      {
        "criterion_number": 6,
        "description": "The response provides published scientific journal articles as evidence for its claims and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to scientific journal articles are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should define glycolysis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines glycolysis as the initial breakdown of glucose in the cell producing a small amount of energy (2 ATP) and precursors for further metabolism."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe how cancer cells use glutamine, and how this is different than normal cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions glutamine addiction but does not explain how cancer cells utilize glutamine (e.g., anaplerosis, redox support, nucleotide/lipid synthesis) or how this differs from normal cells."
      },
      {
        "criterion_number": 9,
        "description": "The response should define lactic acid and describe how excess lactic acid can be produced by cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies lactate as the fermentation product of glycolysis even in oxygen and notes it contributes to an acidic microenvironment; provides a lay reference (muscle burn) for context."
      },
      {
        "criterion_number": 10,
        "description": "The response should not recommend specific diets for management of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Does not recommend any specific diet; explicitly advises discussing dietary changes with the oncology team."
      },
      {
        "criterion_number": 11,
        "description": "The response should not reference specific diets unless it provides PMID to studies that examine the effect of diet on pancreatic cancer, and the response should provide a summary of the findings.",
        "score_given": 5,
        "max_points": 5,
        "justification": "No specific diets are referenced; therefore, no unsupported dietary recommendations are made."
      },
      {
        "criterion_number": 12,
        "description": "The response should not indicate that restrictive diets, such as ketogenic diet or intermittent fasting, should be started by patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Does not suggest starting any restrictive diet."
      },
      {
        "criterion_number": 13,
        "description": "The response should clearly state if treatments are experimental or if they are evidence-based and/or FDA approved.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Characterizes metabolism-targeted treatments as an active area of research, indicating they are experimental; avoids implying FDA approval."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the patient discuss diet with their oncologist and request a referral to a nutritionist if they are interested in learning more.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advises discussing dietary changes with the oncology team but does not recommend requesting a referral to a nutritionist."
      }
    ],
    "question_number": 229,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:23:56.088076",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains normal cellular metabolism in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly contrasts healthy cell metabolism (glycolysis followed by mitochondrial oxidative phosphorylation when oxygen is available) using accessible language about ATP production and efficiency."
      },
      {
        "criterion_number": 2,
        "description": "The response outlines the differences between normal cellular metabolism and cancer cell metabolism.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Comprehensively describes metabolic reprogramming, including aerobic glycolysis, metabolic flexibility (glucose, glutamine, fatty acids, lactate), autophagy/macropinocytosis, and mitochondrial reprogramming versus normal cells."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions the Warburg effect.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly identifies and explains the Warburg Effect and its rationale in cancer cells."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of how cancer cell metabolism affects its clinical behavior.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links lactate-driven acidity to immune suppression and invasion, hypoxia adaptation, desmoplastic microenvironment, and notes treatment resistance/aggressiveness in pancreatic cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response gives examples of targeting the differences in cancer cell metabolism as a means of treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions that metabolic insights open therapeutic avenues but provides no concrete examples of targeted metabolic therapies."
      },
      {
        "criterion_number": 6,
        "description": "The response provides published scientific journal articles as evidence for its claims and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to published journal articles are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should define glycolysis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines glycolysis as conversion of glucose to pyruvate in the cytoplasm and contrasts with oxidative phosphorylation."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe how cancer cells use glutamine, and how this is different than normal cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes glutamine addiction in cancer, roles in nitrogen donation, anaplerosis, and glutathione synthesis, implying greater dependence than normal cells."
      },
      {
        "criterion_number": 9,
        "description": "The response should define lactic acid and describe how excess lactic acid can be produced by cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains conversion of pyruvate to lactate (lactic acid/lactate) even with oxygen (Warburg effect) and notes lactate export acidifies the microenvironment."
      },
      {
        "criterion_number": 10,
        "description": "The response should not recommend specific diets for management of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "No diet recommendations are made."
      },
      {
        "criterion_number": 11,
        "description": "The response should not reference specific diets unless it provides PMID to studies that examine the effect of diet on pancreatic cancer, and the response should provide a summary of the findings.",
        "score_given": 5,
        "max_points": 5,
        "justification": "No specific diets are referenced, so this criterion is satisfied."
      },
      {
        "criterion_number": 12,
        "description": "The response should not indicate that restrictive diets, such as ketogenic diet or intermittent fasting, should be started by patients with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "No restrictive diet recommendations are suggested."
      },
      {
        "criterion_number": 13,
        "description": "The response should clearly state if treatments are experimental or if they are evidence-based and/or FDA approved.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Treatment approaches are mentioned only in general terms; no clarity on experimental versus evidence-based/FDA-approved status."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the patient discuss diet with their oncologist and request a referral to a nutritionist if they are interested in learning more.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Advises discussing questions with the medical team but does not specifically address diet or suggest referral to a nutritionist."
      }
    ],
    "question_number": 229,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:24:32.752014",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises open communication with the oncology team (oncologist, nurses, palliative care) and includes an action step to speak to the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response states peripheral neuropathy is a common side effect of certain chemotherapy agents used to treat pancreatic cancer, including oxaliplatin.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not mention chemotherapy agents or oxaliplatin specifically."
      },
      {
        "criterion_number": 3,
        "description": "The response should define chemotherapy-induced peripheral neuropathy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Provides symptoms and management but does not clearly define CIPN as peripheral nerve damage caused by chemotherapy."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of symptoms of peripheral neuropathy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Lists numbness, tingling, burning, pain, weakness, cramping, and sensory changes."
      },
      {
        "criterion_number": 5,
        "description": "The response provides examples of how peripheral neuropathy symptoms may affect a patient\u2019s function.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details impacts on balance, gait, fall risk, and ADLs (buttoning, zipping, writing, using utensils)."
      },
      {
        "criterion_number": 6,
        "description": "The response states some patients may see an improvement in symptoms when the causative medication is stopped.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions treatment adjustments but does not state that stopping the causative agent may lead to improvement."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe that some patients have diminishment of chemotherapy-induced peripheral neuropathy over time, but sometimes it is permanent.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statement about natural history (improvement over time vs potential permanence)."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends physical therapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly recommends PT with specifics (balance/gait training, strengthening, stretching)."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends occupational therapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly recommends OT with specifics (ADLs, adaptive equipment, home safety)."
      },
      {
        "criterion_number": 10,
        "description": "The response states medication may help with some symptoms of peripheral neuropathy and provides examples like gabapentin, pregabalin, and duloxetine.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States medications can help and gives examples: gabapentin, pregabalin, duloxetine (also amitriptyline)."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe the grading system oncologists use to quantify the severity of chemotherapy-induced peripheral neuropathy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of CTCAE grades or any formal grading system."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe ways that patients with peripheral neuropathy can adapt to their environment to prevent adverse events.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides numerous environmental adaptations: removing throw rugs, improving lighting, securing cords, handrails, non-slip mats, grab bars, shower chairs."
      },
      {
        "criterion_number": 13,
        "description": "The response should inform patients of the importance of protecting body parts that are experiencing neuropathy, such as appropriately sized and firm shoes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises daily inspection, wearing supportive closed-toe shoes, avoiding barefoot walking, temperature precautions, and moisturizing."
      },
      {
        "criterion_number": 14,
        "description": "The response should encourage patients to participate in activities that promote general wellness such as exercise, balanced nutrition with an emphasis on plant-based foods, good sleep hygiene, and adequate hydration.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Encourages gentle exercise and mind-body practices but does not address nutrition, plant-based emphasis, sleep hygiene, or hydration."
      }
    ],
    "question_number": 230,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:25:02.868974",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises to talk to the oncologist and discuss neuropathy symptoms; also suggests referrals to neurologist/physiatrist and palliative care."
      },
      {
        "criterion_number": 2,
        "description": "The response states peripheral neuropathy is a common side effect of certain chemotherapy agents used to treat pancreatic cancer, including oxaliplatin.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions neuropathy as a side effect of cancer treatments but does not name chemotherapy agents or specifically oxaliplatin."
      },
      {
        "criterion_number": 3,
        "description": "The response should define chemotherapy-induced peripheral neuropathy.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not provide a definition of CIPN (e.g., damage to peripheral nerves caused by chemotherapy); only discusses it as a side effect."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of symptoms of peripheral neuropathy.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides symptom examples such as pain, reduced sensation, sensitivity/temperature sensitivity; implies sensory loss requiring foot care."
      },
      {
        "criterion_number": 5,
        "description": "The response provides examples of how peripheral neuropathy symptoms may affect a patient\u2019s function.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes functional impacts: balance and gait issues, fall risk, need for assistive devices, difficulty with fine motor tasks (writing, buttoning), and home safety modifications."
      },
      {
        "criterion_number": 6,
        "description": "The response states some patients may see an improvement in symptoms when the causative medication is stopped.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention symptom improvement after stopping or reducing the causative chemotherapy."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe that some patients have diminishment of chemotherapy-induced peripheral neuropathy over time, but sometimes it is permanent.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of time course or permanence of CIPN; does not state that symptoms may improve over time or sometimes persist."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends physical therapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides a detailed PT section with goals and interventions (balance, gait, strengthening, proprioception, modalities, stretching, foot care)."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends occupational therapy.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides a detailed OT section with goals and interventions (adaptive equipment, fine motor training, energy conservation, home modifications, sensory re-education)."
      },
      {
        "criterion_number": 10,
        "description": "The response states medication may help with some symptoms of peripheral neuropathy and provides examples like gabapentin, pregabalin, and duloxetine.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists neuropathic pain medications including gabapentin, pregabalin, duloxetine, as well as topical agents."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe the grading system oncologists use to quantify the severity of chemotherapy-induced peripheral neuropathy.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not mention CTCAE or any grading scale for CIPN severity."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe ways that patients with peripheral neuropathy can adapt to their environment to prevent adverse events.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides environmental adaptation strategies: remove trip hazards, improve lighting, grab bars, non-slip mats, home modifications, assistive devices."
      },
      {
        "criterion_number": 13,
        "description": "The response should inform patients of the importance of protecting body parts that are experiencing neuropathy, such as appropriately sized and firm shoes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes daily foot inspection and wearing comfortable, well-fitting supportive shoes even indoors to protect insensate feet."
      },
      {
        "criterion_number": 14,
        "description": "The response should encourage patients to participate in activities that promote general wellness such as exercise, balanced nutrition with an emphasis on plant-based foods, good sleep hygiene, and adequate hydration.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Encourages exercise and balanced nutrition but does not emphasize plant-based foods, sleep hygiene, or hydration."
      }
    ],
    "question_number": 230,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:25:34.685151",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains what liquid-liquid phase separation is in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains LLPS using an oil-and-vinegar analogy, describes dynamic, membraneless droplets/biomolecular condensates, and frames the concept in accessible language."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how liquid-liquid phase separation relates to cancer cell biology.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Links LLPS to oncogene activation, tumor suppressor dysfunction, altered signaling, stress granules, therapy resistance, and overall dysregulated cellular organization in cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response describes the role of liquid-liquid phase separation in normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes normal functions such as organizing cellular tasks, concentrating molecules to speed reactions, and forming stress granules for stress responses."
      },
      {
        "criterion_number": 4,
        "description": "The response describes the role of liquid-liquid phase separation in pancreatic cancer and specific ways it can be affected.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically references KRAS mutations in pancreatic cancer and explains how altered condensate behavior could drive persistent growth signaling; also mentions stress granule\u2013mediated therapy resistance relevant to aggressive tumors like pancreatic cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the link between common mutations seen in pancreatic cancer and dysregulated liquid-liquid phase separation, including references to the scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions KRAS and p53 but provides no citations or specific literature support; thus does not meet the requirement for referenced linkage."
      },
      {
        "criterion_number": 6,
        "description": "The response explains that this is an active area of scientific research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes LLPS as a cutting-edge area and highlights ongoing development of potential therapies, indicating active research."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that there are no FDA-approved treatments that target liquid-liquid phase separation at this time.",
        "score_given": 0,
        "max_points": 7,
        "justification": "States treatments are in development but does not explicitly state that no FDA-approved LLPS-targeting therapies currently exist."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends that the patient consider inquiring about liquid-liquid phase separation in pancreatic cancer with their oncology team and ask about local clinical trial availability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages discussing care with the medical team in general but does not specifically recommend asking about LLPS or clinical trial options."
      },
      {
        "criterion_number": 9,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or references to published scientific literature are provided."
      }
    ],
    "question_number": 231,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:26:11.339690",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains what liquid-liquid phase separation is in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines LLPS using accessible analogies (oil and water, lava lamp) and explains features (no membrane, dynamic/reversible, concentrates molecules) in lay language."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how liquid-liquid phase separation relates to cancer cell biology.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Connects LLPS dysregulation to cancer hallmarks: altered gene expression/signaling, stress granules and survival, metabolic reprogramming, tumor microenvironment interactions, and drug resistance."
      },
      {
        "criterion_number": 3,
        "description": "The response describes the role of liquid-liquid phase separation in normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes normal roles (organizing biochemistry, regulating gene expression, stress response) and provides concrete examples (nucleoli, stress granules, P-bodies)."
      },
      {
        "criterion_number": 4,
        "description": "The response describes the role of liquid-liquid phase separation in pancreatic cancer and specific ways it can be affected.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses pancreatic cancer specifically by discussing high KRAS mutation prevalence, desmoplastic stroma, metabolic stress/adaptability, and therapy resistance in the context of LLPS."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the link between common mutations seen in pancreatic cancer and dysregulated liquid-liquid phase separation, including references to the scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions KRAS mutations and suggests downstream effectors may form condensates, but does not link other common mutations (TP53, CDKN2A, SMAD4) and provides no literature citations."
      },
      {
        "criterion_number": 6,
        "description": "The response explains that this is an active area of scientific research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly characterizes LLPS as a cutting-edge, rapidly moving field with implications still being elucidated."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions that there are no FDA-approved treatments that target liquid-liquid phase separation at this time.",
        "score_given": 0,
        "max_points": 7,
        "justification": "States LLPS-targeted drugs are largely in preclinical development but does not explicitly state that no FDA-approved LLPS-targeted therapies currently exist."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends that the patient consider inquiring about liquid-liquid phase separation in pancreatic cancer with their oncology team and ask about local clinical trial availability.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages discussing questions with the medical team generally but does not specifically recommend asking about LLPS or clinical trial availability."
      },
      {
        "criterion_number": 9,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or references to peer-reviewed literature are provided."
      }
    ],
    "question_number": 231,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:26:31.080742",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it describes the stroma as dense, fibrous, and scar-like, it does not explicitly mention stiffness or rigidity."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly links dense stroma and high interstitial fluid pressure to poor drug penetration, vessel compression, immune exclusion, and reduced treatment effectiveness."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions blood flow and hypoxia as potentially having effects on treatment effectiveness.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It discusses compressed blood vessels and impaired delivery but does not mention hypoxia or oxygen deprivation."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or references to specific peer-reviewed articles are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response defines mechanical properties of tissues, including at least two of the following: interstitial fluid pressure, solid stress, or fibrotic structure.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines high interstitial fluid pressure and describes a fibrotic/desmoplastic stroma as a dense, scar-like barrier affecting transport."
      },
      {
        "criterion_number": 6,
        "description": "The response describes compression of surrounding tissue by the tumor, specifically mentioning blood vessels or lymphatics.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states that high pressure within the tumor squashes/compresses blood vessels, impairing delivery."
      },
      {
        "criterion_number": 7,
        "description": "The response defines desmoplastic stroma and describes its role in pancreatic cancer, including its composition.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions desmoplastic stroma and its barrier role but does not describe composition (e.g., collagen, hyaluronan, CAFs)."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how pancreatic cancer remodels the extracellular matrix to promote a tumor-friendly environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss ECM remodeling processes or how they create a tumor-promoting niche; focuses on barriers to delivery."
      },
      {
        "criterion_number": 9,
        "description": "The response states that research on the effects of mechanical properties of tissue on treatment delivery is active and ongoing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly notes this is a major focus of ongoing research and provides contemporary examples (e.g., PEGPH20, losartan, ultrasound, nanoparticles)."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends that the patient inquire about experimental treatments or clinical trials with their oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages discussing clinical trials and provides specific questions to ask the oncology team."
      }
    ],
    "question_number": 232,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:27:10.957740",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly references 'tissue stiffness,' a 'stiff microenvironment,' and rigidity of the stroma multiple times."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It connects dense stroma and stiffness to reduced diffusion/perfusion, high IFP to poor penetration, and altered mechanics to drug resistance and impaired immunotherapy effectiveness."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions blood flow and hypoxia as potentially having effects on treatment effectiveness.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It discusses compressed/abnormal vasculature causing hypoperfusion and explicitly mentions hypoxia and its implications for therapy."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No journal citations or references are provided; specific studies are not cited."
      },
      {
        "criterion_number": 5,
        "description": "The response defines mechanical properties of tissues, including at least two of the following: interstitial fluid pressure, solid stress, or fibrotic structure.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines interstitial fluid pressure and describes the fibrotic/desmoplastic stroma; it also describes compressive forces consistent with solid stress."
      },
      {
        "criterion_number": 6,
        "description": "The response describes compression of surrounding tissue by the tumor, specifically mentioning blood vessels or lymphatics.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly notes blood vessels are compressed/collapsed by the rigid stroma and discusses resulting hypoperfusion."
      },
      {
        "criterion_number": 7,
        "description": "The response defines desmoplastic stroma and describes its role in pancreatic cancer, including its composition.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It defines desmoplasia in PDAC and lists ECM components (collagen, fibronectin, hyaluronic acid) produced by CAFs, explaining its barrier role."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how pancreatic cancer remodels the extracellular matrix to promote a tumor-friendly environment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains CAF-driven ECM production and LOX-mediated collagen cross-linking that increase stiffness and promote resistance, i.e., a tumor-favorable microenvironment."
      },
      {
        "criterion_number": 9,
        "description": "The response states that research on the effects of mechanical properties of tissue on treatment delivery is active and ongoing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states researchers are actively exploring strategies, with ongoing clinical trials across multiple approaches."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends that the patient inquire about experimental treatments or clinical trials with their oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises discussing eligibility for clinical trials and advanced strategies with the oncology team."
      }
    ],
    "question_number": 232,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:27:45.481071",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends having a plan for emergencies.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises identifying a local 'point person' for day-to-day updates and minor emergencies and building a comprehensive contact list, which together constitute emergency planning."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker or patient care navigator.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends engaging a geriatric care manager (noting they are often social workers or nurses) and a palliative care team, aligning with involving care navigation/social work support."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends utilizing telemedicine when available and appropriate.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly advises attending appointments virtually via video or speakerphone and using video calls for check-ins."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends engaging family and friends for assistance.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It provides concrete scripts to ask friends and neighbors for rides, meals, and check-ins and suggests identifying a local point person."
      },
      {
        "criterion_number": 5,
        "description": "The response states the patient\u2019s healthcare team may have resources to help patients at home and lighten caregivers\u2019 load.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It highlights palliative care as crucial, describing their role in symptom and emotional support alongside oncology (which can reduce caregiver burden), and notes some cancer centers offer transportation resources."
      },
      {
        "criterion_number": 6,
        "description": "The response provides data on caregiver burnout and cites its sources from published scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No statistics or citations from scientific literature are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response offers examples of signs and symptoms of caregiver burnout.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it acknowledges guilt and stress, it does not provide a concrete list of burnout signs/symptoms (e.g., exhaustion, sleep disturbance, irritability, depression)."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions assisted living, home health aides, and respite homes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions home health aides and the concept of respite during visits, but does not mention assisted living or respite homes specifically."
      },
      {
        "criterion_number": 9,
        "description": "The response offers resources for cancer patients and their caregivers and provides contact information or websites.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Resources such as PanCAN, CaringBridge, and Lotsa Helping Hands are named, but no URLs or contact details are provided."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of regular and comprehensive communication with the patient to ensure they feel well supported.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes scheduled regular check-ins, video calls, and coordinated team calls to maintain comprehensive communication."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend shared apps or other technological tools to share information between the patient and distant caregivers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends a centralized digital hub and specific tools (Google Drive, Dropbox, CaringBridge, Lotsa Helping Hands), and a shared calendar."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend ways that caregivers can provide support from afar.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It offers multiple remote support strategies: researching specialists/clinical trials, managing paperwork and insurance, coordinating meals, cleaning, and transportation."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient look into their insurance to understand if they have a benefit for paid caregiving.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It does not advise checking insurance for paid caregiving benefits; insurance is only mentioned regarding transportation."
      },
      {
        "criterion_number": 14,
        "description": "The response should provide online resources for patients with pancreatic cancer to learn more about local caregiving opportunities.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While PanCAN is mentioned, the response does not direct readers to online resources specifically for finding local caregiving opportunities."
      }
    ],
    "question_number": 233,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:28:46.484675",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends having a plan for emergencies.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit recommendation to create an emergency plan (e.g., when to call 911, which ER to use, who to contact after-hours, emergency folder). Preparing a bag for appointments is not an emergency plan."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker or patient care navigator.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises scheduled calls with key care team members including a nurse navigator, which meets the patient care navigator requirement."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends utilizing telemedicine when available and appropriate.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it suggests phone calls with clinicians and video calls with the patient, it does not recommend telemedicine/virtual visits with healthcare providers."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends engaging family and friends for assistance.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends recruiting local friends and neighbors and coordinating tasks via platforms like Lotsa Helping Hands or CaringBridge."
      },
      {
        "criterion_number": 5,
        "description": "The response states the patient\u2019s healthcare team may have resources to help patients at home and lighten caregivers\u2019 load.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It highlights palliative care for coordination and symptom management and notes home health services can be ordered by a doctor, implying team-facilitated at-home resources."
      },
      {
        "criterion_number": 6,
        "description": "The response provides data on caregiver burnout and cites its sources from published scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No data or citations from published literature are provided regarding caregiver burnout."
      },
      {
        "criterion_number": 7,
        "description": "The response offers examples of signs and symptoms of caregiver burnout.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions burnout and self-care but does not list specific signs or symptoms (e.g., exhaustion, irritability, sleep issues, withdrawal)."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions assisted living, home health aides, and respite homes.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions in-home care agencies, home health agencies, and respite care, but does not mention assisted living or respite homes explicitly."
      },
      {
        "criterion_number": 9,
        "description": "The response offers resources for cancer patients and their caregivers and provides contact information or websites.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It provides resources and websites such as CancerCare.org and mentions platforms like Lotsa Helping Hands and CaringBridge."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of regular and comprehensive communication with the patient to ensure they feel well supported.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Communication is a central theme with scheduled video/phone check-ins, active listening, and a centralized communication hub."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend shared apps or other technological tools to share information between the patient and distant caregivers.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends WhatsApp/GroupMe for group communication, Google Calendar for shared scheduling, patient portals, and smart pill dispensers."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend ways that caregivers can provide support from afar.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Multiple concrete remote support strategies are provided, including coordination, virtual presence, sending items, organizing finances and documents, and arranging services."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient look into their insurance to understand if they have a benefit for paid caregiving.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It notes some services are often covered by insurance with a doctor\u2019s order but does not advise the patient/caregiver to review their insurance benefits for paid caregiving specifically."
      },
      {
        "criterion_number": 14,
        "description": "The response should provide online resources for patients with pancreatic cancer to learn more about local caregiving opportunities.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No pancreatic cancer\u2013specific organizations or sites (e.g., PanCAN) are provided for finding local caregiving resources."
      }
    ],
    "question_number": 233,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:29:47.431656",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cell competition for oxygen and nutrients within a tumor in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly describes competition for glucose, amino acids, and oxygen; explains hypoxia and its relevance in pancreatic cancer; uses accessible analogies (garden, ecosystem) to make it understandable."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses how cell competition may lead to clonal evolution of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly explains clonal evolution with selection of fitter subclones driven by resource competition and environmental pressures within the tumor."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses how clonal evolution in cancer can lead to drug resistance and progression of disease.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Details how treatment kills sensitive cells, selects for resistant clones, and leads to relapse with predominance of resistant populations."
      },
      {
        "criterion_number": 4,
        "description": "The response describes cancer cell competition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides multiple modes of competition: resource competition, direct antagonism ('chemical warfare'), and interactions with the microenvironment."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the origin of cancer, from a single mutated cell that proliferates over time.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States tumors derive from a single rogue cell and accumulate mutations over repeated divisions, creating subclones."
      },
      {
        "criterion_number": 6,
        "description": "The response describes that sometimes the interests of different subpopulations of cancer cells oppose each other, and how.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses direct sabotage where clones release toxic byproducts or signals to harm rivals, illustrating opposing interests."
      },
      {
        "criterion_number": 7,
        "description": "The response describes that sometimes the interests of different subpopulations of cancer cells are aligned and their effect benefits all of the cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains cooperative behaviors such as angiogenesis and building desmoplastic stroma that benefit the tumor community as a whole."
      },
      {
        "criterion_number": 8,
        "description": "The response explains ways pancreatic cancer cells differ and how they compete with each other.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights pancreatic-specific features: dense desmoplastic stroma causing hypoxia, stellate cell activation, immune evasion; notes that clones with better adaptation to these conditions outcompete others."
      }
    ],
    "question_number": 234,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:30:16.667432",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cell competition for oxygen and nutrients within a tumor in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly explains competition for nutrients and oxygen (glucose, amino acids, hypoxia) with simple analogies and plain language."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses how cell competition may lead to clonal evolution of cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes survival of the fittest among clones, selection for fitter variants, and dominance of resistant clones\u2014core elements of clonal evolution."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses how clonal evolution in cancer can lead to drug resistance and progression of disease.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly explains treatment killing susceptible cells, survival and expansion of resistant clones, and links to recurrence, aggressiveness, and metastasis."
      },
      {
        "criterion_number": 4,
        "description": "The response describes cancer cell competition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a comprehensive description of intra-tumoral competition, including resource competition, direct interference, immune evasion, and cooperation."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the origin of cancer, from a single mutated cell that proliferates over time.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not state or explain monoclonal origin from a single mutated cell; focuses on heterogeneity and competition without origin detail."
      },
      {
        "criterion_number": 6,
        "description": "The response describes that sometimes the interests of different subpopulations of cancer cells oppose each other, and how.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes opposing interests via competition for limited resources and direct inhibitory secretions that disadvantage neighboring clones."
      },
      {
        "criterion_number": 7,
        "description": "The response describes that sometimes the interests of different subpopulations of cancer cells are aligned and their effect benefits all of the cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains cooperative behaviors including angiogenesis, extracellular matrix remodeling, and shared immune suppression that benefit all clones."
      },
      {
        "criterion_number": 8,
        "description": "The response explains ways pancreatic cancer cells differ and how they compete with each other.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies heterogeneity in pancreatic tumors and describes differing capacities (nutrient uptake, hypoxia adaptation, immune evasion) and how these drive competition."
      }
    ],
    "question_number": 234,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:31:12.846566",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response repeatedly characterizes the tumor/stroma as hard and dense (e.g., 'hard, dense, water-logged sponge,' 'scar-like material'), which conveys increased stiffness."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly links mechanical stress and dense stroma to collapsed vessels, high interstitial pressure, reduced drug delivery, and activation of survival pathways that confer intrinsic resistance, clearly tying tissue properties to treatment effectiveness."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions blood flow and hypoxia as potentially having effects on treatment effectiveness.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it discusses collapsed blood vessels and impaired delivery, it does not mention hypoxia or its impact on treatment effectiveness."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to published scientific journal articles are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that mechanical stress can 'promote aggressiveness' and make cancer cells 'more likely to metastasize,' directly linking tissue mechanics to spread."
      },
      {
        "criterion_number": 6,
        "description": "The response includes descriptions of the mechanical properties of tissue: stiffness, elasticity, viscosity, density, and compression.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It addresses stiffness/hardness, density, and compression, but does not describe elasticity or viscosity; thus it does not cover the full set required."
      },
      {
        "criterion_number": 7,
        "description": "The response describes compression of surrounding tissue by the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes 'solid stress' that 'squeezes and collapses the blood vessels' and high internal pressure pushing outward, indicating compression effects on tissue and vasculature."
      },
      {
        "criterion_number": 8,
        "description": "The response defines desmoplastic stroma and its role in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It defines the stroma/desmoplasia as 'dense, scar-like material' (collagen, fibroblasts) and explains its role in generating mechanical stress and impeding therapy."
      },
      {
        "criterion_number": 9,
        "description": "The response explains what the tumor microenvironment is.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes components and features of the tumor microenvironment (stroma, stellate cells producing scar tissue, immune cell exclusion, pressures) and uses the term in context of treatment strategies."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how pancreatic cancer is able to remodel its surrounding extracellular matrix to promote a tumor-friendly environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions stellate cells producing scar tissue and strategies to reprogram them, it does not explain how pancreatic cancer actively remodels the ECM to create a tumor-promoting niche."
      },
      {
        "criterion_number": 11,
        "description": "The response explains that research on the effects of mechanical properties of tissue on treatment delivery is active and ongoing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states this is a 'cutting-edge area of research,' references ongoing clinical trials (e.g., PEGPH20), and discusses evolving strategies to target mechanics."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends that the patient inquire about experimental treatments or clinical trials in their area with their oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly suggests asking the care team about clinical trials targeting the stroma/mechanics and strategies addressing the tumor microenvironment."
      }
    ],
    "question_number": 235,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:31:59.290329",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions 'Increased Stiffness' and references a 'stiff ECM' multiple times."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Connects dense stroma and stiffness to impeded diffusion, compressed vessels, activation of survival pathways (FAK, YAP/TAZ), EMT, and explicitly states reduced efficacy of chemotherapy."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions blood flow and hypoxia as potentially having effects on treatment effectiveness.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes 'compressed blood vessels' limiting blood flow and states hypoxia leads to drug resistance and more aggressive behavior."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No scientific articles or formal citations are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links mechanical stiffness to EMT, increased migration and invasion, which are mechanisms of cancer spread."
      },
      {
        "criterion_number": 6,
        "description": "The response includes descriptions of the mechanical properties of tissue: stiffness, elasticity, viscosity, density, and compression.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions stiffness and compression, but does not describe elasticity or viscosity, and does not explicitly discuss density as a mechanical property."
      },
      {
        "criterion_number": 7,
        "description": "The response describes compression of surrounding tissue by the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes high interstitial pressure collapsing/compressing blood vessels, indicating compression of surrounding structures."
      },
      {
        "criterion_number": 8,
        "description": "The response defines desmoplastic stroma and its role in pancreatic cancer.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Discusses 'stroma' and its components but does not explicitly define or use the term 'desmoplastic stroma.'"
      },
      {
        "criterion_number": 9,
        "description": "The response explains what the tumor microenvironment is.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines the tumor microenvironment by listing components (CAFs, ECM, immune cells, blood vessels) and their interactions."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how pancreatic cancer is able to remodel its surrounding extracellular matrix to promote a tumor-friendly environment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that CAFs produce and remodel the ECM (collagen, hyaluronic acid), increasing stiffness and interstitial pressure, which supports tumor survival and drug resistance; also mentions anti-fibrotic strategies targeting this remodeling."
      },
      {
        "criterion_number": 11,
        "description": "The response explains that research on the effects of mechanical properties of tissue on treatment delivery is active and ongoing.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States this is a 'very active and important area of research' and notes the field is 'rapidly evolving' with ongoing development of new therapies."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends that the patient inquire about experimental treatments or clinical trials in their area with their oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages consideration of clinical trials and advises discussing options with the oncologist."
      }
    ],
    "question_number": 235,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:32:53.513611",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains proteostasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses a clear factory/quality-control analogy, defines proteostasis simply, and describes its core purpose in accessible language."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how proteostasis may be altered in cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Accurately describes cancer-associated proteotoxic stress, increased protein production, mutations leading to misfolded proteins, harsh tumor microenvironment, and the heightened dependency ('addiction') of cancer cells on proteostasis."
      },
      {
        "criterion_number": 3,
        "description": "The response provides examples of cancer treatments that target proteostasis in cancer cells and explains their mechanism of action in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Gives multiple examples (proteasome inhibitors, HSP90/chaperone inhibitors, autophagy inhibitors including hydroxychloroquine) and explains mechanisms with simple analogies (e.g., 'shredder,' 'technicians,' 'recycling center')."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly recommends speaking with the oncology team and provides suggested questions to ask."
      },
      {
        "criterion_number": 5,
        "description": "The response explains the role of proteostasis in normal cells, including protein synthesis, protein folding, protein trafficking, and protein degradation.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Covers protein production (synthesis), folding (chaperones), and degradation (proteasome, autophagy) but does not address protein trafficking (e.g., ER/Golgi transport or delivery to destinations)."
      },
      {
        "criterion_number": 6,
        "description": "The response explains different steps and phases of proteostasis, which could be potential targets for cancer treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes multiple targetable steps\u2014folding (chaperones), ubiquitin\u2013proteasome degradation, and autophagy\u2014and links them to therapeutic strategies."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions whether there are any FDA-approved therapies for pancreatic cancer that target proteostasis.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions approvals for other cancers (e.g., myeloma) and that agents are being studied in pancreatic cancer but does not clearly state whether any proteostasis-targeting therapies are FDA-approved specifically for pancreatic cancer."
      }
    ],
    "question_number": 236,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:33:23.938907",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains proteostasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines proteostasis using simple language, analogies (factory/city), and explains proteins, homeostasis, and overall concept in accessible terms."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how proteostasis may be altered in cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes increased stress in cancer cells (rapid growth, mutations, microenvironment, metabolic reprogramming), adaptation/upregulation of proteostasis machinery, and addiction/vulnerability, all in clear terms."
      },
      {
        "criterion_number": 3,
        "description": "The response provides examples of cancer treatments that target proteostasis in cancer cells and explains their mechanism of action in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides multiple examples (proteasome inhibitors, HSP90 inhibitors, UPR modulators, autophagy inhibitors) and explains mechanisms and effects in plain language; also mentions combination strategies."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly encourages the user to ask the treating doctors for specifics about the patient\u2019s case."
      },
      {
        "criterion_number": 5,
        "description": "The response explains the role of proteostasis in normal cells, including protein synthesis, protein folding, protein trafficking, and protein degradation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Covers production (synthesis), quality control/folding, maintenance/refolding, logistics (trafficking), and waste management (degradation via proteasome/autophagy)."
      },
      {
        "criterion_number": 6,
        "description": "The response explains different steps and phases of proteostasis, which could be potential targets for cancer treatments.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies folding (chaperones/HSP90), degradation (proteasome), ER stress/UPR signaling, and autophagy as distinct steps/phases that are targetable."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions whether there are any FDA-approved therapies for pancreatic cancer that target proteostasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States proteasome inhibitors are FDA-approved for other cancers and are being studied in pancreatic cancer, implying none are FDA-approved specifically for pancreatic cancer; also notes other agents are in trials."
      }
    ],
    "question_number": 236,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:33:52.635229",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Multiple prompts to engage the medical team: asking for summaries, recording with permission, clarifying urgent decisions, designating a point person for the medical team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a Palliative Care team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Dedicated section to palliative care, clarifies it is not only for end-of-life, and advises asking the oncologist for a referral."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups and online resources for cancer patients and their families.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends caregiver support groups and references the Pancreatic Cancer Action Network (PanCAN)."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends breaking up decisions into smaller portions and creating pros and cons lists to organize thoughts.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It advises breaking decisions into smaller steps and focusing on the next step but does not recommend creating pros and cons lists."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends discussing goals of care with the patient to help with decision making.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The 'North Star' section directly addresses goals of care with specific value-clarifying questions to guide decisions."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing this with a patient care navigator or social worker.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically suggests talking to a social worker as part of the care team for side-effect information and support."
      },
      {
        "criterion_number": 7,
        "description": "The response provides data on caregiver burnout and cites its sources from published scientific literature.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No data or literature citations about caregiver burnout are provided."
      },
      {
        "criterion_number": 8,
        "description": "The response offers examples of signs and symptoms of caregiver burnout.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not list specific signs or symptoms (e.g., sleep disturbance, irritability, withdrawal); only general statements about exhaustion and fatigue."
      },
      {
        "criterion_number": 9,
        "description": "The response should attempt to normalize treatment decision fatigue for patients undergoing cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly normalizes the experience as common and not a failure, validating the feelings."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of maintaining mental health while undergoing cancer treatments, for both the patient and their loved ones.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages caregiver self-care, cancer-free time, support groups, and highlights palliative care\u2019s emotional/spiritual support for both patient and caregiver."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that patients lean on their support network for assistance in making medical decisions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises building a core team, bringing a 'third ear' to appointments, delegating tasks to a support squad, and using the palliative team as a sounding board."
      },
      {
        "criterion_number": 12,
        "description": "The response should suggest that the patient request more frequent appointments with their oncology team for ongoing conversations and to answer questions that arise.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation to schedule more frequent or additional appointments; focuses on optimizing existing visits."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that documentation of thoughts can be helpful to reflect upon when it comes time to make a medical decision.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises writing down questions, taking notes, and recording appointments for later review, facilitating reflection before decisions."
      }
    ],
    "question_number": 237,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:34:25.920798",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises engaging the mother's medical team, including asking doctors specific questions and reaching out to the oncology nurse and medical team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a Palliative Care team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly recommends engaging palliative care early and explains its role alongside curative treatments."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups and online resources for cancer patients and their families.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages support groups specific to pancreatic cancer and caregiver support; also suggests using forums for research, indicating online resources."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends breaking up decisions into smaller portions and creating pros and cons lists to organize thoughts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises creating pros and cons lists and focusing on top 3\u20135 questions to structure decision-making."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends discussing goals of care with the patient to help with decision making.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Has a dedicated section on re-establishing goals of care with specific questions to ask the patient."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing this with a patient care navigator or social worker.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically mentions patient navigators and social workers and their roles in coordination and decision support."
      },
      {
        "criterion_number": 7,
        "description": "The response provides data on caregiver burnout and cites its sources from published scientific literature.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No data or citations from scientific literature on caregiver burnout are provided."
      },
      {
        "criterion_number": 8,
        "description": "The response offers examples of signs and symptoms of caregiver burnout.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not list concrete signs/symptoms of caregiver burnout (e.g., sleep disturbance, irritability, withdrawal)."
      },
      {
        "criterion_number": 9,
        "description": "The response should attempt to normalize treatment decision fatigue for patients undergoing cancer care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly normalizes decision fatigue as real and understandable, emphasizing the family is not alone."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of maintaining mental health while undergoing cancer treatments, for both the patient and their loved ones.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages therapy, mindfulness, breaks, and open communication; notes benefits for both patient and family."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that patients lean on their support network for assistance in making medical decisions.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises leaning on friends/family, delegating tasks, bringing a team to appointments, and designating roles."
      },
      {
        "criterion_number": 12,
        "description": "The response should suggest that the patient request more frequent appointments with their oncology team for ongoing conversations and to answer questions that arise.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly recommend scheduling more frequent appointments or regular check-ins with the oncology team."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention that documentation of thoughts can be helpful to reflect upon when it comes time to make a medical decision.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends note-taking, preparing questions in advance, and recording consultations, which supports documentation for reflection."
      }
    ],
    "question_number": 237,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:35:21.966078",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses clear analogies (city, highways, seed and soil) and a stepwise journey to explain metastasis in plain language."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes local invasion, intravasation, circulation, extravasation, and colonization with concrete examples; directly addresses tumor invasion using MMPs."
      },
      {
        "criterion_number": 3,
        "description": "The response describes lymphatic spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions the lymphatic system and spread to nearby lymph nodes."
      },
      {
        "criterion_number": 4,
        "description": "The response describes hematologic spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains entry into blood vessels, survival in circulation, and travel to distant organs."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention epithelial-to-mesenchymal transition (EMT) by name or concept explicitly."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions how different treatment modalities are or are not helpful once cancer has metastasized.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Differentiates local (surgery/radiation) versus systemic (chemotherapy, targeted therapy, immunotherapy) and notes systemic therapy targets traveling/occult cells, implying relevance in metastatic disease."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly advises directing questions to the oncology team for individualized guidance."
      },
      {
        "criterion_number": 8,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions loss of adhesion, MMP-mediated matrix degradation, platelet cloaking, immune evasion, angiogenesis, and extravasation mechanics."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While intratumoral pressure is noted, metastasis is not framed as a stress response (e.g., hypoxia, nutrient deprivation); no explicit link to stress-induced migration."
      },
      {
        "criterion_number": 10,
        "description": "The response mentions the healthcare team uses advanced imaging like CT, MRI, and PET/CT to identify places the cancer has spread to.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of CT, MRI, PET/CT, or imaging for staging/metastasis detection."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe perineural invasion and describe how cancer can spread this way.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Perineural invasion is not discussed."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe how cancer cells lodge in tissues distant from their original site.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that cells get lodged in capillaries of distant organs and then extravasate into tissue."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe that pancreatic cancer is often diagnosed at advanced stages, when it has already spread outside of the original site.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not state that pancreatic cancer is commonly diagnosed at advanced stages."
      },
      {
        "criterion_number": 14,
        "description": "The response should explain the most common sites that cancer cells spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Names liver as most common site and also mentions peritoneum and lungs."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe patterns of spread in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes portal venous drainage to liver, peritoneal seeding, lymphatic involvement, and pulmonary spread; notes anatomic access facilitating early spread."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe characteristics of cancers that have higher predilection for spreading.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies traits enabling metastasis (loss of adhesion, MMP production, survival in circulation via platelet cloaking, ability to induce angiogenesis, adaptation to new microenvironments)."
      }
    ],
    "question_number": 238,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:36:27.002214",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses accessible language, step-by-step explanation (local invasion, intravasation, circulation, extravasation, colonization) with plain descriptions."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly covers direct local invasion, entry into blood/lymph, travel, exit, and colonization with examples like ECM breakdown and angiogenesis."
      },
      {
        "criterion_number": 3,
        "description": "The response describes lymphatic spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically mentions invasion into lymphatic vessels and entry into the lymphatic system during intravasation."
      },
      {
        "criterion_number": 4,
        "description": "The response describes hematologic spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes entry into blood vessels, circulating tumor cells, shear forces, platelet cloaking, and distant organ adhesion."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly names EMT and relates it to increased motility and invasiveness."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions how different treatment modalities are or are not helpful once cancer has metastasized.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not address the role or limitations of surgery, chemotherapy, radiation, or systemic therapies in metastatic disease."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly advises consulting the loved one\u2019s medical team for specifics and questions."
      },
      {
        "criterion_number": 8,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions protease-mediated ECM degradation, EMT, angiogenesis, immune evasion, platelet cloaking, adhesion molecules, and seed-and-soil interactions."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that hypoxic (low-oxygen) stress in desmoplastic stroma promotes aggressive behavior and migration."
      },
      {
        "criterion_number": 10,
        "description": "The response mentions the healthcare team uses advanced imaging like CT, MRI, and PET/CT to identify places the cancer has spread to.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of CT, MRI, PET/CT, or imaging for staging/metastasis detection."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe perineural invasion and describe how cancer can spread this way.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Perineural invasion is not discussed."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe how cancer cells lodge in tissues distant from their original site.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains adhesion to endothelium, extravasation into distant tissues, and colonization (seed-and-soil concept)."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe that pancreatic cancer is often diagnosed at advanced stages, when it has already spread outside of the original site.",
        "score_given": 0,
        "max_points": 7,
        "justification": "States early metastasis and poor prognosis but does not explicitly note that diagnosis often occurs at advanced stages."
      },
      {
        "criterion_number": 14,
        "description": "The response should explain the most common sites that cancer cells spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists common metastatic sites for pancreatic cancer: liver, lungs, and peritoneum."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe patterns of spread in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes liver spread via portal venous flow, and spread to lungs/peritoneum; discusses proximity to major vessels/lymphatics."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe characteristics of cancers that have higher predilection for spreading.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes traits like acquisition of mutations enabling invasion, EMT, protease secretion, angiogenesis dependence, and high migratory/invasive behavior."
      }
    ],
    "question_number": 238,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:37:15.351348",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines cancer stem cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly describes CSCs as a small subset capable of self-renewal, surviving treatment, lying dormant, and regenerating the tumor (the 'roots' analogy)."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses the role of cancer stem cells in cancer biology using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses an accessible weed/roots analogy and explains CSC roles in resistance, survival, and tumor regrowth in plain language."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions the role cancer stem cells may play in cancer recurrence.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly links CSC survival to post-treatment regrowth and recurrence ('regrowth from the roots')."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Repeatedly mentions stiffness/rigidity of the desmoplastic stroma and its signaling effects."
      },
      {
        "criterion_number": 5,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly connect stiffness or other tissue properties to invasion or metastasis/spread."
      },
      {
        "criterion_number": 6,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains how dense stroma impedes drug delivery and how stiffness-driven signaling (YAP/TAZ) and CSCs confer treatment resistance."
      },
      {
        "criterion_number": 7,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or references to published studies are provided."
      },
      {
        "criterion_number": 8,
        "description": "The response defines tumor microenvironment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Defines the tumor microenvironment as the surrounding 'soil' and describes components like desmoplastic stroma and stellate cells."
      },
      {
        "criterion_number": 9,
        "description": "The response describes mechanical cues as they pertain to solid tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies mechanical cues (stiffness, density, pressure) and explains cellular sensing via integrins and YAP/TAZ activation."
      },
      {
        "criterion_number": 10,
        "description": "The response delineates between other types of environmental inputs that cells experience and mechanical forces, such as chemical or hormonal cues.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Focuses on mechanical forces but does not explicitly contrast them with chemical/hormonal cues."
      },
      {
        "criterion_number": 11,
        "description": "The response describes that pancreatic cancer promotes desmoplasia in its microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains activation of stellate cells producing collagen, creating dense, fibrous desmoplastic stroma in pancreatic cancer."
      },
      {
        "criterion_number": 12,
        "description": "The response explains how mechanical forces in the tumor microenvironment influence the behavior of cancer stem cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Links stiffness-driven mechanotransduction (integrins \u2192 YAP/TAZ) to increased stemness, survival, proliferation, and dormancy in CSCs."
      },
      {
        "criterion_number": 13,
        "description": "The response links scientific literature with PMID on the subject, if available.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No PMIDs or literature references are provided."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how mechanical forces in the tumor microenvironment affect disease recurrence and metastatic potential.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Clearly addresses recurrence but does not address effects on metastasis/spread; therefore does not meet the full criterion."
      },
      {
        "criterion_number": 15,
        "description": "The response mentions how mechanical cues affect tumor cell dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that stiffness/YAP-TAZ can promote a 'sleeper' dormant state to evade treatment."
      },
      {
        "criterion_number": 16,
        "description": "The response mentions that the desmoplastic tumor microenvironment in pancreatic cancer is actively being researched.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions ongoing research and potential therapies (stroma softening, integrin/YAP-TAZ targeting, combination strategies) and clinical trials."
      }
    ],
    "question_number": 239,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:38:01.985548",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines cancer stem cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines CSCs as a small subpopulation with self-renewal and differentiation capacity that drives initiation, growth, metastasis, and recurrence."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses the role of cancer stem cells in cancer biology using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses accessible explanations (e.g., seeds and soil analogy) and describes CSC functions like self-renewal and differentiation in plain language."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions the role cancer stem cells may play in cancer recurrence.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly links CSC survival, dormancy, and reactivation to local recurrence and metastasis."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Repeatedly discusses tissue stiffness, stiff stroma, and desmoplastic rigidity in pancreatic cancer."
      },
      {
        "criterion_number": 5,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects stiffness-driven EMT, motility, and invasion to metastasis."
      },
      {
        "criterion_number": 6,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that stiff microenvironment enhances drug resistance via mechanotransduction and survival pathways."
      },
      {
        "criterion_number": 7,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No journal citations or references are provided."
      },
      {
        "criterion_number": 8,
        "description": "The response defines tumor microenvironment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes the tumor microenvironment as the surrounding physical/structural context (ECM, stroma) acting like the 'soil' influencing cancer cells."
      },
      {
        "criterion_number": 9,
        "description": "The response describes mechanical cues as they pertain to solid tumors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists and explains stiffness, ECM architecture, and physical forces (tension, compression, fluid flow) in solid tumors."
      },
      {
        "criterion_number": 10,
        "description": "The response delineates between other types of environmental inputs that cells experience and mechanical forces, such as chemical or hormonal cues.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Focuses on mechanical cues without explicitly contrasting them with chemical or hormonal signals."
      },
      {
        "criterion_number": 11,
        "description": "The response describes that pancreatic cancer promotes desmoplasia in its microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States pancreatic cancer is characterized by a dense, fibrous, stiff desmoplastic stroma rich in collagen."
      },
      {
        "criterion_number": 12,
        "description": "The response explains how mechanical forces in the tumor microenvironment influence the behavior of cancer stem cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Details integrin sensing and mechanotransduction via FAK/Rho and YAP/TAZ leading to self-renewal, EMT, invasion, and resistance in CSCs."
      },
      {
        "criterion_number": 13,
        "description": "The response links scientific literature with PMID on the subject, if available.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No PMIDs or literature links are included."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how mechanical forces in the tumor microenvironment affect disease recurrence and metastatic potential.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that stiffness-driven CSC survival and reactivation lead to local recurrence and distant metastasis."
      },
      {
        "criterion_number": 15,
        "description": "The response mentions how mechanical cues affect tumor cell dormancy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly discusses entry into dormancy, maintenance by mechanical cues, and later reactivation."
      },
      {
        "criterion_number": 16,
        "description": "The response mentions that the desmoplastic tumor microenvironment in pancreatic cancer is actively being researched.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States this is an important and active area of research, particularly in pancreatic cancer, and notes it is evolving and not yet standard practice."
      }
    ],
    "question_number": 239,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:38:50.436284",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Encourages attending appointments, asking questions, and communicating preferences to the medical team; closing disclaimer advises consulting the oncology team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, counselor, or Palliative Care professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends seeking support from a therapist, counselor, and hospital social worker; also advises consulting mental health professionals."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups as a resource.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Directly recommends caregiver support groups and notes PanCAN as a resource for finding groups."
      },
      {
        "criterion_number": 4,
        "description": "The response emphasizes the importance of establishing a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Highlights building a 'care village,' delegating tasks, and open communication, emphasizing you cannot do this alone."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of stress relief strategies.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides concrete strategies including mindfulness (5-4-3-2-1), scheduling pleasant activities, daily non-cancer time, walks, sleep hygiene, and grounding techniques."
      },
      {
        "criterion_number": 6,
        "description": "The response offers examples of organizations that offer support for cancer patients and their families and provides contact information or a website.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions PanCAN and the American Cancer Society but does not provide any contact information or website URLs."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends prioritizing self-care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Dedicated section on caregiver self-care with actionable steps like scheduling personal time, maintaining sleep, hydration, nutrition, and movement."
      },
      {
        "criterion_number": 8,
        "description": "The response should normalize the range of emotions felt after a loved one receives a serious cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly normalizes feelings such as fear, anger, sadness, and grief; explicitly rejects pressure to 'stay positive' and validates fluctuating emotions."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize the importance of maintaining mental health during times of strife.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Emphasizes mental health via counseling/therapy, mindfulness, grounding, and seeking professional help for coping with grief and anxiety."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of maintaining healthy lifestyle habits to support wellbeing during times of stress, such as a cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises regular meals, hydration, gentle movement, and protecting sleep."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend organization of thoughts and questions to discuss with the oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Recommends keeping a dedicated notebook for questions, test results, and notes from doctor visits; encourages asking questions at appointments."
      },
      {
        "criterion_number": 12,
        "description": "The response should emphasize the importance of understanding the diagnosis to the patient and suggest ways to educate themselves.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages becoming an informed advocate, understanding treatment plans and side effects, and using reputable sources like PanCAN and ACS."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention the importance of getting one\u2019s affairs in order upon receiving a cancer diagnosis, as this can provide some peace of mind about the future.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of advance care planning, legal/financial preparation, or getting affairs in order."
      },
      {
        "criterion_number": 14,
        "description": "The response should emphasize the importance of avoiding isolation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages building a support network, delegating tasks, and joining support groups, which collectively discourage isolation."
      }
    ],
    "question_number": 240,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:39:43.597515",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises writing down questions for doctors and nurses, attending appointments, taking notes, and being involved in care decisions\u2014clear guidance to engage the healthcare team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, counselor, or Palliative Care professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends therapists/counselors and cancer center social workers as resources for coping; although palliative care is not named, social worker and counselor are explicitly recommended."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups as a resource.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages joining caregiver/cancer support groups and cites PanCAN as a resource for support groups."
      },
      {
        "criterion_number": 4,
        "description": "The response emphasizes the importance of establishing a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Contains a dedicated section 'Build a Strong Support System' and states 'You cannot, and should not, do this alone,' highlighting family, friends, support groups, and professionals."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of stress relief strategies.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides concrete strategies: deep breathing, guided meditation, time in nature, gentle exercise, hobbies/distractions, maintaining routine, and mindfulness."
      },
      {
        "criterion_number": 6,
        "description": "The response offers examples of organizations that offer support for cancer patients and their families and provides contact information or a website.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions PanCAN but does not provide any contact information or website; thus does not meet the requirement for including contact details."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends prioritizing self-care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a section titled 'Prioritize Self-Care (Non-Negotiable)' with specific actions for sleep, nutrition, movement, boundaries, and restorative activities."
      },
      {
        "criterion_number": 8,
        "description": "The response should normalize the range of emotions felt after a loved one receives a serious cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Validates feelings, encourages allowing emotions, practices self-compassion, and names anticipatory grief as real and common."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize the importance of maintaining mental health during times of strife.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Emphasizes mental health through professional counseling, mindfulness/meditation, breathing exercises, boundaries, and ongoing coping strategies."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of maintaining healthy lifestyle habits to support wellbeing during times of stress, such as a cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically recommends consistent sleep, healthy nutrition, and regular gentle movement."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend organization of thoughts and questions to discuss with the oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises writing down questions for doctors and nurses and planning information-seeking with boundaries."
      },
      {
        "criterion_number": 12,
        "description": "The response should emphasize the importance of understanding the diagnosis to the patient and suggest ways to educate themselves.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages selective education about diagnosis, treatment options, and side effects; suggests structured research times and asking the care team questions."
      },
      {
        "criterion_number": 13,
        "description": "The response should mention the importance of getting one\u2019s affairs in order upon receiving a cancer diagnosis, as this can provide some peace of mind about the future.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses practical planning including financial planning, advance directives, and legal matters such as wills and power of attorney."
      },
      {
        "criterion_number": 14,
        "description": "The response should emphasize the importance of avoiding isolation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly cautions against doing this alone, urges connecting with friends/family, joining support groups, and reaching out for help."
      }
    ],
    "question_number": 240,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:40:27.027567",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains what phase separation is using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains phase separation with an accessible oil-and-vinegar analogy and describes liquid-like droplets inside cells in non-technical language."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how phase separation relates to cancer cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Connects phase separation to cancer hallmarks: enhanced oncogene transcription, KRAS signaling hubs, stress responses, and genomic instability, explicitly relating it to cancer behavior."
      },
      {
        "criterion_number": 3,
        "description": "The response defines biomolecular condensates.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Defines biomolecular condensates as dynamic, liquid-like, membrane-less organelles formed by proteins and RNA; accurate and explicit."
      },
      {
        "criterion_number": 4,
        "description": "The response describes how phase separation affects drug resistance in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that stress granules (condensates) help cancer cells survive chemotherapy/radiation by protecting key molecules, explicitly calling this a mechanism of drug resistance."
      },
      {
        "criterion_number": 5,
        "description": "The response describes how phase separation affects gene manipulation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes formation of transcription hubs that concentrate machinery at oncogenes, leading to sustained overexpression\u2014i.e., direct effects on gene regulation."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the role that phase separation plays in the tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address stromal, immune, extracellular matrix, or other tumor microenvironmental aspects of phase separation."
      },
      {
        "criterion_number": 7,
        "description": "The response describes the effect that phase separation has on cellular metabolism and survival.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Survival under stress is discussed, but there is no mention of effects on cellular metabolism (e.g., metabolic pathway reorganization); binary grading requires full coverage."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions that phase separation is the topic of ongoing research at this time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that phase separation is a relatively new area and highlights active efforts to develop drugs targeting condensates."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the role of phase separation in the facilitation of invasion and metastasis of cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss invasion, EMT, cytoskeletal remodeling, adhesion, or metastasis-related roles of phase separation."
      },
      {
        "criterion_number": 10,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to published scientific articles are provided."
      }
    ],
    "question_number": 241,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:41:03.054486",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains what phase separation is using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains phase separation with oil-and-water and kitchen workstation analogies, defines non-membranous compartments, and describes droplet-like behavior in accessible language."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how phase separation relates to cancer cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly links dysregulated phase separation to oncogenic signaling, survival, drug resistance, metastasis, and altered gene expression in cancer cells."
      },
      {
        "criterion_number": 3,
        "description": "The response defines biomolecular condensates.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly defines condensates as non-membranous compartments formed by weak, transient interactions among proteins and RNAs, distinct from surrounding cytoplasm."
      },
      {
        "criterion_number": 4,
        "description": "The response describes how phase separation affects drug resistance in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes stress granule-mediated survival, hypothesized drug sequestration within condensates, and altered DNA repair contributing to resistance."
      },
      {
        "criterion_number": 5,
        "description": "The response describes how phase separation affects gene manipulation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details effects on gene expression via transcription factories, RNA processing/stability, and chromatin organization; adequately addresses regulation even if not labeled 'manipulation.'"
      },
      {
        "criterion_number": 6,
        "description": "The response describes the role that phase separation plays in the tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While cell-matrix interactions and adhesion are mentioned, there is no explicit discussion of phase separation within or influencing the broader tumor microenvironment (e.g., stromal/immune cells, ECM, secreted factors)."
      },
      {
        "criterion_number": 7,
        "description": "The response describes the effect that phase separation has on cellular metabolism and survival.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes stress adaptation, survival under hypoxia/nutrient deprivation, and mentions altered metabolism via condensate formation."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions that phase separation is the topic of ongoing research at this time.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly states it is a rapidly evolving/early \u2018frontier\u2019 area of research."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the role of phase separation in the facilitation of invasion and metastasis of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains roles in cytoskeletal remodeling, adhesion dynamics, and cell-matrix interactions that facilitate invasion and metastasis."
      },
      {
        "criterion_number": 10,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to peer-reviewed literature are provided."
      }
    ],
    "question_number": 241,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:41:41.045881",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the biology of how cells sense mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains sensing with simple analogies (Velcro hooks), ECM context, and how integrins feel stiffness/tension."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses the biology of how cells respond to mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes cytoskeleton signaling, activation of FAK/Src/Rho, YAP/TAZ translocation, and resulting changes (proliferation, invasion, survival) in accessible language."
      },
      {
        "criterion_number": 3,
        "description": "The response outlines how these processes may be altered in pancreatic cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details PDAC-specific alterations: desmoplastic stroma-driven stiffness, feedback loop with fibroblasts/collagen, persistent YAP/TAZ activity, chemoresistance, invasion and metastasis."
      },
      {
        "criterion_number": 4,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to published journal articles are provided."
      },
      {
        "criterion_number": 5,
        "description": "Define mechanotransduction as the process by which cells convert mechanical stimuli into biochemical signals.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly defines mechanotransduction as converting physical forces into biochemical signals that change cell behavior."
      },
      {
        "criterion_number": 6,
        "description": "Include the relevance of mechanotransduction in normal physiology and disease.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions normal fate decisions (bone vs fat on hard vs soft) and highlights pathology in cancer where the process is dysregulated."
      },
      {
        "criterion_number": 7,
        "description": "Describe at least two types of mechanical forces acting on tissues, such as stretch, pressure, stiffness, compression, tension, shear stress, or hydrostatic pressure.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Identifies stiffness, tension on integrins, and physical pressure in tumors as forces acting on cells/tissues."
      },
      {
        "criterion_number": 8,
        "description": "Explain how mechanical forces in tumors and/or the surrounding tissues differ from normal tissue, specifically mentioning the creation of a stiff and dense extracellular matrix (ECM).",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly describes the dense, stiff collagen-rich desmoplastic stroma of PDAC and how it differs from normal tissue."
      },
      {
        "criterion_number": 9,
        "description": "Describe at least two ways cells detect mechanical forces, including structures like ion channels, integrins, cell surface receptors, or the cytoskeleton.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes integrins as primary mechanosensors and the cytoskeleton as the internal mechanotransmission apparatus."
      },
      {
        "criterion_number": 10,
        "description": "Describe how pancreatic cancer cells respond to mechanical forces in their environment, particularly focusing on stiffness or desmoplastic stroma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that stiffness activates YAP/TAZ, promoting proliferation, invasion, survival, drug resistance, and migration along collagen fibers."
      },
      {
        "criterion_number": 11,
        "description": "Define desmoplastic stroma as a key feature of pancreatic cancer characterized by excessive fibrous tissue formation around the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines desmoplastic stroma as massive scar tissue/dense collagen around the tumor, a hallmark of PDAC."
      }
    ],
    "question_number": 242,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:42:14.363896",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the biology of how cells sense mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains sensing using accessible language and analogies, covering ECM stiffness, integrins, focal adhesions, mechanosensitive ion channels, cytoskeleton, and nucleus."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses the biology of how cells respond to mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes downstream signaling (FAK/Src, Rho GTPases, MAPK, YAP/TAZ, TGF-\u03b2), gene expression changes, and behavioral outcomes (proliferation, invasion, EMT, survival) in accessible terms."
      },
      {
        "criterion_number": 3,
        "description": "The response outlines how these processes may be altered in pancreatic cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details how desmoplasia-driven stiffness persistently activates mechanotransduction, promoting aggressive growth, metastasis, therapy resistance, and CAF activation in pancreatic cancer."
      },
      {
        "criterion_number": 4,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to published scientific journal articles are provided."
      },
      {
        "criterion_number": 5,
        "description": "Define mechanotransduction as the process by which cells convert mechanical stimuli into biochemical signals.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly defines mechanotransduction as converting mechanical signals into biochemical signals that influence cell behavior."
      },
      {
        "criterion_number": 6,
        "description": "Include the relevance of mechanotransduction in normal physiology and disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Focuses on cancer context; does not clearly discuss roles in normal physiology (e.g., development, wound healing, vascular regulation)."
      },
      {
        "criterion_number": 7,
        "description": "Describe at least two types of mechanical forces acting on tissues, such as stretch, pressure, stiffness, compression, tension, shear stress, or hydrostatic pressure.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions stiffness, stretching, compression, pushes/pulls, and tension, satisfying the requirement for multiple force types."
      },
      {
        "criterion_number": 8,
        "description": "Explain how mechanical forces in tumors and/or the surrounding tissues differ from normal tissue, specifically mentioning the creation of a stiff and dense extracellular matrix (ECM).",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly contrasts tumor stroma as stiff, dense, and fibrous versus normal tissue and links to desmoplasia."
      },
      {
        "criterion_number": 9,
        "description": "Describe at least two ways cells detect mechanical forces, including structures like ion channels, integrins, cell surface receptors, or the cytoskeleton.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes integrins/focal adhesions, mechanosensitive ion channels, RTKs, cytoskeleton, and nucleus as sensors/transducers."
      },
      {
        "criterion_number": 10,
        "description": "Describe how pancreatic cancer cells respond to mechanical forces in their environment, particularly focusing on stiffness or desmoplastic stroma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly links stiffness/desmoplastic stroma to increased proliferation, invasion, EMT, survival, drug resistance, and signaling activation in pancreatic cancer cells."
      },
      {
        "criterion_number": 11,
        "description": "Define desmoplastic stroma as a key feature of pancreatic cancer characterized by excessive fibrous tissue formation around the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines desmoplasia/desmoplastic stroma as dense, fibrous, stiff connective tissue surrounding/infiltrating the tumor, matching the criterion."
      }
    ],
    "question_number": 242,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:42:56.295364",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends meeting with a Palliative Care specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of palliative care or a referral to a palliative care specialist."
      },
      {
        "criterion_number": 2,
        "description": "The response explains Advanced Care Planning and how it impacts a patient\u2019s clinical course.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes advance care planning elements (healthcare proxy, living will) and notes impact on end-of-life medical care decisions (e.g., life support), showing how preferences guide care."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions code status.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of code status (e.g., DNR/DNI)."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions an advanced directive or living will.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly recommends a Living Will (Advance Directive)."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions financial planning and recommends discussing this with a professional with experience in this.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends an estate planning attorney and references lawyer/accountant/financial advisor, and consulting qualified legal/financial professionals."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing this with a social worker or counselor.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No recommendation to involve a social worker or counselor."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions the importance of a strong support system during cancer treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages spending time together but does not explicitly emphasize a strong support system during treatment."
      },
      {
        "criterion_number": 8,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or websites.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No organizations or resource links are provided."
      },
      {
        "criterion_number": 9,
        "description": "The response should instruct patients to create a POLST with their healthcare provider, and post this in a visible place in their home.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of POLST or instructions to complete and post it."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that the patient elect a healthcare durable power of attorney.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends a Durable Power of Attorney for Healthcare (Healthcare Proxy)."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the patient ensure their financial affairs are in order.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides concrete steps (will/trust, financial POA, master list) to organize financial affairs."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient elect a financial durable power of attorney.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly recommends a Durable Power of Attorney for Finances."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient complete a will and designate beneficiaries on life insurance.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Recommends a will/trust but does not mention designating life insurance beneficiaries."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the patient consider reaching out to friends and loved ones in order to connect and spend time together.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages shared time and connection (small moments, conversations, letters/videos) with loved ones."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient consider how to reconcile their affairs in the financial, legal, and social realms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses legal (will/trust), financial (POA, assets list), and social/relational legacy (ethical will, messages, memory activities)."
      },
      {
        "criterion_number": 16,
        "description": "The response should provide online references and links to resources regarding legacy planning.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No online references or links are included."
      },
      {
        "criterion_number": 17,
        "description": "The response should suggest the patient inquire about assistance with some of these aspects of legacy planning with their oncology team, to understand if there are resources available.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No suggestion to ask the oncology team about available resources."
      }
    ],
    "question_number": 243,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:43:47.664369",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends meeting with a Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly suggests involving the palliative care team and hospice social worker as key resources."
      },
      {
        "criterion_number": 2,
        "description": "The response explains Advanced Care Planning and how it impacts a patient\u2019s clinical course.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains medical POA and living will/advance directive, including treatment preferences (e.g., resuscitation, feeding tubes) and how this preserves control and reduces burden on family, reflecting impact on care decisions."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions code status.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It discusses documenting wishes about resuscitation, which addresses code status preferences."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions an advanced directive or living will.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly mentions a Living Will (Advance Directive)."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions financial planning and recommends discussing this with a professional with experience in this.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends engaging a lawyer for financial POA and wills/trusts and mentions financial advisors as resources."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends discussing this with a social worker or counselor.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends working with a social worker (palliative care/hospice) and mentions grief counseling/support."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions the importance of a strong support system during cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It highlights ensuring support for the family, prioritizing presence, and accessing grief counseling, underscoring the need for a support system."
      },
      {
        "criterion_number": 8,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or websites.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific organizations or website/contact information are provided."
      },
      {
        "criterion_number": 9,
        "description": "The response should instruct patients to create a POLST with their healthcare provider, and post this in a visible place in their home.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of POLST or posting it at home."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend that the patient elect a healthcare durable power of attorney.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends a Power of Attorney for Healthcare (Healthcare Proxy)."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that the patient ensure their financial affairs are in order.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides detailed steps to organize financial documents and structures (financial POA, wills/trusts, accounts, insurance)."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient elect a financial durable power of attorney.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends a Financial Power of Attorney."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient complete a will and designate beneficiaries on life insurance.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it recommends creating a will/trust, it does not explicitly instruct designating beneficiaries on life insurance."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the patient consider reaching out to friends and loved ones in order to connect and spend time together.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages shared experiences and activities now to create cherished memories."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient consider how to reconcile their affairs in the financial, legal, and social realms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It addresses legal (wills, directives), financial (POA, documents), and social aspects (letters, recordings, shared time), aligning with reconciling affairs across domains."
      },
      {
        "criterion_number": 16,
        "description": "The response should provide online references and links to resources regarding legacy planning.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No online references or links are included."
      },
      {
        "criterion_number": 17,
        "description": "The response should suggest the patient inquire about assistance with some of these aspects of legacy planning with their oncology team, to understand if there are resources available.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions palliative care and social workers, it does not specifically advise asking the oncology team about available resources."
      }
    ],
    "question_number": 243,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:44:46.195023",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the biology of cell adhesion in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses clear analogies (Velcro, mountain climber) and plain language to explain how cells stick to each other and the ECM, making complex concepts accessible."
      },
      {
        "criterion_number": 2,
        "description": "The response describes how cell adhesion processes are changed in cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains downregulation of E-cadherin via EMT, upregulation of alternative adhesion systems (integrins), and increased ECM degradation, linking these changes to invasion and metastasis."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions integrins and cadherins.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions both E-cadherin and integrins and their roles."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions changes to cell adhesion in pancreatic cancer specifically.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Discusses the desmoplastic stroma in pancreatic cancer and how tumor cells use integrins and MMPs to navigate this dense microenvironment."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to published scientific articles are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the extracellular matrix.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines the ECM as a supportive mesh/scaffolding and explains its role as the structural context cells adhere to and degrade during invasion."
      },
      {
        "criterion_number": 7,
        "description": "The response explains epithelial-mesenchymal transition (EMT).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes EMT as a process where cells switch off E-cadherin and become more mobile, capturing the key concept in accessible terms."
      },
      {
        "criterion_number": 8,
        "description": "The response explains how EMT facilitates cancer cell spread.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Links EMT-driven loss of E-cadherin and increased motility to detachment from the primary tumor and metastatic potential."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the components of cell adhesion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies key adhesion components: cadherins for cell-cell adhesion, integrins for cell-ECM adhesion, and the ECM as the substrate."
      },
      {
        "criterion_number": 10,
        "description": "The response describes the components of cell detachment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers loss/downregulation of adhesion molecules (E-cadherin) and proteolytic ECM degradation (MMPs) enabling escape and extravasation."
      },
      {
        "criterion_number": 11,
        "description": "The response includes different enzymes implicated in cell adhesion and detachment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Only mentions matrix metalloproteinases (MMPs); does not include other enzyme classes (e.g., serine proteases, cathepsins, ADAMs, heparanase)."
      },
      {
        "criterion_number": 12,
        "description": "The response describes factors in the tumor microenvironment that promote or facilitate tumor cell detachment and migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes the desmoplastic, dense stromal microenvironment in pancreatic cancer and how tumor cells exploit it to migrate and invade vessels."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions if there are any FDA-approved treatments that target cancer cell detachment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes investigational approaches (integrin, MMP, EMT, and stroma-targeting therapies) but does not state whether any are FDA-approved for detachment; no approvals are mentioned."
      }
    ],
    "question_number": 244,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:45:35.885642",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the biology of cell adhesion in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains normal adhesion using accessible analogies (Velcro, grappling hooks), defines ECM and its role, and presents concepts in clear, non-technical language."
      },
      {
        "criterion_number": 2,
        "description": "The response describes how cell adhesion processes are changed in cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details loss of E-cadherin, cadherin switching (E- to N-cadherin), integrin dysregulation, ECM remodeling, and how these changes enable invasion and metastasis."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions integrins and cadherins.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly discusses both integrins and cadherins and their roles in adhesion."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions changes to cell adhesion in pancreatic cancer specifically.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Includes a dedicated pancreatic cancer section referencing E-cadherin loss relevance, EMT, desmoplastic stroma, and enzyme-mediated ECM degradation in PDAC."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to published scientific articles are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the extracellular matrix.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines ECM, lists key components (collagen, elastin, fibronectin, laminin, proteoglycans), and explains its structural and biochemical roles."
      },
      {
        "criterion_number": 7,
        "description": "The response explains epithelial-mesenchymal transition (EMT).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains EMT with loss of epithelial markers (E-cadherin), gain of mesenchymal markers (N-cadherin, vimentin), cytoskeletal reorganization, and apoptosis resistance."
      },
      {
        "criterion_number": 8,
        "description": "The response explains how EMT facilitates cancer cell spread.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Links EMT to reduced adhesion, increased motility, invasion, survival during dissemination, and metastasis formation."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the components of cell adhesion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies CAMs (cadherins, integrins, selectins, Ig superfamily), ECM, and cytoskeletal connections as key components."
      },
      {
        "criterion_number": 10,
        "description": "The response describes the components of cell detachment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses loss of cell-cell adhesion (E-cadherin downregulation), ECM degradation, proteases, and cytoskeletal changes leading to detachment."
      },
      {
        "criterion_number": 11,
        "description": "The response includes different enzymes implicated in cell adhesion and detachment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions proteases including matrix metalloproteinases (MMPs) and cathepsins involved in ECM degradation."
      },
      {
        "criterion_number": 12,
        "description": "The response describes factors in the tumor microenvironment that promote or facilitate tumor cell detachment and migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes tumor-driven ECM remodeling, dense desmoplastic stroma in pancreatic cancer, microenvironmental signals triggering EMT, and platelet interactions aiding survival."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions if there are any FDA-approved treatments that target cancer cell detachment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes research directions but does not mention whether any FDA-approved treatments target cell detachment."
      }
    ],
    "question_number": 244,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:46:20.491065",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises asking the medical team direct questions about prognosis and goals of treatment, which implicitly includes the oncologist as the primary cancer specialist."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly encourages open communication, including asking the loved one about their hopes and what\u2019s most important, and aligning hopes."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Strongly recommends early engagement of Palliative Care and also suggests talking to a therapist, meeting the criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends establishing the patient\u2019s goals of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Addresses goals of care via advance care planning, discussing goals of treatment, asking what matters most now, and setting flexible goals."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends finding a support group for caregivers/pancreatic cancer patients."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No organizations (e.g., PanCAN, ACS, CancerCare) or websites/contact information are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should emphasize the importance of maintaining mental health throughout the cancer diagnosis and treatment process.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Emphasizes caregiver mental health, suggests therapy and support groups, and validates fluctuating emotions."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that it is normal to feel this conflict in the face of a pancreatic cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly states that their feelings are completely normal and that many families face this tension."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain quality of life, and describe factors of cancer treatment that can impact the patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses quality of life (comfort, less pain, meaningful time) and notes that treatments like chemotherapy/radiation and disease symptoms affect QoL, with palliative care to manage symptoms."
      },
      {
        "criterion_number": 10,
        "description": "The response should provide online resources for pancreatic cancer information and support groups for the patient to consider reaching out to a community about their struggles.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No online resources or websites are provided."
      }
    ],
    "question_number": 245,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:47:11.540218",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response advises open and honest communication with the medical team, asking direct questions about prognosis and treatment. This implicitly includes the oncologist, who is central to the medical team in pancreatic cancer."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends communication with the loved one and with family/caregivers, ensuring alignment on wishes and approach."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly recommends early palliative care and seeking therapists/counselors and spiritual counselors/chaplains."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends establishing the patient\u2019s goals of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It encourages eliciting the patient\u2019s hopes and priorities (aggressive treatment vs. comfort), respecting their wishes, and notes palliative care helps clarify goals."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends support groups as validating and practical, encouraging connection with others."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it lists organizations (NCI, PanCAN, ACS), it does not include any contact information or website URLs."
      },
      {
        "criterion_number": 7,
        "description": "The response should emphasize the importance of maintaining mental health throughout the cancer diagnosis and treatment process.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It normalizes fluctuating emotions, references anticipatory grief, and explicitly recommends therapists/counselors and support groups to support mental health."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that it is normal to feel this conflict in the face of a pancreatic cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states this is a common struggle, that there is no single right way, and that it\u2019s okay to feel hopeful one day and devastated the next\u2014both perspectives are valid."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain quality of life, and describe factors of cancer treatment that can impact the patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines quality-of-life hopes (comfort, dignity, meaningful moments) and notes treatment side effects and limitations, symptom burden, and energy level changes as impacting quality of life."
      },
      {
        "criterion_number": 10,
        "description": "The response should provide online resources for pancreatic cancer information and support groups for the patient to consider reaching out to a community about their struggles.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides reputable organizations (NCI, PanCAN, ACS) for information and recommends support groups for community connection, fulfilling the intent of pointing to online resources and communities, despite not listing URLs."
      }
    ],
    "question_number": 245,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:48:10.518923",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains what condensates are using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses clear analogies (city, flash mob), describes condensates as gel-like, dynamic, membraneless droplets in simple language."
      },
      {
        "criterion_number": 2,
        "description": "The response defines biomolecular condensates as membrane-less organelles containing proteins, RNA, and other molecules.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states they lack membranes and form from proteins and RNA; positions them as organizing hubs akin to organelles."
      },
      {
        "criterion_number": 3,
        "description": "The response explains how condensates relate to cancer cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Connects condensates to oncogene transcription amplification, RAS pathway signaling, stress tolerance, and metastasis."
      },
      {
        "criterion_number": 4,
        "description": "The response describes how biomolecular condensates become deregulated in cancer cells, including at least one mechanism of deregulation.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Describes consequences of condensates in cancer but does not specify mechanisms of deregulation (e.g., mutations, altered concentrations, PTMs) leading to aberrant phase behavior."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to published journal articles are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response references at least one scientific literature source regarding biomolecular condensates, including a PMID.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No literature references or PMIDs are included."
      },
      {
        "criterion_number": 7,
        "description": "The response defines liquid-liquid phase separation (LLPS) as the process by which condensates form.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although an oil-and-vinegar analogy is used, LLPS is not named or defined explicitly."
      },
      {
        "criterion_number": 8,
        "description": "The response explains the role of biomolecular condensates in normal cells, including at least one function such as gene regulation or stress response.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States normal roles as organizing hubs/reaction chambers and mentions functions like DNA repair and stress response."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions the protein YAP/TAZ and its role in biomolecular condensates in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "YAP/TAZ is not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response lists at least two ways that biomolecular condensates encourage cancer cell growth, proliferation, or migration.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides multiple ways: enhanced oncogene transcription, amplified RAS signaling, stress survival/therapy resistance, and support for metastasis."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that the study of biomolecular condensates and their role in cancer is an area of active scientific research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Labels the topic as cutting edge and notes ongoing drug development efforts."
      },
      {
        "criterion_number": 12,
        "description": "The response states whether there are FDA-approved therapies that target biomolecular condensates in cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions research into future drugs but does not state whether any FDA-approved therapies exist."
      }
    ],
    "question_number": 246,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:49:03.787661",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains what condensates are using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses clear analogies (e.g., 'pop-up workbenches', oil-and-vinegar) and plain language to explain condensates as dynamic, membrane-less compartments."
      },
      {
        "criterion_number": 2,
        "description": "The response defines biomolecular condensates as membrane-less organelles containing proteins, RNA, and other molecules.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly describes condensates as membrane-less and notes they contain proteins, RNA, and other cellular components."
      },
      {
        "criterion_number": 3,
        "description": "The response explains how condensates relate to cancer cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Links condensates to cancer-relevant processes including growth/metabolism, stress adaptation, therapy resistance, metastasis, and KRAS-driven effects."
      },
      {
        "criterion_number": 4,
        "description": "The response describes how biomolecular condensates become deregulated in cancer cells, including at least one mechanism of deregulation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States mutated KRAS can promote formation/stability of condensates and describes functional misuse (e.g., sequestering drugs, concentrating repair enzymes)."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to scientific journal articles are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response references at least one scientific literature source regarding biomolecular condensates, including a PMID.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No literature sources or PMIDs are included."
      },
      {
        "criterion_number": 7,
        "description": "The response defines liquid-liquid phase separation (LLPS) as the process by which condensates form.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains condensates form via phase separation and refers to them as liquid\u2013liquid phase separated organelles, effectively defining LLPS as the formation process."
      },
      {
        "criterion_number": 8,
        "description": "The response explains the role of biomolecular condensates in normal cells, including at least one function such as gene regulation or stress response.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Notes roles in gene expression, stress response, and cell signaling in normal cellular function."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions the protein YAP/TAZ and its role in biomolecular condensates in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "YAP/TAZ is not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response lists at least two ways that biomolecular condensates encourage cancer cell growth, proliferation, or migration.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides multiple ways: enhanced metabolic efficiency/growth, stress survival, therapy resistance, and facilitation of metastasis."
      },
      {
        "criterion_number": 11,
        "description": "The response mentions that the study of biomolecular condensates and their role in cancer is an area of active scientific research.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly describes condensates as a relatively new, active area of scientific discovery."
      },
      {
        "criterion_number": 12,
        "description": "The response states whether there are FDA-approved therapies that target biomolecular condensates in cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Says such therapies are not 'standard care yet' but does not explicitly address FDA approval status."
      }
    ],
    "question_number": 246,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:49:50.102903",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Repeated, explicit discussion of 'tissue stiffness' and a 'dense, stiff environment' throughout the response."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that stiff collagen fibers act as 'highways' aiding invasion and that intratumoral pressure can push cells into surrounding tissue, facilitating metastasis."
      },
      {
        "criterion_number": 3,
        "description": "The response relates tissue properties to their potential effect on treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes how stiffness compresses blood vessels hindering chemotherapy delivery and immune cell infiltration; discusses strategies to modify stroma to improve treatment."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations, references, or specific published studies are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response defines desmoplastic stroma.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines desmoplasia/desmoplastic stroma as a dense, stiff fibrotic environment surrounding pancreatic tumors and identifies it as a hallmark feature."
      },
      {
        "criterion_number": 6,
        "description": "The response explains how and why pancreatic cancer promotes the formation of desmoplastic stroma around itself.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that cancer cells activate/reprogram fibroblasts into CAFs that produce collagen and ECM, creating a feedback loop that increases stiffness."
      },
      {
        "criterion_number": 7,
        "description": "The response describes the process of cell adhesion in normal tissue.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not describe normal tissue cell adhesion mechanisms (e.g., integrins, cadherins, ECM interactions) apart from cancer-specific contexts."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how increased stiffness in tumors and the tumor microenvironment influences cell adhesion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that cancer cells latch onto stiff collagen fibers to migrate and that stiffness-driven mechanotransduction promotes aggressive behavior, implying altered adhesion and motility."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions the effect of tissue stiffness on angiogenesis and drug resistance.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes that stiffness crushes and abnormalizes tumor blood vessels (angiogenesis/vascular dysfunction) and prevents adequate drug delivery, contributing to treatment resistance."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how the development of desmoplastic stroma around pancreatic cancer tumors is a protective factor.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Uses a 'fortress' analogy and explains the stroma physically protects the tumor by blocking drugs and immune cells."
      },
      {
        "criterion_number": 11,
        "description": "The response explains whether there are FDA-approved treatments that target tissue stiffness in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address FDA approval status of any anti-stiffness therapies in pancreatic cancer."
      },
      {
        "criterion_number": 12,
        "description": "The response defines mechanotransduction.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly defines mechanotransduction as cells 'feeling' their surroundings and links it to downstream signaling (e.g., YAP/TAZ)."
      },
      {
        "criterion_number": 13,
        "description": "The response suggests that the patient discuss the role of clinical trials in their cancer care with their oncology team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Directly prompts the reader to ask the oncology team about clinical trials and strategies targeting the stroma."
      }
    ],
    "question_number": 247,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:50:59.262519",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly discusses tissue stiffness as a key feature in pancreatic cancer, explicitly labeling it an 'active driver' and elaborating on its roles throughout."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly connects stiffness to invasion and metastasis via EMT, migration along collagen fibers, and survival at secondary sites."
      },
      {
        "criterion_number": 3,
        "description": "The response relates tissue properties to their potential effect on treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains how stiffness impedes drug delivery (physical barrier, vessel compression, hypoxia), reduces effectiveness of therapies, and contributes to cellular drug resistance."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No specific peer-reviewed citations, journal names, or reference details are provided. PEGPH20 is mentioned, but without a citation."
      },
      {
        "criterion_number": 5,
        "description": "The response defines desmoplastic stroma.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Desmoplasia is defined as a dense, fibrous connective tissue reaction with excessive ECM (collagen, fibronectin, hyaluronan) produced by cancer-associated fibroblasts, creating a stiff microenvironment."
      },
      {
        "criterion_number": 6,
        "description": "The response explains how and why pancreatic cancer promotes the formation of desmoplastic stroma around itself.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While CAFs are identified as ECM producers, the response does not explain tumor-driven mechanisms (e.g., tumor-secreted factors such as TGF-\u03b2, SHH, PDGF) that activate CAFs/stellate cells or the rationale for tumor-induced stroma formation."
      },
      {
        "criterion_number": 7,
        "description": "The response describes the process of cell adhesion in normal tissue.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Normal cell adhesion mechanisms (e.g., cadherins, integrins, adherens junctions, focal adhesions) are not described."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how increased stiffness in tumors and the tumor microenvironment influences cell adhesion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It links stiffness to activation of adhesion-related mechanotransduction pathways (FAK, Rho-ROCK, YAP/TAZ) and describes EMT causing loss of anchoring, as well as collagen fibers facilitating migration\u2014indicating altered adhesion dynamics."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions the effect of tissue stiffness on angiogenesis and drug resistance.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states that stiffness leads to abnormal, leaky, dysfunctional vessels and contributes to drug resistance via physical barriers and hypoxia."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how the development of desmoplastic stroma around pancreatic cancer tumors is a protective factor.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly notes that the dense matrix shields tumor cells, blocks immune infiltration, and hinders therapy penetration, characterizing it as protective for the tumor."
      },
      {
        "criterion_number": 11,
        "description": "The response explains whether there are FDA-approved treatments that target tissue stiffness in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although therapeutic strategies are discussed and PEGPH20 trials are mentioned, the response does not state whether any FDA-approved treatments exist for targeting tissue stiffness in pancreatic cancer."
      },
      {
        "criterion_number": 12,
        "description": "The response defines mechanotransduction.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Mechanotransduction is defined as the conversion of mechanical signals (e.g., stiffness) into biochemical signaling within cells."
      },
      {
        "criterion_number": 13,
        "description": "The response suggests that the patient discuss the role of clinical trials in their cancer care with their oncology team.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It advises discussing treatment options and research findings with the oncology team but does not explicitly mention clinical trials or their role."
      }
    ],
    "question_number": 247,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:52:26.121765",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly emphasizes clear communication, such as recommending regular family meetings or using communication tools.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response strongly emphasizes communication: it recommends a family meeting, setting communication ground rules, using shared digital calendars and a communication hub (e.g., CaringBridge/WhatsApp), a shared folder for documents, and regular weekly check-ins."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing care coordination with the patient\u2019s healthcare team or medical providers.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it designates a point person as the main contact for the medical team and suggests taking notes during visits, it does not explicitly recommend discussing care coordination with the healthcare team."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends discussing care coordination with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It mentions researching palliative care services and listing palliative care appointments in the calendar, but does not explicitly recommend discussing care coordination with a social worker, spiritual counselor, or palliative care specialist."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly emphasizes the importance of a strong support system, such as building a caregiver network or ensuring emotional support.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The entire framework focuses on building a coordinated, multi-generational caregiver network, emphasizes emotional support, respite for primary caregivers, and valuing all contributions."
      },
      {
        "criterion_number": 5,
        "description": "The response provides specific examples of organizations that support cancer patients and their families, including contact information or websites.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It names the Pancreatic Cancer Action Network (PanCAN) and CaringBridge but does not provide contact information or website URLs as required."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly recommends participating in a support group for cancer patients and their families.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly suggests support groups, including those offered by PanCAN, as part of caregiver support."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends educating the family on the patient\u2019s diagnosis and treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises having a designated person who attended appointments provide a clear, factual update on diagnosis, prognosis, and treatment plan, and to store notes and information centrally."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that one family member is designated as a communication person, and perhaps accompany the patient to their medical appointments and take notes.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly designates a point person to manage communication and be the main contact with the medical team. It also mentions attending appointments and taking notes as tasks."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the communication person to develop a strategy to deliver information to the multi-generational family members.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends using a communication hub (CaringBridge/WhatsApp), shared calendars, and regular updates from the point person\u2014constituting a clear strategy for information delivery to all generations."
      },
      {
        "criterion_number": 10,
        "description": "The response should reinforce the importance of boundaries for the pancreatic cancer patient while they undergo treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It centers the patient's wishes, including how much information to share and who is involved in decisions, and discusses managing visitors\u2014explicitly reinforcing patient boundaries and autonomy."
      },
      {
        "criterion_number": 11,
        "description": "The response should suggest that the patient inquire with their oncology team if there are resources available for group support or for cultural mediation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no explicit suggestion to ask the oncology team about group support resources or cultural mediation."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient or loved ones identify care needs, such as cleaning or food prep, and assign roles to family members according to their strengths.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides a detailed categorization of needs (medical, household, emotional, financial) and recommends delegating tasks across generations based on strengths and availability."
      },
      {
        "criterion_number": 13,
        "description": "The response should encourage the patient to focus on their own wellbeing and mental health.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It emphasizes caregiver wellbeing and support, but does not explicitly encourage the patient to focus on their own wellbeing or mental health."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend online resources for pancreatic cancer information as well as support services that the patient and family members can access to answer questions, etc.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While PanCAN is mentioned, no specific online resources or websites for pancreatic cancer information or Q&A services are recommended."
      }
    ],
    "question_number": 248,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:54:18.612769",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly emphasizes clear communication, such as recommending regular family meetings or using communication tools.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly recommends a central communication hub, group chats, shared documents/calendars, and regular family meetings with communication guidelines."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing care coordination with the patient\u2019s healthcare team or medical providers.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises designating a primary medical contact to interface with the medical team and suggests attending appointments, asking questions, and medical advocacy."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends discussing care coordination with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly recommends early involvement of palliative care, consulting social workers for resources, and connecting with spiritual care/faith leaders."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly emphasizes the importance of a strong support system, such as building a caregiver network or ensuring emotional support.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Highlights building a support network, roles across family members, counseling, support groups, spiritual support, and caregiver self-care."
      },
      {
        "criterion_number": 5,
        "description": "The response provides specific examples of organizations that support cancer patients and their families, including contact information or websites.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions PanCAN by name but provides no contact information or website; other mentioned tools (Meal Train, CaringBridge) are services without cancer-specific support context or contact details."
      },
      {
        "criterion_number": 6,
        "description": "The response explicitly recommends participating in a support group for cancer patients and their families.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly recommends support groups for both the patient and caregivers."
      },
      {
        "criterion_number": 7,
        "description": "The response explicitly recommends educating the family on the patient\u2019s diagnosis and treatment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Encourages sharing updates and age-appropriate information but does not explicitly state educating the family on diagnosis and treatment."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that one family member is designated as a communication person, and perhaps accompany the patient to their medical appointments and take notes.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Recommends designating a primary medical contact; suggests attending appointments, asking questions, and taking notes."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the communication person to develop a strategy to deliver information to the multi-generational family members.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Proposes concrete strategies: group chats, shared calendars/documents, regular meetings, and age-appropriate updates for all generations."
      },
      {
        "criterion_number": 10,
        "description": "The response should reinforce the importance of boundaries for the pancreatic cancer patient while they undergo treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises respecting the patient\u2019s wishes, energy levels, and need for rest; also discusses boundaries for caregivers."
      },
      {
        "criterion_number": 11,
        "description": "The response should suggest that the patient inquire with their oncology team if there are resources available for group support or for cultural mediation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests palliative care and social workers, it does not specifically advise asking the oncology team about group support or cultural mediation resources."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient or loved ones identify care needs, such as cleaning or food prep, and assign roles to family members according to their strengths.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a detailed role-by-generation framework and suggests practical tasks (meals, errands, chores) and Meal Train sign-ups aligned to strengths and capacity."
      },
      {
        "criterion_number": 13,
        "description": "The response should encourage the patient to focus on their own wellbeing and mental health.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Encourages professional counseling, support groups, spiritual care, and specifically notes respecting the patient\u2019s need for rest and comfort."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend online resources for pancreatic cancer information as well as support services that the patient and family members can access to answer questions, etc.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not provide specific online pancreatic cancer information resources or links; only general apps/services and PanCAN without a website."
      }
    ],
    "question_number": 248,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:55:05.838491",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains epithelial-mesenchymal transition and how this affects a cell\u2019s ability to migrate.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly explains EMT, contrasts epithelial vs mesenchymal states, and links EMT to increased motility via cytoskeletal reorganization."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes direct invasion and explicitly mentions movement toward blood vessels and lymphatic channels as highways to other parts of the body."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers loss of adhesion (E-cadherin), EMT, MMP-mediated ECM degradation, chemotaxis, and cytoskeletal remodeling."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes hypoxia in pancreatic tumors as a trigger that switches on EMT and MMPs, prompting cells to escape\u2014linking stress to invasive/metastatic behavior."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions the healthcare team uses advanced imaging like CT, MRI, and PET/CT to identify places the cancer has spread to.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of CT, MRI, PET/CT, or imaging to assess spread."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions how different treatment modalities are or are not helpful once cancer has metastasized.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss treatment approaches or limitations in the metastatic setting (e.g., surgery vs systemic therapy)."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly advises directing medical questions to the oncology team for case-specific guidance."
      },
      {
        "criterion_number": 8,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses clear analogies (cells as citizens/outlaws, molecular scissors, breadcrumb trails) to explain invasion and spread in accessible language."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe how a cancer cell develops, including DNA mutations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions mutations affecting E-cadherin but does not describe overall cancer development or accumulation of DNA mutations leading to malignancy."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe tumor suppressor genes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of tumor suppressor genes or their roles."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe oncogenes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of oncogenes or oncogenic signaling."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe cell adhesion, and how this process can be altered in cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains normal cell adhesion and the role of E-cadherin; describes how loss of adhesion facilitates invasion."
      },
      {
        "criterion_number": 13,
        "description": "The response should explain the phenomenon of loss of cell-cell adhesion in cancer cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Directly addresses loss of cell-cell adhesion through E-cadherin downregulation and its consequences."
      },
      {
        "criterion_number": 14,
        "description": "The response should define tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes the surrounding stroma, ECM, fibroblasts, and hypoxia as the context in which tumor cells invade, effectively defining the tumor microenvironment."
      },
      {
        "criterion_number": 15,
        "description": "The response should explain how cancer cells can use enzymes to change the tumor microenvironment to their advantage.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains secretion of MMPs to degrade ECM and create paths, altering the microenvironment to facilitate invasion."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe other ways cancer cells can interact with the tumor microenvironment to promote migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes recruitment/corruption of fibroblasts to remodel stroma and creation of tracks; discusses chemokine-driven chemotaxis and hypoxia-driven gene activation."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe any unique ways pancreatic cancer cells are thought to metastasize.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it details dense stroma and hypoxia, it does not describe pancreatic-specific metastatic patterns or routes (e.g., perineural invasion, portal venous spread)."
      },
      {
        "criterion_number": 18,
        "description": "The response should recommend websites that help explain different aspects of pancreatic cancer and provide resources for pancreatic cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No resource or website recommendations provided."
      }
    ],
    "question_number": 249,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:56:34.007604",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains epithelial-mesenchymal transition and how this affects a cell\u2019s ability to migrate.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicit EMT section describes loss of epithelial traits and gain of motility/invasiveness, with clear lay explanation."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Direct invasion and hematogenous spread are mentioned, but lymphatic spread is not addressed."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers multiple mechanisms: loss of adhesion, cytoskeletal changes, protease secretion (MMPs), EMT, and angiogenesis."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not frame metastasis as a response to cell stress."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions the healthcare team uses advanced imaging like CT, MRI, and PET/CT to identify places the cancer has spread to.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No imaging modalities (CT, MRI, PET/CT) are mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions how different treatment modalities are or are not helpful once cancer has metastasized.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions research targets (MMPs, angiogenesis, EMT) but does not discuss treatment modalities or their utility after metastasis."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly advises consulting the medical team for specific information and questions."
      },
      {
        "criterion_number": 8,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses clear analogies (glue, tunnels, highways) and simple language to explain invasion and spread."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe how a cancer cell develops, including DNA mutations.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No discussion of DNA mutations or carcinogenesis."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe tumor suppressor genes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Tumor suppressor genes are not mentioned."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe oncogenes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Oncogenes are not mentioned."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe cell adhesion, and how this process can be altered in cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses adhesion molecules (E-cadherin, integrins), ECM/basement membrane, and their alteration in cancer."
      },
      {
        "criterion_number": 13,
        "description": "The response should explain the phenomenon of loss of cell-cell adhesion in cancer cells.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly explains reduced adhesion proteins and detachment from neighboring cells."
      },
      {
        "criterion_number": 14,
        "description": "The response should define tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes the microenvironment as surrounding stromal/immune components and defines desmoplastic stroma in pancreatic cancer."
      },
      {
        "criterion_number": 15,
        "description": "The response should explain how cancer cells can use enzymes to change the tumor microenvironment to their advantage.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details secretion of MMPs and other proteases to degrade ECM and basement membrane to facilitate invasion."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe other ways cancer cells can interact with the tumor microenvironment to promote migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers CAF recruitment, immune modulation, and angiogenesis as TME interactions promoting migration."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe any unique ways pancreatic cancer cells are thought to metastasize.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not address pancreatic-specific patterns such as perineural invasion or portal venous/liver-dominant spread."
      },
      {
        "criterion_number": 18,
        "description": "The response should recommend websites that help explain different aspects of pancreatic cancer and provide resources for pancreatic cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No website or resource recommendations are provided."
      }
    ],
    "question_number": 249,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:57:28.391704",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response discusses the normal flow of fluid from blood vessels to the extracellular space to the lymphatic system and blood vessels using layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions that lymphatics drain excess fluid and uses a sponge analogy, it does not clearly describe the normal pathway of fluid moving from blood vessels into tissue (interstitial space), then into lymphatics, and returning to the bloodstream."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how fluids move in normal tissue to perform tasks such as nutrient and oxygen delivery, and to manage waste products.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The answer does not explicitly explain normal fluid movement for nutrient/oxygen delivery and waste removal; it focuses on abnormal flow in tumors."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses changes to fluid flow that may occur in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly explains elevated interstitial fluid pressure, leaky/disorganized vessels, and collapsed lymphatics in pancreatic cancer, and how these alter fluid flow."
      },
      {
        "criterion_number": 4,
        "description": "The response describes abnormalities seen in tumors with fluid management.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It details leaky vasculature, poor perfusion, high interstitial fluid pressure, and lymphatic collapse\u2014core abnormalities in tumor fluid handling."
      },
      {
        "criterion_number": 5,
        "description": "The response discusses the implications of altered fluid flow on cancer treatment, including reduced drug delivery or immune cell penetration into the tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It extensively covers reduced drug delivery due to high IFP and poor perfusion, including drugs being pushed out and uneven penetration. Immune cell penetration is not mentioned, but reduced drug delivery is, which satisfies the criterion."
      },
      {
        "criterion_number": 6,
        "description": "The response describes how fluid flow affects cancer behavior.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It connects abnormal fluid dynamics to metastasis (outward flow facilitating spread), hypoxia-induced aggressiveness, and mechanotransduction driving invasiveness."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how low flow to tumor tissue stimulates further cancer cell growth and development.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explains that poor perfusion causes hypoxia, which promotes more aggressive, treatment-resistant, migratory behavior\u2014indicative of tumor progression."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions how altered cellular biology and extracellular structures can impact cancer behavior.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses desmoplastic stroma (ECM) and mechanical stress activating cellular pathways that increase motility and survival."
      },
      {
        "criterion_number": 9,
        "description": "The response provides published scientific journal articles as evidence of its claims and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or specific journal references are provided."
      },
      {
        "criterion_number": 10,
        "description": "The response describes different fluids that exist in a tumor and its environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It mentions plasma leaking from blood vessels, interstitial fluid buildup (\u201cwater-logged\u201d), and movement toward lymphatics, as well as proteins in the fluid."
      },
      {
        "criterion_number": 11,
        "description": "The response describes the tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes stroma, abnormal vasculature, lymphatics, pressure, hypoxia, and mechanical stress, and references microenvironment normalization."
      },
      {
        "criterion_number": 12,
        "description": "The response describes attributes of tumors and the surrounding tissue that disrupt the normal function of fluids.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It identifies dense desmoplastic stroma, vessel leakiness and collapse, and lymphatic collapse as drivers of abnormal fluid function."
      },
      {
        "criterion_number": 13,
        "description": "The response defines desmoplastic stroma and how pancreatic cancer encourages the development of this.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplastic stroma is described as dense, scar-like tissue, but the mechanism of how pancreatic cancer promotes its development (e.g., stellate cell activation, CAF signaling) is not explained."
      },
      {
        "criterion_number": 14,
        "description": "The response defines interstitial fluid pressure.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines high interstitial fluid pressure as fluid buildup creating pressure higher than in vessels, causing outward fluid movement."
      },
      {
        "criterion_number": 15,
        "description": "The response explains how increased interstitial fluid pressure impacts drug delivery, including uneven distribution of exposure in the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states that high IFP pushes drugs out of the tumor and, combined with poor perfusion, results in only peripheral cells receiving adequate drug exposure."
      },
      {
        "criterion_number": 16,
        "description": "The response explains that poor fluid flow in tumor tissue is an active area of scientific research at this time.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly notes this is a critical area of research and mentions strategies like stromal targeting, vessel normalization, and related clinical trials."
      }
    ],
    "question_number": 250,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T21:58:33.011242",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response discusses the normal flow of fluid from blood vessels to the extracellular space to the lymphatic system and blood vessels using layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response describes tumor-related fluid abnormalities and mentions that lymphatics normally drain excess fluid, but it does not clearly explain the normal physiological pathway of fluid moving from blood capillaries to interstitial space to lymphatics and back to the bloodstream in lay terms."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how fluids move in normal tissue to perform tasks such as nutrient and oxygen delivery, and to manage waste products.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it references oxygen and nutrient delivery and waste-like conditions (hypoxia, acidosis), it does not explicitly explain normal tissue fluid movement and its roles in nutrient/waste handling under normal physiology."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses changes to fluid flow that may occur in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It thoroughly covers altered fluid dynamics in pancreatic cancer: leaky/disorganized vasculature, compressed vessels, poor lymphatic drainage, and elevated interstitial fluid pressure."
      },
      {
        "criterion_number": 4,
        "description": "The response describes abnormalities seen in tumors with fluid management.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It details key abnormalities: leaky, tortuous vessels; high IFP; dense ECM; and impaired lymphatics, all directly related to fluid management disruptions."
      },
      {
        "criterion_number": 5,
        "description": "The response discusses the implications of altered fluid flow on cancer treatment, including reduced drug delivery or immune cell penetration into the tumor.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains reduced convective transport, poor penetration, uneven drug distribution, rapid clearance, hypoxia-related drug resistance, and impaired immune infiltration due to stromal barriers."
      },
      {
        "criterion_number": 6,
        "description": "The response describes how fluid flow affects cancer behavior.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It links altered fluid dynamics to hypoxia adaptation, acidosis, EMT, invasion, metastasis, immune evasion, and therapeutic resistance."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how low flow to tumor tissue stimulates further cancer cell growth and development.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states that hypoxia from poor blood flow drives survival, proliferation, aggressive phenotypes, and EMT, indicating low flow fosters tumor progression."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions how altered cellular biology and extracellular structures can impact cancer behavior.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It discusses CAF activation, ECM composition (collagen, hyaluronic acid), and stromal remodeling as drivers of invasion and immune exclusion."
      },
      {
        "criterion_number": 9,
        "description": "The response provides published scientific journal articles as evidence of its claims and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to specific published journal articles are provided."
      },
      {
        "criterion_number": 10,
        "description": "The response describes different fluids that exist in a tumor and its environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It refers to blood within abnormal vessels, interstitial fluid accumulating in the tumor, and lymphatic drainage (implying lymph), as well as water bound by hyaluronic acid and acidic extracellular milieu."
      },
      {
        "criterion_number": 11,
        "description": "The response describes the tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides a detailed overview of the tumor microenvironment, including desmoplasia, ECM components, CAFs, abnormal vasculature, hypoxia, and immune context."
      },
      {
        "criterion_number": 12,
        "description": "The response describes attributes of tumors and the surrounding tissue that disrupt the normal function of fluids.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It specifies dense stroma, collagen/HA-rich ECM, vessel compression and leakiness, and poor lymphatic drainage as factors disrupting normal fluid function."
      },
      {
        "criterion_number": 13,
        "description": "The response defines desmoplastic stroma and how pancreatic cancer encourages the development of this.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines desmoplasia as dense fibrous stroma composed of collagen, hyaluronic acid, and activated CAFs, and identifies pancreatic tumors as characteristically desmoplastic with CAF-driven ECM production."
      },
      {
        "criterion_number": 14,
        "description": "The response defines interstitial fluid pressure.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains fluid leakage and impaired drainage causing pressure buildup in the interstitial space and notes tumor IFP can approach systemic blood pressure, effectively defining IFP."
      },
      {
        "criterion_number": 15,
        "description": "The response explains how increased interstitial fluid pressure impacts drug delivery, including uneven distribution of exposure in the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states high IFP reduces convective drug transport, can push drugs out, and results in uneven intratumoral distribution with poorly exposed 'cold spots.'"
      },
      {
        "criterion_number": 16,
        "description": "The response explains that poor fluid flow in tumor tissue is an active area of scientific research at this time.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It clearly states this is an active research area and lists ongoing strategies (stroma-targeting, vessel normalization, nanoparticles, CED, combinations)."
      }
    ],
    "question_number": 250,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T21:59:22.886943",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing dignity-preserving approaches with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While the response advises including the patient in conversations with doctors and letting him lead appointments, it does not explicitly recommend discussing dignity-preserving approaches with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing dignity-preserving approaches with a Palliative Care specialist.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response suggests working closely with the palliative care team to manage symptoms but does not explicitly recommend discussing dignity-preserving approaches with a palliative care specialist."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly mentions Advance Care Planning and includes either Advance Directives or Living Wills.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of advance care planning, advance directives, or living wills."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends establishing the patient\u2019s goals of care, including understanding and documenting the patient\u2019s preferences and involving them in decision-making.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it encourages involving the patient in care planning and decision-making, it does not explicitly recommend establishing goals of care or documenting preferences."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends support groups for cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Support groups are not mentioned."
      },
      {
        "criterion_number": 6,
        "description": "The response provides specific examples of organizations that support cancer patients and their families, including contact information or websites for each.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No organizations or contact information/websites are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should attempt to normalize feelings of loss of control for cancer patients at the time of diagnosis and/or during cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly states, \"Cancer treatment can make a person feel powerless,\" which normalizes these feelings."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe components of personal dignity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines dignity as being seen, being in control, being respected, and feeling like oneself, and elaborates with examples (privacy, autonomy, grooming, inclusion in conversations)."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the patient, family, and friends of the patient, and oncology care team to respect the patient\u2019s bodily autonomy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It encourages asking before helping, honoring his decisions and \"respecting his 'no',\" maintaining privacy and coverage, and redirecting healthcare professionals to address him directly, all reinforcing bodily autonomy."
      },
      {
        "criterion_number": 10,
        "description": "The response should encourage the patient to prioritize management of side effects and symptoms of cancer or cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It urges proactive symptom management and close work with palliative care to control pain, nausea, and digestive issues."
      },
      {
        "criterion_number": 11,
        "description": "The response should encourage the patient to communicate any side effects or symptoms of cancer or cancer treatment to their oncology care team to ensure they are being offered management solutions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not explicitly instruct the patient to report side effects to the oncology team; it only mentions working with palliative care on symptom management."
      },
      {
        "criterion_number": 12,
        "description": "The response should encourage the patient and family to have open and ongoing communication about the patient\u2019s wishes for medical care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it promotes involving him in care planning and listing questions for appointments, it does not explicitly encourage ongoing communication about his medical care wishes."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient and loved ones promote independence and normalcy in the patient\u2019s life as much as possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends offering choices, letting him do what he can, maintaining grooming, and talking about life beyond cancer to preserve normalcy and independence."
      },
      {
        "criterion_number": 14,
        "description": "The response should encourage the patient to always remember that anything that happens to their body with regard to cancer treatment is their choice.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes honoring his decisions and ensuring he is the primary decision-maker in his medical care, which reflects that treatment choices are his."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient disclose any feelings of overwhelm or loss of autonomy with their oncology team and inquire about resources for support.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It encourages listening and validating feelings but does not direct the patient to disclose feelings of overwhelm or loss of autonomy to the oncology team or ask about support resources."
      },
      {
        "criterion_number": 16,
        "description": "The response should emphasize the importance of prevention of caregiver burnout.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It offers empathy and encourages the caregiver to be gentle with themselves but does not explicitly emphasize preventing caregiver burnout or provide strategies to do so."
      }
    ],
    "question_number": 251,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:00:34.423449",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing dignity-preserving approaches with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response refers generally to the 'medical team' but does not explicitly mention or recommend discussing dignity-preserving approaches with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing dignity-preserving approaches with a Palliative Care specialist.",
        "score_given": 0,
        "max_points": 3,
        "justification": "There is no mention of palliative care or a palliative care specialist."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly mentions Advance Care Planning and includes either Advance Directives or Living Wills.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicit 'Advance Care Planning' section mentions documenting wishes with a living will and appointing a medical power of attorney."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends establishing the patient\u2019s goals of care, including understanding and documenting the patient\u2019s preferences and involving them in decision-making.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes involving him in decisions, respecting his 'No,' advocacy with the medical team, and documenting preferences via advance care planning."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends support groups for cancer patients.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Support groups are suggested for caregivers/family, but there is no explicit recommendation of support groups specifically for the patient."
      },
      {
        "criterion_number": 6,
        "description": "The response provides specific examples of organizations that support cancer patients and their families, including contact information or websites for each.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No organizations, contact information, or websites are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response should attempt to normalize feelings of loss of control for cancer patients at the time of diagnosis and/or during cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It validates emotions and states it's okay to feel fear, anger, sadness, frustration, or despair, and emphasizes preserving control through choices, which normalizes loss-of-control feelings."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe components of personal dignity.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It details autonomy, privacy, symptom control, respectful personal care/hygiene, appearance, involvement in decisions, environment, social and spiritual support\u2014comprehensively covering dignity components."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the patient, family, and friends of the patient, and oncology care team to respect the patient\u2019s bodily autonomy.",
        "score_given": 4,
        "max_points": 4,
        "justification": "It directs family and the medical team to respect his 'No,' involve him in decisions, and preserve privacy, which supports bodily autonomy across stakeholders."
      },
      {
        "criterion_number": 10,
        "description": "The response should encourage the patient to prioritize management of side effects and symptoms of cancer or cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly prioritizes pain and symptom management and urges working closely with the medical team to ensure comfort."
      },
      {
        "criterion_number": 11,
        "description": "The response should encourage the patient to communicate any side effects or symptoms of cancer or cancer treatment to their oncology care team to ensure they are being offered management solutions.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it says 'work closely with the medical team' and 'don't let him suffer silently,' it does not explicitly instruct communicating symptoms to the oncology care team."
      },
      {
        "criterion_number": 12,
        "description": "The response should encourage the patient and family to have open and ongoing communication about the patient\u2019s wishes for medical care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It encourages active listening, involvement in decisions, and advance care planning discussions to document wishes, implying ongoing dialogue."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that the patient and loved ones promote independence and normalcy in the patient\u2019s life as much as possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages empowering choices, wearing personal clothing, adapting hobbies, and explicitly recommends maintaining a sense of normalcy."
      },
      {
        "criterion_number": 14,
        "description": "The response should encourage the patient to always remember that anything that happens to their body with regard to cancer treatment is their choice.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It highlights respecting his right to refuse treatments or visitors and emphasizes autonomy in all decisions."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient disclose any feelings of overwhelm or loss of autonomy with their oncology team and inquire about resources for support.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it validates emotions, it does not advise sharing feelings of overwhelm or loss of autonomy with the oncology team or asking for resources."
      },
      {
        "criterion_number": 16,
        "description": "The response should emphasize the importance of prevention of caregiver burnout.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It acknowledges caregiving is exhausting, encourages seeking support, and emphasizes caregiver well-being, aligning with burnout prevention."
      }
    ],
    "question_number": 251,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:01:23.164464",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Explains how cells respond to mechanical stress, including ECM remodeling, increased contractility, and effects on proliferation, invasion, metastasis, and drug resistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response describes cancer cell and CAF-driven ECM remodeling and stiffening, increased cellular contractility, and links these forces to proliferation (mechanotransduction-driven growth signals), invasion/metastasis (migration and squeezing through spaces), and drug resistance (poor delivery due to vessel collapse and high pressure)."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly relates tissue properties (e.g., stiffness, fibrous stroma) to effects on cancer spread (invasiveness/metastasis).",
        "score_given": 5,
        "max_points": 5,
        "justification": "It connects stiff, aligned collagen fibers and dense stroma to creation of \u2018highways\u2019 that promote invasion and metastasis."
      },
      {
        "criterion_number": 3,
        "description": "Relates tissue properties to treatment effectiveness/resistance, including drug penetration and resistance mechanisms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that stiff, dense stroma collapses blood vessels, raises pressure, and blocks chemotherapy penetration, contributing to resistance."
      },
      {
        "criterion_number": 4,
        "description": "Explains how cells sense mechanical stress (mechanosensing mechanisms like mechanoreceptors, integrins, mechanotransduction pathways).",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mechanotransduction is defined, and integrins are identified as receptors used to sense and grip the stiff environment, conveying force into biochemical signaling."
      },
      {
        "criterion_number": 5,
        "description": "Provides specific citations from published scientific journal articles as evidence.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to published journal articles are provided."
      },
      {
        "criterion_number": 6,
        "description": "Explains normal cell contractility, including actomyosin complex in generating forces for movement.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The actin\u2013myosin system is described as the cellular \u2018muscle\u2019 generating contractile force, and its role in cell movement (\u2018grapple and pull\u2019) is explained."
      },
      {
        "criterion_number": 7,
        "description": "Defines actin, including its role in cellular structure and function.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Actin is presented as part of a filamentous cytoskeletal network that provides structural support and participates in force generation."
      },
      {
        "criterion_number": 8,
        "description": "Defines myosin, including its function in cell contractility.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Myosin is identified as a motor protein that pulls on actin filaments to generate contractile force."
      },
      {
        "criterion_number": 9,
        "description": "Explicitly describes the tumor microenvironment, including its components and characteristics.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It discusses the tumor stroma, ECM, CAFs/pancreatic stellate cells, abnormal vasculature, high pressure, and hypoxia as TME characteristics."
      },
      {
        "criterion_number": 10,
        "description": "Defines the extracellular matrix (ECM), including its composition and function.",
        "score_given": 7,
        "max_points": 7,
        "justification": "ECM is defined as a protein scaffolding composed of molecules like collagen, with functional roles in structural support and guiding cell migration when remodeled."
      },
      {
        "criterion_number": 11,
        "description": "Defines mechanobiology, including its relevance to cancer progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mechanobiology is explicitly named and framed as studying physical forces in cancer growth, spread, and treatment resistance."
      },
      {
        "criterion_number": 12,
        "description": "Explains epithelial-mesenchymal transition (EMT), including its occurrence in pancreatic cancer and impact on spread.",
        "score_given": 0,
        "max_points": 7,
        "justification": "EMT is not mentioned or explained."
      }
    ],
    "question_number": 252,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:01:51.912645",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Explains how cells respond to mechanical stress, including ECM remodeling, increased contractility, and effects on proliferation, invasion, metastasis, and drug resistance.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response details ECM remodeling and active stiffening by cancer cells and fibroblasts, increased contractility, and clearly links mechanical cues to proliferation, invasion/metastasis (durotaxis, squeezing through gaps), and drug resistance (barrier and signaling)."
      },
      {
        "criterion_number": 2,
        "description": "Explicitly relates tissue properties (e.g., stiffness, fibrous stroma) to effects on cancer spread, including invasiveness and metastasis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly connects stiff ECM/desmoplasia to more aggressive, invasive, and metastatic behavior and discusses durotaxis toward stiffer regions."
      },
      {
        "criterion_number": 3,
        "description": "Relates tissue properties to consequences for treatment effectiveness/resistance, including drug penetration and resistance mechanisms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response states that a stiff tumor microenvironment acts as a physical barrier limiting chemotherapy penetration and that mechanosignaling can promote intrinsic drug resistance."
      },
      {
        "criterion_number": 4,
        "description": "Explains how cells sense mechanical stress, including mechanoreceptors, integrins, or mechanotransduction pathways.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions that cells 'sense' stiffness and exhibit durotaxis, it does not describe specific mechanosensors (e.g., integrins, focal adhesions) or mechanotransduction pathways (e.g., FAK, YAP/TAZ)."
      },
      {
        "criterion_number": 5,
        "description": "Provides specific citations from published scientific journal articles.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to specific journal articles are provided."
      },
      {
        "criterion_number": 6,
        "description": "Explains normal cell contractility, including the role of the actomyosin complex in generating mechanical forces for movement.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that the actin\u2013myosin cytoskeleton generates tension and enables shape change and movement, and mentions targeting actin\u2013myosin to inhibit contractility."
      },
      {
        "criterion_number": 7,
        "description": "Defines actin, including its role in cellular structure and function.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Actin is mentioned as part of the cytoskeleton, but there is no explicit definition or description of its structural and functional roles."
      },
      {
        "criterion_number": 8,
        "description": "Defines myosin, including its function in cell contractility.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Myosin is mentioned but not defined; its role as a motor protein generating force on actin is not explicitly described."
      },
      {
        "criterion_number": 9,
        "description": "Explicitly describes the tumor microenvironment, including its components and characteristics.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The TME is described with components (fibroblasts, immune cells, blood vessels, ECM) and characteristics (stiffness, immune exclusion, angiogenesis)."
      },
      {
        "criterion_number": 10,
        "description": "Defines the extracellular matrix, including its composition and function.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The ECM is described functionally as a 'scaffold,' but its composition (e.g., collagens, glycoproteins, proteoglycans) is not specified."
      },
      {
        "criterion_number": 11,
        "description": "Defines mechanobiology, including its relevance to cancer progression.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The concept is discussed implicitly, but the term 'mechanobiology' is not defined or explicitly connected to cancer progression."
      },
      {
        "criterion_number": 12,
        "description": "Explains epithelial-mesenchymal transition (EMT), including its occurrence in pancreatic cancer cells and impact on cancer spread.",
        "score_given": 0,
        "max_points": 7,
        "justification": "EMT is explained and linked to invasion/metastasis generally, but its explicit occurrence in pancreatic cancer cells is not stated."
      }
    ],
    "question_number": 252,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:02:28.140214",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines the extracellular matrix and explains its role in normal cellular biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines ECM function in normal tissue using analogies and specifics: provides structure/anchorage, enables cell-cell/ECM communication, organizes tissues, and is dynamic for growth and repair."
      },
      {
        "criterion_number": 2,
        "description": "The response contrasts the role of the extracellular matrix in cancer cell biology with normal cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly contrasts normal ECM ('garden trellis') with cancer-associated ECM ('dense fortress'), explaining how it shifts from supportive/dynamic to desmoplastic, stiff, and tumor-promoting."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses the potential consequences of an altered extracellular matrix for cancer treatment effectiveness and resistance, including examples like decreased drug and immune cell penetration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states high interstitial pressure collapses vessels, blocking chemotherapy penetration and preventing immune-cell infiltration; also mentions direct resistance signaling."
      },
      {
        "criterion_number": 4,
        "description": "The response discusses the potential consequences of an altered extracellular matrix on cancer cell biology, including examples like angiogenesis and metastasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains pro-survival signaling, apoptosis resistance, proliferation, metabolic use of ECM, and metastasis via aligned collagen 'highways.' While angiogenesis per se is not named, the breadth of cancer cell biology consequences including metastasis is clearly covered."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to published scientific literature are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the different components of the extracellular matrix in normal tissue.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not describe normal ECM components (e.g., collagen subtypes, laminins, fibronectin, proteoglycans, hyaluronan) in a structured way; brief mentions of collagen/fibronectin occur in cancer context, not as a description of normal ECM composition."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how the extracellular matrix changes in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly describes desmoplasia with dense fibrous ECM, high pressure, altered architecture/stiffness, and CAF-driven matrix production/remodeling."
      },
      {
        "criterion_number": 8,
        "description": "The response explains how the changes in the extracellular matrix in pancreatic cancer promote cancer growth and facilitate movement of cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details pro-survival signaling, therapy resistance, nutrient scavenging from ECM, and directional migration along aligned collagen fibers facilitating invasion and metastasis."
      },
      {
        "criterion_number": 9,
        "description": "The response defines desmoplastic stroma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines desmoplasia/desmoplastic reaction as a dense, scar-like, fibrous ECM hallmark of pancreatic cancer."
      },
      {
        "criterion_number": 10,
        "description": "The response defines tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not define the tumor microenvironment as the ensemble of cancer cells, stroma (ECM, fibroblasts), immune cells, vasculature, and signaling molecules."
      },
      {
        "criterion_number": 11,
        "description": "The response describes how desmoplastic stroma causes hypoxia in the tumor microenvironment.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although vessel collapse is mentioned, hypoxia and its mechanistic linkage to desmoplasia are not explicitly described."
      },
      {
        "criterion_number": 12,
        "description": "The response describes how hypoxia in the tumor microenvironment causes inflammation, and how this promotes cancer growth.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No discussion of hypoxia-induced inflammation, HIF-driven cytokines/chemokines, or how that inflammation promotes tumor progression."
      },
      {
        "criterion_number": 13,
        "description": "The response describes how the desmoplastic stroma in the pancreatic cancer microenvironment contributes to treatment resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains both physical resistance (drug/immune exclusion via vessel compression and dense ECM) and biochemical resistance (pro-survival signals conferring chemo/radiation resistance)."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how the desmoplastic stroma in the pancreatic cancer microenvironment can cause symptoms and complications due to mechanical forces on the surrounding structures, specifically mentioning the effect on blood vessels.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While blood vessel compression is noted, the response does not connect stromal mechanical forces to patient symptoms or complications affecting surrounding structures (e.g., biliary obstruction, pain, ischemia)."
      }
    ],
    "question_number": 253,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:03:12.321218",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines the extracellular matrix and explains its role in normal cellular biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines ECM as a non-cellular scaffold composed of proteins and polysaccharides; explains roles in structural support, cell communication, growth, and function."
      },
      {
        "criterion_number": 2,
        "description": "The response contrasts the role of the extracellular matrix in cancer cell biology with normal cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Contrasts normal, organized ECM with the desmoplastic, dense, and dynamic ECM in pancreatic cancer, explaining altered signaling, stiffness, and its effects on tumor behavior."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses the potential consequences of an altered extracellular matrix for cancer treatment effectiveness and resistance, including examples like decreased drug and immune cell penetration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly states that dense ECM impedes chemotherapy penetration and blocks immune cell access; also notes vessel compression reducing drug delivery."
      },
      {
        "criterion_number": 4,
        "description": "The response discusses the potential consequences of an altered extracellular matrix on cancer cell biology, including examples like angiogenesis and metastasis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes how ECM stiffness and remodeling promote cancer cell survival, invasiveness, and creation of migration pathways facilitating metastasis. While angiogenesis is not emphasized, metastasis is covered in depth."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to published scientific journal articles are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the different components of the extracellular matrix in normal tissue.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists key ECM components including collagen, fibronectin, laminin, elastin, hyaluronic acid, and proteoglycans."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how the extracellular matrix changes in pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details desmoplasia with excessive collagen, HA accumulation, increased stiffness, poor vascularization, and activation of pancreatic stellate cells producing ECM."
      },
      {
        "criterion_number": 8,
        "description": "The response explains how the changes in the extracellular matrix in pancreatic cancer promote cancer growth and facilitate movement of cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains growth factor reservoir, survival signaling, mechanical cues enhancing invasiveness, and ECM remodeling creating migration pathways facilitating invasion and spread."
      },
      {
        "criterion_number": 9,
        "description": "The response defines desmoplastic stroma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines desmoplastic stroma as a dense, abundant ECM characteristic of pancreatic tumors and describes it as an active, dynamic microenvironment."
      },
      {
        "criterion_number": 10,
        "description": "The response defines tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Uses the term microenvironment but does not explicitly define the tumor microenvironment or its cellular/structural components."
      },
      {
        "criterion_number": 11,
        "description": "The response describes how desmoplastic stroma causes hypoxia in the tumor microenvironment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains that dense stroma compresses blood vessels leading to poor blood flow and reduced oxygen (hypoxia)."
      },
      {
        "criterion_number": 12,
        "description": "The response describes how hypoxia in the tumor microenvironment causes inflammation, and how this promotes cancer growth.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not describe hypoxia-induced inflammation or link inflammation to tumor promotion; focuses on immunosuppression and barriers instead."
      },
      {
        "criterion_number": 13,
        "description": "The response describes how the desmoplastic stroma in the pancreatic cancer microenvironment contributes to treatment resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly connects dense ECM and vessel compression to impaired drug delivery and immune exclusion, explaining treatment resistance."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how the desmoplastic stroma in the pancreatic cancer microenvironment can cause symptoms and complications due to mechanical forces on the surrounding structures, specifically mentioning the effect on blood vessels.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions blood vessel compression but does not discuss resulting symptoms or complications from mechanical forces on surrounding structures."
      }
    ],
    "question_number": 253,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:03:52.633083",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing relationship challenges or support strategies with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests asking the oncology team for a palliative care referral, it does not explicitly recommend discussing relationship challenges or support strategies directly with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing relationship challenges with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends a referral to Palliative Care for quality of life and support, and encourages seeing a therapist, providing a clear path to discuss relationship challenges with appropriate professionals."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends joining a support group for cancer patients or their families.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends a caregiver support group (in-person or online)."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly emphasizes the importance of self-care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "A dedicated section emphasizes self-care with specific strategies (micro-rescues, therapy, accepting help, anticipatory grief)."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly emphasizes the importance of having a support system during cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It highlights the role of close family and friends, gives concrete ways to engage them, and suggests a point person and tools for coordination."
      },
      {
        "criterion_number": 6,
        "description": "The response provides specific examples of organizations that support cancer patients and their families, including contact information or websites.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists CaringBridge.org (website provided) and the Pancreatic Cancer Action Network (PanCAN)."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that loved ones of a patient with pancreatic cancer seek education about the disease and common symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No explicit recommendation to seek education about pancreatic cancer or its symptoms."
      },
      {
        "criterion_number": 8,
        "description": "The response should encourage open communication between the patients and their loved ones.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It encourages a regular 'State of the Union' check-in and communicating beyond cancer, promoting open, honest dialogue."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the patient to seek support from their loved ones.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It provides multiple strategies to involve loved ones (specific asks for help, visitors, companionship), encouraging reliance on the support network."
      },
      {
        "criterion_number": 10,
        "description": "The response should attempt to normalize the stress that patients feel after receiving a pancreatic cancer diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that what they are experiencing is normal, acknowledges strain, fear, and exhaustion, and normalizes anticipatory grief."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend against behaviors that might isolate the patient after a serious medical diagnosis.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it encourages engagement with others, it does not explicitly caution against isolating behaviors or advise avoiding withdrawal."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient prioritize symptom control to feel as normal as possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends referral to Palliative Care for symptom management and quality of life, which directly supports prioritizing symptom control."
      },
      {
        "criterion_number": 13,
        "description": "The response should indicate that some people may not feel comfortable discussing a serious cancer diagnosis with a friend or loved one, and that this can be a normal response.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It acknowledges others\u2019 grief but does not state that some may avoid or feel uncomfortable discussing the diagnosis as a normal response."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the patient observe which people in their social circle want to be supportive, and to lean on these people.",
        "score_given": 0,
        "max_points": 0,
        "justification": "This criterion has 0 maximum points; while the response does encourage leveraging supportive people, no points can be awarded."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient continue to reach out to friends and loved ones, and try to participate in the same activities they previously did, to maintain relationships.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It suggests 'cancer-free' time, normal conversations, watching movies together, and asking friends to talk about non-cancer topics, supporting continued engagement in familiar activities."
      },
      {
        "criterion_number": 16,
        "description": "The response should suggest that the patient consider creating boundaries with people, including how to handle unsolicited advice.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly addresses setting boundaries with visiting hours, handling unsolicited advice with a prepared response, and managing emotional dumping."
      },
      {
        "criterion_number": 17,
        "description": "The response should recommend that the patient consider activities where they can be fully present with the people they are with, for the best quality interactions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends 'cancer-free' time, intimate non-physical connections (holding hands, reading aloud), and focused check-ins that foster presence and quality interactions."
      }
    ],
    "question_number": 254,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:04:39.080773",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing relationship challenges or support strategies with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention the oncologist or suggest discussing relationship challenges with them."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing relationship challenges with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends engaging a Palliative Care team for emotional and spiritual support, which addresses relationship-related challenges."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends joining a support group for cancer patients or their families.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends support groups for patients and caregivers and explains their benefits."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly emphasizes the importance of self-care.",
        "score_given": 5,
        "max_points": 5,
        "justification": "A dedicated section emphasizes caregiver self-care with concrete strategies (therapy, breaks, accepting help)."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly emphasizes the importance of having a support system during cancer treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages leaning on friends/family, accepting help, designating a communication hub, and using support groups."
      },
      {
        "criterion_number": 6,
        "description": "The response provides specific examples of organizations that support cancer patients and their families, including contact information or websites.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions platforms (CaringBridge, LotsaHelpingHands) but provides no contact information or website links, and does not list major organizations."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that loved ones of a patient with pancreatic cancer seek education about the disease and common symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no recommendation for loved ones to learn about pancreatic cancer or its common symptoms."
      },
      {
        "criterion_number": 8,
        "description": "The response should encourage open communication between the patients and their loved ones.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It repeatedly emphasizes open, honest communication with each other and with family/friends, including setting expectations and sharing vulnerability."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the patient to seek support from their loved ones.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises being specific with requests, telling others how to help, and accepting help, clearly encouraging seeking support."
      },
      {
        "criterion_number": 10,
        "description": "The response should attempt to normalize the stress that patients feel after receiving a pancreatic cancer diagnosis.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It validates the difficulty, states 'It's okay not to be okay,' and normalizes fluctuating emotions and relationship changes."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend against behaviors that might isolate the patient after a serious medical diagnosis.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it promotes connection and adapted activities, it does not explicitly warn against isolating behaviors."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend that the patient prioritize symptom control to feel as normal as possible.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Symptom management or prioritizing symptom control is not discussed."
      },
      {
        "criterion_number": 13,
        "description": "The response should indicate that some people may not feel comfortable discussing a serious cancer diagnosis with a friend or loved one, and that this can be a normal response.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly notes some friends will pull back out of discomfort and frames this as a natural part of the process."
      },
      {
        "criterion_number": 14,
        "description": "The response should recommend that the patient observe which people in their social circle want to be supportive, and to lean on these people.",
        "score_given": 0,
        "max_points": 0,
        "justification": "Although suggested (focus energy on genuinely supportive people), this criterion has 0 maximum points."
      },
      {
        "criterion_number": 15,
        "description": "The response should recommend that the patient continue to reach out to friends and loved ones, and try to participate in the same activities they previously did, to maintain relationships.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It encourages continued connection through adapted or familiar activities (e.g., dinners, walks, movies) and virtual outreach."
      },
      {
        "criterion_number": 16,
        "description": "The response should suggest that the patient consider creating boundaries with people, including how to handle unsolicited advice.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It provides explicit guidance on setting boundaries, saying no, and handling unsolicited advice and toxic positivity."
      },
      {
        "criterion_number": 17,
        "description": "The response should recommend that the patient consider activities where they can be fully present with the people they are with, for the best quality interactions.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests designated 'us' time, quiet connections, sitting together, watching a movie without cancer talk, and focusing on shared memories."
      }
    ],
    "question_number": 254,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:05:34.882463",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains how cancer cells detect mechanical characteristics of their environment.",
        "score_given": 0,
        "max_points": 0,
        "justification": "The response clearly explains detection mechanisms (integrins, cytoskeleton linkages, mechanosensitive ion channels), but this criterion carries no points per rubric."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how cancer cells respond to mechanical characteristics of their environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It details responses to stiffness: increased proliferation/survival, invasion/migration using traction, gene-expression changes via nuclear deformation, and therapy resistance due to pressure and signaling."
      },
      {
        "criterion_number": 3,
        "description": "The response outlines how mechanosensing processes may be altered in pancreatic cancer cells.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It emphasizes a stiff, desmoplastic microenvironment and a vicious cycle with fibroblasts, but does not specify alterations in the cancer cells\u2019 mechanosensing machinery (e.g., changed integrin profiles, FAK/YAP hyperactivation, Piezo/TRP changes) unique to pancreatic cancer cells."
      },
      {
        "criterion_number": 4,
        "description": "The response defines mechanosensing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It provides a clear definition: the ability of cells to detect mechanical properties (stiffness, pressure, shape) and change behavior accordingly."
      },
      {
        "criterion_number": 5,
        "description": "The response describes mechanosensing in normal cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The general cell-based explanation (integrins, cytoskeleton, ion channels, nucleus) describes normal cellular mechanosensing independent of cancer context."
      },
      {
        "criterion_number": 6,
        "description": "The response defines desmoplastic stroma and describes its development in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It defines desmoplasia as dense, collagen-rich stroma, explains fibroblast activation by cancer cells, collagen deposition, tumor stiffening, and the reinforcing feedback loop."
      },
      {
        "criterion_number": 7,
        "description": "The response describes integrins, cytoskeleton, ion channels, and membrane sensors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly describes integrins, the cytoskeleton, and mechanosensitive ion channels as membrane-based sensors, meeting all components listed."
      },
      {
        "criterion_number": 8,
        "description": "The response explains the YAP/TAZ pathway and its role in the development of desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "YAP/TAZ is not mentioned or explained."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions if there are FDA-approved therapies that target the cancer cells\u2019 ability to mechanosense.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It discusses experimental strategies (stroma softening, integrin/FAK inhibition) but does not state whether any FDA-approved mechanosensing-targeted therapies exist."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how cancer cells migrate in response to cues from mechanical forces in their environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explains stiffness-guided migration (traction on collagen fibers, following \"stiffness highways\"), capturing mechanotaxis/durotaxis-driven invasion."
      },
      {
        "criterion_number": 11,
        "description": "The response defines epithelial-mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not defined or discussed."
      },
      {
        "criterion_number": 12,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references are provided."
      }
    ],
    "question_number": 255,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:06:16.250027",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains how cancer cells detect mechanical characteristics of their environment.",
        "score_given": 0,
        "max_points": 0,
        "justification": "The response thoroughly explains detection via integrins, cadherins, ion channels, RTKs, and ECM stiffness; however, this criterion has a maximum of 0 points per the rubric."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how cancer cells respond to mechanical characteristics of their environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Clearly details mechanotransduction: focal adhesions (FAK/Src), cytoskeletal remodeling (actin\u2013myosin, stress fibers), Rho GTPases, YAP/TAZ nuclear translocation, and downstream outcomes (proliferation, survival, EMT, ECM remodeling, drug resistance)."
      },
      {
        "criterion_number": 3,
        "description": "The response outlines how mechanosensing processes may be altered in pancreatic cancer cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes PDAC-specific changes: dense desmoplastic stroma, PSC activation, collagen/hyaluronan deposition and LOX cross-linking leading to stiffness; enhanced integrin/FAK/Src and YAP/TAZ activation; consequences including growth, invasion, chemotherapy resistance, immune evasion."
      },
      {
        "criterion_number": 4,
        "description": "The response defines mechanosensing.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear definition: cells detect physical forces (stiffness, tension, shear) and convert them into biochemical signals that affect gene expression and behavior."
      },
      {
        "criterion_number": 5,
        "description": "The response describes mechanosensing in normal cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Discusses general cellular mechanosensing and contrasts normal soft conditions (YAP/TAZ phosphorylation and cytoplasmic sequestration) with stiff environments; explains baseline cytoskeletal probing and adhesion dynamics."
      },
      {
        "criterion_number": 6,
        "description": "The response defines desmoplastic stroma and describes its development in pancreatic cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Defines desmoplasia as stiff, fibrotic ECM and explains development in PDAC via activated pancreatic stellate cells producing excessive ECM (collagen, hyaluronan) and cross-linking (LOX)."
      },
      {
        "criterion_number": 7,
        "description": "The response describes integrins, cytoskeleton, ion channels, and membrane sensors.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers integrins (and focal adhesions), cytoskeletal elements (actin\u2013myosin, microtubules, intermediate filaments), mechanosensitive ion channels (Piezo1, TRP), and mechanosensitive behavior of RTKs; also mentions cadherins."
      },
      {
        "criterion_number": 8,
        "description": "The response explains the YAP/TAZ pathway and its role in the development of desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains YAP/TAZ regulation by mechanical cues and nuclear translocation on stiffness; notes activation of genes including ECM remodeling, linking pathway activity to features contributing to desmoplastic stroma in PDAC."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions if there are FDA-approved therapies that target the cancer cells\u2019 ability to mechanosense.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions investigational strategies (integrins/FAK, YAP/TAZ inhibitors, hyaluronidase) but does not state whether any are FDA-approved for targeting mechanosensing; no explicit FDA-approved therapies are identified."
      },
      {
        "criterion_number": 10,
        "description": "The response describes how cancer cells migrate in response to cues from mechanical forces in their environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes durotaxis along stiff ECM \u2018tracks,\u2019 traction via actomyosin, shape change, and proteolysis (MMPs) to navigate dense matrix; links mechanical cues to enhanced motility and invasion."
      },
      {
        "criterion_number": 11,
        "description": "The response defines epithelial-mesenchymal transition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines EMT as loss of epithelial traits and acquisition of migratory/mesenchymal characteristics, in the context of mechanosensing and metastasis."
      },
      {
        "criterion_number": 12,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No references or citations to scientific literature are provided."
      }
    ],
    "question_number": 255,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:07:01.499605",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Explains the normal flow of fluid from blood vessels to the extracellular space to the lymphatic system, including nutrient and oxygen delivery and waste management.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response briefly implies normal physiology (blood delivers oxygen; lymphatics drain excess fluid), but it does not clearly explain the full normal pathway of fluid flow from blood to interstitium to lymphatics nor discuss nutrient/waste transport in a structured way. Therefore, it does not meet the full criterion."
      },
      {
        "criterion_number": 2,
        "description": "Describes how fluid flow becomes compromised in tumors, including increased intratumoral pressure due to abnormal blood vessels, poor lymphatic drainage, and dense stroma.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response clearly describes leaky/abnormal blood vessels, collapsed lymphatics, and dense desmoplastic stroma leading to high solid stress and elevated interstitial fluid pressure, meeting all elements."
      },
      {
        "criterion_number": 3,
        "description": "Discusses the implications of altered fluid flow on cancer treatment, specifically mentioning reduced drug delivery and immune cell penetration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly states that compressed vessels prevent chemotherapy delivery and that high pressure/dense stroma impede immune cell (T-cell) penetration, fulfilling the criterion."
      },
      {
        "criterion_number": 4,
        "description": "Explains how increased interstitial fluid pressure impacts drug delivery, including uneven distribution of exposure in the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that high IFP reverses the pressure gradient, pushing drugs out and away from the tumor core, implying heterogeneous/uneven intratumoral distribution. Full credit warranted."
      },
      {
        "criterion_number": 5,
        "description": "Discusses the impact of altered fluid flow on radiation therapy due to hypoxia.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains vessel compression causing hypoxia and that radiation is less effective without oxygen due to reduced free radical formation."
      },
      {
        "criterion_number": 6,
        "description": "Mentions the impact of altered cellular biology and extracellular structures on cancer behavior, including tumor growth, metastasis, and resistance to therapy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions hypoxia-induced survival signaling and resistance, it does not explicitly address tumor growth or metastasis in this context. The criterion requires inclusion of these elements."
      },
      {
        "criterion_number": 7,
        "description": "Describes how low flow to tumor tissue stimulates further cancer cell growth and development.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response notes hypoxia can make cells more aggressive and resistant, but it does not explicitly describe how low perfusion/flow directly stimulates further growth and development."
      },
      {
        "criterion_number": 8,
        "description": "Defines desmoplastic stroma and how pancreatic cancer encourages its development.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines desmoplasia as dense scar-like tissue produced by fibroblasts (stroma up to 90% of the mass) and explains that the tumor recruits fibroblasts to generate this matrix. Full credit."
      },
      {
        "criterion_number": 9,
        "description": "Defines interstitial fluid pressure.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly defines IFP as the pressure of fluid that builds up in the spaces between cells."
      },
      {
        "criterion_number": 10,
        "description": "Describes ways that increased pressure from interrupted fluid dynamics and desmoplastic stroma can cause compression on surrounding structures, leading to blockages and symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response focuses on intra-tumoral vessel compression and treatment delivery; it does not discuss compression of surrounding organs/ducts or related clinical symptoms."
      },
      {
        "criterion_number": 11,
        "description": "Provides specific published scientific journal articles as evidence of its claims, with proper citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No journal articles or citations are provided."
      },
      {
        "criterion_number": 12,
        "description": "Explains that poor fluid flow in tumor tissue is an active area of scientific research at this time.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly states this is a major focus of modern research and lists ongoing strategies and a clinical trial example (PEGPH20), satisfying the criterion."
      }
    ],
    "question_number": 256,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:07:31.888325",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the normal flow of fluid from blood vessels to the extracellular space to the lymphatic system, including nutrient and oxygen delivery and waste management.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It describes that normal tissues have low/slightly negative interstitial pressure facilitating movement of fluid and nutrients from blood vessels into tissue and notes that lymphatic vessels drain excess interstitial fluid. While brief, this covers blood-to-interstitium flow and lymphatic drainage (waste/clearance), and oxygen delivery is implicitly included under nutrient delivery."
      },
      {
        "criterion_number": 2,
        "description": "The response describes how fluid flow becomes compromised in tumors, including increased intratumoral pressure due to abnormal blood vessels, poor lymphatic drainage, and dense stroma.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly attributes elevated IFP to disorganized/leaky vessels, poor lymphatic drainage, rapid proliferation, and particularly desmoplastic stroma in pancreatic cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses the implications of altered fluid flow on cancer treatment, specifically mentioning reduced drug delivery and immune cell penetration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly states reduced drug extravasation/penetration due to opposing pressure gradients and impaired convection/diffusion, and it explains the stromal/IFP barrier to immune cell trafficking and function."
      },
      {
        "criterion_number": 4,
        "description": "The response explains how increased interstitial fluid pressure impacts drug delivery, including uneven distribution of exposure in the tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that high IFP creates outward pressure opposing drug entry and that poor convection/diffusion leads to less drug reaching deeper tumor regions, leaving cells far from vessels 'shielded'\u2014i.e., uneven intratumoral distribution."
      },
      {
        "criterion_number": 5,
        "description": "The response discusses the impact of altered fluid flow on radiation therapy due to hypoxia.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that elevated pressure impairs perfusion causing hypoxia, and hypoxic cells are more radioresistant because oxygen is needed to fix radiation-induced DNA damage."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions the impact of altered cellular biology and extracellular structures on cancer behavior, including tumor growth, metastasis, and resistance to therapy.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It connects microenvironmental changes (dense stroma, high IFP, hypoxia) to therapeutic resistance (radioresistance) and an immunosuppressive milieu, reflecting altered tumor behavior due to ECM/cellular changes."
      },
      {
        "criterion_number": 7,
        "description": "The response describes how low flow to tumor tissue stimulates further cancer cell growth and development.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not describe feedback whereby low perfusion/flow stimulates cancer growth or development (e.g., hypoxia-driven signaling like HIF-mediated proliferation/angiogenesis)."
      },
      {
        "criterion_number": 8,
        "description": "The response defines desmoplastic stroma and how pancreatic cancer encourages its development.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it defines desmoplastic stroma (dense fibrous ECM with collagen and hyaluronic acid) and emphasizes its prominence in pancreatic cancer, it does not explain how pancreatic cancer promotes its development (e.g., CAF activation, Hedgehog/TGF-\u03b2 signaling)."
      },
      {
        "criterion_number": 9,
        "description": "The response defines interstitial fluid pressure.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explains that normal tissues have low/slightly negative interstitial fluid pressure and that tumors have elevated/positive IFP, effectively defining IFP as the pressure within the interstitial space."
      },
      {
        "criterion_number": 10,
        "description": "The response describes ways that increased pressure from interrupted fluid dynamics and desmoplastic stroma can cause compression on surrounding structures, leading to blockages and symptoms.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It mentions compression of intratumoral blood vessels and surgical challenges but does not address compression of surrounding organs/ducts (e.g., biliary or duodenal obstruction) leading to clinical symptoms."
      },
      {
        "criterion_number": 11,
        "description": "The response provides specific published scientific journal articles as evidence of its claims, with proper citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No journal articles or citations are provided."
      },
      {
        "criterion_number": 12,
        "description": "The response explains that poor fluid flow in tumor tissue is an active area of scientific research at this time.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It states that this is a critical point actively studied by researchers and clinicians and mentions ongoing efforts to normalize the microenvironment and reduce IFP."
      }
    ],
    "question_number": 256,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:08:21.031480",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends clear communication with the family regarding how everyone is dealing with the patient\u2019s cancer diagnosis.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicit guidance on open and honest communication, designating a point person, using group updates (e.g., CaringBridge), and holding family meetings addresses clear communication about coping and emotions."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No explicit recommendation to involve or discuss these issues with the patient\u2019s healthcare team (e.g., oncologist, nurses)."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While therapy and support groups are suggested, there is no mention of oncology social workers, chaplains/spiritual care, or palliative care specialists."
      },
      {
        "criterion_number": 4,
        "description": "The response emphasizes the importance of self-care and healthy boundaries.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Strong emphasis on caregiver respite, specific self-care actions, boundary-setting to protect the patient's energy, and reminders that self-care is essential."
      },
      {
        "criterion_number": 5,
        "description": "The response emphasizes the importance of a strong support system for patients with cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages teamwork among siblings, involvement of extended family with concrete tasks, and mutual support across roles, reinforcing a strong support system."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations that support cancer patients and their families and includes contact information or websites.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No cancer-specific organizations or contact details/websites are provided. CaringBridge is mentioned for updates but not as a support organization with contact info."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends participating in a support group for cancer patients and their families.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicit recommendation to use support groups for both patients and caregivers."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends educating the family on the patient\u2019s diagnosis and treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests sharing medical updates in family meetings and through a communication hub, which constitutes educating the family about the diagnosis/treatment status."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage that family members provide emotional support to each other.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages validation of feelings, leaning on each other, listening, and team unity\u2014clear promotion of mutual emotional support."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend pursuit of professional mental health counseling for family members of a patient with pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends a family therapist or counselor experienced in chronic illness and mentions therapy as supportive for caregivers and family."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend resources that patients and families of patients with pancreatic cancer can access for information about the disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No informational resources (e.g., ACS, NCI, PanCAN) are provided."
      },
      {
        "criterion_number": 12,
        "description": "The response should list sources and/or websites for support groups for patients with pancreatic cancer and their family members.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The response recommends support groups but does not list specific sources or websites for finding them."
      },
      {
        "criterion_number": 13,
        "description": "The response should encourage family members to provide assistance and support to their loved ones affected by pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides multiple concrete examples of practical assistance (meals, errands, respite, childcare, visiting boundaries) and emotional support, clearly encouraging active support."
      }
    ],
    "question_number": 257,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:08:57.806673",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends clear communication with the family regarding how everyone is dealing with the patient\u2019s cancer diagnosis.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides detailed communication strategies: designate a point person, decide what to share with the patient\u2019s input, use centralized updates (texts, emails, CaringBridge), and be honest but sensitive about prognosis and treatment."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly advises working with the medical team for symptom management and recommends early involvement of palliative/hospice services, implying engagement with the care team."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Specifically mentions social workers/patient navigators, hospice and palliative care involvement, and faith-based/spiritual support."
      },
      {
        "criterion_number": 4,
        "description": "The response emphasizes the importance of self-care and healthy boundaries.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Dedicated section on caring for yourself, setting boundaries, taking breaks, respite care, and acknowledging personal grief."
      },
      {
        "criterion_number": 5,
        "description": "The response emphasizes the importance of a strong support system for patients with cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages building a network through family coordination, support groups, faith communities, and practical assistance."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations that support cancer patients and their families and includes contact information or websites.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Lists CaringBridge, LotsaHelpingHands, and MealTrain.com (with explicit website), which are recognized support/coordination platforms with web access."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends participating in a support group for cancer patients and their families.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Directly recommends caregiver and family support groups and repeats support groups in resources."
      },
      {
        "criterion_number": 8,
        "description": "The response recommends educating the family on the patient\u2019s diagnosis and treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises honest communication about prognosis and treatment, managing expectations, and age-appropriate explanations for children."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage that family members provide emotional support to each other.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages validation of emotions, patience, regular check-ins among immediate family, sharing memories, and allowing expression of feelings."
      },
      {
        "criterion_number": 10,
        "description": "The response should recommend pursuit of professional mental health counseling for family members of a patient with pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends individual and family therapy, explicitly noting therapists/counselors and grief-specialized mental health support."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend resources that patients and families of patients with pancreatic cancer can access for information about the disease.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not provide disease-specific informational resources (e.g., PanCAN, NCI, ACS) for learning about pancreatic cancer."
      },
      {
        "criterion_number": 12,
        "description": "The response should list sources and/or websites for support groups for patients with pancreatic cancer and their family members.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Recommends support groups but does not list specific organizations or websites that host pancreatic cancer\u2013focused support groups."
      },
      {
        "criterion_number": 13,
        "description": "The response should encourage family members to provide assistance and support to their loved ones affected by pancreatic cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Gives concrete examples of ways extended family can help (meals, childcare, errands, visits, sharing memories) and emphasizes practical and emotional support."
      }
    ],
    "question_number": 257,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:09:33.800874",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses clear analogies (water balloon vs marble) and a step-by-step, accessible description of metastasis, making complex ideas understandable to lay readers."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Covers direct local invasion (ECM infiltration), entry into and exit from the bloodstream (intravasation/extravasation), and explicitly mentions the lymphatic system."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes cytoskeletal reorganization, nuclear softening, detachment from neighbors, squeezing through endothelial gaps, and navigation of the ECM\u2014mechanistic cellular processes enabling spread."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned explicitly."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While physical stresses in circulation are described, metastasis is not framed as a response to cellular stress."
      },
      {
        "criterion_number": 6,
        "description": "The response explains cancer cell deformability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear definition with the water balloon analogy, discusses ability to change shape and squeeze through tight spaces, and links this property to metastatic steps."
      },
      {
        "criterion_number": 7,
        "description": "The response defines extracellular matrix and cytoskeleton.",
        "score_given": 5,
        "max_points": 5,
        "justification": "ECM is described as a complex web of proteins/fibers; the cytoskeleton is defined as an internal scaffolding of protein filaments that gives shape and structure."
      },
      {
        "criterion_number": 8,
        "description": "The response explains cell adhesion processes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains that cells must detach from neighbors to escape the tumor and traverse endothelial gaps during intravasation/extravasation, reflecting adhesion dynamics, even without molecular detail."
      },
      {
        "criterion_number": 9,
        "description": "The response describes how cell deformity changes in cancer cells as compared to normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Contrasts rigid normal cells (marbles) with deformable cancer cells (water balloons) and details cancer-associated softening via cytoskeletal changes and nuclear pliability."
      },
      {
        "criterion_number": 10,
        "description": "The response describes the impact of enhanced deformability of cancer cells on their ability to metastasize.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly states deformability is critical for metastasis and explains its role in tumor escape, ECM invasion, intravasation, survival in circulation, and extravasation."
      },
      {
        "criterion_number": 11,
        "description": "The response describes how cancer cells with increased ability to deform survive stresses that normal cells would not.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that deformable cells better withstand shear and mechanical stresses in the bloodstream compared with more rigid cells."
      },
      {
        "criterion_number": 12,
        "description": "The response describes desmoplastic stroma in the pancreatic cancer tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Specifically highlights the dense, stiff desmoplastic stroma in pancreatic cancer and its barrier-like nature."
      },
      {
        "criterion_number": 13,
        "description": "The response explains how increased deformability capabilities are necessary for cells to travel within the desmoplastic stroma of pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States that pancreatic cancer cells must be exceptionally deformable to escape and traverse the dense stromal environment."
      }
    ],
    "question_number": 258,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:10:11.473999",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses clear, non-technical language and analogies (e.g., flexible balloon) and walks through the steps of metastasis (local invasion, intravasation, circulation, extravasation, colonization) in an accessible way."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly describes local invasion (direct spread), entry into blood and lymphatic vessels (intravasation), travel in the bloodstream, and exit (extravasation)."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions cytoskeletal remodeling, nucleus stiffness, changes in cell\u2013cell adhesion molecules, interaction with endothelial barriers, ECM navigation, and responses to shear stress, all of which are cellular mechanisms involved in metastasis."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned or described."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While biomechanical stresses (shear forces) are discussed, metastasis is not framed as a response to cellular stress; no explicit link between cell stress signaling and initiation of metastasis is made."
      },
      {
        "criterion_number": 6,
        "description": "The response explains cancer cell deformability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear definition with analogy and details how cells change shape, compress, and squeeze through tight spaces; connects deformability to mechanical behavior."
      },
      {
        "criterion_number": 7,
        "description": "The response defines extracellular matrix and cytoskeleton.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines ECM as the scaffolding around cells and the cytoskeleton as the internal scaffolding composed of actin, myosin, and microtubules."
      },
      {
        "criterion_number": 8,
        "description": "The response explains cell adhesion processes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mentions changes in cell\u2013cell adhesion molecules but does not explain adhesion processes or mechanisms (e.g., cadherins/integrins, how adhesion is modulated during invasion)."
      },
      {
        "criterion_number": 9,
        "description": "The response describes how cell deformity changes in cancer cells as compared to normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States cancer cells reorganize the cytoskeleton to be more plastic/less rigid than healthy cells, providing a direct comparison."
      },
      {
        "criterion_number": 10,
        "description": "The response describes the impact of enhanced deformability of cancer cells on their ability to metastasize.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Connects increased deformability to improved invasion, intravasation, survival in circulation, extravasation, and colonization, detailing the impact at each step."
      },
      {
        "criterion_number": 11,
        "description": "The response describes how cancer cells with increased ability to deform survive stresses that normal cells would not.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains survival under shear forces and passage through capillaries; contrasts with rigid cells that would get stuck or rupture."
      },
      {
        "criterion_number": 12,
        "description": "The response describes desmoplastic stroma in the pancreatic cancer tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly describes the dense, stiff, fibrous desmoplastic stroma characteristic of pancreatic tumors and its barrier properties."
      },
      {
        "criterion_number": 13,
        "description": "The response explains how increased deformability capabilities are necessary for cells to travel within the desmoplastic stroma of pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "States highly deformable pancreatic cancer cells are better equipped to overcome the dense stromal barrier and invade, tying deformability to movement within desmoplastic stroma."
      }
    ],
    "question_number": 258,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:10:48.750933",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the normal physiological flow of fluid from blood vessels to the extracellular space and lymphatic system in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response does not clearly describe normal capillary filtration and reabsorption with lymphatic drainage in simple terms. It mentions blood and lymph as 'rivers' but does not explain the typical movement of fluid from blood vessels into interstitial space and then into lymphatics under normal physiology."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses changes to fluid flow in pancreatic cancer, such as increased intratumoral pressure, and how these changes differ from normal tissue.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly describes desmoplastic stroma causing vessel compression, high interstitial fluid pressure, reduced inflow, and outward interstitial flow, contrasting with normal tissue perfusion."
      },
      {
        "criterion_number": 3,
        "description": "The response addresses how altered fluid flow impacts cancer treatment, including drug delivery and immune cell penetration into tumors.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It discusses drug delivery barriers (reduced perfusion, need to break down stroma to improve chemotherapy penetration) but does not address immune cell penetration or trafficking into tumors."
      },
      {
        "criterion_number": 4,
        "description": "The response discusses the potential impacts of altered fluid flow on cancer behavior, including metastasis, proliferation, migration, and invasion.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It covers metastasis and increased invasiveness under shear stress, but does not explicitly address proliferation or migration; therefore it does not meet the full scope required."
      },
      {
        "criterion_number": 5,
        "description": "The response provides at least one citation from a published scientific journal article as evidence for its claims.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No journal citations are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response defines shear stress.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Shear stress is clearly defined as the physical, frictional force exerted by flowing fluid on a surface, using a clear river analogy."
      },
      {
        "criterion_number": 7,
        "description": "The response describes what sources of shear stress exist in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It identifies sources as blood flow in vessels (high shear), lymphatic flow (low shear), and outward interstitial flow from the tumor microenvironment."
      },
      {
        "criterion_number": 8,
        "description": "The response defines mechanobiology.",
        "score_given": 0,
        "max_points": 3,
        "justification": "It defines mechanotransduction but does not define mechanobiology as a field."
      },
      {
        "criterion_number": 9,
        "description": "The response explains that cancer cells can encounter shear stress forces in the tumor, in the bloodstream, and in lymph channels.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Bloodstream and lymphatic encounters are described, but it does not explicitly state that tumor-resident cells experience shear stress within the tumor; it focuses on outward flow without naming shear stress in the tumor compartment."
      },
      {
        "criterion_number": 10,
        "description": "The response describes desmoplastic stroma and how this forms in pancreatic cancer\u2019s tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It describes what desmoplastic stroma is (dense, fibrous, scar-like) but does not explain how it forms (e.g., activation of pancreatic stellate cells/fibroblasts and ECM deposition)."
      },
      {
        "criterion_number": 11,
        "description": "The response explains the effect that the desmoplastic stroma has on fluid flow in and around a pancreatic cancer tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains vessel compression, high interstitial fluid pressure, reduced inflow, and outward flow into surrounding tissue and lymphatics."
      },
      {
        "criterion_number": 12,
        "description": "The response explains how increased shear stress encourages cancer cells to proliferate and metastasize.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Metastatic selection and increased invasiveness under shear stress are discussed, but there is no explanation that shear stress promotes proliferation."
      },
      {
        "criterion_number": 13,
        "description": "The response describes how shear stresses on cancer cells impact drug resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that adaptation to withstand shear stress is associated with increased resistance to chemotherapy."
      }
    ],
    "question_number": 259,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:11:32.842603",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the normal physiological flow of fluid from blood vessels to the extracellular space and lymphatic system in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While blood flow and interstitial fluid flow are mentioned, the response does not explain the normal process of capillary filtration into the interstitial space and return via the lymphatic system in lay terms."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses changes to fluid flow in pancreatic cancer, such as increased intratumoral pressure, and how these changes differ from normal tissue.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It specifically notes the dense desmoplastic stroma in pancreatic cancer, high interstitial fluid pressure, and complex flow patterns, contrasting with normal tissue."
      },
      {
        "criterion_number": 3,
        "description": "The response addresses how altered fluid flow impacts cancer treatment, including drug delivery and immune cell penetration into tumors.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions drug penetration/delivery but does not address immune cell penetration; the criterion requires both."
      },
      {
        "criterion_number": 4,
        "description": "The response discusses the potential impacts of altered fluid flow on cancer behavior, including metastasis, proliferation, migration, and invasion.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It covers survival in circulation, EMT, migration, invasion, metastasis, and effects on proliferation/apoptosis under shear stress."
      },
      {
        "criterion_number": 5,
        "description": "The response provides at least one citation from a published scientific journal article as evidence for its claims.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to published journal articles are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response defines shear stress.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Shear stress is clearly defined as a tangential force parallel to a surface, with an illustrative example."
      },
      {
        "criterion_number": 7,
        "description": "The response describes what sources of shear stress exist in cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It lists blood flow, interstitial fluid flow, and ductal flow as sources of shear stress relevant to cancer, including pancreatic cancer."
      },
      {
        "criterion_number": 8,
        "description": "The response defines mechanobiology.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Mechanotransduction and mechanosensing are described, but mechanobiology is not defined."
      },
      {
        "criterion_number": 9,
        "description": "The response explains that cancer cells can encounter shear stress forces in the tumor, in the bloodstream, and in lymph channels.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Shear stress in the tumor (interstitial) and bloodstream are described, but lymph channels are not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response describes desmoplastic stroma and how this forms in pancreatic cancer\u2019s tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplastic stroma is identified as dense connective tissue, but the formation process (e.g., activation of stellate cells/CAFs, fibrosis) is not described."
      },
      {
        "criterion_number": 11,
        "description": "The response explains the effect that the desmoplastic stroma has on fluid flow in and around a pancreatic cancer tumor.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that the dense stroma increases interstitial fluid pressure and alters flow patterns, impacting transport in and around the tumor."
      },
      {
        "criterion_number": 12,
        "description": "The response explains how increased shear stress encourages cancer cells to proliferate and metastasize.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response notes high shear can induce cell death and discusses context-dependent effects; it does not explain that increased shear stress encourages proliferation and metastasis."
      },
      {
        "criterion_number": 13,
        "description": "The response describes how shear stresses on cancer cells impact drug resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states shear stress can contribute to drug resistance by activating survival pathways and altering membrane properties, reducing chemotherapy susceptibility."
      }
    ],
    "question_number": 259,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:12:16.283089",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response references the 'medical team' and palliative care but does not explicitly advise discussing these issues with the patient's oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly encourages 'Have Open Conversations,' discussing wishes, fears, and what matters to the patient, which promotes open communication between patient and caregivers."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It strongly recommends engaging palliative care early and also suggests speaking with a therapist and support groups, fulfilling this criterion."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends establishing the patient\u2019s goals of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises conversations about what is important to the loved one, their wishes for care, and using 'Five Wishes' for advance care planning\u2014key components of goals-of-care discussions."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It recommends joining a support group and references PanCAN as a resource, endorsing support groups as helpful."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it mentions PanCAN and 'Five Wishes,' it does not provide any website URL, phone number, or other contact information."
      },
      {
        "criterion_number": 7,
        "description": "The response should emphasize the importance of maintaining mental health throughout the cancer diagnosis and treatment process.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes anticipatory grief, suggests therapy and support groups, and stresses caregiver self-care, clearly highlighting the importance of mental health."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that it is normal to feel this conflict in the face of a pancreatic cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states 'It\u2019s Okay to Feel Conflicted' and that these feelings are normal."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain quality of life, and describe factors of cancer treatment that can impact the patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It reframes hope toward quality of life and mentions symptom control (pain, nausea) and palliative care to improve comfort, addressing factors affecting quality of life."
      },
      {
        "criterion_number": 10,
        "description": "The response should provide online resources for pancreatic cancer information and support groups for the patient to consider reaching out to a community about their struggles.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific online resources or links are provided; PanCAN is mentioned but without directing to online platforms or communities."
      }
    ],
    "question_number": 260,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:12:53.802788",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly advises open and honest communication with the medical team, asking direct questions about prognosis, treatment options, benefits, and side effects, and inquiring about clinical trials. The oncologist is the lead of the medical team for pancreatic cancer, so this recommendation encompasses discussing with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response clearly encourages regular check-ins between the loved one and caregivers, discussing needs, information preferences, and emotional support, emphasizing open dialogue and flexibility."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It recommends early discussion of palliative care and explicitly mentions professional counselors, social workers, and spiritual advisors as sources of support."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends establishing the patient\u2019s goals of care.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explicitly addresses understanding goals of care (cure, life prolongation, comfort/quality of life) and notes these goals can shift over time."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises connecting with others through support groups (online or in person) and describes benefits such as reduced isolation and practical tips."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it names the National Cancer Institute and the Pancreatic Cancer Action Network, it does not provide contact information or specific website URLs as required."
      },
      {
        "criterion_number": 7,
        "description": "The response should emphasize the importance of maintaining mental health throughout the cancer diagnosis and treatment process.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It emphasizes acknowledging and processing grief, normalizing emotions, using therapists/counselors, mindfulness, and structured coping strategies (e.g., designated worry time), underscoring mental health maintenance."
      },
      {
        "criterion_number": 8,
        "description": "The response should state that it is normal to feel this conflict in the face of a pancreatic cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly states that balancing hope with realism is a natural difficulty and that grief is normal and healthy."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain quality of life, and describe factors of cancer treatment that can impact the patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines quality of life in terms of comfort, reduced pain, meaningful time, dignity, and joy, and acknowledges treatment benefits/side effects and the role of palliative care in symptom and stress management."
      },
      {
        "criterion_number": 10,
        "description": "The response should provide online resources for pancreatic cancer information and support groups for the patient to consider reaching out to a community about their struggles.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Although it references NCI and PanCAN generally and mentions support groups, it does not provide specific online support group resources or direct links for community engagement."
      }
    ],
    "question_number": 260,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:13:31.855545",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the biology of how cells sense mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains that cells pull on their surroundings to 'feel' stiffness via focal adhesions and describes sensing weak vs strong areas; introduces mechanotransduction in accessible language."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses the biology of how cells respond to mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes responses including migration toward stiffer regions (durotaxis), increased proliferation on stiffness, fibroblast activation and ECM production, and activation of survival pathways."
      },
      {
        "criterion_number": 3,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects stiffness and ECM organization to invasion and metastasis (cells migrate along stiffer tracks toward vessels; stiff microenvironments promote spread)."
      },
      {
        "criterion_number": 4,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that dense, stiff stroma forms a physical barrier, compresses blood vessels, limits drug delivery, and triggers survival signaling that contributes to resistance."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to published scientific articles are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response defines traction forces that exist in normal cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines traction forces as the pushes and pulls a cell exerts on its environment using its cytoskeleton and focal adhesions, applicable to cells generally (i.e., normal cells)."
      },
      {
        "criterion_number": 7,
        "description": "The response defines the extracellular matrix.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes the ECM as the environment around cells (tissue and matrix) composed of protein fibers like collagen, providing a clear lay definition."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how traction forces are changed in cancer cells, as opposed to normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States that cancer cells exert powerful traction forces to pull on collagen, tear paths, and remodel ECM; contrasts behavior by emphasizing increased force generation and matrix remodeling in cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response describes how increased traction forces from pancreatic cancer cells on their environment promote cancer cell proliferation and migration.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains that traction-induced stiffness provides a 'grow' signal increasing proliferation and enables directed migration (durotaxis) toward stiffer regions, aiding spread."
      },
      {
        "criterion_number": 10,
        "description": "The response describes changes in the pancreatic cancer environment that are prompted by traction forces from the cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details traction-driven fibroblast activation, collagen deposition, and desmoplastic stroma formation leading to extreme stiffness and vascular compression."
      },
      {
        "criterion_number": 11,
        "description": "The response defines mechanotransduction.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly defines mechanotransduction as converting physical forces into biochemical signals that change cell behavior."
      },
      {
        "criterion_number": 12,
        "description": "The response defines desmoplastic stroma in pancreatic cancer\u2019s tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines desmoplastic stroma as extremely dense, stiff, fibrotic scar-like tissue surrounding and infiltrating pancreatic tumors."
      },
      {
        "criterion_number": 13,
        "description": "The response describes the effect of desmoplastic stroma on cancer cell\u2019s ability to metastasize.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that the stroma generates mechanical signals that promote metastasis and guides migration along stiff tracks toward vasculature."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how traction forces in cancer cells contribute to drug resistance in pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Links traction-driven stiff stroma and mechanical tension to poor drug penetration and activation of survival pathways, contributing to resistance."
      }
    ],
    "question_number": 261,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:14:21.801388",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains the biology of how cells sense mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly describes how cells 'feel' their surroundings via traction forces, integrins, focal adhesions, and cytoskeleton; uses accessible analogies (e.g., climber) and explicitly mentions mechanosensing."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses the biology of how cells respond to mechanical stress using layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains downstream responses to mechanical cues: migration, directional movement, proliferation, survival, anoikis resistance, ECM remodeling, angiogenesis, and immune evasion in clear, lay terms."
      },
      {
        "criterion_number": 3,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Connects ECM stiffness and fiber alignment to creation of 'highways' for invasion and metastasis; links mechanical properties to spread."
      },
      {
        "criterion_number": 4,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States the dense, stiff desmoplastic stroma hinders drug delivery and immune infiltration, contributing to treatment resistance."
      },
      {
        "criterion_number": 5,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to published scientific journal articles are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response defines traction forces that exist in normal cells.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines traction forces as pushing/pulling forces generated by actin\u2013myosin and transmitted through focal adhesions, explaining their roles in normal cell movement, sensing, and remodeling."
      },
      {
        "criterion_number": 7,
        "description": "The response defines the extracellular matrix.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Defines ECM as a complex network of proteins and carbohydrates that surrounds and supports cells in tissues."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how traction forces are changed in cancer cells, as opposed to normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states cancer cells often have stronger, more persistent traction forces and links this to enhanced invasion and metastasis."
      },
      {
        "criterion_number": 9,
        "description": "The response describes how increased traction forces from pancreatic cancer cells on their environment promote cancer cell proliferation and migration.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Connects increased traction forces and stiff ECM in pancreatic cancer to enhanced migration/invasion and signaling that promotes proliferation."
      },
      {
        "criterion_number": 10,
        "description": "The response describes changes in the pancreatic cancer environment that are prompted by traction forces from the cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes traction-force-driven ECM remodeling: collagen deposition, cross-linking, stiffening, fiber alignment, and creation of channels; highlights desmoplastic stroma in pancreatic cancer."
      },
      {
        "criterion_number": 11,
        "description": "The response defines mechanotransduction.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While mechanosensing is described, the term 'mechanotransduction' is not explicitly defined."
      },
      {
        "criterion_number": 12,
        "description": "The response defines desmoplastic stroma in pancreatic cancer\u2019s tumor microenvironment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines desmoplastic stroma as dense, fibrotic tissue characteristic of pancreatic tumors and identifies contributors (CAFs and cancer cell forces)."
      },
      {
        "criterion_number": 13,
        "description": "The response describes the effect of desmoplastic stroma on cancer cell\u2019s ability to metastasize.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that stiff, aligned ECM fibers and remodeled matrix create paths that facilitate invasion and metastasis."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how traction forces in cancer cells contribute to drug resistance in pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Links traction-force-driven desmoplastic stiffening to physical barriers for drug penetration and protection from therapy."
      }
    ],
    "question_number": 261,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:15:13.863061",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly connects dense/stiff stroma to metastasis via pressure-driven spread and collagen 'highways' that facilitate invasion and dissemination."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes how dense stroma elevates pressure, collapses vessels, impedes drug delivery, and excludes immune cells, reducing treatment efficacy."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions reduced blood flow and hypoxia as potential consequences of tissue thickness which may have effects on treatment effectiveness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that blood vessels are crushed/collapsed, creating hypoxia that promotes survival and therapy resistance."
      },
      {
        "criterion_number": 4,
        "description": "Define viscosity and explain its role in normal cells, including the term \u201cviscosity\u201d and its function in cellular environments.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Mentions 'viscosity' only to redirect to stiffness/density; does not define viscosity or its role in normal cellular or extracellular environments."
      },
      {
        "criterion_number": 5,
        "description": "Describe changes in viscosity within the pancreatic cancer microenvironment, mentioning \u201cviscosity\u201d and specific alterations in cancer.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Focuses on stiffness, density, hyaluronic acid, and pressure; does not describe changes in 'viscosity' or use the term in that context."
      },
      {
        "criterion_number": 6,
        "description": "Define the tumor microenvironment, using the term \u201ctumor microenvironment\u201d and describing its components.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Uses 'tumor microenvironment (TME)' and lists key components (ECM, CAFs, immune cells), adequately defining it."
      },
      {
        "criterion_number": 7,
        "description": "Define desmoplastic stroma and explain its formation in pancreatic cancer, using the term \u201cdesmoplastic stroma\u201d and describing its development.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines 'desmoplastic stroma' as dense fibrous tissue composing most tumor mass and describes formation via CAFs producing ECM (collagen, HA)."
      },
      {
        "criterion_number": 8,
        "description": "Describe the influence of desmoplasia on cancer cells, mentioning \u201cdesmoplasia\u201d and its effects on proliferation, migration, or invasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Discusses mechanotransduction and increased growth/migration in a stiff stroma but does not use the term 'desmoplasia' explicitly."
      },
      {
        "criterion_number": 9,
        "description": "Describe how desmoplasia limits oxygen delivery to tumor tissue, attributing reduced oxygen delivery specifically to \u201cdesmoplasia.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "Attributes vessel collapse and hypoxia to dense/stiff stroma but does not explicitly attribute reduced oxygen delivery to 'desmoplasia.'"
      },
      {
        "criterion_number": 10,
        "description": "Explain how hypoxia affects cancer cell behavior, describing hypoxia\u2019s role in selecting aggressive, therapy-resistant cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States hypoxia triggers signals that promote survival and resistance to therapy, indicating selection for more resilient phenotypes."
      },
      {
        "criterion_number": 11,
        "description": "Describe how desmoplasia limits tumor access by the immune system, mentioning \u201cdesmoplasia\u201d and its impact on immune cell infiltration.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Notes immune exclusion by thick stroma but does not use the term 'desmoplasia' when describing immune cell infiltration limits."
      },
      {
        "criterion_number": 12,
        "description": "Explain how desmoplasia causes drug resistance in pancreatic cancer, connecting \u201cdesmoplasia\u201d to reduced treatment efficacy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Connects dense stroma to reduced drug penetration but does not explicitly link 'desmoplasia' to treatment resistance."
      },
      {
        "criterion_number": 13,
        "description": "Explain how desmoplastic stroma selects for aggressive tumor cell behavior, linking \u201cdesmoplastic stroma\u201d to increased migratory behavior.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes collagen 'highways' and migration but does not explicitly link 'desmoplastic stroma' to selection for increased migratory behavior."
      },
      {
        "criterion_number": 14,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No references or citations to scientific journal articles are provided."
      }
    ],
    "question_number": 262,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:16:03.701102",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It links stiffness/density to EMT, increased migration/invasion, and metastasis via mechanotransduction pathways (e.g., YAP/TAZ, integrins), directly relating physical properties to spread."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential consequences for treatment effectiveness and resistance.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that dense stroma impedes drug penetration, compresses vessels, limits immunotherapy access, and contributes to therapy resistance, clearly connecting tissue properties to treatment effectiveness."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions reduced blood flow and hypoxia as potential consequences of tissue thickness which may have effects on treatment effectiveness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that dense stroma compresses blood vessels, causes poor perfusion and hypoxia, and that these factors limit drug delivery and effectiveness."
      },
      {
        "criterion_number": 4,
        "description": "Define viscosity and explain its role in normal cells, including the term \u201cviscosity\u201d and its function in cellular environments.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although the term \u201cviscosity\u201d is used, the response does not define viscosity nor explain its role in normal cellular environments."
      },
      {
        "criterion_number": 5,
        "description": "Describe changes in viscosity within the pancreatic cancer microenvironment, mentioning \u201cviscosity\u201d and specific alterations in cancer.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response repeatedly mentions increased \u201cviscosity\u201d/resistance to movement and diffusion within the desmoplastic pancreatic tumor microenvironment and connects it to impeded transport of cells and drugs."
      },
      {
        "criterion_number": 6,
        "description": "Define the tumor microenvironment, using the term \u201ctumor microenvironment\u201d and describing its components.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It uses the term \u201ctumor microenvironment (TME)\u201d and describes components including ECM, CAFs, immune cells, and blood vessels."
      },
      {
        "criterion_number": 7,
        "description": "Define desmoplastic stroma and explain its formation in pancreatic cancer, using the term \u201cdesmoplastic stroma\u201d and describing its development.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines desmoplasia/desmoplastic stroma as dense fibrous overgrowth and explains formation via CAF activation and ECM deposition, including a reinforcing feedback loop."
      },
      {
        "criterion_number": 8,
        "description": "Describe the influence of desmoplasia on cancer cells, mentioning \u201cdesmoplasia\u201d and its effects on proliferation, migration, or invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Within the section on desmoplasia and the stiff stroma, it describes effects on cancer cell behavior\u2014enhanced proliferation, EMT, and invasiveness\u2014satisfying the requirement."
      },
      {
        "criterion_number": 9,
        "description": "Describe how desmoplasia limits oxygen delivery to tumor tissue, attributing reduced oxygen delivery specifically to \u201cdesmoplasia.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "While reduced perfusion and hypoxia are described, the text attributes this to \u201cdense stroma\u201d without explicitly using the term \u201cdesmoplasia\u201d in this context."
      },
      {
        "criterion_number": 10,
        "description": "Explain how hypoxia affects cancer cell behavior, describing hypoxia\u2019s role in selecting aggressive, therapy-resistant cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly states that hypoxia drives aggressive behavior, promotes metastasis, and contributes to therapy resistance."
      },
      {
        "criterion_number": 11,
        "description": "Describe how desmoplasia limits tumor access by the immune system, mentioning \u201cdesmoplasia\u201d and its impact on immune cell infiltration.",
        "score_given": 0,
        "max_points": 3,
        "justification": "The response notes that thick stroma impedes immune cell infiltration but does not explicitly attribute this to \u201cdesmoplasia\u201d using that term."
      },
      {
        "criterion_number": 12,
        "description": "Explain how desmoplasia causes drug resistance in pancreatic cancer, connecting \u201cdesmoplasia\u201d to reduced treatment efficacy.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It links dense stroma to poor drug penetration and reduced efficacy but does not explicitly connect the term \u201cdesmoplasia\u201d to drug resistance."
      },
      {
        "criterion_number": 13,
        "description": "Explain how desmoplastic stroma selects for aggressive tumor cell behavior, linking \u201cdesmoplastic stroma\u201d to increased migratory behavior.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Aggressive, migratory behavior is linked to stiffness/ECM, but the phrase \u201cdesmoplastic stroma\u201d is not explicitly tied to this selection effect."
      },
      {
        "criterion_number": 14,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to published journal articles are provided."
      }
    ],
    "question_number": 262,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:17:08.365702",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends a family meeting with a hospital social worker or palliative care specialist and requests a palliative care consultation."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends respectful and open communication.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It provides a detailed section on facilitating sensitive communication, including acknowledging perspectives, validating views, and focusing on values."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions cultural mediators.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It advises finding a 'cultural broker' who can act as a mediator and translate cultural nuances."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends that the patient and family members communicate their important cultural beliefs to their oncology team for better understanding.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It instructs the reader to pull the doctor, nurse, or social worker aside to explain cultural differences and ask for help navigating them."
      },
      {
        "criterion_number": 5,
        "description": "The response strongly recommends that a medical interpreter is present for all medical appointments.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It states to insist on using a professional medical interpreter if there is a language barrier and not to use a family member."
      },
      {
        "criterion_number": 6,
        "description": "The response suggests that the patient request more time for their appointments, especially if a medical interpreter is needed.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no recommendation to request extended appointment time."
      },
      {
        "criterion_number": 7,
        "description": "The response suggests the patient and/or family inquire about services a patient advocacy office could provide.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of a patient advocacy office or inquiring about its services."
      },
      {
        "criterion_number": 8,
        "description": "The response encourages the patient to communicate their preferences around medical decision-making with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes that doctors need to know what the patient wants and focuses on aligning care with the patient's goals and values."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends online resources for both patients and medical teams to learn about particular cultural norms around medical care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No online resources or websites are provided."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends medical teams to complete thorough documentation on patient preferences surrounding communication and medical decision-making.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no explicit recommendation for the medical team to document communication or decision-making preferences."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends organizations that support cancer patients and their families and includes contact information or a website for each.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No organizations or contact information/websites are listed."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends setting boundaries.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it suggests self-care and seeking support, it does not explicitly recommend setting boundaries."
      }
    ],
    "question_number": 263,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:17:39.564245",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with a social worker, spiritual counselor, or Palliative Care specialist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly advises requesting a meeting with a social worker and palliative care specialist and involving spiritual leaders as desired."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends respectful and open communication.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a detailed section on Open Communication Within the Family, including creating a safe space, asking open-ended questions, active listening, and validating feelings."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions cultural mediators.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Specifically recommends asking for a Cultural Broker/Liaison to help mediate and explain perspectives."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends that the patient and family members communicate their important cultural beliefs to their oncology team for better understanding.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Advises explaining the family's cultural background and norms to the medical team and being specific about preferences for information delivery and decision-makers."
      },
      {
        "criterion_number": 5,
        "description": "The response strongly recommends that a medical interpreter is present for all medical appointments.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States to always request a professional medical interpreter when there is a language barrier and cautions against relying on family for interpretation."
      },
      {
        "criterion_number": 6,
        "description": "The response suggests that the patient request more time for their appointments, especially if a medical interpreter is needed.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not advise requesting longer appointment times."
      },
      {
        "criterion_number": 7,
        "description": "The response suggests the patient and/or family inquire about services a patient advocacy office could provide.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No mention of a patient advocacy office or inquiring about its services."
      },
      {
        "criterion_number": 8,
        "description": "The response encourages the patient to communicate their preferences around medical decision-making with their oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages being specific about who receives information first, how information is delivered, and aligning options with the patient\u2019s goals."
      },
      {
        "criterion_number": 9,
        "description": "The response recommends online resources for both patients and medical teams to learn about particular cultural norms around medical care.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No online resources or websites are provided."
      },
      {
        "criterion_number": 10,
        "description": "The response recommends medical teams to complete thorough documentation on patient preferences surrounding communication and medical decision-making.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not suggest that the medical team document preferences."
      },
      {
        "criterion_number": 11,
        "description": "The response recommends organizations that support cancer patients and their families and includes contact information or a website for each.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No organizations or contact information/websites are listed."
      },
      {
        "criterion_number": 12,
        "description": "The response recommends setting boundaries.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises setting boundaries and not being the sole bridge."
      }
    ],
    "question_number": 263,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:18:08.170545",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It repeatedly discusses stiffness of the pancreatic tumor environment/desmoplastic stroma and even mentions elastography to measure stiffness."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explains that soft, deformable cancer cells in a stiff microenvironment can detach, invade, intravasate, and extravasate, facilitating metastasis."
      },
      {
        "criterion_number": 3,
        "description": "The response relates tissue properties to their potential effect on treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It links stromal stiffness to compressed blood vessels, poor drug delivery, chemoresistance, and discusses stromal-targeting therapies to enhance chemotherapy delivery."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to specific published scientific journal articles are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response explains cancer cell deformability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It clearly explains deformability via cytoskeletal reorganization (actin), resulting in softer, more pliable cells that can change shape to traverse tight spaces."
      },
      {
        "criterion_number": 6,
        "description": "The response defines extracellular matrix and cytoskeleton.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines the cytoskeleton as the internal scaffolding (actin filaments) and describes the extracellular matrix/desmoplastic stroma as a dense mesh of collagen, hyaluronic acid, and fibroblasts creating stiffness."
      },
      {
        "criterion_number": 7,
        "description": "The response explains cell adhesion processes.",
        "score_given": 0,
        "max_points": 3,
        "justification": "While it mentions detachment and intravasation, it does not explain adhesion mechanisms (e.g., integrins, cadherins, EMT) or dynamics of cell\u2013cell/cell\u2013matrix adhesion."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how cell deformity changes in cancer cells as compared to normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly contrasts cancer cells as softer and more pliable than healthy cells."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the impact of enhanced deformability of cancer cells on their ability to metastasize.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It connects increased softness/deformability to success at invasion, intravasation, extravasation, and colonization, using a clear analogy and stepwise description."
      },
      {
        "criterion_number": 10,
        "description": "The response explains ways that cancer cells migrate from the primary tumor, including hematologic and lymphatic spread, perineural invasion, and direct invasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It addresses hematologic and mentions lymphatic access but does not discuss perineural invasion or direct invasion into adjacent tissues."
      },
      {
        "criterion_number": 11,
        "description": "The response describes how cancer cells with increased ability to deform survive stresses that normal cells would not.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that rigid healthy cells would get stuck, while soft cancer cells can contort through tiny gaps and traverse vessel walls, implying survival through mechanical constraints."
      },
      {
        "criterion_number": 12,
        "description": "The response explains how increased deformability capabilities are necessary for cells to travel within the desmoplastic stroma of pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It explicitly describes the need for soft, pliable cells to squeeze through the dense, stiff desmoplastic stroma to reach vasculature."
      }
    ],
    "question_number": 264,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:18:45.507943",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response mentions tissue stiffness.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly discusses stiffness of tumor microenvironment and desmoplastic stroma in pancreatic cancer, as well as stiffness/softness of cells."
      },
      {
        "criterion_number": 2,
        "description": "The response relates tissue properties to their potential effect on cancer spread.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Directly links softer, more deformable cells to invasion and metastasis (squeezing through ECM, entering/exiting blood and lymph) and notes how stiff ECM promotes invasion."
      },
      {
        "criterion_number": 3,
        "description": "The response relates tissue properties to their potential effect on treatment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States stiff TME protects from therapy and impedes drug penetration; mentions therapeutic strategies to stiffen cancer cells or soften TME and target mechanotransduction; notes biomarker potential for prognosis/monitoring."
      },
      {
        "criterion_number": 4,
        "description": "The response offers published scientific journal articles as evidence of its claims and provides citations.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to specific published journal articles are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response explains cancer cell deformability.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines elasticity, compares soft vs stiff cells, and explains contributions from cytoskeleton and nuclear stiffness; ties deformability to functional behaviors (squeezing through tight spaces)."
      },
      {
        "criterion_number": 6,
        "description": "The response defines extracellular matrix and cytoskeleton.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes cytoskeleton as internal scaffolding (actin, microtubules, intermediate filaments) and ECM as the scaffolding around cells within the tumor microenvironment."
      },
      {
        "criterion_number": 7,
        "description": "The response explains cell adhesion processes.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains that cancer cells reduce cell\u2013cell adhesion, losing tight connections and enabling individual movement and deformability."
      },
      {
        "criterion_number": 8,
        "description": "The response describes how cell deformity changes in cancer cells as compared to normal cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States many aggressive cancer cells are softer and more deformable than healthy counterparts or non-invasive tumor cells."
      },
      {
        "criterion_number": 9,
        "description": "The response describes the impact of enhanced deformability of cancer cells on their ability to metastasize.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details that deformability facilitates invasion through ECM and intravasation/extravasation via blood and lymphatic vessels, aiding metastasis."
      },
      {
        "criterion_number": 10,
        "description": "The response explains ways that cancer cells migrate from the primary tumor, including hematologic and lymphatic spread, perineural invasion, and direct invasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions hematologic and lymphatic spread and general invasion into surrounding tissues but does not mention perineural invasion."
      },
      {
        "criterion_number": 11,
        "description": "The response describes how cancer cells with increased ability to deform survive stresses that normal cells would not.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes that deformability helps cells navigate mechanical challenges, adapt to crowded environments, evade immune attack, and resist mechanical stress from therapies, implying survival under stresses that would hinder normal cells."
      },
      {
        "criterion_number": 12,
        "description": "The response explains how increased deformability capabilities are necessary for cells to travel within the desmoplastic stroma of pancreatic cancer.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically highlights pancreatic cancer\u2019s stiff desmoplastic stroma and describes soft, flexible cancer cells moving through a dense, stiff matrix, implying the necessity of deformability in this context."
      }
    ],
    "question_number": 264,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:19:27.162918",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Describes how physical space restriction affects cancer cells, mentioning at least two effects (e.g., enhanced migration, nuclear deformation, adaptation).",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response discusses multiple effects: altered migration, nuclear deformation with potential DNA damage, changes in gene expression (mechanotransduction), and treatment resistance."
      },
      {
        "criterion_number": 2,
        "description": "Explains how confinement enhances migration and invasion (e.g., amoeboid migration, increased speed, metastasis).",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly states cells switch to an 'amoeba-like' mode that is faster, facilitating invasion and entry into blood vessels as a step toward metastasis."
      },
      {
        "criterion_number": 3,
        "description": "Explains how confinement can promote genetic mutations (e.g., nuclear deformation, DNA damage, genomic instability).",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes nuclear deformation, transient nuclear envelope rupture, DNA damage, and the possibility of mutations that increase aggressiveness."
      },
      {
        "criterion_number": 4,
        "description": "Explains how confinement enhances survival/adaptation to stress (e.g., upregulate survival signals, resistant to therapies, mechanical stress).",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response notes mechanical stress as a selective pressure, activation of survival and invasion genes, and increased resistance to chemotherapy and radiation."
      },
      {
        "criterion_number": 5,
        "description": "Explains the biology of how cells sense mechanical stress in layman\u2019s terms with at least one analogy/example.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It introduces mechanotransduction as turning physical forces into biochemical signals and uses clear analogies (crowded corridors, boot camp) to convey sensing of confinement."
      },
      {
        "criterion_number": 6,
        "description": "Discusses how cells respond to mechanical stress in layman\u2019s terms with at least one analogy/example.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The response explains adaptation via switching movement styles and reprogramming gene expression, using relatable imagery (water balloon through a keyhole, boot camp)."
      },
      {
        "criterion_number": 7,
        "description": "Provides at least one specific citation from a published scientific journal article.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to specific scientific articles are provided."
      },
      {
        "criterion_number": 8,
        "description": "Relates tissue properties to potential effect on cancer spread with a specific example or mechanism.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It connects dense, stiff stroma and high interstitial pressure to enhanced invasion/metastasis by forcing cells to adopt faster, squeezing migration."
      },
      {
        "criterion_number": 9,
        "description": "Relates tissue properties to treatment effectiveness and resistance with a specific example or mechanism.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that high pressure from dense stroma collapses blood vessels, limiting drug delivery, and that stress-activated pathways promote therapy resistance."
      },
      {
        "criterion_number": 10,
        "description": "Defines confinement in the context of cancer cells (e.g., physical restriction, tumor microenvironment, narrow spaces).",
        "score_given": 5,
        "max_points": 5,
        "justification": "Confinement is clearly framed as squeezing through tight spaces in the dense tumor microenvironment, with physical restriction emphasized throughout."
      },
      {
        "criterion_number": 11,
        "description": "Defines desmoplastic stroma in pancreatic cancer and describes its formation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it describes desmoplastic stroma as dense, fibrous, scar-like tissue, it does not describe how it forms (e.g., activation of stromal cells producing ECM)."
      },
      {
        "criterion_number": 12,
        "description": "Connects desmoplastic stroma to confinement of cancer cells, explaining how it creates physical restriction.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly links the dense, stiff stroma to high pressure and physical confinement that selects for aggressive cell behavior."
      },
      {
        "criterion_number": 13,
        "description": "Mentions hypoxia in pancreatic cancer and why tumors are hypoxic (e.g., low oxygen due to dense stroma).",
        "score_given": 0,
        "max_points": 7,
        "justification": "Hypoxia or low-oxygen conditions are not explicitly mentioned, despite discussing vessel collapse and pressure."
      },
      {
        "criterion_number": 14,
        "description": "States that understanding confinement is an area of active scientific research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response states this is an active area of research and suggests future therapeutic strategies targeting mechanics."
      }
    ],
    "question_number": 265,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:20:08.951410",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes how physical space restriction affects cancer cells, mentioning at least two effects such as \u201cenhanced migration,\u201d \u201cnuclear deformation,\u201d or \u201cadaptation.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly mentions multiple effects of confinement: nuclear deformation, cytoskeletal remodeling, enhanced migration/invasion, metabolic reprogramming, and increased drug resistance."
      },
      {
        "criterion_number": 2,
        "description": "The response explains how confinement enhances migration and invasion, using terms like \u201camoeboid migration,\u201d \u201cincreased speed,\u201d or \u201cmetastasis.\u201d",
        "score_given": 7,
        "max_points": 7,
        "justification": "Directly states that confinement can train cells for metastasis, describes increased motility, and specifically references development of more efficient \u201camoeboid\u201d movement."
      },
      {
        "criterion_number": 3,
        "description": "The response explains how confinement can promote genetic mutations, mentioning \u201cnuclear deformation,\u201d \u201cDNA damage,\u201d or \u201cgenomic instability.\u201d",
        "score_given": 0,
        "max_points": 5,
        "justification": "While nuclear deformation and chromatin changes are discussed, the response does not explicitly mention DNA damage or genomic instability or mutations."
      },
      {
        "criterion_number": 4,
        "description": "The response explains how confinement enhances cancer cells\u2019 ability to survive and adapt to stress, using terms like \u201cupregulate survival signals,\u201d \u201cresistant to therapies,\u201d or \u201cmechanical stress.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes mechanical stress, increased drug resistance, and activation of survival pathways including upregulation of drug efflux pumps."
      },
      {
        "criterion_number": 5,
        "description": "The response explains the biology of how cells sense mechanical stress using layman\u2019s terms, including at least one analogy or example that avoids jargon.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses a plant-in-a-pot analogy and explains that squeezing leads to cellular and nuclear deformation with chromatin changes, conveying mechanosensing in accessible terms."
      },
      {
        "criterion_number": 6,
        "description": "The response discusses the biology of how cells respond to mechanical stress using layman\u2019s terms, including at least one analogy or example that avoids jargon.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes responses such as cytoskeletal remodeling, gene expression shifts, metabolic reprogramming, and migration adaptations, supported by the plant analogy."
      },
      {
        "criterion_number": 7,
        "description": "The response provides at least one specific citation from a published scientific journal article as evidence for its statements.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No scientific journal citations are provided."
      },
      {
        "criterion_number": 8,
        "description": "The response explicitly relates tissue properties to their potential effect on cancer spread, including at least one specific example or mechanism.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links dense, fibrotic stroma and high interstitial pressure to increased invasion and metastasis training, explaining how confinement enhances spread."
      },
      {
        "criterion_number": 9,
        "description": "The response explicitly relates tissue properties to their potential consequences for treatment effectiveness and resistance, including at least one specific example or mechanism.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains how dense stroma and high pressure impede drug penetration and contribute to resistance; mentions stroma-targeting strategies like hyaluronidase."
      },
      {
        "criterion_number": 10,
        "description": "The response defines confinement in the context of cancer cells, using terms like \u201cphysical restriction,\u201d \u201ctumor microenvironment,\u201d or \u201cnarrow spaces.\u201d",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines confinement as physical space restriction and situates it within the tumor microenvironment."
      },
      {
        "criterion_number": 11,
        "description": "The response defines desmoplastic stroma in pancreatic cancer, using terms like \u201cdense,\u201d \u201cfibrous,\u201d \u201cscar-like tissue,\u201d or \u201cstiff extracellular matrix,\u201d and describes its formation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes pancreatic desmoplastic stroma as dense, fibrotic, scar-like tissue rich in collagen and hyaluronic acid with cancer-associated fibroblasts, indicating formation components."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly connects desmoplastic stroma to the confinement of cancer cells, explaining how it creates physical restriction.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States that the dense stroma creates physical confinement and high interstitial pressure that compresses vessels, restricting space."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions the role of hypoxia in pancreatic cancer and describes why pancreatic tumors are in a hypoxic environment, using terms like \u201clow-oxygen\u201d or \u201cdense stroma.\u201d",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mentions hypoxia due to limited oxygen access in confined environments and explains that dense stroma compresses blood vessels, supporting low-oxygen conditions in pancreatic tumors."
      },
      {
        "criterion_number": 14,
        "description": "The response states that understanding confinement is an area of active scientific research.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explicitly states this is a very active area of research."
      }
    ],
    "question_number": 265,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:20:43.224167",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends flexibility in plans and modifications to allow the father to participate in family traditions.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The response repeatedly emphasizes adapting traditions (shorter events, smaller scale, changing timing to energy levels, relocating to home or hospital room, using video calls) to include the father."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of social work, chaplaincy, counseling, or palliative care involvement."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions the importance of a strong support system during cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states, \"You cannot and should not do this alone,\" recommends delegating roles, and encourages accepting help\u2014clearly highlighting the value of a support network."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No organizations or resource websites (e.g., ACS, PanCAN) are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends open communication.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises asking the family what matters most about traditions and promotes shared planning and expectation-setting, which reflects open communication."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Support groups are not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient prioritize management of cancer or cancer-treatment related side effects to feel as \u201cnormal\u201d as possible to be present for himself and his family.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it acknowledges fatigue and digestive issues and suggests activity adjustments, it does not recommend working with the care team to optimize symptom management (e.g., pain, nausea, enzymes, nutrition) to improve function."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the family members consider documentation of the family traditional events with their father, as a way to reminisce and honor his presence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests a memory jar, recording storytelling, shared digital photo albums, and photo album tours\u2014explicit documentation for reminiscence."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the family members to be thoughtful about ways their father can feel included in family events.",
        "score_given": 3,
        "max_points": 3,
        "justification": "It provides multiple strategies to include him\u2014bringing events to him, making him guest of honor, providing comfortable seating, tailoring sensory experiences, and virtual participation."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest that the family seek their father\u2019s input on what meaningful events and activities he desires to participate in.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It recommends asking the family collectively about the essence of traditions but does not explicitly suggest seeking the father\u2019s specific preferences for events or activities."
      }
    ],
    "question_number": 266,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:21:21.629492",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends flexibility in plans and modifications to allow the father to participate in family traditions.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Clearly emphasizes adaptation and flexibility, including scaling down activities, modifying roles, scheduling around energy, and being ready to pivot."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No explicit recommendation to engage a social worker, counselor, chaplain/spiritual care, or palliative care specialist."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions the importance of a strong support system during cancer treatment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Encourages involving the whole family, seeking support, embracing help from friends/community, and mentions support groups, highlighting the value of a strong support system."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No organizations or resource websites (e.g., PanCAN, ACS, CancerCare) are named or linked."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends open communication.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Has a dedicated 'Open Communication & Collaborative Planning' section advising honest discussions with the father and family."
      },
      {
        "criterion_number": 6,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Specifically suggests support groups for caregivers as a resource."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient prioritize management of cancer or cancer-treatment related side effects to feel as \u201cnormal\u201d as possible to be present for himself and his family.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it addresses comfort, rest, and scheduling around energy, it does not recommend active management of treatment side effects with the care team or palliative symptom management to optimize well-being."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the family members consider documentation of the family traditional events with their father, as a way to reminisce and honor his presence.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Includes a detailed section on documenting and preserving memories with photos, videos, oral histories, journals, and recipe books."
      },
      {
        "criterion_number": 9,
        "description": "The response should encourage the family members to be thoughtful about ways their father can feel included in family events.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides multiple strategies for inclusion, such as modifying roles, bringing events to him, virtual inclusion, and sensory-focused participation."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest that the family seek their father\u2019s input on what meaningful events and activities he desires to participate in.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises talking with him about what matters most and includes 'Patient-Led Ideas' to guide activity selection."
      }
    ],
    "question_number": 266,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:21:46.800231",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Explains metastasis in layman\u2019s terms, including movement from primary tumor to other body parts",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses accessible language and analogies to explain that cancer cells leave the primary tumor, move through tissue, enter vessels, and spread to distant sites (metastasis)."
      },
      {
        "criterion_number": 2,
        "description": "Gives examples of spread: direct invasion, lymphatic system, and blood",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly describes burrowing through surrounding tissue (direct invasion) and identifies both bloodstream and lymphatic system as routes of spread."
      },
      {
        "criterion_number": 3,
        "description": "Discusses at least two cellular mechanisms (e.g., amoeboid, mesenchymal, collective, enzymes, signals)",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes amoeboid movement (blebbing), mesenchymal movement (filopodia/lamellipodia, integrins, MMPs), and collective migration."
      },
      {
        "criterion_number": 4,
        "description": "Explicitly mentions epithelial to mesenchymal transition (EMT) by name",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned by name."
      },
      {
        "criterion_number": 5,
        "description": "Clarifies that cancer cells do not swim and lack flagella/cilia",
        "score_given": 0,
        "max_points": 7,
        "justification": "States cells don't have 'fins or tails,' but does not explicitly clarify lack of flagella/cilia or explicitly state that they do not swim."
      },
      {
        "criterion_number": 6,
        "description": "Describes migration in solid tissues and through fluid-filled environments",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains mesenchymal movement through dense tissue and both passive and active behaviors in blood/ascites."
      },
      {
        "criterion_number": 7,
        "description": "Explains hematologic spread and lymphatic metastasis",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details entry into the bloodstream/lymphatic system, survival in circulation, docking/extravasation, and seeding at new sites."
      },
      {
        "criterion_number": 8,
        "description": "Explains amoeboid motility to actively travel through fluid",
        "score_given": 5,
        "max_points": 5,
        "justification": "Amoeboid/bleb-based movement is described and linked to maneuvering within bloodstream/lymphatic fluid."
      },
      {
        "criterion_number": 9,
        "description": "Explains membrane fluctuations enabling active travel through fluid",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes blebbing and shape-shifting (membrane protrusions) used for movement and maneuvering in fluids."
      },
      {
        "criterion_number": 10,
        "description": "Explains chemical gradients with examples and defines chemotaxis",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of chemotaxis or chemical gradients."
      },
      {
        "criterion_number": 11,
        "description": "Describes passive movements of cancer cells in fluid-filled environments",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states cells are carried by the current in blood/ascites as passive travel."
      },
      {
        "criterion_number": 12,
        "description": "Provides links to scientific literature with PMIDs if available",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or PMIDs provided."
      },
      {
        "criterion_number": 13,
        "description": "Defines desmoplastic stroma in pancreatic cancer",
        "score_given": 5,
        "max_points": 5,
        "justification": "Identifies desmoplasia as the dense, fibrous environment of pancreatic tumors."
      },
      {
        "criterion_number": 14,
        "description": "Summarizes ways pancreatic cancer cells migrate in solid tissue",
        "score_given": 3,
        "max_points": 3,
        "justification": "Notes that due to dense fibrous stroma, pancreatic cancer cells rely on mesenchymal 'bulldozer' invasion to escape."
      },
      {
        "criterion_number": 15,
        "description": "Describes the most common way pancreatic cancer cells are thought to spread",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not specify the most common route (e.g., hematogenous spread to the liver via portal circulation)."
      }
    ],
    "question_number": 267,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:22:47.972988",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "Explains metastasis in layman\u2019s terms, including movement from primary tumor to other parts of the body",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines and discusses metastasis in accessible language and clearly states that cancer spreads from the primary site to distant locations."
      },
      {
        "criterion_number": 2,
        "description": "Gives examples of spread: direct invasion, lymphatic system, and blood",
        "score_given": 10,
        "max_points": 10,
        "justification": "Covers direct invasion through ECM, lymphatic spread to nodes, and hematogenous spread with intravasation/extravasation."
      },
      {
        "criterion_number": 3,
        "description": "Discusses at least two cellular mechanisms (e.g., amoeboid, mesenchymal, collective, enzyme production, environmental signals)",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes amoeboid, mesenchymal, and collective migration and mentions protease (MMP) use."
      },
      {
        "criterion_number": 4,
        "description": "Explicitly mentions epithelial to mesenchymal transition (EMT)",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned by name."
      },
      {
        "criterion_number": 5,
        "description": "Clarifies that cancer cells do not swim and lack machinery (e.g., flagella/cilia)",
        "score_given": 7,
        "max_points": 7,
        "justification": "States cancer cells do not actively swim and explicitly notes they lack flagella; conveys the point clearly."
      },
      {
        "criterion_number": 6,
        "description": "Describes migration in solid tissues and through fluid-filled environments",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains movement through ECM/interstitial tissue and through blood/lymph environments."
      },
      {
        "criterion_number": 7,
        "description": "Explains hematologic spread and lymphatic metastasis",
        "score_given": 10,
        "max_points": 10,
        "justification": "Details intravasation, circulation, extravasation in blood and analogous processes in lymphatics."
      },
      {
        "criterion_number": 8,
        "description": "Explains amoeboid motility to actively travel through fluid",
        "score_given": 0,
        "max_points": 5,
        "justification": "Amoeboid motility is described in tissues; active amoeboid propulsion in fluid is not explained."
      },
      {
        "criterion_number": 9,
        "description": "Explains membrane fluctuations enabling active travel through fluid",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of membrane fluctuations or bleb-driven motion in fluids."
      },
      {
        "criterion_number": 10,
        "description": "Explains chemical gradients, provides examples, and defines chemotaxis",
        "score_given": 0,
        "max_points": 5,
        "justification": "Chemotaxis and chemical gradients are not mentioned."
      },
      {
        "criterion_number": 11,
        "description": "Describes passive movements of cancer cells in fluid-filled environments",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly describes passive carriage in blood and lymph with a clear analogy."
      },
      {
        "criterion_number": 12,
        "description": "Provides links to scientific literature with PMIDs if available",
        "score_given": 0,
        "max_points": 5,
        "justification": "No citations or PMIDs are provided."
      },
      {
        "criterion_number": 13,
        "description": "Defines desmoplastic stroma in pancreatic cancer",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplastic stroma is not discussed."
      },
      {
        "criterion_number": 14,
        "description": "Summarizes ways pancreatic cancer cells migrate in their solid tissue environment",
        "score_given": 0,
        "max_points": 3,
        "justification": "Provides general mechanisms but not pancreas-specific stromal context."
      },
      {
        "criterion_number": 15,
        "description": "Describes the most common way pancreatic cancer cells are thought to spread",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not specify common pancreatic routes (e.g., hematogenous spread to liver, peritoneal, or perineural invasion)."
      }
    ],
    "question_number": 267,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:23:37.270954",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines surface tension.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines surface tension using the water droplet analogy: an inward pull at the surface creates a tight 'skin' explaining beading and insects walking on water."
      },
      {
        "criterion_number": 2,
        "description": "The response defines interfacial forces.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains forces at the boundary (interface) between tumor and healthy tissue and references 'interfacial tension' as the physical forces governing adhesion and separation at that boundary."
      },
      {
        "criterion_number": 3,
        "description": "The response describes the influence of surface tension on pancreatic cancer cells, specifically mentioning cell detachment, migration, or tumor spheroid formation.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that lower surface tension makes a tumor more fluid-like, lowering the energy cost for cells to detach; discusses collective migration and links to pancreatic cancer by noting cancer cells can change their surface tension to invade the stiff stroma."
      },
      {
        "criterion_number": 4,
        "description": "The response describes the role of interfacial forces during cancer cell metastasis, specifically mentioning cell detachment, migration, or invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes detachment from the primary tumor, invasion into surrounding tissue, entry into blood/lymph, and leader-follower dynamics driven by interfacial forces."
      },
      {
        "criterion_number": 5,
        "description": "The response states interfacial tissue planes typically serve as barriers for cancer spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not state that interfacial tissue planes serve as barriers; discusses interfaces as battlegrounds but not as typical barriers to spread."
      },
      {
        "criterion_number": 6,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides a clear, accessible description: cells break away, push through tissue, enter blood or lymph, and travel; includes relatable analogies and plain language."
      },
      {
        "criterion_number": 7,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly mentions pushing through surrounding tissue (direct invasion) and entering blood or lymph vessels (hematogenous and lymphatic spread)."
      },
      {
        "criterion_number": 8,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Covers loss of adhesion molecules (E-cadherin), leader\u2013follower collective migration, cytoskeletal remodeling for deformability, and mechanical plasticity facilitating invasion."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention epithelial-to-mesenchymal transition (EMT) explicitly."
      },
      {
        "criterion_number": 10,
        "description": "The response describes cell-to-cell adhesion, specifically in the context of tumor spheroid formation and the balance with surface tension.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Discusses adhesion (E-cadherin) and balance with movement, but does not address tumor spheroid formation or explicitly connect adhesion-surface tension balance to spheroids."
      },
      {
        "criterion_number": 11,
        "description": "The response describes at least two mechanical cues in the tumor microenvironment, such as stiffness or surface tension, and how cancer cells sense these signals.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions stiffness, pressure, and surface tension; explains that forces at the surface drive cytoskeletal changes and cell deformability, implying mechanosensing."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions desmoplastic stroma and its relevance to pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly discusses desmoplastic stroma in pancreatic cancer, emphasizing its stiffness, pressure effects, and impact on drug delivery and invasion."
      },
      {
        "criterion_number": 13,
        "description": "The response defines the extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not define the extracellular matrix; refers to stroma and collagen fibers without providing an ECM definition."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how normal cells and cancer cells interact with the extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not specifically describe interactions of normal versus cancer cells with the ECM; focuses on adhesion changes and navigation of stroma without explicit ECM interaction comparison."
      }
    ],
    "question_number": 268,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:24:24.677643",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines surface tension.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear classical definition of surface tension as cohesive forces at a liquid\u2013gas interface and gives the water strider example."
      },
      {
        "criterion_number": 2,
        "description": "The response defines interfacial forces.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains interfacial forces as forces at boundaries between biological components (cell\u2013fluid, cell\u2013cell, cell\u2013ECM, cell\u2013substrate)."
      },
      {
        "criterion_number": 3,
        "description": "The response describes the influence of surface tension on pancreatic cancer cells, specifically mentioning cell detachment, migration, or tumor spheroid formation.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Discusses membrane surface tension and detachment/migration in general cancer cells but does not specifically address pancreatic cancer cells or tumor spheroid formation."
      },
      {
        "criterion_number": 4,
        "description": "The response describes the role of interfacial forces during cancer cell metastasis, specifically mentioning cell detachment, migration, or invasion.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details adhesion/de-adhesion dynamics with ECM, traction, migration, and invasion and ties these to interfacial forces in metastasis."
      },
      {
        "criterion_number": 5,
        "description": "The response states interfacial tissue planes typically serve as barriers for cancer spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not mention interfacial tissue planes as barriers to spread."
      },
      {
        "criterion_number": 6,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Uses technical descriptions (ECM, adhesion dynamics, durotaxis) without a simple lay explanation of cells breaking away, traveling, and forming new tumors."
      },
      {
        "criterion_number": 7,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not explicitly describe direct invasion, lymphatic spread, or hematogenous spread; only implies movement through tissues and vessels."
      },
      {
        "criterion_number": 8,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Addresses altered adhesion molecules, adhesion/de-adhesion dynamics, ECM remodeling, stiffness sensing (durotaxis), and contractility influencing invasion."
      },
      {
        "criterion_number": 9,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned."
      },
      {
        "criterion_number": 10,
        "description": "The response describes cell-to-cell adhesion, specifically in the context of tumor spheroid formation and the balance with surface tension.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Discusses cell\u2013cell adhesion but does not address tumor spheroid formation or the balance with surface tension."
      },
      {
        "criterion_number": 11,
        "description": "The response describes at least two mechanical cues in the tumor microenvironment, such as stiffness or surface tension, and how cancer cells sense these signals.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions ECM stiffness, membrane surface tension, interstitial fluid pressure, and sensing via durotaxis/chemotaxis leading to directed migration."
      },
      {
        "criterion_number": 12,
        "description": "The response mentions desmoplastic stroma and its relevance to pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplastic stroma and its specific relevance to pancreatic cancer are not mentioned."
      },
      {
        "criterion_number": 13,
        "description": "The response defines the extracellular matrix.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines ECM as the scaffold of proteins and molecules surrounding cells."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how normal cells and cancer cells interact with the extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Describes cancer cell\u2013ECM interactions (adhesion dynamics, remodeling) but does not describe normal cell\u2013ECM interactions for comparison."
      }
    ],
    "question_number": 268,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:25:21.227347",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing uncertainty or care planning with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response mentions working with the medical team and palliative care specialists but does not explicitly recommend discussing uncertainty or care planning with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly advises working with palliative care specialists and suggests a therapist and support groups for the caregiver."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends cancer support groups as helpful resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It states that caregiver support groups can be invaluable, which is an explicit recommendation for support groups in the cancer-care context."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends establishing the patient\u2019s goals of care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it emphasizes quality of life and redefining hope, it does not explicitly mention establishing goals of care or advance care planning."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It provides clear guidance on communication, including \"Communicate Openly, But Not Constantly\" and using check-ins."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific organizations (e.g., PanCAN, ACS, NCCN) are mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response should attempt to normalize the challenge of living with long-term uncertainty.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly validates feelings, explains that eliminating uncertainty is impossible, and promotes living alongside uncertainty and radical acceptance."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend attempting to preserve normal routines in the home as much as possible.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends controlling daily choices (meals, movies, inviting people), creating cancer-free zones, and scheduling worry time, all of which support maintaining normal routines and structure."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize the importance of quality of life when facing a serious diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "There is a dedicated section to \"Focus on Quality of Life\" and explicit mention of symptom control and comfort as priorities."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest ways to maintain good quality of life for patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Concrete suggestions include engaging palliative care for symptom management, redefining hope to daily goals, embracing both/and feelings, redefining intimacy, and identifying small daily joys."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that patients and family members learn about the disease to understand expected outcomes.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It does not advise learning about pancreatic cancer, prognosis, or expected outcomes, nor discussing these with the medical team."
      }
    ],
    "question_number": 269,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:25:55.412512",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly recommends discussing uncertainty or care planning with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 10,
        "justification": "It advises working with the medical team but does not explicitly mention discussing uncertainty or care planning with the oncologist."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly recommends discussing with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly recommends a therapist/counselor and palliative care, and mentions social workers and chaplains as part of the palliative team."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly recommends cancer support groups as helpful resources.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It clearly recommends support groups, specifically for pancreatic cancer patients and caregivers."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly recommends establishing the patient\u2019s goals of care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it discusses advance directives and palliative care, it does not explicitly recommend establishing or discussing the patient\u2019s goals of care."
      },
      {
        "criterion_number": 5,
        "description": "The response explicitly recommends open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explicitly encourages open communication between the patient and spouse about fears, hopes, and practical concerns."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No specific organizations (e.g., PanCAN, ACS, CancerCare) are named."
      },
      {
        "criterion_number": 7,
        "description": "The response should attempt to normalize the challenge of living with long-term uncertainty.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It repeatedly validates and normalizes feelings of uncertainty, anxiety, and grief."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend attempting to preserve normal routines in the home as much as possible.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It suggests mindfulness, a 'Good Day' list, and self-care but does not explicitly recommend preserving normal home routines."
      },
      {
        "criterion_number": 9,
        "description": "The response should emphasize the importance of quality of life when facing a serious diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes savoring small joys, present-focused living, and palliative care aimed at symptom and stress relief, underscoring quality of life."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest ways to maintain good quality of life for patients.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It offers concrete strategies such as mindfulness, small joys, short-term goals, palliative care involvement, symptom management, and memory-making."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that patients and family members learn about the disease to understand expected outcomes.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It advises understanding the treatment plan, potential side effects, and what to expect in the coming weeks, which aligns with learning about expected outcomes."
      }
    ],
    "question_number": 269,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:26:37.219167",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Uses accessible analogies (rock climber, jungle gym) and clearly explains migration/invasion and metastasis concepts in simple language."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Describes direct invasion and blood-borne spread (vascular invasion to bloodstream), but does not mention lymphatic spread; therefore does not include all required routes."
      },
      {
        "criterion_number": 3,
        "description": "The response explains the biology of cell adhesion in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explains integrin-mediated adhesion and focal adhesions with clear analogies (grappling hooks/handholds) and stepwise description of attachment-detachment cycles."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions integrins and cadherins.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions integrins but does not mention cadherins at all."
      },
      {
        "criterion_number": 5,
        "description": "The response contrasts the biology of cancer cell adhesion with normal cell adhesion using layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Does not provide an explicit contrast between normal cell adhesion and cancer cell adhesion behaviors or molecules."
      },
      {
        "criterion_number": 6,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions changes to cell adhesion in pancreatic cancer specifically.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Discusses desmoplasia and invasion pathways but does not mention specific adhesion changes in pancreatic cancer (e.g., E-cadherin loss, integrin switching)."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe cell-to-cell adhesion and include definitions of integrins, collagen, and fibronectin.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Defines integrins and describes collagen as a fiber, but does not mention fibronectin or describe cell-to-cell adhesion."
      },
      {
        "criterion_number": 9,
        "description": "The response should define extracellular matrix.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Defines ECM as a scaffold of proteins and sugars that hold tissues together and lists components; clear, accurate definition."
      },
      {
        "criterion_number": 10,
        "description": "The response should define actin and myosin, and describe how these proteins act to deform cells to assist in traction and movement.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains actin-myosin as internal skeleton/muscles that contract to pull the cell forward, capturing traction-based movement mechanics."
      },
      {
        "criterion_number": 11,
        "description": "The response should define chemotaxis.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions sensing chemical signals but does not define chemotaxis or name the process."
      },
      {
        "criterion_number": 12,
        "description": "The response should define amoeboid migration.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention or definition of amoeboid migration."
      },
      {
        "criterion_number": 13,
        "description": "The response should desmoplastic stroma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Introduces desmoplasia in pancreatic cancer as dense, scar-like tissue; effectively conveys the concept of desmoplastic stroma."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe how pancreatic cancer forms desmoplastic stroma in its environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explain how desmoplastic stroma is generated (e.g., activation of stellate cells, fibroblasts, cytokines, ECM deposition)."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe how pancreatic cells interact with desmoplastic stroma.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains that pancreatic tumors exist in dense ECM and that cancer cells use fiber 'highways' and proteases to navigate and invade, describing interaction with the stroma."
      },
      {
        "criterion_number": 16,
        "description": "The response should define tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not define or explicitly mention the tumor microenvironment."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe how pancreatic cancer cells interact with the tumor microenvironment, and how different elements encourage cell travel, such as inflammation and hypoxia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of specific microenvironmental factors like inflammation or hypoxia promoting migration."
      },
      {
        "criterion_number": 18,
        "description": "The response should describe the effect of DNA mutations, such as KRAS, on a pancreatic cancer cell\u2019s potential to travel outside of the primary site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of genetic drivers (e.g., KRAS, TP53, SMAD4) or their impact on invasion/metastasis."
      }
    ],
    "question_number": 270,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:27:37.372795",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly defines metastasis as spread to distant parts and explains movement in simple language with analogies (grappling hooks, highways), appropriate for lay readers."
      },
      {
        "criterion_number": 2,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions direct invasion of surrounding tissues, and explicitly states eventual entry into blood and lymphatic vessels to metastasize."
      },
      {
        "criterion_number": 3,
        "description": "The response explains the biology of cell adhesion in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes integrin-mediated adhesion and focal adhesions as temporary anchors providing traction using accessible analogies and sequence of forming and releasing adhesions."
      },
      {
        "criterion_number": 4,
        "description": "The response mentions integrins and cadherins.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Integrins are discussed extensively, but cadherins are not mentioned."
      },
      {
        "criterion_number": 5,
        "description": "The response contrasts the biology of cancer cell adhesion with normal cell adhesion using layman\u2019s terms.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit comparison to normal cell adhesion (e.g., stable cell-cell junctions vs. altered adhesion in cancer) is provided."
      },
      {
        "criterion_number": 6,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to published scientific articles are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response mentions changes to cell adhesion in pancreatic cancer specifically.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Discusses desmoplasia and migration in pancreatic cancer but does not mention specific adhesion changes (e.g., altered integrin profiles, E-cadherin loss) in PDAC."
      },
      {
        "criterion_number": 8,
        "description": "The response should describe cell-to-cell adhesion and include definitions of integrins, collagen, and fibronectin.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Defines integrins and mentions collagen and fibronectin as ECM components but does not define collagen or fibronectin, nor does it describe cell-to-cell adhesion."
      },
      {
        "criterion_number": 9,
        "description": "The response should define extracellular matrix.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides a clear lay definition of the ECM as the non-cellular network surrounding cells, listing components and functions."
      },
      {
        "criterion_number": 10,
        "description": "The response should define actin and myosin, and describe how these proteins act to deform cells to assist in traction and movement.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Defines actin cytoskeleton and myosin motors and explains protrusion and contraction mechanics aiding movement."
      },
      {
        "criterion_number": 11,
        "description": "The response should define chemotaxis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines chemotaxis as guided movement along chemical gradients toward higher concentrations of attractants."
      },
      {
        "criterion_number": 12,
        "description": "The response should define amoeboid migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains amoeboid migration as rapid, rounded, low-adhesion movement by squeezing through gaps, akin to an amoeba."
      },
      {
        "criterion_number": 13,
        "description": "The response should desmoplastic stroma.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes desmoplasia/desmoplastic stroma as dense, stiff, collagen-rich ECM accumulation around pancreatic tumors."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe how pancreatic cancer forms desmoplastic stroma in its environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Notes the presence of desmoplasia but does not describe how it is formed (e.g., activation of stellate cells/CAFs, signaling like TGF-\u03b2)."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe how pancreatic cells interact with desmoplastic stroma.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains that pancreatic cancer cells use aligned collagen tracks, secrete MMPs to remodel ECM, and engage in perineural invasion\u2014clear interactions with the stroma."
      },
      {
        "criterion_number": 16,
        "description": "The response should define tumor microenvironment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly define the term 'tumor microenvironment.'"
      },
      {
        "criterion_number": 17,
        "description": "The response should describe how pancreatic cancer cells interact with the tumor microenvironment, and how different elements encourage cell travel, such as inflammation and hypoxia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions stromal cues and chemotaxis but does not address specific TME elements like inflammation or hypoxia promoting migration."
      },
      {
        "criterion_number": 18,
        "description": "The response should describe the effect of DNA mutations, such as KRAS, on a pancreatic cancer cell\u2019s potential to travel outside of the primary site.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No discussion of genetic mutations (e.g., KRAS) or their impact on motility/metastasis."
      }
    ],
    "question_number": 270,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:28:38.714211",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes how normal tissue structure is disrupted in solid cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It contrasts normal, organized ductal epithelium with cancer cells losing shape and polarity; describes ECM reorganization, stiffness, and infiltrative borders disrupting normal architecture."
      },
      {
        "criterion_number": 2,
        "description": "The response describes that cancer cells proliferate in an unchecked fashion, disrupting the architecture of their environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States cancer cells enter a chaotic, proliferative state and that stiffness signals faster growth; growth-generated pressure deforms tissues, indicating unchecked proliferation disrupting structure."
      },
      {
        "criterion_number": 3,
        "description": "The response defines geometry in biology and medicine, and with regards to human cells and their surrounding structures.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly frames geometry as shapes, structures, and forces across micro/meso/macro scales, calling it the tissue\u2019s architecture and explaining how it influences cells and the microenvironment."
      },
      {
        "criterion_number": 4,
        "description": "The response describes that normal cells exist in a neat, orderly, and structured space within their respective tissues.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes healthy ductal cells as organized like neat cobblestones with defined polarity and a structured ECM scaffold."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the components of normal tissue architecture, such as collagen and extracellular matrix.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses the extracellular matrix and specifically mentions collagen fibers and their alignment."
      },
      {
        "criterion_number": 6,
        "description": "The response describes desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Names desmoplasia, describes the dense, stiff, scar-like stroma surrounding pancreatic tumors."
      },
      {
        "criterion_number": 7,
        "description": "The response describes the effect of desmoplastic stroma on pancreatic cell proclivity to migrate and spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that stiffness signals invasiveness and that aligned collagen bundles act as highways aiding tumor cell migration and spread; pressure triggers invasion."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions the role of blood vessels in drug delivery, and how this can be impacted by pancreatic tumors and desmoplastic stroma.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States solid stress collapses intratumoral blood vessels, preventing chemotherapy delivery; describes the stroma forming a physical barrier."
      },
      {
        "criterion_number": 9,
        "description": "The response clearly explains cancer metastasis in layman\u2019s terms, avoiding jargon and providing accessible explanations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses plain language and analogies (amoeba-like movement, highways, popping out) and defines metastasis as spread with accessible descriptions."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly mentions all three main routes of cancer spread: direct invasion, lymphatic spread, and hematogenous spread.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Describes local invasion but does not explicitly mention lymphatic spread or hematogenous (blood-borne) spread."
      },
      {
        "criterion_number": 11,
        "description": "The response discusses at least two cellular mechanisms by which cancer spreads, such as changes in cell shape, loss of adhesion, or influence of the microenvironment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes EMT with shape change, loss of polarity/adhesion, use of ECM fibers for migration, and microenvironmental stiffness promoting invasion."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly mentions epithelial to mesenchymal transition (EMT) by name or describes the process.",
        "score_given": 5,
        "max_points": 5,
        "justification": "EMT is explicitly named and linked to invasive behavior."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions cancer metastasis as a response to cell stress, including stress-induced mechanisms.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Attributes invasion/metastasis initiation to physical confinement and pressure that squeeze or 'pop' cells out, selecting aggressive clones under stress."
      }
    ],
    "question_number": 271,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:29:18.132892",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes how normal tissue structure is disrupted in solid cancer.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains loss of cell polarity and organization, ECM remodeling, disorganized vasculature, and heterogeneous tumor architecture that disrupt normal tissue structure."
      },
      {
        "criterion_number": 2,
        "description": "The response describes that cancer cells proliferate in an unchecked fashion, disrupting the architecture of their environment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly mentions mechanical cues pushing cells toward uncontrolled proliferation and ties this to invasion and architectural disruption."
      },
      {
        "criterion_number": 3,
        "description": "The response defines geometry in biology and medicine, and with regards to human cells and their surrounding structures.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines \u2018geometry\u2019 as tissue architecture/mechanobiology involving shapes, structures, and arrangements of cells, ECM, and vessels affecting cancer behavior."
      },
      {
        "criterion_number": 4,
        "description": "The response describes that normal cells exist in a neat, orderly, and structured space within their respective tissues.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes organized epithelial polarity, columnar ductal cells, clear lumens, and well-organized blood vessel networks in healthy tissues."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the components of normal tissue architecture, such as collagen and extracellular matrix.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses ECM, collagen, fibroblasts, and their roles in tissue structure and signaling."
      },
      {
        "criterion_number": 6,
        "description": "The response describes desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly notes pancreatic cancer\u2019s dense, fibrotic desmoplastic stroma with excessive collagen."
      },
      {
        "criterion_number": 7,
        "description": "The response describes the effect of desmoplastic stroma on pancreatic cell proclivity to migrate and spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that stiff ECM transmits pro-invasive signals and that cancer cells remodel ECM to create channels facilitating migration."
      },
      {
        "criterion_number": 8,
        "description": "The response mentions the role of blood vessels in drug delivery, and how this can be impacted by pancreatic tumors and desmoplastic stroma.",
        "score_given": 7,
        "max_points": 7,
        "justification": "States dense stroma and abnormal, leaky, disorganized vessels impede drug delivery and create hypoxic regions."
      },
      {
        "criterion_number": 9,
        "description": "The response clearly explains cancer metastasis in layman\u2019s terms, avoiding jargon and providing accessible explanations.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses accessible language to describe tumor cells moving through tissue, entering blood/lymph, and traveling to distant sites, with minimal jargon and clear explanations."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly mentions all three main routes of cancer spread: direct invasion, lymphatic spread, and hematogenous spread.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Mentions invasion into surrounding tissue (direct), entry into lymphatic vessels (lymphatic spread), and entry into blood vessels (hematogenous spread)."
      },
      {
        "criterion_number": 11,
        "description": "The response discusses at least two cellular mechanisms by which cancer spreads, such as changes in cell shape, loss of adhesion, or influence of the microenvironment.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes changes in cell shape and polarity, and influence of microenvironmental stiffness/ECM remodeling on invasion and migration."
      },
      {
        "criterion_number": 12,
        "description": "The response explicitly mentions epithelial to mesenchymal transition (EMT) by name or describes the process.",
        "score_given": 5,
        "max_points": 5,
        "justification": "While EMT is not named, the process is described via loss of epithelial polarity and adoption of mesenchymal-like, motile shapes enabling invasion."
      },
      {
        "criterion_number": 13,
        "description": "The response mentions cancer metastasis as a response to cell stress, including stress-induced mechanisms.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not link metastasis specifically to stress-induced mechanisms; hypoxia and stiffness are discussed but not framed as stress-triggered metastasis."
      }
    ],
    "question_number": 271,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:30:04.618511",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends respectful and honest communication.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly promotes honest conversations with the mother about who to tell and what to share, sets expectations with trusted individuals, and suggests a unified message\u2014all framed respectfully."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends maintaining personal boundaries.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises setting limits on visitors, letting calls go to voicemail, using canned responses to intrusive questions, and ignoring unsolicited medical advice\u2014clear boundary-setting guidance."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends support groups and specifically references the Pancreatic Cancer Action Network (PanCAN) for patient and caregiver support."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It lists CaringBridge.org (explicit website) and mentions PanCAN and Meal Train as resources, thereby providing at least one concrete organization with a website link."
      },
      {
        "criterion_number": 5,
        "description": "The response emphasizes the importance of a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The entire \"Circles of Trust\" framework and suggestions to accept help and delegate tasks underscore building and relying on a strong support system."
      },
      {
        "criterion_number": 6,
        "description": "The response should inform the patient and family members that medical records are subject to HIPAA laws, which prevent divulgence of medical information unless a patient has specifically consented to this.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of HIPAA or legal protections regarding medical record confidentiality."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient inform their oncology care team of their wishes to keep their diagnosis confidential.",
        "score_given": 0,
        "max_points": 7,
        "justification": "It does not advise informing the oncology team about confidentiality preferences."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient and family members be careful and thoughtful with social media posting to maintain her confidentiality.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests using private Facebook groups and controlled one-to-many platforms, emphasizing sharing only what the patient is comfortable with\u2014promoting careful social media use."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient and/or family members seek a balance; it is OK to be selective with sharing her diagnostic information however isolation for patients and/or caregivers can accelerate burnout.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it promotes balance and selective sharing, it does not explicitly caution that isolation can worsen caregiver or patient burnout."
      }
    ],
    "question_number": 272,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:30:42.489859",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends respectful and honest communication.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly advises an open and honest conversation about the mother's comfort level and boundaries, emphasizes prioritizing her wishes, and suggests crafting a unified message with gratitude and clarity."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends maintaining personal boundaries.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It repeatedly highlights setting and enforcing boundaries (what to include/exclude, request for confidentiality, designating a spokesperson, controlled disclosure, and polite deflections)."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends caregiver support groups offered by cancer centers and anonymous online forums/support groups as resources for emotional support."
      },
      {
        "criterion_number": 4,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Although it mentions Pancreatic Cancer Action Network (PanCAN) and platforms like CaringBridge, it does not include any contact information or website URLs for these organizations."
      },
      {
        "criterion_number": 5,
        "description": "The response emphasizes the importance of a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The 'Circles of Support' framework and repeated encouragement to lean on core supporters for emotional and practical help clearly emphasize the value of a strong support system."
      },
      {
        "criterion_number": 6,
        "description": "The response should inform the patient and family members that medical records are subject to HIPAA laws, which prevent divulgence of medical information unless a patient has specifically consented to this.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no mention of HIPAA, protected health information, or legal privacy protections regarding medical records."
      },
      {
        "criterion_number": 7,
        "description": "The response should recommend that the patient inform their oncology care team of their wishes to keep their diagnosis confidential.",
        "score_given": 0,
        "max_points": 7,
        "justification": "While it references the medical team as part of the inner circle, it does not explicitly advise informing the oncology care team of specific confidentiality preferences."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that the patient and family members be careful and thoughtful with social media posting to maintain her confidentiality.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly advises avoiding broad social media unless the mother wants to share widely and notes difficulty controlling privacy on such platforms."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that the patient and/or family members seek a balance; it is OK to be selective with sharing her diagnostic information however isolation for patients and/or caregivers can accelerate burnout.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Although it promotes balance and selective sharing, it does not explicitly warn that isolation can accelerate burnout for patients or caregivers."
      }
    ],
    "question_number": 272,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:31:32.105070",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms, avoiding jargon and providing context for a lay audience.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses clear analogies (escape artist), defines metastasis as spread to other parts of the body, and explains processes in accessible language while minimizing jargon."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly mentions and explains the three main routes of cancer spread: direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions vessel and lymphatic walls in passing but does not explicitly name and explain all three routes (direct invasion, lymphatic, hematogenous)."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses at least three cellular mechanisms by which cancer spreads, such as changes in cell shape, breakdown of the extracellular matrix, increased deformability, use of filopodia/invadopodia, or epithelial-to-mesenchymal transition (EMT).",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes actin\u2013myosin-driven motility and protrusions, ECM degradation via MMPs, and increased nuclear deformability via lamin alterations\u2014meeting the requirement for three mechanisms."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly mentions epithelial-to-mesenchymal transition (EMT) and explains its relevance to cancer cell migration and invasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned or explained."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not connect metastasis to cellular stress responses; only mentions DNA damage from nuclear squeezing."
      },
      {
        "criterion_number": 6,
        "description": "The response should define the extracellular matrix.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines ECM as the dense meshwork around cells, providing a functional lay definition."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe the different components of the extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not list or describe specific components (e.g., collagen, laminin, fibronectin, proteoglycans, hyaluronan)."
      },
      {
        "criterion_number": 8,
        "description": "The response should define desmoplastic stroma and describe how this is formed in the pancreatic cancer environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Defines desmoplastic stroma as dense, fibrous, scar-like tissue but does not describe how it forms (e.g., activation of pancreatic stellate cells/cancer-associated fibroblasts, signaling pathways)."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe how cancer cells are able to deform their shapes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains cellular shape changes and nuclear deformation including lamin alterations that increase pliability."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain the cellular cytoskeleton and its main component parts, such as actin and myosin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly explains cytoskeleton, actin-based protrusions, and myosin motor\u2013driven contraction."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe amoeboid movement in cells and include a description of filopodia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Amoeboid motility and filopodia are not discussed; only lamellipodia are mentioned."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe mesenchymal movement in cancer cells and provide examples of enzymes used by cancer cells in this phenomenon.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While MMPs are mentioned, mesenchymal movement is not explicitly described as a distinct migration mode."
      },
      {
        "criterion_number": 13,
        "description": "The response should provide links to any scientific literature it references, including PMID.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or PMIDs are provided."
      },
      {
        "criterion_number": 14,
        "description": "The response should explain how cells can use ion gradients to prompt movement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Ion gradients and their role in migration are not mentioned."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe the importance of pancreatic cancer cells\u2019 ability to deform or \u201csqueeze\u201d in the desmoplastic stromal environment for survival and spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Emphasizes that dense stroma is like a concrete wall and that highly deformable cells are needed to escape and metastasize in pancreatic cancer."
      },
      {
        "criterion_number": 16,
        "description": "The response should include information about how the nucleus is thought to be deformable in cancer cell migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains nuclear stiffness as a barrier, lamin alterations that increase deformability, and consequences like rupture and DNA damage."
      }
    ],
    "question_number": 273,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:32:35.348117",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explains cancer metastasis in layman\u2019s terms, avoiding jargon and providing context for a lay audience.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly explains confined migration and metastasis in accessible language, defines terms as they appear, and provides context about where squeezing occurs."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly mentions and explains the three main routes of cancer spread: direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists local invasion through ECM/around healthy cells (direct invasion), entry and exit from blood vessels (hematogenous spread), and movement through lymphatic vessel walls (lymphatic spread)."
      },
      {
        "criterion_number": 3,
        "description": "The response discusses at least three cellular mechanisms by which cancer spreads, such as changes in cell shape, breakdown of the extracellular matrix, increased deformability, use of filopodia/invadopodia, or epithelial-to-mesenchymal transition (EMT).",
        "score_given": 7,
        "max_points": 7,
        "justification": "Covers increased deformability/shape change, ECM degradation via proteases (MMPs), integrin-mediated adhesion, actin\u2013myosin contractility, invadopodia, mechanosensing, and chemotaxis."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly mentions epithelial-to-mesenchymal transition (EMT) and explains its relevance to cancer cell migration and invasion.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly mention EMT or explain its role; mentions mesenchymal migration but not EMT."
      },
      {
        "criterion_number": 5,
        "description": "The response mentions cancer metastasis as a response to cell stress.",
        "score_given": 0,
        "max_points": 3,
        "justification": "No discussion of metastasis being triggered by cellular stress conditions."
      },
      {
        "criterion_number": 6,
        "description": "The response should define the extracellular matrix.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Defines ECM as the scaffolding material outside cells and explains its nature."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe the different components of the extracellular matrix.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Lists ECM components such as collagen, fibronectin, and laminin."
      },
      {
        "criterion_number": 8,
        "description": "The response should define desmoplastic stroma and describe how this is formed in the pancreatic cancer environment.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of desmoplastic stroma or its formation in pancreatic cancer."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe how cancer cells are able to deform their shapes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains cellular plasticity, cytoskeletal contraction, and nuclear deformability enabling cells to squeeze through tight spaces."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain the cellular cytoskeleton and its main component parts, such as actin and myosin.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes actin filaments, myosin motors generating contractile force, and mentions microtubules."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe amoeboid movement in cells and include a description of filopodia.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Amoeboid movement is described, but filopodia are not mentioned or described."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe mesenchymal movement in cancer cells and provide examples of enzymes used by cancer cells in this phenomenon.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes mesenchymal migration and cites matrix metalloproteinases (MMPs) as proteases used to degrade ECM."
      },
      {
        "criterion_number": 13,
        "description": "The response should provide links to any scientific literature it references, including PMID.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or PMIDs are provided."
      },
      {
        "criterion_number": 14,
        "description": "The response should explain how cells can use ion gradients to prompt movement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of ion gradients or their role in cell motility."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe the importance of pancreatic cancer cells\u2019 ability to deform or \u201csqueeze\u201d in the desmoplastic stromal environment for survival and spread.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not discuss pancreatic desmoplastic stroma or its relevance to squeezing and survival."
      },
      {
        "criterion_number": 16,
        "description": "The response should include information about how the nucleus is thought to be deformable in cancer cell migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains that the nucleus is large and stiff, but in cancer can be softer due to altered lamins/chromatin; also discusses nuclear positioning."
      }
    ],
    "question_number": 273,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:33:14.800275",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines topology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly defines topology in context as the tissue 'city map'\u2014the physical structure and connections (where cells are relative to each other and available pathways)."
      },
      {
        "criterion_number": 2,
        "description": "The response describes how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Covers all three routes: direct invasion via alignment and migration along collagen fibers; lymphatic spread to regional nodes; hematogenous spread via blood vessels with pancreas-to-liver drainage noted."
      },
      {
        "criterion_number": 3,
        "description": "The response states that in cancer care, topology may relate to the organization of tissues, blood vessels, or lymphatics.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly links topology to tissue layout and networks including ECM, blood vessels, lymphatics, and nerves."
      },
      {
        "criterion_number": 4,
        "description": "The response states the anatomic organization of cancer may impact the cancer\u2019s stage or likelihood to respond to certain treatments like surgery or radiation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "States dense stromal topology impedes drug delivery (chemotherapy) and excludes immune cells, affecting treatment effectiveness. While surgery/radiation are not named, the criterion allows examples; treatment responsiveness is clearly tied to anatomic organization."
      },
      {
        "criterion_number": 5,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Uses a clear city map analogy (highways, roads, tunnels) to explain how cells move via blood, lymph, and nerves in accessible language."
      },
      {
        "criterion_number": 6,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions perineural invasion, migration along collagen fibers, tumor\u2013stromal signaling (fibroblast recruitment), and immune exclusion\u2014mechanistic processes enabling spread."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe tissue networks and their component parts.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes cells, ECM, blood vessels, lymphatics, nerves, stroma, and immune cells as components of interconnected tissue networks."
      },
      {
        "criterion_number": 8,
        "description": "The response should define the extracellular matrix and describe its component parts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines ECM as the physical infrastructure between cells and identifies collagen as a core component; further references collagen fibers within the stroma."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe the desmoplastic stroma that pancreatic cancer encourages to grow in its environment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly describes the dense, fibrous desmoplastic stroma characteristic of pancreatic cancer, with collagen-rich, scar-like tissue and activated stromal cells."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe how abnormal tissue, such as desmoplastic stroma, increases in density of tissue network structures and encourages cancer growth and spread.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains that dense stroma increases tissue density, blocks therapies, excludes immune cells, and provides aligned collagen tracks that guide invasion."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe the roles of blood and lymph vessels in cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details hematogenous spread through blood vessels (with pancreatic venous drainage to the liver) and lymphatic spread to nodes."
      },
      {
        "criterion_number": 12,
        "description": "The response should explain how disrupted tissue architecture can encourage cancer growth and spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes architectural remodeling\u2014dense stroma, vessel collapse, aligned fibers, nerve tracts, and immune exclusion\u2014as enabling tumor survival and dissemination."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe cell-to-cell adhesions in normal cells, and how cancer cells can disrupt these adhesions making them more able to migrate.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not address cell-to-cell adhesion mechanisms (e.g., E-cadherin) or how their loss facilitates detachment and migration."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe how mechanical properties of tissue can stimulate tumor growth and spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes stiffness and alignment of collagen fibers directing invasion and elevated pressure collapsing vessels, both mechanical factors impacting spread and treatment delivery."
      }
    ],
    "question_number": 274,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:34:12.618565",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines topology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Clearly defines topology as spatial organization, connectivity, and structural integrity of tissues, focusing on how connections/arrangements are preserved or disrupted rather than precise shape."
      },
      {
        "criterion_number": 2,
        "description": "The response describes how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Addresses direct invasion along ECM 'tracks', perineural invasion, and explicitly discusses abnormal blood and lymphatic vessels enabling tumor cell escape into the bloodstream and lymphatics leading to metastasis."
      },
      {
        "criterion_number": 3,
        "description": "The response states that in cancer care, topology may relate to the organization of tissues, blood vessels, or lymphatics.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Directly connects topology to tissue organization and describes vascular and lymphatic network organization as topological features."
      },
      {
        "criterion_number": 4,
        "description": "The response states the anatomic organization of cancer may impact the cancer\u2019s stage or likelihood to respond to certain treatments like surgery or radiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes effects on drug delivery and early dissemination, it does not explicitly relate anatomic organization to cancer stage or to response to surgery or radiation."
      },
      {
        "criterion_number": 5,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Uses accessible analogies (dense forest, highways/tracks, escape routes) and plain language to explain how cells spread via tissue structures and vessels."
      },
      {
        "criterion_number": 6,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions loss of E-cadherin, altered integrin-mediated ECM interactions, mechanosensing of stiffness driving invasiveness, and perineural invasion\u2014covering cellular mechanisms of dissemination."
      },
      {
        "criterion_number": 7,
        "description": "The response should describe tissue networks and their component parts.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Describes tumor microenvironment networks including ECM fibers, stromal cells, glandular architecture, blood and lymphatic vessels, and nerves, and how they interconnect."
      },
      {
        "criterion_number": 8,
        "description": "The response should define the extracellular matrix and describe its component parts.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Defines ECM as the non-cellular structural scaffold and cites components such as collagen and hyaluronic acid; also discusses fiber alignment and stiffness. Note: minor inaccuracy listing fibroblasts as ECM, but definition and components are otherwise adequately covered."
      },
      {
        "criterion_number": 9,
        "description": "The response should describe the desmoplastic stroma that pancreatic cancer encourages to grow in its environment.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Provides a detailed description of pancreatic cancer\u2013associated desmoplasia, including dense ECM deposition (collagen, hyaluronic acid), fibrotic reaction, and its structural consequences."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe how abnormal tissue, such as desmoplastic stroma, increases in density of tissue network structures and encourages cancer growth and spread.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Explains increased stiffness/density, raised interstitial pressure, drug penetration barriers, and aligned fibers creating migration pathways that foster growth and spread."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe the roles of blood and lymph vessels in cancer spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Discusses angiogenesis and lymphangiogenesis, describes abnormal leaky/tortuous vessels, hypoxia, and their function as escape routes into blood and lymph leading to metastasis."
      },
      {
        "criterion_number": 12,
        "description": "The response should explain how disrupted tissue architecture can encourage cancer growth and spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes loss of organized glandular structure and boundary breaches as key steps in progression; also links architectural distortion and ECM alignment to invasion."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe cell-to-cell adhesions in normal cells, and how cancer cells can disrupt these adhesions making them more able to migrate.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly states normal tight connections, describes loss of E-cadherin and altered integrin-mediated adhesion enabling detachment and migration."
      },
      {
        "criterion_number": 14,
        "description": "The response should describe how mechanical properties of tissue can stimulate tumor growth and spread.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links increased stiffness and mechanical cues in the desmoplastic stroma to more aggressive behavior, invasiveness, therapy resistance, and elevated interstitial pressure."
      }
    ],
    "question_number": 274,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:34:57.246681",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not suggest speaking with the oncologist about how to communicate with the children or about the prognosis/plan."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends seeking support from a school counselor and a therapist specializing in childhood grief, which satisfies the counselor component."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends honest and open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Honesty and openness are emphasized repeatedly (e.g., 'Honesty Builds Trust,' age-appropriate truthful explanations, addressing hard questions directly)."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends tailoring the discussion to the age of the children.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Provides detailed, age-specific guidance for ages 3\u20136, 7\u201312, and 13+, including example language and developmental considerations."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions PanCAN and counseling, it does not specifically recommend cancer support groups."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 10,
        "justification": "PanCAN is named but no website, phone number, or other contact details are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends establishing the patient\u2019s goals of care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "There is no recommendation to discuss or establish goals of care, advance care planning, palliative care goals, or hospice considerations."
      },
      {
        "criterion_number": 8,
        "description": "The response should emphasize the importance of maintaining mental health throughout the cancer diagnosis and treatment process.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It stresses emotional validation, modeling healthy grieving, therapy for parents and children, self-care, and seeking professional support\u2014clearly prioritizing mental health."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that it is normal to feel this conflict in the face of a pancreatic cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It normalizes the conflict by acknowledging the 'tightrope' between optimism and honesty and validates the difficulty of the situation."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain quality of life, and describe factors of cancer treatment that can impact the patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It highlights focusing on comfort and meaningful days (quality of life) and mentions treatment effects like fatigue, hair loss, and feeling weak, which impact quality of life."
      },
      {
        "criterion_number": 11,
        "description": "The response should suggest that the patient and/or family members leverage support systems.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises leaning on friends and family for practical help and emphasizes using external supports like counselors and therapists."
      }
    ],
    "question_number": 275,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:35:42.792222",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing this with the patient\u2019s oncologist.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not mention consulting the oncologist or oncology team about communication with children."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, spiritual worker, counselor, or Palliative Care specialist.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly recommends seeking help from a child life specialist, family therapist, or grief counselor, which meets the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends honest and open communication between patient and caregivers.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It strongly emphasizes honesty and openness, including age-appropriate honesty, inviting questions, presenting a united message, and validating emotions."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends tailoring the discussion to the age of the children.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It provides distinct guidance for younger children, middle childhood, and adolescents with concrete examples."
      },
      {
        "criterion_number": 5,
        "description": "The response recommends cancer support groups as helpful resources.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No mention of cancer support groups is included."
      },
      {
        "criterion_number": 6,
        "description": "The response provides examples of organizations with resources for cancer patients and their families and includes contact information or a website.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No organizations or contact information/websites are provided."
      },
      {
        "criterion_number": 7,
        "description": "The response recommends establishing the patient\u2019s goals of care.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it mentions focusing on comfort and quality time, it does not explicitly recommend establishing or discussing formal goals of care."
      },
      {
        "criterion_number": 8,
        "description": "The response should emphasize the importance of maintaining mental health throughout the cancer diagnosis and treatment process.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It encourages professional mental health support (therapist, grief counselor, child life specialist) and self-care for caregivers, emphasizing emotional wellbeing."
      },
      {
        "criterion_number": 9,
        "description": "The response should state that it is normal to feel this conflict in the face of a pancreatic cancer diagnosis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It validates the difficulty and delicate balance of optimism and honesty and normalizes feelings like fear and sadness, meeting the criterion."
      },
      {
        "criterion_number": 10,
        "description": "The response should explain quality of life, and describe factors of cancer treatment that can impact the patient\u2019s quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It frames optimism around comfort and quality of life and mentions treatment-related changes (tiredness, pain, hair loss), which affect QoL."
      },
      {
        "criterion_number": 11,
        "description": "The response should suggest that the patient and/or family members leverage support systems.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises engaging teachers, school counselors, trusted family, and leaning on one\u2019s support system."
      }
    ],
    "question_number": 275,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:36:18.798984",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes metastatic routes for pancreatic cancer, including local solid tissue invasion, hematologic spread, lymphatic spread, or perineural invasion.",
        "score_given": 0,
        "max_points": 10,
        "justification": "The response discusses local invasion and mentions survival in the bloodstream with distant spread, but it does not clearly describe specific metastatic routes for pancreatic cancer (e.g., lymphatic or perineural spread), which are characteristic of PDAC."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses cell-to-cell adhesions in both normal cells and cancer cells, highlighting differences.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cell-to-cell adhesion via cadherins is discussed, but there is no explicit comparison between normal and cancer cells or how adhesion properties differ in cancer."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions integrins and cadherins.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Cadherins are mentioned, but integrins are not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Metastasis is clearly explained using accessible analogies, describing invasion, travel, and establishment at distant sites in lay language."
      },
      {
        "criterion_number": 5,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Mechanisms such as leader\u2013follower dynamics, chemotaxis, ECM degradation by MMPs, and coordinated adhesion are described."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Epithelial-to-mesenchymal transition (EMT) is not mentioned."
      },
      {
        "criterion_number": 7,
        "description": "The response explains the biology of cell adhesion in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Cell adhesion is explained using clear analogies (e.g., molecular Velcro, clasped hands) and functional descriptions of how adhesion allows group movement."
      },
      {
        "criterion_number": 8,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No sources or journal citations are provided."
      },
      {
        "criterion_number": 9,
        "description": "The response explains the concept of \u201cleader cells\u201d and implies the presence of \u201cfollower cells\u201d in a group of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Leader and follower cells are explicitly described, including their roles."
      },
      {
        "criterion_number": 10,
        "description": "The response describes amoeboid movement in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Amoeboid movement is not mentioned or described."
      },
      {
        "criterion_number": 11,
        "description": "The response describes mesenchymal migration in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While ECM degradation and protrusive movement are described, mesenchymal migration is not explicitly identified or contrasted; the criterion is not fully met."
      },
      {
        "criterion_number": 12,
        "description": "The response defines the extracellular matrix.",
        "score_given": 3,
        "max_points": 3,
        "justification": "The ECM is defined as a complex network of proteins and sugars acting as scaffolding and a barrier."
      },
      {
        "criterion_number": 13,
        "description": "The response defines desmoplastic stroma.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Desmoplastic stroma is described as an intensely dense, fibrous, scar-like environment around PDAC."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how pancreatic cancer cells interact with desmoplastic stroma to encourage cancer cell growth and migration.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response explains how cancer cells overcome the dense stroma via collective migration and MMPs, but does not describe how the stroma supports or encourages cancer cell growth or migration via reciprocal interactions."
      },
      {
        "criterion_number": 15,
        "description": "The response explains how \u201cleader cells\u201d influence a clump of traveling cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Leader cells are said to sense cues, secrete MMPs to clear paths, and pull the group forward while followers push, clearly explaining their influence."
      },
      {
        "criterion_number": 16,
        "description": "The response defines at least one other protein involved in cell-to-cell adhesions.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Only cadherins are discussed; no other adhesion proteins (e.g., claudins, occludins, desmogleins, selectins) are mentioned or defined."
      },
      {
        "criterion_number": 17,
        "description": "The response describes how cells communicate with each other, such as through chemical signals or enzymes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Chemical communication is described (cells release signaling molecules to coordinate), and enzyme-mediated ECM remodeling is discussed."
      }
    ],
    "question_number": 276,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:37:14.707160",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response describes metastatic routes for pancreatic cancer, including local solid tissue invasion, hematologic spread, lymphatic spread, or perineural invasion.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes local invasion (\u201cbreaking through physical barriers\u201d) and hematologic spread via circulating tumor cell (CTC) clusters; frames this within pancreatic cancer\u2019s aggressiveness. Lymphatic and perineural are not mentioned, but at least two routes are clearly described."
      },
      {
        "criterion_number": 2,
        "description": "The response discusses cell-to-cell adhesions in both normal cells and cancer cells, highlighting differences.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains cadherin-mediated adhesion (normal function) and contrasts with cancer: loss in single-cell/EMT vs partial retention in collective migration."
      },
      {
        "criterion_number": 3,
        "description": "The response mentions integrins and cadherins.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly mentions cadherins (E- and N-cadherin) and integrins with roles in cell-cell and cell-ECM adhesion."
      },
      {
        "criterion_number": 4,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Uses accessible analogies (army; scouts/leaders and troops/followers) and plain-language explanations of spread and survival of clusters."
      },
      {
        "criterion_number": 5,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Covers leader-follower mechanics, integrin traction, MMP-mediated ECM degradation, cytoskeletal remodeling, microenvironmental signals (growth factors, chemokines), and ECM stiffness/alignment."
      },
      {
        "criterion_number": 6,
        "description": "The response mentions epithelial to mesenchymal transition.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions EMT and partial EMT explicitly in context of migration modes."
      },
      {
        "criterion_number": 7,
        "description": "The response explains the biology of cell adhesion in layman\u2019s terms.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Describes adhesion as the \u201cglue,\u201d explains cadherins and junctions, and how forces transmit through cell-cell contacts in simple language."
      },
      {
        "criterion_number": 8,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No citations or references to published scientific journal articles are provided."
      },
      {
        "criterion_number": 9,
        "description": "The response explains the concept of \u201cleader cells\u201d and implies the presence of \u201cfollower cells\u201d in a group of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Clearly defines leader cells and follower cells and their distinct roles in collective migration."
      },
      {
        "criterion_number": 10,
        "description": "The response describes amoeboid movement in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Amoeboid migration is not discussed."
      },
      {
        "criterion_number": 11,
        "description": "The response describes mesenchymal migration in cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Does not explicitly describe mesenchymal migration as a mode; EMT is mentioned but mesenchymal migration characteristics are not outlined."
      },
      {
        "criterion_number": 12,
        "description": "The response defines the extracellular matrix.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Defines ECM functionally as the substrate (\u201ctracks\u201d), lists components (collagen, fibronectin, laminin), and discusses its physical properties guiding migration."
      },
      {
        "criterion_number": 13,
        "description": "The response defines desmoplastic stroma.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Describes desmoplastic stroma as the dense stroma (desmoplasia) surrounding pancreatic tumors."
      },
      {
        "criterion_number": 14,
        "description": "The response describes how pancreatic cancer cells interact with desmoplastic stroma to encourage cancer cell growth and migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Links CAFs, ECM stiffness/alignment, and MMP-mediated remodeling to pro-migratory behavior in pancreatic cancer\u2019s desmoplastic context."
      },
      {
        "criterion_number": 15,
        "description": "The response explains how \u201cleader cells\u201d influence a clump of traveling cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains leaders sense environment, generate traction, remodel ECM, and transmit forces through junctions to pull followers."
      },
      {
        "criterion_number": 16,
        "description": "The response defines at least one other protein involved in cell-to-cell adhesions.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions junction types (desmosomes, tight and gap junctions) but does not define specific adhesion proteins (e.g., claudins, occludin, connexins, desmogleins)."
      },
      {
        "criterion_number": 17,
        "description": "The response describes how cells communicate with each other, such as through chemical signals or enzymes.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Notes gap junctions for communication and stromal secretion of growth factors, chemokines, cytokines; discusses MMPs as enzymatic mediators."
      }
    ],
    "question_number": 276,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:38:27.495367",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines curvature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response references curved surfaces and structures but does not explicitly define curvature as a concept (e.g., bending/geometry of surfaces or positive/negative curvature)."
      },
      {
        "criterion_number": 2,
        "description": "The response states that in cancer care, curvature may relate to the organization of tissues, blood vessels, or lymphatics.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly mentions curved collagen fibers in the ECM, blood vessels, lymphatic channels, and nerves as relevant curved structures that guide cancer cell behavior."
      },
      {
        "criterion_number": 3,
        "description": "The response states the anatomic organization of cancer may impact the cancer\u2019s stage or likelihood to respond to certain treatments like surgery or radiation.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it notes perineural invasion makes pancreatic cancer difficult to treat, it does not state how anatomic organization affects formal staging or likelihood of response to surgery or radiation."
      },
      {
        "criterion_number": 4,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Metastasis is described as cancer's ability to spread, with clear lay explanations using concepts like 'highways' and 'contact guidance' along curved structures."
      },
      {
        "criterion_number": 5,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It provides examples of direct invasion (perineural invasion and invasion along ECM fibers) and indicates use of lymphatic channels and blood vessels as pathways for spread."
      },
      {
        "criterion_number": 6,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mechanisms include contact guidance, focal adhesion dynamics, cytoskeletal tension, nuclear deformation, and YAP/TAZ signaling\u2014all relevant to invasion and spread."
      },
      {
        "criterion_number": 7,
        "description": "The response should define the extracellular matrix.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It describes the ECM as a complex network surrounding cells, composed of structures like collagen fibers, which is an adequate functional definition."
      },
      {
        "criterion_number": 8,
        "description": "The response should define epithelial-to-mesenchymal transition (EMT).",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned or defined."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain cancer cell migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains how cells align to curved tracks, adjust adhesions, and become more motile, providing a clear description of migration."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe the effect of mechanical forces on cell signaling.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mechanotransduction is explained, including cytoskeletal tension, nuclear deformation, and activation of YAP/TAZ signaling pathways."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe how varying levels of positive or negative curvature at the cellular level influence EMT and cancer cell migration.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not distinguish positive versus negative curvature and does not connect curvature levels to EMT specifically."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe the effect of mechanical forces of tissues on cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It notes that tumor geometry creates differential forces on outer versus inner tumor cells affecting invasiveness and therapy resistance, reflecting tissue-level mechanical effects."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe desmoplastic stroma in pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Desmoplasia or desmoplastic stroma is not mentioned."
      },
      {
        "criterion_number": 14,
        "description": "The response should include that cellular curvature acts as both a signal and constraint in cancer cell progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Curvature is presented as a signaling cue via mechanotransduction and as a physical constraint limiting stable focal adhesion formation, thereby shaping progression."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe cancer cell membrane tension, and what occurs when this force is too high.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Membrane tension is not discussed, nor are consequences of excessively high membrane tension."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe how high cell surface membrane tension, such as from curvature, can hinder movement of the cytoskeleton.",
        "score_given": 0,
        "max_points": 7,
        "justification": "The effect of high membrane tension on cytoskeletal protrusions or movement is not addressed."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe the effects of mechanical tension at the level of tissue and organs, particularly if imbalanced, on the spread of pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While tumor geometry is mentioned, the response does not discuss organ- or tissue-level tension imbalance and its specific role in pancreatic cancer spread."
      },
      {
        "criterion_number": 18,
        "description": "The response should define paracrine signaling and explain its role in pancreatic cancer cell communication.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Paracrine signaling is not defined or discussed."
      }
    ],
    "question_number": 277,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:39:36.086152",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response defines curvature.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Curvature is conveyed in practical terms as the concavity/convexity of 3D surfaces in the ECM and how these non-flat geometries affect cells (e.g., references to 'concavity or convexity compared to a flat surface' and curved fibers/structures). While not a formal mathematical definition, it is clearly defined in biologically relevant lay terms."
      },
      {
        "criterion_number": 2,
        "description": "The response states that in cancer care, curvature may relate to the organization of tissues, blood vessels, or lymphatics.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response links curvature to ECM architecture (tissue organization) and to vasculature, noting endothelial sensitivity to curvature and that tumor vessels are tortuous/abnormal. This establishes relevance to tissue and blood vessel organization."
      },
      {
        "criterion_number": 3,
        "description": "The response states the anatomic organization of cancer may impact the cancer\u2019s stage or likelihood to respond to certain treatments like surgery or radiation.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that the dense, curved stroma limits drug penetration and contributes to treatment resistance, directly tying tumor architecture to therapeutic response. Although surgery/radiation are not named, the criterion is met by linking anatomy to treatment responsiveness."
      },
      {
        "criterion_number": 4,
        "description": "The response explains cancer metastasis in layman\u2019s terms.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Metastasis is described as spread into surrounding organs and to distant sites, with plain-language parenthetical definitions for intravasation (entry into blood vessels) and extravasation (exit), providing a lay explanation."
      },
      {
        "criterion_number": 5,
        "description": "The response gives examples of how cancer spreads in the body, including direct invasion by the tumor, spread through the lymphatic system, and spread through the blood.",
        "score_given": 0,
        "max_points": 10,
        "justification": "Direct invasion and hematogenous spread are covered, but lymphatic spread is not mentioned; therefore, full set of examples is incomplete."
      },
      {
        "criterion_number": 6,
        "description": "The response discusses some of the cellular mechanisms by which cancer spreads in the body.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mechanistic details include integrin-mediated adhesion, focal adhesion dynamics, cytoskeletal remodeling, mechanotransduction, and signaling pathways (Rho-GTPases, MAPK, PI3K/Akt) that regulate migration/invasion."
      },
      {
        "criterion_number": 7,
        "description": "The response should define the extracellular matrix.",
        "score_given": 10,
        "max_points": 10,
        "justification": "The ECM is defined as a complex 3D network of proteins (collagen, fibronectin, laminin) forming fibers and pores, which cells interact with mechanically and biochemically."
      },
      {
        "criterion_number": 8,
        "description": "The response should define epithelial-to-mesenchymal transition (EMT).",
        "score_given": 0,
        "max_points": 5,
        "justification": "EMT is not mentioned or defined."
      },
      {
        "criterion_number": 9,
        "description": "The response should explain cancer cell migration.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Cancer cell migration is explained via topographical guidance (topotaxis) along curved collagen tracks, navigation through dense stroma, and how physical geometry directs movement."
      },
      {
        "criterion_number": 10,
        "description": "The response should describe the effect of mechanical forces on cell signaling.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mechanotransduction is explicitly described as conversion of mechanical forces (stretch, compression, tension) into biochemical signals, with integrin-mediated activation of pathways (Rho-GTPases, MAPK, PI3K/Akt)."
      },
      {
        "criterion_number": 11,
        "description": "The response should describe how varying levels of positive or negative curvature at the cellular level influence EMT and cancer cell migration.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While curvature\u2019s effects on adhesion/spreading and migration are discussed, there is no discussion of positive vs. negative curvature levels nor any linkage to EMT."
      },
      {
        "criterion_number": 12,
        "description": "The response should describe the effect of mechanical forces of tissues on cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that dense, stiff, fibrotic stroma imposes physical resistance and geometry that influence deformation, movement, and signaling in cancer cells."
      },
      {
        "criterion_number": 13,
        "description": "The response should describe desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Desmoplasia is explicitly described as an extremely dense, fibrotic, collagen-rich stroma characteristic of pancreatic cancer, with functional implications for invasion and drug delivery."
      },
      {
        "criterion_number": 14,
        "description": "The response should include that cellular curvature acts as both a signal and constraint in cancer cell progression.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Curvature is presented as a mechanosensory signal (via integrins/mechanotransduction) and as a physical constraint affecting cell shape and ability to move through the stroma."
      },
      {
        "criterion_number": 15,
        "description": "The response should describe cancer cell membrane tension, and what occurs when this force is too high.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Membrane tension is not addressed; consequences of excessively high membrane tension are not discussed."
      },
      {
        "criterion_number": 16,
        "description": "The response should describe how high cell surface membrane tension, such as from curvature, can hinder movement of the cytoskeleton.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No link is made between membrane tension and cytoskeletal movement hindrance."
      },
      {
        "criterion_number": 17,
        "description": "The response should describe the effects of mechanical tension at the level of tissue and organs, particularly if imbalanced, on the spread of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The dense, fibrotic, mechanically resistant pancreatic stroma is described as guiding invasion and facilitating metastasis, addressing tissue-level mechanical effects on spread."
      },
      {
        "criterion_number": 18,
        "description": "The response should define paracrine signaling and explain its role in pancreatic cancer cell communication.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Paracrine signaling is not mentioned or defined; no role in pancreatic cancer communication is discussed."
      }
    ],
    "question_number": 277,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:40:35.929123",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing plans for celebrations with the patient\u2019s healthcare or oncology team.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response advises ensuring foods/drinks are 'okayed by their medical team' and planning around treatment timing, which implies consulting the oncology/healthcare team when planning celebration elements."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, counselor, or Palliative Care professional.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No mention of social workers, counselors, or palliative care professionals was made."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups as a resource.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Support groups were not referenced."
      },
      {
        "criterion_number": 4,
        "description": "The response offers examples of organizations that support cancer patients and their families and provides contact information or a website.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No organizations, websites, or contact information were provided."
      },
      {
        "criterion_number": 5,
        "description": "The response emphasizes the importance of quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Quality of life is emphasized through themes of presence, comfort, connection, and adapting celebrations to the patient\u2019s energy and preferences."
      },
      {
        "criterion_number": 6,
        "description": "The response emphasizes the importance of establishing a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It suggests managing friends and family involvement, designating a point person, and coordinating visitors, highlighting the role of support networks."
      },
      {
        "criterion_number": 7,
        "description": "The response should emphasize the importance of controlling symptoms related to pancreatic cancer or its treatment.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While fatigue, pain, and nausea are acknowledged, there is no recommendation to actively manage or control symptoms (e.g., with the medical team or medications)."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that caregivers take measures to prevent burnout.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Caregiver self-care or burnout prevention strategies are not explicitly discussed."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that loved ones plan small, meaningful gatherings with the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "The response explicitly recommends short, small gatherings (e.g., a 'birthday hour', 20-minute visits) and meaningful, low-energy activities."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of flexibility when planning events with a patient with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It clearly emphasizes flexibility with Plan A/B/C and being prepared to pivot or cancel without guilt."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that planners of celebrations consider incorporating time for rest and keep gatherings small and simple.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it advises keeping gatherings short and simple, it does not explicitly recommend incorporating time for rest."
      },
      {
        "criterion_number": 12,
        "description": "The response should suggest that a professional therapist or counselor can help maintain mental health in patients experiencing pancreatic cancer.",
        "score_given": 0,
        "max_points": 5,
        "justification": "No recommendation to involve a therapist or counselor for mental health support was provided."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that patients and/or family members take care of any legal and/or medical paperwork as soon as possible.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Legal or medical paperwork (e.g., advance directives, powers of attorney) was not addressed."
      },
      {
        "criterion_number": 14,
        "description": "The response should explain that there will likely be a decline in overall health of the patient over time, and expectation management should be discussed by the patient and their oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no discussion of expected health decline or explicit guidance to align expectations with the oncology team."
      }
    ],
    "question_number": 278,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:41:25.127383",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response recommends discussing plans for celebrations with the patient\u2019s healthcare or oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While it mentions the palliative care team in general, it does not explicitly recommend discussing celebration plans with the oncology or broader healthcare team."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, counselor, or Palliative Care professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It explicitly recommends engaging a palliative care team and social workers/therapists for support."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends cancer support groups as a resource.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Support groups are not mentioned."
      },
      {
        "criterion_number": 4,
        "description": "The response offers examples of organizations that support cancer patients and their families and provides contact information or a website.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No organizations or contact information/websites are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response emphasizes the importance of quality of life.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Quality of life is explicitly emphasized, including the role of palliative care focusing on quality of life from diagnosis."
      },
      {
        "criterion_number": 6,
        "description": "The response emphasizes the importance of establishing a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It encourages involving others strategically, delegating tasks, and coordinating messages, reflecting a strong support system."
      },
      {
        "criterion_number": 7,
        "description": "The response should emphasize the importance of controlling symptoms related to pancreatic cancer or its treatment.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It highlights that the palliative care team can help manage symptoms and improve comfort, linking symptom control to feasibility of celebrations."
      },
      {
        "criterion_number": 8,
        "description": "The response should recommend that caregivers take measures to prevent burnout.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It directly advises caregiver self-care, rest, support, and acknowledging emotions."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend that loved ones plan small, meaningful gatherings with the patient.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends small, intimate, meaningful celebrations and provides examples."
      },
      {
        "criterion_number": 10,
        "description": "The response should emphasize the importance of flexibility when planning events with a patient with pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly says to be flexible, have backup plans, and be ready to reschedule without guilt."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend that planners of celebrations consider incorporating time for rest and keep gatherings small and simple.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It advises keeping events short, allowing breaks, building in downtime, and keeping gatherings small and comfortable."
      },
      {
        "criterion_number": 12,
        "description": "The response should suggest that a professional therapist or counselor can help maintain mental health in patients experiencing pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It recommends social workers/therapists for emotional support for the patient and family."
      },
      {
        "criterion_number": 13,
        "description": "The response should recommend that patients and/or family members take care of any legal and/or medical paperwork as soon as possible.",
        "score_given": 0,
        "max_points": 7,
        "justification": "There is no mention of legal or medical paperwork, advance care planning, or directives."
      },
      {
        "criterion_number": 14,
        "description": "The response should explain that there will likely be a decline in overall health of the patient over time, and expectation management should be discussed by the patient and their oncology team.",
        "score_given": 0,
        "max_points": 5,
        "justification": "It does not address the expected trajectory of health decline or recommend discussing expectations with the oncology team."
      }
    ],
    "question_number": 278,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:42:10.658972",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response clearly explains how changes in tissue density and architecture (cell jamming) influence cancer cell movement, tumor aggressiveness, and metastasis.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response links crowding/jamming to reduced movement, describes unjamming enabling invasion/metastasis, and ties this to PDAC\u2019s dense stroma and aggressiveness."
      },
      {
        "criterion_number": 2,
        "description": "The response defines and explains cancer cell jamming.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear definition using solid\u2013liquid analogy, describes jammed state as high density with strong adhesion and force balance preventing motion."
      },
      {
        "criterion_number": 3,
        "description": "The response defines and describes cancer cells that are in an unjammed state.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explains unjammed state as fluid-like with increased mobility, leader\u2013follower dynamics, cell shape elongation, and weakened adhesions enabling movement."
      },
      {
        "criterion_number": 4,
        "description": "The response describes how cancer cells become unjammed.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details triggers for unjamming including emergence of leader cells, cytoskeletal force generation, cell shape changes, adhesion weakening, and ECM degradation."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the intrinsic properties of cells that contribute to jamming and unjamming of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions intrinsic features: adhesion molecule strength (molecular glue), internal motors/contractility, and cell shape changes contributing to transitions."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the extrinsic properties of cells that contribute to jamming and unjamming of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses extrinsic factors: tissue crowding, dense ECM/desmoplastic stroma in PDAC, and ECM remodeling via proteases creating escape paths."
      },
      {
        "criterion_number": 7,
        "description": "The response explains how unjamming of cancer cells contributes to cancer spread and migration of cancer cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explicitly connects unjamming to invasion and metastasis, describing collective flow, leader cells creating paths, and contribution to PDAC\u2019s early spread."
      },
      {
        "criterion_number": 8,
        "description": "The response explains methods of cancer cell movement.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Mentions independent vs group movement and leader\u2013follower collective invasion but does not explain multiple movement modes (e.g., mesenchymal vs amoeboid) in detail."
      },
      {
        "criterion_number": 9,
        "description": "The response explains how jamming occurs in normal cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not address jamming in normal tissues (e.g., epithelial monolayers, developmental contexts); focuses on tumors only."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly discusses changes to tissue architecture specific to pancreatic cancer, such as desmoplastic reaction, fibrosis, or stromal remodeling.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly discusses PDAC desmoplastic stroma, dense fibrous environment, and how cells remodel it to enable escape."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly discusses the implications of altered tissue architecture on cancer treatment, specifically mentioning reduced drug delivery or immune cell penetration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States dense, jammed tumors hinder chemotherapy penetration and proposes strategies to modulate jamming to improve drug delivery."
      },
      {
        "criterion_number": 12,
        "description": "The response includes citations from published scientific journal articles to support its claims.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to specific scientific studies are provided."
      }
    ],
    "question_number": 279,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:42:52.680297",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response clearly explains how changes in tissue density and architecture (cell jamming) influence cancer cell movement, tumor aggressiveness, and metastasis.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains that high cell density and dense stroma create a jammed state that restricts movement but can paradoxically promote invasion/metastasis via pressure, EMT, and collective invasion; connects mechanical environment to aggressiveness and spread."
      },
      {
        "criterion_number": 2,
        "description": "The response defines and explains cancer cell jamming.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Provides a clear definition using a fluid-to-solid transition due to high density and other factors, with an accessible analogy and mechanistic consequences."
      },
      {
        "criterion_number": 3,
        "description": "The response defines and describes cancer cells that are in an unjammed state.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Describes unjammed as fluid-like where individual cells move freely, extend protrusions, and have higher migratory capacity."
      },
      {
        "criterion_number": 4,
        "description": "The response describes how cancer cells become unjammed.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Details mechanisms including pressure-driven escape at tumor edges and EMT reducing epithelial adhesion and increasing motility; also mentions altering adhesion/stroma as strategies to unjam."
      },
      {
        "criterion_number": 5,
        "description": "The response describes the intrinsic properties of cells that contribute to jamming and unjamming of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Covers cell-cell adhesion strength, cytoskeletal mechanics, and cell stiffness/deformability as determinants of jammed vs unjammed behavior."
      },
      {
        "criterion_number": 6,
        "description": "The response describes the extrinsic properties of cells that contribute to jamming and unjamming of cancer cells.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Addresses ECM density/stiffness, physical confinement, desmoplastic stroma, and interstitial pressure as extrinsic factors shaping jamming."
      },
      {
        "criterion_number": 7,
        "description": "The response explains how unjamming of cancer cells contributes to cancer spread and migration of cancer cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Explains that unjamming via EMT and edge pressure facilitates escape, invasion, and collective migration, linking directly to metastasis."
      },
      {
        "criterion_number": 8,
        "description": "The response explains methods of cancer cell movement.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Mentions protrusion-based crawling of individual cells and collective invasion as movement modes; distinguishes individual vs group migration."
      },
      {
        "criterion_number": 9,
        "description": "The response explains how jamming occurs in normal cells.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Does not discuss jamming phenomena in normal (non-cancer) tissues or cells."
      },
      {
        "criterion_number": 10,
        "description": "The response explicitly discusses changes to tissue architecture specific to pancreatic cancer, such as desmoplastic reaction, fibrosis, or stromal remodeling.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly describes dense desmoplastic, fibrotic, collagen-rich stroma in pancreatic cancer and its mechanical consequences."
      },
      {
        "criterion_number": 11,
        "description": "The response explicitly discusses the implications of altered tissue architecture on cancer treatment, specifically mentioning reduced drug delivery or immune cell penetration.",
        "score_given": 10,
        "max_points": 10,
        "justification": "States that dense stroma leads to high interstitial pressure that impedes drug delivery and suggests strategies to improve drug penetration."
      },
      {
        "criterion_number": 12,
        "description": "The response includes citations from published scientific journal articles to support its claims.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No references or citations to scientific journal articles are provided."
      }
    ],
    "question_number": 279,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:43:33.168194",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly mentions both tissue stiffness and fibrosis in the context of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that CAFs create dense, scar-like fibrous tissue and that stiffness of the environment signals cancer cells, explicitly mentioning both fibrosis and stiffness."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly discusses intercellular communication between pancreatic cancer cells and stromal cells, such as fibroblasts or pancreatic stellate cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It describes cancer cells and CAFs exchanging growth factors/cytokines and using physical contact and mechanical cues, directly addressing cancer\u2013stromal communication."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly connects specific tissue properties, such as stiffness or fibrosis, to the process of cancer spread, including invasion or metastasis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that stiffness acts as a signal for cancer cells to become more aggressive and spread, linking a tissue property to dissemination."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly relates specific tissue properties, such as stiffness or fibrosis, to treatment response or resistance in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that dense fibrotic stroma blocks drug penetration and compresses vessels causing hypoxia, which increases resistance to chemotherapy and radiation."
      },
      {
        "criterion_number": 5,
        "description": "The response provides at least one citation from a published scientific journal article to support its claims.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or references to published scientific articles are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response must describe the concept of pattern formation in cellular structures, including at least two biological processes contributing to these patterns.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines self-organization and details multiple processes: chemical signaling (growth factors/cytokines), physical contact, and mechanical forces, contributing to emergent structures."
      },
      {
        "criterion_number": 7,
        "description": "The response must provide at least two commonly recognizable examples of biological pattern formation, such as embryonic development or tissue architecture.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It references embryonic development as a contrasting blueprint-driven example and uses flocking (birds, fish) as recognizable pattern formation examples; it also mentions tissue architecture via duct/gland formation."
      },
      {
        "criterion_number": 8,
        "description": "The response must describe how organized structures develop in tumors, mentioning at least two mechanisms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It mentions self-organization through local interactions, stromal remodeling by CAFs, angiogenesis, and perineural invasion, providing multiple mechanisms."
      },
      {
        "criterion_number": 9,
        "description": "The response must explain how DNA mutations in cancer cells can change their behavior, linking these changes to pattern formation.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No discussion of DNA mutations (e.g., KRAS, TP53) or how mutations alter cell behavior in relation to pattern formation is included."
      },
      {
        "criterion_number": 10,
        "description": "The response must describe how cancer cells promote angiogenesis, including the secretion of signals for new blood vessel growth.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly states that tumors send out signals to grow their own, often leaky, network of vessels, describing angiogenic signaling."
      },
      {
        "criterion_number": 11,
        "description": "The response must explain how cancer cells interact with tissues in their environment, including interactions with the extracellular matrix.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While interactions with stroma, CAFs, and mechanical stiffness are discussed, the extracellular matrix is not explicitly mentioned or described as part of these interactions."
      },
      {
        "criterion_number": 12,
        "description": "The response must define and describe the extracellular matrix, including its composition or function.",
        "score_given": 0,
        "max_points": 5,
        "justification": "There is no definition or description of the extracellular matrix, its components (e.g., collagen, hyaluronan), or its functions."
      },
      {
        "criterion_number": 13,
        "description": "The response must define and describe desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It uses the term 'Desmoplastic Stroma' and describes it as dense, fibrous tissue produced by CAFs that forms a barrier, compresses vessels, and provides pro-survival signals."
      },
      {
        "criterion_number": 14,
        "description": "The response must explain the influence of the tumor microenvironment on tumor cell pattern formation, including at least one component.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines the tumor microenvironment and details components (CAFs, immune cells, blood vessels) that shape tumor architecture and patterns."
      },
      {
        "criterion_number": 15,
        "description": "The response must describe evolutionary pressures on cancer cells and the acquisition of DNA mutations, including at least one selective advantage.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No evolutionary framework or discussion of selection for mutations conferring advantages (e.g., growth, invasion, therapy resistance) is presented."
      }
    ],
    "question_number": 280,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:44:19.823769",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response explicitly mentions both tissue stiffness and fibrosis in the context of pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states that PDAC has a dense, fibrotic desmoplastic stroma and that the ECM becomes very stiff; it also notes a stiff mechanical environment in PDAC."
      },
      {
        "criterion_number": 2,
        "description": "The response explicitly discusses intercellular communication between pancreatic cancer cells and stromal cells, such as fibroblasts or pancreatic stellate cells.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It details signaling between cancer cells and stromal cells (including CAFs), mentioning growth factors, cytokines, chemokines, and ongoing bidirectional influence."
      },
      {
        "criterion_number": 3,
        "description": "The response explicitly connects specific tissue properties, such as stiffness or fibrosis, to the process of cancer spread, including invasion or metastasis.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explicitly links PDAC\u2019s stiff, fibrotic stroma to promoting invasion and discusses invasive fronts, meeting the invasion/spread link."
      },
      {
        "criterion_number": 4,
        "description": "The response explicitly relates specific tissue properties, such as stiffness or fibrosis, to treatment response or resistance in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains that the desmoplastic stroma shields tumor cells from chemotherapy, forms a barrier to drug delivery, contributes to immune exclusion, and that stiffness/hypoxia promote resistance."
      },
      {
        "criterion_number": 5,
        "description": "The response provides at least one citation from a published scientific journal article to support its claims.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No journal citations or references are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response must describe the concept of pattern formation in cellular structures, including at least two biological processes contributing to these patterns.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines pattern formation and describes multiple contributing processes: cell-cell/ECM adhesion and signaling, reaction-diffusion gradients, mechanical forces, angiogenesis."
      },
      {
        "criterion_number": 7,
        "description": "The response must provide at least two commonly recognizable examples of biological pattern formation, such as embryonic development or tissue architecture.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It cites embryonic development and provides recognizable tissue architecture examples (glandular/ductal structures, vascular networks)."
      },
      {
        "criterion_number": 8,
        "description": "The response must describe how organized structures develop in tumors, mentioning at least two mechanisms.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It explains formation via gradients (oxygen/nutrients, chemokines), mechanical forces (stiffness/compression), angiogenesis, and adhesion/signaling."
      },
      {
        "criterion_number": 9,
        "description": "The response must explain how DNA mutations in cancer cells can change their behavior, linking these changes to pattern formation.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It discusses intra-tumoral genetic heterogeneity producing varied behaviors (migration, drug resistance) and natural selection shaping dominant patterns."
      },
      {
        "criterion_number": 10,
        "description": "The response must describe how cancer cells promote angiogenesis, including the secretion of signals for new blood vessel growth.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It states tumors release factors that stimulate new blood vessel formation and describes the resulting abnormal vascular network."
      },
      {
        "criterion_number": 11,
        "description": "The response must explain how cancer cells interact with tissues in their environment, including interactions with the extracellular matrix.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It details cell-ECM adhesion via integrins, sensing of stiffness, and interactions with stromal cells within the TME."
      },
      {
        "criterion_number": 12,
        "description": "The response must define and describe the extracellular matrix, including its composition or function.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It defines the ECM as a network of proteins (collagen, fibronectin, laminin) and carbohydrates providing structural support and biochemical cues."
      },
      {
        "criterion_number": 13,
        "description": "The response must define and describe desmoplastic stroma in pancreatic cancer.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It describes PDAC\u2019s desmoplastic stroma as dense, fibrotic, collagen- and CAF-rich tissue that surrounds and infiltrates tumor cells and impedes therapy."
      },
      {
        "criterion_number": 14,
        "description": "The response must explain the influence of the tumor microenvironment on tumor cell pattern formation, including at least one component.",
        "score_given": 5,
        "max_points": 5,
        "justification": "It emphasizes the TME\u2019s orchestration of patterns, naming components (CAFs, immune cells, endothelial cells, ECM) and their signaling cross-talk."
      },
      {
        "criterion_number": 15,
        "description": "The response must describe evolutionary pressures on cancer cells and the acquisition of DNA mutations, including at least one selective advantage.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It notes that genetic heterogeneity and natural selection favor traits like high motility and drug resistance, conferring selective advantages shaping tumor patterns."
      }
    ],
    "question_number": 280,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:45:01.593515",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response emphasizes the importance of quality of life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Strong emphasis on comfort, presence, small authentic moments, and aligning activities with the patient's energy and mood (quality over quantity)."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, counselor, or Palliative Care professional.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No explicit recommendation to speak with a social worker, counselor, or palliative care professional about memory-making or care planning. A generic mention of seeing a therapist for self-care is present but does not fulfill the criterion."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Does not suggest engaging the oncology team or other clinicians to support symptom control or planning for meaningful activities."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends cancer support groups as a resource.",
        "score_given": 0,
        "max_points": 7,
        "justification": "Mentions support groups generically for caregiver self-care but does not specify cancer support groups."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of organizations that support cancer patients and their families and provides contact information or a website.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No organizations or contact information/websites are provided."
      },
      {
        "criterion_number": 6,
        "description": "The response emphasizes the importance of establishing a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages involving friends and family, sharing visiting responsibilities, and accepting help to support both patient and caregiver."
      },
      {
        "criterion_number": 7,
        "description": "The response should encourage patients to open lines of communication with their affected family member, such as daily phone calls to check in.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Promotes open emotional communication through letters, gratitude sharing, asking for advice, and expressing love, which fosters ongoing connection."
      },
      {
        "criterion_number": 8,
        "description": "The response should encourage loved ones of a pancreatic cancer patient to consider legacy-building activities, such as photobook creation or writing letters to loved ones.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides multiple legacy-building ideas: recording stories, photo narration, favorite lists/playlists, and writing letters; also preserves recipes."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend keeping family members and loved ones involved in the patient\u2019s life, being mindful of the patient\u2019s energy level.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages involvement of friends and family (e.g., gratitude visits) while emphasizing following the patient's energy and keeping visits/outings short and manageable."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest that the patient and/or family members prioritize symptom management related to cancer or treatment, in order to ensure the patient is feeling their physical best if possible.",
        "score_given": 0,
        "max_points": 10,
        "justification": "No recommendation to optimize symptom management (e.g., pain, nausea) or coordinate with clinicians to improve comfort before activities."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend ways to document events and/or moments for future reference.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests voice memos, taking notes on photos, creating playlists, and preserving recipes\u2014clear documentation strategies."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend the use of technology, such as video calls (e.g., Zoom) to keep in contact with loved ones without having to travel.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of video calls or technology for remote connection; only voice memos and playlists for recording/comfort."
      },
      {
        "criterion_number": 13,
        "description": "The response should emphasize the importance of preventing caregiver burnout.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly advises caregiver self-care, resting, sharing responsibilities, and seeking support from friends, therapists, or support groups."
      }
    ],
    "question_number": 281,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:45:46.687156",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response emphasizes the importance of quality of life.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Multiple statements prioritize comfort, presence, simplicity, and 'quality over grandeur,' clearly centering quality of life."
      },
      {
        "criterion_number": 2,
        "description": "The response recommends discussing this with a social worker, counselor, or Palliative Care professional.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Explicitly advises consulting the 'palliative care team' regarding activities, energy, and pain management."
      },
      {
        "criterion_number": 3,
        "description": "The response recommends discussing this with the patient\u2019s healthcare team.",
        "score_given": 7,
        "max_points": 7,
        "justification": "Advises to 'consult his medical team' and 'check with his doctors' before planning activities."
      },
      {
        "criterion_number": 4,
        "description": "The response recommends cancer support groups as a resource.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No mention of support groups."
      },
      {
        "criterion_number": 5,
        "description": "The response offers examples of organizations that support cancer patients and their families and provides contact information or a website.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No organizations or contact details/websites provided."
      },
      {
        "criterion_number": 6,
        "description": "The response emphasizes the importance of establishing a strong support system.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Encourages delegation, involving family and friends, and leaning on a support system."
      },
      {
        "criterion_number": 7,
        "description": "The response should encourage patients to open lines of communication with their affected family member, such as daily phone calls to check in.",
        "score_given": 0,
        "max_points": 5,
        "justification": "While presence and letters are encouraged, there is no explicit suggestion of ongoing check-ins or daily phone calls."
      },
      {
        "criterion_number": 8,
        "description": "The response should encourage loved ones of a pancreatic cancer patient to consider legacy-building activities, such as photobook creation or writing letters to loved ones.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Provides extensive legacy-building ideas: recording stories, photo albums with commentary, video messages, letters, recipe book, scrapbook, family tree."
      },
      {
        "criterion_number": 9,
        "description": "The response should recommend keeping family members and loved ones involved in the patient\u2019s life, being mindful of the patient\u2019s energy level.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Advises involving other family/friends and repeatedly stresses following his lead and tailoring activities to energy levels."
      },
      {
        "criterion_number": 10,
        "description": "The response should suggest that the patient and/or family members prioritize symptom management related to cancer or treatment, in order to ensure the patient is feeling their physical best if possible.",
        "score_given": 10,
        "max_points": 10,
        "justification": "Recommends checking with doctors/palliative care about energy levels and pain management before activities, emphasizing feasibility and comfort."
      },
      {
        "criterion_number": 11,
        "description": "The response should recommend ways to document events and/or moments for future reference.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Suggests recording voice, video messages, photo albums with commentary, scrapbooks, and taking many photos and videos."
      },
      {
        "criterion_number": 12,
        "description": "The response should recommend the use of technology, such as video calls (e.g., Zoom) to keep in contact with loved ones without having to travel.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No recommendation for video calls or similar technology to maintain contact remotely."
      },
      {
        "criterion_number": 13,
        "description": "The response should emphasize the importance of preventing caregiver burnout.",
        "score_given": 5,
        "max_points": 5,
        "justification": "Explicitly encourages self-care, taking breaks, leaning on support systems, and acknowledging emotional strain."
      }
    ],
    "question_number": 281,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:46:25.014939",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response reviews intercellular communication in pancreatic cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The answer discusses intercellular communication mechanisms in cancer cells generally (chemotaxis, mechanical coupling, leader\u2013follower dynamics) and mentions the desmoplastic stroma in pancreatic cancer, but it does not specifically review intercellular communication in pancreatic cancer cells (e.g., PDAC-specific pathways or interactions)."
      },
      {
        "criterion_number": 2,
        "description": "The response states that tumors are not typically functioning tissues.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not state that tumors are not typically functioning tissues; it even analogizes tumors to a single multicellular organism, which implies coordinated function."
      },
      {
        "criterion_number": 3,
        "description": "The response reviews the biology of intercellular communication.",
        "score_given": 7,
        "max_points": 7,
        "justification": "The response clearly reviews biological mechanisms of intercellular communication, including leader\u2013follower dynamics, chemotaxis and signal relays, mechanical forces from proliferation and crowding, and ECM remodeling."
      },
      {
        "criterion_number": 4,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No citations or PMIDs are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response defines cancer cell waves and explicitly states that there are several different types of waves known to exist in cancer cell biology.",
        "score_given": 0,
        "max_points": 10,
        "justification": "While it defines cancer cell waves as collective migration phenomena, it does not explicitly state that multiple types of waves exist in cancer cell biology."
      },
      {
        "criterion_number": 6,
        "description": "The response describes calcium waves and provides a PMID of referenced scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Calcium waves are not discussed and no PMID is provided."
      },
      {
        "criterion_number": 7,
        "description": "The response describes bioelectric waves and provides a PMID of referenced scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Bioelectric waves are not discussed and no PMID is provided."
      },
      {
        "criterion_number": 8,
        "description": "The response describes metabolic (glycolytic) waves and provides a PMID of referenced scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Metabolic or glycolytic waves are not discussed and no PMID is provided."
      },
      {
        "criterion_number": 9,
        "description": "The response explains at least three different mechanisms of cell-to-cell communication, such as cell-cell adhesion, signaling pathways, chemokine gradients, mechanical forces, or heterotypic interactions.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It explains multiple mechanisms: cell\u2013cell physical coupling/adhesion via leader\u2013follower pulling, mechanical forces from proliferation/jamming, chemotaxis and relay signaling, and ECM remodeling. This satisfies the requirement for at least three mechanisms."
      },
      {
        "criterion_number": 10,
        "description": "The response defines and describes paracrine signaling explicitly.",
        "score_given": 0,
        "max_points": 3,
        "justification": "Although chemotaxis and secreted signals are mentioned, paracrine signaling is not explicitly defined or labeled as such."
      }
    ],
    "question_number": 282,
    "source": "gemini-2.5-pro",
    "graded_at": "2025-11-03T22:47:00.481716",
    "grader_model": "gpt-5"
  },
  {
    "criterion_scores": [
      {
        "criterion_number": 1,
        "description": "The response reviews intercellular communication in pancreatic cancer cells.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The discussion is generic to cancer biology and does not address intercellular communication specifically in pancreatic cancer (e.g., PDAC-specific pathways or cell types)."
      },
      {
        "criterion_number": 2,
        "description": "The response states that tumors are not typically functioning tissues.",
        "score_given": 0,
        "max_points": 5,
        "justification": "The response does not state that tumors are not functioning tissues; it emphasizes coordinated, collective behaviors without contrasting tumors with normal functional tissues."
      },
      {
        "criterion_number": 3,
        "description": "The response reviews the biology of intercellular communication.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It reviews multiple modes of intercellular communication: paracrine and autocrine signaling, gap junctions, exosomes, ECM interactions, cell-cell adhesion, and mechanical forces, providing a coherent biological overview."
      },
      {
        "criterion_number": 4,
        "description": "The response provides published scientific journal articles as evidence for its statements and cites its sources.",
        "score_given": 0,
        "max_points": 7,
        "justification": "No scientific citations or PMIDs are provided."
      },
      {
        "criterion_number": 5,
        "description": "The response defines cancer cell waves and explicitly states that there are several different types of waves known to exist in cancer cell biology.",
        "score_given": 10,
        "max_points": 10,
        "justification": "It defines cancer cell waves as patterns of organized movement or biochemical signaling and enumerates several types (chemical/biochemical, mechanical/physical, metabolic), satisfying the requirement for multiple wave types."
      },
      {
        "criterion_number": 6,
        "description": "The response describes calcium waves and provides a PMID of referenced scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Calcium signaling via gap junctions is mentioned, but calcium waves are not specifically described and no PMID is provided."
      },
      {
        "criterion_number": 7,
        "description": "The response describes bioelectric waves and provides a PMID of referenced scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Bioelectric waves are not explicitly described and no supporting PMID is provided."
      },
      {
        "criterion_number": 8,
        "description": "The response describes metabolic (glycolytic) waves and provides a PMID of referenced scientific literature.",
        "score_given": 0,
        "max_points": 5,
        "justification": "Metabolic waves are briefly mentioned (e.g., glycolysis, pH), but no PMID is provided."
      },
      {
        "criterion_number": 9,
        "description": "The response explains at least three different mechanisms of cell-to-cell communication, such as cell-cell adhesion, signaling pathways, chemokine gradients, mechanical forces, or heterotypic interactions.",
        "score_given": 7,
        "max_points": 7,
        "justification": "It covers multiple mechanisms including paracrine signaling/chemokine gradients, autocrine signaling, gap junctions, exosomes, cell-cell adhesion, ECM interactions, mechanical forces, and heterotypic interactions with stromal and immune cells."
      },
      {
        "criterion_number": 10,
        "description": "The response defines and describes paracrine signaling explicitly.",
        "score_given": 3,
        "max_points": 3,
        "justification": "Paracrine signaling is explicitly defined with examples (chemotaxis, chemokines) and described as diffusion of factors to neighboring cells."
      }
    ],
    "question_number": 282,
    "source": "gemini-2.5-flash",
    "graded_at": "2025-11-03T22:47:34.199622",
    "grader_model": "gpt-5"
  }
]